gene,snp,snippet
AANAT,Rs3760138,autism
AANAT,Rs3760138,autism
ABCA1,Rs2230808,Alzheimer's disease
ABCA1,Rs2230808,polymorphisms and Alzheimer's disease.
ABCA1,Rs2230808,Alzheimer's disease
ABCA1,Rs2230808,schizophrenia and related brain changes.
ABCA1,Rs2230808,polymorphism
ABCA1,Rs2230808,dementia
ABCA1,Rs2230808,polymorphisms.
ABCA1,Rs2230808,Alzheimer's disease
ABCA1,Rs2230808,polymorphisms
ABCA1,Rs2230808, Alzheimer's disease
ABCA1,Rs2230808,cholesterol levels
ABCA1,Rs2230808,Alzheimer's disease
ABCA1,Rs2230808,brain changes
ABCA1,Rs2230808,schizophrenia
ABCA1,Rs2230808,dementia
ABCA1,Rs2230808,HDL cholesterol levels
ABCA1,Rs2230808,ischaemic stroke
ABCA1,Rs2230808,cerebrospinal fluid
ABCA1,Rs2230808,Alzheimer's disease
ABCA1,Rs2230808,Alzheimer's disease
ABCA1,Rs2230808,cholesterol
ABCA1,Rs2230808,Alzheimer's disease
ABCA1,Rs4149268,good cholesterol
ABCA1,Rs4149268,increase in HDL cholesterol
ABCA1,Rs4149268,0.82mg/dl increase in HDL cholesterol
ABCA1,Rs2297404,rs2020927
ABCA1,Rs2297404,rs2230808
ABCA1,Rs2297404,"rs2297404,"
ABCA1,Rs2297404,ver-represented in the healthy controls
ABCA1,Rs2297404,haplotype1
ABCA1,Rs2230808,ABCA1 polymorphisms
ABCA1,Rs2297404,Alzheimer's disease group
ABCA1,Rs2297404,rs2020927 
ABCA1,Rs2297404,rs2230808
ABCA1,Rs2297404,rs2297404
ABCA1,Rs2297404,Alzheimer's disease
ABCA1,Rs2230808,schizophrenia
ABCA1,Rs2230808,Alzheimer's disease
ABCA1,Rs2230808,schizophrenia
ABCA1,Rs2230808,polymorphisms
ABCA1,Rs2297404,TGG
ABCA1,Rs2230808,CSF cholesterol levels
ABCA1,Rs2297404,haplotype1 
ABCA1,Rs2230808,brain changes
ABCA1,Rs2020927,"rs2297404, rs2230808, and rs2020927 haplotype (CAC) was more prevalent in the Alzheimer's disease group"
ABCA1,Rs2020927,rosiglitazone
ABCA1,Rs2020927,patients with Type 2 diabetes
ABCA1,Rs2020927,atherogenic dyslipidaemia
ABCA1,Rs2020927,Type 2 diabetes treated with rosiglitazone.
ABCA1,Rs2020927,atherogenic dyslipidaemia
ABCA1,Rs2020927,Alzheimer's disease group
ABCA1,Rs2020927,healthy controls
ABCA1,Rs2020927,while haplotype1 (TGG) was over-represented in the healthy controls
ABCA1,Rs2020927,haplotype1 
ABCA1,Rs2020927,Type 2 diabetes
ABCA1,Rs2020927,atherogenic dyslipidaemia
ABCA1,Rs2020927,Alzheimer's disease
ABCA1,Rs1883025,Mexican dyslipidemic
ABCA1,Rs1883025,risk for carotid artery disease
ABCA1,Rs1800977,therothrombotic cerebral infarction
ABCA1,Rs1800977,polymorphism
ABCA1,Rs2230808,Alzheimer's disease
ABCA1,Rs2020927,haplotype 
ABCA1,Rs2020927,atherogenic dyslipidaemia
ABCA1,Rs2020927,Alzheimer's disease
ABCA1,Rs2066714,preterm delivery
ABCA1,Rs2230808,schizophrenia 
ABCA1,Rs2230808,dementia
ABCA1,Rs2230808,ischaemic stroke
ABCA1,Rs2230808,Alzheimer's disease
ABCA1,Rs2020927,Type 2 diabetes
ABCA1,Rs2230808,Alzheimer's disease
ABCA1,Rs2230808,Alzheimer's disease
ABCA1,Rs2230806,hyperlipidemic 
ABCA1,Rs2230806,postprandial lipoproteins
ABCA1,Rs2230806,dementia
ABCA1,Rs2230808,ABCA1 polymorphisms
ABCA1,Rs2230806,Alzheimer's disease
ABCA1,Rs2230806,Alzheimer's disease
ABCA1,Rs2230806,Alzheimer's disease
ABCA1,Rs2066714,chronic kidney disease
ABCA1,Rs2230806,coronary artery disease 
ABCA1,Rs2230806,HDL-C
ABCA1,Rs2230806,coronary artery disease
ABCA1,Rs2066714,Japanese individuals
ABCA1,Rs2230806,ischaemic stroke
ABCA12,Rs28940568,"congenital Lamellar ichthyosis, type 2, also called ichthyosis-4A, a significant skin condition."
ABCA12,Rs28940270,"congenital Lamellar ichthyosis, type 2, also called ichthyosis-4A, a significant skin condition."
ABCA12,Rs28940271,congenital Lamellar ichthyosis
ABCA12,Rs28940271,skin condition
ABCA12,Rs28940271,Lamellar ichthyosis
ABCA12,Rs28940271,recessive SNP
ABCA12,Rs28940568,Lamellar ichthyosis
ABCA12,Rs28940271,"congenital Lamellar ichthyosis, type 2, also called ichthyosis-4A, a significant skin condition."
ABCA12,Rs28940568,congenital Lamellar ichthyosis
ABCA12,Rs28940568,skin condition
ABCA12,Rs28940568,recessive SNP
ABCA12,Rs28940568,skin condition
ABCA12,Rs28940270,skin condition
ABCA12,Rs28940271,skin condition
ABCA12,Rs28940270,recessive SNP
ABCA12,Rs28940270,congenital Lamellar ichthyosis
ABCA12,Rs28940270,skin condition
ABCA12,Rs28940270,Lamellar ichthyosis
ABCA12,Rs28940268,congenital Lamellar ichthyosis
ABCA12,Rs28940268,skin condition
ABCA12,Rs28940268,recessive SNP
ABCA12,Rs28940268,skin condition
ABCA12,Rs28940268,"congenital Lamellar ichthyosis, type 2, also called ichthyosis-4A, a significant skin condition."
ABCA12,Rs28940268,Lamellar ichthyosis
ABCA12,Rs28940269,skin condition
ABCA12,Rs28940269,Lamellar ichthyosis
ABCA12,Rs28940269,recessive SNP
ABCA12,Rs28940269,skin condition
ABCA12,Rs28940269,"congenital Lamellar ichthyosis, type 2, also called ichthyosis-4A, a significant skin condition."
ABCA12,Rs28940269,congenital Lamellar ichthyosis
ABCA7,Rs3764650,disease 
ABCA7,Rs78117248,rs78117248(G) allele
ABCA7,Rs78117248,Alzheimer's disease
ABCA7,Rs78117248,ABCA7 gene
ABCA7,Rs7408475,Alzheimer's disease polygenic hazard score
ABCA7,Rs72973581,Alzheimer's disease cases identified
ABCA7,Rs4147929,late onset Alzheimer's disease
ABCA7,Rs3764650,Alzheimer's disease
ABCA7,Rs3764650,Alzheimer's 
ABCA7,Rs200538373,is one of several loss-of-function ABCA7 mutations associated with Alzheimer's disease initially in Icelanders
ABCA7,Rs200538373,late-onset Alzheimer's disease
ABCA7,Rs200538373,Alzheimer's disease
ABCA7,Rs200538373,loss-of-function ABCA7 mutations
ABCA7,Rs200538373,late-onset Alzheimer's disease 
ABCA7,Rs200538373,Alzheimer's disease
ABCA7,Rs113809142,Carriers of one rare rs113809142(G) allele are at roughly more than twice the risk for developing late-onset Alzheimer's disease compared to people having the most common genotype (T;T); 
ABCA7,Rs113809142,"rs113809142, also known as c.4416+2T>G, is one of several loss-of-function ABCA7 mutations associated with Alzheimer's disease"
ABCA7,Rs200538373,developing late-onset Alzheimer's disease compared to people having the most common genotype
ABCB1,Rs2032582,Crohn's disease.
ABCB1,Rs2032582,Crohn's disease.
ABCB1,Rs2032582,heavy smokers
ABCB1,Rs2032582,Crohn's disease
ABCB1,Rs2032582,association with Crohn's disease.
ABCB1,Rs2032582,squamous cell carcinoma
ABCB1,Rs2032582,Crohn's disease
ABCB1,Rs2032582,type of lung cancer called squamous cell carcinoma
ABCB1,Rs2032582,"homozygotes,"
ABCB1,Rs2235035,colorectal cancers
ABCB1,Rs2235035,Crohn disease
ABCB1,Rs2235035,ulcerative colitis
ABCB1,Rs2235035,refractory Crohn disease
ABCB1,Rs2235035,ulcerative colitis
ABCB1,Rs3842,lung cancer
ABCB1,Rs3842,women
ABCB1,Rs3842,cancer
ABCB1,Rs2032582,squamous cell carcinoma
ABCB1,Rs2235035,colorectal cancers
ABCB1,Rs2032582,lung cancer
ABCB1,Rs1128503,major depression
ABCB1,Rs1128503,functional polymorphism (C3435T) of the gene encoding P-glycoprotein
ABCB1,Rs1128503,opiate dependence
ABCB1,Rs1128503,requiring the 'higher' methadone dose
ABCB1,Rs1128503,dementia
ABCB1,Rs1128503,age-matched non-demented control patients
ABCB1,Rs1128503,childhood acute lymphoblastic leukemia
ABCB1,Rs1128503,major depressive disorder
ABCB1,Rs1128503,addictive diseases
ABCB1,Rs1128503,drug-refractory epilepsy
ABCB1,Rs1128503,liver transplant
ABCB1,Rs1128503,ABCB1 polymorphisms
ABCB1,Rs1128503,antidepressant response
ABCB1,Rs1128503,ciclosporin exposure
ABCB1,Rs1128503,Pazopanib-induced hyperbilirubinemia
ABCB1,Rs1128503,Gilbert's syndrome
ABCB1,Rs1128503,nephrotic syndrome
ABCB1,Rs1128503,cancer
ABCB1,Rs1128503,allogeneic hematopoietic stem cell transplantation
ABCB1,Rs1128503,myeloid leukemia
ABCB1,Rs1128503,major depressive disorder
ABCB4,Rs45575636,cholestasis of pregnancy
ABCB4,Rs58238559,atrial fibrillation/flutter
ABCC2,Rs717620,nonalcoholic fatty liver disease
ABCC2,Rs3740065,invasive breast cancer
ABCC2,Rs717620,intrahepatic cholestasis
ABCC2,Rs2273697,neurological adverse drug reactions
ABCC2,Rs2273697,epilepsy
ABCC2,Rs2273697,reduced carbamazepine transport across the cell membrane.
ABCC4,Rs11568658,myocardial infarction
ABCC4,Rs9561778,ADR
ABCC4,Rs9561778,ed that
ABCC4,Rs9561778,breast cancer 
ABCC4,Rs9561778,adverse drug reactions (ADRs)
ABCC4,Rs9561778,gastrointestinal toxicity
ABCC4,Rs9561778,leukopenia/neutropenia
ABCC6,Rs63749823,pseudoxanthoma elasticum
ABCC6,Rs63749823,ABCC6 mutations
ABCC6,Rs63749796,pseudoxanthoma elasticum
ABCC6,Rs63749823,pseudoxanthoma elasticum
ABCC6,Rs63749796,Novel
ABCC6,Rs212077,genes for familial combined hyperlipidemia.
ABCC6,Rs63749796,mutations
ABCC8,Rs151344623,risk
ABCC8,Rs151344624,focal CHI
ABCC8,Rs151344624,"is reported to be 1 in 52, giving an estimated frequency"
ABCC8,Rs151344624,This variant is considered a founder mutation
ABCC8,Rs151344624,somatic loss
ABCC8,Rs151344624,pregnancy 
ABCC8,Rs151344624,mutation 
ABCC8,Rs151344623,focal form of the disease
ABCC8,Rs151344623,somatic loss
ABCC8,Rs151344623,pregnancy
ABCC8,Rs151344623,offspring
ABCC8,Rs151344623,focal
ABCC8,Rs1048095,permanent neonatal diabetes mellitus (PNDM)
ABCC8,Rs151344623,estimated frequency
ABCC8,Rs151344623,"1 in 10,816 in this population"
ABCC8,I5012556,Familial Hyperinsulinism
ABCC8,I5012558,Familial Hyperinsulinism
ABCC8,Rs1048095,permanent neonatal diabetes mellitus
ABCC8,Rs151344623, homozygosity
ABCC8,I5008233,Familial Hyperinsulinism
ABCC8,Rs151344623,pregnancy
ABCC8,Rs151344623,somatic loss of heterozygosity
ABCC8,Rs151344623,variant
ABCC8,Rs151344623,mutation
ABCC8,Rs151344623,compound heterozygosity
ABCC9,Rs4148649,postural changes in 
ABCC9,Rs4148649,associated with postural changes in blood pressure.
ABCC9,Rs4148649,postural changes in blood pressure
ABCC9,Rs4148649,postural changes in blood pressure
ABCC9,Rs4148649,postural changes in blood pressure
ABCC9,Rs4148649,blood pressure
ABCC9,Rs4148649,blood pressure
ABCC9,Rs4148649,Genes controlling postural changes
ABCC9,Rs4148649,ATP-sensitive potassium channel genes
ABCC9,Rs4148649,haplotype
ABCC9,Rs4762865,blood pressure
ABCC9,Rs4762865,blood pressure
ABCC9,Rs4762865,postural changes in 
ABCC9,Rs4762865,postural changes in blood pressure
ABCC9,Rs4762865,postural changes in blood pressure
ABCC9,Rs4762865,postural changes in blood pressure
ABCC9,Rs4762865,blood pressure
ABCC9,Rs4762865,Genes controlling postural changes
ABCC9,Rs4762865,ATP-sensitive potassium channel genes
ABCC9,Rs4762865,associated with postural changes in blood pressure.
ABCC9,Rs4762865,haplotype
ABCC9,Rs4148649,postural changes in blood pressure
ABCC9,Rs4762865,postural changes in blood pressure
ABCC9,Rs4148649,blood pressure
ABCC9,Rs11046232,postural changes in blood pressure
ABCC9,Rs2955503,postural changes
ABCC9,Rs2955503,blood pressure
ABCC9,Rs11046232,blood pressure
ABCC9,Rs11046232,postural changes in 
ABCC9,Rs11046232,postural changes in blood pressure
ABCC9,Rs11046232,postural changes in blood pressure
ABCC9,Rs11046232,blood pressure
ABCC9,Rs11046232,blood pressure
ABCC9,Rs11046232,Genes controlling postural changes
ABCC9,Rs11046232,ATP-sensitive potassium channel genes
ABCC9,Rs11046232,haplotype
ABCC9,Rs11046232,postural changes in blood pressure
ABCC9,Rs2900492,postural changes in blood pressure
ABCC9,Rs2900492,postural changes in blood pressure
ABCC9,Rs2900492,postural changes in blood pressure.
ABCC9,Rs2955503,haplotype
ABCC9,Rs2955503,postural changes
ABCC9,Rs2955503,blood pressure
ABCC9,Rs2955503,ATP-sensitive potassium channel genes
ABCC9,Rs2955503,postural changes
ABCC9,Rs2955503,blood pressure
ABCC9,Rs2955503,haplotype
ABCC9,Rs11046232,associated with postural changes in blood pressure.
ABCD1,Rs398123109,adrenoleukodystrophy (ALD)
ABCD1,Rs398123109,pathogenic for adrenoleukodystrophy (ALD)
ABCD1,Rs398123109,pathogenic for adrenoleukodystrophy (ALD)
ABCD1,Rs398123109,adrenoleukodystrophy
ABCD1,Rs1131691743,adrenoleukodystrophy
ABCD1,Rs398123104,pathogenic for adrenoleukodystrophy (ALD)
ABCD1,Rs398123104,pathogenic for adrenoleukodystrophy
ABCD1,Rs1057518721,"deafness, dystonia, and cerebral hypomyelination"
ABCD1,Rs398123109,adrenoleukodystrophy
ABCG2,Rs2231142,diarrhea 
ABCG2,Rs2231142,"rs2231142, also known as Q141K and C421A, is a SNP in the ABCG2 gene, indicating a missense variant. ""Our data indicate that at least 10% of all gout cases in whites are attributable to this causal variant.""A is the risk allele. A large study totaling 7,699 participants in the Framingham cohort and 4,148 participants in the Rotterdam cohort was conducted, with genome-wide significant SNPs then replicated in 11,000+ Caucasian and ~4,000 African-American individuals who took part in the study of Atherosclerosi"
ABCG2,Rs2231142,Atherosclerosis
ABCG2,Rs2231142,lung cancer
ABCG2,Rs3114018,gout
ABCG2,Rs2231142,"4,000 African-American individuals who took part in the study of Atherosclerosis Risk in Communities"
ABCG2,Rs3114018,gout
ABCG2,Rs3114018,gout
ABCG2,Rs3114018,gout
ABCG2,Rs3114018, Han Chinese 
ABCG2,Rs3114018,gout
ABCG2,Rs3114018,haplotype blocks
ABCG2,Rs2231142,Atherosclerosis Risk
ABCG2,Rs2231142,heterozygotes
ABCG2,Rs2231137,ischemic stroke
ABCG2,Rs2231137,black
ABCG2,Rs2231137,white
ABCG2,Rs2231137,stroke
ABCG2,Rs2231137,allele homozygotes
ABCG2,Rs2231137,ischemic stroke
ABCG2,Rs2231137,stroke
ABCG2,Rs2231137,ischemic stroke
ABCG2,Rs1481012,colorectal cancer
ABCG2,Rs1481012,polymorphisms
ABCG2,Rs1481012,gene-wide
ABCG2,Rs1481012,colorectal cancer
ABCG8,Rs6756629,gallstone disease
ABCG8,Rs6756629,decreased triglyceride levels
ABCG8,Rs6756629,decreased LDL levels
ABCG8,Rs41360247,increases susceptibility to Gallstone disease
ABCG8,Rs6756629,increased HDL cholesterol levels
ABCG8,Rs11887534,Up to 10% of the population attributable risk for gallstones may be accounted for by this SNP.
ABCG8,Rs11887534,"rs11887534, a SNP in the hepatic cholesterol transporter ABCG8 gene, has been implicated in gallstone disease, a process known formally as cholelithiasis."
ABCG8,Rs11887534,"p=1.4x10-14), "
ABCG8,Rs41360247,Gallstone disease
ABO,Rs8176719,blood group type O
ABO,Rs8176719,blood group type A or type B
ABO,Rs8176719,blood group type O status
ABO,Rs8176694,genosets
ABO,Rs8176694,ABO blood group
ABO,Rs7853989,ABO Blood Type
ABO,Rs657152,men and women
ABO,Rs657152,ABO blood group
ABO,Rs657152,women
ABO,Rs657152,ABO histo-blood
ABO,Rs657152,pancreatic cancer
ABO,Rs657152,pancreatic cancer
ABO,Rs574347,SNP
ABO,Rs8176719,blood group type O
ABO,Rs657152,thyroid
ABO,Rs8176719,blood type A
ABO,Rs8176749, SNP
ABO,Rs8176719,"blood type A, B, or AB"
ABO,Rs8176750, A2 type allele
ABO,Rs8176750,A1 type
ABO,Rs8176750,use of genosets.
ABO,Rs8176750,"ABO gene,"
ABO,Rs8176749,determing ABO blood group
ABO,Rs8176749,ABO gene
ABO,Rs574347,genosets
ABO,Rs8176747,ABO Blood Type
ABO,Rs8176746,A/C
ABO,Rs8176746,G/T
ABO,Rs8176743,ABO Blood Type
ABO,Rs8176741,blood group type
ABO,Rs8176740,Influences ABO blood group
ABO,Rs8176719,"blood group types A, B, and AB"
ABO,Rs8176719,type O
ABO,Rs8176719,blood type B
ABO,Rs574347,ABO blood group
ABO,Rs8176694,SNP
ABO,Rs512770,SNP
ABO,Rs2073828,genosets
ABO,Rs2073824,determing ABO blood group
ABO,Rs2073824,ABO gene
ABO,Rs2073824, SNP
ABO,Rs1053878,ABO Blood Type
ABO,Rs1053878,phenotype
ABO,Rs1053878,ABO blood group
ABO,Rs1053878,cis-AB phenotype
ABO,Rs1053878,blood group
ABO,Rs1053878,ABO Blood Type
ABO,Rs1053878,ABO blood group
ABO,Rs1008708453,is reported to be completely correlated to a subtype of O type alleles known as the O2 group
ABO,I4000505,Influences ABO blood group
ABO,I4000504,Influences ABO blood group
ABO,Rs56392308,A2 ABO blood
ABO,Rs2073828,SNP
ABO,Rs41302905,may influence ABO blood group see gs129ABO Blood Type
ABO,Rs2073828,ABO blood group
ABO,Rs41302905,Blood Type
ABO,Rs512770,genosets
ABO,Rs512770,ABO blood group
ABO,Rs507666,regulatory role of histo-blood group antigens in inflammatory adhesion processes.
ABO,Rs507666,sICAM-1 concentrations
ABO,Rs41302905,ABO blood group
ABO,Rs507666,histo
ABO,Rs507666,blood 
ABO,Rs507666,histo-blood
ABO,Rs507666,ABO blood group
ABO,Rs505922,pancreatic cancer
ABO,Rs500498,SNP
ABO,Rs500498,genosets
ABO,Rs500498,ABO blood group
ABO,Rs41302905,may influence ABO blood group
ABO,Rs505922,pancreatic cancer
ABP1,Rs2268999,homozygous minor allele
ABP1,Rs2052129,selective hypersensitivity to ibuprofen
ABP1,Rs2268999,mRNA expression
ABP1,Rs2268999,minor allele
ABP1,Rs2268999,diamine oxidase serum
ABP1,Rs2268999,diamine oxidase gene
ABP1,Rs2268999,single nucleotide polymorphisms
ABP1,Rs2268999,single nucleotide polymorphisms in the diamine oxidase gene with diamine oxidase serum activities
ABP1,Rs2052129,selective NSAID hypersensitivity 
ABP1,Rs2052129,hypersensitivity to ibuprofen
ABP1,Rs2052129,HIT
ABP1,Rs2052129,"histamine intolerance (HIT), "
ABP1,Rs2052129,Caucasian
ABP1,Rs1049742, nucleotide polymorphisms
ABP1,Rs1049742,reduced DAO activity
ABP1,Rs1049742,single nucleotide polymorphisms
ABP1,Rs10156191,hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs)
ABP1,Rs2052129,NSAID hypersensitivity 
ACADM,Rs200724875,Arg206His
ACADM,Rs121434280,temperature-sensitive mutation
ACADM,I5003117,Dehydrogenase Deficiency
ACADM,I5003117,Medium-Chain
ACADM,I5003116,Dehydrogenase Deficiency
ACADVL,Rs113994167,mutations associated with VLCAD deficiency
ACADVL,Rs140629318,pathogenic very long chain acyl-CoA dehydrogenase deficiency mutations
ACAT1,Rs3741049,fatty 
ACAT1,Rs3741049,acid 
ACAT1,Rs3741049,metabolites
ACAT1,Rs779565865,pathogenic variant
ACAT1,Rs3741049,clostridia
ACAT1,Rs3741049,Methylation
ACAT1,Rs3741049,clostridia
ACAT1,Rs3741049,metabolism
ACAT1,Rs3741049,elevated fatty acid metabolites
ACAT1,Rs3741049,Methylation
ACAT1,Rs3741049,3-ketothiolase deficiency
ACAT1,Rs3741049,ketone body metabolism
ACAT1,Rs3741049,ketothiolase 
ACE,Rs4311,diabetic nephropathy.
ACE,Rs4359,anti-hypertensive drug ramipril
ACE,Rs4359,SNP 
ACE,Rs4353,"An association analysis of Alzheimer disease candidate genes detects an ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2M, and LRRTM3."
ACE,Rs4353,Confronting complexity in late-onset Alzheimer disease: application of two-stage analysis approach addressing heterogeneity and epistasis.
ACE,Rs4343,diabetic nephropathy
ACE,Rs4311,increased risk of diabetic nephropathy
ACE,Rs4311,risk of diabetic nephropathy 4x
ACE,Rs4311,risk allele T 
ACE,Rs4353,late-onset Alzheimer disease
ACE,Rs4311,diabetic nephropathy.
ACE,Rs4311,diabetic nephropath
ACE,Rs4293,Alzheimer's disease
ACE,Rs4293,SNP 
ACE,Rs4293,Alzheimer's disease
ACE,Rs4311,diabetic nephropathy 4x.
ACE,Rs4293,Alzheimer's disease.
ACE,Rs12449782,diabetic nephropathy
ACE,Rs12449782,G allele is associated with a slightly increased risk
ACE,Rs12449782,diabetic nephropathy
ACKR1,Rs2814778,Namibian San
ACKR1,Rs2814778,African populations
ACKR1,Rs2814778,European populations and southwestern Native American populations
ACKR1,Rs2814778,Plasmodium vivax malaria
ACKR1,Rs2814778,white blood cell and neutrophil count
ACKR1,Rs2814778,Malaria Resistance (Duffy Antigen)
ACKR1,Rs2814778,rs2814778 (G) allele
ACKR1,Rs2814778, Duffy blood group antigen
ACKR1,Rs2814778,SNP
ACKR1,Rs2814778,CEPH-HGDP
ACKR1,Rs2814778,non-Ashkenazi Jewish populations
ACKR1,Rs2814778,SNP
ACKR1,Rs2814778,rs2814778 (A)
ACKR1,Rs2814778,rs2814778
ACKR1,Rs2814778,Czech gypsies
ACKR1,Rs2814778,DARC gene
ACKR1,Rs2814778,Europeans 
ACKR1,Rs12075,blood group antigen system
ACKR1,Rs12075,p.Gly42Asp
ACKR1,Rs12075,Duffy blood group antigen system
ACKR1,Rs12075,"For some frequencies of the resulting phenotypes for this variant, see the ACKR1 page."
ACKR1,Rs12075,Duffy blood group antigen system
ACKR1,Rs2814778,those with African ancestry. 
ACKR1,Rs2814778,malaria
ACKR1,Rs2814778,Duffy blood group antigen
ACKR1,Rs2814778,Plasmodium vivax malaria 
ACKR1,Rs2814778,Malaria
ACKR1,Rs2814778,Plasmodium vivax malaria
ACKR1,Rs2814778,Malaria Resistance
ACKR1,Rs2814778,Duffy blood group antigen
ACKR1,Rs2814778,Malaria
ACTA2,Rs1926203,lung cancer risk
ACTA2,Rs1926203,Genome-wide significant association
ACTA2,Rs1926203, lung cancer risk
ACTA2,Rs1926203,lung cancer
ACTA2,Rs121434528,ministrokes
ACTA2,Rs121434528,transient ischemic attacks
ACTA2,Rs121434528,arteries at the base of the brain are blocked
ACTA2,Rs121434528,"Moyamoya,"
ACTA2,Rs121434528,moyamoya-like cerebrovascular disease
ACTA2,Rs121434528,familial thoracic aortic aneurysm and dissection (TAAD)
ACTA2,Rs121434528,Strokes
ACTC1,Rs193922680,rare minor allele
ACTC1,Rs193922680,left ventricular noncompaction
ACTC1,Rs193922680,autosomal dominant
ACTC1,Rs193922680,hypertrophic cardiomyopathy (HCM)
ACTC1,Rs193922680,pathogenic/likely pathogenic
ACTC1,Rs193922680,eft ventricular noncompaction
ACTC1,Rs193922680,amilial hypertrophic cardiomyopathy
ACTG1,Rs28999111,deafness
ACTG1,Rs28999111,deafness
ACTG1,Rs28999112,deafness
ACTG1,Rs28999112,deafness
ACTN1,Rs117672662,allele is around 7% in many South American populations
ACTN1,Rs117672662,under 1%
ACTN3,Rs1815739,endurance ability
ACTN3,Rs1815739,life course physical capability
ACTN3,Rs1815739,leg muscle power
ACTN3,Rs1815739,SNPs 
ACTN3,Rs1815739,muscle performance
ACTN3,Rs1815739,athletic status
ACTN3,Rs1815739,polymorphism
ACTN3,Rs1815739, power/sprint performance
ACTN3,Rs1815739,endurance ability
ACTN3,Rs1815739,explosive leg muscle power
ACTN3,Rs1815739,performance phenotypes i
ACTN4,Rs121908415,Focal segmental glomerulosclerosis
ACTN4,Rs121908416,Focal segmental glomerulosclerosis
ACTN4,Rs121908417,Focal segmental glomerulosclerosis
ACTN4,Rs121908417,Focal segmental glomerulosclerosis
ADA,Rs121908739,adenosine deaminase deficiency
ADA,Rs121908739,adenosine deaminase deficiency.
ADA,Rs121908738,adenosine deaminase deficiency
ADA,Rs121908738,adenosine deaminase deficiency.
ADA,Rs121908735,SCID
ADA,Rs121908736,adenosine deaminase deficiency.
ADA,Rs121908735,ADA
ADA,Rs121908736,adenosine deaminase deficiency
ADAM10,I6006818,Alzheimer's disease assocation
ADAM10,Rs145518263,Alzheimer's diseas
ADAM10,Rs145518263,Alzheimer's disease
ADAM10,I6006818,Alzheimer's disease assocation
ADAM10,I6006818,Alzheimer's disease
ADAM10,Rs61751103,Alzheimer's disease
ADAM10,I6006817,Alzheimer's disease assocation
ADAM10,I6006817,Alzheimer's disease assocation
ADAM10,I6006817,Alzheimer's disease
ADAM10,I6006817,Alzheimer's disease
ADAM10,I6006818,Alzheimer's disease assocation
ADAM19,Rs1422795,Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function.
ADAM19,Rs1422795,susceptibility loci in lung cancer
ADAM19,Rs1422795,Individual and cumulative effects of GWAS susceptibility loci in lung cancer: associations after sub-phenotyping for COPD.
ADAM19,Rs1422795,COPD
ADAM19,Rs1422795,lung cancer
ADAM19,Rs1422795,associated with pulmonary function
ADAM33,Rs574174,type 1 diabetes
ADAM33,Rs574174,type 1 diabetes
ADAM33,Rs574174, bronchial hyperresponsiveness
ADAM33,Rs574174,asthma
ADAM33,Rs574174,COPD
ADAM33,Rs574174,psoriasis
ADAM33,Rs574174,immune-mediated diseases
ADAM33,Rs574174,asthma
ADAM33,Rs574174,immune-mediated diseases
ADAM33,Rs574174,asthma and bronchial hyperresponsiveness
ADAM33,Rs44707,asthma 
ADAM33,Rs512625,psoriasis
ADAM33,Rs44707,bronchial hyperresponsiveness.
ADAM33,Rs2787094,genetic susceptibility to childhood allergy and asthma in an African American urban population.
ADAM33,Rs3918396,chronic obstructive pulmonary disease (COPD)
ADAM33,Rs2853209,atopic dermatitis
ADAM33,Rs2853209,atopic dermatitis
ADAM33,Rs2787094,"smoking, and rhinoconjunctivitis in Japanese women: "
ADAM33,Rs2787094,psoriasis susceptibility gene in the Han population of northeastern China. 
ADAM33,Rs574174,polymorphisms
ADAM33,Rs512625,psoriasis
ADAM33,Rs574174,disintegrin
ADAM33,Rs628977,atopic dermatitis
ADAM33,Rs574174,asthma
ADAM33,Rs2787094,asthma in Indian children.
ADAM33,Rs628977,rhinoconjunctivitis
ADAM33,Rs628977,smoking
ADAM33,Rs628977,genetic polymorphisms
ADAM33,Rs628977,atopic dermatitis
ADAM33,Rs628977,polymorphisms
ADAM33,Rs628977,psoriasis susceptibility
ADAM33,Rs628977,psoriasis
ADAM33,Rs628977,early-onset psoriasis
ADAM33,Rs612709,"ADAM33 genetic polymorphisms, smoking, and rhinoconjunctivitis in Japanese women:"
ADAM33,Rs612709,Adam33 polymorphisms are associated with COPD and lung function in long-term tobacco smokers. 
ADAM33,Rs612709,Association of ADAM33 gene polymorphisms with adult allergic asthma and rhinitis in a Chinese Han population.
ADAM33,Rs612709,"ADAM33, a new candidate for psoriasis susceptibility"
ADAM33,Rs612709,type 1 diabetes that have been associated with other immune-mediated diseases.
ADAM33,Rs612709,has been linked to a predisposition to asthma and bronchial hyperresponsiveness
ADAM33,Rs574174,"ADAM33, a new candidate for psoriasis susceptibility"
ADAM33,Rs574174,childhood asthma and lung function in two German populations.
ADAM33,Rs574174,polymorphisms in 16 genes in type 1 diabetes that have been associated with other immune-mediated diseases
ADAM33,Rs574174,linked to a predisposition to asthma and bronchial hyperresponsiveness.
ADAM33,Rs574174,polymorphisms
ADAM33,Rs574174,lung function
ADAM33,Rs574174,metalloprotease
ADAM33,Rs2787094,psoriasis
ADAM33,Rs2787094,bronchial hyperresponsiveness
ADAM33,Rs2787094,COPD and lung function
ADAM33,Rs2787094,adult allergic asthma
ADAM33,Rs2787094,psoriasis
ADAM33,Rs2787094,asthma
ADAM33,Rs2787094,immune-mediated diseases
ADAM33,Rs2787094,type 1 diabetes
ADAM33,Rs2787094,long-term tobacco smokers
ADAM33,Rs2787094,asthma
ADAM33,Rs2787094,rhinoconjunctivitis
ADAM33,Rs2787094,allergy and asthma 
ADAM33,Rs2787094,rhinitis
ADAM33,Rs2787094,asthma
ADAM33,Rs2787094,rhinitis
ADAM33,Rs2787094,adult allergic asthma
ADAM33,Rs2787094,asthma 
ADAM33,Rs2787094,immune-mediated diseases
ADAM33,Rs2787094,type 1 diabetes
ADAM33,Rs2787094,bronchial hyperresponsiveness
ADAM33,Rs2787094,asthma
ADAM33,Rs2280089,bronchial hyperresponsiveness
ADAM33,Rs2280089,asthma
ADAM33,Rs2787094,atopic dermatitis
ADAM33,Rs2787094,Chinese Han population
ADAM33,Rs2787094,German populations
ADAM33,Rs2787094,Japanese children
ADAM33,Rs2787094,Japanese children
ADAM33,Rs2787094,atopic dermatitis
ADAM33,Rs2787094,adult allergic asthma and rhinitis in a Chinese Han population
ADAM33,Rs2787094,psoriasis susceptibility
ADAM33,Rs2787094,two German populations
ADAM33,Rs2787094,childhood asthma and lung function
ADAM33,Rs2787094,atopic dermatitis
ADAM33,Rs2787094,type 1 diabetes
ADAM33,Rs2787094,predisposition to asthma and bronchial hyperresponsiveness
ADAM33,Rs2787094,Japanese women
ADAM33,Rs2787094,immune-mediated diseases
ADAM33,Rs2787094,Han population of northeastern China
ADAM33,Rs2787094,rhinoconjunctivitis
ADAM33,Rs2787094,tobacco smokers
ADAM33,Rs2787094,psoriasis
ADAM33,Rs2787094,asthma
ADAM33,Rs2787094,lung function
ADAM33,Rs2787094,childhood allergy and asthma
ADAM33,Rs2787094,African American urban population
ADAM33,Rs2787094,psoriasis
ADAM33,Rs2787094,Indian children
ADAMTS13,Rs28647808,type-2 diabetes
ADAMTS13,Rs28647808,higher renal or cardiavascular complications
ADAMTS13,Rs28647808,50% higher risk for renal complications
ADCY2,Rs13166360,Bipolar Disorder
ADCY2,Rs13166360,Bipolar Disorder
ADCY2,Rs13166360,BD
ADCY2,Rs13166360,Major Mood Disorders
ADCY2,Rs13166360,Schizophrenia
ADCY2,Rs13166360,bipolar disorder
ADCY2,Rs13166360,bipolar disorder
ADCY2,Rs13166360,Bipolar Disorder
ADCY2,Rs13166360,Bipolar Disorders
ADCY2,Rs13166360,BD
ADCY2,Rs13166360,BD
ADCY2,Rs13166360,recurrent episodes of depression and mania
ADCY2,Rs13166360,Bipolar Disorder (BD)
ADCY2,Rs13166360,bipolar disorder
ADCY2,Rs13166360,"those suffering from bipolar disorder are at a higher risk of suicide, anxiety disorders, and substance abuse"
ADCY3,Rs541941351,reverse orientation of the gene.
ADCY3,Rs541941351,orientation & ambiguous flip
ADCY3,Rs541941351,heterozygotes
ADCY3,Rs541941351,obesity
ADCY3,Rs541941351,potentially causing obesity
ADCY3,Rs541941351,inherited recessively
ADCY3,Rs541941351,obesity
ADCY3,Rs541941351,heterozygotes
ADCY3,Rs541941351,obesity
ADCY3,Rs541941351,ADCY3 gene
ADCY3,Rs541941351,obesity
ADCY3,Rs541941351,rare variant in the ADCY3 gene
ADCY5,Rs796065306,facial myokymia
ADCY5,Rs796065306," autosomal dominant familial dyskinesia,"
ADCY5,Rs796065306,dyskinesia disorder.
ADCY5,Rs796065306,facial myokymia
ADCY5,Rs796065306,facial myokymia
ADCY5,Rs796065306,dyskinesia disorder
ADCY5,Rs796065306,dyskinesia disorder
ADCY5,Rs11708067,glucose and insulin responses
ADCY5,Rs796065306,autosomal dominant familial dyskinesia
ADH1B,Rs6413413, SNP
ADH1B,Rs6413413,SNP
ADH1B,Rs6413413,SNP
ADH1B,Rs6413413,Spaniards
ADH1B,Rs6413413,Spaniards
ADH1B,Rs6413413,Spaniards
ADH1B,Rs6413413,Spaniards
ADH1C,Rs698,"effects of alcohol are higher in individuals who break down (basically, detoxify) ethanol more slowly."
ADH1C,Rs698,Spaniards
ADH1C,Rs28730619,childhood asthma
ADH1C,Rs28730619,GSNOR
ADH1C,Rs283413,affect alcohol metabolism
ADH1C,Rs283413,PD
ADH1C,Rs283413,Parkinson's disease (PD)
ADH1C,Rs283413,neurodegenerative diseases
ADH1C,Rs698,variability in the rate at which alcohol is metabolized
ADH1C,Rs283413,Parkinson's disease
ADH1C,Rs283413,"y the gs211 genoset. Note that the effects of alcohol are higher in individuals who break down (basically, detoxify) ethanol more slowly"
ADH1C,Rs283411,ADH
ADH1C,Rs283411,polymorphism
ADH1C,Rs283411,ADH single nucleotide polymorphism
ADH1C,Rs1693482,"effects of alcohol are higher in individuals who break down (basically, detoxify) ethanol more slowly."
ADH1C,Rs1693482,were shown to affect alcohol metabolism
ADH1C,Rs1693482,Irish alcoholics
ADH1C,Rs283413,alcohol metabolism
ADIPOQ,Rs822395,Single nucleotide polymorphisms
ADIPOQ,Rs822395,breast cancer
ADIPOQ,Rs822395,overweight and obesity.
ADIPOQ,Rs822395,coronary heart disease
ADIPOQ,Rs822395,breast cancer
ADIPOQ,Rs822395,colorectal cancer
ADIPOQ,Rs822395,overweight
ADIPOQ,Rs822396,breast cancer risk
ADIPOQ,Rs822395,coronary artery disease risk
ADIPOQ,Rs822396,incident myocardial infarction and ischemic stroke
ADIPOQ,Rs822396,coronary heart disease
ADIPOQ,Rs822396,type 2 diabetes
ADIPOQ,Rs822396,colorectal cancer
ADIPOQ,Rs822396,ischemic stroke
ADIPOQ,Rs822393, Adipokine
ADIPOQ,Rs822395,obesity
ADIPOQ,Rs182052,ischemic stroke
ADIPOQ,Rs822395,colorectal cancer
ADIPOQ,Rs182052,polymorphisms
ADIPOQ,Rs17300539,obesity
ADIPOQ,Rs17300539,insulin resistance
ADIPOQ,Rs17300539,weight regain
ADIPOQ,Rs17300539,SNP
ADIPOQ,Rs17300539,diabetes risk
ADIPOQ,Rs17300539,diabetes
ADIPOQ,Rs17300539,risk of insulin resistance
ADIPOQ,Rs182052,incident myocardial infarction
ADIPOQ,Rs17300539,increased risk of insulin resistance
ADIPOQ,Rs182052,plasma adiponectin levels
ADIPOQ,Rs182052,type 2 diabetes
ADIPOQ,Rs182052,diabetes-related quantitative traits
ADIPOQ,Rs182052,type 2 diabetes
ADIPOQ,Rs182052,prostate cance
ADIPOQ,Rs182052,insulin sensitivity
ADIPOQ,Rs182052,birth weight
ADIPOQ,Rs182052, ischemic stroke
ADORA2A,Rs5751876,nor with risk for Parkinson's disease
ADORA2A,Rs5751876,not associated with how much coffee one drinks
ADORA2A,Rs5751876,influence how an individual responds to moderate levels (150mg) of caffeine
ADORA2A,Rs5751876,increased subjective levels of anxiety after consumption
ADORA2A,Rs2236624,may increase autistic symptoms and anxiety in autism spectrum disorder
ADORA2A,Rs2236624,Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety.
ADORA2A,Rs5751876,Parkinson's disease
ADRA2A,Rs1800544,clonidine treatment of Irritable bowel syndrome
ADRA2A,Rs1800544,depression
ADRA2A,Rs1800544, treatment
ADRA2A,Rs1800545,ADRA2A gene variant
ADRA2A,Rs1800545,c.-217G>A
ADRA2A,Rs521674,Genetic determinants of target and novelty-related event-related potentials in the auditory oddball respons
ADRA2B,Rs2229169,myocardial infarction
ADRA2B,Rs2229169,Koreans 
ADRA2B,Rs2229169,cardiac heart disease
ADRA2B,Rs2229169,prolonged acute chest pain
ADRA2B,Rs2229169,Chinese 
ADRA2B,Rs2229169,deletion polymorphism
ADRA2B,Rs2229169,"Associations with the number of sudden cardiac deaths and overall cardiac heart disease mortality were also observed, but they would not be significant after correcting for multiple comparisons."
ADRA2B,Rs2229169,This may result in both negative cardiovascular consequences and positive cognitive effects
ADRA2B,Rs2229169,Alpha-2B adrenergic receptors contribute to norepinephrine stimulation in the brain and to peripheral vasoconstriction.
ADRA2B,Rs2229169,"Association of the deletion genotype with small-vessel disease was the main contributor to the risk. In a study of more than 400 young Swiss adults, the carriers of del301–303 polymorphism had about 20% better memory for emotional photographs, both positive and negative"
ADRA2B,Rs2229169,This is a good proxy for alpha-2B-adrenergic receptor gene
ADRB2,Rs1042714,hypertension
ADRB2,Rs1042714,type-2 diabetes
ADRB2,Rs1042713,young asthma patients
ADRB2,Rs1042713,patients using inhalers less than once per day
ADRB2,Rs1042714,obesity
ADRB2,Rs1042713,"age, 3-22 years"
ADRB2,Rs1042713,young Scottish asthma patients
ADRB2,Rs1042713,asthma
ADRB2,Rs1042713,asthma
ADRB2,Rs1042713,"""exacerbations"" of their condition"
ADRB3,Rs4994,coronary angiography
ADRB3,Rs4994,experienced a heart problem
ADRB3,Rs4994,ndividuals were calculated to be at higher risk 
ADRB3,Rs4994,"subtle increases in risk for all of the individual endpoints, and was only seen in women without obstructive coronary artery disease"
AFG3L2,Rs151344523,spinocerebellar ataxia-28
AGT,Rs5050,Alzheimer disease candidate genes
AGT,Rs5050,haplotype clade in ACE
AGT,Rs5050,Alzheimer 
AGT,Rs4762,diabetic retinopathy.
AGT,Rs4762,Alzheimer disease
AGT,Rs4762,coronary artery disease
AGT,Rs5051,essential hypertension
AGT,Rs4762,pre-eclampsia
AGT,Rs4762,diabetic retinopathy
AGT,Rs4762,pre-eclampsia
AGT,Rs4762,coronary artery disease
AGT,Rs4762,heart failure
AGT,Rs4762,pre-eclampsia
AGT,Rs3889728,"pre-eclampsia,"
AGT,Rs3889728,pre-eclampsia
AGT,Rs387906578,OMIM 
AGT,Rs387906578,OMIM
AGT,Rs121912702,OMIM
AGT,Rs4762,Alzheimer disease
AGTR1,Rs5182,reduced risk of heart attack
AGXT,Rs111996685,pathogenic
AHCY,Rs6058017,appearance
AHCY,Rs819134,methylations
AHCY,Rs819147,regulation of biologic methylations
AHCY,Rs819171,regulation of biologic methylations
AHSG,Rs2248690,coronary atherosclerosis
AHSG,Rs2518136,type-2 diabetes
AHSG,Rs2518136,type-2 diabetes
AHSG,Rs2518136,Caucasians
AHSG,Rs2518136,type-2 diabetes
AHSG,Rs2518136,Caucasians
AHSG,Rs2518136,type-2 diabetes
AHSG,Rs4917,reduced plasma lipid levels
AHSG,Rs2593813,leanness 
AHSG,Rs2593813,Homozygosity
AHSG,Rs4917,obesity 
AHSG,Rs4917,body fat levels
AHSG,Rs4917,insulin sensitivity
AHSG,Rs2248690,polymorphisms
AHSG,Rs4917,lower body fat concentrations
AHSG,Rs4917,increased risk for leanness
AHSG,Rs2593813,AHSG gene
AHSG,Rs2248690,polymorphisms
AHSG,Rs2248690,directly associated
AHSG,Rs2248690,functional
AHSG,Rs2248690,nucleotide
AHSG,Rs2077119,SNP
AHSG,Rs2077119,Danish
AHSG,Rs2077119,type-2
AHSG,Rs2077119,diabetes
AHSG,Rs2077119,light protective effect
AHSG,Rs2077119,a SNP
AHSG,Rs2077119,glycoprotein AHSG gene
AHSG,Rs2077119,rs2077119
AHSG,Rs2248690,polymorphism
AHSG,Rs2248690,glycoprotein
AHSG,Rs2248690,type 2 diabetes
AHSG,Rs2248690,French Caucasians
AHSG,Rs2248690,polymorphism
AHSG,Rs2248690,glycoprotein
AHSG,Rs2248690,transcriptional activity
AHSG,Rs2077119,Danish type-2 diabetes patients
AIPL1,Rs62637014,inherited
AIPL1,Rs62637014,Leber congenital amaurosis type 4
AIPL1,Rs62637014,variant
AIPL1,Rs62637014,mutation
AIPL1,Rs62637014,recessively
AIPL1,Rs62637014,recessively
AIPL1,Rs62637014,Leber congenital amaurosis
AIPL1,Rs62637014,mutation 
AIPL1,Rs62637014,inherited
AIPL1,Rs62637014,type 4 
AKT1,Rs3730358,non-small cell lung cancer.
AKT1,Rs3730358,Obstetric Complications
AKT1,Rs3730358,schizophrenia
AKT1,Rs3730358,schizophrenia
AKT1,Rs3730358,lung cancer
AKT1,Rs3730358, cell lung cancer
AKT1,Rs3730358, no
AKT1,Rs3730358, associations with schizophrenia: meta-analyses of 12 candidate genes. Absence of AKT1 mutations in glioblastoma. No association betwee
AKT1,Rs3730358,Korean population
AKT1,Rs2494732,once-a-month cannabis users
AKT1,Rs3730358,glioblastoma
AKT1,Rs3730358,Taiwanese population
AKT1,Rs3730358,schizophrenia
AKT1,Rs2494732,psychotic disorde
AKT1,Rs2494732,mind-altering symptoms
AKT1,Rs2494732,cannabis-related psychosis
AKT1,Rs2494732,"drug-related psychoses,"
AKT1,Rs2494732,", schizophrenia"
AKT1,Rs3730358,polymorphism
ALB,Rs77514449,three genetic variants of human serum albumin modified
ALB,Rs77514449,Amino acid substitutions in inherited albumin variants
ALB,Rs77514449,IIIA
ALB,Rs77514449, IIB
ALB,Rs77514449,human serum albumin
ALB,Rs77514449,Amino acid substitutions in inherited albumin variants from Amerindian and Japanese populations
ALB,Rs77514449,Amerindian
ALB,Rs77514449,inherited albumin
ALB,Rs78340021,analbuminemia
ALB,Rs77514449,albumin variants
ALB,Rs77514449,Japanese
ALB,Rs78340021,Novel nonsense mutation
ALB,Rs78784172,novel splicing mutation
ALB,Rs78340021,nonsense 
ALB,Rs78784172,Analbuminemia
ALB,Rs78784172,splicing mutation
ALB,Rs77050410,Mutations in genetic variants of human serum albumin found in Italy.
ALB,Rs78784172,albuminemia
ALB,Rs79228041,Exome sequencing identifies GRIN2A as frequently mutated in melanoma.
ALB,Rs79228041,Amino acid substitution in two identical inherited human serum albumin variants: albumin Oliphant and albumin Ann Arbor
ALB,Rs79744198,abnormality of albumin
ALB,Rs79744198,The molecular abnormality of albumin
ALB,Rs79744198,Asp----Gly.
ALB,Rs79744198,natural mutants
ALB,Rs79744198,Point
ALB,Rs78340021,analbuminemia 
ALB,Rs76593094,Point substitutions in Japanese alloalbumins.
ALB,Rs79228041,melanoma
ALB,Rs76483862,Point substitutions in Japanese alloalbumins.
ALB,Rs1800580,Albumin Rugby Park
ALB,Rs1800580,truncated albumin variant
ALB,Rs75152012,analbuminemia
ALB,Rs75152012,teroid-sensitive idiopathic nephrotic syndrome
ALB,Rs75152012,acute glomerulonephritis
ALB,Rs75152012,analbuminemia
ALB,Rs75152012,mutation
ALB,Rs76593094,alloalbumins
ALB,Rs75152012, mutational analysis.
ALB,Rs75152012,Congenital analbuminemia with acute glomerulonephritis:
ALB,Rs75152012,analbuminemia
ALB,Rs75152012,mutation
ALB,Rs75152012,Amerindian
ALB,Rs75152012,congenital analbuminemia and steroid-sensitive idiopathic nephrotic syndrome:
ALB,Rs75152012,Analbuminemia
ALB,Rs76483862,alloalbumins
ALB,Rs75152012,glomerulonephritis
ALB,Rs75152012,Turkish
ALB,Rs75152012, Kayseri mutation
ALB,Rs75152012,male
ALB,Rs75152012,Analbuminemia
ALB,Rs75152012,Congenital analbuminemia
ALB,Rs75152012,congenital analbuminemia
ALB,Rs75152012,boy
ALB,Rs75152012,mutational
ALB,Rs75152012,gypsy
ALB,Rs75152012,steroid-sensitive idiopathic nephrotic syndrome
ALDH16A1,Rs150414818,missense variant
ALDH16A1,Rs150414818,serum uric acid levels
ALDH16A1,Rs150414818,genetics
ALDH3A2,Rs1800870,oral cancer
ALDH3A2,Rs1800870,interleukin-10 gene
ALDH3A2,Rs1800870,oral cancer
ALDH3A2,Rs72547571,Sjogren-Larsson syndrome
ALDH5A1,Rs2760118,Reduc
ALDH5A1,Rs2760118,United 
ALDH5A1,Rs3765310,SSADH deficiency
ALDH5A1,Rs3765310,succinate semialdehyde dehydrogenase
ALDH5A1,Rs2760118,ccin
ALDH5A1,Rs2760118,he suc
ALDH5A1,Rs2760118,tive 
ALDH5A1,Rs2760118,e a
ALDH5A1,Rs2760118,King
ALDH5A1,Rs2760118,with S
ALDH5A1,Rs2760118, accumulation 
ALDH5A1,Rs2760118,dyslexia
ALDH5A1,Rs2760118,mutatio
ALDH7A1,Rs864622557,Gly
ALDH7A1,Rs121912708,328C
ALDH7A1,Rs864622557,Val
ALDH7A1,Rs121912707,pyridoxine-dependent epilepsy
ALDH7A1,Rs121912707,pyridoxine-dependent epilepsy
ALDH7A1,Rs121912707,pyridoxine-dependent epilepsy
ALDOB,Rs1800546,avoidance of fructose-containing foods
ALDOB,Rs1800546,European ancestry
ALDOB,Rs1800546,HFI
ALDOB,Rs1800546,autosomal recessive
ALDOB,Rs1800546,phosphate sink
ALDOB,Rs1800546,halt of gluconeogenesis and glycogenolysis
ALDOB,Rs1800546,"bloating, abdominal pain, diarrhea, hypoglycemia, hyperuricemia, mental depression, jaundice, and cirrhosis"
ALDOB,Rs1800546,HFI
ALDOB,Rs1800546,liver failure and death
ALDOB,Rs76917243,ALDOB gene mutation
ALDOB,Rs1800546,severe hypoglycemia
ALDOB,Rs1800546,HFI
ALDOB,Rs1800546,death
ALDOB,Rs1800546,HFI
ALDOB,Rs1800546,HFI
ALDOB,Rs1800546,Italian patients
ALDOB,Rs1800546,American
ALDOB,Rs1800546,Italians
ALDOB,Rs1800546,HFI
ALDOB,Rs1800546,HFI
ALDOB,Rs1800546,Chronic Diarrhea
ALDOB,Rs1800546,hereditary fructose intolerance
ALDOB,Rs1800546,European ancestry
ALDOB,Rs1800546,"altered consciousness, diaphoresis, and seizures"
ALDOB,Rs1800546,HFI
ALDOB,Rs1800546,food aversion to fructose-rich foods
ALDOB,Rs1800546,hereditary fructosuria
ALDOB,Rs1800546,fructose intolerance
ALDOB,I5008215,Hereditary Fructose Intolerance
ALDOB,I5012663,hereditary fructosuria
ALDOB,I5012663,hereditary fructosuria
ALDOB,I5012664,Hereditary Fructose Intolerance
ALDOB,I5012665,Hereditary fructose intolerancers
ALDOB,I5012665,Hereditary fructose intolerance
ALDOB,I5012665,Hereditary 
ALDOB,Rs1800546,=CLINICAL OVERVIEW:=
ALDOB,Rs1800546,hereditary fructosuria
ALDOB,Rs1800546,"bloating, abdominal pain, diarrhea, hypoglycemia, hyperuricemia, mental depression, jaundice, and cirrhosis that can lead to liver failure and death."
ALDOB,I5012665,fructose intolerance
ALDOB,Rs1800546,diaphoresis
ALDOB,Rs1800546,altered consciousness
ALDOB,Rs1800546,seizures
ALDOB,Rs1800546,death
ALDOB,Rs1800546,loss of function of aldolase B
ALDOB,Rs1800546,inability of the body to break down fructose into byproducts for human consumption
ALDOB,Rs1800546,"bloating, abdominal pain, diarrhea, hypoglycemia, hyperuricemia, mental depression, jaundice, and cirrhosis that can lead to liver failure and death"
ALDOB,Rs1800546,"altered consciousness, diaphoresis, and seizures, sometimes resulting in death."
ALDOB,Rs1800546,mental depression
ALDOB,Rs1800546,cirrhosis
ALDOB,Rs1800546,severe hypoglycemia
ALDOB,Rs1800546,hypoglycemia
ALOX5AP,Rs4769874,myocardial infarction
ALOX5AP,Rs4769874,myocardial infarction or ischemic stroke
ALOX5AP,Rs4769874,ischemic stroke
ALOX5AP,Rs4769874,myocardial infarction
ALOX5AP,Rs4076128,women 
ALOX5AP,Rs4076128,breast cancer
ALOX5AP,Rs4076128,higher breast cancer risk
ALOX5AP,Rs4076128,east cancer
ALOX5AP,Rs4769874,ischemic stroke
ALOX5AP,Rs4769874,haplotype
ALOX5AP,Rs9315050,myocardial infarction
ALOX5AP,Rs9551963,5-Lipoxygenase activating protein (ALOX5AP) gene variants associate with the presence of xanthomas in familial hypercholesterolemia.
ALOX5AP,Rs9315050,myocardial infarction
ALOX5AP,Rs9315050,ischemic stroke
ALOX5AP,Rs9551963,myocardial infarction
ALOX5AP,Rs9551963,atherosclerosis
ALOX5AP,Rs9551963,hypercholesterolemia
ALOX5AP,Rs9551963,atherothrombotic cardiovascular disease
ALOX5AP,Rs9551963,"rs9551963, also known as SG13S32, is an ALOX5AP gene SNP that has been defined as part of a haplotype potentially associated with risk for myocardial infarction or ischemic stroke."
ALOX5AP,Rs9551963,Genetic effects in the leukotriene biosynthesis pathway and association with atherosclerosis.
ALOX5AP,Rs9551963,role of LTA4H and ALOX5AP genes in the risk for asthma in Latinos.
ALOX5AP,Rs9551963,ALOX5AP and LTA4H polymorphisms modify augmentation of bronchodilator responsiveness by leukotriene modifiers in Latinos.
ALOX5AP,Rs4076128,ethnicity 
ALOX5AP,Rs9315050,ischemic stroke
ALOX5AP,Rs4076128,breast cancer
ALOX5AP,Rs9551963,ischemic stroke
ALOX5AP,Rs17222842,ischemic stroke
ALOX5AP,Rs17222842,haplotype potentially associated with risk for myocardial infarction or ischemic stroke
ALOX5AP,Rs10507391,myocardial infarction
ALOX5AP,Rs10507391,ischemic stroke
ALOX5AP,Rs10507391,ischemic stroke
ALOX5AP,Rs10507391,cardiovascular disease
ALOX5AP,Rs10507391,atherosclerosis
ALOX5AP,Rs10507391,diabetes
ALOX5AP,Rs10507391,augmentation of bronchodilator responsiveness
ALOX5AP,Rs10507391,myocardial infarction
ALOX5AP,Rs10507391,ischemic stroke
ALOX5AP,Rs10507391,cardiovascular disease
ALOX5AP,Rs10507391,atherosclerosis
ALOX5AP,Rs10507391,atherosclerosis
ALOX5AP,Rs10507391,myocardial infarction
ALOX5AP,Rs10507391,diabetes
ALOX5AP,Rs17222842,risk for myocardial infarction
ALOX5AP,Rs17222814,ischemic stroke
ALOX5AP,Rs17222814,myocardial infarction
ALOX5AP,Rs17222814,bifurcation intima-media thickness
ALOX5AP,Rs17222814,alcohol consumption
ALOX5AP,Rs10507391,Genetic effects in the
ALOX5AP,Rs10507391,leukotriene biosynthesis pathway and association with atherosclerosis
ALOX5AP,Rs10507391,significant (only) in males
ALOX5AP,Rs10507391,ischemic stroke
ALOX5AP,Rs17222814,myocardial infarction or ischemic stroke
ALPL,I6006946,rare/minor allele
ALPL,I6006948,hypophosphatasia
ALPL,I6006946,hypophosphatasia.
ALPL,I6006946,hypophosphatasia
ALPL,I6006951,perinatal form of hypophosphatasia
ALPL,I6006956,pathogenic 
ALPL,I6006953,hypophosphatasia
ALPL,I6006956,hypophosphatasia
ALPL,I6006956,infantile form
ALPL,I6006956,pathogenic for the infantile form of hypophosphatasia.
ALPL,I6006940,odonto. form of hypophosphatasia
ALPL,I6006951,pathogenic for the perinatal form of hypophosphatasia.
ALPL,I6006940,mutations database
ALPL,I6006927,SNP
ALPL,I6006940,pathogenic 
ALPL,I6006940,rare/minor allele
ALPL,I6006940,hypophosphatasia
ALPL,I6006940,hypophosphatasia
ALPL,I6006933,hypophosphatasia
ALPL,I6006927,hypophosphatasia
ALPL,I6006927, pathogenic
ALPL,I6006927,rare/minor allele
ALPL,I6006927,ALPL gene mutations database
ALPL,I6006927,ALPL gene on chromosome 1
ALPL,I6006969,perinatal form of hypophosphatasia
ALPL,I6006927,p.R391C
ALPL,I6006927,c.1171C>T
ALPL,I6006940,ALPL gene on chromosome
ALPL,I6006969,rare/minor allele
ALPL,I6007029,hypophosphatasia
ALPL,I6006989,hypophosphatasia
ALPL,I6006927,i6006927
ALPL,I6007032,hypophosphatasia
ALPL,I6007032,pathogenic 
ALPL,I6007032,allele 
ALPL,I6007032,minor 
ALPL,I6007032,mutations 
ALPL,I6007032,gene 
ALPL,I6007032,chromosome 
ALPL,I6007032,gene 
ALPL,I6007032,hypophosphatasia
ALPL,I6007032,considered pathogenic
ALPL,I6007032,rare/minor allele
ALPL,I6007032,i6007032
ALPL,I6007032,erinatal form of hypophosphatasia
ALPL,I6007029,the rare/minor allele is considered pathogenic
ALPL,I6007029,hypophosphatasia
ALPL,I6007029,is a SNP in the ALPL gene on chromosome 1
ALPL,I6007029,infantile form of hypophosphatasia
ALPL,I6006996,hypophosphatasia.
ALPL,I6006996,hypophosphatasia.
ALPL,I6006996,hypophosphatasia
ALPL,I6006991,P292T
ALPL,I6006991,874C
ALPL,I6006991,i6006991
ALPL,I6006991,hypophosphatasia
ALPL,I6006989,hypophosphatasia
ALPL,I6006989,pathogenic 
ALPL,I6006969,considered pathogenic for the perinatal form of hypophosphatasia.
ALPL,I6006927,pathogenic for the childhood form of hypophosphatasia
ALPL,I5012683,"i5012683, also known as c.1133A>T or p.D378V, is a SNP in the ALPL gene on chromosome 1.Based on the ALPL gene mutations database, the rare/minor allele is considered pathogenic for the infan"
ALPL,I6006927,considered pathogenic for the childhood form of hypophosphatasia.
ALPL,I6006927,gene on chromosome 1
ALPL,I5012683,"i5012683, also known as c.1133A>T or p.D378V, is a SNP in the ALPL gene on chromosome 1.Based on the ALPL gene mutations database, the rare/minor allele is considered pathogenic for the infan"
ALPL,I5012683,hypophosphatasia
ALPL,I5002774,infantile form of hypophosphatasia
ALPL,I5002773,hypophosphatasia
ALPL,I5002772,pathogenic for the perinatal form of hypophosphatasia
ALPL,I5002772,hypophosphatasia
ALPL,I5002771,hypophosphatasia
ALPL,I5002766,hypophosphatasia
ALPL,I5002766,perinatal form
ALPL,I5002766,allele
ALPL,I5002766,mutations
ALPL,I5012683,infantile form of hypophosphatasia
ALPL,I5002766,ALPL gene
ALPL,I5002766,ALPL gene
ALPL,I5002766,SNP
ALPL,I5002766,perinatal form of hypophosphatasia
ALPL,I5002766,is a SNP in the ALPL gene on chromosome
ALPL,I5002766,is considered pathogenic for
ALPL,I5002766,perinatal form of hypophosphatasia
ALPL,I5002766,hypophosphatasia
ALPL,I5002765,hypophosphatasia
ALPL,I5002757,hypophosphatasia
ALPL,I5002756,perinatal form of hypophosphatasia
ALPL,I5002756,pathogenic
ALPL,I5002756,ypophosphatasia
ALPL,I5002766,chromosome
ALPL,I5012684,.Based on the ALPL gene mutations
ALPL,I5002756,perinatal form of hypophosphatasia
ALPL,I6006888,hypophosphatasia
ALPL,I5900451,hypophosphatasia.
ALPL,I6006927,gene mutations
ALPL,I6006927,childhood form of hypophosphatasia
ALPL,I6006927,childhood form of hypophosphatasia.
ALPL,I6006926,hypophosphatasia
ALPL,I6006921,ALPL gene
ALPL,I6006921,the rare/minor allele
ALPL,I6006921,hypophosphatasia
ALPL,I6006921, ALPL gene 
ALPL,I6006921,SNP 
ALPL,I6006921,hypophosphatasia
ALPL,I6006921,childhood
ALPL,I6006912,adult form of hypophosphatasia
ALPL,I6006921,chromosome 1
ALPL,I6006912,"i6006912, also known as c.512A>G or p.H171R, is a SNP in the ALPL gene on chromosome 1.Based on the ALPL gene mutations database, the rare/minor allele is considered pathogenic for the adult form of hypophosphatasia."
ALPL,I6006889,p.T134N
ALPL,I6006912,"i6006912, also known as c.512A>G or p.H171R, is a SNP in the ALPL gene on chromosome 1.Based on the ALPL gene mutations database, the rare/minor allele is considered pathogenic for the adult form of hypophosphatasia"
ALPL,I6006889, gene mutations
ALPL,I6006889,pathogenic
ALPL,I6006889,hypophosphatasia
ALPL,I6006897,hypophosphatasia
ALPL,I6006889,chromosome
ALPL,I6006897,hypophosphatasia.
ALPL,I6006912,hypophosphatasia
ALPL,I6006912,"6006912, also known as c.512A>G or p.H171R, is a SNP in the ALPL gene on chromosome 1.Based on the ALPL gene mutations database, the rare/minor allele is considered pathogenic for the adult form of hypophosphatasia."
ALPL,I6006912,"i6006912, also known as c.512A>G or p.H171R, is a SNP in the ALPL gene on chromosome 1.Based on the ALPL gene mutations database, the rare/minor allele is considered pathogenic for the adult form of hypophosphatasia."
ALPL,I6006912,"i6006912, also known as c.512A>G or p.H171R, is a SNP in the ALPL gene on chromosome 1.Based on the ALPL gene mutations database, the rare/minor allele is considered pathogenic for the"
ALPL,I6006897,rare/minor allele
AMPD1,Rs35859650,recessively inherited mutation
AMPD1,Rs35859650,muscle AMP deaminase deficiency
ANG,Rs17114699,"amyotrophic lateral sclerosis (ALS) in Irish and Swedish populations, but not in Polish populations"
ANG,Rs17114699,Polish
ANG,Rs17114699,amyotrophic lateral sclerosis
ANG,Rs17114699,Irish
ANG,Rs17114699,Swedish
ANGPTL3,Rs398122987,ANGPTL3
ANGPTL3,Rs267606655,coronary artery disease
ANGPTL3,Rs267606655,function variant in the ANGPTL3 gene on chromosome
ANGPTL3,Rs267606655,coronary artery disease.
ANGPTL3,Rs267606655,lowered triglycerides and LDL cholesterol
ANGPTL3,Rs267606655,minor allele
ANGPTL3,Rs267606655, artery disease
ANGPTL3,Rs267606655,coron
ANGPTL3,Rs267606655,coronary artery disease
ANK2,Rs72544141, causes human sinus node disease.
ANK2,Rs72544141,caused by loss of ankyrin-B function
ANK2,Rs72544141,sudden cardiac death
ANK2,Rs72544141,cardiac arrhythmia
ANK2,Rs72544141,causes type 4 long-QT
ANK2,Rs72544141,Ankyrin-B mutation
ANK2,Rs72544141,Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. A cardiac arrhythmia syndrome caused by loss of ankyrin-B function. Dysfunction in ankyrin-B-dependent ion channel and transporter targeting causes human sinus node disease.
ANK2,Rs72544141,cardiac arrhythmia
ANK3,Rs10994336,times compared
ANK3,Rs4948418,bipolar disorder
ANK3,Rs10994336,SNPs|
ANK3,Rs10994336,NutraHacke
ANK3,Rs10994336,his
ANK3,Rs10994336,one
ANK3,Rs4948418,bipolar disorder
ANK3,Rs10994336,disorder
ANK3,Rs10994336,CC genotype
ANK3,Rs10994336,developing
ANK3,Rs10994336,odds
ANK3,Rs10994336,increased
ANK3,Rs10994336,Each T 
ANK3,Rs10994336,rs10994336
ANK3,Rs10994336,blog
ANK3,Rs10994336,23andMe
ANK3,Rs10994336,bipolar
ANO5,Rs137854529,limb-girdle muscular dystrophy
ANO5,Rs137854529,muscular dystrophies
ANO5,Rs137854529,limb-girdle muscular dystrophy
ANO5,Rs137854529,muscular dystrophies
ANO5,Rs137854529,limb-girdle muscular dystrophy
ANO5,Rs137854523,dystrophies
ANO5,Rs137854523,muscular 
ANO5,Rs137854521,limb-girdle muscular dystrophy
ANO5,Rs137854523,muscular dystrophies
ANO5,Rs137854521,muscular dystrophies
ANO5,Rs137854521,limb-girdle muscular dystrophy
ANO5,Rs137854521,muscular dystrophies
ANO5,Rs137854521,limb-girdle muscular dystrophy
ANO5,Rs137854523,chloride 
ANXA11,Rs7091565,was found to be strongly associated with
ANXA11,Rs7091565,sarcoidosis
ANXA11,Rs7091565,sarcoidosis
ANXA11,Rs754594235,pathogenic variant
ANXA11,Rs7091565,sarcoidosis 
ANXA11,Rs1049550,German individuals with sarcoidosis
ANXA11,Rs7091565,was found to be strongly associated with
AOC1,Rs2268999,homozygous minor allele
AOC1,Rs2268999,mRNA expression
AOC1,Rs2268999,minor allele
AOC1,Rs2268999,diamine oxidase serum
AOC1,Rs2268999,diamine oxidase gene
AOC1,Rs2268999,single nucleotide polymorphisms
AOC1,Rs2268999,single nucleotide polymorphisms in the diamine oxidase gene with diamine oxidase serum activities
AOC1,Rs2052129,selective hypersensitivity to ibuprofen
AOC1,Rs2052129,selective NSAID hypersensitivity 
AOC1,Rs2052129,NSAID hypersensitivity 
AOC1,Rs2052129,HIT
AOC1,Rs2052129,"histamine intolerance (HIT), "
AOC1,Rs2052129,hypersensitivity to ibuprofen
AOC1,Rs2052129,Caucasian
AOC1,Rs1049742, nucleotide polymorphisms
AOC1,Rs1049742,reduced DAO activity
AOC1,Rs1049742,single nucleotide polymorphisms
AOC1,Rs10156191,hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs)
AP4E1,Rs760021635,The minor (A) allele of rs760021635 was reported as a mutation in the AP4E1 gene associated with stuttering in a 2015 study.
AP4E1,Rs760021635,mutation 
AP4E1,Rs760021635,stuttering
AP4E1,Rs760021635,stuttering
AP4E1,Rs556450190,AP4E1 gene
AP4E1,Rs760021635,The minor (A) allele
APC,Rs587782557,attentuated familial polyposis
APOA2,Rs5082,coronary artery disease
APOA2,Rs5082,heart disease
APOA2,Rs5082,type-2 diabetes
APOA2,Rs5082,postprandial response to a saturated fat overload
APOA2,Rs5082,Response to Diet and Exercise
APOA2,Rs5082,obesity and heart disease
APOA2,Rs5082,obesity
APOA2,Rs5085,type-2 diabetes
APOA2,Rs5085,APOA2 SNPs
APOA2,Rs5085,type-2 diabetes
APOA2,Rs5085,APOA2 SNPs 
APOA2,Rs6413453,type-2 diabetes
APOA2,Rs6413453,type-2 diabetes
APOA2,Rs6413453,APOA2 SNPs 
APOA2,Rs6413453,type-2 diabetes
APOA2,Rs5085,type-2 diabetes
APOA2,Rs5082,obesity
APOA2,Rs6413453,APOA2 SNPs
APOA2,Rs5082,heart disease
APOA2,Rs5082,increased obesity
APOA2,Rs3813627,severity of coronary atherosclerosis
APOA2,Rs5082,obesity
APOA2,Rs5082,heart disease
APOA2,Rs5082,obesity
APOA2,Rs5082,heart disease 
APOA2,Rs5082,fat 
APOA2,Rs5082,"ages 4, 7 and 10"
APOA2,Rs5082,Body Mass Index 
APOA2,Rs5082,heart disease risk
APOA2,Rs5082,obesit
APOA2,Rs5082,obesity
APOA2,Rs5082,coronary artery disease
APOA2,Rs5082,heart disease
APOA2,Rs5082,type-2 diabetes
APOA2,Rs5082,obesity
APOA2,Rs5082,obesity
APOA5,Rs662799,higher triglyceride levels
APOA5,Rs662799,hypertriglyceridemia
APOA5,Rs662799,SNP 
APOA5,Rs662799,heart attack
APOA5,Rs662799,heart attack
APOA5,Rs662799,SNP 
APOA5,Rs662799,myocardial infarction
APOA5,Rs662799,SNP
APOA5,Rs3135506,prevents weight gain from high fat diets
APOA5,Rs3135506,normolipidemic controls
APOA5,Rs3135506,associated with severe hypertriglyceridemia
APOA5,Rs3135506,severe HTG
APOA5,Rs3135506,hypertriglyceridemia
APOA5,Rs2075291,severe hypertriglyceridemia
APOA5,Rs2075291,doubling of triglyceride levels
APOA5,Rs2075291,risk for hypertriglyceridemia
APOB,Rs144467873,familial hypercholesterolemia type B
APOB,Rs520354,C>T
APOB,Rs520354,Chinese
APOB,Rs520354,biliary tract conditions
APOB,Rs520354,cancer 
APOB,Rs520354,gallstones
APOB,Rs520354,2x risk of bile duct cancer
APOB,Rs693,and LDL-Cholesterol
APOB,Rs520354,men carrying a rs520354(A) allele had a 2x risk of bile duct cancer
APOB,Rs673548,biliary tract cancers and stones
APOB,Rs144467873,apolipoprotein B gene
APOB,Rs673548,coronary heart disease
APOB,Rs673548,risk of biliary tract cancers and stones
APOB,Rs673548,coronary heart disease risk
APOB,Rs693,Elevated Apolipoprotein B
APOB,Rs520354,"biliary tract conditions, including cancer and gallstones,"
APOB,Rs12714264,cardiovascular genetic risk score
APOB,Rs12713559,amilial
APOB,Rs12714264,cardiovascular genetic
APOB,I4000339,Hypercholesterolemia
APOB,I4000339,Hypercholesterolemia
APOB,Rs12713559,SNP
APOB,Rs12714264,SNP
APOB,Rs12713559,hypercholesterolemia
APOB,Rs12713559,type B
APOB,Rs12713559,mutation
APOB,Rs12713559,SNP
APOB,Rs12713559,Hypercholesterolemia
APOB,Rs12713559,Type B
APOB,Rs12713559,familial hypercholesterolemia type B
APOB,Rs12713559,mutation
APOB,Rs12713559,Familial Hypercholesterolemia Type B
APOB,Rs12713559,"familial hypercholesterolemia type B,"
APOB,Rs12714264,cardiovascular genetic risk
APOB,Rs12713559,Familial
APOC3,Rs2542052,longevity
APOC3,Rs2542052,This SNP may be related to longevity
APOC3,Rs2542052,C allele
APOC3,Rs76353203,rs76353203
APOC3,Rs76353203,R19X
APOC3,Rs76353203,apolipoprotein C3 APOC3 gene
APOC3,Rs147210663,decrease in coronary artery disease
APOC3,Rs5128,"genotypes and diabetes exhibited sig. higher triglyceride (p=0.004), total cholesterol (p=0.003) and glucose (p=0.016)"
APOC3,Rs147210663,>40% lower average triglyceride level
APOC3,Rs76353203,rs76353203
APOC3,Rs147210663,loss of function mutations
APOC3,Rs147210663,coronary artery disease
APOC3,Rs138326449,lower average triglyceride level
APOC3,Rs138326449,coronary artery disease
APOC3,Rs140621530,loss of function mutations
APOC3,Rs138326449,corresponding decrease
APOC3,Rs140621530,coronary artery disease
APOC3,Rs147210663,>40% lower average triglyceride level
APOC3,Rs147210663,coronary artery disease
APOC3,Rs140621530,coronary artery disease
APOE,Rs527236160,normal vision
APOE,Rs527236160,symptoms of cardiovascular disease
APOE,Rs527236160,"normal cognitive,"
APOE,Rs527236160,neurological
APOE,Rs527236160,retinal function
APOE,Rs527236160,extremely high cholesterol levels
APOE,Rs527236160,mild atherosclerosis
APOE,Rs7412,Alzheimer's disease
APOE,Rs7412,cardiovascular mortality
APOE,Rs7412,osteoporosis
APOE,Rs7412,Alzheimer's disease
APOE,Rs527236160,homozygous
APOE,Rs7412,coronary artery disease
APOE,Rs7412,Alzheimer's disease
APOE,Rs7412,obstructive sleep apnea in children
APOE,Rs7412,Subarachnoid hemorrhage
APOE,Rs7412,Filipino systemic lupus erythematosus families
APOE,Rs7412,obesity
APOE,Rs527236160,dysbetalipoproteinemia
APOE,Rs449647,Alzheimer's disease
APOE,Rs449647,Alzheimer's disease
APOE,Rs440446,cardiovascular disease
APOE,Rs440446,osteoporosis
APOE,Rs440446,cancer and gallstones
APOE,Rs440446,gallstone disease
APOE,Rs440446,gallbladder cancer
APOE,Rs440446,ampullary cancer
APOE,Rs440446,disorders
APOE,Rs440446,disequilibrium
APOE,Rs440446,haplotype distribution
APOE,Rs440446,late-onset Alzheimer disease
APOE,Rs440446,Alzheimer's disease risk 
APOE,Rs440446,cardiovascular disease
APOE,Rs440446,menopause
APOE,Rs440446,postmenopausal
APOE,Rs440446,cancer
APOE,Rs440446,gallstones
APOE,Rs7412,polymorphisms and menopausal status
APOE,Rs449647,Alzheimer's disease
APOE,Rs449647,Alzheimer's disease
APOE,Rs527236160,DNA 
APOE,Rs7412,Atherosclerosis
APOE,Rs7412,cardiovascular disease
APOE,Rs7412,female reproductive disorders
APOE,Rs7412,Chilean women
APOE,Rs7412,Alzheimer's Disease
APOE,Rs7412,osteoporosis
APOE,Rs7412,postmenopausal women of Northwest India
APOE,Rs7412,Alzheimer disease
APOE,Rs7412,children
APOE,Rs7412,cancer
APOE,Rs7412,Alzheimer's disease
APOE,Rs7412,diabetic nephropathy
APOE,Rs7412,Taiwanese population
APOE,Rs7412,Central Italy population
APOE,Rs769455,obstructive sleep apnea
APOE,Rs769455,Subarachnoid hemorrhage
APOE,Rs769455,obstructive sleep apnea
APOE,Rs769455,Subarachnoid hemorrhage
APOE,Rs769455,obstructive sleep apnea
APOE,Rs769455,Subarachnoid hemorrhage
APOE,Rs769455,Association of ApoE genetic variants with obstructive sleep apnea in children
APOE,Rs769455,Subarachnoid hemorrhage: tests of association with apolipoprotein E and elastin genes.
APOE,Rs7412,gallbladder cancer
APOE,Rs7412,sporadic amyotrophic lateral sclerosis
APOE,Rs7412,carotid artery disease
APOE,Rs7412,white women
APOE,Rs7412,Polycystic ovary syndrome and ovarian response
APOE,Rs7412,Alzheimer's disease
APOE,Rs440446,Alzheimer's disease
APOE,Rs7412,Alzheimer's disease
APOE,Rs7412,Alzheimer's Disease Family
APOE,Rs7412,natural menopause in Caucasian females
APOE,Rs7412,Alzheimer disease
APOE,Rs7412,ischemic stroke
APOE,Rs7412,Alzheimer's disease
APOE,Rs7412,Spanish APOE 4 carriers
APOE,Rs7412,venous thromboembolism
APOE,Rs7412,plasma lipoprotein traits
APOE,Rs7412,multiethnic sample
APOE,Rs7412,coronary heart disease risk
APOE,Rs7412,colorectal cancer
APOE,Rs7412,Brazilian individuals
APOE,Rs7412,cardiovascular risk
APOE,Rs7412,antipsychotic recipients
APOE,Rs7412,Alzheimer's disease
APOE,Rs7412,dyslipidemia
APOE,Rs440446,Alzheimer disease
APOE,Rs527236160,normal cerebrospinal fluid levels of β-amyloid and tau proteins
APOE,Rs440446,osteoporosis
APOE,Rs199768005,might reduce risk of AD
APOE,Rs199768005,markedly reduced risk for AD
APOE,Rs199768005,Familial type 3 hyperlipoproteinemia
APOE,Rs2373115,Alzheimer's risk.
APOE,Rs2373115,risk (OR 4.1) of late-onset Alzheimer's disease
APOE,Rs2373115,risk of Alzheimer's disease
APOE,Rs2373115,odds ratio of 4.06 
APOE,Rs2373115,increased risk for Alzheimer's disease among ApoE4 carriers
APOE,Rs199768005,decrease in AD
APOE,Rs2373115,Alzheimer's
APOE,Rs2373115,Alzheimer's disease
APOE,Rs2373115,Alzheimer
APOE,Rs2373115,Alzheimer's disease
APOE,Rs2373115,Alzheimer's
APOE,Rs267606664,hypertriglyceridemia
APOE,Rs387906567,"hyperlipoproteinemia, type III"
APOE,Rs387906567,autosomal dominant manner
APOE,Rs387906567,defective lipoprotein binding
APOE,Rs2373115, late-onset Alzheimer's disease
APOE,Rs199768005,type 3 hyperlipoproteinemia
APOE,Rs199768005,AD
APOE,Rs199768005,AD
APOE,I5000217,familial hyperlipoproteinemia
APOE,I5000217,hyperlipoproteinemia
APOE,I6007504,familial hyperlipoproteinemia
APOE,I6007504,hyperlipoproteinemia
APOE,Rs121918393,"ApoE-ε2, ApoE-ε3, and ApoE-ε4"
APOE,Rs121918393,type III hyperlipoproteinemia
APOE,Rs121918393,Alzheimer's disease
APOE,Rs121918393,Alzheimer's disease
APOE,Rs121918393,Alzheimer's disease
APOE,Rs440446,Subarachnoid hemorrhage
APOE,Rs121918393,Alzheimer's disease
APOE,Rs121918393,Alzheimer's disease
APOE,Rs121918393,Alzheimer's disease
APOE,Rs121918394,talipoproteinemia. This variant is called i6007512 by 23andMe.The K164Q/K146Q variant is also a dominant mutation leading with high pe
APOE,Rs199768005,AD
APOE,Rs199768005,AD
APOE,Rs199768005,AD
APOE,Rs199768005,AD
APOE,Rs199768005,AD
APOE,Rs405509,Alzheimer's disease
APOE,Rs405509,obstructive sleep apnea
APOE,Rs121918393, Alzheimer's disease
APOE,Rs405509,Alzheimer's disease
APOE,Rs440446,obesity 
APOE,Rs440446,osteoporosis
APOE,Rs440446,disequilibrium 
APOE,Rs440446,Alzheimer 
APOE,Rs440446,Alzheimer's 
APOE,Rs440446,disease 
APOE,Rs440446,disease
APOE,Rs440446,Singaporean Chinese
APOE,Rs440446,polymorphisms 
APOE,Rs440446,insulin resistance
APOE,Rs440446,cancer
APOE,Rs440446,gallstones
APOE,Rs440446,biliary tract conditions
APOE,Rs440446,gallstone disease
APOE,Rs440446,gallbladder cancer
APOE,Rs440446,bile duct cancer
APOE,Rs440446,ampullary cancer
APOE,Rs440446,obesity
APOE,Rs405509,obstructive sleep apnea
APOE,Rs440446,ampullary cancer 
APOE,Rs440446,bile duct cancer
APOE,Rs440446,cardiovascular 
APOE,Rs440446,gallstone disease
APOE,Rs429358, Alzheimer's disease
APOE,Rs440446, gallbladder cancer 
APOE,Rs429358,ethnicity
APOE,Rs429358,late-onset Alzheimer's
APOE,Rs429358,early-onset disease
APOE,Rs429358,increased risk for heart disease
APOE,Rs429358,Alzheimer's disease
APOE,Rs429358,ethnicity
APOE,Rs429358,late-onset Alzheimer's
APOE,Rs429358,early-onset disease
APOE,Rs429358,sex
APOE,Rs429358,heart disease
APOE,Rs429358,Alzheimer's disease
APOE,Rs429358,late-onset Alzheimer's
APOE,Rs429358,early-onset disease
APOE,Rs429358,"heart disease,"
APOE,Rs429358,ApoE status
APOE,Rs439401,snp on the Illumina Human 550
APOE,Rs440446,cancer and gallstones
APOE,Rs429358,increased risk
APOL1,Rs71785313,Trypanosoma brucei rhodesiense. 
APOL1,Rs71785313,kidney disease
APOL1,Rs71785313,Trypanosoma brucei rhodesiense
APOL1,Rs71785313,kidney disease
APOL1,Rs71785313,protection
APOL1,Rs71785313,double heterozygotes
APOL1,Rs71785313,variant
APOL1,Rs71785313,kidney disease
APOL1,Rs71785313,alternative
APOL1,Rs71785313,genotyping
APOL1,Rs71785313,Trypanosoma brucei rhodesiense
APOL1,Rs73885319,kidney disease
APOL1,Rs73885319,Trypanosoma brucei rhodesiense
APOL1,Rs73885319,associate with kidney disease
APOL1,Rs73885319,protection against Trypanosoma brucei rhodesiense
APOL1,Rs71785313,kidney disease
APOL1,Rs71785313,"complete proxy (r2>95%),"
APOL1,Rs60910145,Trypanosoma brucei rhodesiense
APOL1,Rs4419330,A allele 
APOL1,Rs4419330,alleles G1 and G2 of APOL1
APOL1,Rs60910145,kidney disease
APOL1,Rs136175,T allele
APOL1,Rs136175,alleles G1 and G2 of APOL1
APOL1,Rs136175,C allele
APOL1,Rs136175,allele G1
APOL1,Rs136175,alleles G1 and G2 of APOL1
APOL1,Rs136176,A allele 
APOL1,Rs136176,T allele
APOL1,Rs136175,A allele 
APOL1,Rs136176,C allele
APOL1,Rs136176,allele G1
APOL1,Rs136176,alleles G1 and G2 of APOL1
APOL1,Rs4419330,T allele
APOL1,Rs4419330,alleles G1 and G2 of APOL1
APOL1,Rs4419330,C allele
APOL1,Rs136176,alleles G1 and G2 of APOL1
APOL1,Rs4419330,allele G1
APOM,Rs3117582,lung cancer 
APOM,Rs3117582,lung cancer
APOM,Rs3117582,lung cancer
APP,Rs63750671,Alzheimer dementia 
APP,Rs63750671,cerebral haemorrhage 
APP,Rs63750671,Presenile dementia 
APP,Rs63750671,Alzheimer's disease
APP,Rs63750671,cerebral amyloid angiopathy
APP,Rs63750671,cerebral haemorrhage
APP,Rs63750671,Flemish mutation
APP,Rs63750671,Alzheimer's disease
APP,Rs63750671,Presenile Alzheimer dementia
APP,Rs63750671,Presenile dementia
APP,Rs63750671,Alzheimer's disease.
APP,Rs63750671,Alzheimer's disease
APP,Rs63750734,pathogenic for Alzheimer's disease
APP,Rs63750973,Alzheimer's disease
APP,Rs63750847,Alzheimer's disease
APP,Rs63750847,myocardial infarction
APP,Rs63750847,Alzheimer's disease
APP,Rs63750851,early-onset Alzheimer's disease
APP,Rs63751122,Pro
APP,Rs63750868,rare mutation
APP,Rs63750868,Alzheimer's disease
APP,Rs63750921,cerebral amyloid angiopathy
APP,Rs63750921,cerebral amyloid angiopathy
APP,Rs63751039,Alzheimer's disease
APP,Rs63751039,Alzheimer's disease
APP,Rs63751122,Leu
APP,Rs63750671,Alzheimer's disease
APP,Rs63750734,"rs63750734, also known as c.2143G>A, p.Val715Met and V715M, represents a rare mutation in the APP gene.Inherited dominantly, the minor allele is considered pathogenic for Alzheimer's disease"
APP,Rs63750671,cerebral amyloid angiopathy
APP,Rs63750868,Alzheimer's disease
APP,Rs63750579,cerebral amyloid angiopathy
APP,Rs63750671,Alzheimer's disease
APP,Rs145564988,Alzheimer's disease
APP,Rs145564988,Alzheimer's disease
APP,Rs281865161,Alzheimer's disease
APP,Rs281865161,Alzheimer's disease
APP,Rs281865161,double mutation
APP,Rs281865161,gene.
APP,Rs281865161,'Swedish mutation'
APP,Rs281865161,Inherited dominantly
APP,Rs281865161,pathogenic for Alzheimer's disease
APP,Rs63750064,Alzheimer's disease
APP,Rs63750064,rare mutation
APP,Rs63750064,G>C mutation
APP,Rs281865161,early-onset form of Alzheimer's
APP,Rs63750064,inherited dominantly
APP,Rs63750579,cerebral amyloid angiopathy
APP,Rs63750579,pathogenic for cerebral amyloid angiopathy
APP,Rs63750399,Alzheimer's disease
APP,Rs63750064,early-onset Alzheimer's disease
APP,Rs63750066,early-onset Alzheimer's disease
APP,Rs63750066,cerebral amyloid angiopathy
APP,Rs63750399,pathogenic
APP,Rs63750064,early-onset Alzheimer's disease
APP,Rs63750064,early-onset Alzheimer's disease
APP,Rs63750064,inherited dominantly
APP,Rs63750064,"associated with early-onset Alzheimer's disease,"
APP,Rs63750064,G>A mutation
APP,Rs63750066,Alzheimer's disease
AQP4,Rs9951307,severe brain edema
AQP4,Rs9951307,development of brain edema
AQP4,Rs9951307,main water channel in the brain
AQP4,Rs9951307,severe brain edema
AQP4,Rs9951307,middle cerebral artery occlusion with and without severe brain edema
AQP4,Rs9951307,ischemic stroke
AQP4,Rs9951307,severe brain edema
AQP4,Rs9951307,middle cerebral artery occlusion 
AQP4,Rs9951307,middle cerebral artery occlusion
AQP4,Rs9951307,brain edema
AQP4,Rs9951307,brain edema
AQP4,Rs9951307,brain edema
AQP4,Rs9951307,ischemic stroke
AQP4,Rs9951307,brain edema
AQP4,Rs9951307,severe brain edema
AQP4,Rs9951307,main water channel in the brain and is implicated
AQP4,Rs9951307,ischemic stroke
AR,Rs137852591,2 cm shorter than non-carriers
ARG1,Rs377280518,hyperargininemia
ARG1,Rs377280518,argininemia
ARG1,Rs377280518,recessive mutation
ARG1,Rs377280518,chromosome 6
ARG1,Rs377280518,variant
ARG1,Rs2781659,bronchodilator response
ARG1,Rs2781659,lower BDR compared to the homozygous major allele
ARG1,Rs2781659,Asthma
ARG1,Rs2781659,bronchodilator response
ARG1,Rs2781659,Asthma 
ARHGAP24,Rs7660702,Genome-wide association
ARHGAP24,Rs7692808,Genome-wide association
ARID5B,Rs10994982,childhood B-cell acute lymphoblastic leukemia
ARID5B,Rs7089424, racial differences in leukemia incidence.
ARID5B,Rs7089424,childhood acute lymphoblastic leukemia risk
ARID5B,Rs7089424,leukemia
ARID5B,Rs7089424,childhood acute lymphoblastic leukemia risk in the Thai population
ARID5B,Rs7089424,acute lymphoblastic leukemia
ARID5B,Rs10994982,acute lymphoblastic leukemia
ARID5B,Rs10994982,association of ARID5B
ARID5B,Rs7089424,childhood B-cell acute lymphoblastic leukemia
ARID5B,Rs10994982,hildhood B-cell acute lymphoblastic leukemia.
ARID5B,Rs10994982,childhood B-cell acute lymphoblastic leukemia
ARID5B,Rs10994982,confirms the association
ARID5B,Rs10994982,childhood B-cell acute lymphoblastic leukemia.
ARID5B,Rs10994982,childhood B-cell acute lymphoblastic leukemia.
ARID5B,Rs10994982,childhood B-cell acute lymphoblastic leukemia
ARID5B,Rs10994982,childhood B-cell acute lymphoblastic leukemia
ARID5B,Rs10994982,B-cell acute lymphoblastic leukemia
ARMS2,Rs3750847,macular degeneration
ARMS2,Rs3750847,maculopathy
ARMS2,Rs3750847,macular degeneration
ARMS2,Rs3750847,macular degeneration
ARMS2,Rs3750847,Japanese
ARMS2,Rs3750848,age-related macular degeneration
ARMS2,Rs3750848,macular degeneration
ARMS2,Rs3750848,macular degeneration
ARMS2,Rs3750847,macular degeneration
ARMS2,Rs3750848,age-related macular degeneration
ARMS2,Rs3750848,age-related macular degeneration
ARMS2,Rs3750848,polypoidal choroidal vasculopathy
ARMS2,Rs3750847,macular degeneration
ARMS2,Rs3750847,macular degeneration
ARMS2,Rs3750847,"association with ARMD Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. CFH, ELOVL4, PLEKHA1 and LOC387715 genes and susceptibility to age-relate"
ARMS2,Rs3750847,maculopathy
ARMS2,Rs3750847,macular degeneration
ARMS2,Rs3750847,OC387715 in age-related macular degeneration. Genome-wide as
ARMS2,Rs3750847,LOC387715 
ARMS2,Rs10490924,Alzheimer's disease
ARMS2,Rs10490924,polypoidal choroidal vasculopathy
ARMS2,Rs10490924,CFH
ARMS2,Rs10490924,polypoidal choroidal vasculopathy
ARMS2,Rs10490924,neovascular AMD
ARMS2,Rs10490924,geographic atrophy
ARMS2,Rs10490924,choroidal neovascularization
ARMS2,Rs10490924,macular degeneration
ARMS2,Rs3750847,macular degeneration
ARSA,Rs74315455,Gly101Val
ARSA,I6007566,pseudoarylsulfatase A deficiency
ARSA,Rs74315455,Gly101Asp
ARSA,I6007566,sulfatase A deficiency
ARSA,I6007566,A deficiency
ASAP1,Rs3057,perfect pitch
ASAP1,Rs3057,perfect pitch
ASAP1,Rs3057,the ability to hear musical notes
ASL,Rs28940286,c.1153
ASL,Rs28940286, R385
ASL,Rs28940286,Cys
ASL,Rs367543006,Gln116Ter
ASL,Rs749788626,argininosuccinate lyase deficiency
ASL,Rs749788626,argininosuccinate lyase deficiency
ASL,Rs751590073,Arg182Gln
ASL,Rs752100894,argininosuccinate lyase deficiency
ASL,Rs752100894,argininosuccinate lyase deficiency
ASL,Rs752100894,pathogenic
ASL,Rs752100894,argininosuccinate lyase deficiency
ASL,Rs769960006,argininosuccinate lyase deficiency
ASL,Rs769960006,argininosuccinate lyase deficiency
ASL,Rs796051933,1045_1057delGTCATCTCTACGC 
ASL,Rs751590073,R182Q
ASL,Rs28940286,p.Arg385
ASL,Rs202142867,pathogenic for argininosuccinate lyase deficiency
ASL,Rs145138923,Arg12Gln 
ASL,Rs142637046,this mutation is referred
ASL,Rs143793815,argininosuccinate lyase deficiency
ASL,Rs143793815,pathogenic allele
ASL,Rs143793815,argininosuccinate lyase deficiency
ASL,Rs143793815,"T, p.Thr131Met"
ASL,Rs202142867,argininosuccinate lyase deficiency
ASL,Rs143793815,T131M
ASL,Rs143793815,ClinVar
ASL,Rs143793815,argininosuccinate lyase deficiency
ASL,Rs143793815,pathogenicity
ASL,Rs143793815,pathogenic allele
ASL,Rs145138923,R12Q
ASL,Rs145138923,Arg12Gln
ASL,Rs143793815,argininosuccinate lyase deficiency
ASPA,Rs780936696,ASPA gene variant
ASPA,Rs780936696,the minor allele is a pathogenic mutation (for Canavan disease)
ASPA,Rs28940574,Canavan disease
ASPA,Rs104894552,i5006787
ASPA,Rs104894552,D249V23andMe 
ASPA,Rs104894552,Asp249Val
ASPA,Rs12948217,Canavan disease
ASS1,Rs7860909,Argininosuccinate synthase 1
ASS1,Rs35269064,AncestryDNA
ASS1,Rs35269064,benign
ASS1,Rs666174,Argininosuccinate synthase
ASS1,Rs666174,Argininosuccinate synthase 1
ASS1,Rs7860909,Argininosuccinate synthase
ASTN2,Rs4838255,schizophrenic
ASTN2,Rs4838255,result of perphenazine
ASTN2,Rs4838255,schizophrenics
ASXL1,Rs373145711,"Bohring-Opitz syndrome,"
ASXL1,Rs373145711,of somatic mosaicism
ASXL1,Rs373145711,a case of somatic mosaicism
ASXL1,Rs373145711,Bohring-Opitz syndrome
ASXL1,Rs373145711,Bohring-Opitz 
ASXL1,Rs373145711,Bohring-Opitz syndrome
ASXL1,Rs373145711,somatic mosaicism
ASXL1,Rs373145711,somatic mosaicism
ASXL1,Rs373145711,Bohring-Opitz syndrome
ASXL1,Rs373145711,mutation
ASXL1,Rs373145711,mutation
ASXL1,Rs373145711,Bohring-Opitz syndrome
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn disease
ATG16L1,Rs2241880,disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Celiac Diseasers
ATG16L1,Rs2241880,Inflammatory Bowel Diseases
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880, ileal disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,hyperinflammation
ATG16L1,Rs2241880,disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn's disease 
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,NOD2-induced hyperinflammation.
ATG16L1,Rs2241880,disease 
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,autoimmune
ATG16L1,Rs2241880,disease
ATG16L1,Rs2241880,inflammatory bowel diseases
ATG16L1,Rs2241880,celiac disease.
ATG16L1,Rs2241880, inflammatory
ATG16L1,Rs2241880,disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,type 2 diabetes
ATG16L1,Rs2241880,autoimmune and inflammatory diseases
ATG16L1,Rs2241880,inflammation
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,sclerosing cholangitis and primary biliary cirrhosis
ATG16L1,Rs2241880,disease 
ATG16L1,Rs2241880,disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,polymorphism 
ATG16L1,Rs2241880,Asians
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,inflammatory bowel diseases
ATG16L1,Rs2241880,Inflammatory Bowel Diseases
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,ileal disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241879,Crohn's disease
ATG16L1,Rs10210302,homozygotes
ATG16L1,Rs10210302,heterozygotes 
ATG16L1,Rs10210302,Crohn's disease
ATG16L1,Rs2241880,inflammatory bowel disease
ATG16L1,Rs2241880,Crohn disease
ATG16L1,Rs2241880,Celiac Disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,polymorphism 
ATG16L1,Rs2241880,nflammatory bowel disease
ATG16L1,Rs2241880,polymorphisms 
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,inflammatory bowel disease
ATG16L1,Rs2241880,inflammatory bowel disease
ATG16L1,Rs2241880,celiac disease
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn disease
ATG16L1,Rs2241880,type 2 diabetes
ATG16L1,Rs2241880,autoimmune and inflammatory diseases
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,cirrhosis 
ATG16L1,Rs2241880,sclerosing cholangitis
ATG16L1,Rs2241880,inflammatory bowel disease
ATG16L1,Rs2241880,polymorphism 
ATG16L1,Rs2241880,Crohn's disease
ATG16L1,Rs2241880,Crohn's disease
ATIC,Rs4673993,rheumatoid arthritis
ATIC,Rs4673993,polymorphisms 
ATM,Rs1801673,SNPs
ATM,Rs3092856,SNP
ATM,Rs28904921,breast cancer
ATM,Rs28904921,breast cancer
ATM,Rs28904921,cancers
ATM,Rs28904921,breast cancer
ATM,Rs28904921,breast cancer
ATM,Rs28904921,cancers 
ATM,Rs28904921,breast cancer
ATM,Rs28904921,breast cancer
ATM,Rs1801673,allele
ATM,Rs1801673,SNP
ATM,Rs1801673,breast cancer
ATM,Rs1801673,breast cancer
ATM,Rs1801673,SNPs
ATM,Rs1801673,breast cancer
ATM,Rs3092856, ATM gene
ATM,Rs3092856,variant
ATM,Rs1801673,variant
ATM,Rs3092856,breast cancer
ATM,Rs4987945,breast cancer
ATM,Rs4987945,breast cancer
ATM,Rs3218695,breast cancer
ATM,Rs3218695,increased risk
ATM,Rs3218695,breast cancer
ATM,Rs3218695,breast cancer
ATM,Rs3218695,risk for breast cancer
ATM,Rs3092856,SNPs
ATM,Rs3218695,breast cancer
ATM,Rs3218695,breast cancer
ATM,Rs3092856,allele
ATM,Rs3092856,SNP
ATM,Rs3092856,breast cancer
ATM,Rs3092856,breast cancer
ATM,Rs4987945,breast cancer
ATM,Rs3092856,SNPs
ATM,Rs3218695,breast cancer entry
ATM,Rs1801673, ATM gene
ATM,Rs1800056,increased risk
ATM,Rs1800058,contralateral breast cancer
ATM,Rs1800056,breast cancer
ATM,Rs1800056,breast cancer
ATM,Rs1800056,breast cancer
ATM,Rs1800056,breast tumour
ATM,Rs1800056,breast cancer
ATM,Rs1800056,breast cancer
ATM,Rs1800056,breast cancer
ATM,Rs1800056,breast cancer
ATM,Rs1800056,contralateral breast cancer
ATM,Rs1800056,breast tumour
ATM,Rs1800056,breast cancer
ATM,Rs1800056,breast cancer
ATM,Rs1800056,breast cancer
ATM,Rs1800056,increased risk for breast cancer
ATM,Rs1800056,breast cancer
ATM,Rs1801673,SNP
ATM,Rs1800056,breast cancer
ATM,Rs1800056,breast cancer
ATM,Rs1800056,breast cancer
ATM,Rs1800056,breast tumour
ATM,Rs1800056,Breast Cancer
ATM,Rs1800058, breast cancer
ATM,Rs1800058,Breast Cancer
ATM,Rs1800058,breast tumour 
ATM,Rs1800058,breast cancer
ATM,Rs1800058,breast cancer
ATM,Rs1800057,breast cancer susceptibility
ATM,Rs1800057,breast tumour
ATM,Rs1800058,breast tumour 
ATM,Rs1800057,risk for breast cancer
ATM,Rs1800057,radiotolerant prostate brachytherapy
ATM,Rs1800057,post-lumpectomy
ATM,Rs1800057,radio-sensitivity
ATM,Rs1800057,breast cancer.
ATM,Rs1800056,contralateral breast cancer
ATM,Rs1800056,reduced risk
ATM,Rs1800057,Breast Cancer
ATP13A2,Rs1057519292,Gln122Ter
ATP1A2,Rs28933400,with essential hypertension.
ATP7A,Rs2227291,prone to epigenetic alterations
ATP7A,Rs2227291,nonrandom pattern
ATP7A,Rs2227291,X-inactivation in female human embryonic stem cells
ATP7A,Rs2227291,X-inactivation in female human embryonic stem cells
ATP7A,Rs2227291,X-inactivation in female human embryonic stem cells
ATP7A,Rs2227291,X-inactivation in female human embryonic stem cells
ATP7A,Rs2227291,prone to epigenetic alterations
ATP7A,Rs2227291,epigenetic alterations
ATP7B,Rs137853280,common/normal genotype
ATP7B,Rs76151636,associated with Wilson's disease
ATP7B,Rs28942074,disease 
ATP7B,Rs28942074,Wilson's 
ATP7B,Rs28942074,Wilson's disease
ATP7B,Rs137853280,"carry the common/normal genotype,"
ATP7B,Rs137853280,minor homozygote and an affected individual predicted to develop Wilson's disease.
ATP7B,Rs137853280,Ancestry 
ATP7B,Rs76151636,European populations
ATP7B,Rs137853280,Ancestry users
ATP7B,Rs137853280,Wilson's disease
ATP7B,Rs137853280, minor homozygote
ATP7B,Rs137853280,Wilson's disease
ATP7B,Rs137853280,pathogenic mutations 
ATP7B,Rs137853280,Wilson's disease
ATP7B,Rs137853280,Wilson's disease
ATP7B,Rs1061472,Wilson disease
ATP7B,Rs137853280,Promethease
ATP8B4,Rs55687265,systemic sclerosis
ATR,Rs6782400,ataxia-telangiectasia
ATR,Rs6782400,ataxia-telangiectasia
ATR,Rs6782400,was slightly more pronounced in nonsmokers and in carriers
ATR,Rs6782400,were associated with a 43% decreased
ATR,Rs6782400,lung cancer
ATR,Rs6782400,lung cancer
ATR,Rs2227928,pancreatic cancer patients
ATR,Rs2227928,pancreatic cancer
ATR,Rs2227928,pancreatic cancer
ATR,Rs2227928,pancreatic cancer
ATR,Rs2227928,for pancreatic cancer patients
ATXN1,Rs179943,were also significantly associated with Alzheimer’s disease
ATXN2,Rs7137828,longevity
ATXN2,Rs7137828,longevity
ATXN2,Rs7137828,longevity
ATXN2,Rs653178, blood pressure
ATXN2,Rs653178,risk of hypertension
ATXN2,Rs653178,SNP 
ATXN2,Rs653178,hypertension
ATXN2,Rs653178,celiac disease
ATXN2,Rs653178,hypertension
ATXN2,Rs653178,celiac disease
ATXN2,Rs7137828,longevity
ATXN2,Rs653178,celiac disease
AURKA,Rs8173,prostate cancer
AURKA,Rs8173,Bladder cancer
AURKA,Rs8173,prostate cancer risk
AURKA,Rs8173,Bladder cancer
BAAT,Rs1572983,Genetic polymorphism
BAAT,Rs1572983,Japanese individuals
BAAT,Rs1572983,Genetic polymorphism
BAAT,Rs1572983,Genetic polymorphism
BAAT,Rs1572983,bile acid CoA
BAAT,Rs1572983,amino acid N-acyltransferase
BAAT,Rs1572983,Japanese individuals
BACE1,Rs638405,Alzheimer's disease
BACE1,Rs638405,Korean
BACE1,Rs638405,Chinese
BACE1,Rs638405,ncreased risk for Alzheimer's disease
BACE1,Rs638405,Alzheimer's disease
BACE1,Rs638405,Alzheimer's disease
BACE1,Rs638405,Alzheimer's disease
BACE1,Rs638405,ncreased risk for late-onset
BACE1,Rs638405,increased risk for Alzheimer's disease appear to be seen in individuals who are also ApoE4 carriers
BACE1,Rs638405,late-onset Alzheimer's disease
BACE1,Rs638405,increased risk for late-onset Alzheimer's disease
BACE1,Rs4938369,sporadic Alzheimer's disease 
BACE1,Rs4938369,sporadic Alzheimer's disease
BACE1,Rs4938369,Alzheimer's disease
BACE1,Rs638405,late-onset Alzheimer's disease
BAK1,Rs5745582,autoimmune rheumatic diseases
BAK1,Rs513349,autoimmune rheumatic diseases
BAK1,Rs5745582,rheumatic diseases
BAK1,Rs210138,testicular cancer
BAK1,Rs513349,rheumatic diseases
BANK1,Rs17266594,systemic lupus erythematosus genetic associations
BANK1,Rs3733197,gene associated with systemic lupus erythematosus.
BANK1,Rs17266594,autoantibody production
BANK1,Rs17266594,systemic lupus erythematosus
BANK1,Rs17266594,systemic lupus erythematosus
BANK1,Rs17266594,rheumatoid arthritis
BANK1,Rs17266594,odds ratio observed was 1.22
BANK1,Rs17266594,systemic lupus erythematosus
BANK1,Rs17266594,systemic lupus erythematosus susceptibility and autoantibody production
BANK1,Rs17266594,rheumatoid arthritis
BANK1,Rs10516487,systemic lupus erythematosus
BANK1,Rs17266594,systemic lupus
BANK1,Rs17266594,systemic lupus erythematosus
BANK1,Rs10516487,SLE
BANK1,Rs10516487,systemic lupus erythematosus
BANK1,Rs10516487,lupus
BANK1,Rs10516487,lupus
BANK1,Rs10516487,"The association between rs10516487 and lupus was replicated in a study of 1892 European-derived SLE patients and 2652 European-derived controls; the odds ratio observed was 1.22 (CI: 1.11-1.34, corrected p-value=2.59 x 10e-5)."
BANK1,Rs17266594,lupus erythematosus
BANK1,Rs17266594,BANK1 gene
BANK1,Rs10516487,rs17266594 rs10516487 rs3733197 gene associated with systemic lupus erythematosus.
BARD1,Rs3768716,aggressive neuroblastoma
BARD1,Rs6435862,aggressive neuroblastoma
BCAM,Rs1135062,Auberger blood group
BCAM,Rs1135062,Lutheran blood group
BCAR1,Rs7190458,Pancreatic cancer
BCAR1,Rs7190458,pancreatic cancer
BCAR1,Rs7190458,breast cancer
BCHE,Rs28933389,BCHE activity
BCHE,Rs28933389,Pseudocholinesterase Deficiency
BCHE,Rs28933389,Pseudocholinesterase Deficiency
BCKDHA,Rs398123489,p.Arg40Glyfs
BCKDHA,Rs137852870,Old Order Mennonites 
BCKDHA,Rs137852870,Maple Syrup Urine Disease
BCKDHA,Rs137852870,Maple Syrup Urine Disease
BCKDHA,Rs137852870,rs137852870(A) varian
BCKDHA,Rs398123489,mutation
BCKDHA,Rs398123489,Maple Syrup Urine Disease
BCKDHA,Rs398123489,Urine Disease
BCKDHA,Rs398123489,rs398123489
BCKDHA,Rs398123489,c.117delC
BCKDHA,Rs398123489,BCKDHA gene
BCKDHB,I4000422,Urine 
BCKDHB,I4000422,Disease 
BCKDHB,Rs150084361,SNP 
BCKDHB,I4000422,Syrup 
BCKDHB,Rs150084361,dbSNP 
BCKDHB,Rs150084361,rs150084361
BCKDHB,Rs28934895,"Maple Syrup Urine Disease,"
BCKDHB,Rs150084361,rs386834233
BCKDHB,I4000422,DiseaseMaple 
BCKDHB,I4000422,Maple Syrup Urine Disease
BCKDHB,I4000422,moczu 
BCKDHB,I4000422,Chorób 
BCKDHB,I4000422,Maple Syrup Urine Disease Type 1
BCKDHB,I4000422, Maple Syrup Urine Disease
BCKDHB,I4000422,Maple Syrup Urine Disease
BCKDHB,I3002808,Urine Disease
BCKDHB,I3002808,"Maple Syrup Urine Disease, Type 1B"
BCKDHB,I4000422,Urine 
BCL2,Rs956572,bipolar disorder
BCL2,Rs956572,The Bcl-2 gene polymorphism
BCL2,Rs956572,bipolar disorder
BCL2,Rs1801018,cancer 
BCL2,Rs1801018,Chronic myeloid leukemia
BCL2,Rs1801018,azoospermia 
BCR,Rs2156921,depression
BCR,Rs2267015,"rs2267015, a SNP in the BCR gene on chromosome 22, has been associated with increased risk for depression. The odds ratio for carriers of the minor allele (A) are reported as 1.3 (p=0.023) based on a study of 329 Japanese patients"
BCR,Rs3761418,increased risk for depression
BCR,Rs2267015,increased risk for depression
BCR,Rs2267015,depression
BCR,Rs2267013,minor allele
BCR,Rs2267013,depression
BCR,Rs2267013,chromosome
BCR,Rs2267013,BCR gene
BCR,Rs2267013,SNP
BCR,Rs2267013,depression
BCR,Rs140504,allele 
BCR,Rs131690,bipolar disorder
BCR,Rs140504,disorder
BCR,Rs140504,bipolar 
BCR,Rs140504,BCR 
BCR,Rs140504,gene 
BCR,Rs140504,chromosome 
BCR,Rs131702,Japanese
BCR,Rs131702,minor allele
BCR,Rs131702,increased risk for bipolar disorder
BCR,Rs131702,chromosome 22
BCR,Rs131690,Japanese patients.
BCR,Rs131690,bipolar disorder.
BCR,Rs140504,minor 
BDKRB2,Rs945032,"panic disorder, bipolar disorder, and drug abuse|substance abuse"
BDKRB2,Rs945032,drug abuse|substance abuse
BDKRB2,Rs945032,associated with panic disorder
BDKRB2,Rs945032,bipolar disorder
BDNF,Rs7103411,schizoaffective disorder
BDNF,Rs6265,brain-derived neurotrophic
BDNF,Rs6265,short-term motor learning
BDNF,Rs6265,depression 
BDNF,Rs6265,lost memory
BDNF,Rs6265,thinking skills
BDNF,Rs6265,suicidal behaviour
BDNF,Rs6265, Alzheimer's disease
BDNF,Rs6265,lower body mass
BDNF,Rs7103411,Huntington's disease
BDNF,Rs7103411,attention-deficit/hyperactivity disorde
BDNF,Rs7103411,Brain-derived neurotrophic factor
BDNF,Rs7103411,schizophrenia
BDNF,Rs7124442,depressive symptoms
BDNF,Rs7103411,childhood IgA nephropathy
BDNF,Rs7124442,anorexia
BDNF,Rs7124442,bulimia
BDNF,Rs7124442,elderly population.
BDNF,Rs7124442,Altered brain-derived neurotrophic factor blood levels
BDNF,Rs7124442,bulimia
BDNF,Rs7124442,depressive symptoms
BDNF,Rs7124442,anorexia
BDNF,Rs7124442,bulimia
BDNF,Rs7124442,anorexia 
BDNF,Rs7124442,bulimia
BDNF,Rs7124442,asthmatic 
BDNF,Rs6265,A allele
BDNF,Rs7103411,bipolar disorder
BDNF,Rs6265,G allele
BDNF,Rs7124442,anorexia
BDNF,Rs2030324,schizophrenia
BDNF,Rs11030104,"Alzheimer's disease risk for non ApoE4 carriers is affected by the heterozygous form of rs6265, as well as the diplotypes of rs6265, rs11030104, and rs2049045."
BDNF,Rs12291063,Hispanic 
BDNF,Rs12291063,Brain-Derived Neurotrophic Factor
BDNF,Rs12291063,higher BMI
BDNF,Rs12291063,adiposity
BDNF,Rs12291063,in vivo
BDNF,Rs12291063,Human Obesity
BDNF,Rs2049045,"Alzheimer's disease risk for non ApoE4 carriers is affected by the heterozygous form of rs6265, as well as the diplotypes of rs6265, rs11030104, and rs2049045."
BDNF,Rs12291063,Hispanic
BDNF,Rs12291063,African-American
BDNF,Rs12291063,obesity 
BDNF,Rs2030324,nicotine dependence association
BDNF,Rs2030324,schizophrenia
BDNF,Rs2030324,brain-derived neurotrophic factor
BDNF,Rs12291063,Human Obesity
BDNF,Rs2030324,prophylactic lithium response
BDNF,Rs2030324,bipolar disorder
BDNF,Rs2030324,bipolar disorder
BDNF,Rs2030324,major depression
BDNF,Rs2030324,asthmatic
BDNF,Rs2030324,bipolar
BDNF,Rs2030324,bipolar disorde
BDNF,Rs2030324,multiple sclerosis
BDNF,Rs2030324,schizophrenia.
BDNF,Rs2030324,ipolar disorder
BDNF,Rs2030324,major depression
BDNF,Rs2030324,multiple sclerosis
BDNF,Rs2030324,bipolar
BDNF,Rs2030324,schizophrenia
BHMT,Rs585800,norepinephrine levels
BHMT,Rs651852,stress
BHMT,Rs585800,gut environment
BHMT,Rs585800,psychological stress
BHMT,Rs585800,patient's attention levels
BHMT,Rs617219,patient's attention levels.
BHMT,Rs617219,ADD
BHMT,Rs617219,ADHD
BHMT,Rs651852,ADD/ADHD
BHMT,Rs651852,cortisol levels
BHMT,Rs651852,ADD/ADHD
BHMT,Rs651852,gut environment
BHMT,Rs651852,psychological stress
BHMT,Rs651852,convert homocysteine to methionine
BHMT,Rs651852,stress
BHMT,Rs651852,cortisol levels
BHMT,Rs651852,norepinephrine levels
BHMT,Rs651852,gut environment
BHMT,Rs651852,psychological stress
BHMT,Rs651852,patient's attention levels
BHMT,Rs585800,ADD/ADHD
BHMT,Rs651852,norepinephrine levels
BHMT,Rs585800,cortisol levels
BHMT,Rs585800,ADD/ADHD
BHMT,Rs585800,convert homocysteine to methionine
BHMT,Rs3733890,neural tube defects
BHMT,Rs567754,ADD/ADHD
BHMT,Rs567754,stress
BHMT,Rs585800,stress
BHMT,Rs567754,norepinephrine levels
BHMT,Rs567754,gut environment
BHMT,Rs567754,psychological stress
BHMT,Rs567754,convert homocysteine to methionine
BHMT,Rs567754,stress
BHMT,Rs567754,cortisol levels
BHMT,Rs567754,cortisol levels
BHMT,Rs567754,norepinephrine levels
BHMT,Rs567754,gut environment
BHMT,Rs567754,psychological stress
BHMT,Rs567754,patient's attention levels
BHMT,Rs585800,stress
BHMT,Rs585800,cortisol levels
BHMT,Rs585800,norepinephrine levels
BHMT,Rs585800,gut environment
BHMT,Rs585800,psychological stress
BHMT,Rs567754,ADD/ADHD
BLM,I4000396,Bloom syndrome
BLM,Rs2380165,breast cancer
BLOC1S3,Rs2159324,LDL cholesterol and total cholesterol levels
BLOC1S3,Rs2159324,LDL 
BLOC1S3,Rs2159324,cholesterol
BLOC1S3,Rs2159324,cholesterol
BMP2,Rs235754,bone fractures
BMP2,Rs3178250,otosclerosis
BMP2,Rs3178250,otosclerosis 
BMP2,Rs235756,hemochromatosis 
BMP2,Rs235756,C282Y homozygotes
BMP2,Rs235754,speed of sound
BMP2,Rs235754,stiffness
BMP2,Rs235754,women
BMP2,Rs235754,osteoporosis
BMP2,Rs235754,bone density
BMP2,Rs235756,hemochromatosis
BMP2,Rs235754,variant
BMP2,Rs15705,skeletal Class I
BMP2,Rs235754,bone density
BMP2,Rs235754,bone fractures or osteoporosis
BMP2,Rs235754,osteoporosis
BMP2,Rs235754,bone morphogenic protein-2 BMP
BMP2,Rs235754,associated with two parameters associated with bone density
BMP2,Rs235754,likelihood of bone fractures or osteoporosis
BMP2,Rs235754,associated with the ultrasound parameters speed of sound and stiffness.
BMP2,Rs235754,SNP rs235754
BMP2,Rs235754,ultrasound parameters speed of sound and stiffness.
BNC2,Rs10810635,freckles.
BNC2,Rs10738445,adolescent scoliosis (AIS)
BNC2,Rs10738445,intron of the BNC2 gene
BNC2,Rs10738445,chromosome 9
BNC2,Rs10738445,increased BNC2 expression
BNC2,Rs10810635,freckles
BNC2,Rs2153271,freckling
BRAF,Rs121913355,cancers
BRAF,Rs121913355,rasopathy
BRCA1,Rs80357714,BRCA
BRCA1,Rs80357711,breast cancer
BRCA1,Rs80357688,breast cancer
BRCA1,Rs80357688,breast cancer
BRCA1,Rs80357669,deletion variant in the BRCA1 gene
BRCA1,Rs80357654,pathogenic for breast cancer in ClinVar
BRCA1,Rs80357654,variant in the BRCA1 gene
BRCA1,Rs80357654,a variant in the BRCA1 gene considered pathogenic
BRCA1,Rs80357654,breast cancer
BRCA1,Rs80357654,breast cancer
BRCA1,Rs80357641,pathogenic for breast cancer in ClinVar.
BRCA1,Rs80357641,BRCA1 gene
BRCA1,Rs80357641,breast cancer
BRCA1,Rs80357641,pathogenic
BRCA1,Rs80357641,gene
BRCA1,Rs80357641,variant 
BRCA1,Rs80357641,pathogenic 
BRCA1,Rs80357641,breast cancer
BRCA1,Rs80357641,variant in the BRCA1 gene
BRCA1,Rs80357714,breast cancer
BRCA1,Rs80357717,BRCA1 gene
BRCA1,Rs80357714,variant in the BRCA1 gene
BRCA1,Rs80357801,pathogenic 
BRCA1,Rs80357801,breast cancer
BRCA1,Rs80357801,breast cancer
BRCA1,Rs80357786,BRCA1 gene
BRCA1,Rs80357786,breast cancer
BRCA1,Rs80357783,breast cancer
BRCA1,Rs80357783,breast cancer
BRCA1,Rs80357747,breast cancer
BRCA1,Rs80357729,pathogenic for breast cancer
BRCA1,Rs80357714,breast cancer 
BRCA1,Rs80357729,also known as 3746insA
BRCA1,Rs80357729,breast
BRCA1,Rs80357641,rs80357641
BRCA1,Rs80357717,breast cancer
BRCA1,Rs80357717,ClinVar
BRCA1,Rs80357717,breast cancer
BRCA1,Rs80357717,BRCA1 gene considered pathogenic
BRCA1,Rs80357717,breast cancer 
BRCA1,Rs80357717,breast cancer
BRCA1,Rs80357714,pathogenic for breast cancer
BRCA1,Rs80357729,cancer
BRCA1,Rs80357641,4868delAG
BRCA1,Rs80357612,pathogenic for breast cancer
BRCA1,Rs80357641,breast
BRCA1,Rs80357596,BRCA1 gene
BRCA1,Rs80357590,breast cancer in ClinVar.
BRCA1,Rs80357590,BRCA1 gene
BRCA1,Rs80357590,rs80357590
BRCA1,Rs80357583,pathogenic for breast cancer
BRCA1,Rs80357583,pathogenic for breast cancer in ClinVar
BRCA1,Rs80357569,breast cancer
BRCA1,Rs80357558,breast cancer
BRCA1,Rs80357558,BRCA1 gene
BRCA1,Rs80357558,breast cancer
BRCA1,Rs80357558,breast cancer
BRCA1,Rs80357558,pathogenic for breast cancer
BRCA1,Rs80357526,pathogenic
BRCA1,Rs80357526,ClinVar
BRCA1,Rs80357526,breast cancer
BRCA1,Rs80357526,BRCA1
BRCA1,Rs80357526,p.Lys651_Lys652?fs
BRCA1,Rs80357526,c.1953_1956delGAAA
BRCA1,Rs80357801,gene 
BRCA1,Rs80357596,breast cancer
BRCA1,Rs80357641,cancer 
BRCA1,Rs80357597,breast cancer
BRCA1,Rs80357597,variant in the BRCA1 gene 
BRCA1,Rs80357637,pathogenic for breast cancer
BRCA1,Rs80357637,variant in the BRCA1 gene
BRCA1,Rs80357635,breast cancer
BRCA1,Rs80357624,breast cancer
BRCA1,Rs80357623,a variant in the BRCA1 gene considered pathogenic
BRCA1,Rs80357623,breast cancer
BRCA1,Rs80357623,breast cancer
BRCA1,Rs80357612,BRCA1 gene
BRCA1,Rs80357612,variant
BRCA1,Rs80357612,BRCA1 gene
BRCA1,Rs80357612,breast cancer
BRCA1,Rs80357612,breast cancer
BRCA1,Rs80357612,breast cancer
BRCA1,Rs80357609,breast cancer
BRCA1,Rs80357609,BRCA1 gene
BRCA1,Rs80357604,breast cancer
BRCA1,Rs80357604,BRCA1 gene
BRCA1,Rs80357600,breast cancer
BRCA1,Rs80357597,pathogenic for breast cancer
BRCA1,Rs80357597,breast cancer
BRCA1,Rs80357804,pathogenic for breast cance
BRCA1,Rs80357925,breast cancer
BRCA1,Rs80357808,breast cancer
BRCA1,Rs80357971,pathogenic
BRCA1,Rs80357970,BRCA1 gene considered pathogenic for breast cancer in ClinVar
BRCA1,Rs80357970,breast cancer
BRCA1,Rs80357969,a variant in the BRCA1 gene considered pathogenic
BRCA1,Rs80357969, breast cancer
BRCA1,Rs80357969,breast cancer
BRCA1,Rs80357969, breast cancer
BRCA1,Rs80357969,BRCA1 gene
BRCA1,Rs80357945,breast cancer
BRCA1,Rs80357941,breast cancer
BRCA1,Rs80357941, breast cancer
BRCA1,Rs80357526,2072del4
BRCA1,Rs80357925,gene
BRCA1,Rs80357925,variant
BRCA1,Rs80357908,breast cancer
BRCA1,Rs80357908,ClinVar
BRCA1,Rs80357908,BRCA1
BRCA1,Rs80357906,mutation 
BRCA1,Rs80357906,mutation 
BRCA1,Rs80357971,breast cancer
BRCA1,Rs80357906,cancer 
BRCA1,Rs80357971,breast cancer
BRCA1,Rs80357975,breast cancer
BRCA1,Rs80359874,breast cancer
BRCA1,Rs80358158,"rs80358158, also known as c.135-1G>T and c.135-1G>C, represents a variant in the BRCA1 gene"
BRCA1,Rs80357993,breast cancer
BRCA1,Rs80357993,BRCA1 gene
BRCA1,Rs80357993,breast cancer
BRCA1,Rs80357993,variant in the BRCA1 gene
BRCA1,Rs80357993,breast cancer
BRCA1,Rs80357993,breast cancer
BRCA1,Rs80357981,breast cancer
BRCA1,Rs80357981,pathogenic
BRCA1,Rs80357981,pathogenic for breast cancer
BRCA1,Rs80357980,pathogenic for breast cancer
BRCA1,Rs80357980,variant in the BRCA1 gene
BRCA1,Rs80357980,breast cancer
BRCA1,Rs80357980,breast cancer
BRCA1,Rs80357980,pathogenic
BRCA1,Rs80357980,cancer 
BRCA1,Rs80357980,breast 
BRCA1,Rs80357977,breast cancer
BRCA1,Rs80357971,breast cancer
BRCA1,Rs80357804,breast cancer
BRCA1,Rs80357906,breast
BRCA1,Rs80357906,breast cancer
BRCA1,Rs80357853,breast cancer
BRCA1,Rs80357848,breast cancer
BRCA1,Rs80357846,breast cancer
BRCA1,Rs80357846,pathogenic
BRCA1,Rs80357846,gene
BRCA1,Rs80357846,variant
BRCA1,Rs80357846,breast cancer
BRCA1,Rs80357844,breast cancer
BRCA1,Rs80357844,BRCA1 gene 
BRCA1,Rs80357844, breast cancer
BRCA1,Rs80357844,breast cancer
BRCA1,Rs80357829,breast cancer
BRCA1,Rs80357829,pathogenic
BRCA1,Rs80357829,gene
BRCA1,Rs80357829,BRCA1 gene
BRCA1,Rs80357829,breast cancer
BRCA1,Rs80357829,breast cancer
BRCA1,Rs80357823,breast cancer
BRCA1,Rs80357823,breast cancer
BRCA1,Rs80357862,breast cancer
BRCA1,Rs80357906,pathogenic 
BRCA1,Rs80357868,pathogenic 
BRCA1,Rs80357880,breast cancer
BRCA1,Rs80357903,breast cancer 
BRCA1,Rs80357903,breast cancer
BRCA1,Rs80357902,breast cancer
BRCA1,Rs80357902,breast cancer
BRCA1,Rs80357889,breast cancer
BRCA1,Rs80357889,breast cancer in ClinVar
BRCA1,Rs80357889,BRCA1 gene
BRCA1,Rs80357888,breast cancer
BRCA1,Rs80357888,pathogenic
BRCA1,Rs80357888,pathogenic for breast cancer
BRCA1,Rs80357888,breast cancer
BRCA1,Rs80357888,breast cancer
BRCA1,Rs80357887,breast cancer
BRCA1,Rs80357887,breast cancer
BRCA1,Rs80357880,breast cancer in ClinVar.
BRCA1,Rs80357880,variant
BRCA1,Rs80357880,"2224insT, c.2105_2106insT and p.Leu702?fs,"
BRCA1,Rs80357880,rs80357880
BRCA1,Rs80357880, breast cancer 
BRCA1,Rs80357868,breast cancer
BRCA1,Rs80357526,rs80357526
BRCA1,Rs80357508,breast cancer
BRCA1,Rs80357524,BRCA1 gene
BRCA1,Rs4986850,SNP
BRCA1,Rs4986850,SNPedia 
BRCA1,Rs4986850,cancer
BRCA1,Rs4986850,SNPs 
BRCA1,Rs4986850,25
BRCA1,Rs80357524,breast cancer in ClinVar.
BRCA1,Rs4986850,SNPs
BRCA1,Rs4986850,BRCA1 
BRCA1,Rs4986850,SNP
BRCA1,Rs4986850,breast cancer
BRCA1,Rs4986850,breast cancer
BRCA1,Rs4986850,breast cancer
BRCA1,Rs4986850,breast cancer
BRCA1,Rs4986850,breast cancer
BRCA1,Rs4986850,"breast cancer,"
BRCA1,Rs4986850,breast cancer
BRCA1,Rs4986850,breast cancer
BRCA1,Rs4986850,breast cancer
BRCA1,Rs4986850,breast cancer
BRCA1,Rs4986850,minor
BRCA1,Rs386833395,Ashkenazi Jews
BRCA1,Rs55770810,"breast cancer,"
BRCA1,Rs62625308,breast cancer
BRCA1,Rs80356991,breast cancer
BRCA1,Rs80356991,BRCA1 gene
BRCA1,Rs80356925,i6008289
BRCA1,Rs80356925,23andMe 
BRCA1,Rs80356925,ClinVar
BRCA1,Rs80356925,variant 
BRCA1,Rs80356925,BRCA1 
BRCA1,Rs80356925,Ser868Ter
BRCA1,Rs80356925,2603C
BRCA1,Rs80356925,rs80356925
BRCA1,Rs80356925,S868X
BRCA1,Rs80356925,breast cancer
BRCA1,Rs80356925,breast cancer
BRCA1,Rs80356875,breast cancer
BRCA1,Rs80356875,pathogenic
BRCA1,Rs80356875, gene 
BRCA1,Rs80356875,breast cancer
BRCA1,Rs80356875,pathogenic 
BRCA1,Rs62625308,breast cancer
BRCA1,Rs55770810,breast cancer
BRCA1,Rs80357010,breast cancer 
BRCA1,Rs386833395,breast cancer in
BRCA1,Rs273897659,breast cancer 
BRCA1,I5009541,breast cancer
BRCA1,I5009536,breast cancer
BRCA1,I5009526,breast cancer
BRCA1,I5009520,breast cancer
BRCA1,I5009511,breast cancer
BRCA1,I5009493,breast cancer
BRCA1,I4000461,breast cancer
BRCA1,I4000459,breast cancer
BRCA1,I4000459,breast cancer
BRCA1,I4000459,breast cancer
BRCA1,I4000378,breast cancer and ovarian cancer.
BRCA1,I4000378,breast cancer and ovarian cancer.
BRCA1,I4000377,reduced penetrance
BRCA1,I4000377,risk for breast cancer and ovarian cancer
BRCA1,I4000377,BRCA1 gene variant
BRCA1,I4000377,ovarian cancer
BRCA1,I4000377,breast cancer
BRCA1,I4000377,breast cancer
BRCA1,I4000377,ovarian cancer
BRCA1,I5009546,breast cancer
BRCA1,Rs273900730,breast cancer
BRCA1,I5009553,breast cancer
BRCA1,Rs1799950,"along with the two methods used to calculate overall risk estimates for breast cancer, refer to the SNPedia breast cancer entry"
BRCA1,Rs2227945,breast cancer 
BRCA1,Rs2227945,breast cancer
BRCA1,Rs2227945,breast cancer
BRCA1,Rs1799966,breast cancer 
BRCA1,Rs1799966,breast cancer
BRCA1,Rs1799966,breast cancer
BRCA1,Rs1799950,rs1799950
BRCA1,Rs1799950,SNP
BRCA1,Rs1799950, 25 SNPs
BRCA1,Rs1799950,SNPs
BRCA1,Rs1799950,BRCA1 gene
BRCA1,Rs1799950,SNP
BRCA1,Rs1799950,breast cancer
BRCA1,Rs1799950,breast cancer
BRCA1,Rs1799950,breast cancer
BRCA1,Rs1799950,breast cancer
BRCA1,Rs1799950,breast cancer
BRCA1,Rs1799950,breast cancer
BRCA1,Rs1799950,breast cancer
BRCA1,I5009558,breast cancer
BRCA1,Rs80357010,breast cancer
BRCA1,Rs4986850,significant
BRCA1,Rs80357035,breast cancer
BRCA1,Rs80357443,breast cancer
BRCA1,Rs80357443,ClinVar
BRCA1,Rs80357443,BRCA1
BRCA1,Rs80357433,cancer 
BRCA1,Rs80357433,breast 
BRCA1,Rs80357433,BRCA1 gene
BRCA1,Rs80357433,breast cancer
BRCA1,Rs80357405,pathogenic for breast cancer
BRCA1,Rs80357508,breast cancer
BRCA1,Rs80357405,variant in the BRCA1 gene
BRCA1,Rs80357405,pathogenic for breast cancer
BRCA1,Rs80357389,pathogenic for breast cancer
BRCA1,Rs80357389,rare variant in the BRCA1 gene
BRCA1,Rs80357382,breast cancer
BRCA1,Rs80357355,breast cancer
BRCA1,Rs80357355,breast cancer
BRCA1,Rs80357347,breast cancer
BRCA1,Rs80357347,breast cancer
BRCA1,Rs80357405,breast cancer
BRCA1,Rs80357508,BRCA1 gene
BRCA1,Rs80357509,breast 
BRCA1,Rs80357509,cancer 
BRCA1,Rs80357524,rs80357524
BRCA1,Rs80357524,considered pathogenic for breast cancer in ClinVar
BRCA1,Rs80357524,variant in the BRCA1
BRCA1,Rs80357522,breast cancer
BRCA1,Rs80357520,cancer 
BRCA1,Rs80357520,breast 
BRCA1,Rs80357520,pathogenic 
BRCA1,Rs80357520,gene 
BRCA1,Rs80357520,breast 
BRCA1,Rs80357520,cancer 
BRCA1,Rs80357520,rs80357520
BRCA1,Rs80357520,3878delTA
BRCA1,Rs80357511,breast cancer
BRCA1,Rs80357010,BRCA1 gene
BRCA1,Rs80357509,considered pathogenic for breast cancer in ClinVar
BRCA1,Rs80357509,variant in the BRCA1 gene
BRCA1,Rs80357509,breast cancer
BRCA1,Rs80357509,breast cancer
BRCA1,Rs80357509,3485_3485delA 
BRCA1,Rs80357347,pathogenic
BRCA1,Rs80357318,breast cancer
BRCA1,Rs80357511,breast cancer
BRCA1,Rs80357318,variant
BRCA1,Rs80357162,breast cancer
BRCA1,Rs80357161,BRCA1 gene
BRCA1,Rs80357161,breast cancer
BRCA1,Rs80357161,breast cancer in ClinVar.
BRCA1,Rs80357161,BRCA1 gene
BRCA1,Rs80357161,breast cancer
BRCA1,Rs80357131,breast cancer
BRCA1,Rs80357115,breast cancer
BRCA1,Rs80357115,breast cancer
BRCA1,Rs80357115,breast cancer
BRCA1,Rs80357115,pathogenic
BRCA1,Rs80357071,breast cancer
BRCA1,Rs80357071,breast cancer
BRCA1,Rs80357071,breast cancer
BRCA1,Rs80357035,BRCA1 gene
BRCA1,Rs80357035,breast cancer
BRCA1,Rs80357035,breast cancer
BRCA1,Rs80357035,BRCA1 gene 
BRCA1,Rs80357318,BRCA1 gene
BRCA1,Rs80357233,breast cancer
BRCA1,Rs80357233,gene
BRCA1,Rs80357071,pathogenic 
BRCA1,Rs80357233, breast cancer
BRCA1,Rs80357318,breast cancer
BRCA1,Rs80357233,pathogenic
BRCA1,Rs80357318,is a variant in the BRCA1 gene
BRCA1,Rs80357318,pathogenic for breast cancer
BRCA1,Rs80357318,breast cancer
BRCA1,Rs80357292,BRCA1 gene
BRCA1,Rs80357292,variant
BRCA1,Rs80357284,breast cancer
BRCA1,Rs80357284,W1782X
BRCA1,Rs80357284,rs80357284
BRCA1,Rs80357292,breast cancer
BRCA1,Rs80357284,breast 
BRCA1,Rs80357259,is a variant in the BRCA1 gene considered pathogenic for breast cancer
BRCA1,Rs80357259,rs80357259
BRCA1,Rs80357259,breast cancer
BRCA1,Rs80357251,pathogenic for breast cancer
BRCA1,Rs80357251,variant in the BRCA1 gene
BRCA1,Rs80357233,is a variant in the BRCA1 gene considered pathogenic for breast cancer
BRCA1,Rs80357284,cancer 
BRCA1,Rs80357233,rs80357233
BRCA2,Rs1799954,25
BRCA2,Rs1799954,SNPs 
BRCA2,Rs28897756,breast cancer
BRCA2,Rs1799954,SNPedia 
BRCA2,Rs1799954,SNP
BRCA2,Rs1799954,minor
BRCA2,Rs1801426,breast cancer
BRCA2,Rs1801426,breast cancer
BRCA2,Rs1801426,breast cancer
BRCA2,Rs28897756,breast cancer
BRCA2,Rs1799954,SNPs
BRCA2,Rs28897756,breast cancer
BRCA2,Rs1799954,allele 
BRCA2,Rs1799954,BRCA2 
BRCA2,Rs11571833,25
BRCA2,Rs1799954,breast cancer
BRCA2,Rs1799954,increased risk for breast cancer
BRCA2,Rs11571833,allele 
BRCA2,Rs11571833,minor
BRCA2,Rs11571833,SNP
BRCA2,Rs11571833,SNPedia 
BRCA2,Rs11571833,SNPs 
BRCA2,Rs11571833,SNPs
BRCA2,Rs11571833,SNP
BRCA2,Rs11571833,breast cancer
BRCA2,Rs11571833,increased risk for breast cancer
BRCA2,Rs28897756,breast cancer
BRCA2,Rs11571747,"SNP,"
BRCA2,Rs1799954,SNP
BRCA2,Rs28897756,pathogenic
BRCA2,Rs4987117,breast cancer
BRCA2,Rs28897756,risk for breast cancer
BRCA2,Rs11571747, breast cancer
BRCA2,Rs80359550,breast cancer
BRCA2,Rs80359550,breast cancer
BRCA2,Rs4987117,breast cancer
BRCA2,Rs4987117,breast cancer
BRCA2,Rs4987117,breast cancer
BRCA2,Rs4987117,breast cancer
BRCA2,Rs4987117,breast cancer
BRCA2,Rs4987117,BRCA2 gene
BRCA2,Rs4987117,breast cancer
BRCA2,Rs4987117,breast cancer
BRCA2,Rs4987117,BRCA2 gene
BRCA2,Rs4987117,breast cancer
BRCA2,Rs4987117,breast cancer
BRCA2,Rs4987117,calculate overall risk estimates for breast cancer
BRCA2,Rs4987117,increased risk for breast cancer
BRCA2,Rs4987047,allele 
BRCA2,Rs4987047,minor
BRCA2,Rs4987047,SNP
BRCA2,Rs4987047,SNPedia 
BRCA2,Rs4987047,SNPs 
BRCA2,Rs4987047,25
BRCA2,Rs4987047,SNPs
BRCA2,Rs4987047,BRCA2 
BRCA2,Rs4987047,SNP
BRCA2,Rs4987047,breast cancer
BRCA2,Rs4987047,increased risk for breast cancer
BRCA2,Rs28897756,breast cancer
BRCA2,Rs28897756,Dutch families
BRCA2,Rs28897756,breast cancer
BRCA2,Rs11571747,SNP
BRCA2,Rs11571833,BRCA2 
BRCA2,Rs11571747,breast cancer
BRCA2,I5009090,breast cancer
BRCA2,I5005579,developing breast cancer
BRCA2,I5005579,causal/pathogenic BRCA2 mutations
BRCA2,I5005579,breast cancer
BRCA2,I5005579,causal/pathogenic
BRCA2,I5005579,breast cancer
BRCA2,I5005579,mutations
BRCA2,I5005579,breast cancer
BRCA2,I5005578,developing breast cancer
BRCA2,I5005578,causal/pathogenic BRCA2 mutations
BRCA2,I5005578,breast cancer
BRCA2,I5005578,causal/pathogenic
BRCA2,I5005578,breast cancer
BRCA2,I5005578,mutations
BRCA2,I5005578,breast cancer
BRCA2,I5005576,developing breast cancer
BRCA2,I5005576,causal/pathogenic BRCA2 mutations
BRCA2,I5005576,breast cancer
BRCA2,I5005576,causal/pathogenic
BRCA2,I5005576,breast cancer
BRCA2,I5005576,mutations
BRCA2,I5005576,breast cancer
BRCA2,I4000466,cancer
BRCA2,I4000466,breast 
BRCA2,I4000466,mutations 
BRCA2,I4000466,pathogenic 
BRCA2,I4000466,breast cancer
BRCA2,I4000466,breast cancer
BRCA2,I4000379,breast cancer
BRCA2,I5009090,mutations
BRCA2,I5009090,breast cancer
BRCA2,Rs11571747,SNPs 
BRCA2,I5009090,breast cancer
BRCA2,Rs11571747,SNP
BRCA2,Rs11571747,increased risk for breast cancer
BRCA2,Rs11571747,variant in the BRCA2 gene
BRCA2,Rs11571746,allele 
BRCA2,I5009090,causal/pathogenic
BRCA2,Rs11571746,minor
BRCA2,Rs11571746,breast 
BRCA2,Rs11571746,cancer 
BRCA2,Rs11571746,cancer
BRCA2,Rs11571746,breast 
BRCA2,Rs11571746,cancer
BRCA2,Rs11571746,breast 
BRCA2,Rs11571746,minor
BRCA2,Rs11571746,SNPs 
BRCA2,Rs11571747,SNPs
BRCA2,Rs11571746,SNP
BRCA2,I5009090,causal/pathogenic BRCA2 mutations
BRCA2,I5009090,developing breast cancer
BRCA2,I5009091,breast cancer
BRCA2,Rs11571746,gene
BRCA2,I5009091,breast cancer
BRCA2,I5009091,causal/pathogenic
BRCA2,I5009091,mutations
BRCA2,I5009091,causal/pathogenic BRCA2 mutations
BRCA2,I5009091,developing breast cancer
BRCA2,Rs11571746,breast cancer
BRCA2,Rs11571746,breast cancer
BRCA2,Rs11571746,breast cancer
BRCA2,Rs11571746,breast cancer
BRCA2,I5009091,breast cancer
BRIP1,Rs587778134,reduced average lifespan
BRIP1,Rs587778134,cancer
BRIP1,Rs587778134,ovarian cancer
BRIP1,Rs587778134,ovarian cancer
BRIP1,Rs587778134,Icelanders
BRIP1,Rs587778134,ovarian cancer
BRIP1,Rs587778134,cancer
BRIP1,Rs4986764,Kazakhstan.
BRIP1,Rs4986764,prostate cancer.
BRIP1,Rs4986764,breast cancer
BRIP1,Rs4986764,prostate cancer
BRIP1,Rs4986764,familial breast cancer risk
BRIP1,Rs587778134,ovarian cancer
BTBD9,Rs9357271,common sleep disorder
BTBD9,Rs9357271,Tourette syndrome (TS)
BTBD9,Rs9357271,TS without obsessive-compulsive disorder
BTBD9,Rs9357271,syndrome
BTBD9,Rs9357271,restless 
BTBD9,Rs9357271,legs 
BTBD9,Rs9357271,sleep 
BTBD9,Rs9357271,disorder
BTBD9,Rs9357271,Tourette 
BTBD9,Rs9357271,allele
BTBD9,Rs9357271,syndrome 
BTBD9,Rs9357271,obsessive
BTBD9,Rs9357271,compulsive 
BTBD9,Rs9357271,disorder
BTBD9,Rs9394492,"lower frequency of restless legs syndrome, a common sleep disorder,"
BTBD9,Rs9357271,restless legs syndrome
BTBD9,Rs9357271,minor 
BTBD9,Rs9296249,low serum ferritin
BTBD9,Rs3923809,restless legs syndrome
BTBD9,Rs9296249,common sleep disorder
BTBD9,Rs9296249, lower serum ferritin
BTBD9,Rs3923809,restless legs syndrome
BTBD9,Rs3923809,restless legs syndrome
BTBD9,Rs3923809,restless legs syndrome
BTBD9,Rs3923809,restless legs syndrome
BTBD9,Rs3923809,restless legs syndrome
BTBD9,Rs3923809,restless legs syndrome
BTBD9,Rs3923809,restless legs syndrome
BTBD9,Rs3923809,restless legs syndrome
BTBD9,Rs4714156,SNP 
BTBD9,Rs4714156,restless legs syndrome
BTBD9,Rs4714156,restless legs syndrome
BTBD9,Rs4714156,sleep disorder
BTBD9,Rs4714156,restless legs syndrome
BTBD9,Rs9296249,restless legs syndrome
BTBD9,Rs9296249,restless legs syndrome
BTBD9,Rs3923809,restless legs syndrome
BTD,Rs35034250,variants
BTD,Rs35034250,benign
BTD,Rs35034250,pathogenic
BTD,Rs35034250,variant
BTD,Rs35034250,benign
BTD,Rs35034250,pathogenic
BTD,Rs35034250,pathogenic
BTD,Rs13078881,biotinidase deficiency.
BTD,Rs13078881,symptomatic children
BTD,Rs13078881,biotinidase deficienc
BTD,Rs13078881,biotinidase deficiency
BTD,Rs13078881,biotinidase deficiency
BTD,Rs13078881,biotinidase deficiency
BTD,Rs35034250,benign
C21orf91,Rs2824495,labialis
C21orf91,Rs2824499,cold sore
C21orf91,Rs2824499,cold sore
C21orf91,Rs2824499,labialis
C21orf91,Rs2824499,herpes simplex
C21orf91,Rs2824495,cold sore
C21orf91,Rs2824495,cold sore
C21orf91,Rs1062202,cold-sore phenotype
C21orf91,Rs2824495,herpes simplex
C21orf91,Rs1062202,strong association
C21orf91,Rs10446073,phenotype
C21orf91,Rs10446073,cold-sore phenotype
C21orf91,Rs1047978,herpes simplex
C21orf91,Rs10446073,strong association
C21orf91,Rs1047978,cold sore
C21orf91,Rs1047978,cold sore
C21orf91,Rs1062202,phenotype
C21orf91,Rs1047978,labialis
C3,Rs2230201,systemic lupus erythematosus (SLE)
C3,Rs7951,level of the C3 protein was lower
C3,Rs7951,systemic lupus erythematosus (SLE)
C3,Rs2230201,systemic lupus erythematosus (SLE)
C3,Rs2230201,Japanese SLE patients
C3,Rs2230201,higher risk for systemic lupus erythematosus (SLE)
C3,Rs2230201,systemic lupus erythematosus
C3,Rs2230199,ARMD
C3,Rs2230199,ARMD
C3,Rs1047286,ARMD 
C3,Rs1047286,SNP 
C3,Rs1047286,ARMD
C3,Rs10402876,atopic dermatitis patients.
C3,Rs10402876,super-antigens
C3,Rs10402876,Polymorphisms within the C3 gene
C3,Rs10402876,susceptibility to adult asthma.
C3,Rs11569562,bronchial asthma
C5,Rs10985112,rheumatoid arthritis
C5,Rs7026551,Rheumatoid Arthritis
C5,Rs7026551,Rheumatoid Arthritis
C5,Rs7026551,Rheumatoid Arthritis
C5,Rs10985112,Rheumatoid Arthritis
C5,Rs10985112,A allele Genome-wide
C5,Rs10985112,Rheumatoid Arthritis
C5,Rs10985112,wavelet transformation.
C6orf10,Rs498422,Chinese
C6orf10,Rs498422,male infertility
C6orf10,Rs498422,azoospermia
C6orf10,Rs3129934,increased risk for MS
C6orf10,Rs498422,chromosome 6
C6orf10,Rs498422,not Japanese
C6orf10,Rs498422,gene
C6orf10,Rs910049,type-2 diabetes
C6orf10,Rs910049,coronary artery disease
C6orf10,Rs910049,multiple sclerosis
C6orf10,Rs910049,coronary artery disease
C6orf10,Rs910049,sclerosis
C6orf10,Rs910049,type-2 diabetes
C6orf10,Rs910049,type-1 diabetes
C6orf10,Rs910049,multiple sclerosis
C6orf10,Rs910049,type-1 diabetes
C6orf10,Rs3129934,type 1 diabetes
C6orf10,Rs3129934,type 1 diabetes
C6orf10,Rs3129934,type-1 diabetes
C6orf10,Rs3129900,liver injury
C6orf10,Rs3129900,liver injury
C6orf10,Rs3129900, This new pain medication was approved in Europe in late 2006
C6orf10,Rs3129934, autoimmune diseases
C6orf10,Rs3129934,multiple sclerosis
C6orf10,Rs3129934,type 1 diabetes
C6orf10,Rs3129934,MS
C6orf10,Rs3129934,multiple sclerosis
C6orf10,Rs3129934,type-1 diabetes
C6orf10,Rs3129934,type 1 diabetes
C6orf10,Rs3129934, type 1 diabetes
C6orf10,Rs3129934,several autoimmune diseases
C6orf10,Rs3129934,Spanish and American multiple sclerosis patients
C6orf10,Rs3129934,increased risk for multiple sclerosis
C6orf10,Rs3129934,type-1 diabetes
CACNA1A,Rs121908236,Clinical spectrum of episodic ataxia type 2.
CACNA1C,Rs80315385,cardiac L-type calcium channel mutations
CACNA1C,Rs80315385,arrhythmia disorder
CACNA1C,Rs80315385,cardiac L-type calcium channel mutations
CACNA1C,Rs80315385,arrhythmia disorder
CACNA1C,Rs80315385,arrhythmia disorder
CACNA1C,Rs2159100,schizophrenia
CACNA1C,Rs80315385,Severe arrhythmia disorder
CACNA1C,Rs80315385,cardiac L-type calcium channel mutations
CACNA1C,Rs80315385,Severe arrhythmia disorder
CACNA1C,Rs80315385,cardiac L-type calcium channel mutations.
CACNA1C,Rs80315385,cardiac L-type calcium channel mutations
CACNA1C,Rs80315385,arrhythmia disorder
CACNA1C,Rs1006737,decreased outflow of information from medial frontal gyrus
CACNA1C,Rs2159100,bipolar disorder
CACNA1C,Rs2159100,bipolar disorder
CACNA1C,Rs2159100,schizophrenia
CACNA1C,Rs2159100,bipolar disorder
CACNA1C,Rs2159100,schizophrenia
CACNA1C,Rs2159100,bipolar disorder
CACNA1C,Rs121912776,J-wave syndromes
CACNA1C,Rs121912776,sudden cardiac death
CACNA1C,Rs121912776,Loss-of-function
CACNA1C,Rs2159100,schizophrenia
CACNA1C,Rs1006737,medial frontal gyrus
CACNA1D,Rs3774426,hypertension
CACNA1D,Rs3774426,blood pressure
CACNA1D,Rs3774426,hypertension 
CACNA1D,Rs3774426,lowered systolic and diastolic blood pressure
CACNA1D,Rs3774426,hypertension
CACNA1D,Rs3774426,lowered systolic and diastolic blood pressure
CACNA1D,Rs3774426,hypertension with L-type dCCBs (calcium channel blockers)
CACNA1D,Rs312481,systolic and diastolic blood pressure
CACNA1D,Rs312481,hypertension
CACNA1G,Rs12603112,autism
CACNA1G,Rs12603112,autism
CACNA1S,Rs80338779,hypokalaemic periodic
CACNA1S,Rs80338779,CACNA1S gene
CACNA1S,Rs80338779,paralysis
CACNA1S,Rs80338779,hypokalaemic periodic paralysis
CACNA1S,Rs28930069,variant
CACNA1S,Rs28930069,genome
CACNA1S,Rs28930069,exome
CACNA1S,Rs80338779,Early onset of hypokalaemic periodic paralysis caused by a novel mutation of the CACNA1S gene.
CACNA1S,Rs28930069,variant
CACNA1S,Rs28930069,hypokalemic periodic paralysis
CACNA1S,Rs28930069,SNP
CACNA1S,Rs28930069,chromosome 1
CACNA1S,Rs28930069,allele
CACNA1S,Rs1800559,malignant hyperthermia
CACNA1S,Rs1800559,Malignant-hyperthermia
CACNA1S,Rs1800559,malignant hyperthermia
CACNA1S,Rs1800559,hyperthermia
CACNA1S,Rs28930068,"hypokalemic periodic paralysis, type 1"
CACNA1S,Rs28930069,"hypokalemic periodic paralysis, type 1"
CACNA1S,Rs28930069,CACNA1S gene
CACNA1S,Rs1800559,malignant hyperthermia
CACNB2,Rs2799573,bipolar disorder
CACNB2,Rs7076247,C-reactive protein (CRP) protein levels
CACNB2,Rs2799573,bipolar disorder
CACNB2,Rs2799573,major depressive disorder
CACNB2,Rs2799573,schizophrenia
CACNB2,Rs2799573,bipolar disorder
CACNB2,Rs2799573,schizophrenia
CACNB2,Rs2799573,autism spectrum disorder
CACNB2,Rs2799573,major depressive disorder
CACNB2,Rs2799573,bipolar disorder
CACNB2,Rs2799573,ADHD
CACNB2,Rs2799573,psychiatric disorders
CACNB2,Rs11014166,blood pressure
CACNB2,Rs2799573,schizophrenia
CALB1,Rs1805874,no association between rs1805874 and Parkinson's disease
CALB1,Rs1805874,for these populations.
CALB1,Rs1805874,4 Caucasian populations
CALB1,Rs1805874,Parkinson's disease
CALHM1,Rs2986017,late-onset Alzheimer's disease
CALHM1,Rs2986017,Alzheimer's disease
CALR3,Rs142951029,Familial hypertrophic cardiomyopathy
CALU,Rs339097,Caucasians
CALU,Rs339097,African Americans
CALU,Rs339097,rs339097(G) is associated with 14.5% higher therapeutic warfarin dose in African Americans
CALU,Rs339097,"This variant is also more common in African Americans with minor allele frequencies of 11–14% , but only 0.2% in Caucasians"
CAMK1,Rs2304277,risk of ovarian cancer
CAMK1,Rs2304277,cancer 
CAMK1,Rs1052133,lung cancer
CAMK1,Rs1052133,lung cancer
CAMK1,Rs1052133,gallbladder cancer
CAMK1,Rs1052133,bladder cancer
CAMK1,Rs2304277,mutation 
CAMK1,Rs1052133,lung cancer
CAMK1,Rs1052133,gallbladder cancer
CAMK1,Rs1052133,bladder cancer
CAMK1,Rs1052133,lung cancer
CAMK1,Rs1052133,lung cancer
CAMK1,Rs1052133,lung cancer
CAMK1,Rs1052133,gallbladder cancer
CARD11,Rs199692405,severe eczema.
CARD11,Rs199692405,"p.Glu57Asp (E57D), which is reported to be pathogenic"
CARD11,Rs1064795307,pathogenic
CARD11,Rs1064795307,pathogenic
CARD11,Rs199692405, atopic dermatitis
CARD14,Rs281875212,autosomal dominantly inherited psoriasis
CARD14,Rs281875213,gene
CARD14,Rs281875213,chromosome
CARD14,Rs281875213,mutation
CARD14,Rs281875213,psoriasis
CARD14,Rs281875214,autosomal dominantly inherited psoriasis
CARD14,Rs281875214,autosomal dominantly inherited psoriasis
CARD14,Rs281875215,dominantly inherited psoriasis
CARD14,Rs281875215,autosomal dominantly inherited
CARD14,Rs281875215,psoriasis
CARD14,Rs281875212,gain-of-function mutation
CARD9,Rs4077515,ulcerative colitis
CARD9,Rs4077515,Crohn's disease
CASP3,Rs6948,non-Hodgkin lymphoma
CASP3,Rs6948,squamous cell carcinoma
CASP3,Rs6948,risk of squamous cell carcinoma of the head and neck
CASP3,Rs6948, multiple myeloma
CASP3,Rs6948,susceptibility to multiple myeloma
CASP3,Rs1049216,significantly decrease the Non-Hodgkin Lymphoma.
CASP3,Rs6948,squamous cell carcinoma
CASP3,Rs6948,multiple myeloma
CASP3,Rs6948,non-Hodgkin lymphoma
CASP3,Rs1049216,Non-Hodgkin Lymphoma.
CASP3,Rs6948,susceptibility to non-Hodgkin lymphoma
CASP8,Rs3769818,apoptotic and inflammatory pathway genes.
CASP8,Rs3769818,a multigenic approach to DNA-repair
CASP8,Rs3769818,Gallbladder cancer 
CASP8,Rs13113,lymphoma
CASP8,Rs1045485,ovarian cancer 
CASP8,Rs1045485,colorectal cancer
CASP8,Rs1045485, chronic lymphocytic leukemia 
CASP8,Rs1045485, breast cancer
CASP8,Rs1045485,breast cancer
CASP8,Rs1045485,"rs1045485, also known as D302H, is a SNP in the caspase-8 CASP8 gene.PMID 15601643, PMID 17018785, PMID 17293864 Several large studies indicate that the (C) allele of this SNP, located in exon 10 of the CASP8 gene, may reduce the risk of breast cancer "
CASP8,Rs1045485, invasive epithelial ovarian cancer c
CASP9,Rs1052576,lung cancer
CASP9,Rs1052576,bladder cancer
CASP9,Rs1052576,bladder cancer
CASP9,Rs1052576,bladder cancer
CASP9,Rs1052576,liver cancer
CASP9,Rs1052576,myeloma
CASP9,Rs1052576,colon cancer
CASP9,Rs1052576,lymphoma
CASP9,Rs1052576,non-Hodgkin lymphoma
CASP9,Rs1052576,cancer
CASP9,Rs1052576,DNA fragmentation and apoptosis
CASP9,Rs1052576,increased risk of death
CASP9,Rs1052576,nuclear membrane breakdown
CASP9,Rs1052576,cellular transformation
CASP9,Rs1052576,cancers
CASP9,Rs1052576,non-small cell lung cancer
CASP9,Rs1052576,multiple myeloma
CASP9,Rs1052576,gastric cancer
CASP9,Rs1052576,multiple myeloma
CASP9,Rs4645978,rs4645978 is a SNP that has been found to significantly decrease the risk of lung cancer in Koreans.
CASP9,Rs1052576,Non-Hodgkin Lymphoma
CASP9,Rs1052576,general cancer risk
CASP9,Rs4645978,no impact on the risk of multiple myeloma
CASP9,Rs4645978,in Koreans
CASP9,Rs4645978,significantly decrease the risk of lung cancer
CASP9,Rs4645978,rs4645978 
CASP9,Rs4645978,It was also found to have no impact on the risk of multiple myeloma.
CASP9,Rs4645978,multiple myeloma
CASP9,Rs4645978,lung cancer
CASP9,Rs4645978,myeloma
CASP9,Rs4645978,SNP
CASP9,Rs4645978,lung cancer
CASP9,Rs1052576,Multiple myeloma
CASP9,Rs1052576,Non-Hodgkin Lymphoma
CASP9,Rs1052576,dose dependent effect
CASP9,Rs1052576,cancer
CASP9,Rs1052576,chronic lymphocytic leukemia
CASP9,Rs1052576,Non-Hodgkin’s lymphomas
CASP9,Rs1052576,multiple myeloma
CASP9,Rs1052576,ADHD
CASP9,Rs4645978,Koreans
CASP9,Rs1052576,Non-Hodgkin Lymphoma
CASP9,Rs1052576,myeloma 
CASP9,Rs1052576,colon cancer
CASP9,Rs1052576,lung cancer
CASP9,Rs1052576,lymphoma
CASP9,Rs1052576,gastric cancer
CASP9,Rs1052576,cancer 
CASP9,Rs1052576,apoptosis
CASP9,Rs1052576,DNA fragmentation
CASP9,Rs1052576,revention of cellular transformation
CASP9,Rs1052576,Multiple myeloma
CASP9,Rs1052576,immune response
CASP9,Rs1052576,development
CASP9,Rs1052576,cancers
CASP9,Rs1052576,non-Hodgkin lymphoma
CASP9,Rs1052576,non-small cell lung cancer
CASP9,Rs1052576,multiple myeloma
CASP9,Rs1052576,cancer
CASP9,Rs1052576,liver cancer
CASP9,Rs1052576,cancer
CASP9,Rs1052576,nuclear membrane breakdown
CASP9,Rs1052576,bladder cancer
CASP9,Rs1052576,bladder cancer
CASP9,Rs1052576,cancer 
CASP9,Rs1052576,follicular lymphoma
CASP9,Rs1052576,B cell chronic lymphocytic leukemia
CASP9,Rs1052576,marginal zone lymphoma
CASP9,Rs1052576,Follicular lymphoma
CASP9,Rs1052576,B-cell lymphomas
CASP9,Rs1052576,T cell lymphomas
CASP9,Rs1052576,B-cell lymphomas
CASP9,Rs1052576,Diffuse large B cell lymphoma
CASP9,Rs1052576,Non-Hodgkin Lymphoma
CASP9,Rs1052576,bladder cancer
CASP9,Rs1052576,bladder cancer
CASP9,Rs1052576,multiple myeloma
CASP9,Rs1052576,bladder cancer
CASP9,Rs1052576,B-lymphocytes
CASP9,Rs1052576,B-cell lymphomas
CASP9,Rs1052576,multiple myeloma
CAV3,Rs72546667,associated with long-QT syndrome.
CAV3,Rs28936685,rippling muscle disease
CAV3,Rs72546667,muscular dystrophy.
CAV3,Rs72546667,hyper-CK-emia
CAV3,Rs72546667,muscular dystrophy
CAV3,Rs72546667,idiopathic hyper-CK-emia.
CAV3,Rs72546667,muscular dystrophy.
CAV3,Rs72546667,idiopathic hyper-CK-emia.
CAV3,Rs72546668,patients with idiopathic hyper-CK-emia
CAV3,Rs72546668,"""double trouble"" overlapping syndromes"
CAV3,Rs72546668,sudden infant death syndrome
CAV3,Rs72546668, idiopathic hyper-CK-emia
CAV3,Rs72546668,long-QT syndrome
CAV3,Rs72546668,revalence of long-QT syndrome gene variants in sudden infant death syndrome
CAV3,Rs72546668,sudden infant death syndrome
CAV3,Rs72546668,Rippling muscle disease
CAV3,Rs72546668, facioscapulohumeral dystrophy-like phenotype
CAV3,Rs72546668, a patient carrying a heterozygous CAV3 T78M mutation and a D4Z4 partial deletion
CAV3,Rs116840798,skeletal muscle
CAV3,Rs72546668,long-QT syndrome
CAV3,Rs116840795,familial 
CAV3,Rs116840782,rippling muscle
CAV3,Rs116840795,yperCKaemia.
CAV3,Rs116840776,muscular dystrophy
CAV3,Rs116840776,sudden infant death syndrome.
CAV3,Rs116840782,muscular dystrophy
CAV3,Rs116840782,novel caveolin-3 mutation
CAV3,Rs116840782,muscular dystrophy genes
CAV3,Rs116840782,rippling muscle
CAV3,Rs116840795,mutation i
CAV3,Rs116840782,muscular dystrophy genes
CAV3,Rs116840782,CAV3 mutations linked to rippling muscle.
CAV3,Rs116840782,large German family
CAV3,Rs116840785,rippling muscle disease
CAV3,Rs116840785,rippling muscle disease
CAV3,Rs116840785,rippling muscle disease
CAV3,Rs116840785,rippling muscle disease
CAV3,Rs116840785,rippling muscle disease
CAV3,Rs116840788,CAV3 
CAV3,Rs116840788,CAV3 
CAV3,Rs116840788,Japanese
CAV3,Rs116840785,rippling muscle disease.
CBLB,Rs3087243,risk factor for developing rheumatoid arthritis (RA)
CBLB,Rs3087243,type 1 diabetes odds ratio 1.37 and 1.28
CBLB,Rs3087243,acute rejection development
CBLB,Rs3772534,type 1 diabetes
CBLB,Rs3087243,acute rejection
CBLB,Rs3087243,type-1 diabetes
CBLB,Rs3087243,1.5 fold increased risk of type-1 diabetes
CBLB,Rs3087243,type-1 diabetes
CBLB,Rs3087243,1.3 fold increased risk of autoimmune thyroid disease
CBLB,Rs3087243,autoimmune thyroid disease
CBLB,Rs3087243,autoimmune thyroid disease
CBLB,Rs3087243,autoimmune thyroid disease
CBS,Rs5742905,study of 77 polymorphisms in migraine.
CBS,Rs5742905,118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects
CBS,Rs5742905,genes with blood pressure progression and incident hypertension
CBS,Rs5742905,Lack of association of polymorphisms in homocysteine metabolism genes with pseudoexfoliation syndrome and glaucoma
CBS,Rs5742905,"Homocystinuria, the I278T mutation has been associated with B6 responsiveness and arelatively mild clinical phenotype when homozygous."
CBS,Rs5742905, hypertension
CBS,Rs5742905,conotruncal heart defects
CBS,Rs5742905,Homocystinuria
CBS,Rs5742905,conotruncal heart defects
CBS,Rs5742905,spina bifida
CBS,Rs5742905,blood pressure
CBS,Rs5742905,blood pressure progression
CBS,Rs5742905,incident hypertension
CBS,Rs121964972,Homocystinuria
CBS,Rs234706,Ehlers-Danlos syndrome
CBS,Rs234715,autism 
CBS,Rs234715,greater risk for autism
CBS,Rs5742905,spina bifida
CBS,Rs5742905,Homocystinuria
CBS,Rs5742905,pseudoexfoliation syndrome
CBS,Rs5742905,glaucoma
CBS,Rs234715,did not report taking prenatal vitamins periconceptionally.
CCDC122,Rs3088362,increased susceptibility to leprosy 
CCDC174,Rs869025342,infantile hypotonia
CCDC174,Rs869025342,psychomotor retardation
CCL2,Rs4586,Sickle Cell Disease
CCL2,Rs4586,Sickle Cell Disease
CCL2,Rs4586,risk of carotid atherosclerosis
CCL2,Rs4586,imbalance in human target tissues
CCL2,Rs4586,macular degeneration
CCL2,Rs4586,disease
CCL2,Rs4586,Polygenic
CCL2,Rs4586,Monogenic Disease
CCL2,Rs4586,carotid atherosclerosis
CCL2,Rs4586,pulmonary tuberculosis
CCL2,Rs4586,knee osteoarthritis
CCL2,Rs3917887,nephropathy
CCL2,Rs3917887,polymyositis/dermatomyositis
CCL2,Rs3917887,chemotactic 
CCL2,Rs3917887,Monocyte 
CCL2,Rs3917887,cytokine 
CCL2,Rs3917887,inflammatory 
CCL2,Rs4586,MCP-1 promoter variant -362C associated with protection
CCL21,Rs2812378,rheumatoid arthritis
CCL21,Rs2812378,rheumatoid arthritis
CCL21,Rs2812378,rheumatoid arthritis
CCL21,Rs2812378,endometriosis
CCL21,Rs2812378,Endometriosis
CCL21,Rs2812378,autoimmune disease
CCL21,Rs2812378,Korean
CCL21,Rs2812378,rheumatoid arthritis
CCL21,Rs2812378,Caucasian
CCL21,Rs2812378, juvenile idiopathic arthritis
CCL21,Rs2812378,moderate/severe endometriosis
CCL21,Rs2812378,Endometriosis and autoimmune disease:
CCL21,Rs2812378,rheumatoid arthritis
CCL21,Rs2812378,rheumatoid arthritis.
CCL21,Rs2812378,juvenile idiopathic arthritis.
CCL21,Rs2812378,rheumatoid arthritis
CCL21,Rs2812378,rheumatoid arthritis 
CCL21,Rs2812378,rheumatoid arthritis 
CCL21,Rs2812378,rheumatoid arthritis
CCL26,Rs2302009,eosinophilic esophagitis
CCL26,Rs2302009,gastroesophageal reflux disease
CCL26,Rs2302009,esophagitis
CCL26,Rs2302009,eosinophilic esophagitis
CCL26,Rs2302009,esophagitis
CCL26,Rs2302009,gastroesophageal reflux disease
CCL26,Rs2302009,"eosinophilic esophagitis,"
CCL26,Rs2302009,eosinophilic esophagitis
CCR2,Rs1799864,recurrent venous thromboembolism
CCR2,Rs1799864,AIDS 
CCR2,Rs1799864,HIV
CCR2,Rs1799864,AIDS 
CCR3,Rs6441961,trait genetic associations
CCR3,Rs6441961,coeliac disease
CCR3,Rs6441961,celiac disease
CCR3,Rs6441961,diabetes
CCR3,Rs6441961,gut disease
CCR3,Rs6441961,type 1 
CCR3,Rs6441961,immunogenetics 
CCR3,Rs6441961,genetic 
CCR3,Rs6441961,complex 
CCR3,Rs6441961,QTLs 
CCR3,Rs6441961,immunogenetics 
CCR5,Rs2856758,resistance to HIV
CCR5,Rs2856758,resistance to HIV infection
CCR5,Rs2856758,selection pressure from plague (Black Death) or smallpox
CCR5,Rs2856758,coronary heart disease among US women
CCR5,Rs2856758,resistance to HIV infection
CCR5,Rs2856758,resistance to HIV
CCR5,Rs2856758,smallpox
CCR5,Rs2856758,HIV-1
CCR5,Rs1800452,hay-fever
CCR5,Rs2856758,HIV-1 disease
CCR5,Rs333,HIV
CCR5,Rs333,aneurysms
CCR5,Rs333,abdominal aortic aneurysm
CCR5,Rs333,type 1 diabetes
CCR5,Rs2856758,coronary heart disease
CCR5,Rs1800452,SNP-genotyping
CCR5,Rs2856758,plague (Black Death) 
CCR5,Rs1800452,oligonucleotide microarrays
CCR5,Rs1800452,hay-fever
CCR5,Rs1800452,hay-fever
CCR5,Rs1800452,candidate
CCR5,Rs1800452,genotyping 
CCR5,Rs1800452,gene 
CCR5,Rs1800452,SNP
CCR5,Rs1800452,microarrays
CCR5,Rs1800452,oligonucleotide 
CCR5,Rs1800452,immune 
CCR5,Rs1800452,genes 
CCR5,Rs1800452,regulator 
CCR5,Rs1800452,fever 
CCR5,Rs1800452,hay
CCR5,Rs1800452,samples
CCR5,Rs1800452,hay-fever
CD14,Rs2569190,elevated IgE levels
CD14,Rs2569190,cerebrovascular diseases
CD14,Rs5744455,pylori infection
CD14,Rs2569190,non-smokers
CD14,Rs2569190,stroke 
CD14,Rs2569190,smokers 
CD244,Rs6682654,SNPs
CD244,Rs6682654,CD244 gene
CD244,Rs6682654,rs3766379
CD244,Rs6682654,rs6682654
CD244,Rs6682654,rs6682654(G)
CD2AP,Rs9349407,Alzheimer's disease
CD2AP,Rs9349407,Alzheimer
CD33,Rs3865444,Alzheimer's disease
CD33,Rs3865444,Alzheimer's disease
CD40,Rs4810485,Korean ancestry
CD40,Rs4810485,Korean
CD40,Rs4810485,Europeans
CD40,Rs4810485,RA 
CD40,Rs4810485,orean ancestry
CD40,Rs4810485,European ancestry
CD40,Rs1883832,osteopenia
CD40,Rs4810485, rheumatoid arthritis (RA)
CD40,Rs1883832,lymphoma
CD40,Rs1883832,osteoporosis
CD40,Rs4810485,autoimmune disease
CD40,Rs1883832,TT genotype
CD44,Rs1467558,alanine aminotransferase (ALT)
CD44,Rs353644,vaccine-induced immunity to HBV infection
CD58,Rs12044852,multiple sclerosis
CD58,Rs2300747,multiple sclerosis
CD58,Rs2300747,protective
CD58,Rs2300747,multiple sclerosis
CD58,Rs2300747,multiple sclerosis
CD59,Rs587777149,Heterozygotes were unaffected.
CD59,Rs587777149,"This change was found in a multiplex family with strokes, chronic immune-mediated peripheral neuropathy, and hemolysis, all with onset in infancy."
CD59,Rs587777149,"The deletion mutation was originally observed in a 7 month old baby with inherited CD59 deficiency, who went on to develop hemolytic anemia with progressive neurologic deterioration. "
CD59,Rs587777149,rs587777149
CD59,Rs587777149,inherited CD59 deficiency
CD59,Rs587777149,hemolytic anemia with progressive neurologic deterioration.
CD59,Rs397514767,hemolytic anemia and immune-mediated polyneuropathy
CD59,Rs587777149,"strokes, chronic immune-mediated peripheral neuropathy, and hemolysis,"
CDH1,Rs587783047,R63X
CDH1,Rs587783047,gastric cancer 
CDH1,Rs587780787,gastric cancer
CDH1,Rs587780787,hereditary diffuse gastric cancer
CDH1,Rs587780787,pathogenic rare mutation
CDH1,Rs587780784,hereditary diffuse gastric cancer
CDH1,Rs587776398,gastric cancer
CDH1,Rs587780784,pathogenic 
CDH1,Rs587780784,hereditary diffuse gastric cancer
CDH1,Rs587780784,pathogenic rare mutation
CDH1,Rs587780784,hereditary diffuse gastric cancer
CDH1,Rs587780113,gastric cancer
CDH1,Rs587780784,diffuse gastric cancer
CDH1,Rs587783047,gastric cancer in ClinVar
CDH1,Rs863224505,pathogenic rare mutation
CDH1,Rs587783050,pathogenic rare mutation for hereditary diffuse gastric cancer in ClinVar.
CDH1,Rs786201045,gastric cancer
CDH1,Rs786201045,hereditary diffuse gastric cancer
CDH1,Rs786201045,hereditary diffuse gastric cancer
CDH1,Rs786202033,gastric cancer
CDH1,Rs786203752,hereditary diffuse gastric cancer
CDH1,Rs863224505,hereditary diffuse gastric cancer
CDH1,Rs863224505,gastric cancer
CDH1,Rs863224505,pathogenic rare mutation for hereditary diffuse gastric cancer
CDH1,Rs864622655,gastric cancer
CDH1,Rs876660771,cancer 
CDH1,Rs876660771,gastric 
CDH1,Rs35572355,designating it's clinical significance as uncertain
CDH1,Rs587783050,hereditary diffuse gastric cancer
CDH1,Rs1862748,"West Bengal, India"
CDH1,I5004970,gastric cancer
CDH1,Rs1862748,colorectal cancer
CDH1,Rs1862748,rsenic-related skin lesions
CDH1,I5004969,cancer
CDH1,I5004969,gastric 
CDH1,I5004970,gastric cancer
CDH1,I5004970,gastric cancer
CDH1,I5004971,gastric cancer
CDH1,I5004971,gastric cancer
CDH1,I5004974,gastric cancer
CDH1,I5004975,gastric cancer
CDH1,Rs121964874,2095C
CDH1,Rs121964874,Gln699Ter
CDH1,Rs121964874,ClinVar
CDH1,Rs121964874,cancer 
CDH1,I5004969,gastric cancer
CDH1,Rs121964875,hereditary diffuse gastric cancer
CDH1,Rs13689,"West Bengal, India."
CDH1,Rs13689,susceptibility to arsenic-related skin lesions
CDH1,Rs13689,cadherin polymorphisms
CDH1,Rs13689,arsenic-related skin
CDH1,Rs13689,arsenic-related skin lesions
CDH1,Rs13689,E-cadherin polymorphisms
CDH1,Rs121964878,hereditary diffuse gastric cancer in ClinVar.
CDH1,Rs121964875,"Also known as c.59G>A, p.Trp20Ter or W20X, the minor allele is considered a pathogenic rare mutation for hereditary diffuse gastric cancer"
CDH1,Rs121964875,23andMe
CDH1,Rs121964875,hereditary diffuse gastric cancer
CDH1,Rs121964875,pathogenic rare mutation
CDH1,Rs13689,E-cadherin polymorphisms
CDH1,Rs121964875,hereditary diffuse gastric cancer
CDH13,Rs6565113,autism spectrum disorder.
CDH13,Rs8055236,"the odds ratio associated with heterozygotes is 1.91 (CI 1.33-2.74), and for homozygotes, 2.23 (CI 1.56-3.17)."
CDH13,Rs8055236,"rs8055236 has been reported in a large study to be associated with heart disease, in particular, coronary artery disease.The risk allele"
CDH13,Rs8055236,"associated with heart disease, in particular, coronary artery disease"
CDH13,Rs6565113,attention deficit/hyperactivity disorder
CDH13,Rs6565113,autism spectrum disorder
CDH13,Rs6565113,attention-deficit/hyperactivity disorder
CDH13,Rs6565113,attention deficit hyperactivity disorder
CDH13,Rs17216786,clozapine
CDH13,Rs17216786,triglycerides
CDH13,Rs17216786,genotyped
CDH13,Rs17216786,schizophrenics
CDH13,Rs6565113,attention-deficit/hyperactivity disorder
CDH23,Rs111033270,Usher syndrome type 1
CDH23,Rs111033270,missense mutations
CDH23,Rs111033270,alleles
CDH23,Rs111033270,mRNA splicing
CDH23,Rs111033271,Usher syndrome and nonsyndromic deafness.
CDH23,Rs111033271,hearing loss
CDH23,Rs111033271,Usher syndrome
CDH23,Rs111033271,nonsyndromic deafness
CDH23,Rs111033271,nonsyndromic deafness
CDH23,Rs111033271,hearing loss
CDH23,Rs111033271,CDH23 mutations
CDH23,Rs372388344,pathogenic variant
CDH23,Rs111033270,Usher syndrome
CDH23,Rs111033271,Usher syndrome
CDH23,Rs111033270,phenotype heterogeneity
CDH23,Rs111033270,nonsyndromic deafness
CDH23,Rs111033270,Usher syndrome type 1D
CDH23,Rs1052484950,pathogenic
CDH23,Rs1052484950,pathogenic
CDH23,Rs111033270,CDH23
CDH23,Rs111033270,1D
CDH23,Rs111033270,CDH23 
CDH23,Rs111033270,107 
CDH23,Rs111033270,CDH23
CDH23,Rs111033270,mutation
CDH23,Rs111033270,Usher syndrome type 1D
CDH23,Rs111033270,Usher syndrome
CDH23,Rs111033270,nonsyndromic deafness
CDH23,Rs111033270,Usher syndrome type 1
CDH23,Rs111033270,Mutation
CDH23,Rs111033270,cadherin gene family
CDH23,Rs111033270,splicing
CDKAL1,Rs6908425,heterozygotes
CDKAL1,Rs6908425,homozygotes
CDKAL1,Rs7754840,type-2 diabetes
CDKAL1,Rs7754840,type-2 diabetes
CDKAL1,Rs7754840,type-2 diabetes
CDKAL1,Rs7754840,higher glucose
CDKAL1,Rs7754840,type-2 diabetes
CDKAL1,Rs9465871,combined IFG/type 2 diabetes
CDKAL1,Rs9465871,type 2 diabetes
CDKAL1,Rs6908425,Crohn's disease
CDKAL1,Rs9465871,type 2 diabetes
CDKAL1,Rs9465871,metabolic syndrome
CDKAL1,Rs9465871,dietary energy intake
CDKAL1,Rs9465871,type 2 diabetes mellitus
CDKAL1,Rs9465871,type-2 diabetes
CDKAL1,Rs4712523,type 2 diabetes
CDKAL1,Rs9465871,elevated hemoglobin A(1)(c) levels
CDKAL1,Rs4712523,type 1 diabetes
CDKAL1,Rs4712523,type 2 diabetes
CDKAL1,Rs10946398,Type II Diabetes
CDKAL1,Rs10946398,rs10946398 
CDKAL1,Rs10946398,Type II Diabetes
CDKAL1,Rs10946398,C allele
CDKAL1,Rs4712523,ype-2 diabetes 
CDKAL1,Rs4712523,type 2 diabetes
CDKAL1,Rs4712523,type 1 diabetes
CDKAL1,Rs7754840,type-2 diabetes
CDKAL1,Rs4712523,type-2 diabetes
CDKAL1,Rs4712523, type-2 diabetes
CDKAL1,Rs4712523,type 2 diabetes
CDKAL1,Rs4712523,glycated hemoglobin
CDKAL1,Rs4712523,type 2 diabetes
CDKAL1,Rs4712523,type 2 diabetes
CDKAL1,Rs4712523,type 2 diabetes
CDKAL1,Rs4712523,related quantitative traits
CDKN1A,Rs3176336,breast cancer
CDKN1A,Rs1801270,increased tumor susceptibility 
CDKN1A,Rs2395655,leukemia
CDKN1A,Rs2395655,early-onset disorders
CDKN1A,Rs2395655,ovarian cancer
CDKN1A,Rs1801270,"chronic obstructive pulmonary disease (COPD),"
CDKN1A,Rs1801270,lung cancer
CDKN1A,Rs1801270,cancer
CDKN1A,Rs3176336,breast cancer
CDKN1A,Rs2395655,breast cance
CDKN1A,Rs1059234,breast cancer
CDKN1A,Rs1059234,sporadic colorectal cancer
CDKN1A,Rs1059234,squamous cell carcinoma of the head and neck
CDKN1A,Rs1059234,Bladder cance
CDKN1A,Rs1059234,breast cancer 
CDKN1A,Rs1059234,ovarian cancer
CDKN1A,Rs1059234,squamous cell carcinoma of the head and neck
CDKN1A,Rs1059234,Bladder cancer
CDKN1A,Rs1059234,sporadic colorectal cancer
CDKN1B,Rs34330, endometrial cancer
CDKN1B,Rs34330,Chinese
CDKN1B,Rs34330,endometrial cancer
CDKN1B,Rs34330,significant association between
CDKN1B,Rs34330,prostate cancer
CDKN1B,Rs34330,breast cancer
CDKN1B,Rs34330,breast cancer
CDKN1B,Rs34330,breast cancer
CDKN1B,Rs34330,endometrial cancer
CDKN1B,Rs34330,prostate cancer
CDKN1B,Rs34330,endometrial cancer
CDKN1B,Rs34330,prostate cancer 
CDKN1B,Rs34330,breast cancer
CDKN1B,Rs34330,prostate cancer
CDKN2A,Rs3731239,breast cancer
CDKN2A,Rs3731239,ovarian cancer
CDKN2A,Rs3731239,breast cancer
CDKN2A,Rs1800586,cancer.
CDKN2A,Rs1800586,"malignant melanoma,"
CDKN2A,Rs1800586,malignant melanoma
CDKN2B,Rs3217992,older people
CDKN2B,Rs3217992,British population
CDKN2B,Rs3217992,breast cancer
CDKN2B,Rs3217992,single-nucleotide polymorphisms 
CDKN2B,Rs3217992,cell cycle single-nucleotide polymorphisms
CDKN2B,Rs3217992,Multiple Disease Phenotypes Correlate with ANRIL Expression
CDKN2B,Rs3217992,male 
CDKN2B,Rs3217992,myocardial infarctions
CDKN2B,Rs3217992,Han Chinese
CDKN2B,Rs3217992,ovarian cancer risk
CDKN2B,Rs3217992,ovarian cancer
CDKN2B,Rs3217992,myocardial infarctions
CDKN2B,Rs1063192,Myocardial Infarction
CDKN2B,Rs1063192,rs1063192(C) allele
CDKN2B,Rs1063192,myocardial infarctions
CDKN2B,Rs1063192,Han Chinese
CDKN2B,Rs1063192,CDKN2B gene
CDKN2B,Rs1063192,cyclin-dependent kinase inhibitor
CDKN2B,Rs1063192,SNP
CDKN2B,Rs3217992,breast cancer
CDKN2B-AS1,Rs496892,coronary heart disease
CDKN2B-AS1,Rs496892,periodontitis
CDKN2B-AS1,Rs496892,atherosclerotic stroke
CDKN2B-AS1,Rs496892,familial and sporadic intracranial aneurysms
CDKN2B-AS1,Rs4977574,myocardial infarction
CDKN2B-AS1,Rs496892,coronary artery disease
CDKN2B-AS1,Rs496892,Japanese patients
CDKN2B-AS1,Rs496892,periodontitis
CDKN2B-AS1,Rs496892,atherosclerotic stroke
CDKN2B-AS1,Rs496892,intracranial aneurysms
CDKN2B-AS1,Rs4977574,Coronary artery disease
CDKN2B-AS1,Rs496892,coronary artery disease
CDKN2B-AS1,Rs496892,coronary heart disease
CDKN2B-AS1,Rs3218005,ovarian cancer
CDKN2B-AS1,Rs3217992,cell cycle single-nucleotide polymorphisms
CDKN2B-AS1,Rs3218005,breast cancer
CDKN2B-AS1,Rs3218005,association with breast cancer
CDKN2B-AS1,Rs3218005,ovarian cancer
CDKN2B-AS1,Rs3218005,breast cancer
CDKN2B-AS1,Rs3217992,older people
CDKN2B-AS1,Rs3217992,British population
CDKN2B-AS1,Rs3217992,breast cancer
CDKN2B-AS1,Rs3217992,single-nucleotide polymorphisms 
CDKN2B-AS1,Rs3217992,ovarian cancer risk
CDKN2B-AS1,Rs564398,French Europids
CDKN2B-AS1,Rs3217992,Multiple Disease Phenotypes Correlate with ANRIL Expression
CDKN2B-AS1,Rs3217992,male 
CDKN2B-AS1,Rs3217992,myocardial infarctions
CDKN2B-AS1,Rs3217992,Han Chinese
CDKN2B-AS1,Rs3218005,polymorphisms 
CDKN2B-AS1,Rs564398,type 2 diabetes
CDKN2B-AS1,Rs564398,type 2 diabetes
CDKN2B-AS1,Rs564398,Asians
CDKN2B-AS1,Rs3217992,breast cancer
CDKN2B-AS1,Rs662463,aetiology 
CDKN2B-AS1,Rs662463,leukaemia 
CDKN2B-AS1,Rs662463,lymphoblastic 
CDKN2B-AS1,Rs662463,cell 
CDKN2B-AS1,Rs662463,paediatric 
CDKN2B-AS1,Rs662463,"Possible causative variant; OR ~1.72, p=3.3x10e-15."
CDKN2B-AS1,Rs662463,A variant at 9p21.3 functionally implicates CDKN2B in paediatric B-cell precursor acute lymphoblastic leukaemia aetiology (BCP-ALL)
CDKN2B-AS1,Rs564398,type 2 diabetes 
CDKN2B-AS1,Rs564398,type 2 diabetes
CDKN2B-AS1,Rs564398,type 2 diabetes
CDKN2B-AS1,Rs564398,type 2 diabetes
CDKN2B-AS1,Rs564398,type 2 diabetes
CDKN2B-AS1,Rs564398,type 2 diabetes
CDKN2B-AS1,Rs564398,obesity
CDKN2B-AS1,Rs564398,atherosclerotic stroke
CDKN2B-AS1,Rs564398,type 2 diabetes
CDKN2B-AS1,Rs564398,gestational diabetes mellitus
CDKN2B-AS1,Rs564398,Type 2 diabetes-associated genetic variants
CDKN2B-AS1,Rs564398,type 2 diabetes
CDKN2B-AS1,Rs564398,type 2 diabetes
CDKN2B-AS1,Rs564398,type 2 diabetes
CDKN2B-AS1,Rs564398,type 1 diabetes
CDKN2B-AS1,Rs564398,type 2 diabetes
CDKN2B-AS1,Rs564398,type 2 diabetes
CDKN2B-AS1,Rs564398,Han Chinese
CDKN2B-AS1,Rs564398,gestational diabetes mellitus
CDKN2B-AS1,Rs564398,Korean population
CDKN2B-AS1,Rs564398,Western
CDKN2B-AS1,Rs564398,Chinese Han population
CDKN2B-AS1,Rs564398,type 2 diabetes
CDKN2B-AS1,Rs3217992,ovarian cancer
CDKN2B-AS1,Rs1556516,longevity
CDKN2B-AS1,Rs2891168,Italian population
CDKN2B-AS1,Rs2157719,high-grade glioma
CDKN2B-AS1,Rs2157719,regions are associated with
CDKN2B-AS1,Rs2157719,Variants in the CDKN2B and RTEL1 regions
CDKN2B-AS1,Rs2157719,high-grade glioma susceptibility
CDKN2B-AS1,Rs2157719,high-grade glioma
CDKN2B-AS1,Rs2157719,high-grade glioma susceptibility
CDKN2B-AS1,Rs2157719,RTEL1
CDKN2B-AS1,Rs2157719,CDKN2B
CDKN2B-AS1,Rs2151280,Basal Cell Carcinoma
CDKN2B-AS1,Rs17756311,childhood acute lymphoblastic leukemia
CDKN2B-AS1,Rs1556516,longevity
CDKN2B-AS1,Rs1556516,longevity
CDKN2B-AS1,Rs3217992,myocardial infarctions
CDKN2B-AS1,Rs1537375,myocardial infarction
CDKN2B-AS1,Rs1537375,myocardial infarction
CDKN2B-AS1,Rs1412829,Glioma
CDKN2B-AS1,Rs1333042,Myocardial Infarction
CDKN2B-AS1,Rs1333042,Coronary artery disease
CDKN2B-AS1,Rs1333042,Coronary artery disease
CDKN2B-AS1,Rs1063192,Myocardial Infarction
CDKN2B-AS1,Rs1063192,rs1063192(C) allele
CDKN2B-AS1,Rs1063192,myocardial infarctions
CDKN2B-AS1,Rs1063192,Han Chinese
CDKN2B-AS1,Rs1063192,CDKN2B gene
CDKN2B-AS1,Rs1063192,cyclin-dependent kinase inhibitor
CDKN2B-AS1,Rs1063192,SNP
CDKN2B-AS1,Rs1011970,breast 
CDKN2B-AS1,Rs1011970,cancer 
CDKN2B-AS1,Rs1011970,breast cancer
CDKN2B-AS1,Rs2811712,longevity
CDKN2B-AS1,Rs2811712,physical function in older individuals
CDKN2B-AS1,Rs1556516,longevity
CDKN2B-AS1,Rs2811712,reduced physical impairment
CDKN2B-AS1,Rs2811712,elderly Caucasian individuals
CDKN2B-AS1,Rs2891168,myocardial infarction
CDKN2B-AS1,Rs2891168,CAD risk genotype
CDKN2B-AS1,Rs2891168,high-grade glioma susceptibility
CDKN2B-AS1,Rs2891168,periodontitis
CDKN2B-AS1,Rs2891168,coronary heart disease
CDKN2B-AS1,Rs2891168,arterial stiffness
CDKN2B-AS1,Rs2891168,atherosclerosis risk
CDKN2B-AS1,Rs2891168,Coronary artery disease
CDKN2B-AS1,Rs2891168,type 2 diabetes
CDKN2B-AS1,Rs2891168,myocardial infarction
CDKN2B-AS1,Rs2891168,glioma
CDKN2B-AS1,Rs2891168,periodontitis
CDKN2B-AS1,Rs2891168,coronary heart disease
CDKN2B-AS1,Rs2891168,atherosclerosis
CDKN2B-AS1,Rs2891168,type 2 diabetes
CDKN2B-AS1,Rs2811712,Multiple Disease Phenotypes Correlate
CDKN2B-AS1,Rs2811712,severely limited physical function
CDKN2B-AS1,Rs2811712,breast cancer
CDKN2B-AS1,Rs2811712,British population
CDKN2B-AS1,Rs2811712,ovarian cancer
CDKN2B-AS1,Rs2811712,cell cycle single-nucleotide polymorphisms
CDKN2B-AS1,Rs2811712,atherosclerosis
CDKN2B-AS1,Rs2811712,ovarian cancer risk
CDKN2B-AS1,Rs2811712,reduced physical impairment
CDKN2B-AS1,Rs2811712,breast cancer
CDKN2B-AS1,Rs2811712,ovarian cancer
CDKN2B-AS1,Rs2811712,cell cycle single-nucleotide polymorphisms and ovarian cancer risk
CDKN2B-AS1,Rs2811712,atherosclerosis
CDKN2B-AS1,Rs2891168,Coronary artery disease
CDKN2B-AS1,Rs2811712,Multiple Disease Phenotypes
CELSR1,Rs9615362,retracted
CEP290,Rs62638180,inherited disease.
CEP290,Rs752197734,Blueprint Genetics Retinal dystrophy
CEP290,Rs62638180,recessively inherited disease
CEP290,Rs752197734,Blueprint Genetics Retinal dystrophy
CEP290,Rs281865192,congenital blindness
CEP290,Rs281865192,Leber Congenital Amaurosis
CEP290,Rs281865192,Retinal dystrophy
CETP,Rs5882,longevity
CETP,Rs5882,long life
CETP,Rs5882,dementia
CETP,Rs5882,Alzheimer's
CETP,Rs5882,disease
CETP,Rs5882,ementia and Alzheimer's disease 
CETP,Rs5882,Memory Decline
CETP,Rs5882,Dementia
CETP,Rs5882,Cognitive Decline
CETP,Rs5882,Dementia
CETP,Rs708272,coronary artery disease
CETP,Rs708272,cardiovascular risk
CETP,Rs708272,myocardial infarction
CETP,Rs708272,myocardial infarction
CETP,Rs708272,coronary heart disease
CETP,Rs708272,protect individuals from coronary artery disease
CETP,Rs708272,high cardiovascular risk
CETP,Rs708272,reduced coronary heart disease risk in those drinking alcohol
CETP,Rs708272,had a reduced risk (odds ratio 0.21) for CHD in intermediate vs low drinkers
CETP,Rs7499892,decreased HDL cholesterol levels
CETP,Rs5882,ageing
CETP,Rs708272,lead to higher HDL levels
CETP,Rs5882,dementia
CETP,Rs1532624,HDL cholesterol
CETP,Rs4783961,of non-fatal myocardial infarction
CETP,Rs5882,Alzheimer's disease
CETP,Rs1532624,cholesterol levels
CETP,Rs1532624,carotid artery disease
CETP,Rs1532624,Polymorphism
CETP,Rs1532624,myocardial infarction
CETP,Rs1532624,HDL cholesterol levels
CETP,Rs1532624,carotid artery disease
CETP,Rs1532624,HDL cholesterol
CETP,Rs1532624,future myocardial infarction
CETP,Rs1532624,healthy women
CETP,Rs1532624,dyslipidemia
CETP,Rs183130,independent 
CETP,Rs4783961,risk of incident nonfatal myocardial infarction and ischemic stroke.
CETP,Rs183130,lipoprotein 
CETP,Rs2303790,candidate gene polymorphisms
CETP,Rs2303790,ischemic stroke
CETP,Rs2303790, meta-analysis of candidate gene polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients. 
CETP,Rs2303790,ischemic stroke
CETP,Rs1864163,G allele 
CETP,Rs1864163,increase in HDL cholesterol (good cholesterol).
CETP,Rs183130,population 
CFAP43,Rs373911488,T>A
CFAP43,Rs373911488,pathogenic variant
CFAP43,Rs376788209,pathogenic variant
CFAP44,Rs866096259,pathogenic variant
CFH,Rs3753396,atypical haemolytic uremic syndrome
CFH,Rs3753396,hemolytic uremic syndrome.
CFH,Rs3753396,Neovascular age-related macular degeneration
CFH,Rs3753396,age related macular degeneration
CFH,Rs3753396,atypical hemolytic uremic syndrome
CFH,Rs3753396,haemolytic uremic syndrome
CFH,Rs3753394,atypical haemolytic uremic syndrome
CFH,Rs3753396,macular degeneration
CFH,Rs3753394,atypical hemolytic uremic syndrome
CFH,Rs3753394,polypoidal choroidal vasculopathy
CFH,Rs3753394,gene polymorphisms in Chinese patients with polypoidal choroidal vasculopathy
CFH,Rs529825,age
CFH,Rs3753394,"n Caucasians, but not in Japanese Multiple gene polymorphisms"
CFH,Rs3753396, Neovascular age-related macular degeneration
CFH,Rs529825,macular degeneration
CFH,Rs800292,retinopathy
CFH,Rs551397,macular degeneration
CFH,Rs572515,neovascular age related macular degeneration
CFH,Rs572515,neovascular age related macular degeneration 
CFH,Rs7535263,age
CFH,Rs7535263,macular degeneration
CFH,Rs800292,blindness
CFH,Rs800292,macular degeneration
CFH,Rs800292,polypoidal choroidal vasculopathy
CFH,Rs800292,macular degeneration
CFH,Rs800292,coronary heart disease
CFH,Rs800292,polypoidal choroidal vasculopathy
CFH,Rs800292,hemolytic uremic syndrome
CFH,Rs800292,retinitis pigmentosa
CFH,Rs3753394,blindness in old agers
CFH,Rs551397,age
CFH,Rs3753394,age-related macular degeneration
CFH,Rs1061147,macular degeneration (damage to the eye with ageing)
CFH,Rs3753394,polypoidal choroidal vasculopathy
CFH,Rs3753394,age-related macular degeneration 
CFH,Rs1061147,age related macular degeneration
CFH,Rs1061147,macular degeneration
CFH,Rs1061147,age related macular degeneration
CFH,Rs1061147,damage to the eye with ageing
CFH,Rs1061147,macular degeneration
CFH,Rs1061170,Some SNPs in other genes (like C7 and MBL2) may protect individuals with
CFH,Rs1061170,degeneration
CFH,Rs1065489,meningococcal disease.
CFH,Rs1329428,macular degeneration
CFH,Rs1329428,blindness
CFH,Rs1329428,Caucasians
CFH,Rs1329428,Japanese
CFH,Rs1410996,macular degeneration
CFH,Rs1410996,age
CFH,Rs203674,macular degeneration
CFH,Rs3753394,atypical hemolytic uremic syndrome
CFH,Rs3753394,polypoidal choroidal vasculopathy
CFH,Rs3753394,age-related macular degeneration
CFH,Rs3753394,polypoidal choroidal vasculopathy
CFH,Rs3753394,age-related macular degeneration
CFH,Rs203674,age
CFH,Rs3753394,ARMD 
CFH,Rs3753394,atypical haemolytic uremic syndrome
CFH,Rs3753394,AMD 
CFH,Rs3753394,exudative AMD
CFH,Rs3753394,blindness 
CFH,Rs2274700,macular degeneration
CFH,Rs2274700,age
CFH,Rs3753394,exudative AMDCFH variations 
CFI,Rs10033900,genotypes and phenotypes
CFI,Rs10033900, polypoidal choroidal vasculopathy
CFI,Rs10033900,wet-type age-related macular degeneration
CFI,Rs10033900,Genetic analysis
CFI,Rs10033900,age-related macular degeneration
CFI,Rs10033900,wet-type age-related macular degeneration
CFI,Rs10033900,Plasma
CFI,Rs10033900,polypoidal choroidal vasculopathy
CFI,Rs10033900,age-related macular degeneration
CFI,Rs10033900,activation fragments
CFTR,I5006053,Cystic Fibrosis
CFTR,I5006050,Cystic Fibrosis
CFTR,I5006049,Cystic Fibrosis
CFTR,I5006048,Cystic Fibrosisrs
CFTR,I5006047,Cystic Fibrosis
CFTR,I5006047,Cystic Fibrosis
CFTR,I4000325,Cystic Fibrosis
CFTR,I4000324,Cystic Fibrosis
CFTR,I4000324,Cystic Fibrosis
CFTR,I4000324,Cystic Fibrosis
CFTR,I4000322,Cystic Fibrosis
CFTR,I4000322,Cystic Fibrosisrs
CFTR,I4000321,Cystic Fibrosis
CFTR,I4000321,Fibrosis
CFTR,I4000321,Cystic
CFTR,I4000321,ystic Fibrosisr
CFTR,I4000320,most common autosomal recessive disorder in populations with European ancestry
CFTR,I4000320,and lower infection susceptibility
CFTR,I4000320,better anthropometric and lung function measure
CFTR,I4000320,higher frequency of pancreatic sufficiency
CFTR,I4000320,milder disease
CFTR,I5006054,Cystic Fibrosis
CFTR,I4000322,Cystic Fibrosis
CFTR,I5006054,Cystic Fibrosis
CFTR,I5006076,Cystic Fibrosisrs
CFTR,I5006054,Fibrosisrs
CFTR,I4000320,Cystic fibrosis
CFTR,I5006083,Cystic Fibrosis
CFTR,I5006080,Fibrosisrs121909017
CFTR,I5006080,Cystic 
CFTR,I5006080,Cystic Fibrosis
CFTR,I5006076,Cystic Fibrosis
CFTR,I5006075,Cystic Fibrosis
CFTR,I5006083,Cystic Fibrosis
CFTR,I5006074,Cystic Fibrosis
CFTR,I5006072,Cystic Fibrosisrs
CFTR,I5006054,Cystic
CFTR,I5006072,Fibrosisrs121909013
CFTR,I5006071,Cystic Fibrosis
CFTR,I5006071,Cystic Fibrosis
CFTR,I5006070,Cystic Fibrosis
CFTR,I5006070,Cystic Fibrosis
CFTR,I5006063,Cystic Fibrosisrs
CFTR,I5006062,Cystic Fibrosis
CFTR,I5006062,Cystic Fibrosis
CFTR,I5006056,cystic
CFTR,I5006056,fibrosis
CFTR,I5006055,Cystic Fibrosisrs
CFTR,I5006072,Cystic Fibrosisrs
CFTR,I4000320,Cystic Fibrosis
CFTR,I3002449,Cystic Fibrosis
CFTR,I4000320,lower infection susceptibility
CFTR,I4000305,cystic fibrosis
CFTR,I4000305,cystic fibrosis
CFTR,I4000301,Cystic Fibrosisrs
CFTR,I4000301,Cystic Fibrosis
CFTR,I4000301,Cystic Fibrosis
CFTR,I4000297,Cystic Fibrosis
CFTR,I4000296,Cystic Fibrosis
CFTR,I4000296,Cystic Fibrosis
CFTR,I4000295,Cystic Fibrosis
CFTR,I4000294,Cystic Fibrosis
CFTR,I4000306,Cystic Fibrosisrs
CFTR,I4000294,Cystic Fibrosis
CFTR,I4000292,Cystic Fibrosis
CFTR,I4000291,Cystic Fibrosis
CFTR,I3002449,Cystic Fibrosis
CFTR,I3002449,Cystic Fibrosis
CFTR,I3000001,Cystic Fibrosis Delta F508 mutation
CFTR,I3000001,23andMe
CFTR,I3000001,mutation
CFTR,I3000001,Cystic Fibrosis
CFTR,I3000001,Cystic Fibrosis
CFTR,I4000320,cystic fibrosis
CFTR,I4000292,no mutations
CFTR,I4000308,Cystic Fibrosisrs
CFTR,I4000299,Cystic Fibrosis
CFTR,I4000311,Cystic Fibrosis
CFTR,I4000320,better anthropometric and lung function measure
CFTR,I4000320, higher frequency of pancreatic sufficiency
CFTR,I4000320,cystic fibrosis
CFTR,I4000320,cystic fibrosis
CFTR,I4000308,Cystic Fibrosis
CFTR,I4000320,cystic fibrosis
CFTR,I4000320,pancreatic insufficiency
CFTR,I4000320,European 
CFTR,I4000320,autosomal recessive disorder
CFTR,I4000320,Cystic fibrosis
CFTR,I4000320,pancreatic insufficiency
CFTR,I4000320,Cystic Fibrosis
CFTR,I4000320,raised sweat chloride
CFTR,I4000320,respiratory infections
CFTR,I4000313,Cystic Fibrosis
CFTR,I4000314,cystic fibrosissee
CFTR,I4000316,Cystic Fibrosis
CFTR,I4000317,Fibrosisrs76713772
CFTR,I4000316,Cystic Fibrosisrs
CFTR,I4000317,Cystic Fibrosis
CFTR,I4000318,Cystic Fibrosis
CFTR,I4000320,autosomal recessive
CFTR,I4000320,Cystic fibrosis
CHAMP1,Rs863225076,mutations
CHAMP1,Rs863225076,mental retardation
CHAMP1,Rs863225076,mental retardation
CHAMP1,Rs863225076,pathogenic
CHAMP1,Rs863225076,pathogenic
CHAMP1,Rs863225076,gene
CHAMP1,Rs886041988,CHAMP1 
CHAMP1,Rs863225077,autosomal dominant mental retardation
CHAMP1,Rs879255261,autosomal dominant mental retardation
CHAMP1,Rs886041988,1850dup 
CHAMP1,Rs886041988,Lys618Glufs
CHAMP1,Rs886041988,similar 
CHAMP1,Rs863225075,autosomal 
CHAMP1,Rs863225076,autosomal dominant mental retardation
CHAMP1,Rs863225075,CHAMP1 
CHAMP1,Rs200070245,autosomal dominant mental retardation
CHAMP1,Rs863225075,1544G
CHAMP1,Rs863225075,ClinVar
CHAMP1,Rs1131691845,ClinVar
CHAMP1,Rs1131691845,CHAMP1 gene
CHAMP1,Rs1131691845,similar mutations
CHAMP1,Rs1131691845,utosomal dominant mental retardation
CHAMP1,Rs1131691845,CHAMP1 gene
CHAMP1,Rs1131691845,Considered pathogenic
CHAMP1,Rs1131691845,autosomal dominant mental retardation
CHAMP1,Rs782397980,autosomal dominant mental retardation.
CHAMP1,Rs797044961,autosomal dominant mental retardation
CHAMP1,Rs797044963,autosomal dominant mental retardation
CHAMP1,Rs863225074,autosomal dominant mental retardation.
CHAMP1,Rs863225075,Trp515Ter
CHAMP1,Rs200070245,form of autosomal dominant mental retardation
CHCHD10,Rs730880031,okela type of spinal muscular atrophy
CHCHD10,Rs730880031,Late-onset spinal motor neuronopathy
CHEK2,Rs28909982,breast cancer
CHEK2,Rs17879961,"SNP,"
CHEK2,Rs17879961,CHEK2 gene
CHEK2,Rs17879961,SNPs
CHEK2,Rs17879961,rs17879961
CHEK2,Rs1805129,cancer-associated cell cycle regulator
CHEK2,Rs1805129,silent polymorphism
CHEK2,Rs1805129,silent polymorphism
CHEK2,Rs1805129,This SNP represents a silent polymorphism in the cancer-associated cell cycle regulator CHEK2 gene.
CHEK2,Rs17879961,lung cancer
CHEK2,Rs17879961,SNPs
CHEK2,Rs17879961,breast cancer 
CHEK2,Rs17879961,breast cancer
CHEK2,Rs17879961,breast cancer
CHEK2,Rs17879961,breast cancer
CHEK2,I4000462,Breast Cancer
CHEK2,I4000462,Breast Cancer
CHEK2,Rs17879961,breast cancer
CHEK2,Rs17879961,breast cancer
CHEK2,I4000462,Cancerrs555607708
CHEK2,Rs17879961,lung cancer
CHEK2,Rs17879961,breast cancer
CHEK2,Rs17879961,breast cancer
CHEK2,Rs17879961,lung cancer
CHEK2,Rs17879961,breast cancer
CHI3L1,Rs6691378,risk of asthma
CHI3L1,Rs6691378,Danish 
CHI3L1,Rs6691378,asthma
CHI3L1,Rs6691378,asthma
CHI3L1,Rs6691378,type 2 diabetes
CHI3L1,Rs6691378,asthma
CHI3L1,Rs6691378,atopy
CHI3L1,Rs6691378,asthma
CHI3L1,Rs6691378,lung function
CHI3L1,Rs6691378,schizophrenia
CHI3L1,Rs6691378,polymorphisms
CHI3L1,Rs4950928,new population (Han Chinese)
CHI3L1,Rs4950928,ethnically identical population (Japanese)
CHI3L1,Rs6691378,asthma-susceptibility
CHI3L1,Rs4950928,predisposition to schizophrenia
CHI3L1,Rs10399931,coronary heart disease
CHI3L1,Rs10399931,rheumatoid arthritis
CHI3L1,Rs10399931, coronary heart disease
CHI3L1,Rs10399931,coronary artery disease
CHI3L1,Rs10399931,Genetic polymorphisms
CHI3L1,Rs10399931,rheumatoid arthritis.
CHIT1,Rs2297950,asthma
CHIT1,Rs2297950,inflammatory conditions
CHIT1,Rs2297950,chitotriosidase deficiency
CHIT1,Rs2297950, inflammatory bowel disease
CHIT1,Rs2297950,chitotriosidase gene
CHIT1,Rs2297950,Gly102Arg
CHIT1,Rs2297950,single nucleotide polymorphism
CHM,Rs132630267,A 
CHM,Rs132630267,aka 
CHM,Rs132630267,Cys499Ter
CHM,Rs132630267,Cys499Ter
CHM,Rs132630267,c.1497
CHM,Rs132630267,1497C
CHRM2,Rs8191992,No significant association was found between this CHRM2 gene SNP and diverse measures of cognitive ability 
CHRM2,Rs8191992,Synergistic effects of genetic variation in nicotinic and muscarinic receptors on visual attention but not working memory.
CHRM2,Rs8191992,alcoholism spectrum disorders:
CHRM2,Rs8191992,cognition
CHRM2,Rs8191992,cognition
CHRM2,Rs8191992,cognitive ageing 
CHRM2,Rs8191992, cognitive ability 
CHRM2,Rs8191992,bipolar disorder.
CHRM2,Rs324640,SNP
CHRM2,Rs324640,intelligence
CHRM2,Rs324640,higher IQ
CHRM2,Rs324640,genotype
CHRM2,Rs324640,genotype
CHRM2,Rs324640,Caucasians
CHRM2,Rs324640,CHRM2 gene
CHRM2,Rs324640,intelligence
CHRM2,Rs324640,SNAP25 gene
CHRM2,Rs324640,SNPs
CHRM2,Rs324640,genotype
CHRM3,Rs7520974,associated with specific patterns of brain activity
CHRM3,Rs2165870,nausea 
CHRM3,Rs2165870,nausea 
CHRM3,Rs2165870,higher risk for nausea
CHRM3,Rs2165870,post-operative nausea
CHRM3,Rs2165870,post-operative nausea
CHRNA3,Rs1051730,PAD
CHRNA3,Rs8042374,lung cancer
CHRNA3,Rs578776,nicotine dependence
CHRNA3,Rs578776,nicotine dependence
CHRNA3,Rs4887067,Risk Factors for Age-Dependent Nicotine Addiction
CHRNA3,Rs1051730,alcohol abuse
CHRNA3,Rs1051730,peripheral arterial disease
CHRNA3,Rs578776,lung cancer
CHRNA3,Rs1051730,lung cancer
CHRNA3,Rs1051730,lung cancer
CHRNA3,Rs1051730,lung cancer
CHRNA3,Rs1051730,lung cancer
CHRNA3,Rs1051730,Artery Disease
CHRNA3,Rs1051730,lung cancer
CHRNA3,Rs1051730,lung cancer
CHRNA4,Rs3787137,gene
CHRNA4,Rs3787137,gene 
CHRNA4,Rs3787137,gene
CHRNA4,Rs3787137,environment 
CHRNA4,Rs3787137,by
CHRNA4,Rs3787137,gene 
CHRNA4,Rs3787137,Gene
CHRNA4,Rs3787137,Genetic 
CHRNA4,Rs3787137,by
CHRNA4,Rs3787137,variability 
CHRNA4,Rs3787137,acetylcholine 
CHRNA4,Rs3787137,receptors 
CHRNA4,Rs3787137,nicotine 
CHRNA4,Rs3787137,addiction
CHRNA4,Rs3787137,nicotine 
CHRNA4,Rs3787137,SNPs
CHRNA4,Rs3787137,dependence
CHRNA4,Rs3787137,genes 
CHRNA4,Rs3787137,genes 
CHRNA4,Rs1044396,g2b2mh
CHRNA4,Rs1044396,change 
CHRNA4,Rs3787137,nicotine dependence
CHRNA4,Rs3787137,nicotine dependence
CHRNA4,Rs3787137,nicotine dependence
CHRNA4,Rs3787137,nicotine addiction
CHRNA4,Rs1044396,rs1044396 
CHRNA4,Rs3787137,nicotine dependence
CHRNA4,Rs3787137,nicotine dependence
CHRNA4,Rs3787137,nicotine addiction
CHRNA4,Rs3787137,Cholinergic 
CHRNA4,Rs3787137,nicotinic 
CHRNA4,Rs3787137,implicated in a nicotine dependence
CHRNA4,Rs3787137,receptor 
CHRNA5,Rs684513,smoking quantity
CHRNA5,Rs684513,multiple substance dependence phenotypes
CHRNA5,Rs684513,lung cancer
CHRNA5,Rs951266,lung cancer
CHRNA5,Rs684513,nicotine addiction
CHRNA5,Rs6495306,G allele
CHRNA5,Rs684513,bipolar disorder
CHRNA5,Rs6495306,increases susceptibility to Substance dependence
CHRNA5,Rs6495306,Alcohol
CHRNA5,Rs6495306,Substance dependence
CHRNA5,Rs684513,lung cancer
CHRNA5,Rs684513,nicotine dependence
CHRNA5,Rs684513,nicotine dependence 
CHRNA5,Rs951266,Substance dependence
CHRNA5,Rs684513,lung cancer
CHRNA5,Rs684513,COPD
CHRNA5,Rs951266, subunit
CHRNA5,Rs951266,Lung cancer
CHRNA5,Rs951266,Lung cancer
CHRNA5,Rs951266,Peripheral arterial disease
CHRNA5,Rs951266,Substance dependence
CHRNA5,Rs951266,Age-Dependent Nicotine Addiction
CHRNA5,Rs951266,bipolar disorder
CHRNA5,Rs951266,age-dependent nicotine addiction
CHRNA5,Rs951266,nicotine dependence
CHRNA5,Rs4887067,Risk Factors for Age-Dependent Nicotine Addiction
CHRNA5,Rs684513,cognitive performance
CHRNA5,Rs17486278,lung cancer
CHRNA5,Rs684513,susceptibility to heavy smoking
CHRNA5,Rs17486278,nicotine dependence
CHRNA5,Rs17486278,Risk for nicotine dependence
CHRNA5,Rs16969968,smoking
CHRNA5,Rs16969968,lung cancer
CHRNA5,Rs16969968,chronic obstructive pulmonary disease
CHRNA5,Rs16969968,decreased response to a nicotine agonist
CHRNA5,Rs16969968,nicotine dependence
CHRNA5,Rs16969968,cocaine dependence
CHRNA5,Rs16969968,nicotine dependence
CHRNA5,Rs16969968,enhanced pleasurable responses
CHRNA5,Rs16969968,Substance dependence
CHRNA5,Rs16969968,Age-Dependent Nicotine Addiction
CHRNA5,Rs16969968,smoking 
CHRNA5,Rs16969968,nicotine agonist
CHRNA5,Rs16969968,chronic obstructive pulmonary disease
CHRNA5,Rs16969968,cocaine dependence
CHRNA5,Rs17486278,lung cancer
CHRNA5,Rs16969968,nicotine dependence
CHRNA5,Rs16969968,Age-Dependent Nicotine Addiction
CHRNA5,Rs16969968,homozygotes 
CHRNA5,Rs16969968,heterozygotes
CHRNA5,Rs16969968,Nicotine
CHRNA5,Rs17486278,nicotine addiction
CHRNA5,Rs16969968,chronic obstructive pulmonary disease
CHRNA5,Rs16969968,lung cancer 
CHRNA5,Rs16969968,enhanced pleasurable responses
CHRNA5,Rs16969968," nicotine dependence,"
CHRNA5,Rs16969968,SNP
CHRNA5,Rs16969968,Substance dependence
CHRNA7,Rs6494223,Northern Ireland
CHRNA7,Rs6494223,Alzheimer's disease
CHRNA7,Rs6494223,delusions
CHRNA7,Rs6494223,Alzheimer's disease
CHRNA7,Rs6494223,delusions
CHRNA7,Rs6494223,Alzheimer's disease
CHRNA7,Rs3087454,associated with specific patterns of brain activity
CHRNA7,Rs1355920,associated with specific patterns of brain activity
CHRNA7,Rs6494223,delusions
CHRNB3,Rs6474413,T allele
CHRNB3,Rs6474413,1.35 times for carriers
CHRNB3,Rs6474413,Nicotine
CHRNB3,Rs6474413,Substance dependence
CHRNB3,Rs6474413,"increases susceptibility to Substance dependence, Nicotine 1.35 times for carriers of the T allele"
CLCN1,Rs80356694,Decrement of compound muscle action
CLCN1,Rs80356694,dominant myotonia congenita
CLCN1,Rs80356690,chloride
CLCN1,Rs80356690,channel disorde
CLCN1,Rs80356690,autosomal
CLCN1,Rs80356690,Myotonia levior is a chloride channel disorder
CLCN1,Rs80356690,Thomsen's myotonia congenita
CLCN1,Rs80356690,chloride channel disorder
CLCN1,Rs80356690,Myotonia levior
CLCN1,Rs80356690,cause Thomsen's myotonia congenita
CLCN1,Rs80356690,dominant
CLCN1,Rs80356690,chromosome 7
CLCN1,Rs80356690,chromosome 7
CLCN1,Rs80356690,autosomal
CLCN1,I5003253,Myotonia congenitars
CLCN1,I5003253,Myotonia congenitars
CLCN1,I5003259,Myotonia congenitars
CLCN1,I5003260,Myotonia
CLCN1,I5003259,Myotonia 
CLCN1,Rs121912810,Thomsen's myotonia congenita
CLCN1,Rs121912810,Thomsen's myotonia congenita
CLCN1,Rs80356690,Thomsen's myotonia congenita
CLCN1,Rs80356690,Myotonia levior
CLCN1,Rs80356690,mutation
CLDN14,Rs368027306,OMIM
CLDN14,Rs219781,Kidney Stones
CLDN14,Rs219781,Kidney Stones
CLDN14,Rs368027306,SNP
CLDN14,Rs219780,decreased bone mineral density
CLDN14,Rs368027306,ClinVar
CLDN14,Rs74315437,deafness
CLDN14,Rs368027306,deafness
CLDN14,Rs368027306,Inherited in a recessive manner
CLDN14,Rs368027306,considered pathogenic for a form of deafness
CLDN14,Rs74315437,Inherited in a recessive manner
CLDN14,Rs786204841,form of deafness
CLDN14,Rs219780,kidney stones
CLDN14,Rs368027306,deafness
CLDN14,Rs219778,kidney stones
CLDN14,Rs143797113,deafness
CLDN14,Rs219778,have a slightly increased risk of developing kidney stones.
CLDN14,Rs219778,T alleles
CLDN14,Rs143797113,CLDN14 gene
CLDN14,Rs143797113,deafness
CLDN14,Rs143797113,ecessively
CLDN14,Rs143797113,homozygous minor
CLDN14,Rs143797113,heterozgyote form
CLDN14,Rs143797113,minor
CLDN14,Rs143797113,childhood
CLDN14,Rs143797113,deafness 
CLDN14,Rs143797113,recessively
CLDN14,Rs219778,kidney stones
CLDN14,Rs219778,risk of developing kidney stones
CLDN14,Rs143797113,pathogenic 
CLDN16,Rs765256758,OMIM
CLDN16,Rs765256758,pathogenic variant
CLDN16,Rs765256758,Ala139Val
CLEC16A,Rs725613,multiple sclerosis
CLEC16A,Rs725613,multiple sclerosis
CLEC16A,Rs725613,type 1 diabetes
CLEC16A,Rs725613,T1D
CLEC16A,Rs725613,multiple sclerosis
CLEC16A,Rs725613,type-1 diabetes
CLEC16A,Rs725613,type-1 diabetes 
CLEC16A,Rs725613,"10e-3) but also with multiple sclerosis (odds ratio = 1.21, p = 6.7 x 10e-5). rs"
CLEC16A,Rs2903692,type 1 diabetes
CLEC16A,Rs2041733,atopic dermatitis
CLEC16A,Rs2041733,Multi-ancestry genome-wide
CLEC16A,Rs17806056,Common variable immunodeficiency disorder (CVID)
CLEC16A,Rs725613,type-1 diabetes
CLN3,Rs386833721,Blueprint Genetics Retinal dystrophy
CLN3,Rs386833721,Blueprint Genetics Retinal dystrophy
CLOCK,Rs6832769,"The effect remained significant in the replicative American sample, but failed to achieve significance in the Norwegian sample and third sample (though the combined p value remained significant at 0.000865)."
CLOCK,Rs6832769,The A allele of the CLOCK gene SNP rs6832769 was associated with lessened personality_traits|agreeableness (p = 0.00000871) in a group of 3972 Sardinians
CLOCK,Rs4864548,obesity
CLOCK,Rs4864548,"1.8-fold higher risk (CI: 1.31-2.54, p < 0.001)"
CLOCK,Rs4864548,haplotype
CLOCK,Rs4864548,study
CLOCK,Rs4864548,391 overweight patients
CLOCK,Rs4864548,overweight
CLOCK,Rs1554483,"1.8-fold higher risk (CI: 1.31-2.54, p < 0.001)"
CLOCK,Rs1554483,obesity
CLOCK,Rs1554483,haplotype
CLOCK,Rs1554483,study
CLOCK,Rs1554483,391 overweight patients
CLOCK,Rs1554483,overweight
CLOCK,Rs1554483,obesity
CLOCK,Rs4864548,obesity
CLRN1,Rs111033258,Ashkenazi Jews
CLRN1,Rs111033258,Usher Syndrome Type III
CLRN1,Rs111033258,risk allele
CLRN1,Rs111033258,chromosome 3
CLRN1,Rs1085307050,pathogenic
CLRN1,Rs111033258,Usher Syndrome Type III
CLRN1,Rs1085307050,pathogenic
CLRN1,Rs111033258,Usher Syndrome Type III
CLTCL1,Rs1061325,insulin resistance on modern diets.
CMAS,Rs2955503,blood pressure
CMAS,Rs2955503,postural changes
CMAS,Rs2955503,haplotype
CMAS,Rs2955503,postural changes
CMAS,Rs2955503,blood pressure
CMAS,Rs2955503,blood pressure
CMAS,Rs2955503,postural changes
CMAS,Rs2955503,haplotype
CMAS,Rs2955503,ATP-sensitive potassium channel genes
CNGB3,Rs3735967,Achromatopsia: the CNGB3 p.T383fsX mutation results from a founder effect and is responsible for the visual phenotype in the original report of uniparental disomy 14.
CNGB3,Rs397515360,achromatopsia
CNGB3,Rs3735967,uniparental disomy 14
CNGB3,Rs3735967,visual phenotype
CNGB3,Rs3735967,T383fsX mutation
CNGB3,Rs3735967,Achromatopsia
CNGB3,Rs3735967,visual phenotype
CNGB3,Rs397515360, achromatopsia
CNGB3,Rs35365413,macular degeneration
CNGB3,Rs35365413,achromatopsia
CNGB3,Rs121918344,20/200 visual acuity
CNGB3,Rs121918344,nystagmus
CNGB3,Rs121918344,photophobia
CNGB3,Rs121918344,colorblindness
CNGB3,Rs3735967,Achromatopsia
CNNM1,Rs6584273,May Affect Diabetes Risk
CNNM1,Rs6584273,alcohol metabolism
CNNM1,Rs6584273,genetic variation in pathways that metabolize
CNR1,Rs806377, gaze duration for happy faces. (C;C) associated with the highest striatal response is also associated with the longest gaze duration for happy faces
CNR1,Rs806377,ADHD in males than in females with the risk haplotype.
CNR1,Rs806377,haplotype was more associated (p=0.03) with ADHD in males than in females with the risk haplotype.
CNR1,Rs9450898,hippocampus
CNR1,Rs806377,associated (p=0.03) with ADHD in males than in females with the risk haplotype. Cannabis
CNR1,Rs806377,"s806377(C) together with rs6454674(G) make up a haplotype associated (p=0.008) with higher risk of ADHD. In addition, the haplotype was more associated (p=0.03) with ADHD in males than in females with the risk haplotype. Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescents. Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence. Interaction between two independent CNR1 variants increases risk for cocaine dependence in European Americans: a replication study in family-based sample and population-based sample. Candidate genes for cannabis use disorders: findings, challenges and directions. The association between cannabinoid receptor 1 gene (CNR1) and cannabis dependence symptoms in adolescents and young adults. Variation in the human cannabinoid receptor CNR1 gene modulates gaze duration for happy faces."
CNR1,Rs806377,"rs806377(C) together with rs6454674(G) make up a haplotype associated (p=0.008) with higher risk of ADHD. In addition, the haplotype was more associated (p=0.03) with ADHD in males than in females with the risk haplotype. Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescents. Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence. Interaction between two independent CNR1 variants increases risk for cocaine dependence in European Americans: a replication study in family-based sample and population-based sample. Candidate genes for cannabis use disorders: findings, challenges and directions. The association between cannabinoid receptor 1 gene (CNR1) and cannabis dependence symptoms in adolescents and young adults. Variation in the human cannabinoid receptor CNR1 gene modulates gaze duration for happy faces. (C;C) associated with the highest striatal response is also associated with the longest gaze duration for happy faces."
CNR1,Rs806378,obesity
CNR1,Rs806377,03) with ADHD in males than in females with the risk haplotype. Cannabis rec
CNR1,Rs806377,haplotype was more associate
CNR1,Rs806378,fasting colonic motility
CNR1,Rs806378,irritable bowel syndrome-diarrhea
CNR1,Rs806378,overweight
CNR1,Rs806378,obesity
CNR1,Rs806378,nonconstipated irritable bowel syndrome
CNR1,Rs806378,cannabinoid mechanisms and gastric motor functions and satiation in overweight and obesity.
CNR1,Rs806378,asting colonic motility in patients with nonconstipated irritable bowel syndrome.
CNR1,Rs806378,effects on colon transit in irritable bowel syndrome-diarrhea.
CNR1,Rs9450898,cannabinoid receptor 1 (CNR1) gene
CNR1,Rs9450898,hypothalamus
CNR1,Rs9450898,dorsal root ganglia
CNR1,Rs806377, (p=0.03) with ADHD in males than in females with the risk haplotype. Cannab
CNR1,Rs806378,nonconstipated irritable bowel syndrome
CNR1,Rs806377,he risk haplotype. Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescents. Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence. Interaction between two independent CNR1 variants increases risk for cocaine dependence in European Americans: a replication study in family-based sam
CNR1,Rs806377,associated (p=0.03) with ADHD in males than in females with the risk haplotype. Cannabis receptor haplotype associated with fewer cannabis de
CNR1,Rs806377,happy faces
CNR1,Rs806377,"s806377(C) together with rs6454674(G) make up a haplotype associated (p=0.008) with higher risk of ADHD. In addition, the haplotype was more associated (p=0.03) with ADHD in males than in females with the risk haplotype. Cannabis receptor haplotype associated with fewer cannabis dependence symptoms in adolescents. Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence. Interaction between two independent CNR1 variants increases risk for cocaine dependence in European Americans: a replication study in family-based sample and population-based sample. Candidate genes for cannabis use disorders: findings, challenges and directions. The association between cannabinoid receptor 1 gene (CNR1) and cannabis dependence symptoms in adolescents and young adults. Variation in the human cannabinoid receptor CNR1 gene modulates gaze duration for happy faces. (C;C) associated with the highest striatal response is also associated with the longest gaze duration for happy faces."
CNR1,Rs2023239,cannabis dependence
CNR1,Rs6454674,ADHD
CNR1,Rs6454674,schizophrenia
CNR1,Rs6454674,obesity
CNR1,Rs6454674,European
CNR1,Rs6454674,nicotine dependence
CNR1,Rs6454674,obesity
CNR1,Rs6454674,metabolic syndrome in postmenopausal Polish women
CNR1,Rs6454674,cocaine addiction
CNR1,Rs806377,ADHD
CNR1,Rs806377,ADHD
CNR1,Rs806377,ADHD
CNR1,Rs806377,happy faces
CNR1,Rs806377,cannabis dependence
CNR1,Rs806377,adolescents and young adults
CNR1,Rs806377,ADHD
CNR1,Rs806377,cocaine dependence
CNR1,Rs806377,European Americans
CNR1,Rs806377,cannabis dependence
CNR1,Rs806377,adolescents
CNR1,Rs806377,females
CNR1,Rs806377,males
CNR1,Rs806377,cannabis dependence
CNTNAP2,Rs851715,nonsense-word repetition
CNTNAP2,Rs4431523,nonsense-word repetition
CNTNAP2,Rs7794745,autism
CNTNAP2,Rs7794745,autistic children
CNTNAP2,Rs4431523,Speech development 
CNTNAP2,Rs7794745,autism
CNTNAP2,Rs371642222,pathogenic variant
CNTNAP2,Rs2710117,nonsense-word repetition
CNTNAP2,Rs2538991,autism
CNTNAP2,Rs2538976,nonsense-word repetition
CNTNAP2,Rs10246256,nonsense-word repetition
CNTNAP2,Rs4431523,inability of children with typical specific language impairment
COCH,Rs1045644,Meniere's disease
COCH,Rs1045644,Meniere's disease
COCH,Rs28938175,deafness
COCH,Rs28938175,deafness
COL11A1,Rs587782990,Blueprint Genetics Retinal dystrophy
COL11A1,Rs587782990,Blueprint Genetics Retinal dystrophy
COL11A1,Rs1676486,LDH
COL11A1,Rs1676486,musculoskeletal diseases
COL11A1,Rs1676486,Lumbar disc herniation (LDH)
COL11A1,Rs1676486,Japanese
COL1A1,Rs1800215,Connective tissue
COL1A1,Rs1800215,osteoporosis
COL1A1,Rs1800215,linkage disequilibrium
COL1A1,Rs1800215,distribution
COL1A1,Rs1800215,obesity
COL1A1,Rs1800215,disease
COL1A1,Rs1800215,Mutation
COL1A1,Rs1800215,polymorphism
COL1A1,Rs1800215,osteogenesis imperfecta type II
COL1A1,Rs1800215,implications for genotype-phenotype relationships
COL1A1,Rs1800215,related disorders
COL1A1,Rs1800215,related disorders
COL1A1,Rs1800215,prematurity
COL1A1,Rs1800215,osteoporosis
COL1A1,Rs1800215,obesity
COL1A1,Rs1800215,haplotype distribution
COL1A1,Rs1800215,linkage disequilibrium
COL1A1,Rs1800215,polymorphism spectrum in osteogenesis imperfecta
COL1A1,Rs1800215,Connective tissu
COL1A1,Rs1800215,preterm birth
COL1A1,Rs1800215,genes contributing to prematurity
COL1A1,Rs1800215,ten candidate genes
COL1A1,Rs1800215,preterm birth
COL1A1,Rs1800215,complex disorders
COL1A1,Rs1800215,Mutation
COL1A1,Rs1800215,genotype-phenotype
COL1A1,Rs1107946,obesity 
COL1A1,Rs1107946,osteoporosis
COL1A1,Rs1107946,femoral neck bone geometric parameters
COL1A1,Rs1107946,Caucasian and Chinese nuclear families
COL1A1,Rs1800215,Connective tissue and related disorders and preterm birth: clues to genes contributing to prematurity.
COL1A1,Rs1107946,high myopia susceptibility in Japanese
COL1A1,Rs1107946,bone mass and geometry
COL1A1,Rs1107946, osteoporosis
COL1A1,Rs1107946,fracture risk
COL1A1,Rs1107946,bone mineral density
COL1A1,Rs1107946,osteoporotic fractures
COL1A1,Rs1107946,bone mineral density in women
COL1A1,Rs1107946,osteoporosis
COL1A1,Rs1107946, osteoporosis
COL1A1,Rs1107946,postmenopausal osteoporosis in India
COL1A1,Rs1107946,Bone mineral density
COL1A1,Rs1800215,obesity
COL1A1,Rs1800215,osteoporosis
COL1A1,Rs1800215,haplotype distribution
COL1A1,Rs1800215,Mutation
COL1A1,Rs1800215,polymorphism
COL1A1,Rs1800215,osteogenesis imperfecta type II
COL1A1,Rs1107946,reduced bone quality and hip fracture
COL1A2,Rs42524,intracranial aneurysms
COL2A1,Rs121912880,Stickler syndrome type I
COL2A1,Rs121912880,Spondylometaphyseal dysplasia
COL2A1,Rs121912880,Stickler syndrome type I
COL2A1,Rs121912880,mutations
COL2A1,Rs121912880,pathogenic for Spondylometaphyseal dysplasia
COL3A1,Rs1800255,alpha I chain of the type III collagen protein-encoding COL3A1 gene
COL3A1,Rs1800255,compared with the reference genotype (G;G) in populations of Asian and Dutch women.
COL3A1,Rs1800255,A meta-analysis published in 2014 reported that the rs1800255(A;A) genotype was associated with pelvic organ prolapse 
COL3A1,Rs1800255,No significance was found for the heterozygous genotype.
COL3A1,Rs1800255,odds ratio of 5 (CI: 1.4-17.1) between rs1800255(A;A) homozygotes and risk for pelvic organ prolapse.
COL3A1,Rs1800255,Asian and Dutch women.
COL3A1,Rs1800255,genotype
COL3A1,Rs1800255,pelvic organ prolaps
COL3A1,Rs1800255,genotype 
COL3A1,Rs1800255,heterozygous genotyp
COL3A1,Rs1800255,pelvic organ prolapse
COL3A1,Rs1800255,homozygotes
COL3A1,Rs1800255,SNP
COL3A1,Rs1800255,prolapse 
COL3A1,Rs1800255,prolapse 
COL3A1,Rs1800255,organ 
COL3A1,Rs1800255,pelvic 
COL3A1,Rs1800255,SNP 
COL3A1,Rs1800255,collagen
COL3A1,Rs1800255,protein
COL3A1,Rs1800255,SNP 
COL3A1,Rs1800255,risk for pelvic organ prolapse
COL3A1,Rs1800255,associated with pelvic organ prolapse
COL3A1,Rs1057521106,sudden cardiac death patient
COL3A1,Rs1057521106,vascular Ehlers-Danlos syndrome
COL3A1,Rs1800255,"rs1800255, aka c.2092G>A, A698T or p.Ala698Thr, is a SNP in the alpha I chain of the type III collagen protein-encoding COL3A1 gene.A relatively small study (200 patients) reported an odds ratio of 5 (CI: 1.4-17.1) between rs1800255(A;A) homozygotes and risk for pelvic organ prolapse. No significance was found for the heterozygous genotype.A meta-analysis published in 2014 reported that the rs1800255(A;A) genotype was associated with pelvic organ prolapse (OR 4.79; CI: 1.91-11.98, p = .001) compared with the reference genotype (G;G) in populations of Asian and Dutch women."
COL4A3,Rs121912827,familial benign hematuria.
COL4A3,Rs121912827,Mutations
COL4A3,Rs121912826,Mutations
COL4A3,Rs121912826,familial benign hematuria.
COL5A1,Rs61735045,EDS
COL5A1,Rs12722,tendinopathy
COL5A1,Rs12722,Achilles 
COL5A1,Rs12722,COL5A1 
COL5A1,Rs61735045,Ehlers-Danlos syndrome(EDS)
COL5A1,Rs61735045,causative mutation
COL5A1,Rs61735045,EDS
COL5A1,Rs61735045,EDS
COL9A3,Rs61734651,lumbar disc disease
COL9A3,Rs35908728,lumbar disc disease.
COL9A3,Rs35908728,lumbar disc disease
COMT,Rs9332377,hearing loss
COMT,Rs9332377,Cisplatin
COMT,Rs9332377,hearing loss
COMT,Rs769224,disequilibrium at catechol-O-methyltransferase
COMT,Rs4633,chronic pain condition
COMT,Rs4633,Schizophrenia Susceptibility Genetic
COMT,Rs4633,lower expression levels of the COMT protein
COMT,Rs4633,"endometrial cancer,"
COMT,Rs4633,endometrial cancer
COMT,Rs4633,Schizophrenia Susceptibility Genetic
COMT,Rs2097603,related to extracellular dopamine
COMT,Rs2097603,gray matter volume
COMT,Rs165688,immediate reward and brain activation
COMT,Rs165688,immediate reward
COMT,Rs769224,genetic polymorphisms in catecholamine neurotransmitter systems
COMT,Rs165631,breast cancer
COMT,Rs165599,anxiety-related personality traits
COMT,Rs165599,schizophreniapart
COMT,Rs165599,schizophrenia
COMT,Rs165599,bipolar disorder 
COMT,Rs165631,breast cancer
COMT,Rs165688,brain activation.
COMT,Rs165688,correlated with preferences for immediate reward and brain activation.
COMT,Rs165631,breast cancer
COMT,Rs165631,breast cancer
COMT,Rs165631,breast cancer
COMT,Rs165631, breast cancer 
COMT,Rs165631,women carrying either disease-causing BRCA1 or BRCA2 mutations
COMT,Rs165688,rs165688
COMT,Rs165631,breast cancer
CPED1,Rs190543052,femoral fracture
CPED1,Rs190543052,genetic risk
CPED1,Rs190543052,one of five used in genetic risk score for lifetime prevalence of femoral fracture in Japanese males
CPED1,Rs148771817,increase in bone density
CPED1,Rs148771817,increase in bone density
CPED1,Rs148771817,increase in bone density
CPED1,Rs190543052,femoral fracture
CREBBP,Rs3025684,autism-susceptibility
CREBBP,Rs3025684,autism
CREBRF,Rs373863828,35 per cent higher chance of obesity 
CREBRF,Rs373863828,considered insufficient to lead to obesity
CRH,Rs28364015,self-protection behaviors
CRH,Rs28364015,orphaned
CRP,Rs3093059,age-related macular degeneration
CRP,Rs3093059,cardiovascular risk
CRP,Rs3093059,Japanese subjects
CRP,Rs3091244,risk of psoriasis
CRP,Rs3091244,susceptibility to Plasmodium falciparum malaria
CRP,Rs3091244,inflammation
CRP,Rs3091244,psoriasis
CRP,Rs3091244,Crohn disease
CRP,Rs3093059,type 2 diabetes mellitus
CRP,Rs3091244,C-reactive protein levels and body mass index
CRP,Rs3093059,Filipino systemic lupus erythematosus families
CRP,Rs3091244,risk of coronary heart disease
CRP,Rs3093059,neovascular age-related macular degeneration
CRP,Rs3093059,risk of systemic lupus erythematosus
CRP,Rs3093059,ischemic stroke
CRP,Rs3093059,hemorrhagic stroke
CRP,Rs3093059,Chinese Han population
CRP,Rs3093059,coronary artery bypass surgery
CRP,Rs3093061,lupus erythematosus
CRP,Rs3093061,lupus erythematosus
CRP,Rs3093062,functional haplotypes containing
CRP,Rs3093062,which is associated with SLE
CRP,Rs3093059,metabolic-syndrome pathways
CRP,Rs3091244,marker of metastatic prostate cancer
CRP,Rs3091244,neovascular age-related macular degeneration
CRP,Rs3091244,linked to coronary heart disease risk
CRP,Rs1800947,SLE
CRP,Rs1800947,systemic lupus erythematosus
CRP,Rs1800947,"autoimmune disorder SLE,"
CRP,Rs1800947,ystemic lupus erythematosus.
CRP,Rs1800947,autoimmune disorder SLE
CRP,Rs1800947,systemic lupus erythematosus
CRP,Rs2794521,"10,000 individuals"
CRP,Rs2794521,mortality outcome
CRP,Rs2794521,"Associated with at least one ""mortality outcome"""
CRP,Rs3091244,cardiovascular risk
CRP,Rs3091244,prevalent coronary heart disease
CRP,Rs3091244,risk of abdominal aortic aneurysm (AAA)
CRP,Rs3091244,variability in serum C-reactive protein level
CRP,Rs3091244,risk of age-related macular degeneration
CRP,Rs3091244,Neovascular age-related macular degeneration risk
CRP,Rs3091244,risk of incident coronary heart diseas
CRP,Rs3091244,systemic lupus erythematosus
CRP,Rs3091244,CRP levels and hypertension
CRP,Rs3091244,coronary heart disease
CRP,Rs3091244,risk of systemic lupus erythematosus
CRP,Rs3091244,susceptibility to ischemic stroke and hemorrhagic stroke
CRP,Rs3091244,COPD risk and systemic inflammation
CRP,Rs3091244,severe hand osteoarthritis
CRYM,Rs28929490,deafness
CRYM,Rs28929490,deafness
CSF2RB,Rs2072707,schizophrenia
CSF2RB,Rs2284031,schizophrenia
CSF2RB,Rs2072707,schizophrenia.
CSF2RB,Rs11705394,schizophrenia
CSF2RB,Rs11705394,schizophrenia.
CSF2RB,Rs1801117,schizophrenia 
CSNK1D,Rs397514693,Familial Advanced Sleep Phase syndrome 2
CSNK1D,Rs397514693,"rs397514693, also known as His46Arg or H46R, is a SNP in the casein kinase 1, delta CSNK1D gene.Heterozygotes for rs397514693 have been reported to have a sleep disorder, Familial Advanced Sleep Phase syndrome 2 (FASPS2), and it is therefore considered to be inherited as an autosomal dominant trait. "
CSNK1D,Rs397514693,migraine
CSNK1D,Rs397514693,sleep disorder
CSNK1D,Rs104894561,Familial Advanced Sleep Phase syndrome 2
CSNK1D,Rs104894561,autosomal dominant
CSNK1D,Rs104894561,sleep disorder
CSNK1D,Rs104894561,sleep disorder
CSNK1D,Rs104894561,rising time compared to most people
CSNK1D,Rs104894561,~4 hour shift towards earlier bedtime
CSNK1D,Rs104894561,Familial Advanced Sleep Phase syndrome 2
CSNK1D,Rs104894561,sleep disorder
CSNK1D,Rs104894561,Familial Advanced Sleep Phase syndrome 2 (FASPS2)
CTLA4,Rs3087243,acute rejection
CTLA4,Rs3087243,type-1 diabetes
CTLA4,Rs3087243,risk factor for developing rheumatoid arthritis (RA)
CTLA4,Rs3087243,acute rejection development
CTLA4,Rs3087243,autoimmune thyroid disease
CTLA4,Rs4553808,less dramatic reduction in risk
CTLA4,Rs4553808,myasthenia gravis 
CTLA4,Rs4553808,"homozygotes had an odds ratio of 0.05 (CI: 0.00286-0.874, p=0.0023) for the disease compared to healthy individuals,"
CTLA4,Rs3087243,type 1 diabetes odds ratio 1.37 and 1.28
CTLA4,Rs3087243,type-1 diabetes
CTLA4,Rs3772534,type 1 diabetes
CTLA4,Rs3087243,1.5 fold increased risk of type-1 diabetes
CTLA4,Rs3087243,autoimmune thyroid disease
CTLA4,Rs12992492,vitiligo 
CTLA4,Rs231725,biliary cirrhosis
CTLA4,Rs231725,associated with primary biliary cirrhosis
CTLA4,Rs11571316,type-1 diabetes
CTLA4,Rs231778,artefact
CTLA4,Rs3087243,1.3 fold increased risk of autoimmune thyroid disease
CTLA4,Rs3087243,autoimmune thyroid disease
CTLA4,Rs231725,biliary cirrhosis
CTNNA2,Rs1446109,bipolar disorder
CTNNA2,Rs723524,minor alleles
CTNNA2,Rs723524,emotion
CTNNA2,Rs723524,behavior
CTNNA2,Rs723524,human cognition
CTNNA2,Rs723524,handedness
CTNNA2,Rs723524,left-right asymmetrical brain function
CTNNA2,Rs1446109,"cognition, behavior and emotion"
CTNNA2,Rs1446109,handedness
CTNNA2,Rs1446109,European
CTNNA2,Rs11695685,Interleukin 10 (IL10) protein levels
CTNNA2,Rs1007371,minor alleles
CTNNA2,Rs1007371,emotion
CTNNA2,Rs1007371,behavior
CTNNA2,Rs1007371,human cognition
CTNNA2,Rs1007371,handedness
CTNNA2,Rs1007371,left-right asymmetrical brain function
CTNNA2,Rs1446109,left-right asymmetrical brain function
CTNNA3,Rs16922827,retracted
CTNNA3,Rs2306402,late-onset Alzheimer's disease
CTNNA3,Rs2306402,Caucasian patients
CTSD,Rs17571, Alzheimer disease.
CTSD,Rs17571,9.75 fold increase in risk of vCJD
CTSD,Rs17571,risk of Alzheimer's disease
CTSD,Rs17571,Creutzfeldt-Jakob disease
CTSD,Rs17571,risk of variant Creutzfeldt-Jakob disease
CTSD,Rs17571,Alzheimer's disease
CTSD,Rs17571,sporadic Alzheimer's disease:
CTSD,Rs17571,Alzheimer's disease
CTSD,Rs17571,Alzheimer disease
CTSD,Rs17571,Creutzfeldt-Jakob disease
CTSD,Rs17571,Alzheimer's disease
CTSD,Rs17571,cognitive ability and cognitive ageing
CTSD,Rs17571,vCJD 
CTSD,Rs17571,vCJD 
CTSD,Rs17571,Variant Creutzfeldt-Jakob disease
CTSD,Rs17571,Alzheimer's disease
CUBN,Rs10508517,diastolic blood pressure
CUBN,Rs10904849,colorectal cancer
CXCR4,Rs2228014,increased 
CXCR4,Rs2228014,CC 
CXCR4,Rs2228014,5X 
CXCR4,Rs2228014,TT 
CYP17A1,Rs743572,African American
CYP17A1,Rs743572,Chinese women
CYP17A1,Rs743572,breast cancer
CYP17A1,Rs743572,endometriosis
CYP17A1,Rs743572,gastric cancer
CYP17A1,Rs743572,non-small cell lung cancer
CYP17A1,Rs743572,breast cancer
CYP17A1,Rs743572,southern Chinese women
CYP17A1,Rs743572,Caucasian women
CYP17A1,Rs743572,Endometriosis
CYP17A1,Rs743572,breast cancer
CYP17A1,Rs743572,prostate cancer
CYP17A1,Rs743572,endometriosis
CYP17A1,Rs743572,prostate cancer
CYP17A1,Rs743572,postmenopausal breast cancer
CYP17A1,Rs743572,Solitary and multiple uterine leiomyomas
CYP17A1,Rs743572,Polycystic ovary syndrome
CYP17A1,Rs743572,polycystic ovary syndrome
CYP17A1,Rs743572,Brazilian women
CYP17A1,Rs1004467,blood pressure
CYP17A1,Rs1004467,blood pressure and hypertension
CYP17A1,Rs104894139,G>A
CYP17A1,Rs104894147,Phe114Val
CYP17A1,Rs104894149,Cys
CYP17A1,Rs743572,short menstrual cycles
CYP17A1,Rs743572,colorectal cancer
CYP17A1,Rs743572,prostate cancer
CYP17A1,Rs104894149,C>T
CYP17A1,Rs743572,uterine leiomyomas
CYP17A1,Rs743572,prostate cancer
CYP17A1,Rs743572,African-American men
CYP17A1,Rs743572,endometrial cancer
CYP17A1,Rs743572,endometrial cancer
CYP17A1,Rs743572,fibrocystic breast conditions
CYP17A1,Rs743572,Chinese women
CYP17A1,Rs743572,breast and prostate cancer
CYP19A1,Rs4646,breast cancer
CYP19A1,Rs4646,metastatic breast cancer
CYP19A1,Rs700518,potentially linked in a gender-specific manner to hypertension
CYP19A1,Rs727479,endometrial cancer
CYP19A1,Rs727479,age 
CYP19A1,Rs727479,Caucasian 
CYP19A1,Rs727479,Polymorphisms 
CYP19A1,Rs3751591,natural menopause
CYP19A1,Rs727479,polymorphisms 
CYP19A1,Rs3751591,age-related phenotypes
CYP19A1,Rs2470152,prostate cancer
CYP19A1,Rs3751591,age
CYP19A1,Rs3751591,natural menopause
CYP19A1,Rs2470152,serum E2 and E1 levels
CYP19A1,Rs2470152,osteoporosis
CYP19A1,Rs2470152,breast cancer
CYP19A1,Rs2470152,prostate cancer
CYP19A1,Rs2470152,osteoporosis
CYP19A1,Rs727479,Caucasian 
CYP19A1,Rs2470144,rheumatoid arthritis
CYP19A1,Rs3751591,Genetic correlates of longevity
CYP19A1,Rs727479,females
CYP19A1,Rs727479,women
CYP19A1,Rs727479,postmenopausal women
CYP19A1,Rs78310315,Heritage
CYP19A1,Rs78310315,FTDNA
CYP19A1,Rs727479,breast cancer
CYP19A1,Rs727479,postmenopausal
CYP19A1,Rs727479,polymorphism 
CYP19A1,Rs727479,Post-Menopausal Women
CYP19A1,Rs727479,Breast Cancer
CYP19A1,Rs727479,women 
CYP19A1,Rs727479,fibrocystic breast conditions
CYP19A1,Rs727479,breast cancer
CYP19A1,Rs727479,gastric cancer
CYP19A1,Rs727479,Polymorphisms 
CYP19A1,Rs727479,ovarian cancer
CYP19A1,Rs727479,polymorphisms 
CYP19A1,Rs2470144,gastric cancer
CYP19A1,Rs727479,postmenopausal 
CYP19A1,Rs727479,polymorphisms 
CYP19A1,Rs727479, breast carcinoma
CYP19A1,Rs727479,polymorphism 
CYP19A1,Rs727479,Breast Cancer
CYP19A1,Rs727479,breast cancer
CYP19A1,Rs727479,breast cancer
CYP19A1,Rs2470144,epithelial ovarian cancer
CYP19A1,Rs2470152,breast cancer
CYP19A1,Rs2470144,matrix metalloproteinase
CYP19A1,Rs12594287,bone mineral density
CYP19A1,Rs1008805,estrogen and progesterone receptor negative breast cancer
CYP19A1,Rs1008805,breast cancer
CYP19A1,Rs1004984,genetic polymorphisms
CYP19A1,Rs1004984,phenotypes in Chinese women
CYP19A1,Rs1004984,obesity
CYP19A1,Rs10046,Breast Cancer
CYP19A1,Rs10046,breast cancer
CYP19A1,Rs10046,gastric cancer
CYP19A1,Rs10046,epithelial ovarian cancer
CYP19A1,Rs2470144,lymphoma
CYP19A1,Rs10046,postmenopausal breast cancer
CYP19A1,Rs10046,Polycystic ovary syndrome
CYP19A1,Rs10046,female reproductive disorders
CYP19A1,Rs10046,breast carcinoma
CYP19A1,Rs10046,breast cancer
CYP19A1,Rs10046,ovarian cancer
CYP19A1,Rs10046,breast cancer
CYP19A1,Rs10046,blood pressure
CYP19A1,Rs10046,cancer
CYP19A1,Rs10046,hypertension
CYP19A1,Rs12594287,bone mineral density
CYP19A1,Rs12594287,"the 3 snps rs17703883, rs12594287 and rs16964201 affect bone mineral density in men"
CYP19A1,Rs10046,breast cancer
CYP19A1,Rs16964201,bone mineral density
CYP19A1,Rs12594287,affect bone mineral density in men.
CYP19A1,Rs2470144,olymorphisms in the estrogen receptor 1
CYP19A1,Rs2470144,postmenopausal
CYP19A1,Rs2470144,high-density single-nucleotide polymorphism
CYP19A1,Rs2470144,osteoporosis
CYP19A1,Rs2470144,Polymorphisms of estrogen-biosynthesis genes CYP17 and CYP19
CYP19A1,Rs2470144,height variation
CYP19A1,Rs2470144,CYP19 gene polymorphisms
CYP19A1,Rs2470144,gastric cancer
CYP19A1,Rs2470144,lymphoma.
CYP19A1,Rs2470144,rheumatoid arthritis
CYP19A1,Rs2470144,breast cancer
CYP19A1,Rs2470144,osteoporosis
CYP19A1,Rs17703883,affect bone mineral density in men.
CYP19A1,Rs17703883,"the 3 snps rs17703883, rs12594287 and rs16964201 affect bone mineral density in men"
CYP19A1,Rs17703883,bone mineral density
CYP19A1,Rs17703883,bone mineral density
CYP19A1,Rs16964201,affect bone mineral density in men.
CYP19A1,Rs16964201,"the 3 snps rs17703883, rs12594287 and rs16964201 affect bone mineral density in men"
CYP19A1,Rs16964201,bone mineral density
CYP19A1,Rs2470144,Breast Cancer
CYP1A1,Rs2470893,metabolic gene
CYP1A1,Rs2470893,mRNA expression
CYP1A1,Rs2470893,polymorphisms
CYP1A1,Rs2470893,lung cancer
CYP1A1,Rs2470893,childhood leukemia
CYP1A1,Rs2470893,Paternal smoking
CYP1A1,Rs2470893,lung cancer
CYP1A1,Rs2470893,leukemia
CYP1A1,Rs2470893,childhood leukemia risk
CYP1A1,Rs2470893,habitual caffeine consumption
CYP1A1,Rs2470893,genetic polymorphisms
CYP1A2,Rs2470890,sporadic colorectal cancers
CYP1A2,Rs2470890,sporadic colorectal cancers:
CYP1A2,Rs2470890,sporadic colorectal cancers:
CYP21A2,Rs7755898,"associated, when homozygous, with the most severe form of congenital adrenal hyperplasia (salt wasting)"
CYP21A2,Rs7755898,Q318X null allele of the 21-hydroxylase gene
CYP21A2,I5005437,Congenital adrenal hyperplasia
CYP21A2,I5005434,hyperplasiars151344506
CYP21A2,I5005433,Congenital adrenal hyperplasiars
CYP21A2,I5005425,72552754
CYP21A2,I5005427,Congenital adrenal hyperplasia
CYP21A2,I5005427,Congenital adrenal hyperplasiars
CYP21A2,I5005425,Congenital adrenal hyperplasiars
CYP21A2,Rs7755898,a random survey of 10 publicly uploaded genomes showed all 10 to be carriers.
CYP21A2,I5005430,Congenital adrenal hyperplasiars
CYP2C19,Rs5787121,allel 
CYP2C19,Rs5787121,definiuje 
CYP2C19,Rs3814637,Association of warfarin dose with genes involved in its action and metabolism. The largest prospective warfarin-treated cohort supports genetic forecasting.
CYP2C8,Rs3832694,Cytochrome 
CYP2C8,Rs1934980,Bisphosphonate-related osteonecrosis of the jaw
CYP2C8,Rs1934951,(T;T)
CYP2C8,Rs1934951,osteonecrosis of the jaw
CYP2C8,Rs1934951,multiple myeloma
CYP2C8,Rs1934951,multiple myeloma patients
CYP2C8,Rs1934951,higher risk
CYP2C8,Rs1934951,osteonecrosis of the jaw
CYP2C8,Rs1934951,myeloma
CYP2C8,Rs1934951,osteonecrosis of the jaw
CYP2C8,Rs1113129,chronic kidney disease
CYP2C8,Rs1934951,osteonecrosis
CYP2C8,Rs1934951,bisphosphonate therapy
CYP2C9,Rs2017319,human
CYP2C9,Rs2017319,Polymorphisms
CYP2C9,Rs2017319,pharmacogenetic
CYP2C9,Rs12572351,Han population
CYP2C9,Rs4086116,acenocoumarol maintenance dosage
CYP2C9,Rs7089580,"associations with higher warfarin dose, namely, VKORC1-8191 (rs61162043, P = 0.0041) and 18786 in CYP2C9 (rs7089580, P = 0.035) independent of the previous associations with these genes"
CYP2C9,Rs2017319,SNP
CYP2C9,Rs4086116,genome-wide association
CYP2C9,Rs2017319,allelic expression imbalance
CYP2C9,Rs12572351,Han population
CYP2C9,Rs2017319,gene transcription
CYP2C9,Rs2017319,Polymorphisms
CYP2C9,Rs12572351, pharmacodynamics
CYP2C9,Rs12572351,warfarin pharmacokinetics
CYP2C9,Rs12572351,China.
CYP2C9,Rs12572351,pharmacodynamics
CYP2C9,Rs12572351,warfarin pharmacokinetics
CYP2C9,Rs2017319,mRNA processing
CYP2D6,Rs34167214,CYP2D6
CYP2D6,Rs28360521,the significance of either allele
CYP2D6,Rs1080987,CYP2D6
CYP2D6,Rs28360521,SNP
CYP2E1,Rs4646976,haplotypes
CYP2J2,Rs11572325,myocardial infarction
CYP2J2,Rs890293,hypertension
CYP2J2,Rs890293,cardiovascular events
CYP2J2,Rs11572325,myocardial infarction
CYP2J2,Rs890293,ischemic events
CYP2J2,Rs11572325,myocardial infarction
CYP2J2,Rs10889160,myocardial infarction.
CYP2J2,Rs10889160,myocardial infarction
CYP2J2,Rs10889160,myocardial infarction
CYP2J2,Rs11572325,were associated with increased risk
CYP2R1,Rs10741657,vitamin D serum concentrations
CYP2R1,Rs10741657,lower vitamin D
CYP2R1,Rs10741657,vitamin D insufficiency
CYP2R1,Rs10741657,MS risk
CYP3A4,Rs4646437,"genetic polymorphisms,"
CYP3A4,Rs4646437,"cyclosporine concentration, and dose requirement in transplant recipients."
CYP3A4,Rs4646437,human liver microsomes.
CYP4A11,Rs1126742,which encodes an enzyme that converts arachidonic acid to 20-hydroxyeicosatetraenoic acid
CYP4A11,Rs1126742,a metabolite involved in blood pressure regulation in humans
CYP4A11,Rs1126742,hypertension
CYP4F2,Rs1558139,genetic marker
CYP4F2,Rs1558139,haplotype
CYP4F2,Rs1558139,genetic marker
CYP4F2,Rs1558139,hypertension
CYP4F2,Rs2108622,cerebral infarction
CYP4V2,Rs1055138,concluded 
CYP4V2,Rs1055138,ClinVar 
CYP7A1,Rs1125226,"Linkage disequilibrium blocks, haplotype structure, and htSNPs of human CYP7A1 gene."
CYP7A1,Rs1125226,haplotype structure
CYP7A1,Rs1125226,Linkage disequilibrium blocks
DAB2IP,Rs7025486,intracranial aneurysm
DAB2IP,Rs7025486,ischemic stroke
DAB2IP,Rs7025486,AAA
DAB2IP,Rs7025486,arterial and venous disease
DAB2IP,Rs7025486,type 2 diabetes
DAB2IP,Rs7025486,hypertension
DAB2IP,Rs7025486,peripheral arterial disease (PAD)
DAB2IP,Rs7025486,abdominal aortic aneurysm (AAA)
DAB2IP,Rs7025486,20% increased risk of the various vascular diseases
DAB2IP,Rs7025486,myocardial infarction
DAB2IP,Rs7025486,peripheral arterial disease PAD
DAB2IP,Rs7025486,pulmonary embolism (PE)
DAB2IP,Rs7025486,type 2 diabetes
DAB2IP,Rs7025486,hypertension
DAB2IP,Rs7025486,peripheral arterial disease (PAD)
DAB2IP,Rs7025486,abdominal aortic aneurysm (AAA)
DAB2IP,Rs7025486,vascular diseases
DAB2IP,Rs7025486,abdominal aortic aneurysm
DAB2IP,Rs7025486,peripheral arterial disease
DAB2IP,Rs7025486,pulmonary embolism
DAB2IP,Rs7025486,intracranial aneurysm 
DAB2IP,Rs7025486,pulmonary embolism
DAB2IP,Rs7025486,ischemic stroke
DAB2IP,Rs7025486,"smoking, lipid levels, obesity, type 2 diabetes, and hypertension"
DAB2IP,Rs7025486,peripheral arterial disease 
DAB2IP,Rs7025486,abdominal aortic aneurysm
DAB2IP,Rs7025486,peripheral arterial disease PAD
DAB2IP,Rs1571801,prostate cancer
DAB2IP,Rs7025486,abdominal aortic aneurysm (AAA)
DAB2IP,Rs1571801,prostate cancer
DAB2IP,Rs1571801,aggressive prostate cancer
DAB2IP,Rs1571801,prostate cancer
DAB2IP,Rs1571801,aggressive prostate cancer
DAB2IP,Rs1571801,aggressive prostate cancer
DAB2IP,Rs1571801,prostate cancer
DAB2IP,Rs1571801,prostate cancer
DAB2IP,Rs1571801,aggressive prostate cancer
DAB2IP,Rs7025486,early onset myocardial infarction (MI)
DAB2IP,Rs1571801,prostate cancer.
DAB2IP,Rs1571801,aggressive prostate cancer
DAB2IP,Rs1571801,aggressive prostate cancer
DAB2IP,Rs1571801,prostate cancer
DAB2IP,Rs1571801,"Caucasian patients with prostate cancer, "
DAB2IP,Rs7025486,vascular diseases
DAB2IP,Rs1571801,prostate cancer
DAB2IP,Rs1571801,prostate cancer patients
DAB2IP,Rs1571801,aggressive prostate cancer 
DAB2IP,Rs1571801,putative prostate tumor
DAB2IP,Rs1571801,African American
DAB2IP,Rs1571801,also reported to be statistically significant in a population of 210 African-Americans with prostate cancer. 
DAB2IP,Rs1571801,Caucasian patients
DAB2IP,Rs1571801,(nonaggressive) prostate cancer was also higher than average for this SNP
DAB2IP,Rs1571801,aggressive prostate cancer
DAB2IP,Rs1571801,"prostate cancer, but having an aggressive form of it."
DAB2IP,Rs1571801,aggressive prostate cancer
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,Korea
DAO,Rs3918346,boys
DAO,Rs3918346,bipolar affective disorder
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,bipolar disorder
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,autism spectrum
DAO,Rs3918346,bipolar disorder
DAO,Rs4623951,high anxiety
DAO,Rs4623951,schizophrenia
DAO,Rs4623951,schizophrenia
DAO,Rs4623951,schizophrenia
DAO,Rs4623951,schizophrenia
DAO,Rs4623951,schizophrenia
DAO,Rs4623951,schizophrenia
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,schizophrenia 
DAO,Rs3918346,schizophrenia 
DAO,Rs3918346,autism 
DAO,Rs3918346,bipolar affective disorder
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,polymorphisms 
DAO,Rs3918346,autism spectrum disorders
DAO,Rs3918346,bipolar affective disorder
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,schizophrenia 
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,bipolar 
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,schizophrenia
DAO,Rs3918346,bipolar disorder
DAO,Rs3918346,schizophrenia
DAOA,Rs947267,schizophrenia
DAOA,Rs947267,schizophrenia
DAOA,Rs947267,schizophrenia
DAPK1,Rs4877365,Alzheimer's disease
DAPK1,Rs4877365,has been linked to Alzheimer's disease
DAPK1,Rs4878104,Alzheimer's disease
DAPK1,Rs4878104,Alzheimer's disease
DAPK1,Rs4878104,Alzheimer's disease
DBH,Rs739398,conduct problems
DBH,Rs739398,Aggressive behavior
DBH,Rs739398,Aggressive behavior
DBH,Rs739398,variation in genes affecting dopamine turnover
DBH,Rs739398,dopamine turnover
DBH,Rs6271,differential secretion
DBH,Rs6271,decreased homospecific activity and differential secretion
DBH,Rs2519152,DBH gene with plasma dopamine beta-hydroxylase activity
DBH,Rs6271,decreased homospecific activity
DBH,Rs2519152,African Americans
DBR1,Rs149610079,Mutation in DBR1 gene pathogenic
DBR1,Rs149610079,predisposition to brainstem viral encephalitis
DCC,Rs2270954,RNA.
DCC,Rs2270954,individual genetic differences in susceptibility to schizophrenia.
DCC,Rs2270954,homozygous
DCC,Rs2270954,schizophrenia
DCC,Rs2270954,schizophrenia
DCC,Rs2270954,schizophrenia
DCC,Rs17468382,Parkinson's disease
DCC,Rs17468382,Parkinson's disease.
DCDC2,Rs793862,dyslexic individuals
DCDC2,Rs793862,dyslexic individuals
DCDC2,Rs793862,severely dyslexic individuals
DCDC2,Rs793862,Caucasian populations
DCDC2,Rs793862,dyslexia
DCDC2,Rs793862,dyslexic 
DCDC2,Rs793862,dyslexia
DCDC2,Rs793862,Caucasian 
DCDC2,Rs793862,dyslexic 
DCDC2,Rs793862,dyslexic
DCDC2,Rs793862,dyslexic
DCDC2,Rs793862,dyslexic 
DCHS1,Rs768737101,MVP
DCHS1,Rs768737101,Arg2330Cys
DCHS1,Rs768737101,mitral valve prolapse 
DCHS1,Rs768737101,mutation in the DCHS1 gene on chromosome
DCHS1,Rs768737101,mitral valve prolapse
DCHS1,Rs768737101,was reported to be a causative mutation
DCHS1,Rs768737101,mutation.
DCHS1,Rs768737101,Acting as an autosomal dominant
DCHS1,Rs757309797,thoracic aortic aneurysm
DCHS1,Rs768737101,causative mutation for MVP.
DCHS1,Rs768737101,autosomal dominan
DCHS1,Rs768737101,valve prolapse
DCHS1,Rs757309797,sources for thoracic aortic aneurysm.
DCHS1,Rs201457110,mitral valve prolapse
DCHS1,Rs768737101,is a mutation in the DCHS1 gene on chromosome 11
DCHS1,Rs757309797,mitral valve prolapse
DCHS1,Rs201457110,MVP
DDC,Rs2329340,autism
DDC,Rs2329340,migraine with aura
DDC,Rs2044859,increased incidence of migraine
DDC,Rs2044859,with aura
DDC,Rs2044859,without aura
DDC,Rs2044859,migraine patients
DDC,Rs2044859,migraine with aura
DDC,Rs11974297,increased incidence of migraine
DDC,Rs11974297,migraine with aura
DDC,Rs11974297,without aura
DDC,Rs11974297,migraine patients
DDC,Rs11761683,increased incidence of migraine
DDC,Rs11761683,with aura
DDC,Rs11761683,without aura
DDC,Rs11761683,migraine patients
DDC,Rs11761683,migraine with aura
DDC,Rs11974297,with aura
DDX3Y,Rs796483281,23andMe
DFNB31,Rs942519,Tunisian consanguineous family
DFNB31,Rs942519,hereditary non-syndromic recessive hearing loss.
DFNB31,Rs942519, Usher syndrom
DFNB31,Rs942519,onsyndromic cleft lip/palate
DGKH,Rs1012053,Bipolar disorder
DHCR7,Rs11555217,Smith-Lemli-Opitz syndrome
DHCR7,Rs11555217,Smith-Lemli-Opitz syndrome
DHCR7,Rs11555217,causing a lethal form
DHCR7,Rs11555217,Smith-Lemli-Opitz syndrome.
DHCR7,Rs11555217,Smith-Lemli-Opitz syndrome (SLOS)
DHCR7,Rs138659167,Smith-Lemli-Opitz syndrome
DHCR7,Rs138659167,SLO syndrome
DHCR7,Rs138659167,Smith-Lemli-Opitz syndrome
DHCR7,Rs138659167,pathogenic for
DHCR7,Rs138659167,SLO syndrome
DHCR7,Rs28938174,SLO
DHCR7,Rs28938174,"note that c.356A>G (p.His119Arg) is also a known variant for rs28938174, however, it's significance is uncertain (whereas c.356A>T is pathogenic for SLO)"
DHDDS,Rs764831063,Blueprint Genetics Retinal dystrophy
DHDDS,Rs764831063,Blueprint Genetics Retinal dystrophy
DHODH,Rs3213422,rheumatoid arthritis
DHODH,Rs3213422,rheumatoid arthritis
DHODH,Rs3213422, rheumatoid arthritis
DHODH,Rs3213422,allele carrier
DHODH,Rs3213422,A allele 
DIO1,Rs8175347,Gilbert's syndrome 
DIO1,Rs8175347,Gilbert's syndrome
DIO1,Rs8175347,neonatal hyperbilirubinemia
DIO1,Rs8175347,endometrial cancer risk
DIO1,Rs8175347,neonatal hyperbilirubinemia
DIO1,Rs8175347,"The rs8175347 SNP consists of variation of a short (TA)(n) repeat sequence covering the TATA box of the UGT1A1 UDP-glucuronosyltransferase1A1 gene. This SNP is associated with hyperbilirubinaemia (Gilbert's syndrome) and adverse drug reactions, and is used for dosage advice for irinotecan. The low-activity (risk) alleles are rs8175347(TA)7 and (TA)8. UGT1A1 genetic polymorphisms, endogenous estrogen exposure, soy food intake, and endometrial cancer risk. Genome-wide association meta-analysis for total serum bilirubin levels. Serum bilirubin levels on ICU admission are associated with ARDS development and mortality in sepsis. Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism. UGT1A1, SLCO1B1, and SLCO1B3 polymorphisms versus neonatal hyperbilirubinemia"
DIO1,Rs8175347,neonatal hyperbilirubinemia
DIO1,Rs8175347,Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome
DIO1,Rs8175347,are associated with ARDS development and mortality in sepsis
DIO1,Rs8175347,associated with ARDS development and mortality in sepsis.
DIO1,Rs8175347,associated with hyperbilirubinaemia (Gilbert's syndrome)
DIO1,Rs8175347,endogenous estrogen exposure
DIO1,Rs8175347,neonatal hyperbilirubinemia
DIO1,Rs8175347,associated with Gilbert's syndrome 
DIO1,Rs8175347,Pazopanib-induced hyperbilirubinemia
DIO1,Rs8175347,associated with ARDS development and mortality in sepsis
DIO1,Rs8175347,endometrial cancer risk
DIO1,Rs8175347,associated with hyperbilirubinaemia (Gilbert's syndrome)
DIO1,Rs8175347,endometrial cancer risk
DISC1,Rs821577,"neurodevelopmental, synaptogenic"
DISC1,Rs821633,psychosis-related traits
DISC1,Rs821633,large population cohort
DISC1,Rs821633,pathway
DISC1,Rs821633,genes
DISC1,Rs821633,synaptogenic
DISC1,Rs821633,sensory perception
DISC1,Rs821577,bipolar disorder
DISC1,Rs821633,expression of neurodevelopmental
DISC1,Rs821577,schizophrenia
DISC1,Rs1322784,asperger's syndrome
DISC1,Rs6675281,linked to schizophrenia
DISC1,Rs1322784,schizophrenia
DISC1,Rs1322784,asperger's syndrome
DISC1,Rs1538979,schizophrenia
DISC1,Rs1538979,bipolar disorder
DISC1,Rs6675281,linked to schizophrenia
DISC1,Rs3737597,schizophrenia
DISC1,Rs3738402,schizophrenia
DISC1,Rs3737597,schizophrenia
DISC1,Rs6675281,schizophrenia
DKK4,Rs2073664,POLB locus.
DKK4,Rs2073664,haplotype
DKK4,Rs2073664,heterozygosity
DKK4,Rs2073664,locus
DLK1,Rs1802710,brain tumors
DLK1,Rs1802710,lymphomaspopular 
DNAI1,Rs1060503515,p.Tyr397Thrfs
DNAI1,Rs397515363,primary ciliary dyskinesia
DNAJB11,Rs1553850185,Leu77Pro 
DNAJB11,Rs1553850185,230T
DNAJB11,Rs1351138670,Ala160Glufs
DNAJC13,Rs387907571,to be a causative mutation for autosomal dominant Parkinson's disease
DNAJC13,Rs387907571,Dutch-German-Russian Mennonite heritage
DNAJC13,Rs387907571,Caucasian Parkinson's patients
DNAJC13,Rs387907571,Parkinson's disease
DNAJC13,Rs387907571,autosomal dominant Parkinson's disease
DNAJC13,Rs387907571,Parkinson's disease
DNM1,Rs3003609,rs3003609 
DNM1,Rs3003609,600
DNM1,Rs3003609,rs3003609 
DNM1,Rs3003609,DNM1 
DNM1,Rs3003609,dynamin 
DNM1,Rs3003609,SNP 
DNM1,Rs3003609,families
DNM1,Rs3003609,not African-Americans
DNM1,Rs3003609,nicotine dependence
DNM1,Rs3003609,nicotine dependence
DNM1,Rs3003609,Caucasians
DNM1,Rs2502731,functional polymorphism of dynamin 1 gene with nicotine
DNM1,Rs2502731,polymorphism of dynamin 1 gene
DNM1,Rs2502731,nicotine dependence
DNM1,Rs2502731,European and African Americans
DNM1,Rs3003609,heavier smoking 
DNM1,Rs3003609,associated with heavier smoking
DNM2,Rs892086,increased risk for developing Alzheimer's disease
DNM2,Rs892086,genotypes appear to have less DNM2 mRNA in their brains
DNM2,Rs892086,Alzheimer
DNM2,Rs892086,Japanese 
DNM2,Rs892086,late-onset Alzheimer's disease
DNM2,Rs892086,ess DNM2 mRNA in their brains
DNM2,Rs892086,Alzheimer's disease
DNM2,Rs892086,Alzheimer's disease
DNM2,Rs892086,late-onset Alzheimer's disease
DNM3,Rs2421947,Parkinson's disease
DNM3,Rs2421947,Parkinson's disease
DNM3,Rs2421947,LRRK2 mutation
DOCK7,Rs267606655,coronary artery disease
DOCK7,Rs398122987,ANGPTL3
DOCK7,Rs267606655,lowered triglycerides and LDL cholesterol
DOCK7,Rs267606655,function variant in the ANGPTL3 gene on chromosome
DOCK7,Rs267606655,coronary artery disease.
DOCK7,Rs267606655,minor allele
DOCK7,Rs267606655, artery disease
DOCK7,Rs267606655,coron
DOCK7,Rs267606655,coronary artery disease
DPP6,Rs3807218,familial idiopathic ventricular fibrillation
DPP6,Rs10260404,"60404(C;C) homozygotes, 1.60 (CI: 1.32-1.92).A ""C-C"" "
DPP6,Rs10239794,ALS
DPP6,Rs10239794,sporadic form of ALS (Lou Gehrig's disease)
DPP6,Rs10239794,ALS
DPP6,Rs10239794,ALS
DPP6,Rs10239794,ALS
DPP6,Rs10239794,European
DPP6,Rs10239794,Lou Gehrig's disease
DPP6,Rs10239794,ALS
DPYD,Rs1801160,cancer
DRD1,Rs265981,DRD1 gene
DRD1,Rs4532,nly affected males.
DRD1,Rs4532,autism spectrum disorders
DRD1,Rs5326,(early onset) schizophrenia
DRD1,Rs4532,autism
DRD1,Rs265981,nly affected males.
DRD1,Rs265981,autism spectrum disorders
DRD1,Rs265981,autism
DRD1,Rs4532,DRD1 gene
DRD1,Rs1799914,schizophrenia
DRD1,Rs155417,severity and temperament of alcoholism
DRD1,Rs155417,alcoholism
DRD1,Rs155417,polymorphism of dopamine receptor D1
DRD1,Rs1799914,dopamine D1 receptor gene polymorphisms and the risk of schizophrenia.
DRD1,Rs155417,associated with severity and temperament of alcoholism.
DRD1,Rs1799914,Japanese population
DRD1,Rs1799914,Associations between DRDs and schizophrenia in a Korean population
DRD1,Rs155417,polymorphism of dopamine receptor
DRD2,Rs2242592,healthy participants
DRD2,Rs4648317,higher nicotine dependence scores
DRD2,Rs4648317,higher rates of smoking
DRD2,Rs4648317,"smoking and higher nicotine dependence scores,"
DRD2,Rs4648317,receptor 
DRD2,Rs4648317,D2 
DRD2,Rs4648317,dopamine 
DRD2,Rs2242592,schizophrenia
DRD2,Rs4648318,Tourette syndrome
DRD2,Rs2242592,behavioral inhibition
DRD2,Rs2242592,genetic variability in the dopamine receptor
DRD2,Rs2242592,impulsivity/sensation seeking
DRD2,Rs2242592,behavioral inhibition
DRD2,Rs2242592,schizophrenia
DRD2,Rs2242592,schizophrenia
DRD2,Rs2242592,susceptibility 
DRD2,Rs2242592,schizophrenia
DRD2,Rs1800496,independent aspect of decision making in a learning paradigm
DRD2,Rs2242592,impulsivity/sensation
DRD3,Rs167771,autism spectrum disorder
DRD4,Rs587776842,nonfunctional DRD4 protein
DRD4,Rs587776842,chromosome 11
DRD4,Rs587776842,nervous system dysfunctio
DRD4,Rs587776842,variant
DRD4,Rs587776842,autonomic nervous system dysfunction;
DRD4,Rs587776842,DRD4 gene
DRD4,Rs587776842,DRD4 protein
DRD4,Rs1800955,borderline personality traits
DRD4,Rs587776842,allele of rs587776842
DRD4,Rs587776842,autonomic nervous system dysfunction
DRD4,Rs587776842,Heterozygous
DRD4,Rs747302,chromosome 11
DRD4,Rs747302,"rs747302, also known as -616 C/G, is a variant in the promoter upstream of the DRD4 gene on chromosome 11"
DRD4,Rs916457,Japanese schizophrenics.
DRD4,Rs587776842,DRD4 gene
DRD4,Rs587776842,dopamine D2-like receptor family
DRD4,Rs554375713,DRD4 gene on chromosome 11.
DRD4,Rs1800955,schizophrenia
DRD4,Rs1800955,schizophrenic
DRD4,Rs4331145,schizophrenia
DRD4,Rs11246226,schizophrenia
DRD4,Rs11246226,risk of schizophrenia
DRD4,Rs1800955,borderline 
DRD4,Rs1800955,personality
DRD4,Rs1800955,schizophrenia
DRD4,Rs11246226,C allele
DRD4,Rs1800955,dopaminergic polymorphisms
DRD4,Rs1800955,dopaminergic gene polymorphisms
DRD4,Rs1800955,idiopathic intellectual disability
DRD4,Rs1800955,Anorexia Nervosa
DRD4,Rs1800955,schizophrenia
DRD4,Rs1800955,Anorexia Nervosa
DRD4,Rs1800955,schizophrenia
DSP,Rs28931610,chromosome 6
DSP,Rs28931610,skin fragility-woolly hair syndrome (SFWHS)
DSP,Rs28931610,disabling keratoderma
DSP,Rs28931610,desmoplakin
DSP,Rs2076295,alveolar epithelia
DSP,Rs2076295,alopecia
DSP,Rs2076295,"arrhythmogenic right ventricular dysplasia , keratodermas"
DSP,Rs2076295,protein desmoplakin
DSP,Rs28931610,woolly hair syndrome
DSP,Rs2076295,alopecia
DSP,Rs2076295,epithelial homeostasis
DSP,Rs28931610,inheriting two copies
DSP,Rs28931610,rs28931610(T) allele
DSP,Rs28931610,SNP
DSP,Rs28931610,desmoplakin DSP gene
DSP,Rs28931610,chromosome 6
DSP,Rs28931610,keratoderma
DSP,Rs28931610,fragility-woolly hair syndrome (SFWHS)
DSP,Rs2076295,keratodermas
DSP,Rs28931610,chromosomal
DSP,Rs28931610,variant
DSP,Rs28931610,exome
DSP,Rs28931610,genome
DSP,Rs28931610,variant
DSP,Rs28931610,genome sequencing
DSP,Rs2076295,arrhythmogenic right ventricular dysplasia
DSP,Rs28931610, DSP gene mutatio
DSP,Rs2076295,disrupts epithelial homeostasis
DSP,Rs140474226,dilated cardiomyopathy 
DSP,Rs140474226,arrhythmogenic right ventricular dysplasia
DSP,Rs140474226,cardiomyopathy
DSP,Rs140474226,arrhythmogenic right ventricular dysplasia;
DSP,Rs140474226,dilated cardiomyopathy 
DSP,Rs140474226,arrhythmogenic right ventricular dysplasia
DSP,Rs2076295,interstitial pneumonia
DSP,Rs2076295,SNPs
DSP,Rs2076295,SNPs
DSP,Rs2076295,lung diseases
DSP,Rs2076295,ulmonary fibrosis
DSP,Rs140474226,sudden cardiac death patient
DSP,Rs2076295,hypoxemic respiratory insufficiency
DSP,Rs2076295,"progressive scarring of the alveolar interstitium,"
DSP,Rs2076295,IIP
DSP,Rs2076295,IIP
DSP,Rs2076295,IFP
DSP,Rs2076295,IIP
DSP,Rs2076295,loss of tissue integrity
DSP,Rs2076295,idiopathic pulmonary fibrosis
DSP,Rs2076295,IIP
DSP,Rs2076295,IIP
DSP,Rs2076295,IIP.
DSP,Rs2076295,death
DSP,Rs2076295,IFP
DSPP,Rs28929492,deafness
DSPP,Rs28929492,deafness
DTNA,Rs104894654,left ventricular noncompaction.
DTNBP1,Rs742105,clozapine response
DTNBP1,Rs742105,in treatment-resistant schizophrenic patients
DTNBP1,Rs760761,schizophrenia
DTNBP1,Rs760761,"decreased attentional capacity,"
DTNBP1,Rs760761,worse performance on memory tasks
DTNBP1,Rs742105,schizophrenic 
DTNBP1,Rs760761,major depressive disorder
DTNBP1,Rs760761,neuroticism
DTNBP1,Rs760761,anxiety
DTNBP1,Rs909706,associated with haloperidol response
DTNBP1,Rs909706,treatment-resistant schizophrenic patients
DTNBP1,Rs760761,alterations in schizotypal beliefs and experiences
DTNBP1,Rs760761,depression
DTNBP1,Rs2619522,alterations in schizotypal beliefs 
DTNBP1,Rs2619522,worse performance on memory tasks
DTNBP1,Rs1018381,healthy 
DTNBP1,Rs2619522, experiences
DTNBP1,Rs1018381,cognitive impairments
DTNBP1,Rs1018381,decreased attentional capacity
DTNBP1,Rs1018381,worse performance on memory tasks
DTNBP1,Rs1018381,schizophrenia
DTNBP1,Rs1018381, experiences
DTNBP1,Rs2619522,healthy 
DTNBP1,Rs2619522,schizophrenia
DTNBP1,Rs2619522,cognitive impairments
DTNBP1,Rs2619522,decreased attentional capacity
DTNBP1,Rs1018381,alterations in schizotypal beliefs 
DVWA,Rs9864422,Japanese
DVWA,Rs9864422,osteoarthritis 
DVWA,Rs7639618,knee osteoarthritis
DVWA,Rs7639618,osteoarthritis
DVWA,Rs11718863,European and Asian populations.
DVWA,Rs11718863,susceptibility
DVWA,Rs11718863,osteoarthritis
DVWA,Rs11718863,Large replication study and meta-analyses
DVWA,Rs11718863,osteoarthritis
DVWA,Rs11718863,polymorphisms
DVWA,Rs11718863,orientation
DVWA,Rs11718863,"odds ratio is 1.43 (CI: 1.26-1.63, p = 5.2 x 10e-8)"
DVWA,Rs11718863,study of several Japanese patient populations.
DVWA,Rs11718863,osteoarthritis
DVWA,Rs11718863,osteoarthritis
DVWA,Rs11718863,UK populations
DYRK1B,Rs367643250,and type-2 diabetes
DYRK1B,Rs367643250,hypertension
DYRK1B,Rs367643250,central obesity
DYRK1B,Rs367643250,coinheritance of early-onset coronary artery disease
EDA2R,Rs1385699,SNP 
EDA2R,Rs1385699,androgenetic alopecia
EDA2R,Rs1385699,baldness
EDA2R,Rs1385699,baldness|androgenetic alopecia
EDA2R,Rs1385699,400 males
EDAR,Rs365060,denser beard growth.
EDAR,Rs365060,~25% denser beard growth
EDAR,Rs365060,beard thickness 
EDAR,Rs365060,Latin Americans
EDAR,Rs260643,This SNP is associated to straight/curly hair.
EDAR,Rs365060,beard thickness
EDN1,Rs5370,type-2 diabetes
EDN1,Rs5370,diabetic retinopathy
EDN1,Rs5370,edema
EDN1,Rs5370,edema
EDN1,Rs5370,systolic blood pressure
EDN1,Rs5370,pulse pressure
EDN1,Rs5370,rheumatoid arthritis
EDN1,Rs5370,lower HDL cholesterol
EDN1,Rs5370,Hypertension
EDN1,Rs5370,type-2 diabetes
EDN1,Rs5370,diabetic retinopathy
EDN1,Rs5370,edema
EDN1,Rs5370,rheumatoid arthritis
EDN1,Rs5370,HDL cholesterol
EDN1,Rs5370,diabetics
EDN1,Rs587777231,OMIM
EDNRB,Rs5351,therosclerosis
EDNRB,Rs5351,essential hypertension (EHT)
EGF,Rs4444903,race
EGF,Rs4444903,glioma 
EGF,Rs4444903,gliomas 
EGF,Rs4444903,glioblastomas 
EGF,Rs4444903,oligodendrogliomas 
EGF,Rs4444903,gallbladder cancer
EGF,Rs4444903,Indian 
EGF,Rs4444903,females 
EGF,Rs4444903,acute respiratory distress syndrome
EGF,Rs4444903,schizophrenia
EGF,Rs4444903,lung cancer
EGF,Rs4444903,psoriatic arthritis
EGF,Rs4444903,lung cancer
EGF,Rs4444903,Singapore-Chinese
EGF,Rs4444903,Chinese 
EGF,Rs4444903,renal cell carcinoma
EGF,Rs4444903,hepatocellular carcinoma
EGF,Rs4444903,chronic HBV infection
EGF,Rs718768,endometrial cancer
EGF,Rs4444903,Korean 
EGF,Rs4444903,sex
EGF,Rs718768,proliferative vitreoretinopathy
EGF,Rs4444903,hepatocellular carcinoma (liver cancer)
EGF,Rs4444903,age
EGF,Rs4444903,Indian gallbladder cancer patients
EGF,Rs4444903,only in females
EGF,Rs4444903,acute respiratory distress syndrome risk
EGF,Rs4444903,chronic HBV infection
EGF,Rs4444903,hepatocellular carcinoma
EGF,Rs4444903,epidermal growth factor
EGF,Rs4444903,hepatocellular carcinoma (liver cancer)
EGF,Rs4444903,gliomas
EGF,Rs4444903,glioblastomas
EGF,Rs4444903,alcoholic cirrhosis
EGF,Rs4444903,gallbladder cancer
EGF,Rs4444903,schizophrenia
EGF,Rs4444903,lung cancer
EGF,Rs4444903,lung cancer
EGF,Rs4444903,bladder cancer
EGF,Rs4444903,hepatocellular carcinoma
EGF,Rs4444903,chronic HBV infection
EGF,Rs4444903,Caucasian 
EGF,Rs4444903,cirrhosis 
EGF,Rs4444903,oligodendrogliomas
EGFR,Rs121434568,non-small cell lung cancer
EGFR,Rs121434568,tumors
EGFR,Rs121434568,somatic
EGFR,Rs121434568, non-small cell lung cancer
EGFR,Rs121434568,pathogenic
EGFR,Rs121434568,tumors 
EGFR,Rs121434568,non-small cell lung cancer
EGFR,Rs121434568,tumors
EGFR,Rs121434568,non-small cell lung cancer
EGFR,Rs121434568,tumors
EGFR,Rs121434568,non-small cell lung cancer
EGFR,Rs121434568,non-small cell lung cancer
EGFR,Rs121434568,non-small cell lung cancer.
EGLN1,Rs186996510,hypoxia at the high altitudes
EGLN1,Rs186996510,Tibetans
EGLN1,Rs186996510,Tibetans
EGLN1,Rs186996510, hypoxia-inducible 
EGLN1,Rs186996510,hypoxia
EGLN1,Rs186996510,Tibetans 
EGLN1,Rs186996510,hypoxia 
EGLN1,Rs186996510,family hypoxia-inducible factor
EGLN1,Rs12097901,protecting Tibetans from hypoxia at the high altitudes they inhabit.
EGLN1,Rs12097901,gene encodes prolyl hydroxylase 2
EGLN1,Rs12097901,family hypoxia-inducible factor 1 gene
EGLN1,Rs12097901,hypoxia
EGLN1,Rs186996510,Tibetans
EIF2AK4,Rs587777105,pulmonary hypertension
EIF2AK4,Rs587777105,pulmonary capillary hemangiomatosis
EIF2AK4,Rs587777105,pulmonary venoocclusive disease
EIF2AK4,Rs587777106,pulmonary hypertension
EIF2AK4,Rs587777106,pulmonary capillary hemangiomatosis
EIF2AK4,Rs587777106,pulmonary venoocclusive disease
EIF2AK4,Rs587777107,pulmonary venoocclusive disease (PVOD)
EIF2AK4,Rs587777107,pulmonary capillary hemangiomatosis (PCH)
EIF2AK4,Rs587777208,pulmonary capillary hemangiomatosis
EIF2AK4,Rs587777208,pulmonary venoocclusive disease
EIF2AK4,Rs587777208,EIF2AK4 gene 
EIF2AK4,Rs587777208,pulmonary hypertension
EIF2AK4,Rs587777107,pulmonary hypertension
EIF2AK4,Rs587777104,ulmonary capillary hemangiomatosis
EIF2AK4,Rs587777104,pulmonary venoocclusive disease
EIF2AK4,Rs587777103,pulmonary venoocclusive disease
EIF2AK4,Rs587777102,pulmonary hypertension
EIF2AK4,Rs587777104,pulmonary hypertension
EIF2AK4,Rs587777102,pulmonary venoocclusive disease
EIF2AK4,Rs587777102,rare forms of pulmonary hypertension
EIF2AK4,Rs587777102,rare mutation in the EIF2AK4 gene 
EIF2AK4,Rs587777102,pulmonary capillary hemangiomatosis (PCH)
EIF2AK4,Rs587777102,pulmonary capillary hemangiomatosis
EIF2AK4,Rs587777102,"c.1392delT (p.Arg465Valfs), this rare mutation in the EIF2AK4 gene "
EIF2AK4,Rs587777102,"rare forms of pulmonary hypertension, specifically, pulmonary capillary hemangiomatosis (PCH) and pulmonary venoocclusive disease (PVOD)."
EIF2AK4,Rs587777102,when inherited recessively
EIF2AK4,Rs587777103,pulmonary hypertension
EIF2AK4,Rs587777103,pulmonary capillary hemangiomatosis
EIF2AK4,Rs587777102,pulmonary venoocclusive disease (PVOD)
EIF3G,Rs2305795,narcolepsy
EIF3G,Rs2305795,narcolepsy
EIF4G1,Rs113169049,familial Parkinson's disease
EIF4G1,Rs113388242,egarding their pathogenicity
EIF4G1,Rs112176450,mutations
EIF4G1,Rs112176450,EIF4G1 gen
EIF4G1,Rs112176450,pathogenicity
EIF4G1,Rs113169049,Parkinson's disease
EIF4G1,Rs113169049,eukaryotic translation initiation factor 4 gamma
EIF4G1,Rs112176450,allele
EIF4G1,Rs113169049,late-onset disease
EIF4G1,Rs113388242,familial Parkinson's disease
EIF4G1,Rs113388242,dominant mutation
EIF4G1,Rs113388242,Parkinson's disease
EIF4G1,Rs113388242,Parkinson's disease
EIF4G1,Rs113388242,dominant mutation leading to late-onset disease
EIF4G1,Rs113388242,Other mutations in the EIF4G1 gene were also found
EIF4G1,Rs113169049,Parkinson's disease
EIF4G1,Rs112176450,Parkinson's disease
EIF4G1,Rs112176450,dominant mutation 
EIF4G1,Rs112176450,1 EIF4G1 gene
EIF4G1,Rs111290936,C>T
EIF4G1,Rs111290936,eukaryotic translatio
EIF4G1,Rs111290936,chromosome 3
EIF4G1,Rs111290936,familial Parkinson's disease
EIF4G1,Rs111290936,rare allele
EIF4G1,Rs111290936,dominant mutation
EIF4G1,Rs111290936,pathogenicity.
EIF4G1,Rs112019125,Parkinson's disease
EIF4G1,Rs112019125,mutation
EIF4G1,Rs112019125,late-onset disease
EIF4G1,Rs112019125,pathogenicity
EIF4G1,Rs112176450,Parkinson's disease
EIF4G1,Rs112176450,SNP
EIF4G1,Rs112176450,eukaryotic
EIF4G1,Rs112176450," factor 4 gamma,"
EIF4G1,Rs112176450,chromosome 3
ELAC2,Rs4792311,elaC homolog 2 (Escherichia coli) (ELAC2)
ELAC2,Rs4792311,cancer
ELAC2,Rs4792311,prostate cancer
ENG,Rs1800956,intracranial aneurysms
ENG,Rs1800956,intracranial aneurysms
ENG,Rs1800956,intracranial aneurysm
ENG,Rs1800956,(G/C transversion with D366H substitution) of endoglin may play an important role in the pathogenesis of intracranial aneurysms in the Korean population.
ENG,Rs1800956,Sequencing of TGF-beta pathway genes in familial cases of intracranial aneurysm.
ENOSF1,Rs3819102,endometrial cancer
ENOSF1,Rs3819102,endometrial cancer
ENPP1,Rs121908248,Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets.
ENPP1,Rs121908248,autosomal
ENPP1,Rs121908248,generalized 
ENPP1,Rs121908248,ENPP1 
ENPP1,Rs121908248,arterial calcification
ENPP1,Rs121908248,hypophosphatemic rickets
ENPP1,Rs121908248,hypophosphatemic
ENPP1,Rs121908248,of
EPAS1,Rs17039192,knee osteoarthritis.
EPAS1,Rs17039192, osteoarthritis 
EPAS1,Rs17039192,knee osteoarthritis
EPAS1,Rs17039192,knee osteoarthritis
EPCAM,Rs1126497,breast cancer
EPCAM,Rs1126497,breast cancer
EPHA2,Rs11260867," A study involving a case-control cohort from Northern Italy, comprising 126 unrelated"
EPHA2,Rs11260867,SNP
EPHA2,Rs11260867,EPHA2 gene
EPHA2,Rs11260867,causative mutation
EPHA2,Rs11260867,age-related cataracts
EPHA2,Rs11260867,uclear cataracts
EPHA2,Rs11260867,cortical cataracts
EPHA2,Rs11260867,SNPs
EPHA2,Rs11260867,EPHA2 gene
EPHA2,Rs11260867,genotype
EPHA2,Rs11260867,cataracts
EPOR,Rs121918116,autosomal dominant erythrocytosis
EPOR,Rs121918116,rare mutation in the EPOR erythropoietin receptor gene on chromosome 19
EPOR,Rs121918116,erythrocytosis
ERAP1,Rs10050860,functional severity
ERAP1,Rs10050860,ERAP1 polymorphisms 
ERAP1,Rs10050860,ankylosing spondylitis susceptibility
ERAP1,Rs10050860,ankylosing spondylitis
ERAP1,Rs10050860, allele that gives protection
ERAP1,Rs10050860,haplotype with familial ankylosing spondylitis
ERAP1,Rs10050860,ankylosing spondylitis
ERAP1,Rs10050860,ankylosing spondylitis
ERAP1,Rs10050860,inflammatory markers and endoplasmic reticulum aminopeptidase polymorphisms
ERAP1,Rs10050860,polymorphisms and haplotypes are associated with ankylosing spondylitis susceptibility and functional severity in a Spanish population
ERAP1,Rs2287987,SNPs
ERAP1,Rs2549782,pre-eclampsia
ERAP1,Rs2287987, Caucasian
ERAP1,Rs2287987,ankylosing spondylitis
ERAP1,Rs2549782,pre-eclampsia
ERAP1,Rs2549782,Chilean maternal-fetal dyads
ERAP1,Rs2549782,unpaired African American
ERAP1,Rs10050860,ankylosing spondylitis susceptibility
ERAP1,Rs27044, ankylosing spondylitis.
ERAP1,Rs27044,Korean 
ERAP1,Rs27044,ankylosing spondylitis
ERAP1,Rs27044,Caucasian 
ERAP1,Rs27044,ankylosing spondylitis
ERAP1,Rs2287987,ERAP1 gene
ERAP1,Rs10050860,haplotypes
ERAP1,Rs10050860,polymorphisms and ankylosing spondylitis
ERAP1,Rs10050860,endoplasmic reticulum aminopeptidase polymorphisms
ERAP1,Rs10050860,ankylosing spondylitis
ERAP1,Rs10050860,familial ankylosing spondylitis
ERAP1,Rs10050860,ankylosing spondylitis
ERAP1,Rs10050860,ankylosing spondylitis
ERAP1,Rs10050860,ankylosing spondylitis
ERAP1,Rs10050860,ankylosing spondylitis
ERAP1,Rs10050860,ankylosing spondylitis
ERAP1,Rs10050860,familial ankylosing spondylitis
ERAP1,Rs10050860,ankylosing spondylitis
ERAP1,Rs10050860,ankylosing spondylitis
ERAP1,Rs10050860,ankylosing spondylitis
ERAP1,Rs10050860,ankylosing spondylitis
ERAP1,Rs10050860,ankylosing spondylitis
ERAP1,Rs10050860,familial ankylosing spondylitis.
ERAP1,Rs10050860,relationship to inflammatory markers
ERAP1,Rs10050860, ERAP1 polymorphisms
ERAP1,Rs10050860,Serum cytokine receptors
ERAP1,Rs10050860,ankylosing spondylitis
ERAP1,Rs10050860, ERAP1
ERAP1,Rs10050860,ankylosing spondylitis
ERAP1,Rs10050860,polymorphisms 
ERAP1,Rs10050860,nkylosing spondylitis
ERAP1,Rs10050860,ERAP1
ERAP1,Rs10050860,ankylosing spondylitis
ERAP1,Rs10050860,uncommon T allele
ERBB4,Rs707284,major depressive disorder
ERBB4,Rs839523,schizophrenia
ERBB4,Rs839523,schizophrenia
ERBB4,Rs7598440,schizophrenia
ERBB4,Rs7598440,schizophrenia
ERBB4,Rs707284,psychosis risk variants
ERBB4,Rs707284,Han Chinese population
ERBB4,Rs707284,schizophrenia
ERBB4,Rs707284,schizophrenia
ERBB4,Rs707284,bipolar affective disorder
ERBB4,Rs707284,schizophrenia
ERBB4,Rs707284,schizophrenia
ERBB4,Rs707284,psychosis risk variants
ERBB4,Rs707284,major depressive disorder and schizophrenia
ERBB4,Rs707284,bipolar affective disorder
ERBB4,Rs707284,schizophreni
ERBB4,Rs707284,synaptic plasticity and schizophrenia.
ERBB4,Rs707284,schizophrenia
ERBB4,Rs707284,schizophrenia
ERBB4,Rs707284,"Neuregulin 1 in neural development, synaptic plasticity and schizophrenia"
ERCC2,Rs13181,bladder cancer 
ERCC2,Rs13181,bladder cancer
ERCC2,Rs13181,bladder cancer
ERCC2,Rs13181,lung adenocarcinoma
ERCC2,Rs13181,lung adenocarcinoma
ERCC2,Rs13181,non-small cell lung cancer
ERCC2,Rs13181,gallbladder cancer
ERCC2,Rs13181,esophageal squamous cell carcinoma
ERCC2,Rs13181,Lung cancer
ERCC2,Rs13181,gastric and colorectal cancer
ERCC2,Rs13181,Gallbladder cancer
ERCC2,Rs13181,Locally Advanced Head and Neck Cancer
ERCC2,Rs13181,breast cancer
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,adult glioma
ERCC2,Rs13181,systemic lupus erythematosus
ERCC2,Rs13181,colorectal cancer
ERCC2,Rs13181,breast cancer risk
ERCC2,Rs13181,renal cell carcinoma
ERCC2,Rs13181,non-melanoma skin cancer 
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,human breast cancer
ERCC2,Rs13181,pancreatic adenocarcinoma
ERCC2,Rs13181,sophageal adenocarcinoma
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,esophageal squamous cell carcinoma 
ERCC2,Rs13181,sophageal cancer
ERCC2,Rs13181,colorectal cancer risk
ERCC2,Rs13181,bladder cancer
ERCC2,Rs13181,neck squamous cell cancer
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,cancer
ERCC2,Rs13181,colorectal cancer
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,lung adenocarcinoma
ERCC2,Rs13181,bladder
ERCC2,Rs13181,cancer
ERCC2,Rs13181,Lung cancer
ERCC2,Rs13181,colorectal cancer
ERCC2,Rs13181,ung cancer
ERCC2,Rs13181,breast cancer risk
ERCC2,Rs13181,esophageal adenocarcinoma
ERCC2,Rs13181,pancreatic adenocarcinoma
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,non-melanoma skin cancer
ERCC2,Rs13181,cancer
ERCC2,Rs13181,cancer
ERCC2,Rs13181,non-Hodgkin lymphoma
ERCC2,Rs13181,cancer
ERCC2,Rs13181,esophageal cancer
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,ovarian cancer
ERCC2,Rs13181,ovarian cancer
ERCC2,Rs13181,ovarian cancer
ERCC2,Rs13181,cutaneous melanoma risk
ERCC2,Rs13181,ung cancer risk
ERCC2,Rs13181,lung cancer risk
ERCC2,Rs13181,oral precancer and cancer
ERCC2,Rs13181,cancer cells
ERCC2,Rs13181,esophageal cancer
ERCC2,Rs13181,Bladder cancer
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,breast cancer
ERCC2,Rs13181,cancer
ERCC2,Rs13181,pancreatic adenocarcinoma
ERCC2,Rs13181,Polymorphisms
ERCC2,Rs13181,esophageal adenocarcinoma
ERCC2,Rs13181,Polymorphisms
ERCC2,Rs13181,non-Hodgkin lymphoma (NHL)
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,non-melanoma skin cancer
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,Genetic polymorphisms
ERCC2,Rs13181,renal cell carcinoma
ERCC2,Rs13181,single nucleotide polymorphisms
ERCC2,Rs13181,Allelic imbalance
ERCC2,Rs13181,non-Hodgkin lymphoma (NHL)
ERCC2,Rs13181,Bladder cancer
ERCC2,Rs13181,non-small cell lung cancer patients
ERCC2,Rs13181,genetic polymorphisms
ERCC2,Rs13181,adult glioma
ERCC2,Rs13181, lung cancer
ERCC2,Rs13181,Polymorphisms
ERCC2,Rs13181,ovarian cancer
ERCC2,Rs13181,ovarian cancer
ERCC2,Rs13181,ovarian cancer 
ERCC2,Rs13181,cutaneous melanoma
ERCC2,Rs13181,cancer cells
ERCC2,Rs13181,breast cancer 
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,adult glioma
ERCC2,Rs13181,esophageal cancer
ERCC2,Rs13181,human lung cancer
ERCC2,Rs13181,adiposity
ERCC2,Rs13181,ovarian cancer
ERCC2,Rs13181,ovarian cancer
ERCC2,Rs13181,cutaneous melanoma
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,head and neck squamous cell cancer
ERCC2,Rs13181, oral precancer
ERCC2,Rs13181,colorectal cancer 
ERCC2,Rs13181,esophageal squamous cell carcinoma
ERCC2,Rs13181,ovarian cancer
ERCC2,Rs13181,lung cancer
ERCC2,Rs13181,gallbladder cancer
ERCC2,Rs13181,Head and Neck Cancer
ERCC2,Rs13181,lung adenocarcinoma
ERCC2,Rs13181,lung adenocarcinoma
ERCC2,Rs13181,bladder cancer
ERCC2,Rs13181,bladder cancer
ERCC2,Rs13181,gastric and colorectal cancer
ERCC2,Rs13181,bladder cancer risk
ERCC2,Rs13181,Lung cancer
ERCC2,Rs13181,breast cancer
ERCC2,Rs13181,esophageal cancer
ERCC2,Rs13181,colorectal cancer
ERCC2,Rs13181,Lung Cancer
ERCC6,Rs3793784,age-related macular degeneration
ERCC6,Rs3793784,lung cancer risk.
ERCC6,Rs3793784,macular degeneration
ERCC6,Rs3793784,age related macular degeneration
ESCO2,Rs80359862,no phenotype-genotype
ESCO2,Rs80359866,Roberts syndrome
ESCO2,Rs80359866, mutations
ESCO2,Rs80359866,human homolog
ESCO2,Rs80359866,yeast
ESCO2,Rs80359868,Roberts syndrome
ESCO2,Rs80359868, mutations
ESCO2,Rs80359868,human homolog
ESCO2,Rs80359868,sister chromatid cohesion
ESCO2,Rs80359869,phocomelia
ESCO2,Rs80359869,Roberts syndrome
ESCO2,Rs80359869,phocomelia 
ESCO2,Rs80359869,Roberts syndrome
ESCO2,Rs80359869,no phenotype-genotype
ESCO2,Rs80359862,Roberts syndrome
ESCO2,Rs80359868,yeast
ESCO2,Rs80359862,phocomelia 
ESCO2,Rs80359866,sister chromatid cohesion
ESCO2,Rs80359862,phocomelia
ESCO2,Rs80359849,Roberts syndrome
ESCO2,Rs80359849, mutations
ESCO2,Rs80359849,human homolog
ESCO2,Rs80359849,yeast
ESCO2,Rs80359849,sister chromatid cohesion
ESCO2,Rs80359851,intertissue and interindividual variation
ESCO2,Rs80359851,Nmd efficiency
ESCO2,Rs80359851,Nmd efficiency
ESCO2,Rs80359862,Roberts syndrome
ESCO2,Rs80359851,homozygous frameshift mutation
ESCO2,Rs80359851,evidence of intertissue
ESCO2,Rs80359861,phocomelia
ESCO2,Rs80359861,Roberts syndrome
ESCO2,Rs80359861,phocomelia 
ESCO2,Rs80359861,Roberts syndrome
ESCO2,Rs80359861,no phenotype-genotype
ESCO2,Rs80359851,ESCO2
ESR1,Rs2234693,hypogonadotropic hypogonadism
ESR1,Rs2234693,osteoporosis
ESR1,Rs2234693,osteoporotic
ESR1,Rs2234693,reproductive disorders
ESR1,Rs2234693,cancer 
ESR1,Rs2234693,obesity
ESR1,Rs2234693,spontaneous abortion
ESR1,Rs2234693,breast cancer
ESR1,Rs2234693,Polycystic ovary syndrome
ESR1,Rs2234693,endometrial cancer
ESR1,Rs2234693,prostate cance
ESR1,Rs2234693,breast cancer
ESR1,Rs2234693,reproductive disorders:
ESR1,Rs2234693,Alzheimer's disease
ESR1,Rs2234693,cardiovascular phenotypes
ESR1,Rs2234693,Down syndrome
ESR1,Rs2234693,breast cancer
ESR1,Rs2234693,acute lymphoblastic leukemia
ESR1,Rs2234693,osteonecrosis
ESR1,Rs2234693,breast cancer
ESR1,Rs2234693,obesity
ESR1,Rs2234693,obesity and lipolysis
ESR1,Rs2234693,breast cancer
ESR1,Rs2234693,cardiovascular risk
ESR1,Rs2234693,migraine susceptibility.
ESR1,Rs2234693,stroke
ESR1,Rs2234693,osteoporosis 
ESR1,Rs2234693, psychiatric disorders.
ESR1,Rs2234693,hyperlipidemia
ESR1,Rs2234693,schizophrenia
ESR1,Rs2234693,menopause
ESR1,Rs3020314,estrogen receptor-positive breast cancer risk (C) ha
ESR1,Rs3020314,follicular lymphoma
ESR1,Rs3020314,estrogen receptor-positive breast cancer risk
ESR1,Rs3020314,follicular lymphoma
ESR1,Rs2881766,.Carriers of rs2881766(T) alleles
ESR1,Rs2881766,pregnancy-induced hypertension.
ESR1,Rs2295190,allele 
ESR1,Rs2295190,samples 
ESR1,Rs2295190,cancer 
ESR1,Rs2295190,gene
ESR1,Rs2295190,alpha 
ESR1,Rs2295190,receptor 
ESR1,Rs2295190,estrogen 
ESR1,Rs2234693,pediatric acute lymphoblastic leukemia
ESR1,Rs2295190,gene
ESR1,Rs2295190,nuclear 
ESR1,Rs2295190,SNP 
ESR1,Rs2295190,increased risk for ovarian cancer
ESR1,Rs2295190,ovarian cancer
ESR1,Rs2234693,osteoporosis
ESR1,Rs2234693,histopathological tumo
ESR1,Rs2234693,prostate cancer
ESR1,Rs2234693,HIV-infected
ESR1,Rs2234693,late-life depression
ESR1,Rs2234693,anxiety disorders
ESR1,Rs2234693,prostate cance
ESR1,Rs2234693,breast cancer
ESR1,Rs2234693,breast cancer
ESR1,Rs2295190,envelope 
ESR1,Rs2234693,schizophrenia
ESR1,Rs2234693,sexual dimorphism
ESR1,Rs2234693,fertilization
ESR1,Rs2234693,breast cancer
ESR1,Rs2234693,endometrial cancer
ESR1,Rs2234693,breast cancer
ESR1,Rs2234693,breast cancer
ESR1,Rs2234693,breast cancer
ESR1,Rs2234693,endometrial cancer
ESR1,Rs2234693,endometrial cancer
ESR1,Rs2234693,prostate cancer
ESR1,Rs2234693,breast cancer
ESR1,Rs2234693,breast cancer
ESR1,Rs2234693,prostate cancer
ESR1,Rs2234693,prostate cancer
ESR1,Rs2234693,breast cancer
ESR1,Rs2179922,rs2179922(G;G) homozygotes
ESR1,Rs2179922,females
ESR1,Rs2179922,height 
ESR1,Rs2179922,(A;G) or (A;A) genotypes
ESR1,Rs2179922,0.90 - 2.3cm taller
ESR1,Rs2179922,homozygotes
ESR1,Rs2179922,elderly Swedish men
ESR1,Rs2179922,A study of 1153 elderly Swedish men (age 70) concluded that rs2179922(G;G) homozygotes were between 0.90 - 2.3cm taller on average than either (A;G) or (A;A) genotypes. No such association with height was seen for females.
ESR1,Rs2179922,height
ESR1,Rs2152750,increases susceptibility to Bone mineral density variations
ESR1,Rs2144025,psychiatric symptoms.
ESR1,Rs2144025,Bipolar disorder
ESR1,Rs1999805,increases susceptibility to Bone mineral density variations
ESR1,Rs1999805,increases susceptibility to Bone mineral density variations
ESR1,Rs2234693,ischemic stroke
ESR1,Rs2234693,schizophrenics
ESR1,Rs2234693,stroke
ESR1,Rs2234693,lipoprotein cholesterol
ESR1,Rs2234693,osteoporosis
ESR1,Rs2234693,HIV
ESR1,Rs2234693,anxiety disorders
ESR1,Rs2234693,lung adenocarcinoma
ESR1,Rs2234693,lupus erythematosus
ESR1,Rs3020314,breast cancer
ESR1,Rs2234693,schizophrenia
ESR1,Rs2234693,osteoarthritis
ESR1,Rs2234693,osteoarthritis
ESR1,Rs2234693,hot flushes
ESR1,Rs2234693,menopause
ESR1,Rs2234693,body composition in pediatric acute lymphoblastic leukemia
ESR1,Rs2234693,myocardial infarction
ESR1,Rs2234693,altered bone mineral density
ESR1,Rs2234693,obesity
ESR1,Rs2234693,spontaneous abortion
ESR1,Rs2234693,reproductive disorders
ESR1,Rs2234693,dry eye
ESR1,Rs2234693,reproductive disorders
ESR1,Rs2234693,psychiatric disorders
ESR1,Rs2234693,apolipoprotein levels
ESR1,Rs2234693,plasma lipid
ESR1,Rs2234693,Down syndrome
ESR1,Rs2234693,Alzheimer's disease
ESR1,Rs2234693,body height
ESR1,Rs2234693,type 2 diabetes
ESR1,Rs2234693,interaction between lean tissue mass
ESR1,Rs2234693,knee osteoarthritis
ESR1,Rs2234693, breast conditions
ESRRB,Rs2360997,autism spectrum disorder
ESRRB,Rs2360997,attention-deficit/hyperactivity disorder
EXO1,Rs1047840,breast cancer
EXO1,Rs851797,polymorphisms of EXO1 gene
EXO1,Rs851797,polymorphisms of EXO1
EXO1,Rs851797,lung cancer
EXO1,Rs72755295,"breast cancer, GWAS"
EXO1,Rs1776180,female centenarians
EXO1,Rs1776180, German centenarians
EXO1,Rs851797,breast cancer
EXO1,Rs1776180,longevity
EXO1,Rs1776180,female centenarians
EXO1,Rs1635517,breast cancer
EXO1,Rs1635498,breast cancer
EXO1,Rs1047840,breast cancer.
EXO1,Rs1776180,associated with longevity
EYA1,Rs3779748,kidney disease
F11,Rs373297713,deficiency-causing mutations
F11,Rs281875251,Factor XI deficiency
F11,Rs281875251,Factor XI deficiency
F11,Rs121965063,Ashkenazi Jews
F11,I4000399,Factor XI Deficiency
F11,Rs121965063,Ashkenazi Jews
F12,Rs1801020,"Affects heart disease risk for both men and women, based on a study of two Finnish population cohorts"
F2,Rs1799963,cerebral ischemia
F2,Rs1799963,PFO
F2,Rs1799963,hole in the heart
F2,Rs1799963,patent foramen ovale (PFO)
F2,Rs1799963,ischemic stroke
F2,Rs1799963,venous thromboembolism
F2,Rs1799963,Venous thromboembolism
F2,Rs1799963,OR
F2,Rs1799963,Venous thrombosis
F2,Rs1799963,Cerebral venous sinus thrombosis
F2,Rs1799963,Venous Thromboembolism
F2,Rs1799963,thromboembolism
F5,Rs6025,venous thrombosis
F5,Rs6025,thromboembolic events
F5,Rs6025,postmenopausal women
F5,Rs6025,breast cancer
F5,Rs6025,women
F5,Rs6025,ischemic stroke
F5,Rs6025,ischemic stroke
F5,Rs6025,venous thromboembolism
F5,Rs6025,deep venous thrombosis
F5,Rs6025,venous thromboembolism
F5,Rs6025,women
F5,Rs6025,thrombosis
F5,Rs6025,thrombosis
F5,Rs6025,pre-eclampsia or venous thromboembolism
F5,Rs6025,cerebral vein or cerebral sinus thrombosis
F5,Rs6025,Lemierre's syndrome
F5,Rs6025,venous thromboembolism
F5,Rs6025,ischemic stroke
F5,Rs6025,obstetric complications
F5,Rs7542281,ischemic stroke events
F5,Rs7542281,Leiden mutation
F5,Rs6025,Sinhalese women
F5,Rs6025,coronary heart disease
F5,Rs6025,colorectal cancer risk
F5,Rs6025,amyotrophic lateral sclerosis
F5,Rs6025,venous thromboembolism
F5,Rs6025,inflammation and thrombosis
F5,Rs6025,Sri Lankan population
F5,Rs6025,migraine
F5,Rs6025,Sao Miguel's healthy population
F5,Rs6025,hypertension
F5,Rs6025,candidate genes with blood pressure progressio
F5,Rs6025,venous thromboembolism
F5,Rs6025,women
F5,Rs6025,women
F5,Rs6025,nonsmokers younger than 40 years of age with a body mass index below 25 kg/m2
F5,Rs6019,fetal growth.
F5,Rs6019,PTD
F5,Rs6019,PTD
F5,Rs4524,gene variants associated with
F5,Rs4524,deep vein thrombosis
F5,Rs4524,deep vein thrombosis
F5,Rs6019,maternal smoking
F5,Rs4524,deep vein thrombosis.
F5,Rs4524,deep vein thrombosis.
F5,Rs4524,deep vein thrombosis
F5,Rs4524,deep vein thrombosis
F5,Rs4524,deep vein thrombosis
F5,Rs4524,deep vein thrombosis
F5,Rs2269648,ischemic stroke events
F5,Rs4524,Gene variants associated 
F5,Rs2269648,Leiden mutation
F5,Rs6019,non-smoking mothers
F5,Rs6019,fetal growth.
F5,Rs6025,overweight smokers
F5,Rs6025,venous thromboembolism
F5,Rs6025,venous thromboembolism
F5,Rs6025,Caucasian adults in the Danish population
F5,Rs6025,cerebral venous sinus thrombosis
F5,Rs6025,pulmonary embolism
F5,Rs6019,PTD
F5,Rs6025, venous thrombosis 
F5,Rs6025,women
F5,Rs6025,men
F5,Rs6025,Venous Thromboembolism
F5,Rs6025,venous thromboembolism
F5,Rs6019,CC
F5,Rs6019,GC
F5,Rs6025,thrombosis
F5,Rs1800595,venous thrombosis
F9,I5007022,Hemophilia
FABP2,Rs5861422,Type 2 diabetes-associated fatty acid
FADS1,Rs174548,decreased 
FADS1,Rs174548,phosphatidylcholine 
FADS1,Rs174548,allele 
FADS1,Rs174548,metabolites
FADS1,Rs174548,ratio 
FADS1,Rs174548,of 
FADS1,Rs174548,metabolite 
FADS1,Rs174548,SNPs 
FADS1,Rs174548,glycerophospholipids
FADS1,Rs174548,metabolism 
FADS1,Rs174548,fatty 
FADS1,Rs174548,acid 
FADS1,Rs174548,blood 
FADS1,Rs174547,coronary heart disease
FADS1,Rs174546,allergic diseases
FADS1,Rs174548,enzyme 
FADS1,Rs174547,carotid artery disease
FADS1,Rs174547,cardiovascular risk
FADS1,Rs174547,coronary heart disease
FADS1,Rs174547,familial combined hyperlipidemia
FADS1,Rs174547,dyslipidemia 
FADS1,Rs174547,carotid artery disease
FADS1,Rs174547,is associated with plasma lipid profiles
FADS1,Rs174547,macular degeneration
FADS1,Rs174547,hyperlipidemia
FADS2,Rs968567,000 
FADS2,Rs99780,associated with altered (n-6) and (n-3) essential fatty acids in plasma and erythrocyte phospholipids in women during pregnancy and in breast milk during lactation.
FADS2,Rs968567,rheumatoid arthritis
FADS2,Rs968567,rheumatoid arthritis 
FADS2,Rs968567,SNPs 
FADS2,Rs968567,42 
FADS2,Rs968567,01 
FADS2,Rs99780,development of human disease.
FADS2,Rs968567,30
FADS2,Rs968567,rheumatoid arthritis
FADS2,Rs66698963,more susceptible to inflammation
FADS2,Rs66698963,heart disease and colon cancer
FADS2,Rs66698963,inflammation
FADS2,Rs66698963,colon cancer
FADS2,Rs66698963,heart disease 
FADS2,Rs66698963,eart disease and colon cancer
FADS2,Rs482548,Genetic variation in lipid desaturases
FADS2,Rs174570,genetic signatures of diet and climate adaptation
FADS2,Rs174570,decreased cholesterol and increased triglycerides
FADS2,Rs968567,rheumatoid arthritis
FADS3,Rs7115739,enetic signatures of diet and climate adaptation
FADS3,Rs7115739,genetic 
FADS3,Rs7115739,Inuit 
FADS3,Rs7115739,Greenlandic 
FADS3,Rs7115739,show 
FAH,Rs80338899,stop mutation
FAH,Rs80338899,hereditary tyrosinemia type 1
FAH,Rs80338899,hereditary tyrosinemia type I
FAH,Rs80338899,mutation
FAH,Rs80338899,hereditary tyrosinemia type 1 mutation
FAH,Rs80338899,hereditary tyrosinemia type I
FAH,Rs11555096,Tyrosinemia Type I
FAH,I5012861,Tyrosinemia Type I
FAH,I5012867,Tyrosinemia Type I
FAH,I5012867,Tyrosinemia 
FAH,I5012867,Tyrosinemia Type I
FAH,I5012864,Tyrosinemia
FAH,I5012864, Type
FAH,Rs80338901,hereditary tyrosinemia type I
FAH,I5012861,Tyrosinemia
FAH,I5012867,Tyrosinemia Type I
FAH,Rs80338901,gene in French Canadians with hereditary tyrosinemia type I
FAM13A,Rs7671167,lung cancer
FAM71F1,Rs6971091,obesity
FAM71F1,Rs6971091,obesity
FAM71F1,Rs6971091,body mass index (BMI)
FAM71F1,Rs6971091,leptin levels
FANCC,I4000336,Fanconi Anemia
FANCC,I4000336,Fanconi Anemiars
FANCC,I4000336,Anemiars104886456
FANCC,Rs104886456,Fanconi anemia
FANCC,Rs104886456,"Fanconi anemia,"
FANCC,Rs104886456,Fanconi anemia
FANCC,Rs104886459,Fanconi anemia
FANCC,Rs104886459,Fanconi anemia is found mainly in non-Jewish people with European ancestry.
FANCM,Rs144567652,breast cancer 
FANCM,Rs144567652,familial breast cancer cases
FANCM,Rs144567652,two subsequent meta-analyses showed similar breast cancer associations
FBN1,I5043856,Marfan syndrome
FCER1A,Rs2251746, allergies
FCER1A,Rs2251746,High levels of serum IgE
FCER1A,Rs2251746,autoimmune diseases.
FCER1A,Rs2251746, atopic eczema 
FCER1A,Rs2251746,homozygous rs2251746(C;C)
FCER1A,Rs2251746,asthma
FCER1A,Rs2251746,two (T) alleles.
FCER1A,Rs2251746,atopic dermatitis patients.
FCER1A,Rs2251746,FcepsilonRIalpha gene (FCER1A) promoter polymorphisms and total serum IgE levels
FCER1A,Rs2251746,integration of expression QTLs with complex trait genetic associations.
FCGR2B,Rs1050501,Fcgamma 
FCGR2B,Rs1050501,systemic 
FCGR2B,Rs1050501,Fcgamma 
FCGR2B,Rs1050501,IIIA
FCGR2B,Rs1050501,IIB 
FCGR2B,Rs1050501,IIB 
FCGR2B,Rs1050501,FCGR 
FCGR2B,Rs1050501,lupus 
FCGR2B,Rs1050501,SLE
FCGR2B,Rs1050501,Fcgamma 
FCGR2B,Rs1050501,systemic lupus erythematosus
FCGR3A,Rs403016,Chinese lupus patients
FCGR3A,Rs403016,increased risk for developing the disease
FECH,Rs2272783,erythropoietic protoporphyria
FECH,Rs2272783,this is likely to lead
FECH,Rs2272783,lowered expression of that enzyme
FECH,Rs2272783,is a mutation in the ferrochelatase FECH gene
FECH,Rs2272783,erythropoietic protoporphyria
FECH,Rs2269219,rythropoietic protoporphyria
FECH,Rs2272783,lowered expression of that enzyme.
FECH,Rs3848519,erythropoietic protoporphyria
FECH,Rs2269219,erythropoietic 
FECH,Rs2269219,protoporphyria
FECH,Rs2272783,nonfunctional FECH allele
FGF23,Rs28937882,Trp 
FGF23,Rs28937882,Arg
FGF23,Rs28937882,R179W
FGF23,Rs28937882,Arg179Trp
FGFR2,Rs11200014,FGFR2 gene with the strongest association with breast cancer
FGFR2,Rs7895676,sporadic postmenopausal ER+ breast cancer
FGFR2,Rs7895676,breast cancer
FGFR2,Rs7895676,breast cancer
FGFR2,Rs7895676,breast cancer
FGFR3,Rs28931614,th
FGFR3,Rs28931614,G>
FGFR3,Rs28931614,of 
FGFR3,Rs28931614,obl
FGFR3,Rs28931614,e 
FGFR3,Rs28931614,rs28931614
FGFR3,Rs28931614,eceptor 3 FGFR3 gene on chromosome 4. As an autosomal domi
FGFR3,Rs28931614,G380R
FGFR3,Rs28931614,to
FGFR3,Rs28931614,achondroplasia
FGFR3,Rs28931614,1138G
FGFR3,Rs28931614,i6010295 
FGFR3,Rs28931614,known 
FGFR3,Rs28931614, to 
FGFR3,Rs28931614,Gly380Arg
FGFR3,Rs28931614,ang
FGFR3,Rs28931614,SNP 
FGFR3,Rs28931614,) 
FGFR3,Rs28931614,achondroplasia
FGFR3,Rs28931614,autosomal 
FGFR3,Rs28931614,G380R
FGFR3,Rs28931614,Gly380Arg
FGFR3,Rs28931614,1138G
FGFR3,Rs28931614,1138G
FGFR3,Rs28931614,change 
FGFR3,Rs28931614,chromosome 
FGFR3,Rs28931614,rs28931614
FGFR3,Rs28931614,1138G
FGFR3,Rs28931614,SNP
FGFR3,Rs28931614,rar
FGFR3,Rs28931614,achondroplasia
FGFR3,Rs28931614,rs28931614
FGFR3,Rs28931614,23andMe
FGFR3,I5001264,Achondroplasia
FGFR3,I5001267,Achondroplasia
FGFR3,I5001280,Achondroplasia
FGFR3,I5053815,Achondroplasia
FGFR3,I6010281,Achondroplasia
FGFR3,I6010295,Achondroplasiars
FGFR3,I6010295,Achondroplasiars
FGFR3,Rs121913105,achondroplasia
FGFR3,Rs121913105,"SADDAN dysplasia"""
FGFR3,Rs121913105,autosomal dominant manner
FGFR3,Rs121913105,achondroplasia
FGFR3,Rs121913105,"""SADDAN dysplasia"""
FGFR3,Rs28931614,23andMe
FGFR3,Rs121913114,achondroplasia
FGFR3,Rs121913105,FGFR3 gene on chromosome 4.
FGFR3,Rs28931614,dwarfism
FGFR3,Rs28931614,i6010295 
FGFR3,Rs28931614,achondroplasia
FGFR3,Rs28931614,G380R
FGFR3,Rs28931614,Gly380Arg
FGFR3,Rs28931614,1138G
FGFR3,Rs28931614,FGFR3 
FGFR3,Rs28931614,1138G
FGFR3,Rs28931614,rs28931614
FGFR3,Rs28931614,SNP 
FGFR3,Rs28931614,rs28931614
FGFR3,Rs28931614,achondroplasia
FGFR3,Rs28931614,rs28931614
FGFR3,Rs28931614,"achondroplasia, a form of dwarfism"
FGFR3,Rs28931614,SNP
FGFR3P1,Rs13202464,B27 Syndromes
FGFR4,Rs351855,prostate cancer
FGFR4,Rs351855,prostate-cancer
FGFR4,Rs351855,prostate cancer
FGFR4,Rs641101,coronary artery disease
FGFR4,Rs641101,polymorphisms
FGFR4,Rs641101,coronary artery disease
FGFR4,Rs641101,coronary artery disease
FGFR4,Rs641101,Fibroblast growth factor
FGFR4,Rs351855,prostate cancer
FGFR4,Rs641101,Fibroblast growth factor receptor 4 polymorphisms
FGFR4,Rs351855,metastatic prostate cancer
FGFR4,Rs2011077,prostate cancer
FGFR4,Rs351855,prostate cancer
FGFR4,Rs351855,node-positive breast cancer
FGFR4,Rs2011077,5.5-fold increased risk of metastatic prostate cancer
FGFR4,Rs2011077, benign prostate hyperplasia (BPH)
FGFR4,Rs2011077,increased risk of prostate cancer
FGFR4,Rs2011077,rs2011077(G;G) genotype
FGFR4,Rs2011077,prostate cancer patients
FGFR4,Rs2011077,Japanese
FGFR4,Rs2011077,benign prostate hyperplasia
FGFR4,Rs351855,prostate cancer and benign prostate hyperplasia
FKBP5,Rs9470080,depressive symptoms
FKBP5,Rs9470080,inflammatory bowel disease
FKBP5,Rs9470080, childhood trauma
FKBP5,Rs9470080,aggressive behavior
FKBP5,Rs9470080,severity of child abuse
FKBP5,Rs9470080,childhood trauma
FKBP5,Rs9470080,cortisol secretion
FKBP5,Rs9470080,depressive symptoms
FKBP5,Rs9470080,glucocorticoid resistance in inflammatory bowel disease
FKBP5,Rs9470080,cortisol secretion
FKBP5,Rs9470080,adult PTSD symptoms
FKBP5,Rs9470080,PTSD
FKBP5,Rs9470080,aggressive behavior
FKBP5,Rs9470080,childhood trauma
FKBP5,Rs9470080,inflammatory bowel disease
FKBP5,Rs9470080,glucocorticoid resistance
FKBP5,Rs9470080,depressive symptoms
FKBP5,Rs9470080,adult PTSD symptoms
FKBP5,Rs9296158,PTSD
FKBP5,Rs9296158,severity of child abuse
FKBP5,Rs4713902,"most common allele, rs4713902(T), was associated with highest risk. "
FKBP5,Rs4713902,"rs4713902, a SNP in the FKBP5 gene, is associated with increased risk for bipolar disorder in a study of 500+ Caucasian patients."
FKBP5,Rs4713902,bipolar disorder
FKBP5,Rs3800373,PTSD
FKBP5,Rs3800373,severity of child abuse
FKBP5,Rs9470080,aggressive behavior
FKRP,Rs28937900,Limb-girdle muscular dystrophy-dystroglycanopathy
FLCN,Rs41419545,COPD
FLCN,Rs41419545,Folliculin mutations
FLCN,Rs41419545,Folliculin mutations
FLCN,Rs41419545,are not associated with severe COPD
FLG,Rs140980397,pathogenic variant noras a benign polymorphism
FLG,Rs140980397,European and African American ancestry.
FLG,Rs142991475,loss of normal protein function
FLG,Rs150597413,ichthyosis 
FLG,Rs41370446,loss of normal protein function
FLG,Rs558269137,ichthyosis vulgaris
FLG,Rs558269137,ichthyosis vulgaris
FLG,Rs558269137,atopic dermatitis
FLG,Rs558269137,eczema
FLG,Rs61816761,asthma predisposition
FLG,Rs558269137,atopic dermatitis
FLG,Rs558269137,eczema.
FLG,Rs61816761,ichthyosis vulgaris
FLG,Rs61816761,ichthyosis vulgaris
FLG,Rs61816761,atopic dermatitis
FLG,Rs61816761,eczema
FLG,Rs61816761,atopic dermatitis
FLG,Rs140980397,FLG gene
FLG,Rs61816761,type 1 diabetes
FLG,Rs754812742,ichythosis vulgaris
FLG,Rs558269137,ichthyosis vulgaris
FLG,Rs138726443,associated with higher odds of eczema
FLG,Rs140980397,This variant is predicted to cause loss of normal proteinfunction through protein truncation
FLG,Rs138726443,eczema
FLG,Rs114733570,protein truncation
FLG,Rs114733570,loss of normal protein function through protein truncation
FLG,Rs114733570,FLG gene
FLG,Rs114733570,cause loss of normal protein function
FLG,Rs114733570,protein truncation
FLG,Rs114733570,European
FLG,Rs114733570,This variant is predicted to cause loss of normal protein function through protein truncation.
FLG,Rs121909626,ichthyosis vulgaris
FLG,Rs138726443,Dominantly inherited variant pathogenic for ichthyosis vulgaris
FLG,Rs121909626,Japanese patients
FLG,Rs121909626,dermatitis
FLG,Rs121909626,atopic dermatitis
FLG,Rs121909626,Japanese families
FLG,Rs121909626,ichthyosis vulgaris
FLG,Rs121909626,severe presentation of the disease
FLG,Rs121909626,Japanese patients
FLG,Rs121909626,atopic dermatitis
FLG,Rs121909626,Japanese controls
FLG,Rs138726443,eczema
FLG,Rs138726443,chthyosis vulgaris
FLG,Rs138726443,ichthyosis vulgaris
FLG,Rs121909626,ichthyosis vulgaris
FLNB,Rs80356520,"disrupt vertebral segmentation, joint formation and skeletogenesis"
FLNB,Rs80356520,Mutations in the gene encoding filamin B
FLNB,Rs80356520,"disrupt vertebral segmentation, joint formation and skeletogenesis."
FLNB,Rs80356520,vertebral segmentation
FLNB,Rs80356520,skeletogenesis
FLNB,Rs80356520,joint formation
FLNB,Rs80356520,joint formation
FLNB,Rs80356520,vertebral segmentation
FLNB,Rs80356520,skeletogenesis
FMO3,Rs72549331,gene
FMO3,Rs72549331,homozygous 
FMO3,Rs72549331,minor 
FMO3,Rs72549331,genotype 
FMO3,Rs72549331,patient 
FMO3,Rs72549331,trimethylaminuria
FMO3,Rs72549334,trimethylaminuria
FMO3,Rs72549334,trimethylaminuria
FMO3,Rs72549334,trimethylaminuria
FMO3,Rs72549334,homozygous minor genotype
FMO3,Rs72549334,SNP
FMO3,Rs72549334,homozygous
FMO3,Rs72549334,genotype
FMO3,Rs72549334,trimethylaminuria
FMO3,Rs72549334,homozygous
FMO3,Rs72549334,genotype
FMO3,Rs72549326,Homozygous minor genotypes for this SNP 
FMO3,Rs72549334,trimethylaminuria
FMO3,Rs72549326,trimethylaminuria.
FMO3,Rs72549320,trimethylaminuria
FMO3,Rs72549326,trimethylaminuria
FMO3,Rs72549326,trimethylaminuria.
FMO3,Rs1736557,rs1736557
FMO3,Rs1736557,It has been linked to trimethylaminuria
FMO3,Rs61753344,rs61753344
FMO3,Rs61753344,SNP
FMO3,Rs61753344,FMO3
FMO3,Rs61753344,trimethylaminuria
FMO3,Rs61753344,homozygous form
FMO3,Rs1736557,trimethylaminuria
FMO3,Rs72549320,SNP in the FMO3 gene.
FMO3,Rs72549320,observed in an individual with trimethylaminuria
FMO3,Rs72549321,trimethylaminuria
FMO3,Rs72549322,trimethylaminuria
FMO3,Rs72549323,trimethylaminuria
FMO3,Rs72549323,gene
FMO3,Rs72549323,linked
FMO3,Rs72549323,trimethylaminuria
FMO3,Rs61753344,tyramine
FN1,Rs6707530,"cell adhesion, migration and metastasis in mesenchymal tumors."
FN1,Rs137854488,fibronectin deposits
FN1,Rs137854488,glomerulopathy
FN1,Rs137854488,autosomal dominant mutation
FN1,Rs137854488,glomerulopathy with fibronectin deposits (type 2)
FN1,Rs137854488,autosomal dominant mutation 
FN1,Rs137854488,glomerulopathy with fibronectin deposits (type 2)
FN1,Rs137854488,autosomal dominant mutation
FN1,Rs137854488,OMIM
FN1,Rs137854488,autosomal dominant mutation
FN1,Rs137854488,Tyr973Cys
FN1,Rs137854488,glomerulopathy with fibronectin deposits
FN1,Rs137854488,form of glomerulopathy with fibronectin deposits
FOXE1,Rs1867277,thyroid cancer
FOXE1,Rs1867277,causal variant
FOXE1,Rs1867277,allele
FOXE1,Rs1867277,gene
FOXE1,Rs1867277,thyroid cancer
FOXE1,Rs1867277,G>A
FOXE1,Rs1867277,thyroid cancer
FOXE1,Rs1867277,SNP 
FOXE1,Rs1867277,thyroid cancer
FOXO1,Rs2721068,type-2 diabetes
FOXO1,Rs2721068,type-2 diabetes
FOXO3,Rs2764264,greater odds of longevity
FOXO3,Rs1935949,longevity
FOXO3,Rs12212067,FOXO3A gene
FOXO3,Rs12212067,Crohn's disease
FOXO3,Rs12212067,rheumatoid arthritis
FOXP2,Rs2396753,schizophrenia
FOXP2,Rs2396753, grey matter concentration
FOXP2,Rs17137124,rs17137124
FOXP2,Rs17137124,impair speech
FOXP2,Rs17137124,may impair speech
FOXP2,Rs117717824,Latin Americans
FOXP2,Rs10227893,rs17137124
FOXP2,Rs117717824,hair 
FOXP2,Rs117717824,scalp 
FOXP2,Rs10227893,impair speech
FOXP2,Rs10227893,may impair speech
FOXP2,Rs117717824,facial and scalp hair features
FOXP3,Rs3761548, psoriasis
FOXP3,Rs3761548,psoriasis
FOXP3,Rs3761548,Autoimmune thyroiditis
FOXP3,Rs3761548,diabetes
FOXP3,Rs3761548,type I diabetes
FOXP3,Rs3761548,allergic rhinitis in the Hungarian female population.
FOXP3,Rs3761548,atopy in girls
FOXP3,Rs3761548, Dutch birth cohorts
FOXP3,Rs3761548,allergic rhinitis
FOXP3,Rs3761548, Hungarian female population
FOXP3,Rs3761548, Type I Diabetes Genetics Consortium families
FOXP3,Rs3761548,atopy in girls in three Dutch birth cohorts.
FOXP3,Rs3761547,Idiopathic 
FOXP3,Rs3761548,defective transcription of Foxp3 in psoriasis through abrogating E47/c-Myb binding
FOXP3,Rs3761548,hyroiditis and diabetes
FOXP3,Rs3761548, psoriasis 
FOXP3,Rs3761548,allergic rhinitis
FOXP3,Rs3761548,atopy
FOXP3,Rs3761548,Type I Diabetes
FOXP3,Rs3761548,type I diabetes
FOXP3,Rs3761548,psoriasis
FOXP3,Rs3761548,Autoimmune thyroiditis and diabetes
FOXP3,Rs3761548,psoriasis
FOXP3,Rs3761548,type I diabetes in the Type I Diabetes Genetics Consortium families
FOXP3,Rs3761547,Juvenile 
FSHR,Rs386833512,OMIM pathogenic variant
FSHR,Rs386833512,Pro587His
FSHR,Rs6166,less fecund women
FSHR,Rs1394205,29
FSHR,Rs1394205,ak
FTL,Rs1114167274,pathogenic
FTL,Rs1114167274,pathogenic
FTO,Rs7193144,obesity
FTO,Rs7193144,association of this block
FTO,Rs7193144,FTO gene
FTO,Rs7193144,linkage block
FTO,Rs7193144,early onset obesity
FTO,Rs3751812,african americans
FTO,Rs9937053,body weight
FTO,Rs3751812,"body mass index, BMI)"
FTO,Rs3751812,strongest association with body weight
FTO,Rs3751812,co-inherited
FTO,Rs3751812,african americans
FTO,Rs7193144,strongest association.
FTO,Rs3751812,body weight
FTO,Rs7193144,SNP
FTO,Rs9932754,body weight
FTO,Rs7193144,obesity
FTO,Rs7193144,allele
FTO,Rs7204609,body mas
FTO,Rs7204609,obesity and glucose homeostasis 
FTO,Rs7204609,overweight and obesity
FTO,Rs7204609,obesity
FTO,Rs7204609,human obesity
FTO,Rs9922619,body weight
FTO,Rs9932754,severe obesity
FTO,Rs9932754,body weight
FTO,Rs9932754,body mass index
FTO,Rs9932754,severe obesity
FTO,Rs9932754,Japanese
FTO,Rs3751812,body weight
FTO,Rs7193144,FTO gene
FTO,Rs1861868,obesity 
FTO,Rs3751812,one of the co-inherited
FTO,Rs17818902,smoking behavior
FTO,Rs17818902,three tagging SNPs within the FTO gene
FTO,Rs121918214,growth retardation
FTO,Rs121918214,coarse facies
FTO,Rs121918214,early death
FTO,Rs121918214,growth retardation
FTO,Rs121918214,developmental delay
FTO,Rs121918214,coarse facies
FTO,Rs121918214,early death
FTO,Rs121918214,growth retardation
FTO,Rs121918214,developmental delay
FTO,Rs121918214,coarse facies
FTO,Rs121918214,early death
FTO,Rs121918214,GDFD
FTO,Rs1477196,Physical activity
FTO,Rs1477196,obesity
FTO,Rs121918214,developmental delay
FTO,Rs1477196,obesity
FTO,Rs1477196,body mass index and obesity
FTO,Rs1477196,"genomic type 2 diabetes and obesity risk regions to HHEX, SOX4, and IRX3."
FTO,Rs1477196,physical activity
FTO,Rs1477196,FTO gene variants
FTO,Rs1477196,type 2 diabetes and obesity risk
FTO,Rs1477196,body mass index and obesity
FTO,Rs1477196,obesity 
FTO,Rs1477196,above-average physical activity
FTO,Rs1477196,low physical activity
FTO,Rs1477196,obesity 
FTO,Rs1477196,obesity risk
FTO,Rs1477196,diabetes
FTO,Rs1477196,Physical activity
FTO,Rs1477196,diabetes
FUS,Rs929867,variable immunodeficiency (CVID)
FUS,Rs929867,common variable immunodeficiency
FUS,Rs929867,common variable immunodeficiency
FUS,Rs929867,CVID
FUS,Rs929867,minor alleles of rs8056264 and rs929867
FUT2,Rs1047781,Japanese
FUT2,Rs1047781,Caucasians
FUT2,Rs1047781,Japanese
FXN,Rs143396368,Friedreich's ataxia
FXN,Rs148443992,Friedreich's ataxia
FXN,Rs148443992,mutation in the FXN gene on chromosome 9
FXN,Rs147211454,Friedreich's ataxia
FXN,Rs146818694,The minor allele of this SNP is associated with Friedreich's ataxia when inherited in two copies or as a compound heterozygote.
FXN,Rs146818694,Friedreich's ataxia
FXN,Rs146818694,Friedreich's ataxia
FXN,Rs145854903,heterozygote
FXN,Rs148443992,heterozygote
FXN,Rs145854903,Friedreich's ataxia
FXN,Rs145854903,chromosome 9
FXN,Rs145854903,mutation
FXN,Rs145854903,C>T
FXN,Rs144610605,Friedreich's ataxia
FXN,Rs144104124,The minor allele of this SNP is associated with Friedreich's ataxia when inherited in two copies or as a compound heterozygote.
FXN,Rs144104124,Friedreich's ataxia
FXN,Rs144104124,Friedreich's ataxia
FXN,Rs143396368,compound heterozygote
FXN,Rs145854903,minor allele
FXN,Rs148443992,mutation
FXN,Rs151206121,Friedreich's ataxia
FXN,Rs148443992,chromosome 9
FXN,Rs56214919,Friedreich's ataxia
FXN,Rs56214919,Friedreich's ataxia
FXN,Rs143396368,Friedreich's ataxia
FXN,Rs151206121,Friedreich's ataxia
FXN,Rs150676454,Friedreich's ataxia
FXN,Rs149284013,heterozygote
FXN,Rs149284013,ataxia 
FXN,Rs149284013,Friedreich's 
FXN,Rs149284013,SNP 
FXN,Rs149284013,allele 
FXN,Rs149284013,minor
FXN,Rs149284013,chromosome 
FXN,Rs149284013,gene 
FXN,Rs149284013,mutation 
FXN,Rs148698100,Friedreich's ataxia
FXN,Rs148443992,compound heterozygote
FXN,Rs148443992,Friedreich's ataxia
FXN,Rs148443992,SNP
FXN,Rs148443992,allele
FXN,Rs148443992,FXN gen
FXN,Rs143340609,Friedreich's ataxia
FXN,Rs140987490,Friedreich's ataxia
FXN,Rs142157346,Friedreich's ataxia
FXN,Rs138491271,Friedreich's ataxia
FXN,Rs138446138,Friedreich's ataxia
FXN,Rs138446138,Friedreich's ataxia
FXN,Rs143232208,Friedreich's ataxia
FXN,Rs138034837,Friedreich's ataxia
FXN,Rs138034837,Friedreich's ataxia
FXN,Rs104894107,compound heterozygote
FXN,Rs104894107, Friedreich's ataxia 
FXN,Rs138491271,FXN gene on chromosome 9
FXN,Rs104894107,mutation in the FXN gene on chromosome 9
FXN,Rs104894106,SNP
FXN,Rs104894106,heterozygote
FXN,Rs104894106,Friedreich's ataxia 
FXN,Rs104894106, SNP
FXN,Rs104894106,minor allele
FXN,Rs104894106,chromosome
FXN,Rs104894106,FXN gene
FXN,Rs104894106,mutation
FXN,Rs104894107,Friedreich's ataxia
FXN,Rs138491271,mutation
FXN,Rs138446138,Friedreich's ataxia
FXN,Rs138491271,chromosome
FXN,Rs142157346,Friedreich's ataxia
FXN,Rs142133355,Friedreich's ataxia
FXN,Rs141935559,Friedreich's ataxia
FXN,Rs138491271,gene
FXN,Rs141526971,when inherited in two copies
FXN,Rs141526971,as a compound heterozygote
FXN,Rs141526971,Friedreich's ataxia
FXN,Rs141526971,is a mutation in the FXN gene on chromosome 9
FXN,Rs141526971,Friedreich's ataxia
FXN,Rs141935559,Friedreich's ataxia
FXN,Rs141526971,Friedreich's ataxia
FXN,Rs140987490,Friedreich's ataxia
FXN,Rs140987490,mutation in the FXN gene on chromosome 9
FXN,Rs140510894,Friedreich's ataxia
FXN,Rs140472905,Friedreich's ataxia
FXN,Rs140472905,Friedreich's ataxia
FXN,Rs138837292, Friedreich's ataxia
FXN,Rs138491271,heterozygote
FXN,Rs138491271,Friedreich's ataxia
FXN,Rs141526971,Friedreich's ataxia
FYCO1,Rs7652331,prostate cancer
FYCO1,Rs1545985,prostate cancer
G6PC,Rs80356487,glycogen storage disease type 1a
G6PC,Rs80356487,glycogen storage disease type 1a
G6PC,Rs1801175,OMIM 232200.0002
G6PC,Rs1801175,i3002486
G6PC,Rs1801175,rs1801175(T;T)
G6PC,Rs1801175,Glycogen storage
G6PC,Rs1801175,rs1801175(T)
G6PC,Rs1801175,rs1801175(C)
G6PC,Rs80356487,glycogen storage disease type 1a
G6PC,Rs1801175,G6PC
G6PC,Rs1801175,SNP
G6PC,Rs1801175,Arg83Cys
G6PC,Rs1801175,R83C
G6PC,Rs1801175,rs1801175
G6PC,Rs1801175,severity of the disease
G6PC,Rs1801175,Glycogen storage disease type 1A
G6PC,Rs1801175,Ashkenazi Jews
G6PC,Rs1801175,Glycogen storage disease type 1A
G6PC,I3002486,Glycogen Storage Disease Type 1
G6PC,Rs1801175,glucose-6-phosphatase
G6PD,Rs138687036,Cys
G6PD,Rs138687036,Arg
G6PD,Rs137852334,23
G6PD,Rs137852331,i5008443
G6PD,Rs137852331,i5008443
G6PD,Rs137852330,hemolytic anemia
G6PD,Rs137852330,hemolytic anemia
G6PD,Rs137852330,"hemolytic anemia after a specific trigger, such as aspirin or eating fava beans"
G6PD,Rs137852330,favism
G6PD,Rs1557229572,Gln449His
G6PD,Rs137852330,chronic granuloma
G6PD,Rs137852330,hemolytic anemia
G6PD,Rs137852330,chronic granuloma
G6PD,Rs267606835,hemolytic anemia
G6PD,Rs72554665,G>T
G6PD,Rs267606835,chronic granuloma
G6PD,Rs267606835,hemolytic anemia
G6PD,Rs137852330,favism
G6PD,Rs72554665,variant
G6PD,Rs76723693,The authors suggest that when using Hb1Ac values to diagnose
G6PD,Rs76723693,type-2 diabetes
G6PD,Rs76723693, type-2 diabetes
G6PD,Rs76723693,women
G6PD,Rs76723693,type-2 diabetes
G6PD,Rs76723693,lowering HbA1c values
G6PD,Rs76723693,heterozygous women
G6PD,Rs76723693,hemizygous men
G6PD,Rs76723693,type-2 diabetes
G6PD,Rs267606835,chronic granuloma
G6PD,Rs137852318,mild phenotype
G6PD,Rs76723693,men 
G6PD,Rs137852318,"Overall, while the minor allele is reported to lead to a mild phenotype, for the moment it continues to be reported in ClinVar,"
G6PD,Rs1050828,African ancestry
G6PD,Rs1050828,red blood cells
G6PD,Rs1050828,malarial regions
G6PD,Rs1050828,malarial infection
G6PD,Rs1050828,African Americans
G6PD,Rs1050828,lowering HbA1c values by ~0.88%-units 
G6PD,Rs1050828, Hb1Ac values
G6PD,Rs1050828,type-2 diabetes
G6PD,Rs1050828,eastern Sudan (Hausa and Massalit)
G6PD,Rs1050828, Massalit individuals
G6PD,Rs1050828,malarial infection
G6PD,Rs1050828,Caucasian
G6PD,Rs1050828,African American individuals
G6PD,Rs1050828,"lower red blood cell, hemoglobin and hematocrit counts"
G6PD,Rs1050828,Hb1Ac level
G6PD,Rs1050828,African American medical patients
G6PD,Rs137852315,23andMe 
G6PD,Rs1050828,African Americans 
G6PD,Rs1050829,malarial infection 
G6PD,Rs1050829,malarial infection
G6PD,Rs1050829,G6PD deficiency
G6PD,Rs1050828,"lower red blood cell, hemoglobin and hematocrit counts"
G6PD,Rs1163458456,c.99A
G6PD,Rs137852318,benign
G6PD,Rs1050828,mean corpuscular hemoglobin
G6PD,Rs1050828,mean corpuscular volume
G6PD,Rs1050828,malarial infection
G6PD,Rs1050828,G6PD deficiency
G6PD,Rs1050828,oxidative damage
G6PD,Rs1050828,erythrocyte phenotype
GAB2,Rs7101429, SNP
GAB2,Rs7101429," Alzheimer's disease,"
GAB2,Rs7107174,testicular cancer
GAB2,Rs7107174,testicular cancer
GAB2,Rs7107174,testicular cancer
GAB2,Rs7107174,polygenic risk score
GAB2,Rs7107174,testicular cancer page
GAB2,Rs7107174,testicular cancer
GAB2,Rs7107174,disease.
GAB2,Rs7107174,testicular cancer
GAB2,Rs7101429,Alzheimer's disease
GAB2,Rs7107174,associated with slightly higher risk
GAB2,Rs7107174,risk allele T
GAB2,Rs2373115,Alzheimer's
GAB2,Rs2373115,Alzheimer
GAB2,Rs2373115,Alzheimer's disease
GAB2,Rs2373115, late-onset Alzheimer's disease
GAB2,Rs2373115,Alzheimer's
GAB2,Rs2373115,increased risk for Alzheimer's disease among ApoE4 carriers
GAB2,Rs2373115,odds ratio of 4.06 
GAB2,Rs2373115,risk of Alzheimer's disease
GAB2,Rs2373115,risk (OR 4.1) of late-onset Alzheimer's disease
GAB2,Rs2373115,Alzheimer's risk.
GAB2,Rs10793294,Alzheimer's
GAB2,Rs10793294,alleles modify
GAB2,Rs10793294,Alzheimer's risk
GAB2,Rs2373115,Alzheimer's disease
GABRA1,Rs2279020,Gender-specific contribution
GABRA1,Rs2279020,methamphetamine use disorder
GABRA2,Rs497068,alcohol dependence and with brain oscillations
GABRA2,Rs497068,illicit drug use
GABRA2,Rs497068,smoking
GABRA2,Rs497068,alcohol dependence
GABRA2,Rs497068,alcoholism spectrum disorders
GABRA2,Rs497068,influences behavior
GABRA2,Rs497068,alcoholism spectrum disorders
GABRA2,Rs279871,haplotype
GABRA2,Rs279871,SNP
GABRA2,Rs279871,alleles 
GABRA2,Rs279871,Alcoholism
GABRA2,Rs279871,SNP in the GABRA2
GABRA2,Rs279871,Alcoholism
GABRA2,Rs279844,autism
GABRA2,Rs279845,human 
GABRA2,Rs279845,mouse
GABRA2,Rs279845,Australian population
GABRA2,Rs279844,Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism.
GABRA2,Rs279844,Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism.
GABRA2,Rs279844,autism
GABRA2,Rs279836,haplotype
GABRA2,Rs279836,SNP
GABRA2,Rs279836,alleles 
GABRA2,Rs279836,Alcoholism
GABRA2,Rs279836,SNP in the GABRA2
GABRA2,Rs279836,Alcoholism
GABRA2,Rs497068,human brain oscillations
GABRA2,Rs279858,Alcoholism
GABRA2,Rs497068,"alcohol dependence, smoking, and illicit drug use"
GABRA4,Rs2280073,autism
GABRA4,Rs2280073,autism
GABRB1,Rs2351299,autism
GABRB1,Rs2351299,autism
GABRB1,Rs728293,enables expanded screening for allelic imbalance in plasma
GABRB1,Rs728293,severe mental retardation
GABRB1,Rs728293,cataract
GABRB1,Rs728293,coloboma
GABRB1,Rs728293,kyphosis 
GABRB1,Rs728293,maps to the pericentromeric region of chromosome 4
GABRD,Rs142619552,frequently mutated in melanoma
GABRD,Rs142619552,Exome sequencing
GABRD,Rs142619552,GRIN2A
GAD1,Rs3791850,African Americans
GAD1,Rs3791850,Heroin addiction
GAD1,Rs3791850,African Americans
GAD1,Rs3791850,"anxiety disorders, major depression, and neuroticism"
GAD1,Rs3791850,glutamate decarboxylase genes
GAD1,Rs3791850,at-onset of alcohol dependence
GAD1,Rs3791850,Study of Alcohol Dependence. Heroin addiction in African Americans:
GAD1,Rs3791850,anxiety disorders
GAD1,Rs3791850,major depression
GAD1,Rs3791850,neuroticism
GAD1,Rs3791851, glutamic acid decarboxylase genes
GAD1,Rs3791878,implicated in schizophrenia
GAD1,Rs3791851,major depression
GAD1,Rs3791851,neuroticism
GAD1,Rs3791878,schizophrenia
GAD1,Rs3791850,Alcohol Dependence
GAD1,Rs3791878,schizophrenia
GAD1,Rs769407, glutamic acid decarboxylase genes
GAD1,Rs769407,anxiety disorders
GAD1,Rs769407,major depression
GAD1,Rs769407,neuroticism
GAD1,Rs3791851,anxiety disorders
GAD1,Rs3791850,alcohol dependence
GAD1,Rs3791850,neuroticism
GAD1,Rs3791850,major depression
GAD1,Rs11542313,heroin dependence.
GAD1,Rs11542313,Polymorphisms in the glutamate decarboxylase 1 gene
GAD1,Rs12185692, glutamic acid decarboxylase genes
GAD1,Rs12185692,anxiety disorders
GAD1,Rs12185692,major depression
GAD1,Rs12185692,neuroticism
GAD1,Rs1978340,alcohol dependence
GAD1,Rs1978340,heroin dependence.
GAD1,Rs3791850,neuroticism
GAD1,Rs2058725,anxiety disorders
GAD1,Rs2058725, glutamic acid decarboxylase genes
GAD1,Rs2058725,neuroticism
GAD1,Rs2241165, glutamic acid decarboxylase genes
GAD1,Rs2241165,anxiety disorders
GAD1,Rs2241165,major depression
GAD1,Rs2241165,neuroticism
GAD1,Rs3791850,glutamic acid decarboxylase genes
GAD1,Rs3791850,anxiety disorders
GAD1,Rs3791850,major depression
GAD1,Rs3791850,anxiety disorders
GAD1,Rs2058725,major depression
GAD2,Rs1805398,neuroticism
GAD2,Rs1805398, glutamic acid decarboxylase genes
GAD2,Rs1805398,anxiety disorders
GAD2,Rs1805398,major depression
GADL1,Rs201973599,bipolar disorder
GADL1,Rs201973599,lithium treatment
GADL1,Rs201973599,bipolar disorder
GALC,Rs387906955,Krabbe disease
GALC,Rs387906955,a compound heterozygote
GALC,Rs398123175,Krabbe disease
GALC,Rs398123175,Krabbe disease
GALC,Rs398123177,Krabbe disease
GALC,Rs398123177,Krabbe disease
GALC,Rs398123177,Krabbe disease
GALC,Rs748573754,Krabbe 
GALC,Rs748573754,disease 
GALC,Rs748573754,Krabbe disease
GALC,Rs748573754,"c.1657G>A, p.Gly553ArgIdentified in ClinVar as likely pathogenic for Krabbe disease (when inherited in two copies or as a compound heterozygote)"
GALC,Rs748573754,pathogenic
GALC,Rs748573754,Krabbe disease
GALC,Rs752537626,pathogenic
GALC,Rs748573754,heterozygote
GALC,Rs748573754,inherited in two copies
GALC,Rs748573754,compound heterozygote
GALC,Rs749893889,Krabbe disease
GALC,Rs749893889,Krabbe disease
GALC,Rs750524447,Krabbe disease
GALC,Rs750524447,Krabbe disease
GALC,Rs750524447,compound heterozygote
GALC,Rs750524447,pathogenic/pathogenic
GALC,Rs752537626,Krabbe disease
GALC,Rs752537626,Krabbe disease
GALC,Rs752537626,inherited 
GALC,Rs752537626,heterozygote
GALC,Rs387906955,pathogenic
GALC,Rs748573754,Krabbe disease 
GALC,Rs387906955,Krabbe disease
GALC,Rs121908010,Krabbe disease
GALC,Rs387906954,as a compound heterozygote
GALC,Rs752537626,pathogenic for Krabbe disease
GALC,Rs121908010,Krabbe disease
GALC,Rs121908010,inherited
GALC,Rs121908010,heterozygote
GALC,Rs147313927,Krabbe disease
GALC,Rs147313927,Krabbe disease
GALC,Rs147313927,heterozygote
GALC,Rs147313927,Krabbe disease
GALC,Rs147313927,compound heterozygote
GALC,Rs147313927,inherited recessivel
GALC,Rs199847983,likely pathogenic/pathogenic for Krabbe disease
GALC,Rs199847983,inherited in two copies or as a compound heterozygote
GALC,Rs200378205,Krabbe disease
GALC,Rs374635469,Krabbe disease
GALC,Rs374635469,pathogenic
GALC,Rs374635469,probably pathogenic
GALC,Rs374635469,Krabbe disease
GALC,Rs374635469,Krabbe disease
GALC,Rs374635469,Krabbe disease
GALC,Rs374635469,Krabbe disease
GALC,Rs374635469,"probably pathogenic"""
GALC,Rs387906952,Krabbe disease
GALC,Rs387906952,Krabbe disease
GALC,Rs387906954,Krabbe disease
GALC,Rs387906954, compound heterozygote
GALC,Rs387906954,Krabbe disease
GALC,Rs387906954,compound heterozygote
GALC,Rs387906954,Krabbe disease
GALC,Rs387906954,Krabbe disease
GALC,Rs387906955,Krabbe disease
GALNT3,Rs16851009,Parkinson disease
GALNT3,Rs16851009,Parkinson disease
GALNT3,Rs16851009,single-nucleotide polymorphisms implicated in Parkinson disease
GALNT3,Rs16851009,Parkinson's disease
GALNT3,Rs16851009,single-nucleotide polymorphisms
GALNT3,Rs16851009,Parkinson disease
GALNT3,Rs16851009,PARK10
GALNT3,Rs16851009,Parkinson disease
GALNT3,Rs16851009,Parkinson disease 
GALNT3,Rs16851009,Parkinson's disease
GALT,Rs75391579,rs75391579(G)
GALT,Rs75391579,galactosemia
GALT,Rs2070074,Galactosemia
GALT,Rs2070074,galactosemia
GALT,Rs111033647,pathogenic 
GALT,Rs111033640,ages 6-12
GALT,Rs111033640,heterozygotes
GALT,Rs111033640,infants 
GALT,Rs111033640,neutral polymorphism
GALT,Rs111033640,Duarte galactosemia
GALT,Rs111033640,Duarte galactosemia
GAMT,Rs80338736,Guanidinoacetate methyltransferase deficiency
GAMT,Rs80338736,inborn error of creatine metabolism in man
GAMT,Rs80338736,Guanidinoacetate methyltransferase deficiency
GAMT,Rs80338736,Guanidinoacetate methyltransferase deficiency
GAMT,Rs80338736,man.
GAMT,Rs80338736,Guanidinoacetate methyltransferase deficiency
GAMT,Rs55776826,chromosome
GAMT,Rs80338736,Guanidinoacetate methyltransferase deficiency
GAMT,Rs55776826,benign polymorphism
GAMT,Rs55776826,guanidinoacetate N-methyltransferase
GAMT,Rs55776826,intron
GAMT,Rs55776826,G>A
GAMT,Rs80338736,error of creatine metabolism
GATA3,Rs570613,breast cancer
GATA3,Rs570613,Breast Cancer
GATA3,Rs570613,breast cancer
GATA3,Rs570613,Cancer 
GATA3,Rs570613,rs570613 is associated with
GATA3,Rs570613,breast cancer
GATA4,Rs104894073,septal 
GATA4,Rs104894073,defect
GATA4,Rs104894073,atrial 
GATA4,Rs104894073,mutation 
GATA4,Rs104894073,gene
GATA4,Rs104894073,dominant 
GATA4,Rs104894073,autosomal
GATA4,Rs104894073,allele 
GBA,Rs364897,type I Gaucher disease
GBA,Rs421016,L444P 
GBA,Rs421016,Leu444Pro
GBA,Rs421016,amino acid change in the GBA gene
GBA,Rs421016,Gaucher disease 
GBA,Rs421016,Gaucher disease
GBA,Rs421016,"type I, II, or III Gaucher disease"
GBA,Rs421016,Parkinson's
GBA,Rs421016,Parkinson's disease 
GBA,Rs421016,Gaucher disease 
GBA,Rs421016,Gaucher disease 
GBA,Rs421016,Gaucher patients 
GBA,Rs421016,Gaucher's disease
GBA,Rs76763715,Gaucher disease
GBA,Rs76763715,neurological symptoms
GBA,Rs76763715,mild symptoms
GBA,Rs76763715,Gaucher's disease Type I
GBA,Rs76763715,"""non-neuropathic"" type"
GBA,Rs76763715,neurological symptoms
GBA,Rs80356769,a chemical cleavage and GC-clamped denaturing gradient gel electropho
GBA,Rs80356769,ucosid
GBA,Rs80356769,Gaucher disease
GBA,Rs80356769,"mutation is found in about 1 out of 1,000 Ashkenazi Jews"
GBA,Rs80356769,Gaucher disease
GBA,Rs80356769,mutations in exon 9 of the human acid beta-glucosidase gene.
GBA,Rs364897,Gaucher's Disease
GBA,Rs76763715,type 1 Gaucher disease
GBA,Rs2230288,Parkinson's disease.
GBA,Rs2230288,synucleinopathies
GBA,Rs2230288,Gaucher disease.
GBA,I4000386,Gaucher's disease
GBA,I4000386, Gaucher's disease
GBA,I4000386,R496H
GBA,I4000386,isk genotype AA
GBA,I4000386,Gaucher's disease
GBA,I4000417,genotype 
GBA,I4000417,GG
GBA,I4000417,Gaucher's 
GBA,I4000417,disease
GBA,I4000417,SNP 
GBA,I4000419,Gaucher's disease
GBA,I4000419,Gaucher Disease
GBA,I4000419,Gaucher's disease
GBA,I4000419,Gaucher's disease
GBA,I4000419,Gaucher's disease
GBA,I4000419,Gaucher Disease
GBA,Rs104886460,Gaucher's disease
GBA,Rs104886460,Gaucher Type I
GBA,Rs104886460,Type II disease
GBA,Rs104886460,Gaucher Type I disease
GBA,Rs2230288,Gaucher disease
GBA,Rs2230288,polymorphism
GBA,Rs2230288,"""modifier"" variant"
GBA,Rs2230288,rapid eye movement sleep behavior disorder (RBD)
GBA,Rs2230288,Parkinson's disease
GBA,I4000419,Gaucher's disease
GBA,Rs2230288,rapid eye movement sleep behavior disorder (RBD)
GC,Rs4752,dihydroxyvitamin 
GC,Rs7041,COPD
GC,Rs7041,chronic obstructive pulmonary disease
GC,Rs4752,prostate cancer
GC,Rs2282679,vitamin D serum concentrations
GC,Rs2282679,vitamin D insufficiency
GC,Rs17467825,obesity-related traits
GC,Rs4752,Asthma
GCDH,Rs121434369,glutaric acidemia
GCDH,Rs121434369,Caucasians
GCDH,Rs121434369,glutaric acidemia I disease
GCDH,Rs121434367,Amish GA1 mutation
GCDH,Rs121434369,glutaric acidemia I
GCDH,Rs11085825,minor allele homozygote
GCDH,Rs11085825,"lutaric aciduria, type 1"
GCDH,Rs11085825,minor allele homozygote
GCDH,Rs11085825,minor allele homozygote
GCH1,Rs8007201,higher tolerance to pain
GCH1,Rs7142517,pain sensitivity
GCH1,Rs7142517,body mass index and waist circumference
GCH1,Rs752688,capsaicin pain
GCH1,Rs998259,Lumbar Degenerative Disc Disease
GCH1,Rs752688,Polymorphisms
GCH1,Rs8007201,cyclohydrolase
GCH1,Rs8007201,tetrahydrobiopterin
GCH1,Rs8007201,higher tolerance to pain
GCH1,Rs8007201,GTP cyclohydrolase and tetrahydrobiopterin
GCH1,Rs8007201,regulate pain sensitivity and persistence
GCH1,Rs8007201,associated with higher tolerance to pain.
GCH1,Rs8007201,G allele associated with higher tolerance to pain.
GCH1,Rs8007201,GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence
GCH1,Rs8007201,pain sensitivity and persistence
GCH1,Rs8007201,higher tolerance to pain
GCH1,Rs886039379,autosomal dominant dopa-responsive dystonia
GCH1,Rs7142517,Lumbar Degenerative Disc Disease
GCH1,Rs8007201,cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence
GCH1,Rs7142517,Lumbar Degenerative Disc Disease
GCH1,Rs4411417,higher tolerance to pain
GCH1,Rs4411417,capsaicin pain
GCH1,Rs4411417,tolerance to pain
GCH1,Rs10483639,coronary artery disease
GCH1,Rs11158026,Parkinson's disease
GCH1,Rs11158026,Parkinson's disease
GCH1,Rs11158026,border of being considered statistically non-significant
GCH1,Rs11158026,Parkinson's disease
GCH1,Rs17738966,Vasoocclusive Pain
GCH1,Rs17738966,Impaired Vascular Function in Sickle Cell Anemia
GCH1,Rs11158026,allele carriers
GCH1,Rs17738966,Impaired Vascular Function
GCH1,Rs17738966,Susceptibility to Vasoocclusive Pain
GCH1,Rs2878172,Sickle Cell Anemia
GCH1,Rs2878172,Impaired Vascular Function
GCH1,Rs2878172,Susceptibility to Vasoocclusive Pain
GCH1,Rs4411417,Polymorphisms
GCH1,Rs2878172,Vasoocclusive Pain
GCH1,Rs17738966,Sickle Cell Anemia
GCH1,Rs2878172,Impaired Vascular Function in Sickle Cell Anemia
GCHFR,Rs7164342,response to SSRI antidepressants.
GCHFR,Rs7164342,A polymorphism of the GTP-cyclohydrolase I feedback regulator gene alters transcriptional activity and may affect response to SSRI antidepressants.
GCHFR,Rs7164342,response to SSRI antidepressants.
GCHFR,Rs7164342,GTP-cyclohydrolase
GCHFR,Rs7164342,antidepressants
GCHFR,Rs7164342,response to SSRI antidepressants
GCHFR,Rs7164342,polymorphism
GCHFR,Rs7164342,transcriptional activity
GCHFR,Rs7164342,alters transcriptional activity
GCHFR,Rs7163862,response to SSRI antidepressants.
GCHFR,Rs7163862,alters transcriptional activity
GCHFR,Rs7163862,GTP-cyclohydrolase
GCHFR,Rs7163862,antidepressants
GCHFR,Rs7163862,response to SSRI antidepressants
GCHFR,Rs7163862,polymorphism
GCHFR,Rs7163862,A polymorphism of the GTP-cyclohydrolase I feedback regulator gene alters transcriptional activity and may affect response to SSRI antidepressants.
GCHFR,Rs7163862,response to SSRI antidepressants.
GCHFR,Rs7163862,transcriptional activity
GDF2,Rs35129734,T 
GEMIN4,Rs7813,nucleotide polymorphisms
GEMIN4,Rs7813,schizophrenia 
GEMIN4,Rs7813,esophageal cancer
GEMIN4,Rs7813,renal cell carcinoma
GEMIN4,Rs3744741,Single nucleotide polymorphisms of microRNA machinery genes
GEMIN4,Rs3744741,esophageal cancer
GEMIN4,Rs3744741,renal cell carcinoma.
GEMIN4,Rs3744741,Genetic variations in microRNA-related genes 
GFAP,Rs2289681,Polymorphisms at Splicing Regulatory Sites
GFAP,Rs2289681,Neurodegenerative Disease-Related Genes
GGH,Rs11545078,gamma-glutamyl hydrolase activity
GGH,Rs719235,gamma-glutamyl hydrolase activity
GGH,Rs719235,Epigenetic regulation
GGH,Rs719235,acute lymphoblastic leukemia cells
GGH,Rs719235,lymphoblastic leukemia
GGH,Rs11545078,Epigenetic regulation
GGH,Rs11545076,lymphoblastic leukemia
GGH,Rs11545078,lymphoblastic leukemia
GGH,Rs11545076,single nucleotide polymorphisms
GGH,Rs11545076,acute lymphoblastic leukemia cells
GGH,Rs11545076,human gamma-glutamyl hydrolase activity
GGH,Rs11545076,Epigenetic regulatio
GGH,Rs11545078,acute lymphoblastic leukemia cells
GHR,Rs6873545,presence or absence
GHR,Rs6873545,more common
GHR,Rs6873545,less common
GHRL,Rs27647,ghrelin
GHRL,Rs27647,ype 2 diabetes
GHRL,Rs27647,ith obesity.
GHRL,Rs27647,obesity
GHRL,Rs27647,ghrelin receptor gene polymorphisms
GHRL,Rs27647,adiposity
GHRL,Rs26802,metabolic syndrome
GHRL,Rs27647,ghrelin
GHRL,Rs26802,African-American male birth weight.
GHRL,Rs26802,HDL cholesterol levels
GHRL,Rs26802,risk of type 2 diabetes mellitus
GHRL,Rs27647,type 2 diabetes
GJB2,Rs28931594,keratitis-ichthyosis-deafness syndrome
GJB2,Rs28931594,deafness
GJB2,Rs28931594,keratitis-ichthyosis-deafness syndrome
GJB2,Rs28931595,deafness
GJB2,Rs28931595,deafness
GJB2,Rs35887622,mild hearing impairment
GJB2,Rs35887622,relatively late onset and progression
GJB2,Rs35887622,non-syndromic sensorineural deafness 
GJB2,Rs35887622,hearing loss
GJB2,Rs35887622,hearing loss
GJB2,Rs35887622,deafness
GJB2,Rs28931594,deafness
GJB2,Rs28931592,deafness
GJB2,Rs80338947,hereditary hearing loss
GJB2,Rs28931592,deafness
GJB2,Rs104894404,nonsyndromic hearing loss and deafness or keratoderma palmoplantar deafness
GJB2,I6011479,1048
GJB2,I6011476,GJB2 gene varia
GJB2,I6011476,deafness
GJB2,I6011465,deafness
GJB2,I6011465,deafness
GJB2,I6011464,associated with deafness
GJB2,I6011458,gene variant associated with deafness
GJB2,I6011458,recessive
GJB2,I6011458,associated with deafness
GJB2,Rs28931593,deafness
GJB2,Rs35887622,deafness
GJB2,Rs35887622,mild-moderate non-syndromic sensorineural hearing loss
GJB2,Rs35887622,hearing loss
GJB2,I6011452,recessive
GJB2,Rs80338943,deafness
GJB2,Rs80338943,Chinese deaf population
GJB2,Rs80338943,hearing loss
GJB2,Rs80338943,Japanese
GJB2,Rs80338943,childhood deafness
GJB2,Rs80338943,narcotic dependence
GJB2,Rs80338943,nursing
GJB2,Rs80338943,pain
GJB2,Rs80338943,Nursing
GJB2,Rs80338943,Asian
GJB2,Rs80338943,deafness
GJB2,Rs80338943,"Reevaluation of nursing concession to the patient's request, resulting in the development of narcotic dependence."
GJB2,Rs80338943,non-syndromic deafness
GJB2,Rs80338942,"Known as 167delT, this is the most common nonsyndromic recessive deafness-associated SNP in Ashkenazi Jewish populations"
GJB2,Rs80338939,autosomal recessive nonsyndromic hearing loss
GJB2,Rs767178508,deafness
GJB2,Rs72561723,keratitis-ichthyosis-deafness syndrome.
GJB2,Rs72561723,deafness
GJB2,Rs72561723, keratitis-ichthyosis-deafness syndrome.
GJB2,Rs72561723,deafness 
GJB2,Rs72561723,recessive and dominant
GJB2,Rs72561723,keratitis-ichthyosis-deafness syndrome
GJB2,Rs72561723,deafness
GJB2,Rs35887622,hearing impairment
GJB2,Rs35887622,Autosomal recessive nonsyndromic neurosensory deafness 
GJB2,I6011452,deafness
GJB2,Rs28931593,deafness
GJB2,I6011452,recessive GJB2 gene variant associated with deafness
GJB2,I5012709,associated with deafness
GJB2,I5012707,deafness
GJB2,I5012698,gene variant associated with deafness
GJB2,I5012698,associated with deafness
GJB2,I5012698,deafness
GJB2,I5012697,recessive GJB2 gene variant
GJB2,I5012697,deafness
GJB2,I5012697,deafness
GJB2,I5004479,deafness
GJB2,I5004479,recessive GJB2 gene variant
GJB2,I5004479,gene variant associated with deafness
GJB2,I5002003,GJB2 gene varia
GJB2,I5002003,deafness
GJB2,I5002002,recessive GJB2 gene variant associated with deafness
GJB2,I5002002,recessive GJB2 gene variant associated with deafness
GJB2,I5002002,gene variant associated with deafness
GJB2,I5002002,recessive
GJB2,I5002002,deaf
GJB2,I5002001,deafness
GJB2,I5001996,deafness
GJB2,I5001987,1048
GJB2,I4000435,Hearing loss
GJB2,I4000434,Connexin
GJB2,I4000434,Nonsyndromic Sensorineural
GJB2,I6011452,gene variant
GJB2,I5012709,associated with deafness
GJB2,I6011292,gene variant associated with deafness
GJB2,I5012709,gene variant associated with deafness
GJB2,I6011293,recessive
GJB2,I6011452,deafness
GJB2,I6011417,deafness
GJB2,I6011385,deafness
GJB2,I6011385,recessive GJB2 gene variant associated with deafness
GJB2,I6011369,GJB2 gene variant associated with deafness
GJB2,I6011369,recessive
GJB2,I6011369,recessive GJB2 gene variant
GJB2,I6011369,deafness
GJB2,I6011363,deafness
GJB2,I6011292,recessive GJB2 gene variant associated with deafness
GJB2,I6011362,recessive GJB2 gene variant associated with deafness
GJB2,I6011362,deafness
GJB2,I6011362,gene variant associated with deafness
GJB2,I6011362,recessive GJB2 gene variant associated with deafness
GJB2,I6011319,recessive 
GJB2,I6011293,deafness
GJB2,I6011319,deafness
GJB2,I6011302,deafness
GJB2,I6011302,recessive GJB2 gene
GJB2,I6011302,associated with deafness
GJB2,I6011302,deafness
GJB2,I6011309,deafness
GJB2,I6011309,recessive GJB2 gene variant
GJB2,I6011319,deafness
GJB2,I6011319,recessive GJB2 gene variant
GJB2,I6011303,recessive GJB2 gene variant associated with deafness
GLA,Rs28935490,fabry disease
GLA,Rs28935490,mental retardation.
GLA,Rs28935490,hypertrophic cardiomyopathy.
GLA,Rs28935490,hypertrophic cardiomyopathy
GLA,Rs28935490,fabry disease
GLA,Rs28935490,mental retardation.
GLA,Rs28935490,hypertrophic cardiomyopathy.
GLA,Rs28935490,mental retardation
GLA,Rs28935490,fabry disease
GLA,Rs28935490,fabry disease
GLA,Rs199473684,Fabry disease.
GLA,Rs199473684,Fabry disease
GLA,Rs199473684,Fabry disease
GLA,Rs28935490,hypertrophic cardiomyopathy
GLA,Rs28935197,hypertrophic cardiomyopathy
GLA,Rs28935197,HCM
GLA,Rs28935197,pathogenic
GLB1,Rs72555391,Mucopolysaccharidosis type IVB
GLB1,Rs72555391,causative allele
GLB1,Rs72555391,defective alleles
GLB1,Rs72555367,linked to deficiency in the 67-kD spliced variant of beta-galactosidase
GLB1,Rs72555367,infantile GM1-gangliosidosis
GLB1,Rs72555367,Morquio B disease
GLB1,Rs72555366,American patients
GLB1,Rs72555391,Mucopolysaccharidosis type I
GLB1,Rs72555366,acid beta-galactosidase
GLB1,Rs72555366,GM1-gangliosidosis
GLB1,Rs72555366,Mutations
GLB1,Rs72555366,cause GM1-gangliosidosis
GLB1,Rs72555391,galactosidase
GLB1,Rs72555366,Mutations in acid beta-galactosidase cause GM1-gangliosidosis in American patients.
GLB1,Rs72555366,Mutations
GLB1,Rs72555366,American patients.
GLCCI1,Rs37973,asthma
GLCCI1,Rs37973,bronchial asthma 
GLCCI1,Rs37973,pulmonary function
GLCCI1,Rs37973,forced expiratory volume
GLCCI1,Rs37973,asthma
GLCCI1,Rs37973,asthmatics corticosteroid treatment
GLCCI1,Rs37973,bronchial asthma
GLCCI1,Rs37973,inflammation
GLCCI1,Rs37973,asthma
GLCCI1,Rs37973,inflammatory cells apoptosis
GLDC,Rs121964980,23andMe
GLDC,Rs121964979,Ala389Val
GLDC,I5007987,Non-ketotic hyperglycinemia
GLDC,I5007987,ketotic hyperglycinemia
GLDC,I5007987,hyperglycinemia
GLDC,I5007986,Non-ketotic
GLDC,I5007986,hyperglycinemia
GLDC,I5007984,Non-ketotic hyperglycinemia
GLDC,I5007986,hyperglycinemia
GLDC,I5007985,hyperglycinemia
GLDC,I5007984,Non-ketotic hyperglycinemia
GLIS3,Rs1574285,type-1 diabetes
GLIS3,Rs1574285,type-1 diabetes
GLIS3,Rs1574285,type-1 diabetes
GLT8D1,Rs6976,osteoarthritis
GLT8D1,Rs6976,Levels of nucleostemin were raised in chondrocytes
GLT8D1,Rs6976,"with osteoarthritis in functional studies."""
GLT8D1,Rs6976,missense polymorphism within the nucleostemin-encoding
GMPR,Rs1042391,guanosine monophosphate reductase
GMPR,Rs1042391,Identification of common variant alleles of the human guanosine monophosphate reductase gene.
GMPR,Rs1042391,guanosine monophosphate
GNAO1,Rs1114167431,pathogenic
GNAO1,Rs1114167431,pathogenic
GNB3,Rs4963516,alt sensitivity of blood pressure.
GNB3,Rs4963516,beta-polypeptide 3 genes
GNB3,Rs4963516,guanine
GNB3,Rs4963516,alpha-adducin
GNPTAB,Rs137853823,stuttering 
GNPTAB,Rs137853823,stuttering 
GNPTAB,Rs137853823,Female 
GNPTAB,Rs137853823,stutterers 
GNPTAB,Rs137853824,stuttering
GNPTAB,Rs137853824,GNPTAB gene
GNPTAB,Rs137853825,stuttering
GNPTG,Rs137853826,stuttering
GNPTG,Rs137853826,Ala25Glu 
GNPTG,Rs137853826,A25E
GNPTG,Rs137853826,TSR3 gene
GNPTG,Rs137853826,rs137853826 
GNPTG,Rs137853826,GNPTG 
GNPTG,Rs137853826,stuttering 
GNPTG,Rs137853826,stuttering
GOLM1,Rs7019241,Alzheimer's disease
GOLM1,Rs7019241,Alzheimer's disease
GOLM1,Rs10868366,Alzheimer's disease
GOLM1,Rs10868366,Alzheimer's disease
GOLM1,Rs10868366,Alzheimer's disease
GOLM1,Rs10868366,Alzheimer's disease
GPHN,Rs776038451,PIGH
GPHN,Rs776038451,Ser103Pro
GPHN,Rs776038451,OMIM pathogenic variant
GPX1,Rs1050450,disabling osteoarthropathy
GPX1,Rs1050450,Kashin-Beck disease
GPX1,Rs1050450,osteoarthritis
GPX1,Rs1050450,degenerative osteoarthropathy
GPX1,Rs1050450,osteoarthritis
GPX1,Rs1050450,prostate cancer
GPX1,Rs1050450,asthma
GPX1,Rs1050450,lung cancer
GPX1,Rs1050450,breast cancer
GPX1,Rs1050450,schizophrenia
GPX1,Rs1050450,adult brain tumors
GPX1,Rs1050450,medulloblastoma
GPX1,Rs1050450,breast cancer risk
GPX1,Rs1050450,early onset lung cancer
GPX1,Rs1050450,type 2 diabetes
GPX1,Rs1050450,breast cancer
GPX1,Rs1050450,breast cancer
GPX1,Rs1050450,adult brain tumors
GPX1,Rs1050450,oldest old
GPX1,Rs1050450,schizophrenia
GPX1,Rs1050450,breast cancer
GPX1,Rs1050450,healthy humans
GPX1,Rs1050450,prostate cancer risk
GPX1,Rs1050450,European men
GPX1,Rs1050450,men
GPX1,Rs1050450,Auckland
GPX1,Rs1050450,New Zealand
GPX1,Rs1050450,coronary artery calcification
GPX1,Rs1050450,lung cancer
GPX1,Rs1050450,breast cancer
GPX1,Rs1050450,adult brain tumors
GPX1,Rs1050450,Kashin-Beck disease (KBD)
GPX1,Rs1050450,degenerative osteoarthropathy
GPX1,Rs1050450,KBD 
GPX1,Rs1050450,osteoarthritis
GPX1,Rs1050450,Kashin-Beck disease (KBD) is a disabling osteoarthropathy
GPX1,Rs1050450,KBD
GPX1,Rs1050450,lung cancer
GPX1,Rs1050450,breast cancer risk
GPX1,Rs1050450,coronary artery calcification in type 2 diabetes
GPX1,Rs1050450,early onset lung cancer
GPX1,Rs1050450,breast cancer
GPX1,Rs1050450,coronary artery calcification in type 2 diabetes
GPX1,Rs1050450,schizophrenia
GPX1,Rs1050450,breast cancer
GPX1,Rs1050450,prostate cancer
GPX1,Rs1050450,tumor susceptibility
GPX1,Rs1050450,medulloblastoma 
GPX1,Rs1050450,Childhood Cancer Survivor Study
GPX1,Rs1050450,osteoarthritis
GPX1,Rs1050450,Kashin-Beck disease (KBD)
GPX1,Rs1050450,degenerative osteoarthropathy
GPX1,Rs1050450,osteoarthritis
GPX1,Rs1050450,Kashin-Beck disease (KBD)
GPX1,Rs1050450,osteoarthropathy
GPX1,Rs1050450,KBD
GPX1,Rs1050450,KBD
GPX1,Rs1050450,lung cancer
GPX1,Rs1050450,osteoarthritis
GPX4,Rs757228,SNP
GRHPR,Rs80356708,defective allele
GRHPR,Rs80356708,Primary hyperoxaluria type 2
GRHPR,Rs80356708,hydroxypyruvate reductase (GRHPR)
GRHPR,Rs80356708,primary hyperoxaluria type 2.
GRHPR,Rs80356708,glyoxylate reductase (GRHPR) gene 
GRHPR,Rs80356708,primary hyperoxaluria type 2
GRHPR,Rs80356708,primary hyperoxaluria type II
GRHPR,Rs80356708,GRHPR gene
GRHPR,I5012628,Primary hyperoxaluria
GRHPR,Rs80356708,primary hyperoxaluria type II.
GRHPR,Rs80356708,Northern Europeans
GRHPR,Rs80356708,Primary hyperoxaluria type 
GRHPR,I5012628,Primary hyperoxaluria type 2
GRHPR,I5012628,SNP
GRHPR,Rs80356708,glyoxylate reductase/hydroxypyruvate reductase GRHPR gene
GRID1,Rs2814331,scalp 
GRID1,Rs2814331,hair 
GRID1,Rs2814331,facial and scalp hair features
GRID1,Rs2814331,Latin Americans
GRIK1,Rs726002,breast cancer
GRIK1,Rs2832407,non-carriers
GRIK1,Rs2832407,heavy drinking
GRIK1,Rs2832407,rs2832407(C;C) individuals
GRIK1,Rs2832407,alcoholism
GRIK1,Rs2832407,alcoholism
GRIK1,Rs2832407,alcoholism
GRIK1,Rs2832407,patients
GRIN1,Rs11146020,schizophrenia
GRIN1,Rs771610568,pathogenic variant
GRIN1,Rs771610568,pathogenic variant
GRIN1,Rs771610568,pathogenic variant
GRIN1,Rs771610568,pathogenic variant
GRIN2B,Rs3764028,differences in genotype between the North Chinese sporadic Alzheimer's patients 
GRIN2B,Rs7301328,treatment-refractory schizophrenia
GRIN2B,Rs3764028,decreased transcriptional activity
GRIN2B,Rs7301328, impulsive control
GRIN2B,Rs7301328,alcoholism
GRIN2B,Rs7301328,lithium response
GRIN2B,Rs7301328,bipolar disorder
GRIN2B,Rs3764028,reporter 
GRIN2B,Rs7301328,related behaviorsno assoc. 
GRIN2B,Rs3764028,rs3764028 
GRIN2B,Rs1805502,Alzheimer's disease
GRIN2B,Rs1805502,neurodegeneration
GRIN2B,Rs1805502,Chinese Han Population.
GRIN2B,Rs1805502,bipolar disorder
GRIN2B,Rs1805502,obsessive-compulsive disorder
GRIN2B,Rs1805502,Positive association between GRIN2B gene and bipolar disorder in the Chinese Han Population.
GRIN2B,Rs1805502,relevance to neurodegeneration in Alzheimer's disease
GRIN2B,Rs1805502,gene with Korean alcoholism
GRIN2B,Rs1805502,Alzheimer's disease
GRIN2B,Rs1805502,anterior cingulate glutamatergic concentration
GRIN2B,Rs3764028,transcriptional 
GRM3,Rs6465084,schizophrenia
GRM3,Rs6465084,schizophrenia
GRM3,Rs2228595,schizophrenia
GRM3,Rs13242038,schizophrenia
GRM3,Rs13242038,association 
GRM3,Rs13242038,schizophrenia
GRM3,Rs13242038,polymorphisms in GRM3 
GRN,Rs9897526,European populations
GRN,Rs63751294,frontotemporal dementia
GRN,Rs63751294,primary progressive aphasia
GRN,Rs63751294,progranulin haploinsufficiency
GRN,Rs63751294,frontotemporal dementia
GRN,Rs794729669,frontotemporal dementia
GRN,Rs794729669,frontotemporal dementia
GRN,Rs794729671, rs794729671(T) allele is reported
GRN,Rs63751243,ubiquitin-positive frontotemporal lobar degeneration.
GRN,Rs794729672,frontotemporal
GRN,Rs794729672,dementia
GRN,Rs794729672,frontotemporal dementia
GRN,Rs794729672,rare mutation in the GRN gene on chromosome 17
GRN,Rs794729672, frontotemporal dementia
GRN,Rs850713,Associated with risk of amyotrophic lateral sclerosis
GRN,Rs850713,European populations
GRN,Rs9897526,Associated with risk of amyotrophic lateral sclerosis
GRN,Rs794729671,as a dominant mutation pathogenic for frontotemporal dementia.
GRN,Rs63751243,"exhibit aphasia,"
GRN,Rs606231221,ClinVar
GRN,Rs63751243,extrapyramidal features
GRN,Rs63751243,amyotrophic lateral sclerosis.
GRN,Rs193026789,frontotemporal dementia.
GRN,Rs34424835,Associated with risk of amyotrophic lateral sclerosis
GRN,Rs34424835,European populations
GRN,Rs606231220,frontotemporal 
GRN,Rs606231220,frontotemporal dementia
GRN,Rs606231221,ominant mutation pathogenic
GRN,Rs606231221,frontotemporal dementia
GRN,Rs606231220,dominant mutation pathogenic
GRN,Rs606231221,chromosome 17
GRN,Rs63751243,ubiquitin-positive frontotemporal lobar degeneration
GRN,Rs63751243,amyotrophic lateral sclerosis
GRN,Rs63751243,aphasia
GRN,Rs63751243,extrapyramidal features
GRN,Rs63751243,"rs63751243, also known as c.26C>A, p.Ala9Asp and A9D, represents a relatively rare mutation in the GRN gene on chromosome 17. OMIM reports the rs63751243(A) allele as representing a dominantly inherited mutation associated with ubiquitin-positive frontotemporal lobar "
GRN,Rs63751243,"rs63751243, also known as c.26C>A, p.Ala9Asp and A9D, represents a relatively rare mutation in the GRN gene on chromosome 17. OMIM reports the rs63751243(A) allele as representing a dominantly inherited mutation associated with ubiquitin-positive frontotemporal loba"
GRN,Rs606231221,GRN gene
GSK3B,Rs6438552,Parkinson's disease
GSK3B,Rs6779828,schizophrenia
GSK3B,Rs6779828,association with schizophrenia
GSK3B,Rs6438552,may influence brain structure
GSK3B,Rs6438552,brain structure
GSK3B,Rs4072520,association with schizophrenia
GSK3B,Rs4072520,schizophrenia
GSK3B,Rs13321783,Chinese major depressive disorder.
GSK3B,Rs13321783,antidepressant treatment
GSK3B,Rs6438552,Parkinson's disease
GSTP1,Rs1871042,childhood allergic disease.
GSTP1,Rs1871042,childhood allergic disease
GSTP1,Rs1871042,cognitive ageing
GSTP1,Rs1871042,Glutathione s-transferase p1
GSTP1,Rs1871042,glutathione S-transferase P1
GSTP1,Rs1871042,tumor necrosis
GSTP1,Rs1871042,childhood allergic disease.
GSTP1,Rs1871042,oxidative stress
GSTP1,Rs1871042,cognition
GSTP1,Rs6591255,asthma
GSTP1,Rs6591255,American children
GSTP1,Rs1871042,cognitive ageing
GSTP1,Rs1871042,traffic-related air pollution
GSTP1,Rs1871042,cognitive ability
GSTP1,Rs17593068,functional 
GSTP1,Rs1871042,oxidative stress
GSTP1,Rs17593068,studies
GSTP1,Rs17593068,genomic 
GSTP1,Rs1695,docetaxel-induced peripheral neuropathy
GSTP1,Rs1695, premenopausal women
GSTP1,Rs1695,greater breast cancer risk
GSTP1,Rs1695,women
GSTP1,Rs1695,0 Chinese women
GSTP1,Rs1695, asthma
GSTP1,Rs1695,asthma
GSTP1,Rs1695,North American
GSTP1,Rs1695,asthma risk
GSTP1,Rs1871042,cognition
GTF2I,Rs2527367,affect prefrontal cortical response
GTF2I,Rs2527367,anxiety
GTF2I,Rs2527367,Variation
GTF2I,Rs2527367,Williams syndrome
HBA1,I4990131,Alpha Thalassemia
HBA1,I4990131,HBA2
HBA1,I4990131,Alpha Thalassemia
HBA2,I5900722,Alpha Thalassemia
HBA2,I5900722,Alpha Thalassemia
HBA2,I5900722,HBA2 and Alpha Thalassemia
HBA2,I5900722,Alpha Thalassemia
HBA2,I5900722,HBA2
HBA2,I5900735,Thalassemia
HBA2,I5900735,Alpha
HBA2,I5900735,Thalassemia
HBA2,I5900735,Alpha Thalassemia
HBA2,I5900722, Alpha Thalassemia
HBA2,I5900735,Alpha Thalassemia
HBA2,I5900654,Thalassemia
HBA2,I5004436,Thalassemia
HBA2,I5004445,Alpha 
HBA2,I4990131,Alpha Thalassemia
HBA2,I4990131,Alpha Thalassemia
HBA2,I5004432,Thalassemia
HBA2,I5004432,Alpha Thalassemia
HBA2,I4990131,HBA2
HBA2,I5004445,HBA2 
HBA2,I5004436,Alpha 
HBA2,I5004436,HBA2 
HBA2,I5004445,Thalassemia
HBA2,I5004436,Alpha Thalassemia
HBB,Rs33986703,beta-zero thalassemia mutation
HBB,Rs34690599,Beta Thalassemia/ The beta-thalassaemia mutations
HBB,Rs33986703,Human gene mutation
HBB,Rs33986703,thalassemia
HBB,Rs33986703,thalassemia mutation
HBB,Rs33986703,genetic disorder
HBB,Rs33986703,beta 0 thalassemia
HBB,Rs33986703,beta 0 thalassemia
HBB,Rs33915217,Bulgaria
HBB,Rs33931746,based 
HBB,Rs33931746,Microarray
HBB,Rs33931746,SNP allele-frequency
HBB,Rs33915217,South India
HBB,Rs34690599,beta-thalassaemia
HBB,Rs33915217,beta thalassemia
HBB,Rs33915217,Caribbean
HBB,Rs33915217,Cubans
HBB,Rs33986703,beta-zero thalassemia mutation
HBB,Rs35004220,Thalassemia
HCG27,Rs6903896,photic sneeze reflex
HCG27,Rs6903896,photic sneeze reflex
HDC,Rs1894236,Tourette syndrome
HDC,Rs854150,Tourette syndrome
HERC2,Rs2238289,blue eye color
HERC2,Rs1667394,Blond rather than brown hair
HERC2,Rs1667394,Blue rather than brown eyes
HERC2,Rs1667394,Blue rather than green eyes
HERC2,Rs1667394,green versus blue eye color
HERC2,Rs1667394,rs1667394 increases susceptibility to Blond rather than brown hair 4.94 
HERC2,Rs1667394,he A allele rs1667394 increases susceptibility to Blue rather than brown eyes 29.43 times for carriers of the A allele rs1667394 increases susceptibility to Blue rather than green eyes 6.74 times for carriers of the A allele
HERC2,Rs1667394,For green versus blue eye color rs12913832 in OCA2/HERC2 has a score of 51.5 and an estimated allelic OR of 8.43 . 
HERC2,Rs2238289,hair and eye colours
HERC2,Rs916977,blue eye color
HEXA,I4000440,false positive blood test
HEXA,I4000440,change
HEXA,I4000440,protein
HEXA,I4000440,leads to a false positive blood test for Tay-Sachs Disease
HEXA,I4000440,Tay Sachs causing allele
HEXA,I4000440,Tay Sachs diseas
HEXA,I4000440,Disease
HEXA,Rs117160567,observed in large-scale sequencing projects.
HEXA,I4000440,blood test
HEXA,Rs117160567,higher frequency
HEXA,I4000440,person may still carry
HEXA,Rs117160567,Tay Sachs
HEXA,Rs117160567,Tay Sachs
HEXA,Rs117160567,benign
HEXA,Rs117160567,homozygotes
HEXA,Rs117160567,large-scale sequencing projects
HEXA,Rs117160567,Tay Sachs
HEXA,Rs117160567,minor homozygotes
HEXA,I4000440,carrier
HEXA,I4000440,allele
HEXA,I4000440,disease
HEXA,I4000440,true
HEXA,I4000440,rs138058578
HEXA,I4000391,Tay-Sachs Disease
HEXA,I4000391,Tay-Sachs Disease
HEXA,I4000391,infantile form
HEXA,I4000436,Tay-Sachs Disease
HEXA,I4000436,adult form
HEXA,I4000436,Tay-Sachs Disease
HEXA,I4000438,Tay-Sachs Disease; infantile form
HEXA,I4000440,SNP 
HEXA,I4000436,Tay-Sachs Disease
HEXA,I4000440,Tay
HEXA,I4000440,Sachs 
HEXA,I4000440,i4000440
HEXA,I4000440,carrier 
HEXA,I4000440,Tay 
HEXA,I4000440,SNP 
HEXA,I4000440,however 
HEXA,I4000440,chromosome 
HEXA,I4000440,HEXA 
HFE,Rs28934595,Porphyria
HFE,Rs1800730,S65C or Ser65Cys
HFE,Rs1800730,hemochromatosis 
HFE,I3002468,hemochromatosis related
HFE,I3002468,hemochromatosis
HFE,I3002468,hemochromatosis
HFE,Rs1800730,mild form of hemochromatosis
HGF,Rs3735520,tyrosine 
HGF,Rs3735520,polymorphisms in the hepatocyte growth factor gene
HGF,Rs3735520,autism spectrum disorder
HGF,Rs3735520,myopia 
HGF,Rs3735520,MET 
HGF,Rs3735520,High myopia
HGF,Rs3735520,TGFB1
HGF,Rs2286194,Noncoding mutations of HGF are associated with nonsyndromic hearing loss
HGF,Rs3735520,SNPs 
HGF,Rs3735520,HGF 
HGF,Rs3735520,TGIF
HHEX,Rs5015480,type-2 diabetes
HHEX,Rs5015480,type-2 diabetes
HHEX,Rs8050136,type-2 diabetes
HHEX,Rs8050136,block with early onset obesity
HHEX,Rs8050136,minor allele frequency was much lower in Chinese populations
HHEX,Rs8050136,compared to populations of European descent
HHEX,Rs8050136,obesity
HIF1A,Rs11549465,type 1 diabetes
HIF1A,Rs11549465,type 2 diabetes
HLA-A,Rs3093665,population of South Croatia
HLA-A,Rs3093665,lymphotoxin-alpha tag polymorphisms
HLA-A,Rs3093665,tumor necrosis factor 
HLA-A,Rs3093665,prostate cancer mortality
HLA-A,Rs3093665,African American urban population
HLA-A,Rs3093665,genetic susceptibility to childhood allergy
HLA-A,Rs3093665,development of childhood allergic disease
HLA-A,Rs3093665,traffic-related air pollution
HLA-A,Rs3093665,tumor necrosis factor
HLA-A,Rs3093665,asthma
HLA-B,Rs3093668,Adipokine genes and prostate cancer risk
HLA-B,Rs3093668,Evaluation of genetic susceptibility to childhood allergy and asthma in an African American urban population.
HLA-B,Rs3093668,Adipokine genes
HLA-B,Rs3093668,prostate cancer risk
HLA-B,Rs3093668,childhood allerg
HLA-B,Rs79556279,BD
HLA-B,Rs4349859,familial ankylosing spondylitis
HLA-B,Rs3093668,African American urban
HLA-B,Rs6903896,photic sneeze reflex
HLA-B,Rs6903896,photic sneeze reflex
HLA-B,Rs79556279,Behçet's disease
HLA-B,Rs79556279,Behçet's disease (BD)
HLA-B,Rs3093665,prostate cancer mortality
HLA-B,Rs3093668,asthma
HLA-B,Rs3093665,lymphotoxin-alpha tag polymorphisms
HLA-B,Rs3093665,tumor necrosis factor
HLA-B,Rs3093665,population of South Croatia
HLA-B,Rs3093665,tumor necrosis factor 
HLA-B,Rs13202464,B27 Syndromes
HLA-B,Rs2073724,HIV-DNA levels
HLA-B,Rs2073724,Distinct genetic loci
HLA-B,Rs2073724,HIV-RNA
HLA-B,Rs2073724,HIV-1 infection
HLA-B,Rs2073724,HIV-DNA
HLA-B,Rs3093665,traffic-related air pollution
HLA-B,Rs3093665,development of childhood allergic disease
HLA-B,Rs3093665,genetic susceptibility to childhood allergy
HLA-B,Rs3093665,asthma
HLA-B,Rs3093665,African American urban population
HLA-B,Rs2073724,HIV-1 infection
HLA-C,Rs10484554,HIV/AIDS pathogenesis
HLA-C,Rs10484554,HIV Replication
HLA-C,Rs10484554,human genome diversity project populations
HLA-C,Rs10484554,psoriatic arthritis
HLA-C,Rs10484554,psoriasis 
HLA-C,Rs10484554,US/UK
HLA-C,Rs10484554,psoriasis 
HLA-C,Rs10484554,HIV-1 infection
HLA-DPA1,Rs9277378,lymphoma
HLA-DPA1,Rs3077,Chinese
HLA-DPA1,Rs3077,chronic hepatitis B
HLA-DPA1,Rs3077,loci
HLA-DPA1,Rs3077,genetic
HLA-DPA1,Rs3077,hepatitis B virus
HLA-DPA1,Rs3077,vertical transmission
HLA-DPA1,Rs3077,HLA-DPA1 variant
HLA-DPA1,Rs3077,HLA-DPA1 and HLA-DPB1 alleles
HLA-DPA1,Rs3077,multiple-single nucleotide polymorphism genotype
HLA-DPA1,Rs3077,Hepatitis B infection 
HLA-DPA1,Rs3077,hepatitis B
HLA-DPA1,Rs3077,hepatitis B virus 
HLA-DPA1,Rs3077,disequilibrium
HLA-DPA1,Rs3077,Hepatitis B infection
HLA-DPA1,Rs3077,persistent hepatitis B virus infection
HLA-DPB1,Rs9277378,lymphoma
HLA-DPB1,Rs9277535,Hepatitis B infection
HLA-DPB1,Rs9277535,reduce risk
HLA-DPB1,Rs9277535,Hepatitis B infection
HLA-DPB1,Rs9277535,Hepatitis B infection
HLA-DQA1,Rs1129740,It has been associated with Steroid-sensitive nephrotic syndrome (SSNS)
HLA-DQA1,Rs1129740,Rs1129740
HLA-DQA1,Rs1129740,Steroid-sensitive nephrotic syndrome
HLA-DQA1,Rs1071630,Steroid-sensitive nephrotic syndrome
HLA-DQA1,Rs1071630,Steroid-sensitive nephrotic syndrome
HLA-DQA1,Rs1071630,Steroid-sensitive nephrotic syndrome (SSNS)
HLA-DQA1,Rs1071630,Steroid-sensitive nephrotic syndrome (SSNS)
HLA-DQA1,Rs1071630,Steroid-sensitive nephrotic syndrome
HLA-DQA1,Rs1071630,missense variant
HLA-DQB1,Rs7775228,Primary biliary cirrhosis
HLA-DQB1,Rs7775228,fever 
HLA-DQB1,Rs7775228,osteoarthritis
HLA-DQB1,Rs7775228,osteoarthritis 
HLA-DQB1,Rs1063355,rheumatoid arthritis
HLA-DQB1,Rs4988889,Celiac disease
HLA-DQB1,Rs1063355,mold and biotoxin susceptible patients
HLA-DQB1,Rs1063355,anti-CCP-positive rheumatoid arthritis.
HLA-DQB1,Rs1063355,"asthma,"
HLA-DQB1,Rs1049225,Common variable immunodeficiency disorder 
HLA-DQB1,Rs1063355,Disorders of the Respiratory Tract in Children
HLA-DRA,Rs1041885,anti-cyclic citrullinated peptide
HLA-DRA,Rs1041885,rheumatoid arthritis.
HLA-DRA,Rs1041885,Genome-wide association
HLA-DRA,Rs1041885,rheumatoid arthritis.
HLA-DRA,Rs1041885,rheumatoid arthritis
HLA-DRA,Rs2395182,rs2395182 is one of three HLA region SNPs used to tag the DQ2.2 haplotype in gs221.
HLA-DRA,Rs3129878,azoospermia (lack of sperm)
HLA-DRA,Rs9268645,multiple sclerosis
HLA-DRA,Rs9268645,markers
HLA-DRB1,Rs7451962,Multiple sclerosis
HLA-DRB1,Rs7451962,sclerosis 
HLA-G,Rs12722477,"rs12722477, also known as Leu134Ile, a SNP of the HLA-G gene, was significantly associated with Kawasaki disease (odds ratio 3.23, CI = 1.12-9.32), based on an initial study of 48 cases and a replication study with 44 cases."
HLA-G,Rs12722477,SNP
HLA-G,Rs12722477,Kawasaki disease
HMBS,Rs1057518806,"c.958delG (p.Ala320Leufs)reported as likely pathogenic in ClinVar, in gene associated with acute intermittent porphyria"
HMBS,Rs536814318,intermittent porphyria.
HMBS,Rs536814318,acute intermittent porphyria
HMBS,Rs536814318,acute intermittent porphyria
HMBS,Rs536814318,acute intermittent porphyria
HMBS,Rs536814318,acute intermittent porphyria
HMGA2,Rs1042725,increased height
HMGA2,Rs17179670,SNP implicated in Tooth Development
HMGA2,Rs10784502,intracranial volume
HMGA2,Rs1042725,3% of height variability
HMGA2,Rs1042725,men
HMGA2,Rs1042725,population variation in height in both adults and children
HMGA2,Rs1042725,"SNP, HMGA2"
HMGA2,Rs1042725,height
HMGA2,Rs1042725,increased height
HMGA2,Rs1042725,"influence on height, since rare, severe mutations in this gene are known to alter body size in mice and humans"
HMGA2,Rs1042725,height
HMGA2,Rs1042725,alter body size in mice and humans
HMGCR,Rs3846662,cholesterol levels
HMGCR,Rs3846662,plasma concentration
HMGCR,Rs3846662,ow-density lipoprotein cholesterol
HMGCR,Rs3846662,high-density lipoprotein cholesterol
HMGCR,Rs3846662,triglycerides
HMGCR,Rs3846662,apolipoprotein A1
HMGCR,Rs3846662, Apolipoprotein B 
HMGCR,Rs3846662,carotid artery disease
HMGCR,Rs3846663,LDL cholesterol
HMGCR,Rs3846663,Common SNPs in HMGCR
HMGCR,Rs3846663,LDL-cholesterol levels
HMGCR,Rs3846663,The HMG-CoA
HMGCR,Rs3846663,HMGCR
HMGCR,Rs3846662,alternative splicing of exon13
HMGCR,Rs3846662,dyslipidemia alleles
HMGCR,Rs3846662,LDL-cholesterol levels
HMGCR,Rs17238540,stroke
HMGCR,Rs17238540,atherosclerosis
HMGCR,Rs12654264,CRC
HMGCR,Rs12654264,colorectal cancer
HMGCR,Rs12654264,cancer
HMGCR,Rs12654264,cardiovascular disease
HMGCR,Rs12654264,colorectal cancer
HMGCR,Rs12654264,cardiovascular disease
HMGCR,Rs12654264,colorectal cancer
HMGCR,Rs12654264,colorectal cancer
HMGCR,Rs17238540,lower cholesterol levels
HMGCR,Rs17238540,nonfatal myocardial infarction
HMGCR,Rs17238540,stroke
HMGCR,Rs17238540,atherosclerosis
HMGCR,Rs17238540,myocardial infarction
HMGCR,Rs3846662, LDL-Cholesterol
HMGCR,Rs12654264,cardiovascular disease
HMOX1,Rs2071746,subjects carrying both the rs2071746(T;T) and rs242557(A;A) genotypes had a 6.65x increased risk
HMOX1,Rs2071746,Alzheimer's disease
HNF1A,Rs1169300,lung cancer
HNF1A,Rs1169300,cancer
HNF1A,Rs1169300,"colorectal, prostate or breast cancer"
HNF1A,Rs1169305,now considered benign in ClinVar
HNF1A,Rs1169305,benign 
HNF1A,Rs1183910,"associated with higher total cholesterol, LDL choesterol and HDL cholesterol"
HNF1A,Rs1169300,cancer
HNF1A,Rs1183910,owered CRP by 13.8%
HNF1A,Rs1183910,higher total cholesterol
HNF1A,Rs1183910,LDL choestero
HNF1A,Rs1183910,HDL cholesterol
HNF1A,Rs140491072,diabetes
HNF1A,Rs140491072,maturity-onset diabetes
HNF1A,Rs140491072,diabetes
HNF1A,Rs140491072,maturity-onset diabetes of the young (MODY)-3
HNF1A,Rs151344539,Polygenic 
HNF1A,Rs151344538,Polygenic risk variants
HNF1A,Rs151344538,type 2 diabetes
HNF1A,Rs151344538,HNF1A 
HNF1A,Rs151344538,Polygenic 
HNF1A,Rs151344538,diagnosis 
HNF1A,Rs151344539,type 2 diabetes
HNF1A,Rs151344539,HNF1A 
HNF1A,Rs151344539,diagnosis 
HNF1A,Rs193922587,diabetes
HNF1A,Rs193922587,maturity-onset diabetes
HNF1A,Rs193922587,diabetes
HNF1A,Rs193922587,maturity-onset diabetes of the young (MODY)-3
HNF1A,Rs193922587,diabetes 
HNF1A,Rs1169300,cancer risk
HNF1A,Rs140491072,diabetes 
HNF1A,Rs1169300,C-reactive protein levels
HNF1A,Rs151344539,Polygenic risk variants
HNF1A,Rs1169300,prostate or breast cancer
HNF1A,Rs1169288,lower HDL cholesterol
HNF1A,Rs1169288,lower HDL cholesterol
HNF1A,Rs1169288,lower CRP levels
HNF1A,Rs1169288,unrelated Japanese men
HNF1A,Rs1169288,HDL cholesterol
HNF1A,Rs1169288,Ile/Ile genotype
HNF1A,Rs1169288,Leu/Leu genotype
HNF1A,Rs1169288,rs1169288
HNF1A,Rs1169288,Ile27Leu
HNF1A,Rs1169300,C-reactive protein levels
HNF1A,Rs1169288,SNP
HNF1A,Rs1169288,HNF1A (Hepatocyte nuclear factor 1 homeobox A) gene
HNF1A,Rs1169288,The C allele
HNF1A,Rs1169288, HDL cholesterol
HNF1A,Rs1169288,rs1169286
HNF1A,Rs1169288,rs1169288
HNF1A,Rs1169288, rs1169310
HNF1A,Rs1169300,lung cancer
HNF1A,Rs1169300,cancer 
HNF1A,Rs1169288,CRP levels
HNF1A,Rs1169288,haplotype
HNF1A,Rs1169288,minor alleles
HNF1A,Rs1169288,Leu/Leu genotype
HNF1A,Rs1169288,rs2464196
HNF1A,Rs1169288,genotype
HNF1A,Rs1169288,Japanese men
HNF1A,Rs1169288,Leu variant
HNF1A,Rs1169288,encodes
HNF1A,Rs1169288,allele
HNF1A,Rs1169288,HNF1A (Hepatocyte nuclear factor 1 homeobox A) gene
HNF1A,Rs1169288,SNP
HNF1A,Rs1169288,HDL cholesterol
HNF1B,Rs757210,Nondiabetic Finnish Men
HNF1B,Rs757210,HNF1B gene
HNF1B,Rs757210,lipoprotein traits
HNF1B,Rs757210,HNF1B gene
HNF1B,Rs757210,lipoprotein traits
HNF1B,Rs7405696,early-onset prostate cancer
HNF1B,Rs7405696,early-onset prostate cancer
HNF1B,Rs3760511,Prostate cancer
HNF1B,Rs3760511,carriers of the C allele
HNF1B,Rs757210,Nondiabetic
HNMT,Rs1050891,allura red AC and sodium benzoate
HNMT,Rs1050891,quinoline yellow
HNMT,Rs1050891,ponceau 4R
HNMT,Rs1050891,carmoisine
HNMT,Rs1050891,sunset yellow
HNMT,Rs1050891,food additives
HNMT,Rs1050891,ADHD 
HNMT,Rs1050891,age 3 and 8/9
HNMT,Rs1050891,ADHD 
HNMT,Rs1050891,tartrazine
HNMT,Rs1050891,ncrease in ADHD behavior
HNMT,Rs1050891,lack of a C allele
HNMT,Rs1050891,increase in ADHD behavior
HNMT,Rs1050891,ADHD
HNMT,Rs1050891,lack of a C allele
HNMT,Rs1050891,HNMT gen
HNMT,Rs1050891,ADHD
HNMT,Rs1050891,ADHD
HNMT,Rs1050891,food additives
HPD,Rs1154510,hawkinsinuria
HPS5,Rs61884288,Hermansky-Pudlak syndrome
HPS5,Rs61884288,rs61884288(A)
HPS5,Rs61884288,HPS5 gene on chromosome 11
HPS5,Rs61884288, T1098I
HPS5,Rs61884288,p.Thr1098Ile
HPS5,Rs61884288,"rs61884288,"
HPS5,Rs61884288,"pathogenic for Hermansky-Pudlak syndrome, type 5"
HPS5,Rs61884288,"c.3293C>T,"
HRAS,Rs104894229,Gly12Ser
HRAS,Rs28933406,somatic mutation
HRAS,Rs28933406,somatic mutation
HRH4,Rs11662595,Histamine pharmacogenomics
HSD17B4,Rs25640,316G
HSD17B4,Rs25640,polymorphism
HSD17B4,Rs25640,bifunctional 
HSD17B4,Rs25640,316G
HSD17B4,Rs25640,Arg106His
HSD17B4,Rs137853096,G16S
HSD17B4,Rs25640,317G
HSD17B4,Rs25640,Arg106Pro
HSD17B4,Rs137853096,Gly16Ser 
HSD17B4,Rs25640,317G
HSD3B2,Rs770815049,rare mutation in the HSD3B2 gene on chromosome 1
HSD3B2,Rs770815049,chromosome 1
HSD3B2,I5003815,"mutation; congenital adrenal hyperplasia, recessively inherited"
HSD3B2,I5003815,mutation; congenital adrenal hyperplasia
HSD3B2,I5003815,"mutation; congenital adrenal hyperplasia, recessively inherited"
HSD3B2,I5003815,deficiency based on
HSD3B2,I5003811,recessively inherited
HSD3B2,I5003811,congenital adrenal hyperplasia
HSD3B2,I5003811,mutation
HSD3B2,I5003811,deficiency
HSD3B2,I5003811,"deficiency based on HSD3B2 mutation; congenital adrenal hyperplasia, recessively inherited"
HSD3B2,I5003813,"deficiency based on HSD3B2 mutation; congenital adrenal hyperplasia, recessively inherited"
HSPA12A,Rs12259842,freckles
HSPA12A,Rs12259842,freckles.
HSPA1A,Rs1061581,noise-induced hearing loss
HSPA1L,Rs1061581,noise-induced hearing loss
HSPA1L,Rs2227956,noise-induced hearing loss
HSPA1L,Rs2227956,significant association
HSPA1L,Rs2075800,noise-induced hearing loss in the Taiwanese population
HSPA1L,Rs2075800,heat shock protein
HSPA1L,Rs2075800,Association of MICA with rheumatoid arthritis
HSPA1L,Rs2075800,in patients with sarcoidosis
HSPA1L,Rs2075800,rheumatoid arthritis
HSPA1L,Rs2075800,hearing loss
HSPA1L,Rs2075800,Inflammatory gene polymorphism
HSPA1L,Rs2075800,noise-induced hearing loss
HSPA1L,Rs2075800,rheumatoid arthritis
HSPA1L,Rs2075800,sarcoidosis
HSPA1L,Rs2075800,uveitis
HSPA1L,Rs2075800,postoperative myocardial infarction
HSPA1L,Rs2075800,myocardial infarction
HSPG2,Rs762281715,inherited recessively
HSPG2,Rs762281715,inherited dominantly.
HSPG2,Rs762281715,syndrome
HSPG2,Rs762281715,"c.10894C>T, p.Arg3632Ter and R3632XConsidered pathogenic for Schwartz Jampel syndrome type 1 and Lethal Kniest-like syndrome (DDSH) in ClinVar;"
HSPG2,Rs762281715,pathogenic
HSPG2,Rs762281715,syndrome
HSPG2,Rs762281715,note however that the first is inherited recessively while the latter is usually considered to be inherited dominantly.
HTR2A,Rs594242,suicidal behavior
HTR2A,Rs6313,rheumatoid arthritis 
HTR2A,Rs6313,quantitative traits in panic disorder.
HTR2A,Rs655888,chronic fatigue syndrome
HTR2A,Rs655888,chronic fatigue syndrome
HTR2A,Rs655888,chronic fatigue syndrome.
HTR2A,Rs7330461,Caucasian patients
HTR2A,Rs7322347,attention-deficit/hyperactivity disorder
HTR2A,Rs7322347,ADHD
HTR2A,Rs7322347,"5HT2A, DDC and MAOB"
HTR2A,Rs7322347,attention-deficit/hyperactivity
HTR2A,Rs7322347,serotoninergic
HTR2A,Rs7322347,attention-deficit/hyperactivity disorder
HTR2A,Rs655888,linkage disequilibrium with rs643627.
HTR2A,Rs7330461,schizophrenia
HTR2A,Rs7330461,A/A genotype.
HTR2A,Rs7330461,T/T genotype
HTR2A,Rs7330461,associated with an increased treatment response
HTR2A,Rs7330461,Caucasian patients
HTR2A,Rs7330461,schizophrenia
HTR2A,Rs7984966,attention-deficit/hyperactivity
HTR2A,Rs7984966,ADHD
HTR2A,Rs7984966,attention-deficit/hyperactivity
HTR2A,Rs7984966,"association for 5HT2A, DDC and MAOB. "
HTR2A,Rs7984966,C allele associated with ADHD in adults.
HTR2A,Rs7984966,ADHD
HTR2A,Rs7984966, points to the 'T' allele as being the cause.
HTR2A,Rs594242,impulsive suicidal behavior
HTR2A,Rs7330461,Caucasian patients with schizophrenia
HTR2A,Rs594242,aggression
HTR2A,Rs7330461,1115 Caucasian patients with schizophrenia reported that the T/T genotype at rs7330461 is consistently associated with an increased treatment response to 40 mg twice daily pomaglumetad methionil (LY2140023 monohydrate) compared to the A/A genotype.
HTR2A,Rs582385,schizophrenia families
HTR2A,Rs1923886,haplotype CCGCA
HTR2A,Rs1923886,rarer haplotype CCACG confers risk to the disorder
HTR2A,Rs1923886,Haplotype 
HTR2A,Rs1923886,haplotype 
HTR2A,Rs1923886,bipolar 
HTR2A,Rs1923886,disorder 
HTR2A,Rs2224721,haplotype CCGCA
HTR2A,Rs2224721,is protective against bipolar disorder
HTR2A,Rs2224721,rarer haplotype CCACG confers risk to the disorder
HTR2A,Rs2224721,Haplotype 
HTR2A,Rs2224721,haplotype 
HTR2A,Rs2224721,bipolar 
HTR2A,Rs594242,anger
HTR2A,Rs2224721,disorder 
HTR2A,Rs1923886,is protective against bipolar disorder
HTR2A,Rs2770296,is protective against bipolar disorder
HTR2A,Rs2770296,haplotype CCGCA
HTR2A,Rs582385,2A receptor
HTR2A,Rs582385,HTR2A|serotonin
HTR2A,Rs582385,Genetic variation in the HTR2A|serotonin 2A receptor
HTR2A,Rs582385,schizophrenia
HTR2A,Rs582385,schizophrenia
HTR2A,Rs582385,schizophrenia 
HTR2A,Rs582385,suicidal ideation
HTR2A,Rs2770296,disorder 
HTR2A,Rs2770296,bipolar 
HTR2A,Rs2770296,haplotype 
HTR2A,Rs2770296,Haplotype 
HTR2A,Rs2770296,rarer haplotype CCACG confers risk to the disorder
HTR2A,Rs582385,Irish
HTR2B,Rs10194776,associated with increased incidence of
HTR2B,Rs10194776,migraine without aura
HTR2B,Rs16827801,associated with increased incidence of
HTR2B,Rs16827801,migraine without aura
HTR2C,Rs6318,heart attack
HTR2C,Rs6318,bipolar disorder
HTR2C,Rs6318,autistic 
HTR2C,Rs6318,bipolar affective disorder
HTR2C,Rs6318,anti-psychotic induced weight
HTR2C,Rs518147,schizophrenia
HTR2C,Rs6318,bipolar affective disorder
HTR2C,Rs6318,higher stress-related cortisol levels
HTR2C,Rs518147,metabolic syndrome
HTR2C,Rs518147,schizophrenia 
HTR2C,Rs6318,schizophrenic
HTR3A,Rs1176713,schizophrenia 
HTR3A,Rs1176713,serotonin
HTR3A,Rs1176713,hydroxytryptamine 
HTR3A,Rs1062613,harm avoidance 
HTR3A,Rs1062613,schizophrenia
HTR3A,Rs1062613,treatment-resistant schizophrenia
HTRA1,Rs3793917,age-related macular degeneration
HTRA1,Rs932275,macular degeneration
HTRA1,Rs3793917,age-related macular degeneration
HTRA1,Rs3793917,association with age-related macular degeneration
HTRA1,Rs3793917,age-related macular degeneratio
HTRA1,Rs3793917,strongly associated with age-related macular degeneration
HTRA1,Rs3793917,age related macular degeneration
HTRA1,Rs3793917,anti-vascular endothelial growth
HTRA1,Rs3793917,age-related macular degeneration
HTRA1,Rs3793917,age-related macular degeneration
HTRA1,Rs3793917,age-related macular degeneration
HTRA1,Rs3793917,nature age related macular degeneration
HTRA1,Rs2293870,macular degeneration
HTRA1,Rs2293870,HTRA1
HTRA1,Rs2293870,haplotypes
HTRA1,Rs2293870,macular degeneration
IBD5,Rs6596075,Crohn's disease
IBD5,Rs6596075,Crohn's disease
IBD5,Rs11739135,Crohn's disease
IBD5,Rs11739135,Crohn's disease
IDO2,Rs4503083,SNP
IDS,Rs781997631,MPS type II
IFIH1,Rs35337543,hypothyroidism
IFIH1,Rs35337543,at reduced risk of developing
IFNL3,Rs8103142,interleukin-28B
IFNL3,Rs8103142,Japanese patients
IFNL3,Rs8103142,spontaneous hepatitis C virus clearance
IFNL3,Rs8103142,chronic hepatitis C patients
IFNL3,Rs8103142,interleukin-28B
IFNL3,Rs8103142,hepatitis C
IFNL3,Rs8103142,hepatitis C
IFNL3,Rs8103142,chronic hepatitis C 
IFNL4,Rs12979860,fibrosis 
IFNL4,Rs12979860,HIV/hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,HIV
IFNL4,Rs12979860,liver fibrosis
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C.
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,-hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,Hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860, hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C 
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,chronic hepatitis C 
IFNL4,Rs12979860,hepatitis C 
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,chronic hepatitis C
IFNL4,Rs12979860,chronic hepatitis C
IFNL4,Rs12979860,African
IFNL4,Rs12979860,Hepatitis C
IFNL4,Rs12979860,hepatitis C virus
IFNL4,Rs12979860,chronic hepatitis C
IFNL4,Rs12979860,hepatitis B virus 
IFNL4,Rs12979860,HIV 
IFNL4,Rs12979860,hepatitis C 
IFNL4,Rs12979860,chronic hepatitis C 
IFNL4,Rs12979860,chronic hepatitis C
IFNL4,Rs12979860,viral hepatitis
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860, hepatitis C
IFNL4,Rs12979860,hepatitis C virus
IFNL4,Rs12979860,hepatitis C virus
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,HIV
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,chronic hepatitis C
IFNL4,Rs12979860,hepatitis 
IFNL4,Rs12979860,hepatitis 
IFNL4,Rs12979860,hepatitis 
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,hepatitis C.
IFNL4,Rs12979860,hepatitis 
IFNL4,Rs12979860,hepatitis C
IFNL4,Rs12979860,HIV/hepatitis C
IFNL4,Rs12979860,hepatitis C 
IFNL4,Rs12979860,chronic hepatitis C
IFNL4,Rs12979860,HCV-infected
IFNL4,Rs12979860,hepatitis C 
IGF1,Rs6220,in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF level
IGF1,Rs6220,xaliplatin-based chemotherapy
IGF1,Rs6220,early-onset breast cancer. Pharmacogenetic angiogenesis 
IGF1,Rs6220,high-risk breast cancer
IGF1,Rs6220,cancer aetiology
IGF1,Rs6220,colorectal cancer
IGF1,Rs6220,breast cancer risk in Chinese women:
IGF1,Rs2195239,mammographic density
IGF1,Rs2195239,proliferative benign breast disease
IGF1,Rs2195239,multiple myeloma.
IGF1,Rs2195239,reast cancer risk
IGF1,Rs2195239,breast cancer
IGF1,Rs12423791,prostate cancer
IGF1,Rs6220,prostate cancer
IGF1R,Rs34516635,longevity and ageing
IGF1R,Rs34516635,maximal lifetime appearance|height
IGF2BP2,Rs11705701,obesity
IGF2BP2,Rs11705701,insulin sensitivity
IGF2BP2,Rs11705701,insulin sensitivity
IGF2BP2,Rs11705701,obesity
IGF2BP2,Rs11705701,type-2 diabetes
IKBKAP,Rs111033171,cystic fibrosis
IKBKAP,I4000400,Familial Dysautonomia
IKBKAP,Rs111033171,familial dysautonomia
IKBKAP,Rs111033171,Tay–Sachs disease
IKBKAP,Rs111033171,cystic fibrosis
IKBKAP,Rs111033171,familial dysautonomia
IKBKAP,Rs111033171,Ashkenazi Jews
IKBKAP,Rs111033171,Tay–Sachs disease
IKBKAP,Rs111033171,strand flipping issue
IL10,Rs1800871,Crohn's disease
IL10,Rs1800871,Asthma
IL10,Rs1800871,non-Hodgkin lymphoma.
IL10,Rs1800871,prostate cancer
IL10,Rs1800871,AIDS-related non-Hodgkin lymphoma 
IL10,Rs1800871,non-Hodgkin lymphoma
IL10,Rs1800871,knee osteoarthritis
IL10,Rs3024496,asthma
IL10,Rs1800871,rheumatoid arthritis patients
IL10,Rs1800871,biliary tract cancers and stones
IL10,Rs1800871,B-cell lymphoma
IL10,Rs1800871,hepatitis C virus infection
IL10,Rs1800871,Crohn's disease
IL10,Rs1800871,infection following esophagectomy
IL10,Rs1800871,non-Hodgkin's lymphoma.
IL10,Rs1800871,postoperative myocardial infarction
IL10,Rs1800871,melanoma
IL10,Rs1800871,rheumatoid arthritis
IL10,Rs1800896,asthma
IL10,Rs1800871,Epstein-Barr virus
IL10,Rs3024496,allergy
IL10,Rs3024492,asthma
IL10,Rs3024492,allergy
IL10,Rs3024490,pro-inflammatory response
IL10,Rs3024490,higher TNF gene expression
IL10,Rs3024490,lower IL-10 expression
IL10,Rs3024490,IBD and celiac disease
IL10,Rs3024490,IBD
IL10,Rs3024490,inflammatory bowel (IBD) or celiac disease
IL10,Rs3024490,Behçet's disease
IL10,Rs1800896,anti-inflammatory
IL10,Rs1800896,cancer
IL10,Rs1800896,allergy
IL10,Rs1800871,systemic sclerosis
IL10,Rs1800871,heparin-induced thrombocytopenia.
IL10,Rs1800871,gastric cancer
IL10,Rs1800871,Behçet's disease
IL10,Rs1554286,Meniere's disease
IL10,Rs1800871,Crohn's disease
IL10,Rs1518111, human
IL10,Rs1518111,patients
IL10,Rs1518111,systemic inflammation 
IL10,Rs1518111,cytomegalovirus reactivation
IL10,Rs1518111,disease
IL10,Rs1518111,Polymorphisms
IL10,Rs1518111,vitamin D metabolism 
IL10,Rs1518111,Asthma
IL10,Rs1518111,Behcet's disease
IL10,Rs1518111,benign prostate hyperplasia
IL10,Rs1518111,tuberculosis
IL10,Rs1518111,acute coronary syndrome
IL10,Rs1518111,cytomegalovirus
IL10,Rs1518111,Asthma
IL10,Rs1800871,Alzheimer's disease
IL10,Rs1518111,genetic susceptibility
IL10,Rs1518111,tuberculosis
IL10,Rs1518111,acute coronary syndrome
IL10,Rs1518111,prostate hyperplasia
IL10,Rs1800871,endometriosis
IL10,Rs1554286,Behcet's disease
IL10,Rs1554286,type 2 diabetes
IL10,Rs1554286,polypoidal choroidal vasculopathy
IL10,Rs1554286,macular degeneration
IL10,Rs1518111,polymorphisms 
IL10,Rs1554286,polypoidal choroidal vasculopathy
IL10,Rs1554286,neovascular age-related macular degeneration
IL10,Rs1554286,prostate cancer
IL10,Rs1554286,infection
IL10,Rs1554286,chronic hepatitis
IL10,Rs1554286,acute coronary syndrome
IL10,Rs1554286,systemic inflammation
IL10,Rs1518111, Behcet's disease
IL10,Rs1518111,Iranian
IL10,Rs1518111, Korean
IL10,Rs1554286,donor inflammation
IL12B,Rs3212227,psoriatic arthritis (PsA)
IL12B,Rs3212227,cervical cancer
IL12B,Rs3212227,cervical cancer
IL12B,Rs3212227,psoriatic arthritis
IL12B,Rs3212227,psoriasis
IL12B,Rs3212227,psoriasis
IL12B,Rs3212227,PsA
IL12B,Rs3212227,psoriasis
IL12B,Rs2288831,tuberculosis
IL12B,Rs2288831,Asthma
IL12B,Rs2288831,susceptibility to tuberculosis
IL12B,Rs2288831,pulmonary tuberculosis
IL12B,Rs2288831,tuberculosis
IL12B,Rs2288831,Asthma
IL12B,Rs2288831,pulmonary tuberculosis
IL12B,Rs2288831,Asthma
IL12B,Rs2288831,pulmonary tuberculosis
IL12RB2,Rs3790568,susceptibility to radiation dermatitis
IL12RB2,Rs3790568,radiation dermatitis
IL12RB2,Rs3790568,susceptibility to radiation dermatitis
IL12RB2,Rs3790568,susceptibility to radiation dermatitis
IL12RB2,Rs3790565,C allele
IL12RB2,Rs3790565,Primary biliary cirrhosis
IL12RB2,Rs3790565,"HLA, IL12A, and IL12RB2 variants"
IL12RB2,Rs3790565,Primary biliary cirrhosis
IL12RB2,Rs3790565,Primary biliary cirrhosis
IL12RB2,Rs3790565,associated with increased risk of Primary biliary cirrhosis
IL12RB2,Rs3790565,Primary biliary cirrhosis
IL12RB2,Rs3790565,Primary biliary cirrhosis
IL12RB2,Rs3790565,biliary cirrhosis
IL12RB2,Rs3790565,Primary biliary cirrhosis
IL13,Rs20541,genotypes associated with lower IgE/ 23andMe blog psoriasis Europeans rs20541(G)
IL13,Rs20541,rs20541 is a C/T polymorphism on the interleukin 13 gene IL13 associated with IgE levels. 
IL16,Rs4778889,radiation-induced toxicity
IL16,Rs4778889,coronary artery disease
IL16,Rs4778889,IL-16 rs11556218 gene polymorphism
IL16,Rs4778889,risk of coronary artery disease
IL16,Rs4778889,Chinese Han population
IL16,Rs4778889,interleukin-16 polymorphisms 
IL16,Rs4778889,non-small cell lung cancer
IL16,Rs4778889, inflammation-related genes
IL16,Rs4778889,risk of coronary artery disease
IL16,Rs4778889,Graves' disease
IL16,Rs4778889,interleukin (IL)-16 gene polymorphisms
IL16,Rs4778889,gene polymorphism
IL16,Rs4778889,adiation-induced toxicity
IL16,Rs4778889,nasopharyngeal carcinoma
IL16,Rs4778889,Graves' disease
IL16,Rs4778889,risk of nasopharyngeal carcinoma
IL17A,Rs2275913,gastric cancer
IL17A,Rs2275913,gastric cancer
IL17A,Rs2275913,gastric cancer
IL17A,Rs2275913,Japanese
IL17A,Rs2275913,bone marrow transplantation
IL17A,Rs2275913,gastric cancer
IL17A,Rs2275913,acute Graft-Versus-Host Disease
IL17A,Rs2275913,gastric cancer
IL17A,Rs2275913,Japanese
IL17A,Rs2275913,acute Graft-Versus-Host Disease
IL17A,Rs2275913,gastric cancer
IL17A,Rs2275913,gastric cancer
IL17A,Rs2275913,gastric cancer
IL17A,Rs2275913,gastric cancer
IL18,Rs187238,coeliac disease
IL18,Rs187238,allergic disorders
IL18,Rs187238,Czech
IL18,Rs187238,renal cell carcinoma patients
IL18,Rs187238,coronary artery disease
IL18,Rs187238,Alzheimer's disease
IL18,Rs187238,respiratory syncytial virus infection
IL18,Rs187238,preeclampsia
IL18,Rs187238,rheumatoid arthritis
IL18,Rs187238,spontaneous miscarriage
IL18,Rs3882891,levels
IL18,Rs187238,childhood
IL18,Rs187238,Hepatitis B
IL18,Rs187238,Chinese
IL18,Rs187238,idiopathic recurrent pregnancy loss
IL18,Rs187238,Tunisian
IL18,Rs1946518,cervical cancer
IL18,Rs1946519,cervical cancer
IL18,Rs3882891,insulin 
IL18,Rs187238,kidney
IL18,Rs187238,severe malarial anemia
IL18,Rs187238,Chinese
IL18,Rs3882891,postprandial 
IL18,Rs187238,Caucasian males
IL18,Rs187238,oral lichen planus
IL18,Rs187238,men
IL18,Rs187238,hypertension
IL18,Rs187238,sudden cardiac death (SCD)
IL18,Rs187238,coronary heart disease (CHD)
IL18,Rs187238,SCD
IL18,Rs187238,CHD
IL18,Rs187238,coronary atherosclerotic plaque areas
IL18,Rs187238,complicated plaques
IL18,Rs187238,hypertension
IL18,Rs187238,hypertension
IL18,Rs187238,coronary atherosclerotic plaques
IL18,Rs187238,sudden cardiac death
IL18,Rs187238,CHD-related SCD or CAD
IL18,Rs187238,Dalmatian
IL18,Rs187238,type 1 diabetes
IL18,Rs187238,European
IL18,Rs187238,Southern Croatia
IL18,Rs187238,type 1 diabetes
IL18,Rs187238,celiac disease
IL18,Rs187238,rheumatoid arthritis
IL18,Rs187238,human immunodeficiency virus type I infection in adolescents and adults
IL18RAP,Rs2272127,and 
IL18RAP,Rs2272127,herpes simplex virus 1
IL18RAP,Rs2272127,schizophrenia
IL18RAP,Rs2272127, herpes
IL18RAP,Rs2272127,schizophrenia
IL18RAP,Rs2272127,herpes
IL18RAP,Rs2272127,schizophrenia 
IL18RAP,Rs2272127,rs2272127 
IL18RAP,Rs2272127,P 
IL18RAP,Rs2272127,herpes
IL18RAP,Rs2272127,schizophrenia
IL18RAP,Rs11465702,herpes simplex virus 1 (HSV1)
IL18RAP,Rs11465702,schizophrenia
IL18RAP,Rs11465702,herpesrs11465702
IL18RAP,Rs11465702,seropositivity
IL18RAP,Rs11465702,herpes 
IL18RAP,Rs11465702,schizophrenia
IL18RAP,Rs11465702,herpes
IL18RAP,Rs11465702,schizophrenia
IL19,Rs2243191,hepatitis B
IL19,Rs2243191,idiopathic arthritis
IL1B,Rs1143634,Periodontitis 
IL1B,Rs1143634,Peptic ulcer disease
IL1B,Rs1143634, Nephropathy in Type I Diabetes
IL1B,Rs1143634,Myasthenia gravis
IL1B,Rs1143634,Joint destruction in Rheumatoid Arthritis
IL1B,Rs1143634,Inflammatory bowel disease
IL1B,Rs1143634, Duodenal ulcer
IL1B,Rs1143634,Alzheimer's disease
IL1B,Rs1143634,Alopecia Areata
IL1B,Rs1143627,inflammatory bowel disease
IL1B,Rs1143634,larger waist circumference
IL1B,Rs1143634,Western Australian coronary heart disease (CHD) population
IL1B,Rs1143627,basal cell carcinoma of skin.
IL1B,Rs1143627,glucocorticoid resistance
IL1B,Rs1143634, Periodontitis 
IL1B,Rs1143627,rheumatoid arthritis:
IL1B,Rs1143627,hepatocellular carcinoma
IL1B,Rs3087258,alcohol dependence disorder 
IL1B,Rs1143627,radiation-induced toxicity
IL1B,Rs1143634,higher levels of obesity or inflammatory markers
IL1B,Rs1143634, pancreatic cancer
IL1B,Rs3087258,TNF-alpha gene -308 genotype.
IL1B,Rs16944,inflammatory
IL1B,Rs1143627,non-small cell lung cancer
IL1B,Rs3087258,infection following esophagectomy.
IL1B,Rs3087258,Genetic polymorphisms
IL1B,Rs3087258,alcohol toxicity and detoxification outcome
IL1B,Rs3087258,detoxification outcome
IL1B,Rs3087258,alcohol toxicity
IL1B,Rs3087258,alcohol dependence disorder
IL1B,Rs3087258,alcohol dependence disorder
IL1B,Rs3087258,Genetic polymorphisms
IL1B,Rs1143634,Ulcerative colitis
IL1B,Rs3087258,detoxification outcome
IL1B,Rs16944,bipolar disorder
IL1B,Rs16944, Osteoarthritis
IL1B,Rs16944,depression
IL1B,Rs16944,impaired ability to achieve remission
IL1B,Rs16944,gray matter and hypoactivity
IL1B,Rs16944,bipolar individuals
IL1B,Rs16944,schizophrenic
IL1B,Rs16944,schizophrenia
IL1B,Rs16944,multiple mental illnesses
IL1B,Rs3087258,alcohol toxicity
IL1B,Rs1143627,neonatal sepsis
IL1B,Rs1143627,hepatitis B vaccine
IL1B,Rs1143627,non-small cell lung cancer
IL1B,Rs1143627,ankylosing spondylitis
IL1B,Rs1143627,basal cell carcinoma of skin
IL1B,Rs1143627,cancer anorexia/weight loss syndrome
IL1B,Rs1143627,arteriovenous malformation
IL1B,Rs1143627,mood disorders
IL1B,Rs1143627,lung cancer
IL1B,Rs1143627,esophagectomy
IL1B,Rs1143627,hand osteoarthritis
IL1B,Rs1143627,cancers of the upper aerodigestive tract
IL1B,Rs1143627,celiac disease
IL1B,Rs1143623,multi-ethnic country.
IL1B,Rs1143623,gastric cancer
IL1B,Rs1143623,knee osteoarthritis
IL1B,Rs1143623,multiple sclerosis 
IL1B,Rs1143623,Irish
IL1B,Rs1143623,Cytokine response to vitamin E supplementation
IL1B,Rs1143623,rheumatoid arthritis
IL1B,Rs1143623,rheumatoid arthritis: 
IL1B,Rs1143627,breast cancer
IL1B,Rs1143627,Helicobacter pylori infection
IL1B,Rs1143627,Children
IL1B,Rs1143627,infection
IL1B,Rs1143627,follicular lymphoma
IL1B,Rs1143627,cancer anorexia/weight loss syndrome
IL1B,Rs1143627,celiac disease
IL1B,Rs1143627,multiple myeloma
IL1B,Rs1143627,race
IL1B,Rs1143627,brain arteriovenous malformation
IL1B,Rs1143627,intracranial hemorrhage
IL1B,Rs1143627,Organochlorine exposure
IL1B,Rs1143627,non-Hodgkin lymphoma
IL1B,Rs1143627,Korean keratoconus patients
IL1B,Rs1143627,childhood-onset mood disorders
IL1B,Rs1143627,high-dose treatment with stem cell
IL1B,Rs1143627,smoking
IL1B,Rs1143627,non-small cell lung cancer
IL1B,Rs1143627,cancers of the upper aerodigestive tract
IL1B,Rs1143627,cognition
IL1B,Rs1143627,hay-fever
IL1B,Rs1143627,osteoarthritis
IL1B,Rs1143627,diffuse large B-cell lymphoma
IL1B,Rs1143627,biliary tract cancers and stones
IL1B,Rs1143627,China
IL1B,Rs1143627,rheumatoid arthritis
IL1RL1,Rs13431828,Interleukin-1 receptor-like 1
IL1RL1,Rs1420101,nasal polyposis
IL1RL1,Rs1420101,Asthma
IL1RL1,Rs1420101,asthma
IL1RL1,Rs13431828,several SNPs in the IL1RL1 gene appeared to be protective against this condition
IL1RL1,Rs1420101,asthma in childhood
IL1RL1,Rs13431828,surgery-unresponsive chronic rhinosinusitis
IL1RL1,Rs13431828,chronic rhinosinusitis
IL1RL1,Rs11685480,receptor
IL1RL1,Rs11685480,eosinophils
IL1RL1,Rs11685480,serum 
IL1RL1,Rs11685480,polymorphisms 
IL1RL1,Rs11685480,Interleukin
IL1RL1,Rs11685480,eosinophils
IL1RL1,Rs11685480,asthma 
IL1RL1,Rs11685480,polymorphisms 
IL1RL1,Rs11685480,asthma 
IL1RN,Rs9005,knee osteoarthritis
IL1RN,Rs9005,Interleukin 1
IL1RN,Rs9005,knee osteoarthritis
IL1RN,Rs9005,Receptor Antagonist
IL1RN,Rs423904,Ulcerative colitis
IL1RN,Rs423904,Ulcerative colitis
IL1RN,Rs315952,knee osteoarthritis
IL1RN,Rs423904,rs423904 increases susceptibility to Ulcerative colitis 2.60 times for carriers of the T allele
IL2,Rs2069772,Cervical and vulvar cancer
IL20,Rs2981573,palmoplantar pustulosis
IL20,Rs2981573,chronic hepatitis B
IL21,Rs907715,rheumatoid arthritis
IL21,Rs907715,rheumatoid arthritis at a genome-wide
IL23R,Rs7517847,Crohn's disease
IL23R,Rs7517847,Crohn's disease
IL23R,Rs7517847,Crohn's disease
IL23R,Rs7517847,Italian patients
IL23R,Rs7517847,ulcerative colitis
IL23R,Rs7517847,Crohn's Disease
IL23R,Rs7517847,myocardial infarction
IL23R,Rs7517847,Spanish rheumatoid arthritis cohort
IL23R,Rs7517847,German Crohn's disease
IL23R,Rs7517847,Crohn's Disease
IL23R,Rs7517847,Crohn's disease
IL23R,Rs7517847,Brazilian population
IL23R,Rs7517847,New Zealand populations
IL23R,Rs7517847,Crohn's disease
IL23R,Rs1495965,ulcerative colitis
IL23R,Rs1495965,Iranian
IL23R,Rs1495965,north Indians
IL23R,Rs7517847,celiac disease and multiple sclerosis
IL23R,Rs1495965,early disease onset
IL23R,Rs1495965,colonic Crohn's disease
IL23R,Rs1495965,systemic lupus erythematosus
IL23R,Rs1495965,celiac disease
IL23R,Rs1495965,psoriasis
IL23R,Rs1495965,IBD
IL23R,Rs1495965,"Swedish, Finnish, Hungarian and Italian"
IL23R,Rs1495965,Crohn's disease
IL23R,Rs1495965,Brazilian population
IL23R,Rs1495965,Crohn's disease susceptibility
IL23R,Rs1495965,Crohn's disease
IL23R,Rs1495965,Behcet's disease
IL23R,Rs7517847,Spanish IBD patients
IL23R,Rs7517847,Italian
IL23R,Rs7517847,Finnish
IL23R,Rs7539625,osteonecrosis 
IL23R,Rs7539625,femoral 
IL23R,Rs7539625,gene 
IL23R,Rs7539625,receptor 
IL23R,Rs7539625,polymorphisms 
IL23R,Rs7539625,disease 
IL23R,Rs7539625,disease 
IL23R,Rs7539625,Genome
IL23R,Rs7539625,osteonecrosis of femoral head
IL23R,Rs7539625,Crohn's disease
IL23R,Rs7530511,Graves ophthalmopathy
IL23R,Rs7530511,Graves' disease
IL23R,Rs7530511,Graves' disease
IL23R,Rs7530511,psoriasis
IL23R,Rs7517847,north Indians
IL23R,Rs7517847,ulcerative colitis
IL23R,Rs7517847,colonic Crohn's disease
IL23R,Rs7517847,German children
IL23R,Rs7517847,Crohn's disease
IL23R,Rs7517847,Chinese Han population
IL23R,Rs7517847,Vogt-Koyanagi-Harada syndrome
IL23R,Rs7517847,Hungarian population
IL23R,Rs7517847,Sjogren syndrome
IL23R,Rs7517847,ankylosing spondylitis
IL23R,Rs7517847,autoimmune conditions
IL23R,Rs7517847,systemic lupus erythematosus
IL23R,Rs7517847,celiac disease
IL23R,Rs7517847,psoriasis
IL23R,Rs7517847,Hungarian
IL23R,Rs7517847,Swedish
IL23R,Rs1495965,German
IL23R,Rs1495965,Spanish
IL23R,Rs1495965,inflammatory bowel disease
IL23R,Rs11465804,ankylosing spondylitis
IL23R,Rs11465770,protective 
IL23R,Rs11465770,T allele
IL23R,Rs11465770,Crohn's disease
IL23R,Rs11465770,Crohn's disease
IL23R,Rs11465770,Crohn's disease
IL23R,Rs11465770,Crohn's disease
IL23R,Rs11209032,systemic sclerosis
IL23R,Rs11209032,ankylosing spondylitis
IL23R,Rs11209032,systemic sclerosis
IL23R,Rs11209032,ankylosing spondylitis
IL23R,Rs11209032,systemic sclerosis
IL23R,Rs11209032,ankylosing spondylitis
IL23R,Rs11465804,Caucasian
IL23R,Rs10889677,European ancestry
IL23R,Rs10889677,North American patients
IL23R,Rs10889677,Caucasian patients.
IL23R,Rs10889677,ankylosing spondylitis
IL23R,Rs10889677,non-Jewish populations.
IL23R,Rs10889677,Jewish
IL23R,Rs10889677,Crohn's disease
IL23R,Rs10889677,ulcerative colitis 
IL23R,Rs10889677,Graves ophthalmopathy
IL23R,Rs10889677,"Graves' disease,"
IL23R,Rs10889677,ankylosing spondylitis
IL23R,Rs10489629,ankylosing spondylitis.
IL23R,Rs10489629,Caucasian
IL23R,Rs1495965,rheumatoid arthritis
IL23R,Rs10889677,Graves' disease
IL23R,Rs11465804,ankylosing spondylitis
IL23R,Rs10889677,Crohn's disease
IL23R,Rs11465804,ankylosing spondylitis
IL23R,Rs11465804,Caucasian
IL23R,Rs1495965,Behçet's disease
IL23R,Rs1495965,ankylosing spondylitis
IL23R,Rs1495965,systemic sclerosis
IL23R,Rs1495965,Caucasian patients
IL23R,Rs1495965,ehcet's disease
IL23R,Rs1495965,early disease onse
IL23R,Rs1495965,colonic Crohn's disease
IL23R,Rs1495965,systemic lupus erythematosus
IL23R,Rs1495965,Crohn's disease
IL23R,Rs1495965,Crohn's disease susceptibility
IL23R,Rs1495965,rheumatoid arthritis
IL23R,Rs1495965,inflammatory bowel disease
IL23R,Rs1495965,systemic sclerosis
IL23R,Rs1495965,German Crohn's disease
IL23R,Rs1495965,ankylosing spondylitis
IL23R,Rs11465804,ankylosing spondylitis
IL23R,Rs11465804,SNPs
IL23R,Rs11465804,IL23R gene
IL23R,Rs1495965,Behçet's disease
IL23R,Rs11465804,ankylosing spondylitis
IL23R,Rs11805303,Crohn's disease
IL23R,Rs1343151,ankylosing spondylitis
IL23R,Rs11465804,Caucasian
IL23R,Rs1343151,Crohn's Disease
IL23R,Rs1343151,ankylosing spondylitis
IL23R,Rs1343151,rheumatoid arthritis 
IL23R,Rs1343151,rheumatoid arthritis 
IL23R,Rs1343151,Crohn's Disease 
IL23R,Rs1343151,rheumatoid arthriti
IL2RA,Rs3118470,type 1 diabetes and autoimmune thyroiditis
IL2RA,Rs706778,type-1 diabetes
IL2RA,Rs706778,strongly associated
IL2RA,Rs706778,strongly associated with type-1 diabetes
IL2RA,Rs3118470,Type I Diabetes Genetics Consortium
IL2RA,Rs3118470,interleukin-2 receptor-alpha gene
IL2RA,Rs3118470,diabetes
IL2RA,Rs3118470,pre-diabetes to diabetes
IL2RA,Rs3118470,type 1 diabetes
IL2RA,Rs3118470,Type I Diabetes
IL2RA,Rs3118470,Type I Diabetes
IL2RA,Rs3118470,type I diabetes
IL2RA,Rs3118470,autoimmune thyroiditis
IL2RA,Rs3118470,diabetes
IL2RA,Rs3118470,diabetes
IL2RA,Rs3118470,pre-diabetes to diabetes 
IL2RA,Rs3118470,diabetes
IL2RB,Rs743777,myasthenia gravis.
IL2RB,Rs743777,ant colony optimization algorithm. 
IL2RB,Rs743777,rheumatoid arthritis. 
IL2RB,Rs743777,rheumatoid arthriti
IL2RB,Rs743777, rheumatoid arthritis
IL2RB,Rs743777,autoimmune myasthenia gravis
IL2RB,Rs743777,rheumatoid arthritis
IL2RB,Rs743777,rheumatoid arthritis
IL2RB,Rs743777,rheumatoid arthritis
IL2RB,Rs743777,rheumatoid arthritis
IL2RB,Rs743777,rheumatoid arthritis
IL2RB,Rs743777,rheumatoid arthritis
IL2RB,Rs743777,Rheumatoid arthritis
IL2RB,Rs743777,rheumatoid arthritis
IL2RB,Rs743777,Rheumatoid arthritis
IL31,Rs6489188,were strongly associated with nonatopic eczema
IL31,Rs6489188,nonatopic eczema
IL31,Rs11608363,nonatopic eczema
IL31,Rs11608363,were strongly associated with nonatopic eczema
IL4,Rs2243274,Type I Diabetes
IL4,Rs2243268,autoimmune conditions
IL4,Rs2243268,type 1 diabetes
IL4,Rs2243268,non-Hodgkin lymphoma
IL4,Rs2243268,Cytokine polymorphisms
IL4,Rs2243268,Plasmodium falciparum malaria
IL4,Rs2243268,type 1 diabetes
IL4,Rs2243268,non-Hodgkin lymphoma
IL4,Rs2243268,smallpox vaccination
IL4,Rs2243268,biliary tract cancers and stones
IL4,Rs2243268,genetic predisposition to autoimmune conditions
IL4,Rs2243268,aggravation of Plasmodium falciparum malaria by interleukin 4
IL4,Rs2243268,Differences in candidate gene association between European ancestry and African American asthmatic children
IL4,Rs2243268,biliary tract cancers and stones
IL4,Rs2243274,type 1 diabetes.
IL4,Rs2243274,European ancestry
IL4,Rs2243274,African American
IL4,Rs2243274,children.
IL4,Rs2243268,race
IL4,Rs2243268,non-Hodgkin lymphoma
IL4,Rs2243274,type I diabetes
IL4,Rs2243266,asthmatic children
IL4,Rs2243268,type 1 diabetes
IL4,Rs2070874,Visceral leishmaniasis
IL4,Rs2070874,Leishmania chagasi
IL4,Rs2070874,prostate cancer
IL4,Rs2070874,Visceral leishmaniasis (VL)
IL4,Rs2070874,elayed-t
IL4,Rs2070874, with
IL4,Rs2070874,ng fro
IL4,Rs2070874,prostate cancer
IL4,Rs2070874,Leishmania chagasi
IL4,Rs2070874,rs2070874 
IL4,Rs2070874,defining the risk of dying from prostate cancer among patients with the disease
IL4,Rs2243250,myocardial infarction
IL4,Rs2243266,HLA-DRB1
IL4,Rs2243266,interleukin 4
IL4,Rs2243266,interferon-gamma
IL4,Rs2243266,giant cell arteritis
IL4,Rs2070874,rs2070874
IL4,Rs2243266,type 1 diabetes
IL6,Rs2069861,haplotype
IL6,Rs2069861,HFE hemochromatosis penetrance
IL6,Rs2069861,human
IL6,Rs2069861,polymorphisms 
IL6,Rs2069861,type 2
IL6,Rs2069861,diabetic patients
IL6,Rs2069861, influenza
IL6,Rs2069861,Genetic variation
IL6,Rs2069861,impaired renal function
IL6,Rs2069861,diabetes
IL6,Rs2069861,susceptibility to melanoma
IL6,Rs2069861,systemic inflammation
IL6,Rs2069861,COPD risk 
IL6,Rs2069861,susceptibility to melanoma
IL6,Rs2069861,seasonal influenza vaccine response
IL6,Rs2069861,type 2 diabetes
IL6,Rs2069861,risk and systemic inflammation
IL6,Rs2069861,mmunogenetics of seasonal influenza vaccine response
IL6,Rs2069861,COPD
IL6,Rs2069861,type 2 diabetes
IL6,Rs2069861,type 2
IL6,Rs2069861,systemic inflammation
IL6,Rs2069861,IL-6 haplotype
IL6,Rs2069861,type 2 diabetes
IL6,Rs7802308,Asian Indian sibling pairs
IL6,Rs7802308,coronary artery disease
IL6,Rs7802308,coronary artery disease
IL6,Rs7802308,coronary artery disease
IL6,Rs7802308,Asian Indian sibling pairs
IL6,Rs7802308,coronary artery disease
IL6,Rs7802307,affected
IL6,Rs7802307,coronary artery disease
IL6,Rs2069861,haplotypes
IL6,Rs2069861, CRP
IL6,Rs2069861, IL6
IL6,Rs2069861,seasonal influenza vaccine response
IL6,Rs2069861,Interleukin and interleukin receptor gene polymorphisms
IL6,Rs2069861, human chromosome 7p21
IL6,Rs2069837,gender
IL6,Rs2069861, HFE hemochromatosis penetrance
IL6,Rs2069861, HJV
IL6,Rs2069861,BMP4
IL6,Rs2069861,BMP2
IL6,Rs2069861,Interleukin-6 genetic variability and adiposity
IL6,Rs2069861,tagging-SNP haplotype analysis
IL6,Rs2069861,IL6 gene
IL6,Rs2069837,Alzheimer's disease
IL6,Rs2069861,impaired renal function in type 2 diabetic patients
IL6,Rs2069837,Alzheimer's disease
IL6,Rs1800796,osteoarthritis
IL6,Rs1800796,abdominal aortic aneurysm
IL6,Rs1524107,Cardiovascular Health Study
IL6,Rs1524107,IL1beta
IL6,Rs1524107,IL1RN
IL6,Rs1524107,amyloid-A
IL6,Rs1524107,prostate cancer
IL6,Rs1524107,interleukin-6
IL6,Rs1524107,C-reactive protein
IL6,Rs1800796,coronary artery disease
IL6,Rs1524107,human chromosome 7p21
IL6,Rs1524107,cardiovascular disease
IL6,Rs1524107,prostate cancer
IL6,Rs1524107,type 2 diabetic patients
IL6,Rs2069837,Alzheimer's
IL6,Rs13306435,sciatica 
IL6,Rs13306435,haplotype
IL6,Rs13306435,IL6 gene
IL6,Rs13306435,sciatica
IL6,Rs13306435,sciatica patients
IL6,Rs1524107,IL-6 haplotype
IL6,Rs1800796,abdominal aortic aneurysm
IL6,Rs13447446,rs13447446 may be a misassigned reference
IL6,Rs1800796,coronary artery disease
IL6,Rs1800796,elevated blood pressure
IL6,Rs2069837,Alzheimer's disease
IL6,Rs2069832,prostate cancer
IL6,Rs2069832,colon and rectal cancer
IL6,Rs2069832,breast cancer
IL6,Rs2069832,prostate cancer
IL6,Rs2069832,prostate cancer
IL6,Rs2069832,diabetic patients.
IL6,Rs2069832,breast cancer
IL6,Rs2069832,colon and rectal cancer
IL6,Rs2069832,prostate cancer
IL6,Rs2069830,stroke
IL6,Rs2069832,breast cancer
IL6,Rs1800796,polymorphism
IL6,Rs1800796,Asian Indian
IL6,Rs1800796,symptomatic DIP OA
IL6,Rs1800796,abdominal aortic aneurysm
IL6,Rs1800797,interphalangeal osteoarthritis
IL6,Rs1800797,disease
IL6,Rs1800797,coronary artery disease
IL6,Rs2066992,coronary artery disease
IL6,Rs1800796,coronary artery disease
IL6R,Rs4845617,plasma 
IL6R,Rs4845617,gene
IL6R,Rs4845617,receptor 
IL6R,Rs4845617,Interleukin
IL6R,Rs4845617,melanoma
IL6R,Rs4845617,polymorphisms 
IL6R,Rs4845617,gene 
IL6R,Rs4845617,postmenopausal 
IL6R,Rs4845617,interleukin 
IL6R,Rs4845617,Interleukin 
IL6R,Rs4845617,index 
IL6R,Rs4845617,mass
IL6R,Rs4845617,body 
IL6R,Rs4845617,protein
IL6R,Rs4845617,receptor 
IL6R,Rs4845617,diabetes
IL6R,Rs6684439,melanoma risk
IL6R,Rs4845617,receptor 
IL6R,Rs4845617,mineral 
IL6R,Rs6694817,cardiovascular genetic risk score
IL6R,Rs6694817,SNP
IL6R,Rs6694817,cardiovascular genetic
IL6R,Rs6694817,cardiovascular genetic risk
IL6R,Rs6684439,heterozygous
IL6R,Rs4845617,Genetic 
IL6R,Rs6684439,melanoma
IL6R,Rs6684439,melanoma
IL6R,Rs6684439,melanoma
IL6R,Rs4845617,polymorphisms 
IL6R,Rs4845617,breast 
IL6R,Rs4845617,cancer
IL6R,Rs4845617,schizophrenia 
IL6R,Rs6684439,melanoma
IL6R,Rs4845617,bone 
IL6R,Rs4845617,interleukin
IL6R,Rs4845617,receptor 
IL6R,Rs12730935,Multi-ancestry genome-wide
IL6R,Rs12730935,atopic dermatitis
IL6R,Rs2229238,diabetes
IL6R,Rs2229238,susceptibility to melanoma
IL6R,Rs2229238,diabetes risk in women
IL6R,Rs2229238,longevity in older adults
IL6R,Rs4129267,autoimmune inflammatory conditions
IL6R,Rs4129267,Caucasians
IL6R,Rs4129267,Asians
IL6R,Rs4129267,Cardiovascular Disease
IL6R,Rs4129267,diabetes 
IL6R,Rs4129267,Crohn disease
IL6R,Rs4129267,Breast cancer
IL6R,Rs4537545,increases IL-6r and IL-6 levels
IL6R,Rs4537545,inflammatory effects
IL6R,Rs4129267,Asthma 
IL6R,Rs4537545,Inflammation
IL6R,Rs4845617,gene 
IL6R,Rs4845617,Polymorphisms 
IL6R,Rs4537545,amniotic fluid protein concentrations
IL6R,Rs4845617,receptor 
IL6R,Rs4845617,soluble 
IL6R,Rs4845617,allele 
IL6R,Rs4537545,"psoriasis, and inflammation"
IL6R,Rs4845617,interleukin 
IL6R,Rs4537545,Inflammation
IL6R,Rs4537545,inflammatory effects
IL6R,Rs4537545,inflammatio
IL6R,Rs4537545,psoriasis
IL6R,Rs4537545,Crohn disease
IL6R,Rs4537545,stress-related
IL6R,Rs4537545,Crohn disease
IMMP2L,Rs12531640,10^-6
IMPDH1,Rs72624951,Blueprint Genetics Retinal dystrophy
IMPDH1,Rs72624951,Blueprint Genetics Retinal dystrophy
INSL6,Rs77375493,thrombocythemia
INSL6,Rs77375493,polycythemia vera
INSL6,Rs77375493,cancers of the blood
INSL6,Rs77375493,myeloproliferative disorders
INSL6,Rs77375493,idiopathic myelofibrosis
INSL6,Rs77375493,thrombocythemia
INSL6,Rs77375493,olycythemia vera
INSL6,Rs77375493,cancers of the blood
INSL6,Rs77375493,idiopathic myelofibrosis
INSL6,Rs3780378,"body fat, insulin sensitivity and lipid profile."
INSL6,Rs121912472,myeloproliferative disorders
INSL6,Rs121912472,myeloproliferative
INSL6,Rs10815149,myeloproliferative neoplasm
INSL6,Rs10815149,due to stem cells over producing too many of one type of cell
INSL6,Rs10815149,myeloproliferative neoplasm
INSL6,Rs10815149,myeloproliferative neoplasm
INSL6,Rs77375493,ssociated with several myeloproliferative disorders
INSR,Rs2860174,migraine 
INSR,Rs2860174,migraine 
INSR,Rs1864010,rs1864010 
INSR,Rs1864010,associated with the risk of colorectal cancer
IRAK1,Rs1059703,cerebral infarction
IRAK1,Rs1059703,Japanese adults
IRAK3,Rs1882200,asthma candidate gene associations
IRF1,Rs2070729, severe malaria in affected child-parental
IRF1,Rs2070729,African populations
IRF1,Rs2070729,three African
IRF1,Rs2070729,circulating fibrinogen levels
IRF1,Rs2070729,malaria
IRF1,Rs2070729,Lack of association of interferon regulatory factor 1 with severe malaria in affected child-parental trio studies across three African populations. Association of novel genetic Loci with circulating fibrinogen levels: a genome-wide association study in 6 population-based cohorts
IRF1,Rs2070729,severe malaria
IRF5,Rs2004640,rheumatoid arthritis
IRF5,Rs2004640,systemic sclerosis
IRF5,Rs2004640,rheumatoid arthritis
IRF5,Rs2004640,increasing SLE risk
IRF5,Rs2004640,systemic lupus erythematosus (SLE)
IRF5,Rs10954213,systemic lupus erythematosus
IRF5,Rs10954213,lupus erythematosus
IRF5,Rs10954213,primary biliary cirrhosis
IRF5,Rs10954213,IgA nephropathy
IRF5,Rs10954213,lupus nephritis
IRF5,Rs10954213,Shandong Han population
IRF5,Rs10954213,SLE
IRF5,Rs10954213,systemic lupus erythematosus
IRF5,Rs10954213,systemic lupus erythematosus
IRF5,Rs10954213,discoid and subacute cutaneous lupus erythematosus
IRF5,Rs10954213,systemic lupus erythematosus
IRF5,Rs10954213,systemic lupus erythematosus patients
IRF5,Rs2004640,multiple sclerosis
IRF5,Rs6953165,SLE
IRF5,Rs3807306,systemic lupus erythematosus
IRF5,Rs10954213,multiple sclerosis
IRF5,Rs6953165,"requency was found to be significantly increased in SLE patients (P = 8.3 x 10(-5)). While no association was observed for the rs10954213 . significant associations with 3 intron 1 SNPs (-4001, rs69"
IRF5,Rs6953165,SLE
IRF5,Rs6953165,SLE
IRF5,Rs6953165,SLE
IRF5,Rs6953165,SLE
IRF5,Rs6953165,SLE
IRF5,Rs6953165,SLE
IRF5,Rs6953165,SLE
IRF5,Rs41298401,"requency was found to be significantly increased in SLE patients (P = 8.3 x 10(-5)). While no association was observed for the rs10954213 . significant associations with 3 intron 1 SNPs (-4001, rs69"
IRF5,Rs41298401,SLE
IRF5,Rs41298401,SLE
IRF5,Rs41298401,SLE
IRF5,Rs41298401,SLE
IRF5,Rs41298401,SLE
IRF5,Rs41298401,SLE
IRF5,Rs41298401,SLE
IRF5,Rs3807306,multiple sclerosis
IRF5,Rs10954213,psoriasis
IRF5,Rs41298401,SLE
IRF5,Rs10954213,Sjogren's syndrome
IRF5,Rs10954213,SLE
IRF5,Rs10954213,systemic lupus erythematosus
IRF5,Rs10954213,systemic lupus erythematosus
IRF5,Rs10954213,subacute cutaneous lupus erythematosus
IRF5,Rs10954213,systemic lupus erythematosus
IRF5,Rs10954213,systemic lupus erythematosus
IRF5,Rs10954213,high serum interferon-alpha activity
IRF5,Rs10954213,psoriasis
IRF5,Rs10954213,Sjogren's syndrome
IRF5,Rs10954213,lupus
IRF5,Rs10954213,systemic lupus erythematosus
IRF5,Rs10954213,SLE
IRF5,Rs10954213,SLE
IRF5,Rs10954213,SLE
IRF5,Rs10954213,SLE
IRF5,Rs10954213,SLE
IRF5,Rs10954213,Swedish
IRF5,Rs10954213,primary biliary cirrhosis
IRF5,Rs10954213,systemic lupus erythematosus
IRF5,Rs10954213,Systemic Lupus Erythematosus
IRF5,Rs10954213,lupus nephritis
IRF5,Rs10954213,systemic lupus erythematosus
IRF5,Rs10954213,human lupus
IRF5,Rs10954213,systemic lupus erythematosus
IRF5,Rs10954213,UK SLE families
IRF5,Rs10954213,Japanese SLE patients
IRF5,Rs10954213,increasing SLE risk
IRF5,Rs10954213,Caucasian
IRF5,Rs10954213,SLE
IRF5,Rs10954213,SLE
IRF5,Rs10954213,SLE
IRF5,Rs10954213,Japanese
IRF5,Rs10954213,SLE
IRF5,Rs10954213,SLE
IRF5,Rs10954213,Japanese
IRF5,Rs10954213,Systemic Lupus Erythematosus
IRF5,Rs10954213,systemic sclerosis
IRF5,Rs10954213,IgA nephropathy
IRF5,Rs10954213,Korean
IRS1,Rs1801123,type I diabetes
IRS1,Rs1801123,Genetic variation in insulin-like growth factor signaling genes
IRS1,Rs1801123,No association of the IRS1 and PAX4 genes with type I diabetes
IRS1,Rs1801123,BRCA1 and BRCA2 carriers
IRS1,Rs1801123,PAX4
IRS1,Rs1801123,breast cancer risk
IRS1,Rs1801123,BRCA2
IRS1,Rs1801123,BRCA1
IRS1,Rs1801123,breast cancer
IRS1,Rs1801123,type I diabetes
IRS1,Rs1801123,breast cancer
IRS1,Rs1801123,IRS1 
ITGA2B,Rs80277041,Glanzmann's thrombasthenia
ITGA2B,Rs80277041,Glanzmann's thrombasthenia
ITGA2B,Rs80002943,Glanzmann's thrombasthenia
ITGA2B,Rs80002943,Glanzmann's thrombasthenia
ITGA2B,Rs76811038,Glanzmann's thrombasthenia
ITGA2B,Rs76811038,Glanzmann's thrombasthenia
ITGA2B,Rs137852911,Glanzmann's thrombasthenia
ITGA2B,Rs137852910,Glanzmann's thrombasthenia
ITGA2B,Rs137852911,Glanzmann's thrombasthenia
ITGA2B,Rs137852909,Glanzmann's thrombasthenia
ITGA2B,Rs137852909,Glanzmann's thrombasthenia
ITGA2B,Rs137852908,Glanzmann's thrombasthenia
ITGA2B,Rs137852908,Glanzmann's thrombasthenia
ITGA2B,Rs137852907,Glanzmann's thrombasthenia
ITGA2B,Rs137852907,Glanzmann's thrombasthenia
ITGA2B,Rs137852906,Glanzmann's thrombasthenia
ITGA2B,Rs137852906,Glanzmann's thrombasthenia
ITGA2B,Rs137852910,Glanzmann's thrombasthenia
ITGAV,Rs3738919,CI: 1.3â€“2.9
ITGAV,Rs3738919,rheumatoid arthritis (RA)
ITGAV,Rs3738919,rheumatoid arthritis (RA)
ITGAV,Rs3738919,RA
ITGAV,Rs9333289,autosomal recessive retinitis pigmentosa
ITGB3,Rs5918,heart attack
ITGB3,Rs5918,breast cancer
ITGB3,Rs5918,Non-Hodgkin Lymphoma
ITGB3,Rs5918,early onset heart disease
ITGB3,Rs5918,myocardial infarction
ITGB3,Rs5918,"heart disease,"
ITGB3,Rs5918,"myocardial infarction,"
ITGB3,Rs5918,"2' allele of the platelet specific alloantigen system is encoded by rs5918(C), and it has"
ITGB3,Rs5918,blood-thinning
ITPA,Rs6139030,Hepatitis C
ITPA,Rs6139030,thrombocytopenia
ITPA,Rs6139030,higher ris
ITPA,Rs6139030,Carriers of the C allele
ITPA,Rs6139030,Hepatitis C
ITPA,Rs6139030,thrombocytopenia 
ITPA,Rs6139030,thrombocytopenia
ITPA,Rs1127354,anemia 
ITPA,Rs1127354,hemolytic anemia
ITPA,Rs1127354,rheumatoid arthritis
ITPA,Rs1127354,autosomal recessive anonychia
ITPA,Rs1127354,febrile neutropenia
ITPA,Rs1127354,chronic hepatitis C
ITPKC,Rs28493229,Kawasaki disease
ITPKC,Rs28493229,Kawasaki Disease
ITPKC,Rs28493229,Han Chinese
ITPKC,Rs28493229,Kawasaki Disease
ITPKC,Rs28493229,cervical squamous cell carcinoma
ITPKC,Rs28493229,Kawasaki disease
ITPKC,Rs28493229,Kawasaki Disease
ITPKC,Rs28493229,coronary artery aneurysms
ITPKC,Rs28493229,Kawasaki Disease
ITPKC,Rs28493229,Kawasaki Disease:
ITPKC,Rs28493229,Kawasaki disease.
ITPKC,Rs28493229,coronary artery aneurysms
ITPKC,Rs28493229, Kawasaki disease
ITPKC,Rs28493229,Kawasaki Disease
ITPKC,Rs28493229,cervical squamous cell carcinoma
ITPKC,Rs28493229,Intravenous Immunoglobulin-Resistant Kawasaki Disease
ITPKC,Rs28493229,coronary artery lesion
ITPKC,Rs28493229,coronary artery aneurysms
ITPKC,Rs28493229,Kawasaki Diseas
ITPR3,Rs3748079,rheumatoid arthritis
ITPR3,Rs2296336,disequilibrium
ITPR3,Rs2296336,type-1 diabetes
ITPR3,Rs2296336,type-1 diabetes
ITPR3,Rs2296336, linkage disequilibrium 
ITPR3,Rs2296336,diabetes
ITPR3,Rs2296336, homozygotes
ITPR3,Rs2296336,SNP
ITPR3,Rs2296336,heterozygotes
ITPR3,Rs2296336,diabetes
ITPR3,Rs2296336,type-1 
ITPR3,Rs2296336,Swedish 
ITPR3,Rs2296336, type-1
JAK2,Rs77375493,idiopathic myelofibrosis
JAK2,Rs77375493,thrombocythemia
JAK2,Rs77375493,polycythemia vera
JAK2,Rs77375493,myeloproliferative disorders
JAK2,Rs77375493,idiopathic myelofibrosis
JAK2,Rs77375493,thrombocythemia
JAK2,Rs77375493,olycythemia vera
JAK2,Rs77375493,cancers of the blood
JAK2,Rs77375493,cancers of the blood
JAK2,Rs3780378,"body fat, insulin sensitivity and lipid profile."
JAK2,Rs121912472,myeloproliferative disorders
JAK2,Rs121912472,myeloproliferative
JAK2,Rs10815149,myeloproliferative neoplasm
JAK2,Rs10815149,due to stem cells over producing too many of one type of cell
JAK2,Rs10815149,myeloproliferative neoplasm
JAK2,Rs10815149,myeloproliferative neoplasm
JAK2,Rs77375493,ssociated with several myeloproliferative disorders
JUP,Rs113994177,Naxos disease
JUP,Rs113994177,palmoplantar keratoderma
JUP,Rs113994177,woolly hair
JUP,Rs113994176,novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy
JUP,Rs113994177,arrhythmogenic right ventricular cardiomyopathy
KCNA3,Rs2821557,olfactory function
KCNA3,Rs2821557,olfactory dysfunction
KCNA3,Rs2821557,fasting plasma glucose
KCNA3,Rs2821557,olfactory dysfunction
KCNA3,Rs2821557,loss of olfactory function
KCNA3,Rs2821557,olfactory dysfunction
KCNA3,Rs2821557,loss of olfactory function with age
KCNA3,Rs2821557,olfactory dysfunction
KCNA5,Rs45477792,affecting an amino acid in exon 1 of the KCNA5 potassium channel gene
KCNA5,Rs45477792,cardiac arrhythmias
KCNA5,Rs45477792,cardiac arrhythmias
KCNA5,Rs45438698,"Note that this allele is rare; it was not observed in African-American or Asian populations, however it is reported to be present at a frequency of 1.1% among Caucasians."
KCNA5,Rs45438698,"The risk allele is rs45438698(A), and carriers receiving quinidine or propafenone for the treatment of cardiac arrhythmias may be resistant to the drug (and thus treatment)"
KCNA5,Rs45438698,"R578K, affecting an amino acid in exon 1 of the KCNA5 potassium channel gene, may mediate the response to drugs such as quinidine and propafenone"
KCNB1,Rs756529,LV hypertrophy in humans
KCNE1,Rs74315446,a common cause of severe long-QT syndrome.
KCNE1,Rs74315445,long QT syndrome
KCNE1,Rs74315445,long QT syndrome
KCNE1,Rs74315445,long QT syndrome
KCNE1,Rs74315445,catecholaminergic polymorphic ventricular tachycardia
KCNE1,Rs74315445,Lange-Nielsen and Romano-Ward forms of Long-QT syndrome
KCNE1,Rs74315446,long QT syndrome and suppress IKs function.
KCNE1,Rs74315445,jervell
KCNE1,Rs74315445,suppress IKs function
KCNE1,Rs74315445,Lange-Nielsen syndrome
KCNE1,Rs727957,Influences QT interval
KCNE1,Rs1805128,Influences QT interval
KCNE1,Rs74315445,Jervell
KCNH2,Rs121912515,long QT syndrome
KCNH2,Rs121912515,polymorphisms 
KCNH2,Rs121912515,QT syndrome
KCNH2,Rs121912515,long QT syndrome
KCNH2,Rs121912515,polymorphisms
KCNH2,Rs121912515,QT syndrome
KCNH2,Rs121912515,QT syndrome
KCNH2,Rs121912515,polymorphisms
KCNH2,Rs121912515,mutations
KCNH2,Rs121912515,FAMILION long QT syndrome genetic test.
KCNH2,Rs121912515,long QT syndrome.
KCNH2,Rs121912515,long QT syndrome
KCNH2,Rs121912515,pathogenic mutations
KCNH2,Rs121912512,homozygous HERG mutation
KCNH2,Rs121912512,severe neonatal long QT syndrome
KCNH2,Rs1137617,potentially inherited
KCNH2,Rs1137617,cardiac arrhythmia
KCNH2,Rs1036145,hippocampal volume
KCNH2,Rs1036145,hippocampal activity
KCNH2,Rs1036145,declarative memory task
KCNH2,Rs1036145,activity in the dorsolateral prefrontal cortex
KCNH2,Rs1036145, risk for schizophrenia
KCNH2,Rs1036145,hippocampal activity
KCNH2,Rs1036145,brain parameters
KCNH2,Rs1036145,activity in the dorsolateral prefrontal cortex (DLPFC)
KCNH2,Rs1036145,schizophrenia
KCNH2,Rs1137617,The rs1137617(C) and (T) alleles
KCNH2,Rs1137617,are both common and encode the same amino acid (tyrosine; TYR)
KCNH2,Rs1137617,considered pathogenic for cardiac arrhythmia
KCNH2,Rs1036145,eclarative memory task
KCNJ1,Rs59172778,type 2 Bartter syndrome
KCNJ1,Rs59172778,Bartter syndrome
KCNJ1,Rs59172778,Bartter syndrome
KCNJ1,Rs59172778,Bartter syndrome
KCNJ1,Rs59172778,Bartter syndrome 
KCNJ1,Rs59172778,Bartter syndrome
KCNJ1,Rs59172778,type 2 Bartter syndrome
KCNJ1,Rs59172778,Bartter syndrome
KCNJ1,Rs59172778,Bartter syndrome
KCNJ1,Rs59172778,Bartter syndrome
KCNJ1,Rs59172778,Bartter syndrome
KCNJ11,Rs80356616,permanent neonatal diabetes
KCNJ11,Rs80356616,neonatal diabetes syndrome and other neurological features
KCNJ11,Rs80356616,epilepsy
KCNJ11,Rs80356616,developmental delay
KCNJ11,Rs80356616,neonatal diabetes
KCNJ11,Rs80356616,neonatal diabetes plus neurological features
KCNJ11,Rs80356616,neonatal diabetes
KCNJ11,Rs80356616,permanent neonatal diabetes
KCNJ11,Rs80356613,Relapsing diabetes can result from moderately activating mutations in KCNJ11.
KCNJ11,Rs80356616,Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features.
KCNJ11,Rs5215,type-1 diabetes
KCNJ11,Rs193929336,permanent neonatal diabetes
KCNJ11,Rs193929336,neonatal diabetes
KCNJ11,Rs193929336,activating mutations
KCNJ11,Rs193929336,activating 
KCNJ11,Rs193929336,activating mutations
KCNJ11,Rs193929336,diabetes
KCNJ11,Rs193929339,Relapsing diabetes can result from moderately activating mutations in KCNJ11.
KCNJ11,Rs5215, type-1 diabetes 
KCNJ11,Rs193929336,mutations 
KCNMA1,Rs762705295,pathogenic variant
KCNQ1,Rs120074194,long QT syndrome
KCNQ1,Rs120074194,Vasoactive intestinal polypeptide (VIP)
KCNQ1,Rs120074194,Huntington's disease
KCNQ1,Rs120074194,forme fruste long-QT syndrome
KCNQ1,Rs120074194,long-QT syndrome
KCNQ1,Rs120074194,Jervell
KCNQ1,Rs120074194,Lange-Nielsen syndrome
KCNQ1,Rs120074194,swimming-triggered arrhythmia syndromes
KCNQ1,Rs12720459,potassium voltage-gated channel
KCNQ1,Rs120074195,short QT-interval syndrome
KCNQ1,Rs12576239,Influences QT interval
KCNQ1,Rs12720459,SNP 
KCNQ1,Rs120074194,long QT syndrome
KCNQ1,Rs12720459,SNP
KCNQ1,Rs12720459,mutations
KCNQ1,Rs12720459,less severe forms 
KCNQ1,Rs12720459,Long QT syndrome
KCNQ1,Rs12720459,Long QT syndrome
KCNQ1,Rs120074195,long-QT syndrome
KCNQ1,Rs120074194,Jervell and Lange-Nielsen syndrome
KCNQ1,Rs120074194,swimming-triggered arrhythmia syndromes
KCNQ1,Rs120074194,forme fruste long-QT syndrome
KCNQ1,Rs104894252,cardiac arrhythmias
KCNQ1,Rs120074194,long-QT syndrome genes
KCNQ1,Rs104894252,cardiac arrhythmias
KCNQ1,Rs104894252,cardiac arrhythmias
KCNQ1,Rs104894252,long QT syndrome
KCNQ1,Rs104894252,cardiac arrhythmias
KCNQ1,Rs104894252,long QT syndrome
KCNQ1,Rs104894252,cardiac arrhythmias
KCNQ1,Rs120074188,Recessive Romano-Ward syndrome
KCNQ1,Rs104894252,long QT syndrome
KCNQ1,Rs120074190,mutation 
KCNQ1,Rs120074190,mutations 
KCNQ1,Rs120074190,QT syndrome
KCNQ1,Rs120074193,arrhythmogenic trigger
KCNQ1,Rs120074193,inherited long QT syndrome
KCNQ1,Rs120074193,long-QT syndrome 
KCNQ1,Rs120074193,lethal cardiac arrhythmias
KCNQ1,Rs120074193,sudden death
KCNQ1,Rs120074194,Huntington's disease
KCNQ1,Rs120074188,FAMILION long QT syndrome
KCNQ4,Rs80358279,KCNQ4 pore-region mutation
KCNQ4,Rs80358279,deafness
KCNQ4,Rs80358276,autosomal dominant hearing loss
KCNQ4,Rs80358271,responsible 
KCNQ4,Rs80358271,DFNA2 
KCNQ4,Rs80358271,KCNQ4 
KCNQ4,Rs28937589,deafness
KCNQ4,Rs28939710,deafness
KCNQ4,Rs28939710,deafness Mutations
KCNQ4,Rs28937589,deafness
KCNQ4,Rs28937588,deafness
KCNQ4,Rs28937588,deafness
KCNQ4,Rs80358271,autosomal dominant deafness
KDM5D,Rs2032623,HIV progression
KDM5D,Rs2032634,results
KDM5D,Rs2032623,HAART outcome
KDM5D,Rs2032623,Y chromosome
KDM5D,Rs2032623,"Association of Y chromosome haplogroup I with HIV progression, and HAART outcome."
KDM5D,Rs2032623,HIV progression
KDM5D,Rs2032623,Y chromosome haplogroup I
KDM5D,Rs2032623,HAART outcome.
KDR,Rs7691507,VEGF
KDR,Rs7691507,VEGFR
KDR,Rs7691507,KDR
KDR,Rs2125489,neovascular age-related
KDR,Rs2125489,VEGFR-2
KDR,Rs2125489,VEGFA
KDR,Rs2125489,Polymorphisms
KDR,Rs2125489,neovascular age-related macular degeneration
KDR,Rs2125489,macular degeneration
KDR,Rs1870377,age-related macular degeneration
KDR,Rs1870377,Gilbert's syndrome
KDR,Rs1870377,Pazopanib-induced hyperbilirubinemia
KDR,Rs1870377,Gilbert's syndrome UGT1A1 polymorphism
KDR,Rs1531289,chronic myeloid leukemia
KDR,Rs1531289,neovascular age-related macular degeneration
KDR,Rs1531289,Polymorphisms in the VEGFA and VEGFR-2 genes
KDR,Rs1870377,Gilbert's syndrome
KEL,Rs8176059,Non-ABO Blood Groups
KEL,Rs8176059,Non-ABO Blood Groups
KEL,Rs8176038,KEL blood group
KEL,Rs8176038,alleles
KEL,Rs8176038,antigens
KIAA0319,Rs4352670,dyslexia
KIAA0319,Rs12193738,histone
KIAA0319,Rs12193738,reading disabilities
KIAA0319,Rs4236032,developmental dyslexia
KIAA0319,Rs4236032,susceptibility to developmental dyslexia.
KIAA0319,Rs4236032,developmental dyslexia
KIAA0319,Rs4352670,KIAA0319 on chromosome 6p
KIAA0319,Rs4352670,developmental dyslexia
KIF1A,Rs548204329, uncovered in hereditary spastic paraplegia
KIF1A,Rs548204329,hereditary spastic paraplegia
KIF1A,Rs548204329,Arg11Trp
KIF1B,Rs10492972,multiple sclerosis
KIF1B,Rs10492972,disease
KIF1B,Rs10492972,multiple sclerosis
KIF1B,Rs10492972,Alzheimer disease
KIF1B,Rs10492972,multiple sclerosis
KIF1B,Rs10492972,multiple sclerosis
KIF1B,Rs10492972,multiple sclerosis
KIF1B,Rs17401966,HBV-related hepatocellular carcinoma susceptibility gene
KIF1B,Rs17401966,not associated with development of chronic hepatitis B.
KIF5A,Rs113247976,Lou Gehrig's disease
KIF5A,Rs113247976,minor allele of this SNP located in the 3' terminal area of the KIF5A gene
KIF5A,Rs113247976,Lou Gehrig's disease
KIF5A,Rs113247976,ALS
KIF5A,Rs113247976,minor allele of this SNP
KIF5A,Rs113247976,Lou Gehrig's disease
KIF5A,Rs113247976,ALS
KIF5A,Rs113247976,Lou Gehrig's disease
KIF5A,Rs113247976,ALS
KIF5A,Rs113247976,ALS
KIRREL3,Rs1939992,Autosomal recessive ichthyosis with hypotrichosis
KIT,Rs28933968,somatic mutation
KIT,Rs28933968,somatic mutation
KITLG,Rs4590952,protection from sun damage
KITLG,Rs4590952,sun damage
KITLG,Rs4590952,testicular cancer
KITLG,Rs4590952,testicular cancer
KITLG,Rs4590952,KITLG p53-binding response element
KITLG,Rs4590952,linked to both testicular cancer and protection from sun damage
KITLG,Rs4590952,testicular cancer
KITLG,Rs4590952,protection from sun damage
KITLG,Rs3782179,testicular cancer
KITLG,Rs12821256,Europeans
KITLG,Rs3782179,Testicular germ cell tumor 
KITLG,Rs12821256,lighter hair color
KITLG,Rs12821256,blond hair color
KITLG,Rs12821256,more likely to have blond than brown hair color
KITLG,Rs12821256,Dutch
KITLG,Rs12821256,Icelanders
KITLG,Rs12821256,blond than brown hair color
KITLG,Rs12821256,blond hair color
KITLG,Rs3782179,testicular cancer
KL,Rs211239,allele
KL,Rs2249358,priapism
KL,Rs2249358,anemia 
KL,Rs2249358,priapism
KL,Rs2249358,rs2249358(G) allele
KL,Rs2249358,rs211239
KL,Rs2249358,KLOTHO gene
KL,Rs211239,carriers
KL,Rs2249358,rs2249358
KL,Rs211239,priapism
KL,Rs2249358,dbSNP orientation
KL,Rs211239,KLOTHO gene
KL,Rs211239,priapism
KL,Rs211239,sickle cell anemia
KL,Rs211239,priapism
KL,Rs211239,cell 
KL,Rs211239,sickle cell anemia
KL,Rs211239,sickle 
KL,Rs211239,priapism
KL,Rs211239,allele
KL,Rs211239,SNPs
KL,Rs211239,anemia 
KLF6,Rs10508266,Lung cancer
KLF6,Rs10508266,Lung cancer risk.
KLF6,Rs10508266,significant association
KLF6,Rs10508266,Lung cancer risk.
KLK3,Rs17632542,prostate cancer
KLK3,Rs17632542,PSA levels
KRAS,Rs61764370,no evidence for any association
KRAS,Rs61764370,triple-negative breast cancer
KRAS,Rs61764370,ovarian cancer
KRAS,Rs727503110,Gln22
KRAS,Rs61764370, breast cancer
KRAS,Rs17388587,risk of endometriosis.
KRAS,Rs1137282,endometriosis
KRAS,Rs61764370,ovarian cancer
KRIT1,Rs267607204,cerebral cavernous malformation
KRIT1,Rs267607204,"KRIT1 gene, c.987C>A, p.Cys329Ter, C329X mutationrs267607204(A) is considered a dominantly inherited pathogenic mutation for cerebral cavernous malformation."
KRIT1,Rs374303823,G>A
KRIT1,Rs886039402,1267
KRT14,Rs60831116,heterozygous C-to-A transversion at cDNA position
KRT14,Rs60831116,dermatopathia pigmentosa reticularis
KRT14,Rs60831116,DERMATOPATHIA PIGMENTOSA RETICULARIS
KRT14,Rs60831116,DERMATOPATHIA PIGMENTOSA RETICULARIS
KSR2,Rs10444502,decreased total cholesterol levels
KSR2,Rs4767631,LDL cholesterol
LAMA2,Rs12193446,risk of nearsightedness
LAMB3,I5012671,Herlitz typers
LAMB3,I5012672,typers80356682
LAMB3,I5012672,Epidermolysis bullosa
LAMB3,I5012671,epidermolysis bullosa
LAMB3,I5012671,junctional
LAMB3,I5012669,epidermolysis bullosa
LAMB3,I5012669,"epidermolysis bullosa, junctional, Herlitz type"
LAMB3,I5012669,Herlitz typers
LAMB3,I5012669,junctional
LAMB3,I5012671,epidermolysis bullosa
LAMB3,I5012669,epidermolysis bullosa
LBP,Rs2232596,hematopoietic cell
LDB3,Rs45487699,rare mutation in the LDB3 gene on chromosome 10
LDB3,Rs45487699,left ventricular noncompaction
LDB3,Rs45487699,a form of left ventricular noncompaction
LDB3,Rs121908337,ventricular noncompaction
LDB3,Rs121908337,ventricular noncompaction
LDB3,Rs121908338,left ventricular noncompaction
LDLRAP1,Rs755104973,pathogenic variant
LEP,Rs2071045,endometrial cancer
LEP,Rs2167270,rheumatoid arthritis
LEP,Rs2167270,hypertension
LEP,Rs2167270,prostate cancer
LEP,Rs2167270,Adipokine
LEP,Rs2167270,colon cancer
LEP,Rs2071045,obesity-related genes
LEP,Rs2071045,Genetic polymorphisms
LEP,Rs2071045,endometrial cancer
LEP,Rs2071045,obesity-related genes
LEP,Rs2071045,weight regain
LEP,Rs17151919,spina bifida
LEP,Rs17151919,glucose metabolism
LEP,Rs17151919,Genes
LEP,Rs17151919,spina bifida
LEP,Rs17151919,spina bifida.
LEPR,Rs1137101,cardiomyopathy patients
LEPR,Rs1137101,"allele is significantly associated with type-2 diabetes,"
LEPR,Rs1137101,may be associated with obesity in women with a psychotic disorder treated with atypical antipsychotic drugs
LEPR,Rs1137101,Gln223Arg polymorphism could be considered a disease susceptibility modulating factor both in ischemic heart disease or dilated cardiomyopathy patients.
LEPR,Rs6700896,ower CRP and associated with increased weight and body mass index
LEPR,Rs8179183,rs8179183
LEPR,Rs6700896,associated with increased weight and body mass index
LEPR,Rs1137101,ischemic heart disease
LEPR,Rs8179183,mostly Caucasian patients
LEPR,Rs8179183,less likely to gain significant weight
LEPR,Rs6700896,increased weight and body mass index
LEPR,Rs1137101,olymorphism could be considered a disease susceptibility modulating factor
LEPR,Rs1137101,represents a very common variant in the LEPR gene on chromosome 1
LEPR,Rs1137101,obesity 
LEPR,Rs1137101,rs1137101 may be associated with
LEPR,Rs1137101,obesity 
LEPR,Rs1137101,type-2 diabetes
LEPR,Rs1137101,concludes that the rs1137101(G) allele is significantly associated with
LEPR,Rs1137101,the (G) allele encodes the Arg/R allele
LEPR,Rs1137101,allele encodes the Gln/Q codon
LEPR,Rs1137100,risk of dying
LEPR,Rs1137100,prostate cancer among patients with the disease
LEPR,Rs1137100,"affect glucose tolerance and insulin response,"
LEPR,Rs1137101,psychotic disorder
LHCGR,Rs121912532,hyperplasia
LHCGR,Rs13405728,polycystic ovary syndrome
LHCGR,Rs13405728,hirsutism
LHCGR,Rs13405728,Polycystic Ovary Syndrome
LHCGR,Rs13405728,PCOS
LHCGR,Rs2293275,polycystic ovary syndrome
LHCGR,Rs2293275,spermatogenetic damage
LHCGR,Rs2293275,male infertility
LHCGR,Rs2293275,breast cancer
LHCGR,Rs2293275,Alzheimer's disease
LHCGR,Rs121912532,adenoma
LHCGR,Rs13405728,PCOS
LHCGR,Rs121912532,Leydig cell
LHCGR,Rs121912532,gonadotrophin subunit
LHCGR,Rs121912532,LH receptor gene
LHCGR,Rs121912518,familial male precocious puberty
LHCGR,Rs121912518,familial male precocious puberty
LHCGR,Rs121912518,male
LHCGR,Rs121912532,mutations of the LH receptor gene
LHCGR,Rs121912532,bovine rhinotracheitis virus
LHCGR,Rs121912518,familial male precocious puberty
LHCGR,Rs121912532,LH receptor gene.
LHCGR,Rs121912532,polymorphisms
LHCGR,Rs121912532,human lutropin receptor
LHCGR,Rs121912532,Leydig cell 
LHCGR,Rs121912532,lutropin/choriogonadotropin receptor (LHR)
LHCGR,Rs121912532,gonadotrophins
LIG4,Rs10131,invasive serous ovarian cancer
LIG4,Rs10131,DNA damage response
LIG4,Rs10131,invasive serous ovarian cancer 
LIG4,Rs10131, DNA damage response
LINC-PINT,Rs6971499,Pancreatic cancer
LINC-PINT,Rs6971499,against Pancreatic cancer.
LINC-PINT,Rs6971499,pancreatic cancer
LINC-PINT,Rs6971499,European
LINC-PINT,Rs157935,Carcinoma 
LINC-PINT,Rs4593472,"breast cancer, GWAS"
LINC-PINT,Rs157935,parental imprinting effect
LINC-PINT,Rs157935,Basal Cell Carcinoma
LINC-PINT,Rs6971499,pancreatic cancer
LIPC,Rs261342,BeadChip
LIPC,Rs3829462,brachial artery endothelial function and treadmill exercise
LIPC,Rs8023503,hyperalphalipoproteinemia
LIPC,Rs3829462,brachial artery endothelial function
LIPC,Rs3829462,echocardiographic dimensions
LIPC,Rs3829462,HDL cholesterol
LIPC,Rs3825776,a SNP in the region of the LIPC gene on chromosome 15
LIPC,Rs3825776,Lou Gehrig's disease
LIPC,Rs261342,HumanCVD
LIPC,Rs1800588,coronary artery disease
LIPC,Rs261342,rs12593008 
LIPC,Rs261342,rs261342
LIPC,Rs261332,susceptibility to Elevated HDL-Cholesterol for carriers of the A allele A allele is associated with 1.41mg/dl increase in HDL cholesterol (good cholesterol).
LIPC,Rs261332,Elevated HDL-Cholesterol
LIPC,Rs1800588,colorectal cancer
LIPC,Rs1800588,coronary heart disease
LIPC,Rs1800588,risk for carotid artery disease
LIPC,Rs1800588,higher HDL levels
LIPC,Rs261342,rs8028759
LIPT1,Rs786205156,mutation
LIPT1,Rs786205156,mutations
LIPT1,Rs786205156,severe metabolic disorde
LIPT1,Rs786205156,LIPT1 gene 
LIPT1,Rs786205156,metabolic disorder
LIPT1,Rs786205156,LIPT1 gene
LIPT1,Rs786205156,lipoyltransferase 1 deficiency
LIPT1,Rs786205156,severe metabolic disorder
LIPT1,Rs786205156,chromosome 2.
LIPT1,Rs786205156,lipoyltransferase 1 deficiency
LIPT1,Rs786205156,death
LIPT1,Rs137973334,lipoyltransferase 1
LIPT1,Rs137973334,LIPT1 gene
LIPT1,Rs137973334,LIPT1 gene on chromosome 2
LIPT1,Rs137973334,R98G
LIPT1,Rs137973334,p.Arg98Gly
LIPT1,Rs137973334,c.292C>G
LIPT1,Rs137973334,rs137973334
LIPT1,Rs137973334,severe metabolic disorder often leading to death soon after birth
LIPT1,Rs137973334,lipoyltransferase 1 deficiency
LIPT1,Rs137973334,lipoyltransferase 1 deficiency
LIPT1,Rs786205156,causative
LMNA,Rs587777892,Charcot-Marie-Tooth disease.
LMNA,Rs587777892,nucleotide
LMNA,Rs267607577,cardiomyopathy
LMNA,Rs267607577,cardiomyopathy
LOC105377329,Rs356182,parkinson's disease
LOC729065,Rs2200733,higher risk for postoperative atrial fibrillation
LOC729065,Rs2200733,atrial fibrillation
LOC729065,Rs2200733,atrial flutter
LOC729065,Rs2200733,atrial fibrillation
LOC729065,Rs2200733,AF/AFL disease
LOC729065,Rs2200733,atrial fibrillation 
LOC729065,Rs2200733,AF 
LOC729065,Rs2200733,cardioembolic stroke
LOC729065,Rs2200733,ischemic stroke 
LOC729065,Rs2200733,cardioembolic stroke (CES) (
LOC729065,Rs2200733,ischemic stroke 
LOC729065,Rs2200733,AF/AFL disease
LOC729065,Rs2200733,atrial flutter (AFL) 
LOC729065,Rs2200733,atrial fibrillation (AF)
LOXL1,Rs3825942,exfoliation glaucoma
LOXL1,Rs3825942,primary open angle glaucoma
LOXL1,Rs3825942,glaucoma
LOXL1,Rs3825942,exfoliation ''syndrome''
LOXL1,Rs3825942,exfolation ''glaucoma''
LOXL1,Rs3825942,XFS
LOXL1,Rs3825942,XFG
LOXL1,Rs3825942,pseudoexfoliation glaucoma (PEXG)
LOXL1,Rs3825942,pseudoexfoliation (PEX)
LOXL1,Rs3825942,XFG
LOXL1,Rs3825942,pseudoexfoliation glaucoma
LOXL1,Rs3825942,Decreased total antioxidants status
LOXL1,Rs893817,pseudoexfoliation glaucoma
LOXL1,Rs893817,primary open-angle glaucoma
LOXL1,Rs3825942,GGT
LOXL1,Rs3825942,blindness
LOXL1,Rs2165241,open-angle glaucoma
LOXL1,Rs3825942,exfoliation syndrome
LOXL1,Rs3825942,glaucoma
LOXL1,Rs1078967,glaucoma
LOXL1,Rs1078967,exfoliation glaucoma
LOXL1,Rs1078967,exfoliation glaucoma
LOXL1,Rs1078967,association with exfoliation glaucoma
LOXL1,Rs1078967,possible genoset partner
LOXL1,Rs201011613,exfoliation syndrome (XFS)
LOXL1,Rs201011613,XFS
LOXL1,Rs2165241,Glaucoma
LOXL1,Rs3825942,"drome'', which has "
LOXL1,Rs3825942,"lele was the risk allele, in contrast to other populations.{PMID "
LOXL1,Rs3825942,firmed as risk for pseudoexfoliation (PEX) and pseudoexfoliation glaucom
LOXL1,Rs3825942, glaucoma
LOXL1,Rs3825942,exfoliation glaucoma
LOXL1,Rs2165241,exfoliation glaucoma
LPA,Rs7770628,protein levels
LPA,Rs7770628,Lipoprotein A (LPA) protein levels
LPA,Rs55730499,longevity
LPA,Rs55730499,longevity
LPA,Rs55730499,longevity
LPA,Rs55730499,longevity
LPL,Rs285,Alzheimer's disease pathophysiology
LPL,Rs326,risk for lower high-density lipoprotein (HDL)
LPL,Rs326,rs326 
LPL,Rs326,Caucasians and African-Americans.
LPL,Rs285,young women
LPL,Rs285, stroke
LPL,Rs285,ethnicity
LPL,Rs285,HDL cholesterol levels
LPL,Rs285, coronary disease
LPL,Rs285,lipid fractions
LPL,Rs285,Gene-centric association
LPL,Rs285,polymorphism
LPL,Rs285,the stroke
LPL,Rs285,coronary disease
LPL,Rs285,Alzheimer's disease
LPL,Rs285,lipoprotein lipase
LPL,Rs285,Alzheimer's disease pathophysiology
LPL,Rs285,lipids and apolipoproteins
LPL,Rs285,lipid fractions
LPL,Rs285,coronary disease
LPL,Rs285,HDL cholesterol levels
LPL,Rs285,Seven lipoprotein lipase gene polymorphisms
LPP,Rs9860547,Allergies
LPP,Rs1464510,type 1 diabetes
LPP,Rs9860547,Allergies
LPP,Rs9851967,Celiac Disease
LPP,Rs4686484,celiac diseas
LPP,Rs4686484,celiac disease
LPP,Rs4686484,altered risk for celiac disease
LPP,Rs1464510,coeliac disease
LPP,Rs1464510,type 1 diabetes
LPP,Rs1464510,celiac disease
LPP,Rs1464510,type 2 diabetes
LPP,Rs9860547,Allergies
LPP,Rs1464510,juvenile idiopathic arthritis
LPP,Rs1464510,autoimmune and inflammatory diseases
LPP,Rs13076312,Vitiligo
LPP,Rs13076312,Vitiligo
LPP,Rs1464510,type 2 diabetes
LPP,Rs13076312,Vitiligo
LPP,Rs1464510,type 1 diabetes
LPP,Rs1464510,celiac disease
LPP,Rs1464510,type 1 diabetes
LPP,Rs1464510,coeliac disease susceptibility
LPP,Rs1464510,autoimmune and inflammatory diseases
LRP4,Rs2306033,Osteoporotic fractures
LRP5,Rs4988321,fractures
LRP5,Rs4988321,osteoporosis-pseudoglioma syndrome
LRP5,Rs4988321,bone mass
LRP5,Rs4988321,Oropharyngeal skeletal disease
LRP5,Rs4988321,bone mass
LRP5,Rs4988321,bone mass
LRP5,Rs4988321,osteoporosis
LRP5,Rs4988321,bone mineral density
LRP5,Rs4988321,bone mass 
LRP5,Rs4988321,high-bone-mass disorders
LRP5,Rs4988321,osteoporosis-pseudoglioma syndrome
LRP5,Rs4988321,bone density
LRP5,Rs4988321,bone mass
LRP5,Rs4988321,reduced bone mineral density (BMD)
LRP5,Rs4988321,osteoporotic or osteopenic men
LRP5,Rs4988321,Oropharyngeal skeletal disease
LRP5,Rs4988321,high-bone-mass disorders
LRP5,Rs4988321,vertebral fractures
LRP5,Rs4988321,vertebral fractures
LRP5,Rs4988321,reduced lumbar spine BMD
LRP5,Rs4988321,femoral neck BMD
LRP5,Rs4988321,BMD
LRP5,Rs4988321,spine BMD
LRP5,Rs4988321,peak bone mass in non-sedentary men
LRP5,Rs4988321,Oropharyngeal skeletal disease
LRP5,Rs4988321,high-bone-mass disorders
LRP5,Rs4988321,bone mineral density
LRP5,Rs4988321,"vertebral fractures and reduced bone mineral density (BMD),"
LRP5,Rs4988321,physical activity
LRP5,Rs4988321,femoral neck BMD
LRP5,Rs4988321,hip or spine BMD
LRP5,Rs4988321,osteoporotic or osteopenic men
LRP5,Rs28939709,Autosomal recessive familial exudative vitreoretinopathy
LRP5,Rs28939709,LRP5
LRP5,Rs3736228, reduced bone mineral density
LRP5,Rs3736228,osteoporosis 
LRP5,Rs3736228,osteoporotic 
LRP5,Rs3736228,osteoporosis 
LRP5,Rs3736228,decreased bone mineral density
LRP5,Rs3736228,osteoporosis 
LRP5,Rs3736228,osteoporotic 
LRP5,Rs3736228,osteoporotic 
LRP5,Rs3736228,Caucasian 
LRP5,Rs491347,associated with obesity phenotypes
LRP5,Rs3736228,men
LRP5,Rs491347, obesity phenotypes
LRP5,Rs4988321,BMD
LRP5,Rs4988321,reduced lumbar spine BMD density
LRP5,Rs4988321,vertebral fractures
LRP5,Rs4988321,reduced bone mineral density
LRP5,Rs4988321,vertebral fractures
LRP5,Rs491347,low-density lipoprotein receptor-related protein 5
LRP5,Rs4988300,obesity
LRP5,Rs4988300,obesity
LRP5,Rs491347,Low-density lipoprotein receptor-related protein 5 (LRP5)
LRP5,Rs491347,whites
LRP5,Rs491347,Chinese
LRP5,Rs491347,bone mass
LRP5,Rs4988300,obesity
LRPPRC,I5012749,French Canadian Type
LRPPRC,I5012749,Leigh syndrome
LRPPRC,I5012749,Leigh syndrome
LRRC43,Rs6489188,nonatopic eczema
LRRC43,Rs6489188,were strongly associated with nonatopic eczema
LRRC43,Rs11608363,nonatopic eczema
LRRC43,Rs11608363,were strongly associated with nonatopic eczema
LRRK2,Rs34637584,Parkinson's disease.
LRRK2,Rs34637584,Parkinson's disease
LRRK2,Rs34637584,Parkinson's disease
LRRK2,Rs34637584,familial Parkinson's disease
LRRK2,Rs34637584,Parkinson's disease
LRRK2,Rs34637584,Parkinson's disease
LRRK2,Rs34637584,Parkinson's Disease 
LRRK2,Rs34637584,Parkinson's disease
LRRK2,Rs34637584,Parkinson patients
LRRK2,Rs34637584,Parkinson patients
LRRK2,Rs34637584,leukemia
LRRK2,Rs34637584,colon cancer
LRRK2,Rs34637584,Parkinson's disease
LRRK2,Rs34637584,Parkinson's disease 
LRRK2,Rs34637584,Parkinson's disease
LRRK2,Rs34637584,Parkinson's disease
LRRK2,Rs34778348,Parkinson's disease
LRRK2,Rs34778348,Parkinson's disease
LRRK2,Rs34637584,Parkinso
LRRK2,Rs7308720,Parkinson disease
LRRK2,Rs35870237,pathogenic
LRRK2,Rs35870237,type 8
LRRK2,Rs35870237,Parkinson disease
LRRK2,Rs35870237,dominant
LRRK2,Rs35870237,autosomal
LRRK2,Rs35870237,type 
LRRK2,Rs35870237,MDSGene
LRRK2,Rs35870237,I2020T
LRRK2,Rs35870237,Ile2020Thr 
LRRK2,Rs35870237,6059T
LRRK2,Rs35870237,definitely pathogenic
LRRK2,Rs35870237,autosomal dominant Parkinson disease
LRRK2,Rs35801418,autosomal dominant Parkinson disorder
LRRK2,Rs34778348,Parkinson
LRRK2,Rs34637584,Parkinson
LRRK2,Rs34637584, Parkinson's diseas
LRRK2,Rs34637584,Parkinson's disease
LRRK2,Rs33939927,Arg1441Cys
LRRK2,Rs33939927,4321C
LRRK2,Rs33939927,Arg1441Ser
LRRK2,Rs33939927,4321C
LRRK2,Rs33939927,disease
LRRK2,Rs33939927,Parkinson
LRRK2,Rs33939927,4321C
LRRK2,Rs33939927,LRRK2 
LRRK2,Rs33939927,Parkinson disease
LRRK2,Rs33939927,Parkinson's disease
LRRK2,Rs33939927,Parkinson disease
LRRK2,Rs33939927,Movement Disorder
LRRK2,Rs33939927,Parkinson's disease
LRRK2,Rs281865054,calls 
LRRK2,Rs33939927,rs33939927 
LRRK2,Rs33939927,pathogenic
LRRK2,Rs33939927,Arg1441Gly
LRRK2,Rs33939927,type 
LRRK2,Rs34637584,Parkinson's disease
LRRK2,Rs34637584,Parkinson's disease
LRRK2,Rs34637584,Parkinson's disease
LRRK2,Rs34637584,Parkinson's disease
LRRK2,Rs34637584,Parkinson's disease
LRRK2,Rs34637584,Parkinson's Disease
LRRK2,Rs33939927,MDSGene
LRRK2,Rs34637584,Parkinson's disease
LRRK2,Rs34637584,colon cancer
LRRK2,Rs33995883,Crohn's disease
LRRK2,Rs33995883,Parkinson's
LRRK2,Rs33995883,Parkinson's disease
LRRK2,Rs33949390,more likely to develop the disease than noncarriers
LRRK2,Rs33949390,"A study of Chinese patients with Parkinson's disease concluded that in this population, after adjustments were made for age, age of onset, and gender,"
LRRK2,Rs33949390,Parkinson's disease
LRRK2,Rs34637584,Parkinson's disease.
LSAMP,Rs4404477,main coronary artery disease
LSAMP,Rs4404477,risk haplotype
LSAMP,Rs4404477,coronary artery disease
LSAMP,Rs4404477,heart disease
LSAMP,Rs1676232,heart disease
LSAMP,Rs1676232,coronary artery disease
LSAMP,Rs1676232,main coronary artery disease
LSAMP,Rs1676232,risk haplotype
LSP1,Rs3817198,breast cancer
LSP1,Rs3817198,SNPs
LSP1,Rs3817198,breast cancer
LTA,Rs746868,Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk
LTA,Rs746868,Lymphotoxin-alpha gene and risk of myocardial infarction
LTA,Rs746868,Family-based analysis of tumor necrosis factor and lymphotoxin-alpha tag polymorphisms with type 1 diabetes
LTA,Rs746868,Molecular genetics of myocardial infarction
LTA,Rs746868,Lymphotoxin-alpha gene and risk of myocardial infarction
LTA,Rs746868,Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk.
LTA,Rs746868,"Genetic variants in T helper cell type 1, 2 and 3 pathways and gastric cancer risk"
LTA,Rs746868,tumor necrosis factor and lymphotoxin-alpha tag polymorphisms with type 1 diabetes
LTA,Rs746868,Molecular genetics of myocardial infarction.
LTA,Rs746868,"Genetic variants in T helper cell type 1, 2 and 3 pathways and gastric cancer risk"
LTA,Rs746868,"Genetic variants in T helper cell type 1, 2 and 3 pathways and gastric cancer risk"
LTA,Rs928815,Family-based analysis of tumor necrosis factor and lymphotoxin-alpha tag polymorphisms with type 1 diabetes in the population
LTA,Rs746868,Lymphotoxin-alpha gene and risk of myocardial infarction
LTA,Rs746868,Family-based analysis of tumor necrosis factor and lymphotoxin-alpha tag polymorphisms with type 1 diabetes
LTA,Rs746868,Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk
LTA,Rs746868,"Genetic variants in T helper cell type 1, 2 and 3 pathways and gastric cancer risk"
LTA,Rs746868,Molecular genetics of myocardial infarction.
LTA,Rs746868,Family-based analysis of tumor necrosis factor and lymphotoxin-alpha tag polymorphisms with type 1 diabetes
LTA,Rs746868,Lymphotoxin-alpha gene and risk of myocardial infarction
LTA,Rs746868,Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk
LTA,Rs746868,"Genetic variants in T helper cell type 1, 2 and 3 pathways and gastric cancer risk"
LTA,Rs746868,Molecular genetics of myocardial infarction.
LTA,Rs746868,Family-based analysis of tumor necrosis factor and lymphotoxin-alpha tag polymorphisms with type 1 diabetes
LTA,Rs746868,Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk
LTA,Rs746868,Molecular genetics of myocardial infarction.
LTA,Rs746868,Lymphotoxin-alpha gene and risk of myocardial infarction
LTA,Rs746868,myocardial infarction
LTA,Rs746868,"Genetic variants in T helper cell type 1, 2 and 3 pathways"
LTA,Rs746868,tumor necrosis factor and lymphotoxin-alpha (TNF-LTA)
LTA,Rs1799964,mortality
LTA,Rs1799964,"~10,000 individuals"
LTA,Rs1799964,Graves' disease
LTA,Rs1799964, disease
LTA,Rs1800630, Raynaud's phenomenon
LTA,Rs1800630,systemic lupus erythematosus (SLE)
LTA,Rs1800630,SLE 
LTA,Rs1800630,SLE
LTA,Rs2844482,endometriosis
LTA,Rs2844482,rubella vaccine-induced immunity
LTA,Rs2844482,endometriosis
LTA,Rs746868,breast cancer
LTA,Rs746868,Lymphotoxin-alpha gene and risk of myocardial infarction
LTA,Rs746868,Molecular genetics of myocardial infarction.
LTA,Rs746868,"T helper cell type 1, 2 and 3 pathways and gastric cancer risk"
LTA,Rs746868, C
LTA,Rs746868,"Lymphotoxin-alpha gene and risk of myocardial infarction in 6,928 cases and 2,712 controls in the ISIS case-control study"
LTA,Rs746868,tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk
LTA,Rs746868,type 1 diabetes
LTA,Rs746868,myocardial infarction
LTA,Rs746868,Polish population
LTA,Rs746868,gastric cancer
LTA,Rs746868,population of South Croatia
LUM,Rs3759223,high myopia
LUM,Rs3759223,pathological myopia
LUM,Rs3759223,high myopia
LUM,Rs3759223,High myopia
LUM,Rs2268578,corneal thickness.
LUM,Rs2268578,breast cancer
LUM,Rs2268578,"breast cancer,"
LUM,Rs2268578,normal variation in central corneal thickness
LUM,Rs2268578,decorin and lumican genes
LUM,Rs2268578,breast cancer
LZTS1,Rs28937897,somatic mutation
LZTS1,Rs28937897,somatic mutation
MAD1L1,Rs28939694,somatic mutation
MAD1L1,Rs28939694,somatic mutation
MAGEL2,Rs773586710,Gln666Serfs
MAGEL2,Rs773586710,OMIM pathogenic variant
MAGEL2,Rs773586710,MAGEL2
MAOA,Rs72554632,impulsive aggressiveness
MAOA,Rs72554632,mild mental retardation
MAOA,Rs72554632,impulsive aggressiveness
MAOA,Rs72554632,recessive X-linked disorder
MAOA,Rs72554632,Brunner syndrome
MAOA,Rs72554632,mild mental retardation
MAOA,Rs72554632,impulsive aggressiveness
MAOA,Rs72554632, MAOA deficiency
MAOA,Rs72554632,Brunner syndrome
MAOA,Rs72554632,mild mental retardation
MAOA,Rs72554632,Brunner syndrome
MAOA,Rs72554632,Brunner syndrome
MAOA,Rs6609257,Sexually dimorphic
MAOA,Rs3027407,Financial and psychological risk
MAOA,Rs3027407,Sexually dimorphic
MAOA,Rs3027400,Sexually dimorphic
MAOA,Rs3027400,neuropsychological functioning
MAOA,Rs3027400,migraine-free
MAOA,Rs3027400,migraine
MAOA,Rs3027400,migraine without aura
MAOA,Rs3027400,and 528 sex-matched migraine-free controls Differential association 
MAOA,Rs3027400,migraine without aura among a sample of 528 migraine patients
MAOA,Rs2072743,"a haplotype consisting of rs3027400(G) and rs2072743(C) associated with increased incidence of migraine without aura among a sample of 528 migraine patients (308 without aura, 220 with aura) and 528 sex-matched migraine-free controls"
MAOA,Rs6609257,ADHD
MAOB,Rs3027415,adult ADHD inattentive type
MAOB,Rs3027415,attention-deficit/hyperactivity disorder
MAOB,Rs3027415,adult ADHD inattentive type
MAOB,Rs3027415,attention-deficit/hyperactivity disorder
MAOB,Rs1799836,Parkinson's disease
MAOB,Rs1799836,Parkinson's disease
MAOB,Rs1799836,conditional logistic regression
MAOB,Rs1799836,Parkinson's disease
MAP2K5,Rs12593813,restless legs syndrome
MAP2K5,Rs884202,rs884202
MAP2K5,Rs12593813,Restless Legs Syndrome
MAP2K5,Rs12593813,sleep disorder
MAP2K5,Rs11635424,sleep disorder
MAP2K5,Rs884202,lower frequency of restless legs syndrome
MAP2K5,Rs11635424,sleep disorder
MAP2K5,Rs11635424,restless legs syndrome
MAP2K5,Rs11635424,restless legs syndrome
MAP2K5,Rs11635424,common sleep disorder
MAP2K5,Rs11635424,restless legs syndrome
MAP2K5,Rs11635424,restless legs syndrome
MAPK1,Rs2283792,single-nucleotide polymorphisms
MAPK1,Rs2283792,genomewide 
MAPK1,Rs2283792,locus
MAPK1,Rs2283792,progressive supranuclear palsy
MAPK1,Rs2283792,progressive supranuclear palsy
MAPK1,Rs2283792,genomewide
MAPK1,Rs2283792,progressive supranuclear palsy
MAPK1,Rs2283792,novel risk locus
MAPK1,Rs2283792,single-nucleotide polymorphisms
MAPT,Rs3785883,diverse ethnic Parkinson's disease cohorts
MAPT,Rs3785883,Parkinson's disease
MAPT,Rs3785883,late onset Alzheimer's disease
MAPT,Rs3785883,Creutzfeldt-Jakob disease
MAPT,Rs3785883,Parkinson's disease
MAPT,Rs3785883,Parkinson disease
MAPT,Rs3785883,Parkinson's disease
MAPT,Rs3785883,Linkage disequilibrium
MAPT,Rs3785883,Parkinson disease
MAPT,Rs3785883,Alzheimer's disease
MAPT,Rs63750424,Alzheimer's disease
MAPT,Rs3785883,susceptibility to Creutzfeldt-Jakob disease
MAPT,Rs3785883,Parkinson disease
MAPT,Rs3785883,associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition
MAPT,Rs3785883,Genetic susceptibility in Parkinson's disease.
MAPT,Rs63750424,frontotemporal dementia
MAPT,Rs8070723,times lower odds of progressive supranuclear palsy.
MAPT,Rs8070723,Genomewide association study for susceptibility genes contributing to familial Parkinson disease.
MAPT,Rs8070723,SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease.
MAPT,Rs3785883,Parkinson disease
MAPT,Rs3785883,tauopathy
MAPT,Rs3785883,Parkinson's disease
MAPT,Rs3785883,Alzheimer's disease
MAPT,Rs143624519,neurodegenerative diseases
MAPT,Rs3785883,Parkinson disease
MAPT,Rs1052553,Haplotypes and gene expression implicate the MAPT region for Parkinson disease
MAPT,Rs1052553,The distribution and most recent common ancestor of the 17q21 inversion in humans
MAPT,Rs1052553,Independent and joint effects of the MAPT and SNCA genes in Parkinson disease
MAPT,Rs143624519,neurodegenerative diseases
MAPT,Rs143624519,"neurodegenerative conditions, including Alzheimer's disease, frontotemporal dementia, and dementia with Lewy bodies"
MAPT,Rs143624519,autosomal-dominant disease
MAPT,Rs143624519, increases susceptibility to several neurodegenerative conditions
MAPT,Rs143624519,frontotemporal dementia
MAPT,Rs143624519,dementia with Lewy bodies
MAPT,Rs143624519,Alzheimer's disease
MAPT,Rs17651507,schizophrenia
MAPT,Rs1800547,Parkinson's disease
MAPT,Rs1800547,late-onset Parkinson's disease
MAPT,Rs1800547,parkinson's disease
MAPT,Rs1800547,Parkinson's disease
MAPT,Rs1800547,parkinson's disease
MAPT,Rs3785883,Parkinson disease
MAPT,Rs3785883,Parkinson's disease
MAPT,Rs3785883,Parkinson's disease
MAPT,Rs17651507,schizophrenia
MAT1A,Rs2993763,SNP
MAX,Rs7158173,waist circumference
MAX,Rs7158173,anthropometric trait
MAX,Rs7158173,waist circumference
MAX,Rs387906650,paraganglioma-pheochromocytoma
MAX,Rs387906650,C>T
MAX,Rs387906650,mutation
MAX,Rs387906650,this mutation is predisposing for a hereditary cancer (paraganglioma-pheochromocytoma) syndrome
MAX,Rs387906650,predisposing for a hereditary cancer
MBL2,Rs1800451,noninfectious systemic inflammatory response syndrome.
MBL2,Rs1800451,ulmonary tuberculosis
MBL2,Rs1800451,asymptomatic Plasmodium falciparum infection
MBL2,Rs1800451,diabetic nephropathy.
MBL2,Rs1800451,type 1 diabetes
MBL2,Rs1800451,late-onset Alzheimer disease
MC1R,Rs1805007,red hair
MC1R,Rs2228479,"red (or blond) hair and poor tanning,"
MC1R,Rs2228479,ommonly associated with red (or blond) hair and poor tanning
MC1R,Rs2228479,poor tanning
MC1R,Rs2228479,red (or blond) hair
MC1R,Rs1805008,MelanomaParkinson's disease
MC1R,Rs1805008,red hair color (redheads)
MC1R,Rs1805007,Freckling
MC1R,Rs1805007,melanoma
MC1R,Rs1805007,mutations 
MC1R,Rs34474212,red hair related
MC1R,Rs1805007,mutation 
MC1R,Rs34474212,redheads
MC1R,Rs1805007,females
MC1R,Rs11547464,red hair color
MC1R,Rs11547464,missense mutation
MC1R,Rs11547464,red hair color
MC1R,Rs1805007,redheads 
MC1R,Rs11547464,red 
MC1R,Rs11547464,mutation 
MC1R,Rs11547464,color 
MC1R,Rs1805005,associated with light blond hair color
MC1R,Rs1805005,associated with light blond hair color in one study
MC1R,Rs1805007,red hair color (redheads)
MC1R,Rs1805007,redheaded
MC1R,Rs11547464,hair 
MC2R,Rs28926173,longevity
MC2R,Rs28926173,longevity
MC2R,Rs28926173,longevity
MC2R,Rs28926173,longevity
MC2R,Rs2186944,infantile spasms
MC2R,Rs1893220,infantile spasms
MC2R,Rs2186944,infantile spasms
MC2R,Rs1893220,infantile spasms
MC2R,Rs1893220,ACTH
MC2R,Rs2186944,ACTH
MC4R,Rs52820871,obesity
MC4R,Rs52820871,obesity 
MC4R,Rs52820871,obesity 
MC4R,Rs13447324,dominantly inherited mutation
MC4R,Rs13447324,pathogenic for obesity
MC4R,Rs13447324,obesity
MC4R,Rs13447324,obesity
MC4R,Rs12970134,obesity in polycystic ovary syndrome
MC4R,Rs12970134,small for gestational age
MC4R,Rs12970134,metabolic syndrome
MC4R,Rs12970134,effects on body mass index and insulin resistance
MC4R,Rs12970134,obesity-associated
MC4R,Rs12970134,obesity 
MC4R,Rs12970134,diabetes risk in women
MC4R,Rs12970134,common obesity variant
MC4R,Rs12970134,associated with obesity
MC4R,Rs10871777,Obesity
MC4R,Rs10871777,Obesity
MC4R,Rs12970134,polycystic ovary syndrome
MCM6,Rs145946881, PMID 23029545
MCM6,Rs145946881,PMID 17159977
MCM6,Rs145946881,C/G(-13907
MCM6,Rs145946881,rs41525747
MCM6,Rs145946881,T/G(-13915
MCM6,Rs145946881,rs145946881
MCM6,Rs145946881,"""G/C-14010"""
MCM6,Rs145946881,lactase LCT gene
MCM6,Rs145946881,MCM6 gene
MCM6,Rs145946881,SNPs
MCM6,Rs145946881,rs41380347
MCOLN1,I4000425,Mucolipidosis
MCOLN1,Rs104886461,n autosomal recessive neurodegenerative lysosomal storage disorder
MDM2,Rs117039649,ovarian
MDM2,Rs117039649,breast 
MDM2,Rs937283,hereditary retinoblastoma.
MDM2,Rs117039649,ovarian cancer
MDM2,Rs117039649,Caucasians
MDM2,Rs117039649,breast cancer
MDM4,Rs1380576,MDM4 variant
MDM4,Rs1380576,HPV16-associated squamous cell carcinoma of oropharynx.
MDM4,Rs1380576,Modifying effect of MDM4 variants on risk of HPV16-associated squamous cell carcinoma of oropharynx.
MDM4,Rs4245739,apoptosis
MDM4,Rs4245739,Europe
MDM4,Rs4245739,United States.
MDM4,Rs4245739,"prostate cancer,"
MDM4,Rs4245739,Breast Cancer
MDM4,Rs4245739,ovarian cancer
MDM4,Rs4245739,squamous cell carcinoma
MECP2,Rs1734792,systemic lupus erythromatosis
MECP2,Rs1734792,lupus 
MECP2,Rs1734792,female 
MECP2,Rs1734792,systemic lupus erythematosus.
MECP2,Rs1734792,systemic lupus erythematosus
MECP2,Rs1734792,lupus 
MECP2,Rs1734792,Korean 
MECP2,Rs1734787,Caucasian
MECP2,Rs1734792,Caucasian 
MECP2,Rs1734792,systemic lupus erythromatosis
MECP2,Rs1734787,"CI: 1.26â€“1.60, p = 1.6Ã—10e-08"
MECP2,Rs1734787,Korean
MECP2,Rs1734787,female disease
MECP2,Rs1734787,systemic lupus erythromatosis
MEFV,Rs224204,juvenile idiopathic arthritis
MEFV,Rs224204,juvenile idiopathic arthritis
MEFV,Rs121907890,familial Mediterranean fever
MEFV,Rs121907890,Arab and Armenian
MEFV,Rs121907890,"Sephardic Jews,"
MEFV,Rs121907890,"Turks,"
MEFV,Rs121907890,Mediterranean fever
MEFV,Rs28940579,inflammatory
MEFV,Rs11466023,familial Mediterranean fever
MEFV,Rs224204,Caucasian
MEFV,Rs104895097,familial Mediterranean fever
MEFV,Rs104895097,familial Mediterranean fever 
MEFV,Rs104895094,Mediterranean fever
MEFV,Rs104895093,familial Mediterranean fever
MEFV,Rs121907890,familial Mediterranean fever
MEFV,Rs104895097,"more common among Turks, Sephardic Jews, and people of Arab and Armenian ancestry"
MEFV,Rs28940580,inflammatory response
MEFV,Rs28940580,familial Mediterranean fever
MEFV,Rs61752717,"amyloidosis,"
MEFV,Rs61752717,higher frequencies of arthritis and arthralgia
MEFV,Rs61752717,earlier age of onset
MEFV,Rs61752717,Mediterranean Fever (FMF) 
MEFV,Rs61752717," amyloidosis,"
MEFV,Rs61752717,arthralgia
MEFV,Rs28940579,infectious disease
MEFV,Rs61752717,arthritis
MEFV,Rs28940580,The symptoms of familial Mediterranean fever are caused by the person's own inflammatory response; it is not an infectious disease.
MEFV,Rs28940580,not an infectious disease
MEFV,Rs28940580,inflammatory response
MEFV,Rs28940580,familial Mediterranean fever
MEFV,Rs28940580,infectious disease
MEFV,Rs104895085,"more common among Turks, Sephardic Jews, and people of Arab and Armenian ancestry"
MEFV,Rs28940580,"The condition is more common among Turks, Sephardic Jews, and people of Arab and Armenian ancestry."
MEFV,Rs104895085,person's own inflammatory response
MEFV,Rs28940579,Mediterranean fever
MEFV,Rs104895081,mutations 
MEFV,I4000409,Mediterranean Feverrs
MEFV,I4000407,Familial Mediterranean
MEFV,I4000407,autosomal recessive (carrier);
MEFV,I4000407,Fever
MEFV,I4000407,recessive 
MEFV,I4000407,autosomal
MEFV,I4000407,Mediterranean
MEFV,I4000407,Familial
MEFV,I4000407,autosomal recessive
MEFV,I4000407,Familial Mediterranean Fever
MEFV,I4000406,Familial Mediterranean Fever
MEFV,I4000406,Familial Mediterranean Fever
MEFV,I4000404,Mediterranean
MEFV,I4000404,fever
MEFV,Rs104895085,familial Mediterranean fever
MEFV,I4000410,Familial Mediterranean Fever
MEFV,I4000410,rs104895097
MEFV,I4000407,Fever
MEFV,I4000410,Mediterranean 
MEFV,Rs104895081,FMF
MEFV,Rs104895081,MEFV 
MEFV,Rs104895081,familial Mediterranean fever
MEFV,Rs104895081,familial Mediterranean fever (FMF)
MEFV,Rs104895081,familial Mediterranean fever
MEFV,Rs104895079,mutations 
MEFV,Rs104895079,FMF
MEFV,Rs104895081,Mediterranean fever (FMF)
MEFV,Rs104895079,familial Mediterranean fever
MEFV,Rs104895079,familial Mediterranean fever (FMF)
MEFV,Rs104895079,familial Mediterranean fever
MEFV,Rs104895079,Mediterranean fever (FMF)
MEFV,I4000410,Familial 
MEFV,I4000410,Feverrs104895097
MEFV,Rs104895079,MEFV 
MEIS1,Rs2300478,MEIS1 gene
MEIS1,Rs2300478,not associated with 
MEIS1,Rs2300478,rs2300478 
MEIS1,Rs2300478,not associated with
MEIS1,Rs2300478,ADHD
MEIS1,Rs2300478,restless legs syndrome
MEIS1,Rs2300478,common sleep disorder
MEIS1,Rs2300478,ADHD
MEIS1,Rs6710341,restless legs syndrome
MEIS1,Rs2300478,Restless Legs Syndrome
MEIS1,Rs2300478,restless 
MEIS1,Rs6710341,restless legs syndrome
MEIS1,Rs6710341,sleep disorder
MEIS1,Rs6710341,restless legs syndrome
MEIS1,Rs9789535,restless leg syndrome
MEIS1,Rs6710341,sleep disorder
MEIS1,Rs2300478,common sleep disorder
MEIS1,Rs2300478,restless legs syndrome
MEIS1,Rs2300478,restless legs syndrome
MEIS1,Rs12469063, Replication of restless legs syndrome loci in three European populat
MEIS1,Rs2300478, linked to restless legs syndrome
MEIS1,Rs12469063,restless legs syndrome
MEIS1,Rs12469063,d with restless 
MEIS1,Rs12469063,restless legs syndrome
MEIS1,Rs12469063,common sleep disorder
MEIS1,Rs12469063,restless legs syndrome
MEIS1,Rs12469063,restless legs syndrome
MEIS1,Rs2300478,common sleep disorder
MEIS1,Rs12469063,restless legs syndrome
MEIS1,Rs12469063,restless legs syndrome
MEIS1,Rs12469063,restless legs syndrome
MEIS1,Rs12469063,restless legs syndrome 
MEIS1,Rs12469063,restless legs
MEIS1,Rs12469063,European
MEIS1,Rs12469063,sleep disorders 
MEIS1,Rs2192954,restless leg syndrome
MEIS1,Rs2300478,MEIS1 gene
MEIS1,Rs12469063,sleep disorder
MEN1,Rs28931612,somatic mutation
MEN1,Rs28931612,somatic mutation
MET,Rs38857,autism susceptibility
MET,Rs38857,schizophrenia
MET,Rs38857,MET 
MET,Rs38857,schizophrenia 
MET,Rs38857,hepatocyte growth factor receptor
MET,Rs38857,genetic variation in the MET proto-oncogene
MET,Rs38857,refractive error and ocular biometrics
MET,Rs38857,Caucasian 
MET,Rs38857,Caucasian
MET,Rs38857,general cognitive ability
MET,Rs38845,utism
MET,Rs38857,autism
MET,Rs38845,Autism Consortium (IMGSAC
MET,Rs2237717,ability to recognize facial emotion
MET,Rs2237717,chronic rhinosinusitis
MET,Rs2237717,neurocognition
MET,Rs2237717,tumor metastasis
MET,Rs2237717,autism 
MET,Rs2237717,schizophrenia
MET,Rs2237717,rhinosinusitis
MET,Rs2237717,nasal polyps
MET,Rs38845,autism
MET,Rs38845,transmembrane receptor tyrosine kinase of the hepatocyte growth factor/scatter factor MET gene
MET,Rs2237717,schizophrenia
MFN2,Rs864622480,Charcot-Marie-Tooth disease
MFN2,Rs864622480,pathogenic 
MFN2,Rs864622480,"Charcot-Marie-Tooth disease,"
MGMT,Rs16906252,0001
MGMT,Rs2308327,colorectal cancer risk
MGMT,Rs2308327,lung cancer
MGMT,Rs2308327,lung cancer
MGMT,Rs16906252,tumors
MGMT,Rs16906252,colorectal 
MGMT,Rs16906252,MGMT 
MGMT,Rs16906252,95
MGMT,Rs12268840,Homozygous carriers
MGMT,Rs16906252,methylation 
MGMT,Rs16906252,52
MGMT,Rs12268840, higher risks of adenocarcinoma
MGMT,Rs12268840,frequent acid reflux
MGMT,Rs12268840,adenocarcinoma of the esophagus
MGMT,Rs12268840,adenocarcinoma of the esophagus
MGMT,Rs16906252,multivariate 
MICA,Rs1051792,associated with a reduced overall survival and an increased risk of relapse
MICA,Rs4418214,AIDS
MICA,Rs4349859,familial ankylosing spondylitis
MICA,Rs1051792,transplant
MICA,Rs1051792,and an increased risk of relapse 
MICA,Rs1051792,"According to these results, the presence of the G allele in the patient associated with the incidence of cGvHD "
MICA,Rs1051792,"rs1051792, also known as MICA-129, Val129Met and V129M, is a G>A transition at residue 129 of the MHC class I polypeptide-related sequence A MICA gene."
MICA,Rs1051792,"This risk was independent of acute GvHD, suggesting that the residue 129 play a role in alloimmune responses and thus maybe protective against GvHD,"
MIR4761,Rs769224,genetic polymorphisms in catecholamine neurotransmitter systems
MIR4761,Rs769224,disequilibrium at catechol-O-methyltransferase
MIR4761,Rs4633,chronic pain condition
MIR4761,Rs4633,Schizophrenia Susceptibility Genetic
MIR4761,Rs4633,lower expression levels of the COMT protein
MIR4761,Rs4633,"endometrial cancer,"
MIR4761,Rs4633,endometrial cancer
MIR4761,Rs4633,Schizophrenia Susceptibility Genetic
MIR4761,Rs165688,immediate reward and brain activation
MIR4761,Rs165688,immediate reward
MIR4761,Rs165688,correlated with preferences for immediate reward and brain activation.
MIR4761,Rs165688,rs165688
MIR4761,Rs165631,women carrying either disease-causing BRCA1 or BRCA2 mutations
MIR4761,Rs165631, breast cancer 
MIR4761,Rs165631,breast cancer
MIR4761,Rs165631,breast cancer
MIR4761,Rs165631,breast cancer
MIR4761,Rs165631,breast cancer
MIR4761,Rs165631,breast cancer
MIR4761,Rs165631,breast cancer
MIR4761,Rs165688,brain activation.
MIR6766,Rs113994095,mitochondrial DNA depletion syndrome type 4A
MIR6766,Rs113994095,ophthalmoparesis
MIR6766,Rs113994095,"dysarthria,"
MIR6766,Rs113994095,sensory ataxic neuropathy
MIR6766,Rs113994095,syndromes involving ataxias
MIR6766,Rs113994095,mutation
MIR6766,Rs113994095,recessive
MIR6766,Rs113994095,POLG gene
MIR6766,Rs113994095,allele
MIR6766,Rs113994095,chromosome 15
MKLN1,Rs3847109,young-onset type 2 diabetes
MLH1,Rs1800734,immunohistochemistry 
MLH1,Rs1800734,colorectal cancer
MLH1,Rs1800734,homozygosity
MLH1,Rs193922370,hereditary colon cancer
MLH1,Rs193922370,Founding mutations
MLH1,Rs193922370,hereditary colon cancer.
MLH1,Rs193922370,mutations and Alu-mediated recombination in hereditary colon cancer.
MLLT10,Rs11012732,meningioma
MLLT10,Rs11012732,meningioma
MLLT10,Rs11012732,European ancestry
MLLT10,Rs11012732,meningioma
MLLT10,Rs11012732,meningioma
MMACHC,Rs751828470,PRDX1
MMACHC,Rs751828470,pathogenic variant
MMEL1,Rs6684865,rheumatoid arthritis
MMEL1,Rs3748816,Primary Biliary Cirrhosi
MMEL1,Rs3748816,loci.
MMEL1,Rs3748816,rheumatoid arthritis
MMEL1,Rs3748816,celiac disease
MMEL1,Rs3748816,genome-wide
MMEL1,Rs3748816,biliary cirrhosis
MMEL1,Rs6684865,rheumatoid arthritis
MMEL1,Rs3748816,G allele
MMEL1,Rs3748816,Primary Biliary Cirrhosis
MMEL1,Rs3748816,rheumatoid arthritis
MMEL1,Rs3748816,celiac disease
MMEL1,Rs3748816,primary biliary cirrhosis
MMEL1,Rs3748816,rheumatoid arthritis
MMEL1,Rs3748816,celiac disease
MMEL1,Rs3748816,primary biliary cirrhosis
MMEL1,Rs3748816,odds of primary biliary cirrhosis.
MMP1,Rs1144393,chronic kidney disease
MMP2,Rs2285053,Chinese patients with lumbar disc disease
MMP2,Rs2285053,gene on chromosome
MMP2,Rs2285053,carriers were at lower risk for the disorder
MMP2,Rs2287074,lacunar stroke
MMP2,Rs2241145,stroke
MMP2,Rs7201,small vessel infarcts
MMP2,Rs2287074,lacunar stroke
MMP2,Rs2287074,small vessel infarcts
MMP2,Rs2287076,small vessel infarcts
MMP2,Rs2287076,small vessel infarcts
MMP2,Rs2287076,lacunar stroke
MMP2,Rs243847,breast cancer
MMP2,Rs7201,lacunar stroke
MMP2,Rs7201,small vessel infarcts
MMP2,Rs7201,lacunar stroke
MMP2,Rs2241145,breast cancer
MMP2,Rs2287076,lacunar stroke
MMP2,Rs2241145,small vessel infarcts
MMP2,Rs2287074,small vessel infarcts
MMP2,Rs2241145,stroke
MMP2,Rs2241145,acunar stroke
MMP2,Rs1030868,lacunar stroke
MMP2,Rs1030868,small vessel infarcts
MMP2,Rs1030868,lacunar stroke
MMP2,Rs1030868,small vessel infarcts
MMP2,Rs2241145,lacunar stroke.
MMP2,Rs2241145,small vessel infarcts
MMP2,Rs2241145,lacunar stroke
MMP2,Rs2241145,breast cancer
MMP2,Rs2241145,breast cancer
MMP2,Rs2241145,stroke
MMP2,Rs2241145,stroke
MMP2,Rs2241145,breast cancer
MMP2,Rs2241145,stroke.
MMP2,Rs2241145,lacunar stroke
MMP2,Rs2241145,small vessel infarcts
MMP2,Rs2241145,breast cancer susceptibility
MMP2,Rs2241145,small vessel infarcts
MMP3,Rs650108,SNPs
MMP3,Rs679620,Achilles tendinopathy
MMP3,Rs679620,Achilles tendinopathy
MMP3,Rs679620,diastolic
MMP3,Rs650108,Achilles tendinopathy
MMP3,Rs3025058,risk for myocardial infarction
MMP3,Rs3025058,reduced risk of recurrent venous thromboembolism
MMP3,Rs3025058,worse progression of coronary artery disease after angioplasty.
MMP3,Rs3025058,coronary atherosclerosis
MMP3,Rs3025058,coronary artery disease
MMP3,Rs650108,Achilles tendinopathy
MMP7,Rs12184413,breast cancer
MMP7,Rs12184413,and endometrial cancer risk.
MMP7,Rs12184413,No association between matrix metalloproteinase
MMP7,Rs12184413, MMP-7 gene
MMP7,Rs12184413,Genetic polymorphisms
MMP7,Rs12184413,reduced risk for breast cancer
MMP7,Rs12184413,rs12184413(T;T)
MMP7,Rs12184413,endometrial cancer
MMP7,Rs12184413,breast cancer
MMP7,Rs11568819,breast cancer
MMP7,Rs10502001,Genetic polymorphisms in the MMP-7 gene and breast cancer survival
MMP7,Rs11568819,endometrial cancer
MMP7,Rs11568819,breast cancer
MMP7,Rs11568819,breast cancer
MMP7,Rs11568819,endometrial cancer risk
MMP7,Rs11568819,breast cancer
MMP7,Rs11568819,breast cancer
MMP7,Rs10502001,Genetic polymorphisms in MMP7 and reduced serum levels associate with the development of bronchiolitis obliterans syndrome after lung transplantation
MMP7,Rs10502001,Common MMP-7 polymorphisms and breast cancer susceptibility:
MMP7,Rs10502001,Differential allelic expression in the human genome
MMP7,Rs11568819,breast cancer
MMP9,Rs2250889,There was an additive effect of having additional MMP9 risk alleles
MMP9,Rs17577,sporadic Alzheimer's disease
MMP9,Rs17577,lung cancer
MMP9,Rs17577,recovery from hepatitis B virus infection
MMP9,Rs17577,susceptibility to lymphoma.
MMP9,Rs17577,cardiovascular disease risk
MMP9,Rs2250889,"rs2250889, a SNP also known as P574R, is located in the MMP9 gene"
MMP9,Rs17577,pneumonia.
MMP9,Rs17577,breast cancer risk:
MMP9,Rs2250889,lung cancer
MMP9,Rs2250889,"744 Chinese patients with incident lung cancer rs2250889(C;G) heterozygotes and rs2250889(C;C) homozygotes had 1.46-fold (CI: 0.94-2.26) and 1.69-fold elevated risk (CI: 1.10-2.60) for lung cancer, respectively, compared with the (G;G) genotype"
MMP9,Rs17577,breast cancer
MMP9,Rs17577,coronary heart disease
MMP9,Rs17577,non-atopic asthma
MMP9,Rs17577,patients with cutaneous malignant melanoma.
MMP9,Rs17577,lung cancer
MMP9,Rs17577,cutaneous malignant melanoma
MMP9,Rs17576,cigarette smoking
MMP9,Rs17576,chronic obstructive pulmonary disease
MMP9,Rs17576,myocardial infarction
MMP9,Rs17576,heart disease
MMP9,Rs17576,Alzheimer's disease
MMP9,Rs17576,lung cancer
MMP9,Rs17576,hepatitis B virus infection
MMP9,Rs17576,lymphoma
MMP9,Rs17576,glaucoma
MMP9,Rs17576,type 2 diabetes
MMP9,Rs17576,leukemia
MMP9,Rs17577,Alzheimer's disease
MMP9,Rs17576,malignant melanoma
MPL,Rs146249964,Ashkenazi Jewish
MPL,Rs146249964,CAMT
MPL,Rs146249964,Ashkenazi Jewish
MPL,Rs146249964,CAMT (congenital amegakaryocytic thrombocytopenia)
MPL,Rs146249964,carrier frequency was estimated to be 1 in 75
MPZ,Rs121913584,pathogenic
MPZ,Rs121913584,dominantly inherited disorder
MPZ,Rs121913584,Charcot-Marie-Tooth disease type 1B
MPZ,Rs121913584,dominantly inherited disorder
MPZ,Rs121913584,pathogenic for Charcot-Marie-Tooth disease type 1B
MPZ,Rs121913584,Charcot-Marie-Tooth disease type 1B
MPZ,Rs121913584,Charcot-Marie-Tooth disease
MPZ,Rs121913584,Charcot-Marie-Tooth disease type 1B
MRE11A,Rs774277300,colorectal cancer
MRE11A,Rs774277300,hereditary cancer-predisposing syndrome
MSH2,Rs193922371,nonpolyposis colorectal cancer.
MSH2,Rs193922371,heterozygosity
MSH2,Rs193922371,tumors.
MSH2,Rs193922371,microsatellite-unstable
MSH2,Rs2303428,sporadic renal cell carcinoma
MSH2,Rs2303428,sporadic renal cell carcinoma
MSH2,Rs2303428,Endometrial cancer
MSH2,Rs2303428,invasive serous ovarian cancer
MSH2,Rs2303428,microsatellite-unstable colorectal cancer
MSH2,Rs193922371, hereditary
MSH2,Rs2303428,Endometrial cancer
MSH2,Rs193922371,mutations
MSH2,I5900960,Lynch syndrome
MSH2,Rs193922371,homozygous
MSH2,Rs193922371,germline
MSH2,I5008753,Lynch syndromer
MSH2,I5008753,Lynch syndromers
MSH2,I5008753,Lynch
MSH2,I5008753,Lynch syndromers
MSH2,Rs193922371,germline mutations 
MSH2,Rs193922371,HNPCC
MSH2,Rs193922371,Slovakia
MSH2,Rs193922371,heterozygous
MSH2,I5008753,syndrome
MSH3,Rs863221,colorectal cancer
MSH3,Rs863221,located in MSH3
MT-ATP6,I3000812,allele
MT-ATP6,I3000812,PhyloTree
MT-ATP6,I3000812,haplogroups
MT-ATP6,I3000812,derived
MT-ATP6,I3000812,haplogroup
MT-ATP6,I3000812,haplogroup
MT-ATP6,I3000812,ancestral
MT-ATP6,I3000812,allele
MT-ATP6,I3000812,ancestral
MT-CO3,I3001497,influences haplogroups
MT-CO3,I3001497,fl
MT-CO3,I3001497,fl
MT-ND1,Rs41402945,ancestral_allele
MT-ND1,Rs41524046,SNP 
MT-ND1,Rs41402945,derived_allele
MT-ND1,Rs41402945,haplogroup
MT-ND1,Rs41402945,derived
MT-ND1,Rs41402945,ancestral
MT-ND1,Rs41402945,PhyloTree
MT-ND1,Rs41402945,haplogroups
MT-ND1,Rs199476118,Leber's optic atrophy
MT-ND1,Rs41402945,haplogroup
MT-ND4,Rs2853493,Mitochondrial Haplogroup
MT-ND4,Rs2853493,11467
MT-ND4,Rs28358282,haplogroup
MT-ND4,Rs28358282,ancestral
MT-ND4,Rs28358282,haplogroups
MT-ND4,Rs2853493,A11467G
MT-ND4,Rs199476112,Leber's optic atrophy
MT-ND4,I3000989,haplogroups
MT-ND4,I3000989,haplogroup
MT-ND4,I3000989,ancestral_haplogroup
MT-ND4,I3000989,derived_haplogroup
MT-ND4,Rs199476112,Leber's optic atrophy
MT-ND5,I3001191,haplogroups
MT-ND5,I3001191,ancestral_haplogroup
MT-ND5,I3001191,derived_haplogroup
MT-ND5,I3001191,derived_haplogroup
MT-ND5,I3001191,haplogroup
MT-ND5,I3001191,ancestral
MT-ND5,I3001191,derived_allele
MT-ND5,I3001191,ancestral_allele
MT-ND5,I3001191,derived_haplogroup
MT-ND5,I3001191,haplogroup
MT-ND5,I3001191,ancestral_haplogroup
MT-ND5,I3001191,haplogroups
MTHFD1,Rs760889414,pathogenic variant
MTHFD1,Rs8003379,"rs8003379 is reported to represent a risk factor for abdominal aortic aneurysm (AAA), with odds ratio of 0.41 (CI: 0.26-0.65)."
MTHFD1,Rs781065280,pathogenic variant
MTHFD1,Rs760889414,OMIM pathogenic variant
MTHFD1,Rs760889414,Glu225Ter
MTHFD1,Rs760889414,MTHFD1
MTHFD1,Rs760889414,pathogenic variant
MTHFD1,Rs2236225,hanolamine N-methyltransferase and methylenetetrahydrofol
MTHFD1,Rs760889414,Glu225Ter
MTHFD1,Rs2236225,nucleotide polymorphisms in one-carbon metabolism genes with prostate cancer risk. Lack of association of polymorphisms
MTHFD1,Rs2236225,enetic polymorphisms in methyl-group metabolism and epigenetics: lessons from humans and mouse models. Low-penetrance alle
MTHFD1,Rs2236225,"genase influence biomarkers of choline metabolism when folate intake is restricted. Epigenetic mechanisms for nutrition determinants of later health outcomes. Development of a fingerprinting panel using medically relevant polymorphisms. 118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects. Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis. Genetics of human neural tube defects. Application of sex-specific single-nucleotide polymorphism filters in genome-wide association data. Populat"
MTHFD1,Rs2236225,teine metabolism in celiac disease. Folate and choline metabolism gene variants in relation to ovarian cancer risk in the Polish populati
MTHFD1,Rs2236225, are associated with nonsyndromic cleft lip and/or palate in 
MTHFD1,Rs1076991,influences embryonic development
MTHFD1,Rs1076991,embryonic development.
MTHFD1,Rs2236225,ha
MTHFD1L,Rs6922269,coronary artery disease
MTHFD1L,Rs6922269,coronary artery disease
MTHFD1L,Rs6922269,heart disease
MTHFD1L,Rs12525353,associated with blood pressure
MTHFD1L,Rs6922269,heart disease
MTHFD1L,Rs12525353,associated with blood pressure
MTHFD1L,Rs12525353,blood pressure
MTHFD1L,Rs11754661,Alzheimer's disease
MTHFD1L,Rs12525353,associated with blood pressure
MTHFR,Rs17421511,schizophrenia
MTHFR,Rs17421511,schizophrenia
MTHFR,Rs17421511,schizophrenia
MTHFR,Rs1801131,brain cance
MTHFR,Rs1801131,brain cancer
MTHFR,Rs1801131,meningioma
MTHFR,Rs1801131,schizophrenia
MTHFR,Rs2066462,SNP 
MTHFR,Rs2066470,"Associated with lean body mass but not fat body mass in a study of ~1,800 Caucasians"
MTHFR,Rs3737964,"Associated with lean body mass but not fat body mass in a study of ~1,800 Caucasians"
MTHFR,Rs4846048,"Associated with lean body mass but not fat body mass in a study of ~1,800 Caucasians"
MTHFR,Rs17421511,schizophrenia
MTHFR,Rs1801131,glioma
MTHFR,Rs17367504,Hypertension
MTHFR,Rs1801131,schizophrenia 
MTHFR,Rs17367504,high blood pressure
MTHFR,Rs12121543,gene cluster
MTHFR,Rs17037396,schizophrenia
MTHFR,Rs17037396,schizophrenia
MTHFR,Rs17037396,schizophrenia
MTHFR,Rs17367504,Blood Pressure
MTHFR,Rs17367504,Hypertension
MTHFR,Rs17037396,schizophrenia
MTHFR,Rs17367504,High Blood Pressure
MTHFR,Rs17367504,High Blood Pressure 
MTHFR,Rs17367504,0.89 x odds of high blood pressure
MTHFR,Rs17367504,Hypertension
MTHFR,Rs17367504,is associated with 0.89 x odds
MTHFR,Rs17367504, high blood pressure
MTHFS,Rs6495446,disease 
MTHFS,Rs6495446,kidney 
MTHFS,Rs6495446,chronic 
MTHFS,Rs6495446,allele 
MTHFS,Rs6495446,allele 
MTHFS,Rs6495446,minor 
MTHFS,Rs6495446,allele 
MTHFS,Rs6495446,emphasis 
MTHFS,Rs6495446,kidney 
MTHFS,Rs6495446,SNP 
MTHFS,Rs6495446,disease 
MTHFS,Rs6495446,Asian 
MTHFS,Rs6495446,European 
MTHFS,Rs6495446,23andMe 
MTHFS,Rs6495446,rs6495446
MTHFS,Rs6495446,000 
MTHFS,Rs6495446,Framingham 
MTHFS,Rs6495446,SNP 
MTHFS,Rs6495446,rs6495446
MTHFS,Rs6495446,MTHFS 
MTHFS,Rs6495446,times
MTRR,Rs2303080,shortage
MTRR,Rs2303080,Mutation
MTRR,Rs2303080,Methyl-B12
MTRR,Rs2303080,"Mutation can cause shortage, suggesting a need for more B12."
MTRR,Rs162036,glaucoma
MTRR,Rs162036,pseudoexfoliation syndrome
MTRR,Rs162036,single nucleotide polymorphisms
MTRR,Rs162036,glaucoma
MTRR,Rs162036,pseudoexfoliation syndrome
MTRR,Rs162036,prostate cancer risk
MTRR,Rs162036,single nucleotide polymorphisms
MTRR,Rs162036,prostate cancer
MTTP,Rs3816873,nonalcoholic fatty liver disease.
MTTP,Rs755155385,Blueprint Genetics Retinal dystrophy
MTTP,Rs755155385,Blueprint Genetics Retinal dystrophy
MTTP,Rs3816873,nonalcoholic fatty liver disease
MTTP,Rs3816873,type-2 diabetes
MTTP,Rs3816873,impaired glucose tolerance
MTTP,Rs3816873,microsomal triglyceride transfer protein genes
MTTP,Rs146064714,abetalipoproteinemia
MTTP,Rs3816873,polymorphisms
MTTP,Rs3816873,type-2 diabetes
MTTP,Rs3816873,protective against impaired glucose tolerance
MTTP,Rs3816873,polymorphism
MTTP,Rs3816873,rare allele
MTTP,Rs17029215,severity of coronary atherosclerosis
MTTP,Rs3816873,glutamate-cysteine
MUC1,Rs4072037, Chinese
MUC1,Rs4072037,gastric cancer
MUC1,Rs4072037,population
MUC1,Rs4072037,Chinese
MUC1,Rs4072037, gastric cancer 
MUC1,Rs4072037,Genetic
MUC1,Rs4072037,men
MUC1,Rs4072037,gallstone disease
MUC1,Rs4072037,splicing
MUC1,Rs4072037,MUC1 as a Putative Prognostic Marker 
MUC1,Rs4072037,Prostate Cancer
MUC1,Rs4072037,patients
MUC1,Rs4072037,dry eye
MUC1,Rs4072037,estrogen receptor alpha gene polymorphisms
MUC1,Rs4072037,humans
MUC1,Rs4072037,polymorphisms
MUC1,Rs4072037,cancer
MUT,Rs564069299,variant 
MUT,Rs564069299,pathogenic 
MUT,Rs535411418,pathogenic mutation
MUT,Rs121918257,Hispanics
MUT,Rs121918254,recurrent pathogenic variant
MUT,Rs121918257,common pathogenic variant
MUT,Rs121918254,Gly623Arg 
MUT,Rs121918253,pathogenic variant
MUT,Rs121918253,pathogenic variant seen in Japan
MUT,Rs121918252,African Americans and Nigerians
MUT,Rs121918254,G623R
MUTYH,Rs3219489,non-small cell lung cancer risk
MUTYH,Rs3219489,age-related macular degeneration
MUTYH,Rs34612342,Germline bi-allelic mutations
MUTYH,Rs34612342,multiple adenomatous polyps
MUTYH,Rs34612342,colorectal cancer
MUTYH,Rs36053993,ancestors
MUTYH,Rs36053993,alternative designations 
MUTYH,Rs36053993,People with two copies of a single mutation
MUTYH,Rs36053993,higher risk of developing multiple adenomatous polyps and colorectal cancer.
MUTYH,Rs371848318,OMIM
MUTYH,Rs3219489,breast cancer
MUTYH,Rs36053993,most common pathogenic mutations in
MUTYH,Rs3219489,Bladder cancer
MUTYH,Rs3219489,rimary sclerosing cholangitis and cholangiocarcinoma
MUTYH,Rs143353451,is considered pathogenic in ClinVar for a hereditary cancer-predisposing syndrome (polyposis)
MUTYH,Rs147487160,Germline 
MUTYH,Rs147487160,Colorectal 
MUTYH,Rs147487160,Prevalence 
MUTYH,Rs147487160,Gene Mutations
MUTYH,Rs147487160,Germline Cancer
MUTYH,Rs147487160,Colorectal Cancer
MUTYH,Rs147487160,Early-Onset Colorectal Cancer
MUTYH,Rs147487160,Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal Cancer
MUTYH,Rs143353451, c.545G>A (p.Arg182His or R182H)
MUTYH,Rs143353451,hereditary cancer-predisposing syndrome (polyposis)
MUTYH,Rs143353451,polyposis
MUTYH,Rs143353451,hereditary cancer-predisposing syndrome
MVK,Rs2287218,CHD
MVK,Rs2287218,IS
MVK,Rs2287218,HDL-C levels.
MVK,Rs2287218,IS
MVK,Rs2287218,ischemic stroke
MVK,Rs2287218,increased risk of coronary heart disease 
MVK,Rs2287218,CHD
MVK,Rs2287218,ischemic stroke
MVK,Rs2287218,coronary heart disease
MYBPC3,Rs113358486,cardiomyopathy
MYBPC3,Rs113358486,Hypertrophic Cardiomyopathy
MYBPC3,Rs113358486,hypertrophic cardiomyopathy
MYBPC3,Rs113358486,pathogenicity
MYBPC3,Rs113358486,Hypertrophic Cardiomyopathy
MYBPC3,Rs113358486,familial hypertrophic cardiomyopathy (HCM)
MYBPC3,Rs11570112,hypertrophic cardiomyopathy
MYBPC3,Rs181834806,Hypertrophic Cardiomyopathy.
MYBPC3,Rs11570112,pathogenic mutation
MYBPC3,Rs181834806,genetically misdiagnosed
MYBPC3,Rs113358486,hypertrophic cardiomyopathy
MYBPC3,Rs111683277,idiopathic dilated cardiomyopathy
MYBPC3,I5046245,familial hypertrophic cardiomyopathy
MYBPC3,Rs111683277,familial or idiopathic dilated cardiomyopathy
MYBPC3,Rs111683277,hypertrophic cardiomyopathy
MYBPC3,Rs111683277,familial hypertrophic cardiomyopathy (HCM)
MYBPC3,Rs111437311,"c.1624+2T>C, is reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy"
MYBPC3,Rs111437311,Hypertrophic cardiomyopathy
MYBPC3,Rs111437311,familial hypertrophic cardiomyopathy (HCM
MYBPC3,I5046245,hypertrophic cardiomyopathy
MYBPC3,I5046245,familial hypertrophic cardiomyopathy
MYBPC3,I5046245,familial hypertrophic cardiomyopathy
MYBPC3,I5046177,hypertrophic cardiomyopathy
MYBPC3,I5005171,familial hypertrophic cardiomyopathy
MYBPC3,Rs111683277,hypertrophic cardiomyopathy
MYH14,Rs648298,deafness
MYH14,Rs648298,deafness
MYH14,Rs28940307,deafness
MYH14,Rs28940306,deafness
MYH14,Rs28940306,deafness
MYH14,Rs28940307,deafness
MYH6,Rs365990,Icelandic
MYH6,Rs365990,"European descent,"
MYH6,Rs365990,atrial fibrillation
MYH6,Rs365990,ick sinus syndrome
MYH6,Rs365990,advanced AV block
MYH7,Rs121913627,mutation
MYH7,Rs121913627,HCM
MYH7,Rs121913627,familial hypertrophic cardiomyopathy (HCM)
MYH7,Rs121913627,four most common
MYH7,Rs121913627,hypertrophic cardiomyopathy
MYH7,I6015303,familial hypertrophic cardiomyopathy
MYH7,Rs121913627,variant
MYH7,Rs121913627,rare
MYH7,I6015303,hypertrophic cardiomyopathy
MYH7,Rs121913627,pathogenic/likely pathogenic
MYH9,Rs80338827,Epstein syndrome
MYH9,Rs80338828,hereditary deafness
MYH9,Rs80338828,late-onset progressive hereditary hearing impairment due to cochleosaccular degeneration
MYH9,Rs80338828,Human nonsyndromic hereditary deafness
MYH9,Rs80338828,mutation in nonmuscle myosin MYH9
MYH9,Rs80338835,May-Hegglin anomaly.
MYH9,Rs80338829,Fechtner and Sebastian syndromes
MYH9,Rs80338835,May-Hegglin anomaly
MYH9,Rs80338835,May-Hegglin anomaly
MYH9,Rs80338835,Fechtner and Sebastian syndromes
MYH9,Rs80338835,The May-Heggllin/Fechtner Syndrome Consortium
MYH9,Rs80338827,renal disorder with mutations in the nonmuscle myosin heavy chain 9 gene
MYH9,Rs80338829,May-Hegglin anomaly
MYH9,Rs80338827,autosomal dominant macrothrombocytopenias:
MYH9,Rs80338828,five-generation family
MYH9,Rs80338827,Epstein syndrome: another renal disorder with mutations in the nonmuscle myosin heavy chain 9 gene.
MYH9,Rs80338827,Nonmuscle myosin heavy chain
MYH9,Rs739097,schizophrenia with non-deficit in sustained attention and executive function
MYH9,Rs739097,nonsyndromic cleft lip and palate
MYH9,Rs739097,kidney disease
MYH9,Rs80338826,MYH9
MYH9,Rs80338826,Fechtner and Sebastian syndrome
MYH9,Rs80338826,May-Hegglin anomaly
MYH9,Rs80338826,IIA mutations
MYH9,Rs80338826,autosomal dominant macrothrombocytopenias
MYH9,Rs80338826,May-Hegglin anomaly
MYH9,Rs80338826,"Fechtner, Sebastian, Epstein, and Alport-like syndromes"
MYH9,Rs80338827,macrothrombocytopenias
MYH9,Rs80338827,"May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes. "
MYH9,Rs80338826,The May-Heggllin/Fechtner Syndrome
MYLK,Rs387906781,aortic dissections
MYLK,Rs936170,lower risk of asthma
MYLK,Rs387906782,familial aortic dissections
MYLK,Rs387906782,light chain kinase
MYLK,Rs387906781,Mutations
MYLK,Rs387906782,Mutations in myosin
MYLK,Rs387906781,familial aortic dissections
MYLK,Rs387906781,cause familial aortic dissections
MYLK,Rs387906781,familial aortic dissections
MYLK,Rs387906781,familial aortic dissections
MYLK,Rs387906781,familial aortic dissections
MYO18B,Rs869312740,pathogenic variant
MYO6,Rs28936390,deafness
MYO6,Rs28936390,deafness
MYO6,Rs28936391,deafness
MYO6,Rs28936391,deafness
MYO7A,Rs111033178,Usher 
MYO7A,Rs111033178,syndrome 
MYO7A,Rs1052030,vestibular dysfunction
MYO7A,Rs1052030,deafness
MYO7A,Rs111033174,Characterization of Usher syndrome type I gene mutations in an Usher syndrome patient population.
MYOC,Rs74315329,primary open angle glaucoma 
MYOC,Rs74315337,136C>T
MYOC,Rs74315330,glaucoma patients
MYOC,Rs74315330,mutations
MYOC,Rs74315330,Myocilin
MYOC,Rs74315330,Myocilin mutations
MYOC,Rs74315329,athogenic autosomal dominant
MYOC,Rs74315329, harb
MYOC,Rs74315329,A polygenic risk score influencing the likelihood of glaucoma progression
MYOC,Rs74315335,Gln337Arg
MYOC,Rs74315329,primary open angle glaucoma
MYOC,Rs74315329,pathogenic autosomal dominant mutation
MYOC,Rs74315329,nonsense mutation
MYOC,Rs74315329,glaucoma
MYOC,Rs74315329,glaucoma
MYOC,Rs74315329,family history
MYOC,Rs74315329,adults
MYOC,Rs74315329,early-onset or juvenile onset
MYOC,Rs74315329,early-onset or juvenile onset
MYOC,Rs74315329,open angle glaucoma
NAGPA,Rs139526942,stuttering 
NAGPA,Rs139526942,NAGPA
NAGPA,Rs139526942,rs139526942 
NAGPA,Rs139526942,16
NAGPA,Rs139526942,NAGPA 
NAGPA,Rs139526942,rs139526942
NAGPA,Rs139526942,Arg328Cys 
NAGPA,Rs139526942,982C
NAGPA,Rs139526942,stuttering
NAGPA,Rs139526942,R328C
NAT2,Rs1801279,more complete explanation
NAT2,Rs1801280,detoxifying protein
NAT2,Rs1801280,SNP in the NAT2 gene
NAT2,Rs1801279,inherited
NAT2,Rs1801279,protein
NAT2,Rs1801279,N-acetyltransferase
NAT2,Rs1801279,variant
NAT2,Rs1801279,variant
NBN,Rs1805794,glioma
NBN,Rs1805794,cell carcinoma
NBN,Rs1805794,breast cancer
NBN,Rs1805794,bladder cancer
NBN,Rs1805794,oral premalignant lesions
NBN,Rs1805794,lung cancer
NBN,Rs1805794,non-Hodgkin lymphoma (NHL)
NBN,Rs1805794,Bladder cancer
NBN,Rs1805794,Prostate Cancer
NBN,Rs1805794,invasive serous ovarian cancer
NBN,Rs1805794,acute lymphoblastic leukemia
NBN,Rs1805794,primary antibody deficiency syndromes IgAD and CVID
NBN,Rs1805794,systemic lupus erythematosus
NBN,Rs1805794,breast cancer
NBN,Rs1805794,non-Hodgkin's lymphoma
NBN,Rs1805794,breast cancer
NBN,Rs1805794,non-Hodgkin's lymphoma
NBN,Rs1805794,breast cancer
NBN,Rs1805794,Breast cancer 
NBN,Rs34767364,breast cancer
NBN,Rs34767364,Variations in the NBN/NBS1 gene
NBN,Rs34767364,breast cancer
NBN,Rs1805794,Prostate Cancer
NBN,Rs1805794,acute lymphoblastic leukemia
NBN,Rs1805794,CVID
NBN,Rs1805794,primary antibody deficiency syndromes IgAD
NBN,Rs1805794,systemic lupus erythematosus
NBN,Rs1805794,ovarian cancer
NBN,Rs1805794,Breast cancer
NBN,Rs1805794,bladder cancer
NBN,Rs1805794,bladder cancer
NBN,Rs34767364,breast cancer.
NBN,Rs1805794,breast cancer
NBN,Rs1805794,cancer
NBN,Rs1805794,bladder cancer.
NBN,Rs1805794,ovarian cancer
NBN,Rs1805794,smoking
NBN,Rs1805794,on-Hodgkin lymphoma
NBN,Rs1805794,non-Hodgkin's lymphoma.
NBN,Rs1805794,Taiwanese patients.
NBN,Rs1805794,ovarian cancer.
NBN,Rs1805794,bladder cancer
NBN,Rs1805794,French Canadian
NBN,Rs1805794,breast cancer
NBN,Rs1805794,breast cancer
NBN,Rs1805794,renal cell carcinoma
NBN,Rs1805794,oral premalignant lesions
NBN,Rs1805794,Bladder cancer
NBN,I5012770,numerous cancers
NBN,I5012770,Nijmegen breakage syndrome
NBN,Rs1805794,bladder cancer
NBN,Rs1805794,adult glioma
NBN,Rs1805794,breast cancer.
NBN,Rs1805794,reast cancer
NBN,Rs1805794,bladder cancer
NBN,Rs1805794,ovarian cancer
NBN,Rs1805794,breast cancer
NBN,Rs1805794,breast cancer
NBN,Rs1805794,cancer
NBN,Rs1805794,breast cancer
NBN,Rs1805794,familial breast cancer
NBN,Rs1805794,ovarian cance
NBN,Rs1805794,renal cell carcinoma
NBN,Rs1805794,adult glioma
NBN,Rs1805794,bladder cancer
NBN,Rs1805794,oral premalignant lesions
NBN,Rs1805794,lung cancer
NBN,Rs1805794,non-Hodgkin lymphoma
NBN,Rs1805794,Bladder cancer
NBN,Rs1805794,bladder cancer.
NBN,Rs1805794,breast cancer
NCF4,Rs4821544,Caucasians
NCF4,Rs4821544,Crohn's disease
NCF4,Rs4821544,inflammatory bowel disease
NCF4,Rs4821544,Crohn's disease
NCF4,Rs4821544,New Zealand
NCF4,Rs4821544, patients
NCF4,Rs4821544,carriers of the C allele
NCF4,Rs4821544,Crohn's disease
NCF4,Rs4821544,inflammatory bowel disease
NCF4,Rs4821544,ileal Crohn's disease
NCF4,Rs4821544,controls
NDRG1,I5008730,Charcot-Marie-Tooth disease
NDRG1,I5008730,Charcot-Marie-Tooth disease
NDRG1,I5008730,type 4D
NDST3,Rs11098403,increased risk for schizophrenia
NEFL,Rs58640772,pathogenic variant
NF1,Rs199474785,p.Leu844Phe
NF1,Rs199474785,L844Fsee
NF2,Rs587776562,type 2
NF2,Rs587776562,neurofibromatosis
NF2,Rs587776562,"mutation in the NF2 gene is also known as c.240+1G>T, and it is considered pathogenic for neurofibromatosis, type 2."
NF2,Rs1060503670,A>G
NF2,Rs587776562,neurofibromatosis
NFKB1,Rs4648127,lung cancer
NFKB1,Rs4648022,NHL
NFKB1,Rs4648022,95
NFKB1,Rs4648022,0037
NFKB1,Rs4648022,84
NFKB1,Rs4648022,41
NFKB1,Rs4648022,rs4648022
NFKB1,Rs1585215,disease
NFKB1,Rs4648022,Non-Hodgkin's lymphoma
NFKB1,Rs1585215, heterozygotes
NFKB1,Rs1585215,homozygotes
NFKB1,Rs1585215,Hodgkin lymphoma
NFKB1,Rs1585215,SNP
NFKB1,Rs4648022,NHL
NFKBIL1,Rs2230365,non-Hodgkin lymphoma
NFKBIL1,Rs2230365,rheumatoid arthritis
NGF,Rs6330,trait anxiety
NGF,Rs6330,females
NGF,Rs6330,females
NGF,Rs6330,males
NGF,Rs6330,anxiety related personality traits
NGF,Rs6330,gender-dependent
NGF,Rs6330,males
NGF,Rs6330,females had higher levels of trait anxiety
NGF,Rs6330,anxiety related personality traits
NGF,Rs6330,subjects of German descent
NGF,Rs6330,German descent
NGLY1,Rs201337954,congenital disorder of deglycosylation (CDDG)
NGLY1,Rs201337954,disorder of deglycosylation 
NGLY1,Rs201337954,defective N-glycanase
NGLY1,Rs201337954,leads to congenital disorder of deglycosylation (CDDG)
NINJ2,Rs11833579,ischemic (or incident) stroke.
NINJ2,Rs11833579,ischemic stroke
NINJ2,Rs11833579,total stroke and ischemic stroke
NINJ2,Rs11833579,stroke
NINJ2,Rs11833579,stroke
NLRP1,Rs6502867,linked to generalized vitiligo 
NLRP1,Rs6502867,vitiligo
NLRP1,Rs6502867,generalized vitiligo
NLRP1,Rs12150220,juvenile idiopathic arthritis
NLRP1,Rs12150220,systemic lupus erythematosus
NLRP1,Rs12150220,rheumatoid arthritis
NLRP1,Rs12150220,multiple sclerosis
NLRP1,Rs12150220,type-1 diabetes
NLRP1,Rs12150220,autoimmune Addison's disease
NLRP1,Rs12150220,autoimmune diseases
NLRP1,Rs6502867,linked to generalized vitiligo Individuals
NLRP1,Rs115799546," multiple sclerosis and malignant melanoma,"
NLRP1,Rs115799546,"when inherited recessively, the rs115799546(T) allele (in dbSNP orientation) may cause both conditions."
NLRP1,Rs115799546,multiple sclerosis
NLRP1,Rs115799546,multiple sclerosis and malignant melanoma
NLRP1,Rs115799546,when inherited recessively
NLRP1,Rs115799546,malignant melanoma
NLRP1,Rs115799546,rare mutation
NLRP1,Rs115799546,multiple sclerosis
NLRP1,Rs115799546,malignant melanoma
NLRP1,Rs115799546,nherited recessively
NLRP1,Rs115799546,may cause both conditions.
NLRP12,Rs774895361,OMIM pathogenic variant
NLRP12,Rs774895361,Trp
NLRP12,Rs774895361,Ter
NLRP12,Rs774895361,OMIM pathogenic variant
NLRP3,Rs3806265,juvenile idiopathic arthritis
NLRP3,Rs3806265,juvenile idiopathic arthritis
NLRP3,Rs145268073,"related periodic fevers syndromes"".Overall, "
NLRP3,Rs145268073,autoinflammatory diseases
NLRP3,Rs145268073,hearing loss
NOD2,Rs2067085,haplotype 
NOD2,Rs2067085,Helicobacter pylori
NOD2,Rs2067085,NOD1 and NOD2 genes polymorphisms
NOD2,Rs2067085,north Indians
NOD2,Rs2067085,gastric cancer
NOD2,Rs2067085,ulcerative colitis 
NOD2,Rs2067085,North Indians
NOD2,Rs2067085,ulcerative colitis
NOD2,Rs2067085,allelic heterogeneity
NOD2,Rs2067085,Ashkenazi Jews
NOD2,Rs2067085,Crohn disease
NOD2,Rs2067085,gastric cancer in a Chinese population
NOD2,Rs2067085,gastric 
NOD2,Rs2067085,risk for Crohn disease in Ashkenazi Jews
NOD2,Rs2067085,gastric cancer
NOD2,Rs2067085,ulcerative colitis
NOD2,Rs2067085,Crohn disease
NOD2,Rs2067085,gastric cancer
NOD2,Rs2067085,ulcerative colitis
NOD2,Rs2067085,ulcerative colitis
NOD2,Rs2067085,cancer 
NOD2,Rs2067085,Helicobacter 
NOD2,Rs2067085,disease 
NOD2,Rs2067085,Crohn 
NOD2,Rs2067085,Chinese population
NOD2,Rs2067085,ulcerative colitis among North Indians
NOD2,Rs2076756,Crohn's disease
NOD2,Rs2067085,Ashkenazi 
NOD2,Rs2076756,Crohn's disease
NOD2,Rs9302752,associated with susceptibility to Crohn's disease
NOD2,Rs9302752,TNFSF15 genes
NOD2,Rs9302752,risk allele is C
NOD2,Rs9302752,in Asians
NOD2,Rs9302752,greater susceptibility to leprosy
NOD2,Rs9302752,The risk allele is C
NOD2,Rs5743289,autoinflammatory disorders
NOD2,Rs5743277, genetic risk score for inflammatory bowel disease
NOD2,Rs5743277,11 SNPs used
NOD2,Rs5743277,R703COne
NOD2,Rs5743277,NOD2 SNP
NOD2,Rs5743277,inflammatory bowel disease
NOD2,Rs5743277,inflammatory bowel disease
NOD2,Rs5743277,inflammatory bowel disease
NOD2,Rs3135499,transmission disequilibrium of gene variants
NOD2,Rs3135499,Asthma families
NOD2,Rs2076756,cancer etiology
NOD2,Rs2076756,underlie human diseases
NOD2,Rs2076756,pediatric-onset inflammatory bowel disease
NOD2,Rs2076756,Asthma
NOD2,Rs2076756,Crohn's disease
NOD2,Rs2076756,European populations
NOD2,Rs2076756,Crohn's disease
NOD2,Rs2076756,pediatric-onset inflammatory bowel disease
NOD2,Rs2076756,Asthma
NOD2,Rs2076756,Crohn's disease
NOD2,Rs2067085,Crohn disease
NOD2,Rs5743289,autoinflammatory disorders
NOD2,Rs2066847,insertion
NOD2,Rs17221417,autoimmune and inflammatory diseases
NOD2,Rs17221417,inflammation
NOD2,Rs17221417,Crohn disease
NOD2,Rs17221417,Crohn's disease
NOD2,Rs17221417,Crohn disease
NOD2,Rs17221417,Crohn's disease
NOD2,Rs104895462,Blau syndrome
NOD2,Rs104895462,mutations
NOD2,Rs104895462,mutations in Blau syndrome
NOD2,Rs104895461,Blau syndrome
NOD2,Rs104895461,mutations
NOD2,Rs104895461,mutations in Blau syndrome
NOD2,Rs104895460,Blau syndrome
NOD2,Rs104895460,mutations
NOD2,Rs104895460,mutations in Blau syndrome
NOD2,Rs104895444,inflammatory bowel disease
NOD2,Rs104895444,genetic risk
NOD2,Rs104895444,11 SNPs used in a genetic risk score
NOD2,Rs2066847,Crohn's disease
NOD2,Rs104895444,inflammatory bowel disease
NOD2,Rs104895444,inflammatory bowel disease
NOD2,Rs104895431,inflammatory bowel disease
NOD2,Rs104895431,genetic risk
NOD2,Rs104895431,inflammatory bowel disease
NOD2,Rs104895431,inflammatory bowel disease
NOD2,Rs17221417,type 2 diabetes
NOD2,Rs2066844,Crohn's disease 
NOD2,Rs17221417,not associated with the risk of type 2 diabetes
NOD2,Rs2066844,inflammatory bowel disease
NOD2,Rs2066847,SNPs
NOD2,Rs2066847,insertion
NOD2,Rs2066847,SNPs
NOD2,Rs2066847,Crohn's disease
NOD2,Rs2066845,associated with sarcoidoisis
NOD2,Rs2066845,inflammatory bowel diseas
NOD2,Rs2066844, Crohn's disease
NOD2,Rs2066845,Crohn's disease
NOD2,Rs2066845,inflammatory bowel disease.
NOD2,Rs2066845,sarcoidoisis
NOD2,Rs2066845,psoriatic arthritis
NOD2,Rs2066845,Crohn's disease
NOD2,Rs2066845,Gly908Arg
NOD2,Rs2066845,psoriatic arthritis
NOD2,Rs2066845," sarcoidoisis,"
NOD2,Rs2066845,inflammatory bowel disease.
NOD2,Rs2066845,Crohn's disease
NOD2,Rs2066845,psoriatic arthritis
NOD2,Rs2066845,sarcoidoisis
NOD2,Rs2066845,inflammatory bowel disease
NOD2,Rs2066845,Chinese 
NOD2,Rs2066845,psoriatic arthritis
NOD2,Rs2066845,sarcoidoisis
NOD2,Rs2066845,Chinese patients with inflammatory bowel disease
NOD2,Rs2066845,Crohn's disease
NOD2,Rs2066845,psoriatic arthritis
NOD2,Rs2066845,Crohn's disease
NOS1,Rs7977109,Polygenic Phenotype
NOS1,Rs7977109,Monogenic Disease with a Polygenic Phenotype
NOS1,Rs7977109,restless legs syndrome
NOS1,Rs7977109,NOS1 gene
NOS1,Rs7977109,Sickle Cell Disease
NOS1,Rs7977109,chromosome 12 
NOS1,Rs7977109,Polygenic Phenotype
NOS1,Rs7977109,German
NOS1,Rs7977109,most associated with the syndrome.
NOS1,Rs7977109,significant association
NOS1,Rs7977109,Cell Disease
NOS1,Rs7977109,Monogenic Disease
NOS1,Rs7977109,Disease
NOS1,Rs7977109,restless legs syndrome in ~900 patients
NOS1,Rs7977109,Monogenic
NOS1,Rs7977109,odds ratio of 0.76 (CI: 0.64 -0.90
NOS1,Rs7977109,SNP 
NOS1,Rs3782206,Chinese
NOS1,Rs3782206,paranoid schizophrenia
NOS1,Rs3782206,rs3782206 
NOS1,Rs3782221,schizophrenia
NOS1,Rs7977109,Sickle Cell Disease
NOS1,Rs3782221,Bipolar I disorder
NOS1,Rs3782221,Parkinson's disease
NOS1,Rs41279104,mood disorders
NOS1,Rs41279104,depressive disorder
NOS1,Rs41279104,depressive disorder
NOS1,Rs41279104,fluvoxamine response in major depressive disorder in the Japanese population.
NOS1,Rs73208120,colorectal cancer
NOS1,Rs7977109,restless legs syndrome
NOS1,Rs7977109,German
NOS1,Rs7977109,SNPs 
NOS1AP,Rs12742393,gene expression
NOS1AP,Rs12742393,enhanced transcription factor binding
NOS1AP,Rs10918594,gotes had a 12.5 msec longer QT interval compared to major hom
NOS1AP,Rs12742393,schizophrenia risk factor
NOS1AP,Rs12029454,Influences QT interval
NOS1AP,Rs12742393,schizophrenia
NOS1AP,Rs12742393,schizophrenia
NOS1AP,Rs12742393,possible schizophrenia risk factor - 
NOS1AP,Rs7538490,diabetes
NOS1AP,Rs16857031,Influences QT interval
NOS1AP,Rs7538490,diabetes
NOS1AP,Rs7538490,obesity
NOS1AP,Rs7538490,type-2 diabetes
NOS1AP,Rs7538490,type-2 diabetes
NOS1AP,Rs10918594,"er allele have a longer QT interval. A follow-up study determined that one rs10918594(G) allele was associated with a 3.6-ms (CI: 2.7 - 4.4ms, p=6.9x10(-17)) increase in QT interval duration, and"
NOS1AP,Rs7538490,obesity
NOS1AP,Rs12742393,enhanced transcription factor binding and gene expression of NOS1AP (nitric oxide synthase 1 adaptor protein)
NOS1AP,Rs10918594,diabetic EAs
NOS1AP,Rs7538490,type-2 diabetes
NOS1AP,Rs10918594,cardiac problem
NOS1AP,Rs10918594,abnormal heart rhythms
NOS1AP,Rs10494366,abnormal heart rhythms
NOS1AP,Rs10494366,Caucasian ancestry
NOS1AP,Rs10494366,shorter QT intervals
NOS1AP,Rs10494366,longer QT interval
NOS1AP,Rs10494366,sudden death due to a cardiac problem
NOS1AP,Rs10494366,longer QT interval
NOS1AP,Rs10494366,longer QT interval
NOS1AP,Rs10494366,increase in QT interval
NOS1AP,Rs10494366,increased mortality risk
NOS1AP,Rs10494366,mortality rates were higher
NOS1AP,Rs10494366,reduced mortality rate
NOS1AP,Rs10918594,abnormal heart rhythms
NOS1AP,Rs10494366,adjusted QT interval
NOS1AP,Rs10494366,whites
NOS1AP,Rs10494366,whites
NOS1AP,Rs10494366,blacks
NOS1AP,Rs10494366,diabetic EAs
NOS2,Rs2779251,chronic lymphocytic leukemia
NOS2,Rs2779251,inflammatory bowel disease susceptibility.
NOS2,Rs3729508,Single nucleotide polymorphisms
NOS2,Rs2779251,inducible nitric oxide synthase gene (NOS2A) 
NOS2,Rs2779251,on inflammatory bowel disease
NOS2,Rs2779251,inflammatory bowel disease
NOS2,Rs2779251,chronic lymphocytic leukemia 
NOS2,Rs2297518,urinary bladder cancer
NOS2,Rs2297518,prostate cancer
NOS2,Rs2297518,rheumatoid arthritis
NOS2,Rs2297518,non-small cell lung cancer
NOS2,Rs2297518,radiation-induced toxicity
NOS2,Rs2297518,Korean men with benign prostatic hyperplasia
NOS2,Rs2297518,prostatic volume
NOS2,Rs2297518,type 2 diabetes
NOS2,Rs2297518,invasive pneumococcal disease
NOS2,Rs3729508,nitric oxide
NOS2,Rs2297518,China
NOS2,Rs2297518,aphthous stomatitis
NOS2,Rs3729508,Single nucleotide polymorphisms
NOS2,Rs4795067,Parkinson's disease
NOS2,Rs3729508,exhaled nitric oxide
NOS2,Rs2297518,biliary tract cancers and stones
NOS2,Rs8078340,South African population
NOS2,Rs8078340,susceptibility to TB
NOS2,Rs8078340,malaria-resistance
NOS2,Rs8078340,malaria-resistance variants
NOS2,Rs8078340,malaria
NOS2,Rs8078340,malaria 
NOS2,Rs8078340,TB
NOS2,Rs3729508,genes
NOS2,Rs8078340,ec
NOS2,Rs4795067,adult brain tumors
NOS2,Rs4795067,polymorphisms 
NOS2,Rs4795067,synthase 
NOS2,Rs4795067,psoriatic arthritis
NOS2,Rs4795067,brain tumors
NOS2,Rs4795067,oxidative stress
NOS2,Rs4795067,Parkinson's disease
NOS2,Rs4795067,psoriatic arthritis
NOS2,Rs8078340,malaria suscepti
NOS2,Rs2297518,Parkinson's disease
NOS2,Rs2297518,biliary tract cancers and stones
NOS2,Rs2297518,cognition
NOS2,Rs2297518,aphthous stomatitis
NOS2,Rs2297518,rheumatoid arthritis
NOS2,Rs2297518,lung cancer
NOS2,Rs2297518,benign prostatic hyperplasia
NOS2,Rs2297518,Parkinson's disease
NOS2,Rs2297518,inflammatory bowel disease 
NOS2,Rs2297518,non-Hodgkin lymphoma
NOS2,Rs2297518,Parkinson's disease
NOS2,Rs2297518,synthase gene polymorphisms and prostate cancer risk.
NOS2,Rs2297518,rinary bladder cancer pathogenesis
NOS2,Rs2297518,lung cancer.
NOS2,Rs1060826,Parkinson's disease.
NOS2,Rs1060826,respiratory syncytial virus bronchiolitis
NOS2,Rs1060826,Parkinson disease
NOS2,Rs1060826,Parkinson's disease
NOS2,Rs1060822,aphthous stomatitis
NOS2,Rs2297518,inflammatory bowel disease
NOS2,Rs2297518,urinary bladder cancer
NOS2,Rs2297518,non-Hodgkin lymphoma
NOS2,Rs2297518,diabetes-associated combination of SNPs
NOS2,Rs2297518,pneumococcal disease
NOS2,Rs2297518,cognitive ability and cognitive ageing
NOS2,Rs2297518,Parkinson's disease
NOS2,Rs2297518,inflammatory responses
NOS2,Rs2297518,fetal growth
NOS2,Rs2297518,non-Hodgkin lymphoma
NOS2,Rs2297518,urinary bladder cancer pathogenesis
NOS2,Rs2297518,rheumatoid arthritis
NOS2,Rs2297518,non-small cell lung cancer
NOS2,Rs2297518,benign prostatic hyperplasia
NOS2,Rs2297518,aphthous stomatitis
NOS2,Rs2297518,pneumococcal disease
NOS2,Rs2297518,prostatic hyperplasia
NOS2,Rs2297518,prostate cancer
NOS2,Rs2297518,biliary tract cancers and stones
NOS2,Rs2297518,Parkinson's disease
NOS2,Rs2297518,inflammatory bowel disease
NOS2,Rs2297518,non-Hodgkin lymphoma
NOS2,Rs2297518,prostatic volume
NOS2,Rs2297518,rheumatoid arthritis
NOS3,Rs891512,diastolic blood pressure
NOS3,Rs891512,blood pressure
NOS3,Rs891512,blood pressure
NOS3,Rs4496877,nephropathy
NOS3,Rs3918227,hypoxic-ischemic encephalopathy
NOS3,Rs3918227,NOS3 tag polymorphisms 
NOS3,Rs3918227,hypoxic-ischemic encephalopathy
NOS3,Rs891512,systolic blood pressure
NOS3,Rs3918227,Parkinson's disease
NOS3,Rs3918227,Habitual energy expenditure
NOS3,Rs891512,hypertension
NOS3,Rs891512,eNOS polymorphism rs891512 (G24943A) is associated with
NOS3,Rs891512,is an intronic variant in the NOS3 gene significantly associated with blood pressure
NOS3,Rs891512,was significantly associated with blood pressure
NOS3,Rs891512,GG homozygotes had significantly lower levels of diastolic blood pressure
NOS3,Rs891512,is associated with
NOS3,Rs891512,hypertension 
NOS3,Rs891512,is an intronic variant in the NOS3 gene significantly associated with blood pressure
NOS3,Rs891512,"The intronic variant, IVS25+15 G-->A, was significantly associated with blood pressure"
NOS3,Rs891512,GG homozygotes had significantly lower levels of diastolic blood pressure
NOS3,Rs891512,hypertension 
NOS3,Rs891512,were significantly associated with ABI (ankle-brachial index) in both subsets
NOS3,Rs3918227,Parkinson's disease
NOS3,Rs891512,protective haplotype C-T-A (rs2070744-rs1799983-rs891512) was observed (P = 0.01) with a pronounced effect against suicide completion
NOS3,Rs891512,suicide
NOS3,Rs3918227,polymorphisms
NOS3,Rs3918226,venous thromboembolism
NOS3,Rs3918227,Parkinson's disease
NOS3,Rs1799983,associated with an ~2x risk (p=0.006) of developing pre-eclampsia (pregnancy-induced hypertension)
NOS3,Rs1799983,increases risk of ischemic heart disease
NOS3,Rs3918227,hypoxic-ischemic encephalopathy
NOS3,Rs1799983,left ventricular hypertrophy in human essential hypertension
NOS3,Rs3918226,type 2 diabetes mellitus
NOS3,Rs3918226,hypertension
NOS3,Rs3918226,venous thromboembolism
NOS3,Rs3918226,hypertension
NOS3,Rs3918226,venous thromboembolism
NOS3,Rs3918226,essential hypertension
NOS3,Rs3918226,coronary heart disease 
NOS3,Rs1799983,not associated with risk of acute myocardial infarction in that population.
NOS3,Rs3918226,amyotrophic lateral sclerosis
NOS3,Rs3918226,hypertension
NOS3,Rs3918226,hypertension
NOS3,Rs3918226,metabolic syndrome
NOS3,Rs3918226,venous thromboembolism
NOS3,Rs3918226,hypertension
NOS3,Rs3918226,hypertension 
NOS3,Rs3918227,Parkinson's disease
NOS3,Rs3918227,hypoxic-ischemic encephalopathy
NOS3,Rs3918227,Parkinson's disease
NOS3,Rs3918227,hypoxic-ischemic encephalopathy
NOS3,Rs3918226,type 2 diabetes mellitus
NOTCH1,Rs41309764,progressive aortic valve disease
NOTCH1,Rs41309764,early developmental defect
NOTCH1,Rs41309764,bicuspid aortic valve
NOTCH1,Rs41309764,progressive aortic valve disease
NPAS2,Rs1811399,autism
NPAS2,Rs1811399,autism
NPAS2,Rs1811399,autism
NPAS2,Rs1811399,inheritance
NPAS2,Rs2305160,non-Hodgkin's lymphoma
NPAS2,Rs2305160,prostate cancer
NPAS2,Rs2305160,depressive disorders.
NPHS2,Rs12406197,benign
NPHS2,Rs12406197,Likely benign
NPPA,Rs5068,Europeans
NPPA,Rs5068,hypertension
NPPA,Rs5068,lower blood pressure
NPPA,Rs5068,natriuretic peptide
NPPA,Rs5068,hypertension
NPPA,Rs5068,increased circulating natriuretic peptide
NPPA,Rs5068,lower blood pressure
NPPA,Rs5067,reduced (50% or 76%) risk
NPPA,Rs5067,asthma patients
NPPA,Rs5067,asthma 
NPPA,Rs5067,asthma 
NPPB,Rs198389,chronic heart failure (CHF) 
NPTN,Rs7171755,cortical thickness
NPTN,Rs7171755,cortical thickness
NPTN,Rs7171755,verbal and nonverbal intelligence
NPTN,Rs7171755,verbal and nonverbal IQ
NPTN,Rs7171755,slight decrease in verbal and nonverbal intelligence (IQ)
NPY,Rs16147,Early-Onset atherosclerosis
NPY,Rs16147,consistent with the function of NPY as an anxiolytic peptide
NPY,Rs16147,account for more than half of the variation in expression in vivo
NPY,Rs16147,Early-Onset atherosclerosis
NPY,Rs16139,depressive disorder
NPY,Rs16139,depressive disorders
NPY,Rs16139,diabetic retinopathy
NPY,Rs16139,polymorphisms
NPY,Rs16139,early-onset atherosclerosis
NPY,Rs1468271,Neuropeptide Y gene polymorphisms confer risk of early-onset atherosclerosis.
NPY,Rs1468271, edema and BMI
NPY,Rs1468271, weight loss induced by dietary carbohydrate restriction
NPY,Rs1468271,early-onset atherosclerosis
NPY,Rs16139,metabolic syndrome
NR1H3,Rs2167079,progressive supranuclear palsy
NR1H3,Rs61731956,multiple sclerosis
NR1H3,Rs61731956,multiple sclerosis
NR1H3,Rs61731956,multiple sclerosis
NR1H3,Rs61731956,"severe, progessive disease"
NR1H3,Rs61731956,multiple sclerosis
NR1H3,Rs61731956,sclerosis
NR1H3,Rs61731956,loss of function 
NR1H3,Rs61731956,progessive disease
NR1H3,Rs61731956,disease
NR1H3,Rs7120118,supranuclear palsy
NR1H3,Rs61731956,70% chance of developing the disease
NR1H3,Rs11039155,heart disease
NR1H3,Rs11039155,diabetes
NR1H3,Rs11039155,metabolic syndrome
NR1H3,Rs11039155,heart disease
NR1H3,Rs11039155,type-2 diabetes
NR1H3,Rs11039155,metabolic syndrome
NR1H3,Rs10838681,single-nucleotide polymorphisms
NR1H3,Rs10838681,genomewide 
NR1H3,Rs10838681,progressive supranuclear palsy
NR1H3,Rs10838681,locus
NR1H3,Rs10838681,progressive supranuclear palsy
NR1H3,Rs10838681,single-nucleotide polymorphisms
NR1H3,Rs10838681,genomewide
NR1H3,Rs10838681,progressive supranuclear palsy
NR1H3,Rs10838681,novel risk locus
NR1I2,Rs1523127,inflammatory bowel disease
NR1I2,Rs1523127,chronic periodontitis
NR1I2,Rs1523127,deep vein thrombosis.
NR1I2,Rs1523127,deep vein thrombosis
NR3C1,Rs6195,blood pressure
NR3C1,Rs6195,glucocorticoid receptor polymorphisms
NR3C1,Rs6195,asthma
NR3C1,Rs6195,Crohn's disease
NR3C1,Rs6195,altered bone mineral density
NR3C1,Rs6195,acute lymphoblastic leukemia
NR3C1,Rs6195,Glucocorticoid receptor gene polymorphisms
NR3C1,Rs6195,asthma
NR3C1,Rs6195,inflammatory bowel disease
NR3C1,Rs6195,Genetic polymorphisms
NR3C1,Rs6195,anovulatory polycystic ovary syndrome
NR3C1,Rs6195,Glucocorticoid receptor polymorphism
NR3C1,Rs6195,bipolar patients
NR3C1,Rs6195,Glucocorticoid receptor gene
NR3C1,Rs6195,glucocorticoid resistance
NR3C1,Rs6195,altered gene expression
NR3C1,Rs10482605,associated with major depression.
NR3C1,Rs6195,increased body mass index
NR3C1,Rs6195,glucocorticoid receptor polymorphism
NR3C1,Rs10052957,growth in fetal and early postnatal life
NR3C1,Rs10052957,completed suicide
NR3C1,Rs10052957,inflammatory bowel disease
NR3C1,Rs10052957,bipolar patients.
NR3C1,Rs10052957,polymorphisms 
NR3C1,Rs10052957,polymorphism 
NR3C1,Rs10052957,inflammatory bowel disease
NR3C1,Rs10482605,regulation of glucocorticoid expression
NR3C1,Rs10482605,mRNA stability
NR3C1,Rs6195,coronary artery disease
NR3C1,Rs10482605,rs10482605(C) and rs6198
NR3C1,Rs10482682,Glucocorticoid receptor gene variant in the 3' untranslated region is associated with multiple measures of blood pressure
NR3C1,Rs6195,glucocorticoid sensitivity
NR3C1,Rs10052957,growth 
NR3C2,Rs1490453,fibrinogen
NR3C2,Rs1490453,increased fibrinogen levels
NRG1,Rs7835688,NRG1 Hirschsprung's disease
NRG1,Rs7835688,NRG1
NRG1,Rs7835688,Hirschsprung's disease
NRG1,Rs3924999,Alzheimer's disease with psychosis
NRG1,Rs3924999,significant association between rs3924999 and Alzheimer's disease with psychosis
NRG1,Rs3924999,Alzheimer's disease with psychosis
NRG1,Rs7835688,Fine mapping of the NRG1 Hirschsprung's disease locus.
NRXN1,Rs17041183,Nicotine
NRXN1,Rs17041183,G allele
NRXN1,Rs2024513,schizophrenia
NRXN1,Rs17041183,Substance dependence
NRXN1,Rs2024513,schizophrenia
NRXN1,Rs12467557,rs12467557 increases susceptibility
NRXN1,Rs2024513,schizophrenia
NRXN1,Rs2193225,nicotine dependence
NRXN1,Rs2193225,has been reported to be associated with increased risk for nicotine dependence.
NRXN1,Rs6721498,nicotine dependence.
NRXN1,Rs17041183,polymorphism
NRXN1,Rs6721498,increased risk for nicotine dependence.
NRXN1,Rs2024513,"associated with higher risk,"
NRXN1,Rs17041183,linkage disequilibrium
NRXN1,Rs10490162,Nicotine
NRXN1,Rs12623467,C allele
NRXN1,Rs12623467,increases susceptibility
NRXN1,Rs12623467,Nicotine
NRXN1,Rs12623467,Substance dependence
NRXN1,Rs12623467,susceptibility to Substance dependence
NRXN1,Rs12623467,Substance dependence
NRXN1,Rs12467557,Substance dependence
NRXN1,Rs12467557,C allele
NRXN1,Rs10490162,allele
NRXN1,Rs10490162,1.65 times for carrier
NRXN1,Rs10490162,Substance dependence
NRXN1,Rs10490162,susceptibility
NRXN1,Rs12623467,Substance dependence
NRXN3,Rs7147705,ALS
NSD1,Rs28932178,Sotos syndrome
NSD1,Rs28932178,autistic patients
NSD1,Rs28932178,autism
NSD1,Rs28932178,macrocephaly and learning disabilities
NSD1,Rs28932178,autism spectrum disorders and macrocephaly.
NSD1,Rs28932178,"Sotos syndrome,"
NSD1,Rs28932178,autism spectrum disorders and macrocephaly
NSD1,Rs28932178,increased risk for autism
NSD1,Rs28932178,autistic patients
NSD1,Rs28932178,Sotos syndrom
NSD1,Rs28932178,macrocephaly and learning disabilities
NSD1,Rs28932178, overgrowth syndrome
NSD1,Rs28932178,macrocephaly
NSD1,Rs28932178,autism spectrum disorders
NSMCE3,Rs199905054,chromosome breakage syndrome
NSMCE3,Rs199905054,fatal pneumonia
NSMCE3,Rs199905054,lung disease immunodeficiency
NSMCE3,Rs199905054,chromosome breakage syndrome
NSMCE3,Rs199905054,pneumonia
NSMCE3,Rs199905054,lung disease immunodeficiency and chromosome breakage syndrome (LICS)
NTF3,Rs6332,Adult attention deficit hyperactivity disorder (ADHD)
NTF3,Rs6332,the A-allele and increased scores
NTF3,Rs6332,high-risk male subjects
NUDT15,Rs116855232,leukopenia
NUDT15,Rs116855232,leukopenia
NUP153,Rs2228375,ancestral allele
NUTF2,Rs2271293,"decreased LDL cholesterol, increased HDL, and decreased triglycerides"
OAS1,Rs3741981,diabetes association
OAS1,Rs3741981,multiple sclerosis
OBSCN,Rs71180793,84 
OBSCN,Rs71180793,SNP 
OBSCN,Rs71180793,Familial Bipolar Disorder
OBSCN,Rs71180793,bipolar disorder
OBSCN,Rs71180793,Familial 
OBSCN,Rs71180793,SNP 
OBSCN,Rs71180793,Sequencing 
OBSCN,Rs71180793,Disorder
OBSCN,Rs71180793,heterozygotes
OBSCN,Rs71180793,noncompaction
OBSCN,Rs71180793,OBSCN 
OBSCN,Rs71180793,Bipolar Disorder
OBSCN,Rs71180793,ventricular noncompaction
OBSCN,Rs55883237,"left ventricular noncompaction,"
OBSCN,Rs55883237,left ventricular noncompaction
OCA2,Rs4778241,blue-brown eye color
OCA2,Rs4778241,hair color and skin pigmentation
OCA2,Rs4778241,blue-brown eye color
OCA2,Rs4778241,blue eye color
OCA2,Rs4778241,blue eyes
OCA2,Rs4778138,freckling
OCA2,Rs1800414,reduction in skin pigmentation
OCA2,Rs1800414,skin color
OCA2,Rs1800414,skin pigmentation
OGG1,Rs2304277,risk of ovarian cancer
OGG1,Rs2304277,mutation 
OGG1,Rs2304277,cancer 
OGG1,Rs1052133,lung cancer
OGG1,Rs1052133,lung cancer
OGG1,Rs1052133,gallbladder cancer
OGG1,Rs1052133,bladder cancer
OGG1,Rs1052133,gallbladder cancer
OGG1,Rs1052133,lung cancer
OGG1,Rs1052133,gallbladder cancer
OGG1,Rs1052133,bladder cancer
OGG1,Rs1052133,lung cancer
OGG1,Rs1052133,lung cancer
OGG1,Rs1052133,lung cancer
OPN1LW,Rs2315122,colorblindness
OPN1LW,Rs2315123,colorblindness
OPN1MW,Rs28935199,colorblind
OPN1MW,Rs28935199,"change from an arginine to a glutamine in the green opsin protein at position 330,"
OPN1MW,Rs28935199,Japanese male homozygous for the rs28935199 (A) allele
OPN1MW,Rs28935199,X chromosome harboring the green and red opsin genes
OPN1MW,Rs28935199,Colorblindness 
OPRD1,Rs2236857,African Americans
OPRD1,Rs533123,anorexia nervosa
OPRD1,Rs533123,anorexia nervosa
OPRD1,Rs533123,European anorexia nervosa patients
OPRD1,Rs2236857,Heroin addiction
OPRD1,Rs1042114,carriers of the G allele
OPRD1,Rs2234918,gender
OPRD1,Rs2234918,heroin addiction
OPRD1,Rs12749204,Substance dependence
OPRD1,Rs2234918,heroin addiction
OPRM1,Rs1799972,citalopram treatment
OPRM1,Rs1799972,citalopram treatment
OPRM1,Rs1799972,depressive disorder.
OPRM1,Rs1799972,Expansion of the human mu-opioid receptor gene architecture:
OPRM1,Rs1799972,Association of mu-opioid receptor variants and response to citalopram treatment in major depressive disorder.
OPRM1,Rs1799972,mu-opioid receptor gene architecture
OPRM1,Rs1799972,citalopram treatment
OPRM1,Rs1799972,major depressive disorder.
OPRM1,Rs563649,single nucleotide polymorphism
OPRM1,Rs563649,responses to alcohol
OPRM1,Rs563649,pain sensitivity
OPRM1,Rs563649,widespread pain
OPRM1,Rs1799972,depressive disorder
OPRM1,Rs10485057,rs10485057(G) allele
OPRM1,Rs1799972,mu-opioid receptor variants
OPRM1,Rs10485057,SNP
OPRM1,Rs10485057,higher likelihood of smoking initiation and nicotine dependence.
OPRM1,Rs10485057,higher likelihood of smoking initiation and nicotine dependence.
OPRM1,Rs10485057,nicotine dependence.
OPRM1,Rs10485057,rs10485057 
OPRM1,Rs10485057,1 OPRM1 gene
OPRM1,Rs10485057,OPRM1
OPRM1,Rs10485057,SNP 
OPRM1,Rs10485057,688 
OPRM1,Rs10485057,study 
OPRM1,Rs10485057,rs10485057
OPRM1,Rs10485057,allele 
OPRM1,Rs10485057,likelihood 
OPRM1,Rs10485057,rs10485057
OPRM1,Rs10485057,gene
OPTN,Rs825411,Paget’s disease of bone
OPTN,Rs825411,23andMe
OPTN,Rs825411,Paget’s disease of bone
OPTN,Rs825411,Paget’s disease of bone
OPTN,Rs825411,Paget’s disease of bone
OPTN,Rs1561570,23andMe
OPTN,Rs1561570,Paget’s disease of bone
OPTN,Rs1561570,Paget’s disease of bone
OPTN,Rs1561570,Paget’s disease of bone
OPTN,Rs1561570,Paget’s disease of bone
OR10A2,Rs72921001,allele
OR10A2,Rs72921001,allele
OR10A2,Rs72921001,allele
OR7D4,Rs5020278,smell of a testosterone-derived steroid
OR7D4,Rs5020278,"perceive the smell to be both weaker, and more sweet, with some likening it to vanilla or honey"
OR7D4,Rs5020278,Genetic variation in a human odorant receptor alters odour perception
OR7D4,Rs61729907,Human subjects with RT/WM or WM/WM genotypes
OR7D4,Rs61729907,genome-wide
OR7D4,Rs61729907,ndividuals with homozygous mutations
ORMDL3,Rs8067378,asthma
ORMDL3,Rs8067378,asthma
ORMDL3,Rs8067378,asthma 
ORMDL3,Rs8067378, mexican children
ORMDL3,Rs7216389,Scottish asthma patients
ORMDL3,Rs7216389,childhood asthma
ORMDL3,Rs7216389,British and German patients
ORMDL3,Rs8067378,susceptibility to childhood asthma
ORMDL3,Rs8067378,asthma
ORMDL3,Rs7216389,susceptibility to childhood asthma
ORMDL3,Rs8067378,Asthma
ORMDL3,Rs8067378,childhood asthma
ORMDL3,Rs8067378,childhood asthma
ORMDL3,Rs8067378,asthma
ORMDL3,Rs8067378,asthma
ORMDL3,Rs8067378,mexican children
ORMDL3,Rs8067378,asthma and autoimmune disease
ORMDL3,Rs8067378,Asthma-susceptibility
ORMDL3,Rs8067378,autoimmune disease
ORMDL3,Rs4378650,Puerto Ricans
ORMDL3,Rs8067378,childhood asthma
ORMDL3,Rs4378650,African American 
ORMDL3,Rs12603332,asthma
ORMDL3,Rs12603332,asthma 
ORMDL3,Rs12603332,autoimmune disease.
ORMDL3,Rs12603332,asthma
ORMDL3,Rs12603332,asthma and autoimmune disease
ORMDL3,Rs12603332,asthma
ORMDL3,Rs12603332,asthma
ORMDL3,Rs12603332,asthma and autoimmune disease.
ORMDL3,Rs12603332,asthma
ORMDL3,Rs12603332,asthma 
ORMDL3,Rs12603332,Puerto Ricans
ORMDL3,Rs12603332,asthma
ORMDL3,Rs12603332,autoimmune disease
ORMDL3,Rs12603332,asthma
ORMDL3,Rs4378650,asthma 
ORMDL3,Rs2305480,asthma
ORMDL3,Rs2305480,asthma
ORMDL3,Rs2305480,asthma
ORMDL3,Rs12603332,African American 
ORMDL3,Rs2305480,asthma
OTC,Rs5963409,Alzheimer's disease
OTOF,Rs28937591,deafness
OTOF,Rs28937591,deafness
OXT,Rs17339677,oxytocin/neurophysin
OXTR,Rs53576,stress 
OXTR,Rs53576,heart rates
OXTR,Rs53576,"affect, loneliness and intelligence"
OXTR,Rs53576,"marital discord, depression, and education status"
OXTR,Rs53576,sensitive parenting
OXTR,Rs53576,maternal education level
OXTR,Rs53576,hear and understand conversations in noisy environments.
OXTR,Rs53576,difficulty hearing
OXTR,Rs53576,saliva cortisol levels
OXTR,Rs53576,stress
OXTR,Rs53576,structural and functional alterations
OXTR,Rs53576,grey matter volume
OXTR,Rs53576,hypothalamus volume
OXTR,Rs53576,reward dependence
OXTR,Rs53576,higher levels of dispositional empathy 
OXTR,Rs53576,prosocial temperament
OXTR,Rs53576,autism
OXTR,Rs53576, G to A change
OXTR,Rs53576,"Culture, distress,"
OXTR,Rs53576,stress
OXTR,Rs53576,depression
OXTR,Rs53576,marital discord
OXTR,Rs53576,autism
OXTR,Rs53576,more sensitive
OXTR,Rs53576,more empathetic
OXTR,Rs53576,less lonely
OXTR,Rs53576,empathy
OXTR,Rs53576,less affected by stress 
OXTR,Rs53576,autism 
OXTR,Rs53576,emotional reactivity
OXTR,Rs53576,empathy
OXTR,Rs53576,hearing and understanding
OXTR,Rs53576,empathy and stress
OXTR,Rs2268490,OXTR
OXTR,Rs2268490,prosociality
OXTR,Rs2268490,influence prosociality
OXTR,Rs237887,OXTR
OXTR,Rs237887,prosociality
OXTR,Rs237887,influence prosociality
OXTR,Rs237889,participants homozygous for the C allele
OXTR,Rs237889,participants homozygous for the T allele
OXTR,Rs4564970,Alcohol and aggressive behavior
OXTR,Rs53576,empathetic
OXTR,Rs53576,feel less lonely
OXTR,Rs53576,Korean 
OXTR,Rs53576,Americans
OXTR,Rs53576,marital discord
OXTR,Rs53576,stress
OXTR,Rs53576,Forty-five female
OXTR,Rs53576,emotional support seeking.
OXTR,Rs53576,less lonely
OXTR,Rs53576,more empathetic
OXTR,Rs53576,sensitive parents
OXTR,Rs53576,"empathetic, feel less lonely, employ more sensitive parenting techniques, and have lower rates of autism"
OXTR,Rs53576,depression
OXTR,Rs53576,Caucasian 
OXTR,Rs53576,autism
OXTR,Rs53576,prosocial temperament
OXTR,Rs53576,grey matter volume in the hypothalamus
OXTR,Rs53576,lower cortisol responses to stress
OXTR,Rs53576,female
OXTR,Rs53576,Two hundred three healthy German male university students
OXTR,Rs53576,empathy and stress
P2RY11,Rs2305795,narcolepsy
P2RY11,Rs2305795,narcolepsy
PADI3,Rs144944758,hair syndrome
PADI3,Rs144944758,Uncombable hair syndrome
PADI3,Rs144944758,Uncombable hair syndrome variant in PADI3 gene
PADI3,Rs142129409,Uncombable hair syndrome
PADI3,Rs142129409,Uncombable hair syndrome variant
PADI4,Rs1748035,homozygotes (AA)
PADI4,Rs1748035,1.68 times for homozygotes
PADI4,Rs1748035,heterozygotes
PADI4,Rs1748035,increases susceptibility to Rheumatoid Arthritis 1.20 times
PADI4,Rs1748035,polymorphism
PADI4,Rs1748035,linkage disequilibrium
PADI4,Rs1748035,homozygotes
PADI4,Rs1748035,heterozygotes (AG)
PADI4,Rs1748035,ncreases susceptibility to Rheumatoid Arthritis 1.09 times
PADI4,Rs1748035,linkage disequilibrium
PADI4,Rs1748035,Rheumatoid Arthritis
PADI4,Rs1748035,disequilibrium with a polymorphism
PADI4,Rs1748035,heterozygotes (AG)
PADI4,Rs1748035,Rheumatoid Arthritis
PADI4,Rs1748035,disequilibrium with a polymorphism
PADI4,Rs1748035,linkage disequilibrium
PADI4,Rs1748035,polymorphism
PADI4,Rs1748035,polymorphism
PADI4,Rs2240335,Rheumatoid Arthritis
PADI4,Rs1748035,Rheumatoid Arthritis 
PADI4,Rs2240340,rheumatoid arthritisin
PADI4,Rs2240340,rheumatoid arthritis (RA)
PADI4,Rs2240340,rheumatoid arthritis
PADI4,Rs2240340,rheumatoid arthritis
PADI4,Rs2240340,rheumatoid arthritis (RA)
PADI4,Rs2240339,Rheumatoid Arthritis
PADI4,Rs1748035,increases susceptibility to Rheumatoid Arthritis 2.00 times
PADI4,Rs2240339,Rheumatoid Arthritis
PADI4,Rs2240338,Rheumatoid Arthritis
PADI4,Rs2240335,polymorphism 
PADI4,Rs2240335,Rheumatoid Arthritis
PADI4,Rs2240335,increases susceptibility to Rheumatoid Arthritis
PADI4,Rs2240335,Rheumatoid Arthritis
PADI4,Rs2240335,Rheumatoid Arthritis
PADI4,Rs2240335,carriers of the G allele
PADI4,Rs2240339,Rheumatoid Arthritis
PADI4,Rs1748035,disequilibrium with a polymorphism
PADI4,Rs1748035,homozygotes (AA)
PADI4,Rs1748035,polymorphism
PADI4,Rs1748031,T allele
PADI4,Rs1748031,Rheumatoid Arthritis
PADI4,Rs1621005,carriers of the G allele
PADI4,Rs1621005,susceptibility to Rheumatoid Arthritis
PADI4,Rs1621005,Arthritis 
PADI4,Rs1621005,Rheumatoid 
PADI4,Rs1621005,Rheumatoid Arthritis
PADI4,Rs11203367,Rheumatoid Arthritis
PADI4,Rs11203367,Rheumatoid Arthritis
PADI4,Rs11203367,Rheumatoid Arthritis
PADI4,Rs11203366,ankylosing spondylitis
PADI4,Rs11203366,rheumatoid arthritis
PADI4,Rs11203366,erosive joint status
PADI4,Rs11203366,anti-cyclic citrullinated peptide antibody 
PADI4,Rs11203366,rheumatoid arthritis
PADI4,Rs1748031,susceptibility
PADI4,Rs1748031,increases susceptibility to Rheumatoid Arthritis
PADI4,Rs11203366,autoimmunity to peptidyl arginine deiminase type 4
PADI4,Rs1748033,heterozygotes
PADI4,Rs1748033,Rheumatoid Arthritis
PADI4,Rs1748035,Rheumatoid Arthritis
PADI4,Rs1748035,Rheumatoid Arthritis 
PADI4,Rs1748035,Rheumatoid Arthritis
PADI4,Rs1748035,disequilibrium with a polymorphism
PADI4,Rs1748035,Rheumatoid Arthritis
PADI4,Rs1748035,Rheumatoid Arthritis
PADI4,Rs1748035,Rheumatoid Arthritis
PADI4,Rs1748035,Rheumatoid Arthritis
PADI4,Rs1748035,Rheumatoid Arthritis
PADI4,Rs1748035,Rheumatoid Arthritis
PADI4,Rs1748033,Rheumatoid Arthritis
PADI4,Rs1748033,heterozygotes
PADI4,Rs1748033, homozygotes
PADI4,Rs1748033,Rheumatoid Arthritis
PADI4,Rs1748035,Rheumatoid Arthritis
PADI4,Rs1748033,homozygotes
PAH,Rs5030858,phenylalanine hydroxylase PAH gene on chromosome 12
PAH,I4000477,Phenylketonuria
PAH,Rs5030858,SNP 
PAH,Rs5030858,phenylketonuria
PAH,Rs5030858,mutant
PAH,Rs5030858,phenylalanine hydroxylase
PAH,Rs5030858,phenylketonuria
PAH,Rs1522305,phenylalanine hydroxylase
PAH,I4000478,Phenylketonuriars
PAH,Rs5030858,phenylketonuria
PAH,Rs1522305,increased risk for schizophrenia.
PAH,I4000475,ketonu
PAH,I4000476,Phenylketonuria
PAH,I3003398,Phenylketonuria
PAH,I3003403,Phenylketonuria
PAH,I4000470,Phenylketonuriar
PAH,I4000475,42933
PAH,I4000472,Phenylketonuria
PAH,I4000473,Phenylketonuriars76296470
PAH,I4000473,Phenylketonuria
PAH,I4000475,Phenylketonuriars
PAH,I4000470,Phenylketonuria
PALB2,Rs587776409,Ser319Terfs
PALB2,Rs515726124,Breast-Cancer
PALB2,Rs515726124,PALB2see
PALB2,Rs515726124,Breast-Cancer
PALB2,Rs180177102,cancer 
PALB2,I4000488,breast cancer
PALB2,Rs515726065,Breast-Cancer
PALB2,Rs180177102,breast cancer
PALLD,Rs12510359,SNP
PALLD,Rs12510359,3657 
PALLD,Rs12510359,613 
PALLD,Rs12510359,598 
PALLD,Rs12510359,1211
PALLD,Rs12510359,2772 
PALLD,Rs12510359,885 
PALLD,Rs12510359,GG
PALLD,Rs12510359,AG
PALLD,Rs12510359,rs12510359 
PALLD,Rs12510359,an independent study of 3657 patients with myocardial infarction (885 women and 2772 men) and 1211 control individuals (598 women and 613 men) did not observe any correlation to this SNP.
PALLD,Rs12510359,rs12510359 increases susceptibility to Myocardial Infarction 0.98 times for heterozygotes (AG) and 1.40 times for homozygotes (GG)
PALLD,Rs1071738,metastasis
PALLD,Rs12510359,40 
PARK7,Rs3766606,sporadic Parkinson's disease
PARK7,Rs3766606,Parkinson's disease
PARK7,Rs3766606,healthy controls
PARK7,Rs3766606,192 patients with sporadic Parkinson's disease and 198 healthy controls
PARK7,Rs74315351,autosomal recessive
PARK7,Rs74315351,Parkinson disease
PARK7,Rs74315351,pathogenic
PARK7,Rs74315351,autosomal recessive
PARK7,Rs74315351,Movement Disorder Society Genetic mutation database
PARK7,Rs3766606,Parkinson's disease
PARK7,Rs74315351,early-onset
PARK7,Rs74315353,Parkinson disease 
PARK7,Rs74315353,Parkinson disease
PARK7,Rs74315354,Haplotype
PARK7,Rs74315351,definitely pathogenic
PARK7,Rs28938172,"autosomal recessive, early-onset Parkinson disease (type 7)"
PARK7,Rs74315351,Parkinson disease
PARK7,I5047046,Parkinson's disease
PARK7,I5047046,digenic
PARK7,I5047037,Parkinson's disease
PARK7,I5047037,type 7
PARK7,I5047037,rs74315351
PARK7,I5047038,"Parkinson's disease, type 7"
PARK7,I5047044,Parkinson's disease
PARK7,I5047044,type 7
PARK7,I5047043,"Parkinson's disease, type 7"
PARK7,I5047046,Parkinson's disease
PARK7,I5047046,recessive/early-onset
PARK7,I5047046,digenic
PARK7,I5047046,Parkinson's disease
PARK7,I5047046,recessive/early-onset
PARK7,I5047046,digenic
PARK7,I5047044,Parkinson's disease
PAX2,Rs75399846,pathogenic variant
PAX2,Rs75399846,pathogenic variant
PAX5,Rs398123063,autosomal dominant B cell precursor acute lymphoblastic leukemia (B-ALL)
PCDH11X,Rs5984894,Alzheimer disease
PCDH11X,Rs5984894,Alzheimer's disease
PCDH11X,Rs5984894,increased risk for the disease in females
PCDH11X,Rs5984894,Alzheimer's disease
PCDH11X,Rs5984894,X chromosome
PCDH11X,Rs5984894,SNP
PCDH11X,Rs5984894,Alzheimer's disease
PCDH15,I5012804,Usher Syndrome Type I
PCSK9,Rs562556,LDL cholesterol levels.
PCSK9,Rs562556,rs505151 
PCSK9,Rs562556,LDL 
PCSK9,Rs562556,function
PCSK9,Rs72646508,coronary events
PCSK9,Rs562556,gain
PCSK9,Rs562556, 'gain-of-function' mutations
PCSK9,Rs562556,LDL cholesterol
PCSK9,Rs562556,'gain-of-function' mutations
PCSK9,Rs562556,higher LDL cholesterol levels
PCSK9,Rs67608943,lowered LDL-C level
PCSK9,Rs67608943,coronary events
PCSK9,Rs67608943,lowered LDL-C level 
PCSK9,Rs67608943,coronary events
PCSK9,Rs72646508,coronary events
PCSK9,Rs72646508,SNP
PCSK9,Rs72646508,gene
PCSK9,Rs72646508,cholesterol
PCSK9,Rs72646508,LDL-C
PCSK9,Rs505151,cholesterol metabolism
PCSK9,Rs67608943,plasma LDL-C levels being up to 40% lower than average
PCSK9,Rs505151,higher LDL cholesterol levels
PCSK9,Rs562556,of
PCSK9,Rs505151,men 
PCSK9,Rs505151,women
PCSK9,I5000370,hypercholesterolemia
PCSK9,Rs137852912,familial hypercholesterolemia
PCSK9,Rs137852912,pathogenic
PCSK9,Rs137852912,hypercholesterolemia
PCSK9,Rs137852912,coronary artery disease
PCSK9,Rs137852912,SNP
PCSK9,Rs2479409,Molecular population genetics of PCSK9
PCSK9,Rs2479409,PCSK9
PCSK9,Rs28362263,coronary events.
PCSK9,Rs137852912,coronary artery disease
PCSK9,Rs28362263,coronary events.
PCSK9,Rs28362263,coronary events.
PCSK9,Rs28362286,Coronary Artery Risk
PCSK9,Rs28942111,autosomal dominantly inherited familial hypercholesterolemia
PCSK9,Rs28942111,"rs28942111, also known as c.381T>A, p.Ser127Arg and S127R, is one of the first missense mutations in the PCSK9 gene found to lead to autosomal dominantly inherited familial hypercholesterolemia.See OMIM 607786.0001"
PCSK9,Rs505151,higher LDL cholesterol levels
PCSK9,Rs505151,low-density lipoprotein cholesterol levels
PCSK9,Rs505151,serum lipid levels
PCSK9,Rs505151,European 
PCSK9,Rs505151,polygenic hypercholesterolemia
PCSK9,Rs28362263,coronary events
PDE4B,Rs952635,implicated in type-2 diabetes
PDE4B,Rs952635,type-2 diabetes
PDE4B,Rs4655595, homozygotes
PDE4B,Rs4655595, heterozygotes
PDE4B,Rs4655595, type-2 diabetes.
PDE4B,Rs4655595,type-2 diabetes
PDE4B,Rs4655595, type-2 diabetes
PDE4B,Rs4655595,type-2 diabetes
PDE4D,Rs702553,ischemic stroke
PDE4D,Rs702553,biracial population
PDE4D,Rs702553,risk of cerebral infarction
PDE4D,Rs702553,ischemic stroke
PDE4D,Rs702553,activating protein
PDE4D,Rs702553,Stroke
PDE4D,Rs702553, cerebral infarction
PDE4D,Rs702553,Phosphodiesterase 4D polymorphisms
PDE4D,Rs702553,5-lipoxygenase
PDE4D,Rs702553,Phosphodiesterase 4D and 5-lipoxygenase activating protein
PDE4D,Rs702553,Phosphodiesterase 4D polymorphisms
PDE4D,Rs702553,cerebral infarction
PDE4D,Rs702553,ischemic stroke
PDE4D,Rs1544791,Asthma-susceptibility
PDE4D,Rs1544791,Asthma
PDE4D,Rs12188950,ischemic stroke 
PDE4D,Rs12188950,ischemic stroke
PDE4D,Rs12188950,Swedish 
PDE4D,Rs702553,Phosphodiesterase 4D
PDX1,Rs9581943,Pancreatic cancer.
PDX1,Rs80356661,decreased half-life of insulin promoter factor 1
PDX1,Rs80356661,Agenesis of human pancreas
PDX1,Rs80356661,decreased half-life of insulin promoter factor 1.
PDX1,Rs9581943,pancreatic cancer
PDX1,Rs80356661,Agenesis of human pancreas
PDX1,Rs80356661,insulin promoter factor 1
PDX1,Rs80356661,Agenesis of human pancreas
PDX1,Rs80356661,Agenesis of human pancreas
PDZD7,Rs753034799,pathogenic variant
PDZD7,Rs953422571,pathogenic variant
PEMT,Rs4244593,schizophrenia
PEMT,Rs4244593,schizophrenia
PEMT,Rs4244593,PEMT 
PEMT,Rs4244593,schizophrenia
PEMT,Rs4244593,PEMT gene in schizophrenia
PER2,Rs121908635,sleep disorder
PER2,Rs121908635,Familial Advanced Sleep Phase Syndrome
PEX1,Rs28939678,peroxisome biogenesis disorders
PEX1,Rs61750420,peroxisome biogenesis disorders
PEX1,Rs61750420,"NALD, IRD, and Zellweger syndrome"
PEX1,Rs61750420,peroxisome biogenesis disorders
PEX1,Rs61750420,Zellweger syndrome
PEX1,Rs61750420,peroxisome biogenesis disorders
PEX1,I5012688,Spectrum
PEX1,Rs61750420,peroxisome biogenesis disorders 
PEX1,I5012688,disorderZellweger 
PEX1,I5012688,biogenesis 
PEX1,I5012688,Peroxisome 
PEX1,I5012688,disorder
PEX1,I5012688,Syndrome
PEX1,I5012688,Spectrum
PEX1,I5012688,Syndrome 
PEX7,Rs267608252,Analysis 
PEX7,Rs267608252,Pathogenic 
PEX7,Rs267608252,Mendelian 
PEX7,Rs267608252,Disease
PEX7,Rs267608252,biocurators 
PEX7,Rs267608252,Mendelian 
PEX7,Rs267608252,disease
PEX7,Rs267608252,Genetics 
PEX7,Rs267608252,Genetics Retinal dystrophy (266 gene)
PEX7,Rs267608252,Pathogenic Regulatory Variants in Mendelian Disease
PEX7,Rs267608252,Genome 
PEX7,Rs267608255,Rhizomelic chondrodysplasia punctata type 1
PEX7,Rs267608255,Rhizomelic chondrodysplasia punctata type 1
PEX7,Rs61753238,mutation in the PEX7 gene
PEX7,Rs61753238,autosomal recessive disorder Rhizomelic chondrodysplasia punctata type 1 disorder
PEX7,Rs61753238,autosomal recessive disorder Rhizomelic chondrodysplasia punctata type 1 disorder
PEX7,Rs267608252,dystrophy 
PEX7,Rs267608252,Whole
PEX7,Rs61753238,autosomal recessive disorder Rhizomelic chondrodysplasia punctata type 1 disorder
PEX7,Rs1805137,Rhizomelic chondrodysplasia punctata type 1
PEX7,Rs1805137,Rhizomelic chondrodysplasia punctata type 1
PEX7,I3002517,Rhizomelic Chondrodysplasia
PEX7,I5006214,Rhizomelic chondrodysplasia punctata type 1
PEX7,I5006214,chondrodysplasia
PEX7,I6055953,Rhizomelic chondrodysplasia punctata type 1
PEX7,I6055953,Rhizomelic chondrodysplasia punctata type 1
PEX7,I6055954,Rhizomelic chondrodysplasia punctata type 1
PEX7,I6055954,chondrodysplasia
PEX7,Rs121909153,Rhizomelic chondrodysplasia punctata type 1
PEX7,Rs121909153,Rhizomelic chondrodysplasia punctata type 1
PEX7,Rs121909153,Rhizomelic chondrodysplasia punctata type 1
PEX7,Rs121909153,Rhizomelic chondrodysplasia punctata type 1
PEX7,Rs121909154,Rhizomelic chondrodysplasia punctata type 1
PEX7,Rs121909154,Rhizomelic chondrodysplasia punctata type 1
PEX7,Rs121909154,PEX7
PEX7,Rs148591292,Rhizomelic chondrodysplasia punctata type 1
PEX7,Rs148591292,Rhizomelic chondrodysplasia punctata type
PEX7,Rs121909153, chondrodysplasia punctata
PGM1,Rs11208257, overall Indian population
PGM1,Rs11208257,Europeans
PGM1,Rs11208257,traditional medicine of India
PGM1,Rs11208257,variant
PGM1,Rs11208257,chromosome 1.
PGM1,Rs11208257,gene
PGM1,Rs11208257,Ayurveda
PGR,Rs3740753,gene polymorphism with male infertility
PGR,Rs660541,ovarian and breast cancer
PGR,Rs3740753,reducing recurrent preterm birth
PGR,Rs3740753,caucasian/hispanic patients with 17-alpha-hydroxyprogesterone caproate
PGR,Rs3740753,PROGINS allele
PGR,Rs3740753,breast cancer risk
PGR,Rs3740753,endometrial cancer
PGR,Rs1870019,ovarian cancer
PGR,Rs10895068,ovarian cancer
PGR,Rs1870019,endometrial cancer 
PGR,Rs10895068,female reproductive cancer:
PGR,Rs3740753,PROGINS allele association in ovarian and breast cancer risk
PGR,Rs1870019,ovarian and breast cancer
PGR,Rs481775,colorectal cancer
PGR,Rs613120,endometrial cancer is ambiguous
PGR,Rs516693,ovarian and breast cancer
PGR,Rs543215,endometrial cancer is ambiguous
PGR,Rs543215,ovarian and breast cancer
PGR,Rs565186,haplotype Gs286
PGR,Rs565186,endometrial cancer
PGR,Rs565186,ovarian and breast cancer risk
PGR,Rs608995,ovarian cancer
PGR,Rs608995,ovarian cancer
PGR,Rs608995,ovarian cancer
PGR,Rs608995,ovarian cancer
PGR,Rs608995,Ovarian Cancer
PGR,Rs613120,ovarian and breast cancer
PGR,Rs660541,endometrial cancer is ambiguous
PGR,Rs10895068,ovarian cancer
PGR,Rs516693,endometrial cancer is ambiguous
PGR,Rs10895068,breast cancer
PGR,Rs1042838,breast cancer
PGR,Rs10895068,postmenopausal breast cancer
PGR,Rs10895068,breast cancer
PGR,Rs1042838,ovarian cancer
PGR,Rs1042838,endometrial cancer
PGR,Rs1042838,ovarian cancer
PGR,Rs1042838,ovarian cancer
PGR,Rs1042838,ovarian cancer
PGR,Rs1042838,endometrial cancer
PGR,Rs1042838,ovarian cancer
PGR,Rs1042838,ovarian cancer
PGR,Rs1042838,Caucasians
PGR,Rs1042838,serous (endometrial) cancers
PGR,Rs1042838,endometrial cancer
PGR,Rs1042838,European 
PGR,Rs1042838,female 
PGR,Rs1042838,invasive endometrioid subtype
PGR,Rs1042838,males
PGR,Rs10895068,female reproductive cancer
PGR,Rs10895068,ovarian cancer
PGR,Rs10895068,ovarian cancer
PGR,Rs10895068,ovarian cancer
PGR,Rs10895068,"(breast, endometrial and ovarian) cancer"
PGR,Rs10895068,breast cancer
PGR,Rs1042838,females 
PGR,Rs10895068,postmenopausal breast cancer
PGR,Rs1042838,Breast Cancer
PGR,Rs1042838,breast cancer
PGR,Rs1042838,endometriosis
PGR,Rs1042838,breast cancer
PGR,Rs1042838,breast cancer
PGR,Rs10895068,breast cancer
PHIP,Rs768324201,pathogenic variant
PIEZO1,Rs200970763,xerocystosis
PIEZO1,Rs200970763,xerocytosis
PIEZO1,Rs200970763,xerocytosis
PINK1,Rs2298298,A allele associated with higher
PINK1,Rs45539432,Parkinson disease
PINK1,Rs45539432,Parkinson's
PINK1,Rs45539432,Parkinson's disease
PINK1,Rs45478900,Parkinson's disease could develop earlie
PINK1,Rs45478900,Parkinson's disease
PINK1,Rs45478900,rare mutation
PINK1,Rs3131713,higher PINK1 transcript levels
PINK1,Rs3131713,whites
PINK1,Rs3131713,European 
PINK1,Rs3131713,plasma nonesterified fatty acid 
PINK1,Rs3131713,transcript abundance
PINK1,Rs3131713,diabetes
PINK1,Rs3131713,obesity 
PINK1,Rs2298298,European whites
PINK1,Rs74315359,23andMe
PINK1,Rs2298298,ranscript abundance
PINK1,Rs2298298,plasma nonesterified fatty acid concentrations
PINK1,I5003747,Parkinson's disease
PINK1,I5003750,"Parkinson's disease, type 6"
PINK1,Rs10799655,obesity 
PINK1,Rs10799655,diabetes
PINK1,Rs10799655,higher PINK1 transcript levels.
PINK1,Rs10799655,PINK1 gene
PINK1,Rs10799655,abundance and plasma nonesterified fatty acid concentrations
PINK1,Rs10799655,diabetes
PINK1,Rs10799655,transcript abundance and plasma nonesterified fatty acid concentrations
PINK1,Rs119451946,Pro
PINK1,Rs119451946,Leu
PINK1,Rs2298298,obesity
PINK1,Rs2298298,diabetes
PINK1,Rs10799655,obesity
PITX1,Rs6872664,transcription 
PITX1,Rs6872664,autism 
PITX1,Rs6872664,genetic 
PITX1,Rs6872664,gene 
PITX1,Rs6872664,chromosome 
PITX1,Rs6872664,homeodomain 
PITX1,Rs6872664,analysis
PITX1,Rs6872664,autism 
PITX1,Rs6872664,autism
PITX1,Rs6872664,autism
PITX1,Rs121909109,"allele is considered a dominant mutation leading to talipes equinovarus, based on an analysis of a 5-generation family segregating asymmetric right-sided predominant clubfoot."
PITX1,Rs6872664,polymorphisms 
PITX1,Rs121909109,aka c.388G>A (p.Glu130Lys)rs121909109 represents a variant in the PITX1 gene on chromosome 5
PITX1,Rs121909109,talipes equinovarus
PKD1,Rs199476097,autosomal dominant polycystic kidney disease
PKD1,Rs199476098,Polycystic Kidney disease
PKD1,Rs199476098,autosomal dominant polycystic kidney disease
PKD1,Rs369825780,polycystic kidney disease
PKD1,Rs199476098,Polycystic Kidney disease
PKD1,Rs199476098,autosomal dominant polycystic kidney disease
PKD1,Rs199476097,Polycystic Kidney disease
PKD1,Rs199476098,definitely pathogenic
PKD1,Rs199476098,highly likely pathogenic
PKD1,Rs199476098,Polycystic Kidney disease
PKD1,Rs199476096,autosomal dominant polycystic kidney disease
PKD1,Rs199476095,autosomal dominant polycystic kidney disease
PKD1,Rs199476096,Polycystic Kidney disease
PKD1,Rs199476095,PKD Foundation database.
PKD1,Rs199476095,highly likely pathogenic
PKD1,Rs199476095,definitely pathogenic
PKD1,Rs199476095,Polycystic Kidney disease
PKD1,Rs199476095,autosomal dominant polycystic kidney disease
PKD1,Rs199476095,Polycystic Kidney disease
PKD1,Rs199476095,autosomal dominant polycystic kidney disease
PKD1,Rs199476095,Polycystic Kidney disease
PKD1,Rs199476095,Polycystic Kidney disease
PKD1,Rs199476098,autosomal dominant polycystic kidney disease
PKD1,Rs199476094,autosomal dominant polycystic kidney disease
PKD1,Rs199476098,Polycystic Kidney disease
PKD1,Rs200520583,autosomal dominant polycystic kidney disease
PKD1,Rs199476098,highly likely pathogenic
PKD1,Rs199476094,Polycystic Kidney disease
PKD1,Rs369825780,pathogenic
PKD1,Rs369825780,ClinVar
PKD1,Rs369825780,autosomal dominant polycystic kidney disease
PKD1,Rs34197769,ClinVar
PKD1,Rs34197769,PKD1 
PKD1,Rs34197769,Ala3512Val
PKD1,Rs34197769,SNP
PKD1,Rs2432403,autosomal dominant polycystic kidney disease
PKD1,Rs2432403,autosomal dominant polycystic kidney disease
PKD1,Rs2432403,highly likely pathogenic
PKD1,Rs199476098,definitely pathogenic
PKD1,Rs2432403,definitely pathogenic
PKD1,Rs199476101,autosomal dominant polycystic kidney disease
PKD1,Rs199476101,Polycystic Kidney disease
PKD1,Rs199476100,autosomal dominant polycystic kidney disease
PKD1,Rs199476100,Polycystic Kidney disease
PKD1,Rs199476100,autosomal dominant polycystic kidney disease
PKD1,Rs199476100,Polycystic Kidney disease
PKD1,Rs199476100,autosomal dominant polycystic kidney disease
PKD1,Rs199476099,Polycystic Kidney disease
PKD1,Rs199476098,autosomal dominant polycystic kidney disease
PKD1,Rs199476098,Polycystic Kidney disease
PKD1,Rs199476098,autosomal dominant polycystic kidney disease
PKD1,Rs199476101,Polycystic Kidney disease
PKD1,Rs1616940,polycystic kidney diseas
PKD1,Rs151257298,SNP
PKD1,Rs1616940,autosomal
PKD1,Rs148812376,end-stage renal disease
PKD1,Rs148812376,few cysts.
PKD1,Rs148812376,when homozygous
PKD1,Rs148812376,autosomal dominant polycystic kidney disease
PKD1,Rs148812376,ESRD
PKD1,Rs148812376,hypomorphic mutation
PKD1,Rs148812376,few cysts
PKD1,Rs148812376, autosomal dominant polycystic kidney disease
PKD1,Rs148812376,end-stage renal disease (ESRD) 
PKD1,Rs1064794207,"dominant polycystic kidney disease,"
PKD1,Rs1064794207,"polycystic kidney disease,"
PKD1,Rs1064793762,dominant polycystic kidney disease
PKD1,Rs1064793762,SNP
PKD1,Rs1064793762,ClinVar
PKD1,Rs1064793762,GeneDX
PKD1,Rs1060499718,utosomal dominant polycystic kidney disease
PKD1,Rs1060499702,pathogenic for autosomal dominant polycystic kidney disease
PKD1,Rs1060499702,autosomal dominant polycystic kidney disease
PKD1,Rs1060499702,polycystic kidney disease
PKD1,Rs1057518897,hypertension
PKD1,Rs1057518897,multiple renal cysts
PKD1,Rs1057518897,polycystic kidney disease
PKD1,Rs1616940,dominant
PKD1,Rs148812376,hypomorphic mutation
PKD1,Rs148812376,autosomal dominant polycystic kidney disease
PKD1,Rs148812376,ADPKD
PKD1,Rs148812376,development of just a few cysts.
PKD1,Rs1616940,definitely pathogenic
PKD1,Rs1616940,SNP
PKD1,Rs148812376,associated with adult onset ADPKD
PKD1,Rs1616940,highly likely pathogenic
PKD1,Rs1616940,definitely pathogenic
PKD1,Rs1616940,autosomal dominant polycystic kidney disease
PKD1,Rs1616940,polycystic kidney disease
PKD1,Rs151257298,polycystic kidney disease
PKD1,Rs151257298,dominant
PKD1,Rs151257298,autosomal
PKD1,Rs151257298,pathogenic
PKD1,Rs151257298,definitely pathogenic
PKD1,Rs1616940,allele
PKD1,Rs151257298,allele
PKD1,Rs148812376,hypomorphic mutation
PKD1,Rs148812376,end-stage renal disease
PKD1,Rs148812376,autosomal dominant polycystic kidney disease
PKD1,Rs151257298,SNP
PKD1,Rs151257298,polycystic kidney disease
PKD1,Rs151257298,SNP 
PKD1,Rs151257298,pathogenic
PKD1,Rs151257298,autosomal
PKD1,Rs151257298,dominant 
PKD1,Rs151257298,polycystic kidney disease
PKD1,Rs151257298,autosomal dominant polycystic kidney disease
PKD1L3,Rs9938025,dry earwax
PKD1L3,Rs9938025,European ancestry
PKD2,Rs749004212,23andMe
PKD2,Rs749004212,PKD mutation
PKD2,Rs749004212,PKD mutation database as definitely pathogenic
PKD2,Rs200001068,23andMe
PKD2,Rs200001068,Arg306Ter
PKD2,Rs200001068,916C
PKD2,Rs200001068,23andMe 
PKD2,Rs145877597,Autosomal Polycystic Kidney Disease 
PKD2,Rs200001068,i5047394
PKHD1,I5012610,Polycystic Kidney disease
PKHD1,I6016818,PKHD1
PKHD1,I6016818,see PKHD
PKHD1,I6016808,PKHD
PKHD1,I6016787,see
PKHD1,I6016714,7837se
PKHD1,I6016699,polycystic kidney disease
PKHD1,I5012612,Autosomal Recessive Polycystic Kidney disease
PKHD1,I5012611,Polycystic kidney disease
PKHD1,I5012609,polycystic kidney disease
PKHD1,I6016692,PKHD1
PKHD1,I5000047,Autosomal Recessive
PKHD1,I5000046,recessive polycystic kidney disease
PKHD1,I5000046,autosomal 
PKHD1,I5000047,Polycystic Kidney
PKHD1,I5000046,autosomal recessive polycystic kidney disease
PKHD1,I5000046,polycystic kidney disease
PKHD1,I5000044,polycystic kidney disease
PKHD1,I5000043,Autosomal recessive polycystic kidney disease
PKHD1,I5000043,Autosomal recessive polycystic kidney disease
PKHD1,I5000043,Autosomal recessive polycystic kidney disease
PKNOX2,Rs750338,substance dependence
PKNOX2,Rs12284594,"In white women, each G increased risk of multiple addictions"
PKNOX2,Rs12284594,each G increased risk of multiple addictions
PKNOX2,Rs12284594,white women
PKNOX2,Rs12284594,multiple addictions
PKP2,Rs193922674,dysplasia/cardiomyopathy
PKP2,Rs193922674,arrhythmogenic right ventricular cardiomyopathy 
PKP2,Rs193922674,familial arrhythmogenic right ventricular dysplasia/cardiomyopathy
PKP2,Rs193922674,arrhythmogenic right ventricular cardiomyopathy
PKP2,Rs193922674,arrhythmogenic right ventricular dysplasia/cardiomyopathy
PKP2,Rs193922674,arrhythmogenic right ventricular
PKP2,Rs193922674,ditazole
PKP2,Rs193922674, platelets
PKP2,Rs193922674,Ditazole
PKP2,Rs121434421,mice engineered to contain this mutation exhibit right ventricular dysfunction resembling the ARVD phenotype when subjected to endurance exercising
PKP2,Rs121434421,"The rs121434421(T) allele is reported as pathogenic for ARVD type 9 in ClinVar by two sources, acting in a dominant manner"
PKP2,Rs121434421,"rs121434421, also known as c.2203C>T, p.Arg735Ter and R735X, is a rare mutation in the PKP2 gene on chromosome 12."
PKP2,Rs121434421,right ventricular dysfunction
PLA2G6,Rs2284063,Melanoma
PLA2G6,Rs2284063,Melanoma
PLB1,Rs1534480,SNP 
PLB1,Rs1534480,This SNP is associated to excessive sweating.
PLB1,Rs1534480,excessive sweating
PLCB1,Rs718712,insomnia
PLCB1,Rs718712,insomnia
PLCE1,Rs2274223,Han Chinese
PLCE1,Rs2274223,esophageal cancer
PLCE1,Rs2274223,esophageal squamous cell carcinoma
PLCE1,Rs2274223,greater risk for gastric cancer
PLIN1,Rs894160,Obesity
PLIN1,Rs894160,"subjects with higher complex carbohydrate intake, the minor allele was protective against obesity"
PLIN1,Rs894160,"subjects with lower carbohydrate intake, the minor allele was associated with increased obesity"
PLIN1,Rs894160,weight loss
PLIN1,Rs894160,increased obesity
PLIN1,Rs894160,type 2 diabetes
PLIN1,Rs894160,obesity
PLIN1,Rs894160,Obesity 
PLIN1,Rs894160,metabolic syndrome risk
PLTP,Rs3843763,high-density lipoprotein
PLTP,Rs3843763,cholesterol plasma
PLXNB3,Rs6643791,white matter volume
PLXNB3,Rs6643791,human-specific
PLXNB3,Rs6643791,higher vocabulary performance scores
PLXNB3,Rs2266879,non-carriers
PLXNB3,Rs6643791,ncreased white matter volume
PLXNB3,Rs2266879,higher vocabulary performance scores
PLXNB3,Rs2266879,human-specific
PLXNB3,Rs2266879,'haplotype A'
PLXNB3,Rs2266879,white matter volume
PMEL,Rs765828110,pigmentary glaucoma
PMEL,Rs756974126,pigment dispersion syndrome
PMEL,Rs756974126,pigmentary glaucoma
PMEL,Rs756974126,blindness
PMEL,Rs748713829, young adults
PMEL,Rs756974126,pigment dispersion syndrome (PDS)
PMEL,Rs756974126,pigmentary glaucoma (PG)
PMEL,Rs756974126,a major cause of blindness
PMEL,Rs765828110,pigment dispersion syndrome (PDS) in the iris
PMEL,Rs765828110,blindness in young adults
PMEL,Rs770516374,blindness in young adults.
PMEL,Rs765828110,pigmentary glaucoma
PMEL,Rs765828110,blindness
PMEL,Rs770516374,non-synonymous mutation
PMEL,Rs770516374,PMEL gene
PMEL,Rs770516374,causing pigment dispersion syndrome 
PMEL,Rs770516374,pigmentary glaucoma
PMEL,Rs773241850,pigment dispersion syndrome (PDS)
PMEL,Rs773241850,pigmentary glaucoma (PG)
PMEL,Rs773241850,blindness
PMEL,Rs748713829,blindness
PMEL,Rs765828110,pigment dispersion syndrome
PMEL,Rs748713829, pigmentary glaucoma (PG)
PMEL,Rs142410496,pigmentary glaucoma (PG)
PMEL,Rs748713829,pigment dispersion syndrome (PDS) 
PMEL,Rs142410496,pigment dispersion syndrome (PDS)
PMEL,Rs142410496,blindness in young adults
PMEL,Rs142410496,variant allele
PMEL,Rs142410496,non-synonymous mutation
PMEL,Rs142410496,dominant 
PMEL,Rs142410496,pigment dispersion syndrome
PMEL,Rs142410496,pigmentary glaucoma
PMEL,Rs142410496,cause of blindness
PMEL,Rs148258956,"n the iris, which 15-20% of the time develops into pigmentary glaucoma "
PMEL,Rs148258956,blindness
PMEL,Rs748713829, iris
PMEL,Rs148258956,pigment dispersion syndrome
PMEL,Rs748713829,pigmentary glaucoma 
PMEL,Rs748713829,blindness
PMEL,Rs748713829,PMEL gene
PMEL,Rs748713829,pigment dispersion syndrome (PDS)
PMEL,Rs748713829,pigmentary glaucoma (PG)
PMEL,Rs748713829,blindness
PMEL,Rs748713829,mutation
PMEL,Rs148258956,pigmentary glaucoma
PMEL,Rs748713829,dominant
PMM2,Rs28936415,glycosylation
PMM2,Rs28936415,Congenital disorder
PMM2,Rs28936415,Congenital disorder of glycosylation
PMM2,I5012680,Congenital Disorder of Glycosylation Type 1a
PMM2,I5012680,Congenital Disorder of Glycosylation
PMM2,Rs28936415,Congenital disorder
PMS2,Rs267608154,Lynch syndrome
PMS2,Rs267608154,aka c.853_856delACAG and also c.853_856delACAGACAG; both are considered in ClinVar to be pathogenic for Lynch syndrome
PMS2,Rs267608154,Lynch syndrome
PMS2,Rs1805323,Huntington disease
PMS2,Rs1805323,"multiple spinocerebellar ataxia,"
PMS2,Rs1059060,cis-acting regulatory single nucleotide polymorphisms in cancer cells
PMS2,Rs1059060,Allelic imbalance
PMS2,Rs1059060,cancer cells
PMS2,Rs1805323,poly-glutamine (aka Poly-Q) diseases
PNMT,Rs3764351,N-methyltransferase gene
PNPLA3,Rs738409,alcoholic cirrhosis
PNPLA3,Rs2281135,human diseases and traits.
PNPLA3,Rs738409,alcoholic liver disease
PNPLA3,Rs738409,Nonalcoholic fatty liver disease
PNPLA3,Rs738409,increased hepatic fat levels 
POLD1,Rs201503929,Heterozygotes
POLD1,Rs397514632,endometrial cancer
POLD1,Rs397514632,colorectal cancer
POLD1,Rs397514632,also known as c.1433G>A
POLD1,Rs397514632,represents a very rare variant in the POLD1 gene on chromosome 19
POLD1,Rs397514633,Heterozygotes
POLD1,Rs397514632,colorectal cance
POLD1,Rs397514632,tumors
POLD1,Rs397514632,endometrial cancer
POLD1,Rs397514633,colorectal cancer
POLD1,Rs201503929,colorectal cancer
POLD1,Rs397514632,"considered to be a high penetrance, dominant mutation significantly increasing one's risk"
POLD1,Rs397514632,occuring predominantly or exclusively in the large bowel
POLD1,Rs201212113,Heterozygotes
POLD1,Rs201038430,Heterozygotes
POLD1,Rs201212113,colorectal cancer
POLD1,Rs1052471,colorectal cancer
POLD1,Rs1052471,Heterozygotes
POLD1,Rs143340270,colorectal cancer
POLD1,Rs146530638,colorectal cancer
POLD1,Rs143340270,Heterozygotes
POLD1,Rs199700312,colorectal cancer
POLD1,Rs199700312,Heterozygotes
POLD1,Rs201010746,colorectal cancer
POLD1,Rs201010746,Heterozygotes
POLD1,Rs201038430,colorectal cancer
POLD1,Rs146530638,Heterozygotes
POLE,Rs483352909,colorectal cancer
POLE,Rs483352909,for females
POLE,Rs483352909,males
POLE,Rs483352909,age 70 years
POLE,Rs483352909,CRC
POLE,Rs483352909,colorectal cancer
POLE,Rs483352909,cumulative risk of developing CRC
POLE,Rs200403177,significantly higher risk of colorectal cancer
POLE,Rs200403177,colorectal cancer
POLE,Rs138207610,colorectal cancer
POLE,Rs138207610,colorectal cancer
POLG,Rs113994098,mitochondrial DNA depletion syndrome type 4A (Alpers syndrome)
POLG,Rs113994098,sensory ataxic neuropathy
POLG,Rs113994098,dysarthria
POLG,Rs113994098,ophthalmoparesis 
POLG,Rs113994098,represents a mutation in the POLG gene on chromosome 15
POLG,Rs113994098,rs113994098(A) allele is associated with a variety of syndromes
POLG,Rs113994098,ophthalmoparesis 
POLG,Rs113994098,ataxias
POLG,Rs113994098,mitochondrial DNA depletion syndrome type 4A
POLG,Rs113994098,Alpers syndrome
POLG,Rs113994098,sensory ataxic neuropathy
POLG,Rs113994098,dysarthria
POLG,Rs113994098,ataxias
POLG,Rs113994097,ophthalmoparesis (SANDO)
POLG,Rs113994095,recessive
POLG,Rs113994097,sensory ataxic neuropathy
POLG,Rs113994094,23andMe 
POLG,Rs113994095,mutation
POLG,Rs113994095,POLG gene
POLG,Rs113994095,chromosome 15
POLG,Rs113994097,dysarthria
POLG,Rs113994095,syndromes involving ataxias
POLG,Rs113994095,allele
POLG,Rs113994095,sensory ataxic neuropathy
POLG,Rs113994095,"dysarthria,"
POLG,Rs113994095,ophthalmoparesis
POLG,Rs113994097,ataxias
POLG,Rs113994097,mitochondrial DNA depletion syndrome type 4A (Alpers syndrome) 
POLG,Rs113994095,mitochondrial DNA depletion syndrome type 4A
POLR3B,Rs12300729,allele
POLR3B,Rs138249161,hypomyelinating leukodystrophy
POLR3B,Rs12300729,ancestral 
POLR3B,Rs12300729,minor 
POLR3B,Rs12300729,gene
POLR3B,Rs12300729,gene
POLR3B,Rs12300729,minor allele
POLR3B,Rs12300729,ancestral allele
POLR3B,Rs12300729,allele 
POMC,Rs1009388,chronic heart failure
POMC,Rs1009388,alcohol or drug dependence
POMC,Rs1009388,"genes for leptin, leptin receptor, and proopiomelanocortin"
PON2,Rs7493,diseases
PON2,Rs7493,atherosclerosis
PON2,Rs7493,immunity
PON2,Rs7493,activity
PON2,Rs7493,lactonase 
PON2,Rs7493,gene
PON2,Rs7493,paraoxonase 
PON2,Rs7493,"problems with innate immunity, atherosclerosis, and other diseases."
PON2,Rs7493,atherosclerosis
PON2,Rs7493,mpaired (lower) lactonase activity
PON2,Rs17876088,Lou Gehrig's disease
PON2,Rs17876088,sporadic form of ALS (Lou Gehrig's disease).
PON2,Rs12704795,ALS (Lou Gehrig's disease)
PON2,Rs12704795,Paraoxonase
PON2,Rs12704795,polymorphisms and development of renal dysfunction in type 2 diabetes:
PON2,Rs12704795,Lou Gehrig's disease
PON2,Rs12704795,systemic lupus erythematosus
PON2,Rs12704795,intron of the PON2 gene
PON2,Rs17876088,ALS
PON2,Rs12704795,cardiovascular-renal disease risk in Mexican Americans
PON3,Rs10487132,amyotrophic lateral sclerosis
PON3,Rs10487132,amyotrophic 
PON3,Rs10487132,sclerosis 
PON3,Rs10487132,lateral 
POP1,Rs769183311,variant
POP1,Rs374828868,pathogenic 
POP1,Rs374828868,variant
POP1,Rs769183311,OMIM 
POP1,Rs769183311,pathogenic 
POT1,Rs756198077,colorectal cancer
POT1,Rs756198077,minor allele
POT1,Rs756198077,Inherited dominantly
PPARA,Rs4253778, diabetes
PPARA,Rs4253623,hypertensive men/women
PPARA,Rs4253623,postmenopausal women
PPARA,Rs4253623,slightly higher risk of nonfatal myocardial infarction
PPARA,Rs4253623,hypertensive men/women
PPARA,Rs4253623,postmenopausal women
PPARA,Rs4253778,type 2
PPARA,Rs4253623,postmenopausal women and hypertensive men/women
PPARA,Rs4253623,slightly higher risk of nonfatal myocardial infarction
PPARA,Rs4253623,hypertensive
PPARA,Rs4253623,nonfatal myocardial infarction
PPARA,Rs135551,95% myocardial infarction
PPARA,Rs4253623,associated with a slightly higher risk of nonfatal myocardial infarction
PPARG,Rs4684847,"~10,000 individuals"
PPARG,Rs4684847,"Associated with at least one ""mortality outcome"""
PPARG,Rs4135247,Chinese population
PPARG,Rs4135247,risk of lung cancer
PPARG,Rs2292101,Framingham Heart
PPARG,Rs28936407,somatic mutation
PPARG,Rs2292101,diabetes
PPARG,Rs2197423,type-2 diabetes
PPARG,Rs4684847,baseline body mass
PPARG,Rs28936407,somatic mutation
PPARG,Rs4684847,blood pressure
PPARG,Rs709158,inflammatory responses
PPARG,Rs6802898,type-2 diabetes
PPARG,Rs6802898,type-2 diabetes
PPARG,Rs709158,single nucleotide polymorphisms
PPARG,Rs709158,obesity
PPARG,Rs709158, baseline cholesterol levels
PPARG,Rs2197423,type-2 diabetes
PPARG,Rs709158,obesity
PPARG,Rs709158,cholesterol
PPARG,Rs709158,single nucleotide polymorphisms in genes
PPARG,Rs709158,Single nucleotide polymorphisms in obesity-related
PPARG,Rs4684847,"study of 9,000+ individuals"
PPARG,Rs1899951,Chinese population
PPARG,Rs1801282,diabetes.
PPARG,Rs1801282,vascular death
PPARG,Rs1151996,bone mass
PPARG,Rs1151996,dietary fat interaction influences bone mass
PPARG,Rs13073869,lung cancer
PPARG,Rs13073869,type 2 diabetes
PPARG,Rs13073869,diabetes
PPARG,Rs13073869,lung cancer
PPARG,Rs13073869,type 2 diabetes
PPARG,Rs13073869,diabetes 
PPARG,Rs17036314,peroxisome proliferator-activated receptor gamma PPARG gene
PPARG,Rs17036314,overweight
PPARG,Rs13073869,Chinese population
PPARG,Rs17036314,type-2 diabetes (T2D)
PPARG,Rs17036314,impaired glucose tolerance (IGT)
PPARG,Rs1801282,symptomatic coronary artery disease
PPARG,Rs1801282,type-2 diabetes 
PPARG,Rs1801282,metabolic syndrome
PPARG,Rs1801282,ischemic heart disease
PPARG,Rs1801282,diabetes
PPARG,Rs1801282,ype-2 diabetes 
PPARG,Rs1801282,"metabolic syndrome,"
PPARG,Rs1801282,coronary artery disease
PPARG,Rs1899951,risk of lung cancer
PPARGC1A,Rs7665116,Huntington’s disease
PPARGC1A,Rs7665116,Huntington disease
PPARGC1A,Rs7665116,Huntington disease age of onset.
PPARGC1A,Rs7665116,Huntington’s patients of Italian descent 
PPARGC1A,Rs7665116,Huntington’s age of onset
PPARGC1A,Rs7665116,loss of motor coordination symptom of Huntington’s disease
PPARGC1A,Rs7665116,Huntington’s disease
PPARGC1A,Rs7665116,German patients 
PPARGC1A,Rs7665116,Huntington’s disease
PPARGC1A,Rs7665116,Huntington’s disease
PPARGC1A,Rs2970848,Localization of sequence variations in PGC-1alpha influence their modifying effect in Huntington disease.
PPARGC1A,Rs2970848,Huntington disease.
PPARGC1A,Rs2290602,nonalcoholic fatty liver disease
PPARGC1A,Rs2290602,polymorphisms
PPARGC1A,Rs2290602,"odds ratio of 2.73 (CI: 1.48-5.06, corrected p = 0.014)"
PPARGC1A,Rs2290602,200 Japanese adults
PPARGC1A,Rs2290602,nonalcoholic fatty liver disease
PPARGC1A,Rs2290602,nonalcoholic fatty liver disease (NAFLD)
PPARGC1A,Rs2290602,polymorphisms
PPARGC1A,Rs2290602,nonalcoholic fatty liver disease (NAFLD)
PPARGC1A,Rs2970848,PGC-1alpha as modifier of onset age in Huntington disease.
PPARGC1B,Rs251468,freckles.
PPARGC1B,Rs251468,freckles
PPP1CB,Rs1114167429,pathogenic
PPP1CB,Rs1114167429,pathogenic
PPP2R5D,Rs863225081,hypotonia
PPP2R5D,Rs863225081,autism
PPP2R5D,Rs863225081,macrocephaly
PPP2R5D,Rs863225082,intellectual disability
PPP2R5D,Rs863225082,macrocephaly
PPP2R5D,Rs863225082,hypotonia
PPP2R5D,Rs863225082,autism
PPP2R5D,Rs863225082,gene
PPP2R5D,Rs863225082,macrocephaly
PPP2R5D,Rs863225082,"with intellectual disability, macrocephaly, hypotonia, and autism;"
PPP2R5D,Rs863225082,macrocephaly
PPP2R5D,Rs863225082,hypotonia
PPP2R5D,Rs863225082,autism
PPP2R5D,Rs863225082,intellectual disability
PPP2R5D,Rs863225082,hypotonia
PPP2R5D,Rs863225082,autism
PPP2R5D,Rs863225081,intellectual disability
PPP2R5D,Rs863225082,dominant
PPP2R5D,Rs863225081,autism
PPP2R5D,Rs863225079,intellectual disability
PPP2R5D,Rs863225081,macrocephaly
PPP2R5D,Rs863225081,hypotonia
PPP2R5D,Rs863225079,"macrocephaly, hypotonia"
PPP2R5D,Rs863225079,autism
PPP2R5D,Rs863225079,intellectual disability
PPP2R5D,Rs863225079,macrocephaly
PPP2R5D,Rs863225079,hypotonia
PPP2R5D,Rs863225079,hypotonia
PPP2R5D,Rs863225079,autism
PPP2R5D,Rs863225079,macrocephaly
PPP2R5D,Rs863225081,macrocephaly
PPP2R5D,Rs863225081,hypotonia
PPP2R5D,Rs863225081,autism
PPP2R5D,Rs863225081,macrocephaly
PPP2R5D,Rs863225081,hypotonia
PPP2R5D,Rs863225081,autism
PPP2R5D,Rs863225081,de novo (dominant) missense variant
PPP2R5D,Rs863225081,intellectual disability
PPP2R5D,Rs863225081,dominant
PPT1,Rs137852695,Neuronal ceroid lipofuscinosis
PPT1,Rs137852696,Neuronal ceroid lipofuscinosis
PPT1,Rs137852696,Neuronal ceroid lipofuscinosis 
PPT1,Rs137852696,Neuronal ceroid lipofuscinosis
PPT1,Rs137852696,Neuronal ceroid lipofuscinosis 
PPT1,Rs137852696,lipofuscinosis
PPT1,Rs137852695,Neuronal ceroid lipofuscinosis 
PPT1,Rs137852695,Neuronal ceroid lipofuscinosis
PPT1,Rs137852695,Neuronal ceroid lipofuscinosis 
PPT1,Rs137852695,lipofuscinosis
PPT1,I5012624,Neuronal ceroid lipofuscinosis (PPT1-related)
PPT1,I5012623,Neuronal ceroid lipofuscinosis
PPT1,I5012623,Neuronal ceroid lipofuscinosis
PPT1,I5012622,Neuronal ceroid lipofuscinosis (PPT1-related)
PPT1,I5012622,Neuronal ceroid lipofuscinosis
PRF1,Rs104894182,Cys279Tyr
PRF1,Rs28933374,Pro
PRF1,Rs28933374,Leu
PRKAG2,Rs28938173,Familial hypertrophic cardiomyopathy
PRKAG2,Rs28938173,Familial hypertrophic cardiomyopathy
PRKCA,Rs4790904,allele is A
PRKCA,Rs4790904,post-traumatic stress disorder
PRKCA,Rs4790904,memory capacity
PRKCA,Rs4790904,memory capacity
PRKCA,Rs4790904,post-traumatic stress disorder
PRKCA,Rs4790904,PKCα (PRKCA)
PRKCG,Rs121918517," the rare rs121908517(G) allele is reported to lead in a dominant manner to spinocerebellar ataxia, type 14. "
PRKCH,Rs3783799,ubcortical silent brain infarction
PRKCH,Rs3783799,lacunar infarction
PRKCH,Rs3783799,Japanese patients
PRKCH,Rs3783799,Chinese Han population
PRKCH,Rs3783799,subcortical silent brain infarction
PRKCH,Rs3783799,Asian populations
PRKCH,Rs3783799,stroke
PRKCH,Rs3783782,rheumatoid arthritis
PRKCH,Rs3783799,stroke
PRKCH,Rs3783782,SNPs 
PRKCH,Rs3783782,42 
PRKCH,Rs3783782,01 
PRKCH,Rs3783782,30
PRKCH,Rs3783782,000 
PRKCH,Rs3783782,rheumatoid arthritis
PRKCH,Rs3783782,rheumatoid arthritis
PRKCH,Rs3783782,rheumatoid arthritis 
PRM1,Rs35576928,infertilityMale 
PRM1,Rs35576928,protamine 
PRM1,Rs35576928,Arg34Ser 
PRM1,Rs35576928,infertility 
PRM1,Rs35576928,102G
PRM1,Rs35576928,102G
PRM1,Rs35576928,107G
PRNP,Rs28933385,Creuzfeldt-Jakob Disease
PRNP,Rs28933385,Creutzfeldt-Jakob disease
PRNP,Rs28933385,Creutzfeldt-Jakob disease
PRNP,Rs28933385,Familial Creutzfeldt-Jakob disease 
PRNP,Rs28933385,Creutzfeldt-Jacob disease 
PRNP,Rs28933385,Familial Creutzfeldt-Jakob disease 
PRNP,Rs28933385,familial Creutzfeldt-Jakob disease 
PRNP,Rs28933385,encephalopathy 
PRNP,Rs28933385,Fatal Familial Insomnia
PRNP,Rs1799990,primary progressive aphasia
PRNP,Rs28933385,supranuclear palsy
PRNP,Rs1799990,CJD
PRNP,Rs1799990,vCJD
PRNP,Rs1799990,vCJD
PRNP,Rs1799990,Creutzfeldt-Jakob disease
PRNP,Rs16990018,Jamaicans
PRNP,Rs16990018,healthy members
PRNP,Rs16990018,temporal lobe epilepsy
PRNP,Rs16990018,Prion disease
PRNP,Rs11538758,neurodegeneration
PRNP,Rs11538758,inherited Gerstmann-Straussler-Scheinker syndrome
PRNP,Rs1799990,Creutzfeldt-Jakob disease
PROC,Rs369504169,low anticoagulant activity
PROC,Rs2069912,sepsis 
PROC,Rs2069912,organ dysfunction
PROC,Rs146922325,venous thromboembolism 
PROC,Rs369504169,low anticoagulant activity observed for variant
PROC,Rs121918154,Arg272Cys
PROC,Rs121918148,Glu62Ala
PROC,Rs121918145,Pro210Leu
PROC,Rs146922325,venous thromboembolism
PRODH,Rs450046,neural circuitry
PRODH,Rs450046, genetic mechanisms
PRODH,Rs450046,schizophrenia.
PRODH,Rs450046,schizophrenia
PRODH,Rs450046,anxiety
PRODH,Rs450046,schizotypy 
PRODH,Rs450046,schizophrenia
PRODH,Rs450046,schizophrenia
PRODH,Rs4819756,schizophrenia
PRODH,Rs450046,"rs372055(C), rs450046(G), rs385440(A) haplotype carriers "
PRODH,Rs450046,exhibited attenuated PPI + verbal memory 
PRODH,Rs450046, as well as higher anxiety 
PRODH,Rs450046,and schizotypy 
PRODH,Rs450046,schizophrenia
PRODH,Rs450046,Functional polymorphisms in PRODH are associated with risk and protection for schizophrenia and fronto-striatal structure and function.
PRODH,Rs450046,schizophrenia
PRODH,Rs450046,Executive function
PRODH,Rs450046,schizophrenia
PRODH,Rs450046,fronto-striatal structure
PRODH,Rs450046,rs450046 was most strongly positively associated with schizophrenia in families.
PRODH,Rs450046,polymorphisms in PRODH
PRODH,Rs450046,schizophrenia
PRODH,Rs2870983,schizophrenia
PRODH,Rs450046,schizophrenia
PRODH,Rs450046,anxiety
PRODH,Rs450046,schizophrenia
PRODH,Rs450046,schizophrenia
PRODH,Rs450046,schizophrenia
PRODH,Rs450046,schizophrenia
PRODH,Rs450046,schizophrenia
PRODH,Rs450046,haplotype
PRODH,Rs450046,schizophrenia in families
PRODH,Rs450046,schizophrenia
PRODH,Rs450046,endophenotypes
PRODH,Rs450046,compared to noncarriers
PRODH,Rs450046,"""extended endophenotypes"
PRODH,Rs450046,higher anxiety
PRODH,Rs450046,verbal memory
PRODH,Rs450046,schizotypy
PROM1,Rs796051882,Blueprint Genetics Retinal dystrophy
PROM1,Rs796051882,Blueprint Genetics Retinal dystrophy
PROS1,Rs138925964,2 - 4 fold higher VTE risk
PROS1,Rs138925964,thromboembolism
PROS1,Rs138925964,mutation 
PROS1,Rs138925964,VTE
PROS1,Rs138925964,venous thromboembolism
PROS1,Rs138925964,venous thromboembolism
PROS1,Rs121918472,S501P
PROS1,Rs121918472,p.Ser501Pro
PROS1,Rs121918472,c.1501T>C
PROS1,Rs121918472,venous thromboembolism
PROS1,Rs1131691605,SNP
PROS1,Rs121918472,"SNP, rs121918472(C)"
PRRC2A,Rs1046089,gene
PRRC2A,Rs3132453,reduced risk for developing Non-Hodgkin Lymphoma
PRRC2A,Rs3132453,rs3132453
PRRC2A,Rs3132453,Non-Hodgkin Lymphoma 
PRRC2A,Rs1046089,association between rs1046089 and severe malaria
PRRC2A,Rs1046089,"2,162 case-controls"
PRRC2A,Rs1046089,severe malaria
PRRC2A,Rs1046089,severe malaria
PRRC2A,Rs1046089,SNP 
PRRC2A,Rs1046089,BAT2 gene
PRRC2A,Rs1046089,malaria.
PRRC2A,Rs1046089,SNP
PRSS1,Rs111033566,hereditary pancreatitis)
PRSS1,Rs144422014,hereditary pancreatitis
PRSS1,Rs111033566, pancreatitis
PRSS1,Rs397507441,TGACAAGAT
PRSS1,Rs397507441,c.63_71dup
PRSS1,Rs144422014,hereditary pancreatitis
PRSS1,Rs111033566,mutations at this SNP 
PRSS1,Rs111033566, to
PRSS1,Rs111033566, (T;T). It
PRSS1,Rs111033566,hereditary pancreatitis
PRSS1,Rs111033566,n from
PRSS1,Rs111033565,caused by a mutation in the cationic trypsinogen gene
PRSS1,Rs111033565,Hereditary pancreatitis
PRSS1,Rs111033565,chronic pancreatitis
PRSS1,Rs111033565,pancreatitis
PSEN1,Rs63750083,Jalisco mutation
PSEN1,Rs63750083,Alzheimer's disease
PSEN1,Rs63750004,"autosomal dominant,"
PSEN1,Rs63750004,early-onset Alzheimer's disease
PSEN1,Rs63750004,Alzheimer's disease
PSEN1,Rs63750004,pathogenic
PSEN1,Rs63750004,early-onset Alzheimer's disease
PSEN1,Rs63749962,Alzheimer's disease
PSEN1,Rs63749962,presenilin 1 PSEN1 gene
PSEN1,Rs63749962,rs63749962(G)
PSEN1,Rs63750083,early-onset Alzheimer's disease
PSEN1,Rs63749962,SNP
PSEN1,Rs63749962,Tyr115Asp
PSEN1,Rs63749962,Y115D
PSEN1,Rs63749962,c.343T>G
PSEN1,Rs63749962,Tyr115His
PSEN1,Rs63749962,Y115H
PSEN1,Rs63749962,c.343T>C
PSEN1,Rs63749962,rs63749962(C)
PSEN1,Rs63750083,Alzheimer's disease
PSEN1,Rs63750218,Alzheimer's disease
PSEN1,Rs63750218,Alzheimer's disease.
PSEN1,Rs63749962," ""definitely"" pathogenic"
PSEN1,Rs63750450,"pathogenic for early-onset Alzheimer's disease according to AlzForum.Reported in to be a ""definitely"" "
PSEN1,Rs63750307,Alzheimer's
PSEN1,Rs63750307,Alzheimer's disease
PSEN1,Rs63750301,Alzheimer's
PSEN1,Rs63750299,early-onset Alzheimer's disease
PSEN1,Rs63750231,SNP 
PSEN1,Rs63750231,SNP
PSEN1,Rs63750083,early-onset Alzheimer's disease.
PSEN1,Rs63750231,early-onset Alzheimer's disease
PSEN1,Rs63750231,Alzheimer's disease
PSEN1,Rs63750231,dominant mutation
PSEN1,Rs63750231,SNP
PSEN1,Rs63750231,early-onset Alzheimer's disease
PSEN1,Rs63750231,early-onset Alzheimer's disease
PSEN1,Rs63750227,25G>A
PSEN1,Rs63750218,pathogenic mutation for Alzheimer's disease
PSEN1,Rs63750218,SNP in the presenilin 1 PSEN1 gene
PSEN1,Rs63750231,dominant mutation leading
PSEN1,Rs63749962,Alzheimer's disease
PSEN1,Rs63750307,mutation 
PSEN1,Rs63749962,1 PSEN1 gene
PSEN1,Rs28930977,SPASTIC PARAPARESIS
PSEN1,Rs28930977,"Dementia,"
PSEN1,Rs28930977,FAMILIAL
PSEN1,Rs28930977,"ALZHEIMER DISEASE,"
PSEN1,Rs28930977,APRAXIA
PSEN1,Rs28930977,SPASTIC PARAPARESIS
PSEN1,Rs28930977,Dementia
PSEN1,Rs28930977,ALZHEIMER DISEASE
PSEN1,Rs28930977,"APRAXIA,"
PSEN1,Rs17125721,Alzheimer's disease
PSEN1,I5047580,early-onset Alzheimer's disease
PSEN1,I5047580,associated with early-onset Alzheimer's diseaser
PSEN1,I5047580,gene mutation
PSEN1,I5047580,early-onset Alzheimer's disease
PSEN1,I5047571,early-onset Alzheimer's disease.
PSEN1,I5047571,early-onset Alzheimer's disease
PSEN1,I3002721,Alzheimer's diseasers
PSEN1,Rs63749962,autosomal dominant
PSEN1,I5047580,PSEN1 gene mutation
PSEN1,Rs3025786,Spanish
PSEN1,I5047580,gene mutation potentially associated with early-onset Alzheimer's disease
PSEN1,Rs3025786,decreased AD risk
PSEN1,Rs3025786,associated with Alzheimer's disease
PSEN1,Rs63749911,Alzheimer's disease
PSEN1,Rs63749885, early-onset
PSEN1,Rs63749885,pathogenic
PSEN1,Rs63749885,rare
PSEN1,Rs63749885,dominant
PSEN1,Rs63749885,autosomal 
PSEN1,Rs63749885,Inherited
PSEN1,Rs63749885,Alzheimer's disease.
PSEN1,Rs63749885,Alzheimer's
PSEN1,Rs3025786,gene
PSEN1,Rs63749885, SNP
PSEN1,Rs3025786,Spanish
PSEN1,Rs3025786,associated with Alzheimer's disease
PSEN1,Rs63749911,Alzheimer's disease
PSEN1,Rs63749824,Alzheimer's disease
PSEN1,Rs3025786,Alzheimer's disease
PSEN1,Rs63749805,pathogenic for early-onset Alzheimer's disease
PSEN1,Rs3025786,llele carriers have a decreased AD risk
PSEN2,Rs63750666,Alzheimer's
PSEN2,Rs63750666,early-onset Alzheimer's disease
PSEN2,Rs63750666,2 PSEN2 gene
PSEN2,Rs63750666,Alzheimer's disease
PSEN2,Rs63750215,causative for early-onset
PSEN2,Rs63750215,Alzheimer's disease
PSEN2,Rs63750048,Alzheimer's disease
PSEN2,Rs63750197,dilated cardiomyopathy
PSEN2,Rs63750197,Alzheimer's disease
PSEN2,Rs63750110,penetrance of this mutation
PSEN2,Rs63750110,Alzheimer'
PSEN2,Rs63750110,early-onset Alzheimer's disease
PSEN2,Rs63750666,early-onset Alzheimer's disease
PSEN2,Rs63750197,incomplete penetrance
PSEN2,Rs63750110,early-onset Alzheimer's disease
PSEN2,Rs63750666,"rs63750666, also known as c.1289C>T, T430M or Thr430Met, is a SNP in the presenilin 2 PSEN2 gene."
PSEN2,Rs63750666,Alzheimer's disease
PSEN2,Rs63750666,Alzheimer's
PSEN2,Rs63750666,may have reduced penetrance.
PSEN2,Rs63750666,presenilin 2 PSEN2 gene
PSEN2,Rs63750666,early-onset Alzheimer's disease
PSEN2,Rs63750666,Alzheimer
PSEN2,Rs63750666,early-onset disease
PSEN2,Rs63750666,"Acting as an autosomal dominant, the rare rs63750666(T) allele has been suggested to lead to early-onset Alzheimer's disease. "
PSEN2,Rs63750666,Alzheimer's patient 
PSEN2,Rs63750812,Alzheimer's disease
PSEN2,Rs755101354,early-onset Alzheimer's disease
PSEN2,Rs755101354,early-onset Alzheimer's disease
PSEN2,Rs775145486,Alzheimer's disease
PSEN2,Rs63749884,causative for early-onset Alzheimer's disease
PSEN2,Rs63750666,an autosomal dominant
PSEN2,Rs63749884,Alzheimer's
PSEN2,Rs63750666,Alzheimer's
PSEN2,Rs61761208,Alzheimer's disease
PSEN2,Rs63749884,early-onset Alzheimer's disease;
PSEN2,Rs150400387,mutation 
PSEN2,Rs150400387,Alzheimer's disease
PSEN2,Rs150400387,autosomal dominant manner
PSEN2,Rs150400387,Korean 
PSEN2,Rs150400387,Alzheimer's
PSEN2,Rs150400387,mutation
PSEN2,Rs150400387,"mutations in the PSEN2 gene lead to early-onset Alzheimer's disease,"
PSEN2,Rs150400387,reported in a 49 year old Korean patient as being pathogenic
PSEN2,Rs150400387,at least 4 individuals with Alzheimer's carrying this mutation
PSEN2,Rs1800680,A SNP in the PSEN2 gene.
PSEN2,Rs200754713,pathogenic
PSEN2,Rs200754713,autosomal dominant
PSEN2,Rs200754713,dementia
PSEN2,Rs200754713,Frontotemporal
PSEN2,Rs200754713,Frontotemporal dementia
PSEN2,Rs200754713,language impairment.
PSEN2,Rs61761208,minor allele
PSEN2,Rs61761208,Alzheimer's disease
PSEN2,Rs200754713,behavioral abnormalities
PSEN2,Rs61761208,AlzForum
PSEN2,Rs533813519,autosomal dominant manner
PSEN2,Rs533813519,early-onset Alzheimer's disease
PSEN2,Rs533813519,Alzheimer's disease
PSEN2,Rs61761208,early-onset Alzheimer's disease
PSEN2,Rs367855127,early-onset Alzheimer's disease
PSEN2,Rs28936380,early-onset Alzheimer's disease
PSEN2,Rs28936379,early-onset Alzheimer's disease
PSEN2,Rs28936379,Alzheimer's disease
PSEN2,Rs28936379,Alzheimer's disease
PSEN2,Rs367855127,early-onset Alzheimer's disease
PSG2,Rs707746,Essential Tremor
PSG2,Rs707746,amyotrophic lateral sclerosis
PSG2,Rs707746,amyotrophic lateral sclerosis
PSG2,Rs707746,amyotrophic lateral sclerosis
PSG2,Rs707746,amyotrophic lateral sclerosis
PSG2,Rs707746,Functional considerations suggest that the pathogenic effects of ET-specific FUS mutations are different from the effects observed when FUS is mutated in amyotrophic lateral sclerosis cases;
PTEN,Rs1060500116,truncation
PTEN,Rs1060500116,stop codon and a truncated protein
PTEN,Rs1060500116,Cowden syndrome
PTEN,Rs1060500116,hamartoma tumor syndrome
PTEN,Rs1057520900,hamartoma tumor syndrome
PTEN,Rs1060500116,The minor allele
PTEN,Rs1057520900,likely to be a benign variant
PTEN,Rs1060500116,Cowden syndrome
PTGS1,Rs10306114,European patients
PTGS1,Rs10306114,"experienced bleeding,"
PTGS2,Rs5275,colorectal cancers
PTGS2,Rs5275,oral premalignant lesions
PTGS2,Rs5275,aggressive prostate cancer
PTGS2,Rs5275,colon cancer
PTGS2,Rs5275,prostate cance
PTGS2,Rs5275,Danish
PTGS2,Rs5275,colorectal cancer
PTGS2,Rs5275,inflammatory diseases
PTGS2,Rs5275,Scottish and Danish
PTGS2,Rs5275,lung cancer
PTGS2,Rs5275,hepatocellular carcinoma
PTGS2,Rs5275,breast cancer
PTGS2,Rs5275,acute coronary syndrome in coronary artery disease
PTGS2,Rs5275,prostate cancer risk
PTGS2,Rs5275,coronary and carotid calcium
PTGS2,Rs5275,Korean population
PTGS2,Rs5275,cervical cancer
PTGS2,Rs5275,cancers
PTGS2,Rs5275,breast cancer risk
PTGS2,Rs5275,Caucasian bladder cancer patients
PTGS2,Rs5275,breast cancer risk
PTGS2,Rs689469,polymorphisms in the COX-2 gene
PTGS2,Rs5275,Parkinson's disease
PTGS2,Rs5275,prostate cancer risk
PTGS2,Rs5275,advanced colorectal adenoma
PTGS2,Rs5275,colorectal cancer Allellic
PTGS2,Rs5275,Gallbladder cancer
PTGS2,Rs5275,Diabetes
PTGS2,Rs5275,esophageal cancer
PTGS2,Rs689465,Cyclooxygenase-2 polymorphisms 
PTGS2,Rs5275,breast cancer
PTGS2,Rs5275,depression
PTGS2,Rs689465,Polymorphisms in cycloxygenase-2 gene
PTGS2,Rs689465,breast cancer
PTGS2,Rs689465,acute myeloid leukemia 
PTGS2,Rs689465, gastric cancer.
PTGS2,Rs689465,Helicobacter pylori infection 
PTGS2,Rs689465,esophageal cancer:
PTGS2,Rs689465,Pyrosequencing of polymorphisms in the COX-2 gene (PTGS2)
PTGS2,Rs689465,(A;A) genotypes
PTGS2,Rs689465,mild asthma
PTGS2,Rs689465, mild asthma
PTGS2,Rs689465,breast cancer
PTGS2,Rs689465,acute myeloid leukemia
PTGS2,Rs5275,coronary thrombosis
PTGS2,Rs689465,gastric cancer
PTGS2,Rs689465,esophageal cancer
PTGS2,Rs689465,mild asthma
PTGS2,Rs689465,asthma
PTGS2,Rs689465,breast cancer prognosis:
PTGS2,Rs689465,Chinese population.
PTGS2,Rs689465,acute myeloid leukemi
PTGS2,Rs689465,gastric cancer.
PTGS2,Rs689465,esophageal cancer
PTGS2,Rs689465,Australian patients.
PTGS2,Rs689465,mild asthma
PTGS2,Rs5275,treatment resistant depression
PTGS2,Rs5275,chinese population
PTGS2,Rs5275,gastric cancer
PTGS2,Rs689465,Helicobacter pylori infection
PTGS2,Rs5275,gastric cancer
PTGS2,Rs5275,colorectal cancer
PTGS2,Rs5275,prostate cancer
PTGS2,Rs5275,breast cancer
PTGS2,Rs5275,prostate cancer susceptibility
PTGS2,Rs5275,coronary thrombosis
PTGS2,Rs5275,esophageal cancer
PTGS2,Rs5275,Gallbladder cancer
PTGS2,Rs5275,hepatocellular carcinoma
PTGS2,Rs5275,lung cancer
PTGS2,Rs5275,chronic inflammatory diseases
PTGS2,Rs5275,olorectal cancer
PTGS2,Rs5275,breast cancer
PTGS2,Rs5275,colon cancer
PTGS2,Rs5275,prostate cancer risk.
PTGS2,Rs5275,oral premalignant lesions
PTGS2,Rs5275,colorectal cancers
PTGS2,Rs5275,coronary artery disease
PTGS2,Rs5275,coronary syndrome
PTGS2,Rs5275,Diabetes
PTGS2,Rs5275,knee osteoarthritis
PTGS2,Rs5275,prostate cancer risk
PTGS2,Rs5275,cancers
PTGS2,Rs5275,breast cancer
PTGS2,Rs5275,breast cancer
PTGS2,Rs5275,Parkinson's disease
PTGS2,Rs5275,colorectal adenoma
PTGS2,Rs5275,colorectal cancer
PTGS2,Rs4648261,reduction in colorectal cancer risk
PTGS2,Rs4648261,colorectal cancer risk
PTGS2,Rs5275,gastric cancer
PTGS2,Rs5275,bladder cancer
PTGS2,Rs5275,breast cancer
PTGS2,Rs5275,colorectal adenoma
PTGS2,Rs5275,colorectal cancer
PTGS2,Rs5275,coronary thrombosis
PTGS2,Rs5275,esophageal cancer
PTGS2,Rs5275,Gallbladder cancer
PTGS2,Rs5275,lung cancer
PTGS2,Rs5275,inflammatory bowel disease
PTGS2,Rs5275,chronic inflammatory diseases
PTGS2,Rs5275,breast cancer
PTGS2,Rs5275,prostate cancer
PTGS2,Rs5275,colon cancer
PTGS2,Rs5275,prostate cancer
PTGS2,Rs5275,coronary artery disease
PTGS2,Rs5275,polymorphisms
PTGS2,Rs5275,polymorphisms
PTGS2,Rs5275,acute coronary syndrome
PTGS2,Rs5275,prostaglandin-endoperoxide synthase 2 variant
PTGS2,Rs5275,prostate cancer
PTGS2,Rs5275,Parkinson's disease
PTGS2,Rs5275,polymorphism
PTGS2,Rs5275,polymorphisms
PTGS2,Rs5275,knee osteoarthritis
PTGS2,Rs5275,breast cancer
PTGS2,Rs5275,polymorphisms
PTGS2,Rs5275,breast cancer
PTGS2,Rs5275,polymorphisms
PTGS2,Rs5275,cancers
PTGS2,Rs5275,cervical cancer
PTGS2,Rs5275,prostate cancer
PTGS2,Rs5275,polymorphism
PTPN11,Rs12229892, gastric atrophy--opposite
PTPN11,Rs12229892,Japanese
PTPN11,Rs12229892,gastric cancer
PTPN11,Rs12229892,gastric atrophy
PTPN11,Rs12229892,Helicobactor pylori seropositivity
PTPN11,Rs12229892,gastric cancer
PTPN11,Rs12229892,gastric atrophy
PTPN11,Rs12229892,intron 3 with Helicobactor pylori seropositivity
PTPN11,Rs12229892,PTPN11 G/A polymorphism
PTPN11,Rs12229892,gastric atrophy--opposite
PTPN11,Rs12229892,PTPN11 polymorphism
PTPN11,Rs12229892,gastric cancer
PTPN11,Rs12229892,polymorphism and gastric atrophy
PTPN2,Rs1893217,diabetes
PTPN2,Rs1893217,diabetes
PTPN2,Rs1893217,type I diabetes.
PTPN2,Rs1893217,type 1 diabetes
PTPN2,Rs1893217,celiac disease
PTPN2,Rs1893217,PTPN2
PTPN2,Rs1893217,Crohn's disease
PTPN2,Rs1893217,ANGPT1
PTPN2,Rs1893217,diabetes
PTPN2,Rs1893217,autophagy
PTPN2,Rs1893217,PTPN2 gene
PTPN2,Rs514000,Crohn's disease
PTPN2,Rs1893217,COG6
PTPN2,Rs1893217,type 1 diabetes.
PTPN2,Rs2542151,Crohn's disease
PTPN2,Rs1893217,Crohn's disease
PTPN2,Rs1893217,type-1 diabetes
PTPN2,Rs1893217,Crohn's disease
PTPN2,Rs1893217,type-1 diabetes
PTPN2,Rs1893217,type 1 diabetes
PTPN2,Rs1893217,diabetes
PTPN2,Rs1893217,pre-diabetes to diabete
PTPN2,Rs1893217,idiopathic arthritis 
PTPN2,Rs1893217,type I diabetes
PTPN2,Rs1893217,type 1 diabetes
PTPN2,Rs1893217,celiac disease
PTPN2,Rs1893217,multiple sclerosis
PTPN2,Rs1893217,autoimmune diseases 
PTPN2,Rs1893217,Crohn's disease-associated polymorphism
PTPN22,Rs33996649,rheumatoid arthritis
PTPN22,Rs33996649,RA
PTPN22,Rs33996649,Chinese
PTPN22,Rs33996649,rheumatoid arthritis
PTPN22,Rs3761935,PTPN22 gene
PTPN22,Rs3761935,VKH disease
PTPN22,Rs3761935,rheumatoid arthritis
PTPN22,Rs3761935,PTPN22 genetic variation
PTPN22,Rs3761935,rheumatoid arthritis
PTPN22,Rs33996649,Caucasian
PTPN22,Rs33996649,ulcerative colitis
PTPN22,Rs33996649,rheumatoid arthritis
PTPN22,Rs1310182,rheumatoid arthritis
PTPN22,Rs33996649,Crohn's disease
PTPN22,Rs12730735,rheumatoid arthritis
PTPN22,Rs12730735,rheumatoid arthritis
PTPN22,Rs12730735,rheumatoid arthritis
PTPN22,Rs33996649,autoimmune diseases
PTPN22,Rs1310182,rheumatoid arthritis
PTPN22,Rs1310182,type 1 diabetes
PTPN22,Rs1310182,psoriasis of early onset
PTPN22,Rs1310182,rheumatoid arthritis
PTPN22,Rs12730735,rheumatoid arthritis
PTPRC,Rs17612648, systemic sclerosis 
PTPRC,Rs17612648,C77G polymorphism
PTPRC,Rs17612648,liver transplant rejection.
PTPRC,Rs17612648,transversion
PTPRD,Rs4626664,restless legs syndrome
PTPRD,Rs4626664,restless legs syndrome
PTPRD,Rs4626664,restless legs syndrome
PTPRD,Rs4626664,Restless Legs Syndrome
PTPRD,Rs4626664,restless legs syndrome
PTPRD,Rs4626664,Restless Legs Syndrome: 
PTPRD,Rs1975197,Restless Legs Syndrome
PTPRD,Rs1975197,European
PTPRD,Rs1975197,restless legs syndrome
PTPRD,Rs1975197,estless legs syndrome
PTPRD,Rs1975197,restless legs syndrome
PTPRD,Rs1975197,restless legs syndrome
PTPRQ,Rs147541734,PTPRQ gene variant
PTPRQ,Rs147541734,causative for a recessive form of deafness
PTPRQ,Rs190166486,PTPRQ gene variant
PTPRQ,Rs190166486,causative for a recessive form of deafness
PTPRQ,Rs61729287,deafness
PTPRQ,Rs749210663,deafnes
PYGM,Rs119103252,PYGM gene
QDPR,Rs744731,bipolar disorder
QDPR,Rs744731,bipolar disorder
RAB27A,Rs104894497,Ala87Pro
RAB27A,Rs104894497,Griscelli syndrome
RAB27A,Rs104894497,familial hemophagocytic
RAB27A,Rs104894497,pathogenic
RAB27A,Rs104894497,Griscelli syndrome
RAB27A,Rs104894497,familial hemophagocytic lymphohistiocytosis
RAB27A,Rs104894497,"Griscelli syndrome,"
RAB27A,Rs104894497,familial hemophagocytic lymphohistiocytosis
RAB27A,Rs104894497,i5003825
RAB27A,Rs104894497,23andMe 
RAB27A,Rs104894497,lymphohistiocytosis
RAB27A,Rs104894497,2016 
RAB27A,Rs104894497,259G
RAB27A,Rs104894497,ClinVar 
RAB6B,Rs2280673,Hemochromatosis
RAD50,Rs2240032,repair pathway genes and familial breast cancer
RAD50,Rs2244012,SNPs 
RAD50,Rs2244012,tagging
RAD50,Rs2244012,disequilibrium 
RAD50,Rs2244012,genes
RAD50,Rs2244012,DNA 
RAD50,Rs2244012,structure 
RAD50,Rs2244012,genes 
RAD50,Rs2244012,methylation
RAD50,Rs2244012,gene 
RAD50,Rs2244012,smokers
RAD50,Rs2244012,DNA 
RAPSN,Rs104894299,120660 
RAPSN,Rs104894299,Asn88Lys 
RAPSN,Rs104894299,N88K
RAPSN,Rs104894299,RAPSN 
RAPSN,Rs104894299,rs104894299
RAPSN,Rs104894299,192 
RAPSN,Rs104894299, ExAC
RAPSN,Rs104894299,OMIM
RAPSN,Rs104894299,001591
RAPSN,Rs104894299,N88K 
RAPSN,Rs104894299,601592
RAPSN,Rs104894299,0001
RAPSN,Rs104894299,264C
RAPSN,Rs104894299,myasthenic 
RAPSN,Rs104894299,myasthenic syndrome
RAPSN,Rs45547231,congenital myasthenic syndrome
RAPSN,Rs104894299,rs104894299
RAPSN,Rs104894299,homozygotes
RAPSN,Rs104894299,congenital myasthenic syndrome
RAPSN,Rs104894299,inherited recessively
RAPSN,Rs104894299,congenital myasthenic syndrome
RAPSN,Rs104894299,congenital myasthenic syndrome
RAPSN,Rs104894299,"ongenital myasthenic syndrome. For more information, see OMIM 601592.0001."
RAPSN,Rs104894299,congenital myasthenic syndrome
RAPSN,Rs104894299,inherited recessively
RAPSN,Rs104894299,congenital myasthenic syndrome.
RAPSN,Rs104894299,"ongenital myasthenic syndrome. For more information, see OMIM 601592.0001."
RAPSN,Rs104894299,chromosome 11
RAPSN,Rs104894299,RAPSN gene
RAPSN,Rs104894299,very rare
RAPSN,Rs104894299,only 192 times
RAPSN,Rs104894299,homozygotes
RAPSN,Rs104894299,N88K mutation
RAPSN,Rs104894299,common one
RAPSN,Rs104894299,congenital myasthenic syndrome
RARG,Rs2229774,cardiotoxicity
RARG,Rs2229774,cancer
RARG,Rs2229774,cancer
RB1,Rs4151620,are associated with a reduced risk
RB1,Rs2854344,breast cancer
RB1,Rs2854344,ovarian cancer
RB1,Rs4151620,ovarian cancer
RB1,Rs4151620,ovarian cancer
RB1,Rs4151620,breast cancer
RB1,Rs4151620,rs4151620 is perfectly correlated with rs2227311
RB1,Rs4151620,is located in the 5'-untranslated region of P2RY5
RB1,Rs4151620,is predicted to affect P2RY5 transcription
RB1,Rs4151620,to be associated with
RB1,Rs2854344,ovarian cancer
RB1,Rs4151620,contains the open reading frame for the P2RY5 gene
RB1,Rs2854344,women 
RB1,Rs2854344,ovarian cancer
RB1,Rs2854344,white non-Hispanic origin
RB1,Rs2854344,ovarian cancer
RB1,Rs2227311,linked to ovarian cancer
RB1,Rs2227311,alleles have a 5X reduced risk of developing ovarian cancer
RB1,Rs2854344,breast cancer
RB1,Rs2854344,ovarian cancer
RB1,Rs2854344,ovarian cancer
RB1,Rs2227311,ovarian cancer
RB1,Rs2854344,ovarian cancer risk
RB1,Rs2854344,invasive epithelial ovarian cancer
RB1,Rs2854344,white non-Hispanic
RB1,Rs2854344,ovarian cancer
RB1,Rs2854344,invasive epithelial ovarian cancer
RB1,Rs2854344,women
RBFOX1,Rs7498702,psychiatric 
RBFOX1,Rs7498702,personality 
RBFOX1,Rs7498702,Genome
RBFOX1,Rs3785234,major depression
RBFOX1,Rs7498702,psychiatric disorders
RELN,Rs7341475,schizophrenia
RELN,Rs7341475, schizophrenia
RELN,Rs7341475,schizophrenia
RELN,Rs7341475,schizoaffective disorder
RELN,Rs7341475,schizoaffective disorder
RELN,Rs607755,females
RELN,Rs3914132,hearing loss
RELN,Rs607755,Alzheimer's disease
RELN,Rs3914132,cause hearing loss
RELN,Rs3914132,otosclerosis
RELN,Rs3914132,otosclerosis
RELN,Rs607755,Alzheimer's disease
RET,Rs2435357,Hirschsprung disease
RET,Rs2742234,Chinese 
RET,Rs2742234,Hirschsprung's disease 
RET,Rs2742234,RET 
RET,Rs2742234,Hirschsprung's disease
RET,Rs3026785,protection from Hirschsprung disease
RET,Rs2506004,binding of transcription factors and gene expression.
RET,Rs2506004,Hirschsprung's disease
RET,Rs2506004,Hirschsprung disease
RET,Rs2435357,greater affect in males
RET,Rs2435357,intron
RET,Rs1800860,hypertension
RET,Rs2435357,Hirschsprung disease
RET,Rs2435357,males
RET,Rs17158558,Hirschsprung disease
RET,Rs1799939,primary vesicoureteric reflux (pVUR) 
RET,Rs1800860,Caucasian
RET,Rs17158558,Hirschsprung disease
RET,Rs2435357,Hirschsprung disease
RET,Rs2435357,Hirschsprung disease
RET,Rs2435357,males
RET,Rs1800860,renal insufficiency
RGS2,Rs4606,schizophrenia 
RGS2,Rs4606,post-traumatic stress disorder
RGS2,Rs4606,postdisaster 
RGS2,Rs4606,Americans
RGS2,Rs4606,African 
RGS2,Rs4606,Caucasian
RGS2,Rs4606,social anxiety disorder
RGS2,Rs4606,Parkinson's 
RGS2,Rs4606,avoident
RGS2,Rs4606,shy
RGS2,Rs4606,anxiety related disorders
RGS2,Rs4606,anxiety
RGS2,Rs2746072,immunoreactivity
RGS2,Rs2746072,polymorphisms
RGS2,Rs2746071,Association of RGS2 and RGS5 variants with schizophrenia symptom severity.
RGS2,Rs4606,behaviourally restrained
RGS7,Rs670659,deep vein thrombosis
RGS7,Rs670659,deep vein thrombosis
RGS7,Rs670659,deep vein thrombosis
RGS7,Rs670659,deep vein thrombosis.
RGS7,Rs670659,Gene variants associated 
RGS7,Rs670659,gene variants associated with
RGS7,Rs670659,deep vein thrombosis
RGS7,Rs670659,deep vein thrombosis
RGS7,Rs716743,multiple sclerosis
RGS7,Rs716743,linkage and association to chromosome 1q43
RGS7,Rs670659,deep vein thrombosis
RGS7,Rs670659,deep vein thrombosis.
RGS7,Rs6697953,linkage and association to chromosome 1q43
RGS7,Rs1380304,multiple sclerosis
RGS7,Rs4659583,linkage and association to chromosome 1q43
RGS7,Rs10495476,multiple sclerosis
RGS7,Rs6697953,multiple sclerosis
RGS7,Rs1342449,multiple sclerosis
RGS7,Rs1342449,linkage and association to chromosome 1q43
RGS7,Rs1380304,linkage and association to chromosome 1q43
RGS7,Rs10495476,linkage and association to chromosome 1q43
RGS7,Rs1573073,linkage and association to chromosome 1q43
RGS7,Rs261809,multiple sclerosis
RGS7,Rs261809,linkage and association to chromosome 1q43
RGS7,Rs4659583,multiple sclerosis
RGS7,Rs1573073,multiple sclerosis
RHCE,Rs676785,blood group
RHCE,Rs676785,blood group
RHCE,Rs676785,Rh C
RHCE,Rs676785,c blood group
RHD,Rs121912762,immunization
RHD,Rs121912762,anti-D antibodies
RHD,Rs121912762,transfusion
RHD,Rs121912762,pregnancy
RHD,Rs121912762,RHD D(VII)
RHD,Rs121912762,Rh+
RHD,Rs121912762,Rh-positive variant
RHD,Rs121912762,antigen Rh40
RHD,Rs121912762,lack of epD8 and the expression
RHD,Rs121912762,RHD gene
RHD,Rs121912762,D(VII)
RIPK2,Rs42490,leprosy
RIPK2,Rs42490,Leprosy
RNASEL,Rs486907,cancer
RNASEL,Rs486907,prostate cancer
RNASEL,Rs486907,hereditary-prostate-cancer (HPC)
RNASEL,Rs486907,cancer
RNASEL,Rs486907,cancers
RNASEL,Rs486907,prostate cancer
RNASEL,Rs486907,hereditary-prostate-cancer (HPC)
RNASEL,Rs627839,risk of dying 
RNASEL,Rs627839,prostate cancer 1 
RNASEL,Rs627839,SNP
RNASEL,Rs486907,cancer
RNASEL,Rs627839, prostate cancer 
RNASEL,Rs627839,disease
RNASEL,Rs627839,hereditary prostate cancer 1
RNASEL,Rs627839,defining the risk of dying from prostate cancer
RNASEL,Rs627839,hereditary
RNASEL,Rs486907,cancers
RNASEL,Rs486907,Finnish families
RNASEL,Rs486907,SNP
RNASEL,Rs486907,cancer
RNASEL,Rs3738579,head and neck squamous cell carcinomas
RNASEL,Rs3738579,breast cancer
RNASEL,Rs3738579,cancer forms
RNASEL,Rs486907,cancer 
RNASEL,Rs486907,cancers
RNASEL,Rs486907,increased cancer risk
RNASEL,Rs486907,prostate cancer
RNASEL,Rs3738579,carcinoma of the uterine cervix
RNASEL,Rs486907,SNP 
RNASEL,Rs486907,cancer risk
RNASEL,Rs486907,cancers
RNASEL,Rs486907,increased cancer risk
RNASEL,Rs486907,prostate cancer
RNASEL,Rs486907,SNP 
RNASEL,Rs486907,hereditary-prostate-cancer (HPC)
RNLS,Rs2576178,hypertension
RNLS,Rs2296545,essential hypertension
RNLS,Rs2296545,hypertension
RNLS,Rs2296545,late-onset Alzheimer disease
RNLS,Rs2296545,chromosome 10
RNLS,Rs2296545,late-onset Alzheimer disease
RNLS,Rs2296545,Renalase gene
RORA,Rs12912233,circadian rhythm
RORA,Rs12912233,trait depression 
RPE65,Rs121918844,mutations
RPE65,Rs121918844,screening panel
RPE65,Rs121918844,congenital
RTEL1,Rs6010620,central and northern parts of China
RTEL1,Rs6010620,German
RTEL1,Rs6010620,European
RTEL1,Rs6010620,sporadic AD
RTEL1,Rs6010620,Chinese
RTEL1,Rs6010620,skin lesions of AD
RTEL1,Rs6010620,skin inflammation
RTEL1,Rs6010620,AD
RTEL1,Rs6010620,AD
RTEL1,Rs6010620,AD
RTEL1,Rs6010620,non-atopic inflammatory diseases
RTEL1,Rs6010620,Chinese Han
RTEL1,Rs201540674,mutation
RTEL1,Rs4809219,Multi-ancestry genome-wide
RTEL1,Rs4809219,atopic dermatitis
RTEL1,Rs6010620,atopic dermatitis (AD)
RTEL1,Rs6010620,Germany
RTEL1,Rs6010620,AD
RTEL1,Rs6010620,chronic inflammatory skin disorders
RTEL1,Rs6010620,children
RTEL1,Rs6010620,adults
RTEL1,Rs6010620,eczema
RYR1,Rs193922878,hyperthermia
RYR1,Rs193922770,malignant hyperthermia
RYR1,Rs193922770,malignant hyperthermia
RYR1,Rs193922747,malignant hyperthermia
RYR1,Rs193922747,malignant hyperthermia
RYR1,Rs121918596,RYR1
RYR1,Rs121918596,deletion SNP
RYR1,Rs121918596,malignant hyperthermia
RYR1,Rs121918596,malignant hyperthermia
RYR1,Rs193922770, SNP
RYR1,Rs121918596,malignant hyperthermia
RYR1,Rs121918596,deletion SNP
RYR1,Rs121918596,SNP in the RYR1 gene
RYR1,Rs121918596,malignant hyperthermia
RYR1,Rs121918594,Mutations in RYR1 in malignant hyperthermia and central core disease.
RYR1,Rs121918596,gene associated
RYR1,Rs193922770,malignant hyperthermia
RYR1,Rs193922770,gene considered causative for malignant hyperthermia
RYR1,Rs193922770,Trp
RYR1,Rs193922816,"p.R2454C, is a SNP in the RYR1 gene considered causative for malignant hyperthermia."
RYR1,Rs193922816,złośliwej 
RYR1,Rs193922816,gene 
RYR1,Rs193922816,hyperthermia
RYR1,Rs193922816,gene considered causative for malignant hyperthermia.
RYR1,Rs193922807,malignant hyperthermia
RYR1,Rs193922770,Arg
RYR1,Rs193922807,hyperthermia
RYR1,Rs193922802,malignant hyperthermia
RYR1,Rs193922772,causative for malignant hyperthermia.
RYR1,Rs193922772,SNP in the RYR1 gene
RYR1,Rs121918594,"rs121918594, aka p.Arg2458His or p.R2458H, is a SNP in the RYR1 gene leading to increased susceptibility to malignant hyperthermia when heterozygous."
RYR1,Rs193922772,hyperthermia
RYR1,Rs193922772,malignant hyperthermia
RYR1,Rs193922802,"rs193922802, aka p.Ala2350Thr or p.A2350T, is a SNP in the RYR1 gene considered causative for malignant hyperthermia"
RYR1,Rs121918594,malignant hyperthermia and central core disease
RYR1,Rs193922772,malignant hyperthermia.
RYR1,Rs121918593,heterozygous
RYR1,Rs118192170,central core disease
RYR1,Rs121918594,malignant hyperthermia
RYR1,Rs118192170,SNP
RYR1,Rs118192170,central core disease
RYR1,Rs118192170,SNP
RYR1,Rs118192163,malignant hyperthermia when heterozygous
RYR1,Rs118192161,central core disease
RYR1,Rs118192161,malignant hyperthermia
RYR1,Rs118192161,melanoma
RYR1,Rs118192161,malignant hyperthermia
RYR1,Rs118192124,C>T
RYR1,Rs118192122,His
RYR1,Rs118192122,Arg
RYR1,Rs118192122,gene considered causative for malignant hyperthermia
RYR1,Rs118192122,malignant hyperthermia
RYR1,Rs118192170,heterozygous
RYR1,Rs118192172,malignant hyperthermia
RYR1,Rs118192170,malignant hyperthermia
RYR1,Rs118192172,female
RYR1,Rs121918593,malignant hyperthermia
RYR1,Rs121918592,malignant hyperthermia
RYR1,Rs118192177,heterozygous
RYR1,Rs118192172,MH
RYR1,Rs118192177,RYR1 gene
RYR1,Rs118192177,SNP
RYR1,Rs118192177,malignant hyperthermia
RYR1,Rs118192177,malignant hyperthermia
RYR1,Rs118192176, malignant hyperthermia
RYR1,Rs118192176,RYR1 gene
RYR1,Rs118192176,SNP
RYR1,Rs118192175,increased susceptibility to malignant hyperthermia
RYR1,Rs118192175,malignant hyperthermia
RYR1,Rs118192172,"a 62 year old female carrying this variant who had ""no family or personal history of MH, despite having surgery with general anesthesia thrice""."
RYR1,Rs118192172,malignant hyperthermi
RYR1,Rs118192176,heterozygous
RYR2,Rs41315858,arrhythmogenic right ventricular cardiomyopathy
RYR2,Rs41315858,mutations in the cardiac ryanodine receptor gene
RYR2,Rs41315858,arrhythmogenic right ventricular cardiomyopathy
RYR2,Rs41315858,arrhythmogenic right ventricular cardiomyopathy type 2 
RYR2,Rs41315858,arrhythmogenic right ventricular cardiomyopathy
RYR2,Rs34967813,amilial polymorphic ventricular tachycardia
RYR2,Rs34967813,arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2)
RYR2,Rs34967813,Cardiac Arres
RYR2,Rs34967813,heart failure and sudden cardiac death
RYR2,Rs34967813,"genotype negative, exercise-induced long QT syndrome"
RYR2,Rs34967813,catecholaminergic polymorphic ventricular tachycardia
RYR2,Rs2050656,linkage and association to chromosome 1q43
RYR2,Rs2050656,multiple sclerosis
RYR2,Rs1933129,linkage and association to chromosome 1q43
RYR2,Rs1933129,multiple sclerosis
RYR2,Rs10925388,linkage and association to chromosome 1q43
RYR2,Rs10925388,multiple sclerosis
RYR2,Rs34967813,cardiac arrest
SARDH,Rs140559739,sarcosinemia
SBF2,Rs10734652,p=0.048)
SBF2,Rs10734652,Chinese
SBF2,Rs10734652,Caucasians
SBF2,Rs10734652,"""suggestively"" (p=0.07)"
SBF2,Rs10734652,"2,000+ Chinese"
SBF2,Rs10734652,study of 1000+ Caucasians
SBF2,Rs10734652,height
SCARB1,Rs9919713,lipid levels
SCARB1,Rs9919713,sex-specific regulation of human Scavenger receptor class B type 1 (SR-BI)
SCARB1,Rs9919713,Rancho Bernardo population
SCARB1,Rs9919713,Mexican-American men
SCARB1,Rs9919713,Mexican-American women.
SCARB1,Rs9919713,type-2 diabetes
SCARB1,Rs9919713,fasting glucose 
SCARB1,Rs74830677,coronary heart disease
SCARB1,Rs74830677,coronary heart disease
SCARB1,Rs5888,"Subgroup analysis indicated that the odds ratio for exudative forms of ARMD was even higher (3.6; CI: 1.7-7.6, p>0.0015) for rs5888(C;T) heterozygotes"
SCARB1,Rs5888,"two Caucasian populations totaling 2,498 patients, rs5888(C;T) heterozygotes had an increased odds ratio of 2.9 (CI: 1.6-5.3, p<0.002) for age-related macular degeneration (ARMD) based on a pooled analysis"
SCARB1,Rs5888,"rs5888 is a SNP in the scavenger receptor class B, member 1 SCARB1 gene"
SCARB1,Rs4765623,brain function and genetics
SCARB1,Rs4765623,physiogenomic analysis
SCARB1,Rs4765623,antipsychotic olanzapine
SCARB1,Rs4765623,gain significant weight 
SCARB1,Rs4765623,gain significant weight
SCARB1,Rs74830677,high plasma HDL-C levels
SCG3,Rs3764220,to obesity
SCG3,Rs3764220,resistant 
SCG3,Rs3764220,obesity phenotype
SCG3,Rs3764220,resistant (OR 9.3) to obesity
SCG3,Rs3764220,obesity phenotype
SCG3,Rs3764220,obesity phenotype
SCG3,Rs3764220,transcriptional activity
SCG3,Rs3764220,obesity
SCG3,Rs3764220,obesity
SCG3,Rs3764220,minor alleles seemed to be resistant
SCN2A,Rs121917749,infantile 
SCN2A,Rs121917750,benign familial neonatal-infantile seizures
SCN2A,Rs121917749,neonatal
SCN2A,Rs121917749,dominant 
SCN2A,Rs121917749,seizures 
SCN2A,Rs121917749,gene 
SCN2A,Rs121917749,chromosome 
SCN2A,Rs121917749,mutation 
SCN2A,Rs121917749,benign familial neonatal-infantile seizures
SCN3A,Rs755440336,Asp815Asn
SCN3A,Rs755440336,OMIM pathogenic variant
SCN3A,Rs755440336,SCN3A
SCN3A,Rs774195502,pathogenic variant
SCN3A,Rs774195502,pathogenic variant
SCN4A,Rs774452124,SCN4A gene variant 
SCN4A,Rs121908548,myotonia
SCN4A,Rs121908548,paramyotonia congenita
SCN4A,Rs121908548,"encompass potassium-aggravated myotonia without muscle weakness and/or cramps in the fingers, toes, and eyelids."
SCN4A,Rs121908548,dominantly inherited
SCN4A,Rs121908548,paramyotonia congenita
SCN4A,Rs774452124,predisposition to Sudden Infant Death Syndrome
SCN4A,Rs121908548,"cramps in the fingers, toes, and eyelids"
SCN4A,Rs121908548,muscle weakness 
SCN4A,Rs121908548,potassium-aggravated myotonia
SCN4A,Rs121908548,potassium aggravated myotonia
SCN4A,Rs121908548,paramyotonia congenita
SCN4A,Rs121908548,rare mutation in the SCN4A gene on chromosome 17
SCN5A,Rs12053903,Influences QT interval
SCN9A,Rs12478318,lower post-operative pain following surgery
SCN9A,Rs12478318,small fiber neuropathy and increased pain
SCN9A,Rs4369876,congenital insensitivity to pain
SCN9A,Rs73969684,small fiber neuropathy
SCN9A,Rs73969684,paroxysmal extreme pain disorder
SCN9A,Rs73969684,yawning
SCN9A,Rs73969684,pain-related disorders
SCN9A,Rs73969684,cause small fiber neuropathy
SCN9A,Rs73969684,pain-related disorders
SCN9A,Rs73969684,children
SCN9A,Rs73969684,small fiber neuropathy 
SCN9A,Rs73969684,paroxysmal extreme pain disorder
SCN9A,Rs73969684,associated with yawning
SCN9A,Rs73969684,children
SCN9A,Rs73969684, pain-related disorders
SCN9A,Rs12478318,congenital insensitivity to pain (CIP)
SCN9A,Rs73969684,paroxysmal extreme pain disorder (often associated with yawning)
SCN9A,Rs12478318,patient carrying this complex allele
SCN9A,Rs12478318,pain
SCN9A,Rs12478318,increased pain
SCN9A,Rs12478318,small fiber neuropathy
SCN9A,Rs121908910,insensitivity to pain
SCN9A,Rs121908910,rs121908910
SCN9A,Rs121908910,2986C
SCN9A,Rs121908910,Arg996Cys 
SCN9A,Rs121908910,R996C
SCN9A,Rs121908910,SCN9A 
SCN9A,Rs121908910,chromosome
SCN9A,Rs121908908,insensitivity to pain
SCN9A,Rs121908910,SNP 
SCN9A,Rs121908910,insensitivity to pain
SCN9A,Rs121908916,insensitivity to pain
SCN9A,Rs121908917,insensitivity to pain
SCN9A,Rs121908917, insensitivity to pain
SCN9A,Rs12478318,lower post-operative pain following surgery
SCN9A,Rs12478318,mall fiber neuropathy
SCN9A,Rs121908910,Inherited 
SDHB,Rs74315366,phaeochromocytoma
SDHB,Rs74315366,malignant sympathetic extraadrenal paragangliomas
SDHB,Rs74315366,phaeochromocytoma
SDHB,Rs74315366,novel succinate dehydrogenase subunit B gene mutation
SDHB,Rs74315366,causes familial malignant sympathetic extraadrenal paragangliomas.
SDHB,Rs74315366,pheochromocytoma
SDHB,Rs74315366,patients with apparently sporadic sympathetic paragangliomas
SDHB,Rs74315366,familial malignant sympathetic extraadrenal paragangliomas
SDHB,Rs74315366,patients with paragangliomas
SDHB,Rs74315366,phaeochromocytoma
SDHB,Rs74315366,pheochromocytoma
SDHB,Rs74315366,Germline SDHB mutations are common in patients with
SDHB,Rs74315366,sporadic sympathetic paragangliomas
SDHB,Rs74315366,paragangliomas
SDHB,Rs74315366,paragangliomas
SDHB,Rs74315366,succinate dehydrogenase genetic testing
SDHB,Rs74315366,sporadic sympathetic paragangliomas.
SDHB,Rs111430410,hereditary paragangliomatosis
SDHB,Rs74315366,pressure
SDHB,Rs74315366,familial malignant sympathetic extraadrenal paragangliomas
SDHB,Rs111430410,familial renal cell carcinoma
SDHB,Rs111430410,renal oncocytoma
SDHB,Rs111430410,renal phenotype
SDHB,Rs111430410,Germline SDHB mutations
SDHB,Rs111430410,familial renal cell carcinoma
SDHB,Rs111430410,renal oncocytoma
SDHB,Rs111430410,hereditary paragangliomatosis
SDHB,Rs111430410,familial renal cell carcinoma
SDHB,Rs111430410,renal oncocytoma
SDHB,Rs111430410,hereditary paragangliomatosis
SDHB,Rs74315366,pheochromocytoma
SDHB,Rs111430410,renal phenotype
SDHB,Rs74315366,extraadrenal 
SDHB,Rs74315366,paragangliomas
SDHD,Rs34677591,paragangliomas and pheochromocytomas
SDHD,Rs34677591,cancers
SDHD,Rs34677591,pheochromocytomas
SDHD,Rs34677591,cancers
SDHD,Rs11214077,benign 
SDHD,Rs34677591,paragangliomas
SELE,Rs5361,not at increased risk.
SELE,Rs5361,heterozygous carriers
SELE,Rs5361,several thrombotic disorders
SELE,Rs5361,4X higher risk for recurrent venous thromboembolism (VTE)
SELE,Rs5361,recurrent venous thromboembolism (VTE
SELE,Rs5361,thrombotic disorders
SELE,Rs5361,recurrent venous thromboembolism
SELE,Rs5361,thrombotic disorders
SELE,Rs5361,homozygous carriers
SEPSECS,Rs773876739,Pontocerebellar hypoplasia type 2D
SEPSECS,Rs773876739,considered pathogenic
SEPSECS,Rs773876739,Pontocerebellar hypoplasia type 2D
SEPSECS,Rs267607036,Pontocerebellar hypoplasia type 2D
SEPSECS,Rs267607036,Pontocerebellar hypoplasia type 2D
SEPSECS,Rs267607035,Pontocerebellar hypoplasia type 2D
SEPSECS,Rs267607035,Pontocerebellar 
SEPSECS,Rs267607035,pathogenic 
SEPSECS,Rs267607035,Pontocerebellar hypoplasia type 2D
SERPINA1,Rs61761869,SERPINA1 genotype
SERPINA1,Rs28931568,emphysema
SERPINA1,Rs7151526,effects on AAT activity
SERPINA1,Rs28931568,emphysema
SERPINA1,Rs28931569,emphysema
SERPINA1,Rs28931569,emphysema
SERPINA1,Rs61761869,alpha1-antitrypsin deficiency
SERPINA1,Rs7151526,strong association of the rs7151526(A)
SERPINA1,Rs61761869,associated with alpha1-antitrypsin deficiency.
SERPINA1,Rs6647,"rs6647, also known in ClinVar as c.710T>C, p.Val237Ala and V237A, and originally known as Val213, represents the site of the variation in the SERPINA1 gene that distinguishes the two Pi-M1 alleles, both of which are considered to be normal"
SERPINA1,Rs6647,"The rs6647(T) allele encodes the more common (in Caucasians) Pi-M1V (for Val) allele; rs6647(C) encodes the Pi-M1A (for Ala) allele, thought to be the ancestral/original allele in humans but now somewhat less common than Pi-M1V."
SERPINA1,Rs7151526,A recent study showed
SERPINA1,Rs7151526,anca-associated vasculitides
SERPINA1,Rs7151526,anca-associated vasculitides
SERPINA1,Rs1802959,P-family
SERPINA1,Rs61761869,Pro393Thr
SERPINA1,Rs1802959,liver disease
SERPINA1,Rs1802959,alpha-1-antitrypsin alleles
SERPINA1,Rs1802959,Alpha 1-antitrypsin deficiency
SERPINA1,Rs11832,no association
SERPINA1,Rs11832,pulmonary emphysema
SERPINA1,Rs11832,pulmonary emphysema
SERPINA1,Rs11832,pulmonary emphysema
SERPINA1,Rs121912713,dominant mutation
SERPINA1,Rs121912713,thrombin
SERPINA1,Rs121912713,bleeding disorder
SERPINA1,Rs1802959, emphysema
SERPINA1,Rs17751769, pulmonary emphysema
SERPINA1,Rs1802959,Alpha 1-antitrypsin deficiency
SERPINA1,Rs1802959,emphysema
SERPINA1,Rs1802959,liver disease
SERPINA1,Rs1802959,Alpha 1-antitrypsin deficiency
SERPINA1,Rs1802959,emphysema
SERPINA1,Rs1802959,liver disease
SERPINA1,Rs1303,pulmonary emphysema
SERPINA3,Rs4934,chronic obstructive pulmonary disease
SERPINA3,Rs4934,Lung cancer
SERPINA3,Rs1800463,finds no association
SERPINA3,Rs1800463,pulmonary emphysema
SERPINA3,Rs1800463,pulmonary emphysema
SERPINA3,Rs17473,pulmonary emphysema
SERPINA3,Rs17473,emphysema
SERPINA3,Rs17473,pulmonary 
SERPINA3,Rs1800463,pulmonary emphysema
SERPINC1,Rs201381904,dbSNP
SERPINC1,Rs2227589,lower anticoagulant activity and levels
SERPINC1,Rs2227589,deep vein thrombosis
SERPINC1,Rs2227589,vein thrombosis
SERPINC1,Rs201381904,anticoagulant activity
SERPINC1,Rs201381904,antithrombin
SERPINC1,Rs201381904,thromboembolism (VTE)
SERPINC1,Rs121909547,thrombophilia
SERPINC1,Rs121909569,Ser148Pro mutation
SERPINC1,Rs121909567,antithrombin III deficiency
SERPINC1,Rs121909547,thrombophilia
SERPINC1,Rs121909547,Korean venous thromboembolism
SERPINC1,Rs121909547,thromboembolism patients screened for thrombophilia
SERPINC1,Rs121909547,Korean venous thromboembolism
SERPINC1,Rs121909569,Korean venous thromboembolism patients screened for thrombophilia
SERPINE1,Rs34857375,Functional genetic polymorphisms
SERPINE1,Rs34857375,female reproductive disorders
SERPINE1,Rs34857375,Polycystic ovary syndrome
SERPINE1,Rs34857375,ovarian response
SERPINE1,Rs34857375,endometriosis
SERPINE1,Rs6092,associated with obesity and fat distribution
SERPINE1,Rs6092,pneumonia
SERPINE1,Rs6092,myocardial infarction
SERPINE1,Rs6092,predicts osteonecrosis in children with acute lymphoblastic leukemia
SERPINE1,Rs6092,depression
SERPINE1,Rs6092,autism spectrum disorder
SERPINE1,Rs34857375,ovarian response
SERPINE1,Rs6092,menopause
SERPINE1,Rs34857375,female reproductive disorders
SERPINE1,Rs6092,obesity
SERPINE1,Rs34857375,Polycystic ovary syndrome
SERPINE1,Rs34857375,Functional genetic polymorphisms
SERPINE1,Rs2227692,gastric cancer
SERPINE1,Rs2227692,gastric cancer
SERPINE1,Rs2227692,gastric cancer
SERPINE1,Rs2227692,study of 612 Korean patients
SERPINE1,Rs2227692,gastric cancer
SERPINE1,Rs2227692,gastric cancer
SERPINE1,Rs2227692,1.6x greater risk
SERPINE1,Rs2227692,diffuse gastric cancer
SERPINE1,Rs2227692,p = .00084
SERPINE1,Rs34857375,Functional genetic polymorphisms
SERPINE1,Rs34857375,female reproductive disorders
SERPINE1,Rs2227692,genotypes
SERPINF1,Rs1136287,macular degeneration
SERPINF1,Rs1136287,macular degeneration
SERPINF1,Rs1136287,ARMD
SERPING1,Rs28940870,ype II hereditary angioedema
SERPING1,Rs28940870,Arg444Cys
SERPING1,Rs28940870,.Arg466Cy
SERPING1,Rs28940870,Arg444Ser
SERPING1,Rs28940870,Arg466Ser
SERPING1,Rs281875170,SERPING1
SERPING1,Rs281875170,Gly184Arg
SERPING1,Rs112565881,SERPING1
SERPING1,Rs1005510,not associated with age-related macular degeneration
SERPING1,Rs1005510,age-related macular degeneration
SERPING1,Rs1005510,SERPING1 
SERPING1,Rs1005510,macular degeneration
SERPING1,Rs121907948,c.1397G>A
SETD1A,Rs762131795,Rare loss-of-function variants in SETD1A
SETD1A,Rs762131795,variants in SETD1A are associated with schizophrenia and developmental disorders
SETD1A,Rs762131795,are associated with schizophrenia and developmental disorders.
SETD1A,Rs770913157,schizophrenia
SETD1A,Rs770913157,developmental disorders
SETD1A,Rs869312829,also known as c.518-2A>G Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders.
SETD1A,Rs869312831,developmental disorders
SETD1A,Rs869312829,schizophrenia 
SETD1A,Rs869312829,developmental disorders
SETD1A,Rs869312829,developmental disorders
SETD1A,Rs869312829,schizophrenia
SETD1A,Rs869312829,schizophrenia
SETD1A,Rs869312829,developmental disorders
SETD1A,Rs869312829,schizophrenia
SETD1A,Rs869312830,schizophrenia and developmental disorders.
SETD1A,Rs869312831,schizophrenia and developmental disorders
SETD1A,Rs869312831,schizophrenia
SETD1A,Rs869312829,loss-of-function
SETD1A,Rs762131795,developmental disorders
SETD1A,Rs755127868,associated with schizophrenia and developmental disorders
SETD1A,Rs761709838,Rare loss-of-function variants in SETD1A
SETD1A,Rs61744449,schizophrenia
SETD1A,Rs762131795,schizophrenia
SETD1A,Rs61744449, loss-of-function 
SETD1A,Rs61744449,schizophrenia and developmental disorders
SETD1A,Rs754369980,schizophrenia
SETD1A,Rs754369980, and developmental disorders
SETD1A,Rs754369980,Rare loss-of-function variants in SETD1A 
SETD1A,Rs754369980, developmental disorders
SETD1A,Rs61744449,developmental disorders
SETD1A,Rs755127868,schizophrenia
SETD1A,Rs755127868,developmental disorders
SETD1A,Rs755127868,loss-of-function
SETD1A,Rs755127868,schizophrenia and developmental disorders
SETD1A,Rs761709838,schizophrenia
SETD1A,Rs761709838,developmental disorders
SETD1A,Rs761709838,schizophrenia
SETD1A,Rs761709838,developmental disorders
SETD1A,Rs754369980,schizophrenia
SEZ6L,Rs688034,homozygotes
SEZ6L,Rs688034,heterozygotes
SEZ6L,Rs688034,coronary artery disease
SEZ6L,Rs688034,heart disease
SEZ6L,Rs688034,heart disease
SEZ6L,Rs688034,coronary artery disease
SEZ6L,Rs688034,heart disease
SEZ6L,Rs688034,coronary artery disease
SGLT1,Rs17683430,sugar metabolism.
SGLT1,Rs33954001,sugar metabolism.
SGLT1,Rs33954001, defining a haplotype
SGLT1,Rs33954001,sugar metabolism
SGLT1,Rs33954001,haplotype in the SGLT1 gene
SGLT1,Rs17683430, defining a haplotype
SGLT1,Rs17683011,haplotype in the SGLT1 gene
SGLT1,Rs17683430,haplotype in the SGLT1 gene
SGLT1,Rs17683011,sugar metabolism.
SGLT1,Rs17683011, defining a haplotype
SGLT1,Rs17683011,sugar metabolism
SGLT1,Rs17683430,sugar metabolism
SGSH,Rs770947426,recessively inherited disorder
SGSH,Rs770947426,Sanfilippo syndrome type A
SGSH,Rs7503034,Benign
SGSH,Rs144143780,mucopolysaccharidosis type IIIA
SGSH,Rs144143780,Sanfilippo syndrome type A
SGSH,Rs144143780,Sanfilippo syndrome type A
SGSH,Rs144143780,mucopolysaccharidosis type IIIA
SGSH,Rs144143780,mucopolysaccharidosis type IIIA
SGSH,Rs144143780,Sanfilippo syndrome type A
SGSH,Rs144143780,mucopolysaccharidosis type IIIA (MPS3A).
SGSH,Rs104894637,recessively inherited disorder
SGSH,Rs104894637,pathogenic mutations associated with Sanfilippo syndrome type A
SGSH,Rs104894637,mutation
SGSH,Rs104894637,SGSH gene on chromosome 17
SGSH,Rs104894637,Ser66Trp
SGSH,Rs104894637,rare mutation
SGSH,Rs104894635,mucopolysaccharidosis type IIIA
SGSH,Rs104894635,"Sanfilippo syndrome type A,"
SGSH,Rs104894637,mucopolysaccharidosis type IIIA 
SH2B3,Rs148636776,"essential thrombocythemia,"
SH2B3,Rs148636776,familial erythrocytosis type 1
SH2B3,Rs148636776,thrombocythemia
SH2B3,Rs148636776,erythrocytosis type 1 
SH2D1A,Rs111033626,Lymphoproliferative syndrome
SH2D1A,Rs111033630,X-linked Lymphoproliferative syndrome
SH2D1A,Rs111033630,X-linked Lymphoproliferative syndrome
SH2D1A,Rs111033627,pathogenic
SH2D1A,Rs111033627,Lymphoproliferative syndrome
SH2D1A,Rs111033627,X-linked Lymphoproliferative syndrome
SH2D1A,Rs111033626,"X-linked Lymphoproliferative syndrome, type 1"
SH2D1A,Rs111033626,"Lymphoproliferative syndrome, type 1"
SH2D1A,Rs111033624,i5003046
SH2D1A,Rs111033624,"(p.Arg32Thr)considered pathogenic for X-linked Lymphoproliferative syndrome, type 1"
SH2D1A,Rs111033624,Lymphoproliferative 
SH2D1A,Rs111033624,ClinVar23andMe 
SH2D1A,Rs111033624,linked
SH2D1A,Rs111033624,C 
SH2D1A,Rs111033624,95G
SH2D1A,Rs111033624,Arg32Thr
SH2D1A,Rs111033624,X-linked Lymphoproliferative syndrome
SH2D1A,Rs111033624,Lymphoproliferative syndrome
SH2D1A,Rs111033623,Lymphoproliferative syndrome
SH2D1A,Rs111033623,Lymphoproliferative syndrome
SHANK3,Rs767058690,Phelan-McDermid syndrome.
SHANK3,Rs767058690,autism
SHANK3,Rs767058690,chromosome 22
SHANK3,Rs767058690,SHANK3 gene
SHANK3,Rs767058690,mutation
SHANK3,Rs767058690,Phelan-McDermid syndrome.
SHANK3,Rs767058690,autism 
SHANK3,Rs767058690,SHANK3 gene
SHBG,Rs6259,premenopausal women
SHBG,Rs6259,premenopausal
SHBG,Rs6259,postmenopausal women
SHBG,Rs6259,endometrial cancer
SHBG,Rs6259,Ovarian cancer
SHBG,Rs6259,Polycystic ovary syndrome
SHBG,Rs6259,postmenopausal breast cancer
SHBG,Rs6259,human spermatogenic defect
SHBG,Rs6259,gastric cancer
SHBG,Rs6259,breast cancer
SHBG,Rs858518,polymorphism
SHBG,Rs6259,systemic lupus erythematosus
SHBG,Rs6259,schizophrenia
SHBG,Rs6259,type 2 diabetes
SHBG,Rs6259,postmenopausal women
SHBG,Rs6259,polycystic ovary syndrome
SHBG,Rs858518,sex-hormone binding globulin (SHBG) gene
SHBG,Rs858518,mostly testosterone and estradiol
SHBG,Rs858518,best-fitting combination
SHBG,Rs858518,"of rs6259, rs858521, and rs727428 and body mass index, waist, hip, age, and smoking status accounted for 24% of the variance in SHBG levels"
SHBG,Rs6259,endometrial cancer
SHBG,Rs6259,postmenopausal women
SHBG,Rs6259,polycystic ovary syndrome
SHBG,Rs6257,sex 
SHBG,Rs6259,endometrial cancer
SHBG,Rs6259,systemic lupus
SHBG,Rs12150660,gastric cancer
SHBG,Rs1799941,Sex Hormone Regulation
SHBG,Rs1799941,Sex Hormone Regulation
SHBG,Rs6257,potential breast cancer variant
SHBG,Rs6257,Ovarian cancer risk
SHBG,Rs6257,breast cancer
SHBG,Rs6257,Ovarian cancer
SHBG,Rs6257,type 2 diabetes in postmenopausal women
SHBG,Rs6257,rs6257 
SHBG,Rs6257,globulin
SHBG,Rs6257,Mendelian 
SHBG,Rs6259,cancer 
SHBG,Rs6259,with polycystic ovary syndrome. Quantitative trait analysis suggests polymorphisms of estrogen-related genes regulate human sperm concentrations and motility.
SHBG,Rs6257,Ovarian 
SHBG,Rs6257,binding 
SHBG,Rs6259,ess of Mendelian randomization in observational epidemiolog
SHBG,Rs6257,binding 
SHBG,Rs6257,sex 
SHBG,Rs6257,Usefulness 
SHBG,Rs6257,risk 
SHOX,Rs137852552,skeletal abnormalities
SHOX,Rs137852552,Turner syndrome
SHOX,Rs137852552,SHOX Deficiency
SHOX,Rs137852552,idiopathic short stature
SHROOM3,Rs17319721,transplant rejection
SHROOM3,Rs17319721,SNP is associated with increased risk
SHROOM3,Rs17319721,is associated with increased SHROOM3 transcription
SHROOM3,Rs17319721,chronic kidney disease (CKD)
SHROOM3,Rs17319721,kidney transplant rejection
SHROOM3,Rs17319721,chronic kidney disease
SHROOM3,Rs17319721,increased expression
SHROOM3,Rs17319721,is a SNP located in an intron of the SHROOM3 gene on chromosome 4
SIPA1,Rs3741378,breast cancer
SIPA1,Rs931127,breast cancer
SIPA1,Rs931127,lymph node metastasis
SIRT1,Rs3758391,Finnish adults
SIRT1,Rs3758391,improved cognition
SIRT1,Rs3758391,better cognitive function
SIRT1,Rs3758391,longevity
SIRT1,Rs10997875,bipolar disorder in the Japanese population
SIRT1,Rs3758391,lower cardiovascular disease
SIRT1,Rs10997875,depressive disorder in the Japanese population
SIRT1,Rs10997875,bipolar disorder
SIRT1,Rs10997875,schizophrenia
SIRT1,Rs10997875,major depressive disorder
SIRT1,Rs10997875,schizophrenia 
SIX5,Rs80356461,branchio-oto-renal syndrome
SIX5,Rs80356461,mutated
SIX5,Rs80356461,branchio-oto-renal syndrome.
SLC12A3,Rs2289116,diabetic nephropathy and type-2 diabetes
SLC12A3,Rs2289116,diabetic nephropathy and type-2 diabetes
SLC12A3,Rs138977195,Familial hypokalemia-hypomagnesemia
SLC12A3,Rs138977195,recessively inherited
SLC12A6,Rs35583475,Ancestry
SLC12A6,Rs35583475,reverse/minus strand
SLC12A6,Rs35583475,forward/plus strand
SLC12A6,Rs35583475,SLC12A6 gene
SLC12A6,Rs35583475,cDNA
SLC12A6,Rs35583475,alleles
SLC12A6,Rs35583475,c.963C>T variant
SLC12A6,Rs35583475,benign
SLC12A6,Rs35583475,23andMe
SLC12A6,Rs35583475,alleles
SLC12A6,Rs121908428,ACCPN mutations
SLC12A6,Rs35583475,Andermann syndrome
SLC12A6,Rs35583475,pathogenic
SLC12A6,Rs35583475,benign
SLC12A6,Rs35583475,recessively inherited
SLC12A6,Rs35583475,Andermann syndrome
SLC12A6,Rs35583475,Andermann syndrome
SLC12A6,Rs35583475,Andermann syndrome
SLC12A6,Rs35583475,Andermann syndrome
SLC12A6,Rs35583475,inherited disorder
SLC12A6,I5012575,Peripheral Neuropathy
SLC14A1,Rs78242949,"f two copies of it are inherited, the result is"
SLC14A1,Rs78242949,the Finnish type null variant.
SLC14A1,Rs78242949,lack of the Jk Kidd blood group antigen
SLC16A11,Rs117767867,Native American population
SLC16A11,Rs117767867,type-2 diabetes
SLC16A11,Rs117767867,east Asian
SLC16A11,Rs117767867,Europeans
SLC16A11,Rs117767867,Africans.
SLC17A5,I5012634,disease
SLC17A5,I5012634,disease
SLC18A1,Rs2270641,schizophrenia 
SLC18A1,Rs2270641,European descent
SLC18A1,Rs2270641,schizophrenia
SLC18A1,Rs2270641,European descent
SLC18A2,Rs60912143,denoted a reduced transcription activity haplotype
SLC18A2,Rs60912143,reduced transcription activity haplotype of SLC
SLC18A2,Rs60912143,transcription activity haplotype
SLC18A2,Rs60912143,reduced transcription activity haplotype of SLC18A2/VMAT2
SLC18A2,Rs60912143,SNP
SLC18A2,Rs60912143,SNP denoted a reduced transcription activity haplotype
SLC19A1,Rs1051266,plasma folate women
SLC19A1,Rs1051266,GA and AA genotypes
SLC19A1,Rs1051266,higher red blood cell folate concentrations
SLC19A1,Rs1051266,serum folate or homocysteine levels methotrexate
SLC1A2,Rs1042113,schizophrenia
SLC1A2,Rs1042113,neurological disorders
SLC1A2,Rs1042113,amyotrophic lateral sclerosis.
SLC1A2,Rs1042113,schizophrenia
SLC1A2,Rs1042113,hypothesis
SLC1A2,Rs1042113,amyotrophic lateral sclerosis
SLC1A2,Rs1042113,Koreans
SLC22A4,Rs2073838,rheumatoid arthritis
SLC22A4,Rs2073838,rheumatoid arthritis
SLC22A4,Rs2073838,rheumatoid arthritis
SLC22A4,Rs11568506,Crohn's disease
SLC22A4,Rs1050152,Crohn's disease
SLC22A4,Rs11568506,psoriasis
SLC22A5,Rs17622208,Crohn's Disease
SLC22A5,Rs17622208,IBD risk factor
SLC22A5,Rs2631367,autoimmune disease
SLC22A5,Rs2631367,Crohn's disease
SLC24A4,Rs12590273,Alzheimer's disease polygenic hazard score
SLC24A5,Rs2470102,Skin color
SLC25A12,Rs2292813,autism
SLC25A12,Rs6716901,Asperger syndrome
SLC25A12,Rs2292813,autism
SLC25A12,Rs2292813,autism
SLC25A12,Rs2292813,Autism
SLC25A12,Rs6716901,Asperger syndrome
SLC25A12,Rs2292813,autism
SLC25A12,Rs2292813,autism
SLC25A12,Rs2292813,Autism
SLC25A12,Rs2292813,autism
SLC25A12,Rs2292813,autism
SLC25A12,Rs2292813,autism
SLC25A12,Rs2292813,autism
SLC25A12,Rs2292813,autism
SLC25A12,Rs2292813,autism
SLC25A12,Rs2292813,autism
SLC25A13,Rs80338727,nine mutations
SLC25A13,Rs80338727,diagnosis methods
SLC25A13,Rs80338727,two novel mutations
SLC25A13,Rs80338727,Japanese population
SLC25A13,Rs80338727,early and late onset patients
SLC25A13,Rs80338727,Screening
SLC25A13,Rs80338727,nine mutations. 
SLC25A13,Rs80338727,diagnosis methods 
SLC25A13,Rs80338727,citrin deficiency
SLC25A13,Rs80338727,Japanese population
SLC25A13,Rs80338727,citrin deficiency
SLC25A13,Rs80338727,early and late onset patients
SLC25A13,Rs80338727,mutations
SLC25A13,Rs80338727,Screening
SLC25A13,Rs80338727,mutations
SLC25A13,Rs121908532,gene
SLC25A13,Rs80338727,two novel mutations
SLC26A4,I5012618,Pendred Syndrome
SLC26A4,I5012618,Hearing loss
SLC26A4,I5012618,Syndromers28939086
SLC26A4,I5012618,lossPendred 
SLC26A4,I5012618,Hearing loss
SLC26A4,I5012618,Pendred Syndrome
SLC26A4,Rs111033244,Pendred Syndrome
SLC26A4,Rs111033199,Pendred Syndrome
SLC26A4,Rs111033199,hearing loss
SLC26A4,Rs111033199,hearing loss condition
SLC26A4,Rs111033205,Pendred syndrome
SLC26A4,Rs111033205,large spectrum of mutations in France and phenotypic heterogeneity
SLC26A4,Rs111033220,Pendred Syndrome
SLC26A4,I5012618,Hearing loss
SLC26A4,Rs111033199,Pendred Syndrome
SLC26A4,I5012618,Pendred Syndromers
SLC26A4,I5000696,10
SLC26A4,I5012616,Pendred Syndromers
SLC26A4,I5000003,Hearing loss
SLC26A4,I5000003,Hearing loss
SLC26A4,I5012618,Hearing loss
SLC26A4,I5000696,Hearing loss
SLC26A4,I5000696,Pendred Syndrome
SLC26A4,I5000696,Hearing loss
SLC26A4,I5000003,Pendred Syndrome
SLC26A4,I5000696,słuchu 
SLC26A4,I5000696,Hearing 
SLC26A4,I5000696,lossPendred 
SLC26A4,I5012616,Hearing loss
SLC26A4,I5012616,Pendred Syndrome
SLC26A4,I5012616,Hearing loss
SLC26A4,I5000696,Pendred Syndrome
SLC2A1,Rs267607059,mutation
SLC2A1,Rs267607059,symptoms
SLC2A1,Rs75485205,SLC2A1 gene
SLC2A1,Rs267607059,milder
SLC2A1,Rs267607059,Patients
SLC2A1,Rs267607059,heterozygous
SLC2A1,Rs267607059,heterozygous
SLC2A1,Rs267607059,parents
SLC2A1,Rs267607059,sister 
SLC2A1,Rs267607059,mutations
SLC2A1,Rs267607059,asymptomatic
SLC2A1,Rs267607059,inherited
SLC2A1,Rs267607059,recessively
SLC2A1,Rs267607059,deficiency
SLC2A1,Rs267607059,inherited
SLC2A1,Rs267607059,dominantly
SLC2A1,Rs267607059,rare 
SLC2A1,Rs267607059,younger 
SLC2A9,Rs3733591,old order amish
SLC2A9,Rs3733591,uric acid levels
SLC2A9,Rs12498742,European ancestry
SLC2A9,Rs12498742,SNP
SLC30A8,Rs3802177,type-2 diabetes
SLC30A8,Rs3802177,Japanese patients
SLC30A8,Rs3802177,significant for type-2 diabetes risk
SLC30A8,Rs3802177,rs3802177 
SLC30A8,Rs3802177,SNP 
SLC30A8,Rs200185429,diabetes
SLC30A8,Rs3802177,type-2 diabetes
SLC30A8,Rs200185429,type-2 diabetes
SLC30A8,Rs200185429,type-2 diabetes
SLC30A8,Rs3802177,type-2 diabetes
SLC34A3,Rs121918239,rare mutation in the SLC34A3 gene on chromosome 9
SLC34A3,Rs121918239,rs121918239(A) mutation
SLC34A3,Rs121918239,hypophosphatemic rickets with hypercalciuria
SLC37A4,Rs80356489,glycogen storage disease type 1b
SLC37A4,Rs80356489,Hepatocellular carcinoma
SLC37A4,Rs80356489, Hepatocellular carcinoma in type 1a glycogen storage disease with identification of a glucose-6-phosphatase
SLC37A4,Rs80356489,Hepatocellular carcinoma
SLC37A4,I5012878,Glycogen Storage Disease Type 1
SLC37A4,I5012878,Glycogen Storage Disease Type 1brs
SLC37A4,Rs80356489,This mutation is reported by 23andMe as accounting for approximately 40%
SLC39A4,Rs1057523837,acrodermatitis enteropathica
SLC39A4,Rs1057523837,pathogenic
SLC39A4,Rs1057523837,acrodermatitis enteropathica
SLC39A4,Rs1057523837,acrodermatitis enteropathica
SLC39A4,Rs121434292,"Note that dbSNP reports the existence of an alternate alternate allele, c.283C>A (p.Arg95Ser), but the pathogenicity is not reported."
SLC45A2,Rs35391,hair color
SLC45A2,Rs6867641,skin color variation
SLC45A2,Rs6867641,Promoter polymorphisms
SLC45A2,Rs35391,skin pigmentation
SLC45A2,Rs26722,hair color and skin pigmentation
SLC45A2,Rs26722,skin cancer
SLC45A2,Rs26722,"darker eye, hair, and skin color"
SLC45A2,Rs183671,hair graying
SLC45A2,Rs35391,alleles
SLC4A1,Rs2285644,Non-ABO Blood Groups
SLC4A1,Rs2285644,Japanese 
SLC4A1,Rs2285644,Chinese 
SLC4A1,Rs5036,variation in anion transport in erythrocytes
SLC4A1,Rs2285644,Oriental people of Mongolian descent
SLC4A1,Rs5036,variation in anion transport in erythrocytes
SLC4A1,Rs769664228,OMIM pathogenic variant
SLC4A1,Rs769664228,pathogenic 
SLC4A1,Rs5036,"benign,"
SLC4A1,Rs2285644,indigenous American (North or South) ancestors
SLC4A1,Rs2285644,South American Indians
SLC4A1,Rs2285644,East Asian
SLC4A1,Rs2285644,Asians
SLC4A1,Rs2285644,Di(a+b+)
SLC4A1,Rs2285644,Di(a-b+)
SLC4A1,Rs2285644,indigenous peoples of the Americas (in both North and South America)
SLC4A1,Rs2285644,(Di(a+b+)
SLC4A1,Rs2285644,people with some ancestors from those groups
SLC4A1,Rs2285644,Caucasians and Blacks
SLC4A1,Rs2285644,Asians
SLC4A1,Rs2285644,East Asians
SLC5A2,Rs61742739,cause a familial form of renal glycosuria
SLC6A2,Rs5558,rare Cysteine variant
SLC6A2,Rs5558,increased norepinephrine transport
SLC6A2,Rs5558,decrease in desipramine
SLC6A2,Rs5558,major depression
SLC6A2,Rs5558,major depression
SLC6A2,Rs5558,Cysteine variant 
SLC6A2,Rs5558,insensitivity to protein kinase C
SLC6A2,Rs5568,ADHD
SLC6A2,Rs5558,decrease in desipramine (tricyclic antidepressant) potency
SLC6A2,Rs5568,associated with better response to treatment of ADHD
SLC6A2,Rs5568,ADHD
SLC6A2,Rs5558,decrease in desipramine
SLC6A2,Rs5568,associated with better response
SLC6A2,Rs5569,ADHD
SLC6A2,Rs5569,ADHD
SLC6A2,Rs5558,down-regulation
SLC6A2,Rs5558,insensitivity to protein kinase C
SLC6A2,Rs5558,major depression
SLC6A2,Rs40147,preliminary 
SLC6A2,Rs5558,increased norepinephrine transport
SLC6A2,Rs11568324,protection for ADHD
SLC6A2,Rs11568324,rare allele conferring protection for ADHD
SLC6A2,Rs1861647,ADHD
SLC6A2,Rs36029,Pharmacogenetics of antidepressant response
SLC6A2,Rs36029,antidepressant response
SLC6A2,Rs3785143,Attention deficit hyperactivity disorder
SLC6A2,Rs1861647,ADHD
SLC6A2,Rs3785157,ADHD
SLC6A2,Rs3785157,candidate genes
SLC6A2,Rs40147,Dymorficzne 
SLC6A2,Rs40147,płciowe 
SLC6A2,Rs40147,genów 
SLC6A2,Rs40147,genetic 
SLC6A2,Rs40147,ADHD
SLC6A2,Rs3785157,ADHD
SLC6A3,Rs37022,ipolar disorder
SLC6A3,Rs2963238,schizophrenia
SLC6A3,Rs2963238,seizures
SLC6A3,Rs2963238,Caucasian
SLC6A3,Rs2963238,Brazilian
SLC6A3,Rs6350,Financial and psychological risk attitudes
SLC6A3,Rs37022,alcohol-dependent
SLC6A3,Rs37022,nfluence on alcohol and tobacco consumption magnitude in alcohol-dependent individuals. 
SLC6A3,Rs6350,acute post-surgical pain
SLC6A3,Rs37022,schizophrenia 
SLC6A3,Rs37022,bipolar disorder
SLC6A3,Rs37022,schizophrenia
SLC6A3,Rs37022,Croatian population
SLC6A3,Rs431905514,31+
SLC6A3,Rs431905514,c.1031
SLC6A3,Rs2963238,extrapyramidal syndrome
SLC6A3,Rs37022,bipolar disorder:
SLC6A3,Rs2963238,cocaine abuse
SLC6A3,Rs2963238,schizophrenia
SLC6A3,Rs2963238,severe symptoms upon alcohol withdrawal
SLC6A3,Rs2963238,seizures
SLC6A3,I5005473,Infantile Parkinsonism-dystonia
SLC6A3,Rs2652511,attention deficit hyperactivity disorder
SLC6A3,Rs2652511,attention-deficit/hyperactivity disorder
SLC6A3,Rs2652511,attention deficit/hyperactivity disorder
SLC6A3,Rs2652511,deficit hyperactivity disorder
SLC6A3,Rs2652511,haplotype
SLC6A3,Rs2652511,dopamine
SLC6A3,Rs2652511,analysis of 51 genes
SLC6A3,Rs2652511,polymorphism
SLC6A3,Rs2652511,attention-deficit/hyperactivity disorder
SLC6A3,Rs2963238,seizures
SLC6A3,Rs2963238,alcohol withdrawa
SLC6A3,Rs2652511,association between
SLC6A3,Rs2963238,extrapyramidal syndrome in schizophrenia.
SLC6A3,Rs2652511,attention deficit/hyperactivity disorder
SLC6A3,Rs2652511,dopamine
SLC6A3,Rs2652511,Brazilian children
SLC6A4,Rs4251417,diarrhoea 
SLC6A4,Rs4583306,increased risk
SLC6A4,Rs4583306,haplotype
SLC6A4,Rs4583306,panic disorder
SLC6A4,Rs4583306,haplotype 
SLC6A4,Rs4583306,panic disorder
SLC6A4,Rs4251417,polymorphism in the serotonin transporter gene
SLC6A4,Rs4251417,irritable bowel syndrome in women
SLC6A4,Rs4251417,ADHD
SLC6A4,Rs3794808,Association 
SLC6A4,Rs4251417,functional polymorphism in the serotonin transporter gene
SLC6A4,Rs4251417,NEO-PI-R Neuroticism
SLC6A4,Rs4251417,Sexually dimorphic
SLC6A4,Rs4251417,diarrhoea predominant irritable bowel syndrome
SLC6A4,Rs3794808,of the serotonin transporter gene and NEO-PI-R Neuroticism: No association 
SLC6A4,Rs3794808,The haplotype A-A-G
SLC6A4,Rs3794808,"The haplotype A-A-G for SNPs rs3794808, rs140701 and rs4583306 has a 1.7x increased"
SLC6A4,Rs3794808,orphisms or haplotypes in the serotonin transporter gene in a community-based sample of German healthy volunteers. Examination of ass
SLC6A4,Rs4583306,panic disorder.
SLC6A4,Rs4251417,diarrhoea predominant irritable bowel syndrome in women
SLC6A4,Rs4583306,has a 1.7x increased risk for panic disorder.
SLC6A4,Rs6354,portopulmonary hypertension
SLC6A4,Rs6354,serotonin transporter gene
SLC6A4,Rs6354,systemic sclerosis
SLC6A4,Rs6354,"Study of Depression, Anxiety, and Personality Measures."
SLC6A4,Rs6354,patients with portopulmonary hypertension.
SLC6A4,Rs6354,association with drinking intensity
SLC6A4,Rs6354,frontotemporal lobar degeneration
SLC6A4,Rs6354,susceptibility to autism and rigid-compulsive behaviors
SLC6A4,Rs6354,unctional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women.
SLC6A4,Rs6354,systemic sclerosis
SLC6A4,Rs6354,Personality Measures
SLC6A4,Rs6354,functional polymorphism
SLC6A4,Rs6354,Anxiety
SLC6A4,Rs6354,Flanking Single Nucleotide Polymorphisms
SLC6A4,Rs6354,Neuroticism
SLC6A4,Rs3794808,serotonergic 
SLC6A4,Rs6354,Serotonin transporter polymorphisms
SLC6A4,Rs6354,frontotemporal lobar degeneration
SLC6A4,Rs6354,polymorphisms
SLC6A4,Rs6354,rigid-compulsive behaviors
SLC6A4,Rs6354,autism
SLC6A4,Rs6354,diarrhoea predominant irritable bowel syndrome
SLC6A4,Rs6354,Depression
SLC6A4,Rs3794808,The haplotype A-A-G 
SLC6A4,Rs3794808,BLSA 
SLC6A4,Rs3794808,dopaminergic pathway with schizophrenia
SLC6A4,Rs2066713,schizophrenia
SLC6A4,Rs2066713,Neuroticism
SLC6A4,Rs2066713,irritable bowel syndrome
SLC6A4,Rs2066713,diarrhoea
SLC6A4,Rs2066713,sclerosis
SLC6A4,Rs2066713,migraine
SLC6A4,Rs2066713,depression
SLC6A4,Rs2066713,Chronic Fatigue Syndrome
SLC6A4,Rs2066713,schizophrenia
SLC6A4,Rs2066713,Chronic Fatigue Syndrome
SLC6A4,Rs2066713,autism
SLC6A4,Rs2066713,irritable bowel syndrome
SLC6A4,Rs2066713,diarrhoea
SLC6A4,Rs11080122,Neuroticism
SLC6A4,Rs1042173,this association was not seen in Hispanics.
SLC6A4,Rs1042173,compared with an average of 8.58 for carriers of a rs1042173(G)
SLC6A4,Rs1042173,Caucasians of with the rs1042173(T;T) genotype consumed an average of 11.17 drinks per drinking day
SLC6A4,Rs1042173,alcoholism 
SLC6A4,Rs1042173,"is a SNP in the solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 SLC6A4 gene"
SLC6A4,Rs1042173,seeking treatment for alcoholism
SLC6A4,Rs3794808,"serotonin transporter gene variation with smoking, chronic obstructive pulmonary disease, and its depressive symptoms."
SLC6A4,Rs2066713,depression
SLC6A4,Rs2066713,ADHD
SLC6A4,Rs2066713,ystemic sclerosis
SLC6A4,Rs2066713,migraine
SLC6A4,Rs3794808,Differences and similarities in the serotonergic diathesis for suicide attempts and mood disorders:
SLC6A4,Rs3794808,Examination of association of genes in the serotonin system to autism
SLC6A4,Rs3794808,"haplotype A-A-G for SNPs rs3794808, rs140701 and rs4583306 has a 1.7x increased risk for panic disorder."
SLC6A4,Rs3794808,"Association of serotonin transporter gene variation with smoking, chronic obstructive pulmonary disease, and its depressive symptoms"
SLC6A4,Rs28914832,drinking intensity
SLC6A4,Rs28914832,Characterization of a functional polymorphism
SLC6A4,Rs28914832,autism
SLC6A4,Rs28914832,autism and rigid-compulsive behaviors
SLC6A4,Rs28914832,heterogeneity
SLC6A4,Rs28914832,serotonin
SLC6A4,Rs28914832,functional polymorphism
SLC6A4,Rs28914832,autism.
SLC6A4,Rs28914832,susceptibility to autism and rigid-compulsive
SLC6A4,Rs28914832,Allelic heterogeneity
SLC6A4,Rs28914832,drinking intensity.
SLC6A4,Rs28914832,autism
SLC6A4,Rs28914832,autism
SLC6A4,Rs25532,obsessive compulsive disorder (OCD) 
SLC6A4,Rs25532,obsessive compulsive disorder
SLC6A4,Rs28914832,drinking intensity.
SLC7A5,Rs757972971,SLC7A5
SLC7A5,Rs757972971,SLC7A5
SLC7A5,Rs757972971, 16.The rs757972971(A) allele
SLC7A5,Rs757972971,Pro375Leu
SLC7A5,Rs757972971,autism
SLC7A5,Rs757972971,rs757972971
SLC7A5,Rs757972971,autism
SLC7A5,Rs757972971,P375L
SLC9A9,Rs1995356,depression
SLCO1B1,Rs4363657,statin-induced myopathy
SLCO1B1,Rs4363657,homozygotes
SLCO1B1,Rs4363657,statin metabolism
SLCO1B1,Rs4363657,myopathy
SLCO1B1,Rs11045879,hyperbilirubinemia
SLCO1B1,Rs11045879, locus
SLCO1B1,Rs11045879,bilirubin levels and unconjugated hyperbilirubinemia
SLCO1B1,Rs4363657,lower cholesterol levels
SLCO1B3,Rs11045585,severe leukopenia/neutropenia
SLCO1B3,Rs11045585,non-leukopenia/neutropenia
SLCO1B3,Rs11045585,rs11045585
SLCO1B3,Rs11045585,SNPs
SLCO1B3,Rs11045585,eukopenia/neutropenia
SLCO1B3,Rs11045585,rs11045585
SLCO1B3,Rs11045585,rs12762549
SLCO1B3,Rs11045585,higher risk of docetaxel-induced leukopenia/neutropenia
SLCO1B3,Rs11045585,leukopenia/neutropenia
SLCO1B3,Rs11045585,predict whether docetaxel will induce leukopenia/neutropenia
SLCO1B3,Rs11045585,Japanese patients
SLCO1B3,Rs11045585,non-leukopenia/neutropenia
SLCO1B3,Rs11045585,leukopenia/neutropenia
SLCO1B3,Rs11045585,leukopenia/neutropenia
SLCO1B3,Rs11045585,leukopenia/neutropenia
SLCO1B3,Rs11045585,leukopenia/neutropenia
SLCO1B3,Rs11045585,leukopenia/neutropenia
SLITRK1,Rs150504822,plus/FWD orientation
SLITRK1,Rs150504822,minus/REV orientation
SLITRK1,Rs9546538,Tourette syndrome
SMAD3,Rs17293443,"A subsequent replication study of Icelanders yielded lower odds (1.15, CI:1.07–1.23,p=3 × 10e−4)"
SMAD3,Rs17293443,"less common allele for this SNP, rs17293443(C), is actually associated with a slightly higher likelihood of giving birth to fraternal (dizygotic) twins (odds ratio 1.27, CI:1.19–1.35, p=1.57 × 10e−8) compared to carriers of the (T) allele"
SMAD3,Rs17293443,giving birth to fraternal (dizygotic) twins
SMAD3,Rs17228212,Myocardial infarction
SMAD3,Rs17228212,SNP 
SMAD3,Rs17228212,heart disease
SMAD6,Rs12913975,brain metastasis
SMAD6,Rs12913975,brain metastasis
SMAD6,Rs12913975,different cancers
SMAD7,Rs736839,sickle cell anemia
SMAD7,Rs736839,Monogenic Disease
SMAD7,Rs736839,sickle cell leg ulcers
SMAD7,Rs736839,sickle cell disease
SMAD7,Rs736839,sickle cell anemia
SMAD7,Rs736839,sickle cell anemia
SMAD7,Rs736839,Disease
SMAD7,Rs736839,Sickle Cell Anemia
SMAD7,Rs736839,disease
SMAD7,Rs736839,sickle cell anemia
SMAD7,Rs58920878,colorectal cancer
SMAD7,Rs58920878,colorectal cancer
SMAD7,Rs12953717, colorectal cancer
SMAD7,Rs12953717,heterozygotes
SMAD7,Rs12953717,homozygotes
SMAD7,Rs12953717,colorectal cancer
SMAD7,Rs4464148,SMAD7 gene associated with risk for colorectal cancer
SMAD7,Rs4939827,colorectal cancer
SMAD7,Rs4939827,colorectal cancer
SMAD7,Rs4464148,colorectal cancer
SMARCAD1,Rs1114167276,pathogenic
SMARCAD1,Rs1114167276,pathogenic
SMARCAD1,Rs1114167277,pathogenic
SMARCAD1,Rs1114167277,pathogenic
SMN1,Rs104893934,spinal muscular atrophy
SMN1,Rs104893932,recessively inherited type 3 spinal muscular atrophy
SMN1,Rs104893933,ecessively inherited type 1 spinal muscular atrophy
SMN1,Rs104893932,ecessively inherited type 3 spinal muscular atrophy
SMN1,Rs104893932,This SNP is referred to as i5005738 by 23andMe
SMN1,Rs104893932,The rare rs104893932(G) allele is a mutation associated with
SMN1,Rs104893932,rs104893932
SMN1,Rs104893932,SNP 
SMN1,Rs104893932,23andMe
SMN1,Rs104893932,i5005738 
SMN1,Rs104893932,) 
SMN1,Rs104893934,Werdnig-Hoffmann disease
SMN1,Rs104893932,SMN1 
SMN1,Rs104893932,s a mutation in the SMN1 gene on chromosome 5
SMN1,Rs104893934,spinal muscular atrophy
SMN1,Rs75660264,type 3 spinal muscular atrophy
SMN1,Rs104893935,type 1 or 2 spinal muscular atrophy
SMN1,Rs104893932,S262G
SMN1,Rs77804083,recessively inherited type 2 spinal muscular atrophy
SMN1,Rs77804083,type 2 spinal muscular atrophy
SMN1,Rs76871093,spinal muscular atrophy
SMN1,Rs76871093,mutation in the SMN1 gene 
SMN1,Rs76871093, spinal muscular atrophy
SMN1,Rs104893934,Werdnig-Hoffmann disease
SMN1,Rs76871093,spinal muscular atrophy
SMN1,Rs76871093,type 2 or 3 spinal muscular atrophy
SMN1,Rs75660264,he rare rs75660264(T) allele is a mutation associated with the recessively inherited type 3 spinal muscular atrophy
SMN1,Rs104893935,recessively inherited type 1 or 2 spinal muscular atrophy
SMN1,Rs104893935,The rare rs104893935(G) allele is a mutation associated with
SMN1,Rs104893935,is a mutation in the SMN1 gene on chromosome 5
SMN1,Rs104893935,type 1 or 2 spinal muscular atrophy
SMN1,Rs76871093,type 2 or 3 spinal muscular atrophy
SMN1,Rs104893932,Ser262Gly 
SMN1,Rs104893932,rs104893932
SMN1,Rs104893932,784A
SMN1,I5005727,spinal muscular atrophy
SMN1,I5005728,spinal muscular atrophy
SMN1,I5005729,muscular atrophy
SMN1,I5005729,spinal muscular atrophy
SMN1,I5005733,spinal muscular atrophy
SMN1,I5005733,rs77804083
SMN1,I5005733,muscular atrophy
SMN1,I5005733,muscular 
SMN1,I5005734,spinal muscular atrophy
SMN1,I5005735,spinal muscular atrophy
SMN1,I5005737,spinal muscular atrophy
SMN1,I5005737,spinal muscular atrophy
SMN1,I5005739,spinal muscular atrophy
SMN1,I5005739,spinal muscular atrophy
SMN1,Rs104893922, inherited type 1 spinal muscular atrophy
SMN1,I5005738,spinal muscular atrophy
SMN1,Rs104893930,recessively inherited type 2 spinal muscular atrophy
SMN1,Rs104893932,type 3 spinal muscular atrophy
SMN1,Rs104893932,rs104893932
SMN1,Rs104893932,allele 
SMN1,Rs104893922,utation in the SMN1 gene on chromosome 5.T
SMN1,Rs104893932,muscular 
SMN1,Rs104893931,23andMe
SMN1,Rs104893931,type 3 spinal muscular atrophy
SMN1,Rs104893932,atrophy
SMN1,Rs104893931,SMN1 gene
SMN1,Rs104893931,mutation
SMN1,Rs104893931,ecessively inherited type 3 spinal muscular atrophy.
SMN1,Rs104893931,mutation 
SMN1,Rs104893930,spinal muscular atrophy
SMN1,Rs104893931,chromosome 5
SMN2,Rs4916,spinal muscular atrophy (SMA)
SMN2,Rs4916,spinal muscular atrophy
SMPD1,Rs387906289,Niemann-Pick Disease Type A
SMPD1,Rs387906289,Niemann
SMPD1,Rs387906289,Pick 
SMPD1,Rs387906289,Type 
SMPD1,Rs387906289,Disease 
SMPD1,Rs387906289,Niemann-Pick Disease Type A
SMPD1,I4000430,Disease 
SMPD1,Rs120074118,Niemann-Pick Disease Type A
SMPD1,I4000430,Niemann-Pick Disease
SMPD1,Rs120074124,Niemann-Pick Disease Type A
SMPD1,I4000383,Niemann-Pick Disease Type A
SMPD1,I4000381,Niemann-Pick Disease Type A
SMPD1,I4000381,Niemann-Pick Disease Type
SNAP25,Rs3746544,ADHD 
SNAP25,Rs3746544,ADHD
SNAP25,Rs3746544,. 
SNAP25,Rs3746544,ADHD 
SNAP25,Rs3746544,schizophrenia
SNAP25,Rs3746544,hypothesis
SNAP25,Rs3746544,polymorphism
SNAP25,Rs3746544,alleles
SNAP25,Rs3746544,ADHD 
SNAP25,Rs3746544,schizophrenia
SNAP25,Rs3746544,SNPs
SNAP25,Rs3746544,genetic
SNAP25,Rs3746544,ADHD
SNAP25,Rs3787283,schizophrenia
SNAP25,Rs3787283,SNPs
SNAP25,Rs3787283,ADHD
SNAP25,Rs3787283,genetic variation 
SNAP25,Rs3787283,schizophrenia
SNAP25,Rs3787283,ADHD
SNAP25,Rs8636,hyperactivity 
SNAP25,Rs8636,disorder 
SNAP25,Rs8636,attention deficit hyperactivity disorder
SNAP25,Rs8636,SNAP25
SNAP25,Rs8636,eastern Indian
SNAP25,Rs8636,attention deficit hyperactivity disorder
SNAP25,Rs3746544,attention-deficit hyperactivity disorder
SNAP25,Rs3746544,alleles
SNAP25,Rs3746544,ADHD
SNAP25,Rs363039,increased intelligence
SNAP25,Rs3746544,ADHD
SNAP25,Rs3746544, major depressive disorder
SNAP25,Rs362584,neurotic traits
SNAP25,Rs362584,personality_traits
SNAP25,Rs362584,neurotic traits
SNAP25,Rs362584,The G allele of SNAP25 gene
SNAP25,Rs362584,personality_traits
SNAP25,Rs362584,neurotic traits
SNAP25,Rs363039,Caucasian
SNAP25,Rs363039,higher intelligence in children
SNAP25,Rs363039,most associated in adults
SNAP25,Rs363043,higher intelligence in children
SNAP25,Rs3746544,schizophrenia
SNAP25,Rs3746544, ADHD
SNAP25,Rs362584, less of a trend
SNAP25,Rs3746544,ADHD
SNAP25,Rs3746544, ADHD
SNAP25,Rs3746544,schizophrenia
SNAP25,Rs3746544,schizophrenia
SNAP25,Rs3746544,schizophrenia
SNAP25,Rs3746544,ADHD
SNAP25,Rs3746544,major depressive disorder
SNAP25,Rs3746544,attention-deficit hyperactivity disorder
SNAP25,Rs3746544, ADHD
SNAP25,Rs3746544,Korean
SNAP25,Rs3746544,ADHD
SNAP25,Rs3746544,ADHD 
SNAP25,Rs3746544,ADHD
SNCA,Rs356165,Parkinson's
SNCA,Rs356165,is a SNP in the 3' UTR of the alpha-synuclein SNCA gene
SNCA,Rs356165,Parkinson's disease
SNCA,Rs356165,Parkinson's
SNCA,Rs356165,Parkinson's disease
SNCA,Rs356165,It has been associated in some studies
SNCA,Rs2736990,Parkinson's disease
SNCA,Rs2736990,PD 
SNCA,Rs2736990,PD 
SNCA,Rs2736990,PD 
SNCA,Rs2736990,PD 
SNCA,Rs2736990,PD 
SNCA,Rs356165,Parkinson diseas
SNCA,Rs2736990,PD
SNCA,Rs2736990,Parkinson
SNCA,Rs356165,Parkinson's disease
SNCA,Rs356165,Lewy body
SNCA,Rs356165,are associated with
SNCA,Rs7684318,The risk allele appears
SNCA,Rs431905511,autosomal dominant Parkinson disease
SNCA,Rs431905511,Parkinson disease
SNCA,Rs431905511,Parkinson disease
SNCA,Rs2736990,PD
SNCA,Rs356165,Alzheimer's
SNCA,Rs356165, Parkinson's disease.
SNCA,Rs356165,Parkinson's disease
SNCA,Rs356165,A study of 330 Chinese with Parkinson's found no association with rs356165 and risk for Parkinson's.
SNCA,Rs356165,with Parkinson's disease.
SNCA,Rs356165,It has been associated 
SNCA,Rs356165,rs356165 is a SNP in the 3' UTR of the alpha-synuclein SNCA gene.
SNCA,Rs356165,Lewy body pathology
SNCA,Rs356165,Alzheimer's
SNCA,Rs356165,Parkinson's disease
SNCA,Rs356165,are associated with multiple system atrophy
SNCA,Rs2736990,PD
SNCA,Rs2736990,PD
SNCA,Rs2736990,PD
SNCA,Rs104893878,Parkinson disease
SNCA,Rs104893878,"Considered ""probably pathogenic"""
SNCA,Rs104893878,Parkinson disease
SNCA,Rs104893878,autosomal dominant Parkinson disease
SNCA,Rs2736990,PD 
SNCA,Rs104893877,Parkinson's disease
SNCA,Rs2736990,Parkinson’s disease
SNCA,Rs104893877,Parkinson disease.
SNCA,Rs104893877,Parkinson's disease
SNCA,Rs104893875,autosomal dominant Parkinson disease
SNCA,Rs104893875,Parkinson disease
SNCA,Rs104893875,disease
SNCA,Rs104893875,Parkinson 
SNCA,Rs104893875,Parkinson disease
SNCA,Rs104893877,Parkinson's disease
SNCA,Rs2736990,neurodegenerative disorder characterized by the degradation of dopamine-producing neurons in the substantia nigra
SNCA,Rs104893877,Parkinson's disease
SNCA,Rs2736990,PD
SNCA,Rs2736990,PD
SNCA,Rs2736990,PD 
SNCA,Rs2736990,SNP 
SNCA,Rs2736990,Parkinson’s disease
SNCA,Rs2736990,SNP 
SNCA,Rs2736990,PD
SNCA,Rs2736990,PD
SNCA,Rs2736990,PD 
SNCA,Rs2736990,PD
SNCA,Rs2736990,PD
SNCA,Rs2736990,PD
SNCA,Rs2736990,PD
SNCA,Rs2736990,PD
SNCA,Rs2736990,PD
SNCA,Rs2736990,PD
SNX10,Rs398123011,osteopetrosis
SNX10,Rs398123011,mutation
SNX10,Rs398123011,osteopetrosis
SNX9,Rs78503206,thinking cilantro tastes like soap
SNX9,Rs78503206,less chance of thinking cilantro tastes like soap
SOAT1,Rs1044925,Polymorphism
SOAT1,Rs1044925,lower risk of Alzheimer's disease.
SOAT1,Rs1044925,"cholesterol acyltransferase with cerebrospinal fluid cholesterol levels, brain amyloid load, and risk for Alzheimer's disease."
SOAT1,Rs1044925,lower serum lipids in a specific ethnic group
SOAT1,Rs1044925,gene and serum lipid levels in the Guangxi Bai Ku Yao and Han populations
SOAT1,Rs1044925,cholesterol
SOAT1,Rs1044925,in the
SOAT1,Rs1044925,Alzheimer's disease
SOAT1,Rs1044925,Alzheimer's disease
SOAT1,Rs1044925,Alzheimer's disease.
SOAT1,Rs1044925,brain amyloid load
SOAT1,Rs1044925,cerebrospinal fluid cholesterol levels
SOAT1,Rs1044925,Alzheimer's disease
SOAT1,Rs1044925,Alzheimer's disease
SOAT1,Rs1044925,Han
SOAT1,Rs1044925,Ku Yao
SOAT1,Rs1044925,Guangxi Bai
SOCS1,Rs33977706,obesity
SOCS1,Rs33977706,body mass index
SOCS1,Rs33977706,obesity
SOCS1,Rs33977706,obesity
SOCS1,Rs33977706,SNP 
SOCS2,Rs11107116,faster growth during infancy
SOCS2,Rs11107116,4.7 mm of adult height
SOD1,Rs80265967,mutation
SOD1,Rs80265967,amyotrophic lateral sclerosis
SOD1,Rs80265967,superoxide dismutase 
SOD1,Rs121912442,polymorphism
SOD1,Rs121912438,polymorphism
SOD1,Rs121912441,amyotrophic lateral sclerosis
SOD1,Rs1041740,cardiovascular mortality
SOD1,Rs121912442,A polymorphism on the SOD1 gene known as A4V.
SOD2,Rs2758346,Alzheimer's disease
SOD2,Rs2758346,Alzheimer's disease.
SOD2,Rs2758346,rs2758346 rs4880 and rs2855116 association with Alzheimer's diseaseThe T allele appears to be more common in late-onset Alzheimer's disease
SOD2,Rs2855116,late-onset Alzheimer's disease
SOD2,Rs2855116,Alzheimer's disease
SOD3,Rs8192287,chronic obstructive pulmonary disease
SOD3,Rs8192288,COPD.
SOD3,Rs8192288,chronic obstructive pulmonary disease
SOD3,Rs8192288,chronic obstructive pulmonary disease
SOD3,Rs8192287,COPD.
SOD3,Rs8192287,chronic obstructive pulmonary disease
SOD3,Rs699473,glioma
SOD3,Rs699473,brain tumors 
SOD3,Rs1799895,detrimental in pulmonary vascular disease
SOD3,Rs1799895,alveolar lung disease
SOD3,Rs1799895,ischemic heart disease
SOD3,Rs1799895,risk for lung disease
SOD3,Rs699473,meningioma
SORL1,Rs3824968,Alzheimer's disease
SORL1,Rs3824968,cerebral small-vessel disease in hypertensive patients
SORL1,Rs3824968,Risk for Late-onset Alzheimer Disease
SORL1,Rs3824968,Alzheimer's disease
SORL1,Rs3824968,progression of mild cognitive impairment to dementia
SORL1,Rs3824968,Alzheimer's disease
SORL1,Rs3824968,Alzheimer's disease
SORL1,Rs3824968,Alzheimer's disease
SORL1,Rs3824968,cerebrovascular and neurodegenerative changes related to Alzheimer disease
SORL1,Rs3824968,Alzheimer's
SORL1,Rs3824968,mild cognitive impairment
SORL1,Rs3824968,adults with Down syndrome
SORL1,Rs689021,Alzheimer's disease
SORL1,Rs3824968,Associated With Risk for Late-onset Alzheimer Disease
SORL1,Rs3824968,Chinese Population
SORL1,Rs689021,Down syndrome.
SORL1,Rs689021,Alzheimer's disease
SORL1,Rs689021,Alzheimer's disease
SORL1,Rs689021,Alzheimer's 
SORL1,Rs689021,Alzheimer disease.
SORL1,Rs689021,Alzheimer's disease:
SORL1,Rs689021,Alzheimer's disease
SORL1,Rs689021,Alzheimer's disease.
SORL1,Rs726601,"gene that show some association with increased (or decreased) risk for Alzheimer's disease in a study of 1,400 Caucasians"
SORL1,Rs3824968,cerebrovascular and neurodegenerative changes related to Alzheimer disease
SORL1,Rs3824968,late-onset Alzheimer's disease
SORL1,Rs3824968,lzheimer's disease in adults with Down syndrome
SORL1,Rs3824968,Down syndrome
SORL1,Rs1699103,Alzheimer's disease
SORL1,Rs1699103, increased (or decreased) risk for Alzheimer's disease
SORL1,Rs1699103,Caucasians
SORL1,Rs1699103,Alzheimer's disease
SORL1,Rs1792113,SORL1 gene that show some association with increased
SORL1,Rs1792113,"risk for Alzheimer's disease in a study of 1,400 Caucasians."
SORL1,Rs2070045,"SORL1 gene,"
SORL1,Rs2070045,Alzheimer's disease
SORL1,Rs3824968,Alzheimer's
SORL1,Rs3824968,Alzheimer's disease
SORL1,Rs11218343,Alzheimer’s disease
SORL1,Rs3824968,Alzheimer's disease in adults with Down syndrome
SORL1,Rs3824968,late-onset Alzheimer's disease
SORL1,Rs3824968,Alzheimer's disease
SORL1,Rs3824968,cerebrovascular and neurodegenerative changes related to Alzheimer disease.
SORL1,Rs3824968,Alzheimer's disease
SORL1,Rs3824968,Alzheimer's disease
SORL1,Rs3824968,mild cognitive impairment
SORL1,Rs3824968,progression of mild cognitive impairment to dementia.
SORL1,Rs3824968,Alzheimer's disease
SORL1,Rs3824968,Risk for Late-onset Alzheimer Disease in the Chinese Population.
SORL1,Rs3824968,cerebral small-vessel disease in hypertensive patients
SORL1,Rs3824968,Alzheimer's disease 
SORL1,Rs3824968,Alzheimer's disease
SORL1,Rs3824968, Alzheimer's disease
SORT1,Rs17646665,Swedish/Scandinavian
SORT1,Rs17646665,Alzheimer's Disease
SOS1,Rs397517149,A>C
SOST,Rs387906320,Gln24Ter
SOX5,Rs10842262,non-obstructive azoospermia
SOX5,Rs1464500,schizophrenics
SOX5,Rs10842262,non-obstructive azoospermia
SPI1,Rs3740688,Alzheimer's disease polygenic hazard score
SPIB,Rs3745516,biliary cirrhosis
SPIB,Rs3745516,SNP
SPIB,Rs3745516,SPIB
SPINK5,Rs2303067,associated with susceptibility to atopic dermatitis
SPINK5,Rs2303067,rs2303067(A;A) homozygotes
SPINK5,Rs2303067,Atopic carriers of rs2303067
SPINK5,Rs2303067,rs2303067 and the development of asthma
SPINK5,Rs2303067,predisposition to asthma
SPINK5,Rs2303067,susceptibility to atopic dermatitis
SPINK5,Rs2303067,children
SPINK5,Rs2303064,atopic dermatitis
SPINK5,Rs2303067, asthma and asthma symptoms
SPINK5,Rs2303064,has been associated with susceptibility
SPINK5,Rs2303064,SPINK5 gene
SPINK5,Rs2303064,atopic dermatitis
SPINK5,Rs2303064,atopic dermatitis
SPINK5,Rs2303067,associated with predisposition to asthma
SPINK5,Rs2303067,children with a combination of asthma and atopic dermatitis 
SPTA1,Rs35948326,autosomal recessive spherocytosis
SPTLC1,Rs119482081,type 1
SPTLC1,Rs119482081,ulcers
SPTLC1,Rs119482081,"hereditary sensory neuropathy,"
SRD5A2,Rs9332964,Japenese males with micropenis.
SRD5A2,Rs9332964,homozygous rs9332964(A;A) genotype
SRD5A2,Rs9332964,micropenis.
SRD5A2,Rs9332964,Polymorphisms in SRD5A2
SRD5A2,Rs9332964,catalyzes the conversion of testosterone in the body
SRD5A2,Rs523349,ovarian cancer 
SRD5A2,Rs523349,white 
SRD5A2,Rs523349,ovarian cancer
SRD5A2,Rs523349,non-Hispanic
SRD5A2,Rs523349,epithelial ovarian cancer
SRD5A2,Rs523349,ovarian cancer
SRD5A2,Rs523349,ovarian cancer
SRD5A2,Rs523349,Caucasian 
SRD5A2,Rs523349,ovarian cancer
SRD5A2,Rs523349,invasive epithelial ovarian cancer
SRD5A2,Rs523349,ovarian cancer
SRD5A2,Rs523349,ovarian cancer
SRD5A2,Rs523349,ovarian cancer
SRD5A2,Rs523349,invasive 
SREBF1,Rs2297508,type-2 diabetes
SREBF1,Rs2297508,type-2 diabetes
SREBF1,Rs2297508,type-2 diabetes
SREBF1,Rs11868035,type 2 diabetes
SREBF1,Rs11868035,Parkinson's disease
SREBF1,Rs11868035,schizophrenia
SREBF1,Rs2297508,type-2 diabetes
SREBF1,Rs11868035,type 2 diabetes
SREBF1,Rs11868035,Parkinson's disease
SREBF1,Rs11868035,schizophrenia
SREBF1,Rs11868035,type-2 diabetes
SREBF1,Rs11868035,type-2 diabetes
SREBF1,Rs11868035,Parkinson's disease
SREBF1,Rs11868035,type-2 diabetes
SRRM2,Rs149019598,Papillary thyroid carcinoma (PTC)
SSUH2,Rs72546667,idiopathic hyper-CK-emia.
SSUH2,Rs72546667,muscular dystrophy.
SSUH2,Rs72546667,idiopathic hyper-CK-emia.
SSUH2,Rs72546667,muscular dystrophy.
SSUH2,Rs72546667,hyper-CK-emia
SSUH2,Rs72546667,associated with long-QT syndrome.
SSUH2,Rs28936685,rippling muscle disease
SSUH2,Rs72546667,muscular dystrophy
SSUH2,Rs72546668,patients with idiopathic hyper-CK-emia
SSUH2,Rs72546668,long-QT syndrome
SSUH2,Rs72546668,sudden infant death syndrome
SSUH2,Rs72546668, idiopathic hyper-CK-emia
SSUH2,Rs72546668,revalence of long-QT syndrome gene variants in sudden infant death syndrome
SSUH2,Rs72546668,sudden infant death syndrome
SSUH2,Rs72546668,Rippling muscle disease
SSUH2,Rs72546668, facioscapulohumeral dystrophy-like phenotype
SSUH2,Rs72546668, a patient carrying a heterozygous CAV3 T78M mutation and a D4Z4 partial deletion
SSUH2,Rs116840798,skeletal muscle
SSUH2,Rs72546668,"""double trouble"" overlapping syndromes"
SSUH2,Rs116840795,familial 
SSUH2,Rs72546668,long-QT syndrome
SSUH2,Rs116840795,yperCKaemia.
SSUH2,Rs116840795,mutation i
SSUH2,Rs116840776,muscular dystrophy
SSUH2,Rs116840782,muscular dystrophy
SSUH2,Rs116840782,rippling muscle
SSUH2,Rs116840782,novel caveolin-3 mutation
SSUH2,Rs116840782,muscular dystrophy genes
SSUH2,Rs116840782,rippling muscle
SSUH2,Rs116840782,large German family
SSUH2,Rs116840782,muscular dystrophy genes
SSUH2,Rs116840776,sudden infant death syndrome.
SSUH2,Rs116840785,rippling muscle disease.
SSUH2,Rs116840785,rippling muscle disease
SSUH2,Rs116840785,rippling muscle disease
SSUH2,Rs116840785,rippling muscle disease
SSUH2,Rs116840785,rippling muscle disease
SSUH2,Rs116840785,rippling muscle disease
SSUH2,Rs116840788,CAV3 
SSUH2,Rs116840788,Japanese
SSUH2,Rs116840788,CAV3 
SSUH2,Rs116840782,CAV3 mutations linked to rippling muscle.
STAG3,Rs376787666,recessively inherited mutation in the STAG3 gene
STAG3,Rs376787666,primary ovarian insufficiency
STAG3,Rs376787666,primary ovarian insufficiency
STAR,Rs193922393,Congenital adrenal hyperplasia
STAR,Rs193922393,homozygous frameshift mutation
STAR,Rs104894089,Val187Met
STAR,Rs193922393,congenital lipoid adrenal hyperplasia
STAT3,Rs7211777,carriers of the AT haplotype
STAT3,Rs7211777,breast cancer
STAT3,Rs6503695,multiple sclerosis
STAT3,Rs6503695,response of chronic myeloid leukemia to interferon alpha
STAT3,Rs6503695,nonalcoholic fatty liver disease
STAT3,Rs6503695,insulin resistance
STAT3,Rs6503695,obesity
STAT3,Rs6503695,obesity
STAT3,Rs6503695,insulin resistance
STAT3,Rs6503695,multiple sclerosis 
STAT3,Rs6503695,twins
STAT3,Rs6503695,nonalcoholic fatty liver disease
STAT3,Rs6503695,chronic myeloid leukemia
STAT3,Rs12951971,atopic dermatitis
STAT3,Rs6503695,obesity 
STAT3,Rs6503695,insulin resistance
STAT3,Rs12951971,Multi-ancestry genome-wide
STAT3,Rs6503695,obesity 
STAT3,Rs6503695,insulin resistance
STAT3,Rs6503695,male 
STAT3,Rs6503695,female 
STAT4,Rs7601754,systemic lupus erythematosus
STAT4,Rs8179673,Inflammatory Bowel Diseases
STAT4,Rs8179673,Crohn's disease
STAT4,Rs8179673,juvenile idiopathic arthritis
STAT4,Rs8179673,type 1 diabetes
STAT4,Rs8179673,lupus erythematosus
STAT4,Rs8179673,rheumatoid arthritis
STAT4,Rs7601754,systemic lupus erythematosus
STAT4,Rs8179673,Abnormal Genetic and Epigenetic Changes in Signal Transducer and Activator of Transcription 4 
STAT4,Rs7601754,alleles of IRF5
STAT4,Rs7601754,anti-dsDNA
STAT4,Rs7601754,systemic lupus erythematosus
STAT4,Rs7601754,rheumatoid arthritis
STAT4,Rs7601754, Hong Kong Chinese
STAT4,Rs7601754,systemic lupus erythematosus
STAT4,Rs7601754,Japanese population
STAT4,Rs8179673,rheumatoid arthritis in the Korean population
STAT4,Rs7601754,polymorphisms
STAT4,Rs8179673,rheumatoid arthritis susceptibility genes
STAT4,Rs7601754,systemic lupus erythematosus
STAT4,Rs8179673,early-onset type 1 diabetes
STAT4,Rs8179673, Inflammatory Bowel Diseases.
STAT4,Rs8179673,colonic Crohn's disease
STAT4,Rs8179673,juvenile idiopathic arthritis
STAT4,Rs8179673,rheumatoid arthritis
STAT4,Rs8179673,late-onset type 1 diabetes.
STAT4,Rs8179673,"early-onset type 1 diabetes,"
STAT4,Rs8179673,STAT4 polymorphism
STAT4,Rs8179673,additive effects
STAT4,Rs8179673,STAT4 for systemic lupus erythematosus
STAT4,Rs8179673,systemic lupus erythematosus
STAT4,Rs8179673,putative rheumatoid arthritis
STAT4,Rs8179673,rheumatoid arthritis
STAT4,Rs8179673,Pathogenesis of Inflammatory Bowel Diseases
STAT4,Rs8179673,colonic Crohn's disease and early disease onset
STAT4,Rs8179673,juvenile idiopathic arthritis
STAT4,Rs8179673,rheumatoid arthritis
STAT4,Rs8179673,type 1 diabetes
STAT4,Rs8179673,severe disease manifestations of systemic lupus erythematosus
STAT4,Rs7601754,systemic lupus erythematosus
STAT4,Rs7601754,evere disease manifestations of systemic lupus erythematosus.
STAT4,Rs7601754,severe disease manifestations 
STAT4,Rs11889341,polymorphisms
STAT4,Rs11889341,lupus erythematosus
STAT4,Rs11889341,lupus erythematosus
STAT4,Rs11889341,rheumatoid arthritis
STAT4,Rs10181656,IgA nephropathy
STAT4,Rs10181656,lupus nephritis
STAT4,Rs10181656,early disease 
STAT4,Rs10181656,colonic Crohn's disease
STAT4,Rs10181656,rheumatoid arthritis
STAT4,Rs10181656,systemic lupus erythematosus
STAT4,Rs10181656,rheumatoid arthritis and juvenile idiopathic arthritis
STAT4,Rs10181656, type 1 diabetes
STAT4,Rs10181656,Inflammatory Bowel Diseases
STAT4,Rs10181656,systemic lupus erythematosus
STAT4,Rs10181656,type 1 diabetes
STAT4,Rs10181656,rheumatoid arthritis
STAT4,Rs7601754,systemic lupus erythematosus
STAT4,Rs11889341,lupus erythematosus
STAT4,Rs11889341,rheumatoid arthritis
STAT4,Rs10181656,systemic lupus erythematosus (SLE
STAT4,Rs11889341,Bowel Diseases
STAT4,Rs7601754,Korean population
STAT4,Rs7601754,rheumatoid arthritis
STAT4,Rs7601754,ystemic lupus erythematosus 
STAT4,Rs7601754,lupus erythematosus
STAT4,Rs7601754,systemic lupus erythematosu
STAT4,Rs7601754,rheumatoid arthritis 
STAT4,Rs7574865,Scleroderma
STAT4,Rs11889341,juvenile idiopathic arthritis
STAT4,Rs7574865,multiple sclerosis
STAT4,Rs7574865,Crohn's disease
STAT4,Rs7574865,rheumatoid arthritis
STAT4,Rs7574865,type-1 diabetes
STAT4,Rs7574865, autoimmune disease
STAT4,Rs7574865,SLE
STAT4,Rs7574865,lupus (SLE)
STAT4,Rs7574865,rheumatoid arthritis
STAT4,Rs3821236,Systemic lupus erythematosus
STAT4,Rs7574865,ulcerative colitis
STAT5B,Rs9900213,chronic myeloid leukemia
STAT5B,Rs6503691,polymorphisms
STAT5B,Rs6503691,dilated cardiomyopathy
STAT5B,Rs6503691,chronic myeloid leukemia
STAT5B,Rs6503691,SNPs
STAT5B,Rs6503691,cervical cancer
STOX1,Rs10509305,pre-eclampsia
STOX1,Rs10509305,pregnancy-induced hypertension
SUOX,Rs773125,rheumatoid arthritis
SUOX,Rs773125,rheumatoid arthritis 
SUOX,Rs773125,SNPs 
SUOX,Rs773125,42 
SUOX,Rs773125,01 
SUOX,Rs773125,30
SUOX,Rs773125,000 
SUOX,Rs773125,rheumatoid arthritis
SUOX,Rs202085145,Sulfocysteinuria
SUOX,Rs202085145,sulfite oxidase deficiency
SUOX,Rs121908009,isolated sulfite oxidase deficiency
SUOX,Rs121908009,SULFITE OXIDASE DEFICIENCY
SUOX,Rs121908007,sulfite oxidase SUOX gene
SUOX,Rs121908007,sulfite oxidase deficiency
SUOX,Rs121908007,sulfite oxidase deficiency
SUOX,Rs121908007,sulfite oxidase deficiency
SUOX,Rs773125,rheumatoid arthritis
SURF1,Rs782316919,Leigh syndrome
SURF1,Rs28933402,Leigh syndrome
SYPL2,Rs62623713,morbid obesity
SYPL2,Rs62623713,morbidly obese
TAB2,Rs237025,type 1 diabetes
TAB2,Rs237025,rheumatoid arthritis 
TAB2,Rs237025,type 2 diabetes 
TAB2,Rs237025,Type I Diabetes 
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,juvenile idiopathic arthritis
TAB2,Rs237025,diabetic nephropathy
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,type 1 diabetes
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,juvenile idiopathic arthritis
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,genome-wide single-nucleotide polymorphisms
TAB2,Rs237025,diabetic nephropathy loci
TAB2,Rs237025,type 2 diabetes
TAB2,Rs237025,Vogt-Koyanagi-Harada (VKH) syndrome
TAB2,Rs237025,ubiquitin-like modifier 4 (SUMO4) polymorphisms
TAB2,Rs237025,I Diabetes Genetics Consortium
TAB2,Rs237025,rheumatoid arthritis 
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,psoriasis vulgaris
TAB2,Rs237025,rheumatoid arthritis 
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,juvenile idiopathic arthritis
TAB2,Rs237025,rheumatoid arthritis 
TAB2,Rs237025,diabetic nephropathy
TAB2,Rs237025,type 2 diabetes
TAB2,Rs237025,psoriasis vulgaris
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,rheumatoid arthritis
TAB2,Rs237025,Type I Diabetes
TAB2,Rs237025,type-1 diabetes
TAB2,Rs237025,type 1 diabetes 
TAB2,Rs237025,rheumatoid arthritis 
TAB2,Rs237025,nile idiopathic arthritis
TAB2,Rs237025,rheumatoid arthritis 
TAB2,Rs237025,diabetic nephropathy 
TAB2,Rs237025,type 2 diabetes
TAB2,Rs237025,psoriasis vulgaris
TAB2,Rs237025,type 2 diabetes
TAF1,Rs864321630,Pro596Ser
TAGAP,Rs1738074,rheumatoid arthritis.
TAGAP,Rs1738074,rheumatoid arthritis
TAGAP,Rs1738074,celiac disease
TAGAP,Rs1738074,celiac disease
TAGAP,Rs1738074,type 2 diabetes
TAGAP,Rs1738074,autoimmune and inflammatory diseases
TAGAP,Rs1738074,coeliac disease
TAGAP,Rs1738074,type 1 diabetes
TAP2,Rs1800454,systemic lupus erythematosus
TAP2,Rs1800454,ATP-binding cassette transporter 2 gene
TAP2,Rs1800454,systemic lupus erythematosus
TARBP1,Rs10489896,visual memory and organization
TARDBP,Rs80356717,mutations in individuals with sporadic
TARDBP,Rs80356719,amyotrophic lateral sclerosis
TARDBP,Rs80356719,TARDBP mutations in amyotrophic lateral sclerosis
TARDBP,Rs80356717,familial amyotrophic lateral sclerosis
TARDBP,Rs80356715,sporadic amyotrophic lateral sclerosis
TARDBP,Rs80356715,sporadic and familial amyotrophic lateral sclerosis
TARDBP,Rs80356715,familial and sporadic amyotrophic lateral sclerosis
TARDBP,Rs80356715,sporadic amyotrophic lateral sclerosis
TARDBP,Rs80356715,sporadic and familial amyotrophic lateral sclerosis
TARDBP,Rs80356715,familial and sporadic amyotrophic lateral sclerosis
TARDBP,Rs80356715,sporadic amyotrophic lateral sclerosis
TAS1R,Rs307377,Influences taste
TAS1R,Rs307377,tasting ability
TAS1R3,Rs307377,Influences taste
TAS1R3,Rs307377,tasting ability
TBX21,Rs11650354,26
TBX21,Rs16947078,Caucasian children
TBX21,Rs16947078,allergic asthma
TBX21,Rs2240017,heterozygotes. These heterozgotes are reported to improve better over time in response to corticosteroid treatment for asthma than the rs2240017(G;G) homozygotes.
TBX21,Rs4794067,2.15 fold higher risk
TBX21,Rs4794067,decrease the risk of lupus
TBX21,Rs4794067,intractable Graves' disease
TBX21,Rs4794067,aspirin-induced asthma
TBX21,Rs11650354,13 
TBX21,Rs4794067,risk of intractable Graves' disease
TBX21,Rs4794067,aspirin-induced asthma
TBX21,Rs11650354,homozygotes 
TBX21,Rs4794067,lupus
TBX21,Rs11650354,rs11650354
TBX21,Rs11650354,Caucasian 
TBX21,Rs11650354,TBX21 
TBX21,Rs11650354,rs16947078
TBX21,Rs11650354,increased risk for allergic asthma
TBX21,Rs11650354,Caucasian children
TBX21,Rs11650354,asthma 
TBX21,Rs11650354,asthma
TBX21,Rs11650354,rs11650354
TBX21,Rs11650354,allergic asthma
TBX21,Rs11650354,allergic asthma
TBX21,Rs11650354,allergic asthma
TBX21,Rs11650354,allergic asthma
TBXAS1,Rs4725563,myocardial infarction
TBXAS1,Rs4725563,ischemic stroke.
TBXAS1,Rs4725563,"eicosanoid genes,"
TBXAS1,Rs4725563,non-fatal myocardial infarction
TBXAS1,Rs4725563,ischemic stroke
TCF7L2,Rs7895340,polymorphism
TCF7L2,Rs7895340,polycystic ovary syndrome (PCOS)
TCF7L2,Rs7895340,glucose intolerance
TCF7L2,Rs7895340,cardiovascular disease
TCF7L2,Rs7895340,colon cancer
TCF7L2,Rs7895340,nephropathy
TCF7L2,Rs7895340,type 2 diabetes
TCF7L2,Rs7895340,type 2 diabetes
TCF7L2,Rs7895340,coronary artery disease
TCF7L2,Rs7895340,glucose intolerance
TCF7L2,Rs7895340,nephropathy
TCF7L2,Rs7895340,all-cause mortality
TCF7L2,Rs7895340,cardiovascular disease
TCF7L2,Rs7895340,single nucleotide polymorphisms
TCF7L2,Rs7895340,colon cancer
TCF7L2,Rs7895340,reduced acute insulin response
TCF7L2,Rs7895340,gene polymorphisms
TCF7L2,Rs7895340,gene polymorphism
TCF7L2,Rs7895340,type 2 diabetes
TCF7L2,Rs7895340,coronary artery disease 
TCF7L2,Rs7895340,polycystic ovary syndrome
TCF7L2,Rs7903146,Type-2 diabetes
TCF7L2,Rs7903146,type-2 diabetes
TCF7L2,Rs7903146,type-2 diabetes
TCF7L2,Rs7903146,association with type 2 diabetes
TCF7L2,Rs7903146,odds ratio of 1.25
TCF7L2,Rs7903146,increased risk of colorectal cancer
TCF7L2,Rs7895340,obese
TCF7L2,Rs7903146,each risk allele increased type-2 diabetes risk by 1.34x
TCF7L2,Rs7903146,impaired insulin secretion
TCF7L2,Rs7903146,type-2 diabetes.
TCF7L2,Rs7903146,risk for type-2 diabetes
TCF7L2,Rs7903146,associated with type-2 diabetes
TCF7L2,Rs7903146,strongly predicted future type-2 diabetes.
TCF7L2,Rs7903146,risk of Type-2 diabetes
TCF7L2,Rs7903146,type 2 diabetes
TCF7L2,Rs7903146,type 2 diabetes
TCF7L2,Rs7903146,colorectal cancer
TCF7L2,Rs7903146,type-2 diabetes
TCF7L2,Rs7903146,type-2 diabetes
TCF7L2,Rs7903146,type-2 diabetes
TCF7L2,Rs7903146,type-2 diabetes
TCF7L2,Rs7903146,type-2 diabetes
TCF7L2,Rs7903146,diabetes
TCF7L2,Rs7903146,type-2 diabetes
TCF7L2,Rs7903146,type-2 diabetes
TCF7L2,Rs7895340,impairment of glucose metabolism
TCF7L2,Rs290487,type 2 diabetes
TCF7L2,Rs7895340,type 2 diabetes
TCF7L2,Rs290481,TCF7L2
TCF7L2,Rs290481,polycystic ovary syndrome (PCOS)
TCF7L2,Rs290481,late-onset Alzheimer disease
TCF7L2,Rs290481,Pleiotropic effects of TCF7L2 gene variants and its modulation in the metabolic syndrome: from the LIPGENE study
TCF7L2,Rs290481,A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease.
TCF7L2,Rs290481,metabolic syndrome
TCF7L2,Rs290481,women
TCF7L2,Rs290481,glucose intolerance
TCF7L2,Rs290481,polycystic ovary syndrome
TCF7L2,Rs290481,PCOS
TCF7L2,Rs290481,Alzheimer disease
TCF7L2,Rs290481,Alzheimer 
TCF7L2,Rs290481,Pleiotropic 
TCF7L2,Rs290481,metabolic syndrome
TCF7L2,Rs290481,glucose intolerance
TCF7L2,Rs290481,polycystic ovary syndrome
TCF7L2,Rs290481,late-onset Alzheimer disease
TCF7L2,Rs11196205,associated with type-2 diabetes
TCF7L2,Rs11196205,type-2 diabetes
TCF7L2,Rs10885406,type-2 diabetes
TCF7L2,Rs290481,disease
TCF7L2,Rs290481,TCF7L2
TCF7L2,Rs290481,metabolic syndrome
TCF7L2,Rs290487,type 2 diabetes
TCF7L2,Rs4506565,type-2 diabetes
TCF7L2,Rs4506565, type-2 diabetes
TCF7L2,Rs4506565,type-2 diabetes.
TCF7L2,Rs4506565,"equal power to estimate risk for type-2 diabetes,"
TCF7L2,Rs4506565,associated with type-2 diabetes
TCF7L2,Rs4506565,associated with type-2 diabetes
TCF7L2,Rs3814570,rs3814570
TCF7L2,Rs3814570,TCF7L2 gene
TCF7L2,Rs3814570,"transcription factor 7-like 2 (T-cell specific, HMG-box)"
TCF7L2,Rs3814570,SNP
TCF7L2,Rs3814570,rs3814570
TCF7L2,Rs3814570,PCOS
TCF7L2,Rs3814570,glucose intolerance in women
TCF7L2,Rs3814570,polycystic ovary syndrome (PCOS)
TCF7L2,Rs3814570,ulcerative colitis
TCF7L2,Rs3814570,colonic Crohn's disease
TCF7L2,Rs3814570,Crohn's disease
TCF7L2,Rs7903146,1.97-fold (CI:1.37 - 2.82) increased odds for type 2 diabetes 
TCF7L2,Rs290487,type 2 diabetes
TCF7L2,Rs290487,type 2 diabetes
TCF7L2,Rs290487,susceptibility to type 2 diabetes
TCF7L2,Rs7895340,gene polymorphisms
TCHH,Rs11803731,facial and scalp hair features
TCHH,Rs11803731,hair curliness
TCHH,Rs11803731,variance in hair morphology
TCN1,Rs526934, lower plasma vitamin B12 levels
TCN1,Rs526934,educe transport of cobalamin
TDP2,Rs3212236,allele 
TDP2,Rs9461045,dyslexia
TDP2,Rs9461045,dyslexia A
TDP2,Rs3212236,dyslexia 
TDP2,Rs3212236,study 
TDP2,Rs3212236,dyslexia 
TDP2,Rs3212236,300
TDP2,Rs3212236,02
TDP2,Rs3212236,developmental dyslexia
TDP2,Rs3212236,developmental dyslexia
TDP2,Rs2143340,dyslexia
TDP2,Rs2143340,dyslexic
TDP2,Rs2143340,dyslexia
TDP2,Rs2143340,poor reading performance
TDP2,Rs3212236,rs3212236 
TECTA,Rs28939690,deafness
TECTA,Rs28939690,deafness
TECTA,Rs28939691,deafness
TECTA,Rs28939691,deafness
TEK,Rs80338909,venous malformations.
TEK,Rs80338909,Multiple cutaneous and mucosal venous malformations
TEK,Rs80338909,cutaneous and mucosal venous malformations.
TEK,Rs80338909,inherited venous malformations
TEK,Rs80338908,Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2
TEK,Rs80338909,Multiple cutaneous and mucosal venous malformations
TEK,Rs80338908,cutaneous and mucosal venous malformations
TEK,Rs80338908,venous malformations
TEK,Rs80338908,Vascular dysmorphogenesis
TEK,Rs80338908,cutaneous and mucosal venous malformations
TEK,Rs80338908,venous malformations
TEK,Rs80338908,Vascular dysmorphogenesis
TEK,Rs80338908,Multiple cutaneous and mucosal venous malformations
TEK,Rs387906745,Multiple cutaneous and mucosal venous malformations.
TEK,Rs80338908,mutant Tie-2 causing venous malformations signals
TENM2,Rs2937573,Sensitivity to the Sound of Chewing (Misophonia)
TENM2,Rs2937573,Misophonia
TENM2,Rs2937573,Sensitivity to the Sound of Chewing
TENM2,Rs2937573,Misophonia
TERC,Rs12696304,some forms of cancer
TERC,Rs12696304,cancer
TERC,Rs12696304,heart disease
TERC,Rs12696304,ancer
TERC,Rs12696304,heart disease
TERC,Rs12696304,premature aging
TERC,Rs12696304,mean leukocyte telomere
TERC,Rs12696304,reduced longevity
TERC,Rs12696304,heart disease
TERC,Rs12696304,European 
TERC,Rs12696304,age-associated diseases
TERT,Rs2736100,lung cancer
TERT,Rs2736100,serous ovarian cancer
TERT,Rs2736100,lung adenocarcinoma
TERT,Rs2736100,glioma
TERT,Rs2736100,bladder cancer risk
TERT,Rs2736100, lung cancer
TERT,Rs2736100,cervical cancer
TERT,Rs2736100,ovarian cancer risk
TERT,Rs2736100,lung adenocarcinoma
TERT,Rs2736100,cancer
TERT,Rs2736100,cancer
TERT,Rs2736100,lung cancer
TERT,Rs2736100,glioma
TERT,Rs2736100,high-grade glioma
TERT,Rs2736098,cancers
TERT,Rs2736100,Lung cancer susceptibility
TERT,Rs2736098,pancreatic cancer
TERT,Rs2736098,European
TERT,Rs2736098,Asians
TERT,Rs2736098,Pancreatic cancer
TERT,Rs2736098,Asians 
TERT,Rs2736098,pancreatic cancer
TERT,Rs2736098,protective effect
TERT,Rs2736098,pancreatic cancer
TERT,Rs2736098,Pancreatic cancer
TERT,Rs2736100,risk of lung adenocarcinoma
TERT,Rs2736100,Glioma
TERT,Rs2736098,Europeans
TF,Rs1049296,it may reduce the effectiveness of some bacterial transferrin binding proteins
TF,Rs1799899,iron deficiency anemia
TF,Rs1799899,anemia in menstruating white women.
TF,Rs1799899,iron deficiency anemia
TF,Rs1799852,deficiency anaemia risk
TF,Rs1049296,Pathogens may scavenge iron
TF,Rs1049296,Alzheimer's disease
TF,Rs1049296,"rs1049296(T), was associated with slightly increased risk"
TF,Rs1049296,Alzheimer's disease
TF,Rs1049296,have been linked at times to various conditions
TF,Rs1049296,is best known as the basis for the C1/C2 subtypes of the transferrin TF gene
TF,Rs1049296,Alzheimer's
TF,Rs1799899,anemia
TF,Rs1049296,Alzheimer's
TF,Rs1799899,lower total iron binding capacity
TFAM,Rs1937,late-onset Alzheimer's disease
TFR2,Rs80338881,Juvenile hemochromatosis
TFR2,Rs80338891,severe iron overload
TFR2,Rs80338891,Hemochromatosis
TFR2,Rs80338886,transferrin receptor 2 gene
TFR2,Rs80338886,hemochromatosis
TFR2,Rs80338886,mutations
TFR2,Rs80338881,hemochromatosis genes
TFR2,Rs80338881,pathogenic mutations
TFR2,Rs80338881,adult hemochromatosis
TFR2,Rs80338881,Juvenile hemochromatosis
TFR2,Rs80338881,pathogenic mutations of adult hemochromatosis
TFR2,Rs80338881,Juvenile hemochromatosis
TFR2,Rs80338881,pathogenic mutations of adult hemochromatosis genes
TFR2,Rs80338881,hemochromatosis
TG,Rs142698837,dyshormonogenesis
TG,Rs142698837,OMIM 
TG,Rs142698837,significance
TG,Rs142698837,229G
TG,Rs142698837,G77SClinVar 
TG,Rs142698837,Gly77Ser
TG,Rs142698837,uncertain
TGFB1,Rs1800469,women
TGFB1,Rs4803455,high myopia
TGFB1,Rs4803455,high myopia
TGFB1,Rs1800469,breast cancer
TGFB1,Rs1800469,COPD
TGFB1,Rs1800469,smoking is the main risk factor
TGFB1,Rs1800469,chronic obstructive pulmonary disease (COPD)
TGFB1,Rs1800469,poor cosmetic
TGFB1,Rs1800469,COPD
TGFB1,Rs1800469,breast cancer
TGFB1,Rs1800469,women
TGFB1,Rs1800469,Caucasian
TGFB1,Rs1800469,smokers
TGFB1,Rs1800469,smoking
TGFB1,Rs1800469,chronic obstructive pulmonary disease (COPD)
TGFB1,Rs1800469,radiation-induced fibrosis (scarring)
TGFB2,Rs863223797,healthy young adult who died suddenly.
TGFB3,Rs4252338,No association between 3 polymorphisms of transforming growth factor beta3 gene and essential hypertension in Chinese.
TGFB3,Rs4252338,essential hypertension
TGFBR1,Rs7871490,"appears relevant to colon cancer rs334348, rs334349 and rs1590 (in total linkage disequilibrium with each other) and a fourth marker, rs7871490"
TGFBR1,Rs334349,"appears relevant to colon cancer rs334348, rs334349 and rs1590 (in total linkage disequilibrium with each other) and a fourth marker, rs7871490"
TGFBR1,Rs1590,"appears relevant to colon cancer rs334348, rs334349 and rs1590 (in total linkage disequilibrium with each other) and a fourth marker, rs7871490"
TGFBR1,Rs334348,"appears relevant to colon cancer rs334348, rs334349 and rs1590 (in total linkage disequilibrium with each other) and a fourth marker, rs7871490"
TH,Rs6356,risk of essential hypertension in the Northern Chinese Han population
TH,Rs6578993,Genetic determinants of target and novelty-related event-related potentials in the auditory oddball respons
TH,Rs6356,"associations with schizophrenia, affective disorders, and alcoholism"
TH,Rs6356,Financial and psychological risk attitudes
TH,Rs6356,cardiovascular risk
TH,Rs6356,adolescents
TH,Rs6356,schizophrenia
TH,Rs6356,schizophrenia
TH,Rs6356,Dopaminergic pathway gene polymorphisms
TH,Rs6356,Type I Diabetes
TH,Rs6356,type I diabetes
TH,Rs6356,essential hypertension
TH,Rs6356,cardiovascular risk
TH,Rs3842727,suicidal behavior
TH,Rs6356,single nucleotide polymorphisms
TH,Rs2070762,repressor
TH,Rs10840491,schizophrenia
TH,Rs10840491,lack of association
TH,Rs10840491,polymorphism
TH,Rs2070762,transcriptional 
TH,Rs10840491,schizophrenia.
TH,Rs10840491,Tyrosine hydroxylase
TH,Rs10840491,polymorphism
TH,Rs10840491,schizophrenia
TH,Rs10840491,Tyrosine hydroxylase
TH,Rs10840491,polymorphism
TH,Rs10840491,schizophrenia
TH,Rs2070762,allele 
TH,Rs2070762,enhancer 
TH,Rs10840491,schizophrenia
THSD1,Rs371717283,potentially strongly associated
THSD1,Rs9536062,minor homozygotes
THSD1,Rs9536062,non-immune hydrops fetalis
THSD1,Rs776400380,potentially strongly associated
THSD1,Rs776400380,intracranial Aneurysm.
THSD1,Rs776400380,heterozygotes
THSD1,Rs776400380,chromosome 13.
THSD1,Rs776400380,gene
THSD1,Rs371717283,intracranial Aneurysm.
THSD1,Rs776400380,rare variant
THSD1,Rs371717283,chromosome 13.
THSD1,Rs371717283,gene
THSD1,Rs371717283,rare variant
THSD1,Rs201805081,potentially strongly associated
THSD1,Rs201805081,intracranial Aneurysm.
THSD1,Rs201805081,heterozygotes
THSD1,Rs201805081,chromosome 13.
THSD1,Rs201805081,gene
THSD1,Rs201805081,rare variant
THSD1,Rs371717283,heterozygotes
TIMP2,Rs8179090,thoracic adolescent idiopathic scoliosis
TIMP2,Rs8179090,Polymorphisms 
TIMP2,Rs8179090,polymorphism 
TIMP2,Rs8179090,breast cancer
TIMP2,Rs8179090,thoracic adolescent idiopathic scoliosis
TIMP2,Rs8179090,Polymorphisms
TIMP2,Rs8179090,thoracic adolescent idiopathic scoliosis.
TIMP2,Rs8179090,polymorphism
TIMP2,Rs8179090, breast cancer
TIMP2,Rs8179090,breast cancer
TIPARP,Rs7651446,epithelial ovarian cancer
TIPARP,Rs7651446,epithelial ovarian cancer
TIPARP,Rs2665390,serous 
TIPARP,Rs2665390,allele
TIPARP,Rs2665390,cancer 
TIPARP,Rs2665390,genome
TIPARP,Rs2665390,subtype 
TIPARP,Rs2665390,polymerase 
TIPARP,Rs2665390,chromosomal 
TIPARP,Rs2665390,SNP
TIPARP,Rs2665390,ovarian cancer
TIPARP,Rs2665390,ovarian cancer
TIPARP,Rs2665390,gene
TK2,Rs886039669,inherited condition
TK2,Rs281865499,syndrome
TK2,Rs281865499,myopathic form
TK2,Rs281865499,inherited condition
TK2,Rs281865500,mitochondrial
TK2,Rs281865500,inherited condition
TK2,Rs281865500,myopathic form
TK2,Rs281865501,mitochondrial
TK2,Rs281865501,syndrome
TK2,Rs281865501,myopathic form
TK2,Rs281865498,inherited condition
TK2,Rs281865500,syndrome
TK2,Rs281865498,myopathic form
TK2,Rs281865501,inherited condition
TK2,Rs281865498,mitochondrial
TK2,Rs281865497,inherited condition
TK2,Rs281865497,myopathic form
TK2,Rs281865497,syndrome
TK2,Rs281865497,mitochondrial
TK2,Rs281865496,inherited condition
TK2,Rs281865496,myopathic form
TK2,Rs281865496,syndrome
TK2,Rs281865496,mitochondrial
TK2,Rs281865495,inherited condition
TK2,Rs281865495,myopathic form
TK2,Rs281865495,syndrome
TK2,Rs281865495,mitochondrial
TK2,Rs281865498,syndrome
TK2,Rs281865502,mitochondrial
TK2,Rs281865494,inherited condition
TK2,Rs281865502,myopathic form
TK2,Rs886039669,myopathic form
TK2,Rs886039669,syndrome
TK2,Rs886039669,mitochondrial
TK2,Rs863224235,inherited condition
TK2,Rs863224235,myopathic form
TK2,Rs863224235,syndrome
TK2,Rs863224235,mitochondrial
TK2,Rs281865507,inherited condition
TK2,Rs281865507,myopathic form
TK2,Rs281865507,syndrome
TK2,Rs281865507,mitochondrial
TK2,Rs281865506,inherited condition
TK2,Rs281865506,myopathic form
TK2,Rs281865502,syndrome
TK2,Rs281865506,syndrome
TK2,Rs281865505,inherited condition
TK2,Rs281865505,myopathic form
TK2,Rs281865505,syndrome
TK2,Rs281865505,mitochondrial
TK2,Rs281865504,inherited condition
TK2,Rs281865504,myopathic form
TK2,Rs281865504,syndrome
TK2,Rs281865504,mitochondrial
TK2,Rs281865503,inherited condition
TK2,Rs281865503,myopathic form
TK2,Rs281865503,syndrome
TK2,Rs281865503,mitochondrial
TK2,Rs281865502,inherited condition
TK2,Rs281865506,mitochondrial
TK2,Rs281865494,myopathic form
TK2,Rs281865499,mitochondrial
TK2,Rs281865494,mitochondrial
TK2,Rs142291440,inherited condition
TK2,Rs142291440,myopathic form
TK2,Rs142291440,syndrome
TK2,Rs142291440,mitochondrial
TK2,Rs138439950,inherited condition
TK2,Rs138439950,myopathic form
TK2,Rs138439950,syndrome
TK2,Rs138439950,mitochondrial
TK2,Rs137886900,inherited condition
TK2,Rs137886900,myopathic form
TK2,Rs137886900,syndrome
TK2,Rs137886900,mitochondrial
TK2,Rs137854432,inherited condition
TK2,Rs281865486,mitochondrial
TK2,Rs137854432,myopathic form
TK2,Rs137854432,mitochondrial
TK2,Rs137854431,inherited condition
TK2,Rs137854431,myopathic form
TK2,Rs137854431,syndrome
TK2,Rs137854431,mitochondrial
TK2,Rs137854430,inherited condition
TK2,Rs137854430,myopathic form
TK2,Rs137854430,syndrome
TK2,Rs137854430,mitochondrial
TK2,Rs137854429,inherited condition
TK2,Rs137854429,myopathic form
TK2,Rs137854429,mitochondrial
TK2,Rs281865494,syndrome
TK2,Rs137854432,syndrome
TK2,Rs281865486,syndrome
TK2,Rs137854429,syndrome
TK2,Rs281865486,inherited condition
TK2,Rs281865493,inherited condition
TK2,Rs281865493,myopathic form
TK2,Rs281865493,syndrome
TK2,Rs281865493,mitochondrial
TK2,Rs281865492,inherited condition
TK2,Rs281865492,myopathic form
TK2,Rs281865492,syndrome
TK2,Rs281865492,mitochondrial
TK2,Rs281865486,myopathic form
TK2,Rs281865491,myopathic form
TK2,Rs281865491,syndrome
TK2,Rs281865491,mitochondrial
TK2,Rs281865490,inherited condition
TK2,Rs281865490,myopathic form
TK2,Rs281865491,inherited condition
TK2,Rs281865490,mitochondrial
TK2,Rs281865487,mitochondrial
TK2,Rs281865490,syndrome
TK2,Rs281865487,myopathic form
TK2,Rs281865487,inherited condition
TK2,Rs281865488,mitochondrial
TK2,Rs281865488,syndrome
TK2,Rs281865487,syndrome
TK2,Rs281865488,inherited condition
TK2,Rs281865489,mitochondrial
TK2,Rs281865489,syndrome
TK2,Rs281865489,myopathic form
TK2,Rs281865489,inherited condition
TK2,Rs281865488,myopathic form
TLR1,Rs5743592,Genetic variation and haplotype structures of innate immunity genes
TLR1,Rs5743592,eastern India
TLR1,Rs5743551, sepsis-related
TLR1,Rs5743551,gram-positive infection in sepsis
TLR2,Rs3804100, diabetes 
TLR2,Rs3804100,allergic asthma
TLR2,Rs3804100,Asthma
TLR2,Rs3804100,type-1 diabetes
TLR2,Rs3804100,allergic asthma
TLR3,Rs5743305,Toll-like receptor signaling pathway
TLR3,Rs5743305,polymorphisms
TLR3,Rs5743305,cancer risk
TLR3,Rs5743305,Toll-like receptor signaling pathway
TLR3,Rs5743305,prostate cancer
TLR3,Rs1879026,measles vaccine
TLR4,Rs11536889,developing neutropenia in children with leukemia
TLR4,Rs1554973,chorionic plate inflammation
TLR4,Rs1554973,pregnant women
TLR4,Rs1554973, cervical 
TLR4,Rs1554973,neonatal sepsis
TLR4,Rs1554973,infection
TLR4,Rs1554973,polymorphic
TLR4,Rs1554973, prostate cancer risk
TLR4,Rs1554973,Traffic-related air pollution
TLR4,Rs1554973, asthma 
TLR4,Rs1554973,rheumatoid arthritis
TLR4,Rs1554973, polymorphisms
TLR4,Rs1554973,nflammation
TLR4,Rs1554973,fetal
TLR4,Rs1554973,chorionic plate inflammation 
TLR4,Rs1554973,women
TLR4,Rs1554973,SNP 
TLR4,Rs11536889,prostate cancer in Korean men
TLR4,Rs1554973,rheumatoid arthritis
TLR4,Rs1554973,oxidative stress
TLR4,Rs1554973,Traffic-related air pollution
TLR4,Rs1554973,asthma
TLR4,Rs11536889,hepatitis B virus recurrence after liver transplantation
TLR4,Rs1927911,hypertensive men/women
TLR4,Rs1927911,postmenopausal women
TLR4,Rs1927911,nonfatal myocardial infarction
TLR4,Rs1927911,hypertensive men/women
TLR4,Rs1927911,postmenopausal women
TLR4,Rs1927911,nonfatal myocardial infarction
TLR4,Rs1927911,hypertensive men/women
TLR4,Rs1554973,oxidative stress genes
TLR4,Rs1927911,postmenopausal women
TLR4,Rs1554973,neonatal sepsis. 
TLR4,Rs1554973,prostate cancer
TLR4,Rs1554973,asthma
TLR4,Rs1554973,No evidence of major effects in several Toll-like receptor gene polymorphisms in rheumatoid arthritis.
TLR4,Rs1554973,rs1554973 was associated with increased risk when present in the fetal genome.
TLR4,Rs1554973,chorionic plate inflammation
TLR4,Rs1554973,infection in neonatal sepsis
TLR4,Rs1554973,prostate cancer risk
TLR4,Rs1927911,nonfatal myocardial infarction
TLR4,Rs11536889,severe gastric atrophy in Japanese
TLR4,Rs1554973,pregnant
TLR4,Rs11536889,"Traffic-related air pollution, oxidative stress genes, and asthma"
TLR4,Rs11536889,ischemic stroke
TLR4,Rs11536889,myocardial infarction
TLR4,Rs11536889,prostate cancer
TLR4,Rs11536889,leukemia
TLR4,Rs11536889,hepatitis B
TLR4,Rs11536889,severe gastric atrophy
TLR4,Rs11536889,prostate cancer
TLR4,Rs11536889,asthma
TLR4,Rs11536889,autoimmune pancreatitis
TLR4,Rs11536889,liver fibrosis
TLR4,Rs11536889,autoimmune pancreatitis
TLR4,Rs11536889,chemic stroke
TLR4,Rs11536889,myocardial infarction
TLR4,Rs11536889,prostate cancer
TLR4,Rs11536889,leukemia
TLR4,Rs10759932,clinically significant inflammation
TLR4,Rs10759932,mother's genome
TLR4,Rs10759932,chorionic plate inflammation
TLR4,Rs11536889,prostate cancer
TLR4,Rs11536889,prostate cancer
TLR4,Rs11536889,chronic hepatitis C
TLR4,Rs11536889,chronic hepatitis 
TLR4,Rs11536889,liver fibrosis
TLR4,Rs11536889,sarcoidosis-related uveitis in Japan
TLR4,Rs11536889,liver fibrosis in Caucasians with chronic hepatitis C infection
TLR4,Rs11536889,prostate cancer mortality
TLR4,Rs11536889,autoimmune pancreatitis
TLR4,Rs11536889,nonfatal myocardial infarction 
TLR4,Rs11536889,ischemic stroke
TLR4,Rs11536889,eastern India
TLR4,Rs11536889,children 
TLR4,Rs11536889,prostate cancer risk
TLR4,Rs11536889,prostate cancer
TLR4,Rs11536889,leukemia
TLR4,Rs11536889,neutropenia
TLR4,Rs11536889,hepatitis B
TLR4,Rs11536889,gastric atrophy
TLR4,Rs11536889,prostate cancer risk
TLR4,Rs11536889,asthma
TLR4,Rs11536889,oxidative stress genes
TLR4,Rs11536889,pertussis 
TLR6,Rs5743809,Kawasaki disease
TLR6,Rs5743815,associated with risk for developing Non-Hodgkin Lymphoma
TLR6,Rs5743815,V427A
TLR6,Rs5743815,risk for developing Non-Hodgkin Lymphoma
TLR6,Rs5743815,Non-Hodgkin Lymphoma
TLR6,Rs5743815,TLR6 gene
TLR6,Rs35220466,"rs35220466, also known as p.Arg247Lys, represents an infrequent variant in the TLR6 gene."
TLR6,Rs5743809,causative
TLR6,Rs35220466,"causative, when inherited recessively (or as a compound heterozygote), for Kawasaki disease."
TLR6,Rs35220466,infrequent variant in the TLR6 gene
TLR6,Rs35220466,"It is reported as likely to be causative, when inherited recessively (or as a compound heterozygote), for Kawasaki disease."
TLR6,Rs5743809,Kawasaki disease
TMC1,Rs1796993,autosomal recessive hearing impairment.
TMC1,Rs1796993,TMC1 gene 
TMC1,Rs1796993,Pakistani families
TMC1,Rs1796993,recessive hearing impairment.
TMEM43,Rs113449357,cardiomyopathy
TMEM43,Rs113449357,cardiomyopathy
TMEM43,Rs63750743,"Carrying a single rs63750743(T) allele is reported to lead, sooner or later, to arrhythmogenic right ventricular dysplasia type 5"
TMIE,Rs28942097,deafness
TMIE,Rs28942097,deafness
TMIE,Rs28942096,deafness
TMIE,Rs28941781,deafness
TMIE,Rs28941781,deafness
TMIE,Rs28942096,deafness
TMPRSS3,Rs28939084,deafness
TMPRSS3,Rs28939084,deafness
TMPRSS6,Rs5756506,serum ferritin levels
TMPRSS6,Rs5756506,HFE hereditary haemochromatosis
TMPRSS6,Rs5756506,A novel association between a SNP in CYBRD1 and serum ferritin levels in a cohort study of HFE hereditary haemochromatosis.
TNF,Rs3093664,allergy
TNF,Rs3093665,tumor necrosis factor
TNF,Rs3093665,traffic-related air pollution
TNF,Rs3093665,development of childhood allergic disease
TNF,Rs3093665,genetic susceptibility to childhood allergy
TNF,Rs3093665,asthma
TNF,Rs3093665,African American urban population
TNF,Rs3093665,population of South Croatia
TNF,Rs3093668,Adipokine genes and prostate cancer risk
TNF,Rs3093665,lymphotoxin-alpha tag polymorphisms
TNF,Rs3093665,prostate cancer mortality
TNF,Rs3093664,prostate cancer
TNF,Rs3093668,Evaluation of genetic susceptibility to childhood allergy and asthma in an African American urban population.
TNF,Rs3093668,Adipokine genes
TNF,Rs3093668,prostate cancer risk
TNF,Rs3093668,childhood allerg
TNF,Rs3093668,asthma
TNF,Rs3093668,African American urban
TNF,Rs3093665,tumor necrosis factor 
TNF,Rs3093664,rheumatoid arthritis
TNF,Rs3093664,asthma
TNF,Rs3093664,polymorphisms
TNF,Rs1799964,mortality
TNF,Rs3093664, type 1 diabetes
TNF,Rs1799964,Graves' disease
TNF,Rs1799964, disease
TNF,Rs1800630, Raynaud's phenomenon
TNF,Rs1800630,systemic lupus erythematosus (SLE)
TNF,Rs1800630,SLE 
TNF,Rs1800630,SLE
TNF,Rs1800750, recurrent acute otitis
TNF,Rs1799964,"~10,000 individuals"
TNF,Rs3093662,d severe malaria in African populations. Association of MICA with rheumatoid arthritis independent of known HLA-DRB1 risk alleles in a family-based and a case control study. Toll-lik
TNF,Rs3093662,morphisms and female reproductive disorders: part II--endometriosis. Distinct genetic loci control plasma HIV-RNA and cellula
TNF,Rs3093664,tumor necrosis factor
TNF,Rs3093664,female reproductive disorders
TNF,Rs3093664,polymorphisms
TNF,Rs3093664,lymphotoxin-alpha
TNF,Rs3093664,traffic-related air pollution
TNF,Rs3093664,tumor necrosis factor
TNF,Rs3093662,ict rheumatoid arthritis using random forests. Leprosy and the adaptation of human toll-like receptor 1. Evaluatio
TNF,Rs3093664,allergic disease
TNFAIP3,Rs582757,systemic lupus erythematosus
TNFAIP3,Rs5029939,Systemic lupus erythematosus
TNFAIP3,Rs5029939,lupus 
TNFAIP3,Rs582757,tumor
TNFAIP3,Rs582757,psoriasis
TNFAIP3,Rs582757,autoimmune diseases
TNFAIP3,Rs582757,rheumatoid arthritis
TNFAIP3,Rs582757,"characterized by skin lesions, which are raised, often red and scaly"
TNFAIP3,Rs582757,systemic sclerosis
TNFAIP3,Rs582757,variants of psoriasis
TNFAIP3,Rs582757,associated with multiple autoimmune diseases
TNFAIP3,Rs582757,candidate causal variants of psoriasis
TNFAIP3,Rs582757,associated with multiple autoimmune diseases
TNFAIP3,Rs2230926,Sjogren's Syndrome-associated Non-Hodgkin Lymphoma
TNFAIP3,Rs582757,celiac disease
TNFAIP3,Rs2230926,systemic lupus erythematosus (SLE)
TNFAIP3,Rs582757,"characterized by skin lesions, which are raised, often red and scaly"
TNFAIP3,Rs2230926,rheumatoid arthritis
TNFAIP3,Rs2230926,Systemic lupus erythematosus (SLE)
TNFAIP3,Rs2230926,rheumatoid arthritis
TNFAIP3,Rs2230926,Systemic lupus erythematosus (SLE)
TNFAIP3,Rs2230926,systemic lupus erythematosus (SLE)
TNFAIP3,Rs2230926,Sjogren's Syndrome
TNFAIP3,Rs2230926,Non-Hodgkin Lymphoma
TNFAIP3,Rs2230926,systemic lupus erythematosus
TNFAIP3,Rs2230926, Synd
TNFAIP3,Rs2230926,psoriasis
TNFAIP3,Rs2230926,lupus nephritis
TNFAIP3,Rs2230926,hematologic manifestations
TNFAIP3,Rs2230926,autoimmune rheumatic conditions
TNFAIP3,Rs2230926,systemic lupus erythematosus
TNFAIP3,Rs2230926,autoimmune diseases
TNFAIP3,Rs2230926,psoriasis
TNFAIP3,Rs2230926,Sjögren's syndrome
TNFRSF1A,Rs4149570,non-small cell lung cancer
TNFRSF1A,Rs4149570,Japanese patients
TNFRSF1A,Rs4149570,Crohn's disease
TNFRSF1A,Rs4149570,rheumatoid arthritis
TNFRSF1A,Rs4149570,apoptosis
TNFRSF1A,Rs4149570,early-stage non-small-cell lung cance
TNFRSF1A,Rs4149570, inflammation
TNFRSF1A,Rs4149577,ankylosing spondylitis
TNFRSF1A,Rs4149584,s f
TNFRSF1A,Rs4149579,tumor necrosis
TNFRSF1A,Rs4149579,tumor necrosis
TNFRSF1A,Rs4149579,tumor necrosis factor
TNFRSF1A,Rs4149584, two SN
TNFRSF1A,Rs4149584,odds
TNFRSF1A,Rs4149584,"gene that each (independently) increase risk for multiple sclerosis,"
TNFRSF1A,Rs4149570,tumour
TNFRSF1A,Rs4149577,Association of STAT3 and TNFRSF1A with ankylosing spondylitis
TNFRSF1A,Rs4149570,immune regulator genes of hay-fever 
TNFRSF1A,Rs1800693,10
TNFRSF1A,Rs1800693,SNP 
TNFRSF1A,Rs104895217,dominantly inherited autoinflammatory syndromes
TNFRSF1A,Rs1800693,rs1800693 
TNFRSF1A,Rs1800693,SNP 
TNFRSF1A,Rs1800693,TNFRSF1A 
TNFRSF1A,Rs1800693,000
TNFRSF1A,Rs1800693,sclerosis
TNFRSF1A,Rs1800693,TNFRSF1A 
TNFRSF1A,Rs1800693,rs1800693 
TNFRSF1A,Rs1800693,SNPs 
TNFRSF1A,Rs1800693,SNP
TNFRSF1A,Rs1800693,rs1800693
TNFRSF1A,Rs1800693,2 
TNFRSF1A,Rs1800693,31
TNFRSF1A,Rs1800693,6x10
TNFRSF1A,Rs1800693,gene 
TNFRSF1A,Rs1800693,rs4149584
TNFSF15,Rs6478109,associated with spondyloarthritis
TNFSF15,Rs6478109,Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFalpha
TNFSF15,Rs6478109,"Comprehensive linkage and association analyses identify haplotype, near to the TNFSF15 gene, significantly associated with spondyloarthritis."
TNFSF15,Rs6478109,TNFSF15 is an ethnic-specific IBD gene. IBD-associated TL1A gene (TNFSF15) haplotypes determine increased expression of TL1A protein.
TNFSF15,Rs6478109,rritable bowel syndrome
TNFSF15,Rs6478109,irritable bowel syndrome
TNFSF15,Rs6478109,Strategies and issues in the detection of pathway enrichment in genome-wide association studies.
TNFSF15,Rs6478108,Asians
TNFSF15,Rs6478108,irritable bowel syndrome
TNFSF15,Rs6478108,inflammatory bowel disease
TNFSF15,Rs6478108,pediatric-onset inflammatory bowel disease
TNFSF15,Rs6478108,spondyloarthritis
TNFSF15,Rs6478108,leprosy
TNFSF15,Rs6478108,Korean
TNFSF15,Rs6478108,Crohn's disease
TNMD,Rs1155974,plasma glucose levels
TNMD,Rs1155974,T2D
TNNI3,Rs267607127, familial hypertrophic cardiomyopathy
TNNI3,Rs267607127,allele
TNNI3,Rs267607127,chromosome 19
TNNI3,Rs267607127,rare mutation
TNNI3,Rs267607127,G>A
TNNI3,Rs267607127,mutation 
TNNI3,Rs267607127,cardiomyopathy
TNNI3,Rs267607127,hypertrophic 
TNNI3,Rs121917761,chromosome 19
TNNI3,Rs104894730,type 1
TNNI3,Rs121917761,G>A
TNNI3,Rs121917761,familial restrictive cardiomyopathy
TNNI3,Rs267607127,familial hypertrophic cardiomyopathy
TNNI3,Rs104894730,cardiomyopathy
TNNI3,Rs104894730,single copy
TNNI3,Rs104894730,chromosome 19
TNNI3,Rs104894730,rare mutation
TNNI3,Rs104894729,familial hypertrophic cardiomyopathy (HCM)
TNNI3,Rs104894729,"familial restrictive cardiomyopathy, type 1"
TNNI3,Rs121917761,rare mutation
TNNI3,Rs267607127,mutation
TNNI3,Rs267607127, G203S
TNNI3,Rs267607127,c.607G>A
TNNI3,Rs104894729,familial hypertrophic cardiomyopathy (HCM)
TNNI3,Rs397516347,sudden cardiac death
TNNI3,Rs397516347,HCM
TNNI3,Rs397516347,hypertrophic cardiomyopathy
TNNI3,Rs397516347,sudden cardiac death patient
TNNI3,Rs397516347,familial hypertrophic cardiomyopathy
TNNI3,Rs397516347,pathogenic/likely pathogenic
TNNI3,Rs397516347,familial hypertrophic cardiomyopathy
TNNI3,Rs267607129,"dilated cardiomyopathy, type 1FF"
TNNI3,Rs267607129,is reported to lead to
TNNI3,Rs267607129,represents a rare mutation in the TNNI3 gene on chromosome 19.A
TNNI3,Rs267607127,23andMe
TNNI3,Rs267607127,i5007738
TNNI3,Rs267607127,OMIM 191044.0014
TNNI3,Rs267607127,hypertrophic cardiomyopathy
TNNI3,Rs267607127,rs267607127(A) allele
TNNI3,Rs267607127,hromosome 19.A
TNNI3,Rs397516347,hypertrophic cardiomyopathy
TNNI3,Rs267607127,p.Gly203Ser
TNNI3,Rs267607127,rs267607127
TNNI3,Rs104894729,"familial restrictive cardiomyopathy, type 1"
TNNI3,Rs267607127,TNNI3 gene
TNNI3,Rs104894729,"familial restrictive cardiomyopathy, type 1"
TNNI3,Rs104894724,rs104894724
TNNI3,Rs104894724,familial hypertrophic cardiomyopathy (HCM)
TNNI3,Rs104894724,familial retrictive cardiomyopathy
TNNI3,Rs104894724,amilial hypertrophic cardiomyopathy
TNNI3,Rs104894724,724(T) allele is reported to lead to familial retrictive cardiomyopathy
TNNI3,I5048706,dilated cardiomyopathy
TNNI3,I5007738,familial hypertrophic cardiomyopathy type 7
TNNI3,I5007736,"dilated cardiomyopathy, type 1"
TNNI3,I5007736,dilated cardiomyopathy
TNNI3,I5007735,restrictive cardiomyopathy
TNNI3,I5007733,type 1
TNNI3,I5007733,familial restrictive cardiomyopathy
TNNI3,I5007733,"familial restrictive cardiomyopathy, type 1"
TNNI3,I5007729,hypertrophic cardiomyopathy
TNNI3,I5007729,familial hypertrophic cardiomyopathy
TNNI3,I5007728,familial hypertrophic cardiomyopathy
TNNI3,I5007728,type 7
TNNI3,I5007728,hypertrophic cardiomyopathy
TNNI3,Rs104894729, familial hypertrophic cardiomyopathy (HCM)
TNNI3,Rs104894724,TNNI3 gene on chromosome 19
TNNI3,Rs104894724,c.433C>G
TNNI3,I5007733,familial restrictive cardiomyopathy
TNNI3,Rs104894724,rs104894724(G)
TNNI3,Rs104894728,cardiomyopathy
TNNI3,Rs104894728,hypertrophic 
TNNI3,Rs104894727,familial hypertrophic cardiomyopathy
TNNI3,Rs104894727,"hypertrophic cardiomyopathy,"
TNNI3,Rs104894727,TNNI3 gene
TNNI3,Rs104894728,familial hypertrophic cardiomyopathy
TNNI3,Rs104894724,he rare minor allele of this variant is reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
TNNI3,Rs104894724,familial retrictive cardiomyopathy
TNNI3,Rs104894724,amilial hypertrophic cardiomyopathy
TNNI3,Rs104894724,p.Arg145Gly or R145G
TNNI3,Rs104894724,One mutation
TNNI3,Rs104894724,i3002796
TNNI3,Rs104894724,191044.0008
TNNI3,Rs104894724,cardiomyopathy
TNNI3,Rs104894724,rs104894724(T)
TNNI3,Rs104894724, R145W
TNNI3,Rs104894724, p.Arg145Trp
TNNI3,Rs104894724,c.433C>T
TNNI3,Rs104894724,23andMe
TNNI3,Rs104894724,OMIM 191044.0001
TNNI3,Rs104894724,two rare mutations
TNXB,Rs12198173,HIV-1 infection
TNXB,Rs12198173,HIV-DNA
TNXB,Rs12198173,HIV-1 infection
TNXB,Rs12198173,Distinct genetic loci
TNXB,Rs12198173,HIV-DNA levels
TNXB,Rs12198173,HIV-RNA
TOMM40,Rs2075650,associated with the rarer rs2075650(G) allele
TOMM40,Rs2075650,Alzheimer's disease
TOMM40,Rs157580,late-onset Alzheimer's disease
TOMM40,Rs157580,carotid artery disease
TOMM40,Rs157580,Alzheimer's disease
TOMM40,Rs157580,Alzheimer's disease
TOMM40,Rs157580,late-onset Alzheimer's disease
TOMM40,Rs157580,late-onset Alzheimer's disease 
TOMM40,Rs157580,metabolic-syndrome
TOMM40,Rs157580,bstructive sleep apnea in children.
TOMM40,Rs157580,late-onset Alzheimer's disease
TOMM40,Rs157580,Alzheimer's disease
TOMM40,Rs10524523,Alzheimer's disease
TOMM40,Rs157580,Hippocampal atrophy
TOR1A,Rs2296793,dystonia 
TOR1A,Rs2296793,SNPs
TOR1A,Rs2296793,Cis 
TOR1A,Rs2296793,Trans 
TOR1A,Rs2296793,sex
TOR1A,Rs2296793,dystonia
TOR1A,Rs2296793,torsion 
TOR1A,Rs80358233,torsion dystonia
TOR1A,Rs80358233,Ashkenazi Jews
TOR1A,Rs80358233,autosomal dominant torsion dystonia
TOR1A,Rs2296793,genetic 
TOR1A,Rs2296793,age
TOR1A,Rs2296793,modification 
TOR1A,Rs2296793,torsion dystonia
TOR1A,I4000446,torsion dystonia
TOR1A,I4000446,deltaE302
TOR1A,Rs13283584,age
TOR1A,Rs13283584,sex
TOR1A,Rs13283584,dystonia
TOR1A,Rs2296793,torsion dystonia.
TOR1A,Rs1801968,developing torsion dystonia
TOR1A,Rs1801968,modifier of the TOR1A variant
TOR1A,Rs1801968,reduce the odds of developing torsion dystonia
TOR1A,Rs2296793,dystonia
TOR1A,Rs2296793,SNP
TOR1A,Rs1801968,torsion dystonia
TPD52,Rs1042638,cancer
TPD52,Rs1042638,breast cancer.
TPD52,Rs1042638,leucine 
TPD52,Rs1042638,breast 
TPH1,Rs1799913,14x higher risk for developing heroin addiction
TPH1,Rs211105,Polymorphism
TPH1,Rs211105,schizophrenia
TPH1,Rs1800532,schizophrenia
TPH1,Rs1800532,related to schizophrenia
TPH1,Rs1800532,schizophrenia
TPH1,Rs1799913,cerebrospinal fluid 5-hydroxyindole acetic acid
TPH1,Rs1799913,rs1799913(C;C) 
TPH1,Rs1799913,"only for Hispanics,"
TPH1,Rs1799913,9x higher risk for developing heroin addiction
TPH1,Rs1799913,Tryptophan hydroxylase gene 1
TPH1,Rs1799913,heroin addiction
TPH1,Rs1799913,homovanillic acid concentrations
TPH1,Rs1799913,cerebrospinal fluid 5-hydroxyindole acetic acid
TPH1,Rs1799913,Tryptophan hydroxylase gene 1 (TPH1)
TPH1,Rs1799913,neuroleptics:
TPH1,Rs1799913,heroin addiction
TPH1,Rs1799913,heroin addiction
TPH1,Rs1799913,A779COnly for Hispanics
TPH2,Rs1487276,suicide attempts
TPH2,Rs1487276,bipolar affective disorder
TPH2,Rs1487276,tryptophan hydroxylase II
TPH2,Rs1487276,genetic variation
TPH2,Rs1386494,female
TPH2,Rs1487276,suicide attempts.
TPH2,Rs1487276,bipolar affective disorder
TPH2,Rs1843809,attention-deficit/hyperactivity disorder
TPH2,Rs1386494,gender-specific effect
TPH2,Rs1487276,tryptophan hydroxylase II
TPH2,Rs4290270,heroin addiction
TPH2,Rs4565946,Tourette's Syndrome
TPH2,Rs7954758,tryptophan hydroxylase 2
TPH2,Rs4565946,obsessive compulsive disorder
TPH2,Rs4565946,rs4570625 
TPH2,Rs4565946,disorderTourette
TPH2,Rs4565946,pathogenesis 
TPH2,Rs7305115,susceptibility to suicide.
TPH2,Rs7954758,bipolar I disorder
TPH2,Rs7954758,bipolar I disorder
TPH2,Rs7954758,Romanian population
TPH2,Rs1386494, panic disorder
TPH2,Rs4565946,early-onset
TPH2,Rs1386494,low occurrence of suicidality 
TPH2,Rs120074176,major depression.
TPH2,Rs1386494, Malaysians
TPH2,Rs1007023,bipolar affective disorder
TPH2,Rs1007023,suicide attempts.
TPH2,Rs1007023,tryptophan hydroxylase II
TPH2,Rs1007023,genetic variation
TPH2,Rs1007023,tryptophan hydroxylase II
TPH2,Rs1007023,bipolar affective disorder
TPH2,Rs1007023,suicide attempts
TPH2,Rs1386494,schizophrenic patients
TPH2,Rs120074176,ADHD
TPH2,Rs1386494,mental health disorders
TPH2,Rs1386494,"suicidality, alcoholism and depression."
TPH2,Rs120074176,Norwegian female
TPH2,Rs1386494, major depression
TPH2,Rs1386494,schizophrenia in Asian populations
TPH2,Rs1386494,psychiatric disorders
TPH2,Rs1386494,alcohol-related suicide behavior
TPH2,Rs1386494,alcohol-dependent patients
TPH2,Rs1386494, Caucasian populations
TPH2,Rs1386494,suicide attempts
TPH2,Rs1386494,major depression
TPH2,Rs1386494,Finnish population 
TPH2,Rs1386494, Caucasian patients
TPH2,Rs1386494,completed suicide
TPM1,Rs104894505,Mutations
TPM1,Rs28934269,Familial hypertrophic cardiomyopathy
TPM1,Rs104894505,cardiomyopathy
TPM1,Rs104894505,alpha-tropomyosin
TPM1,Rs104894505,Mutations
TPM1,Rs104894505,alpha-tropomyosin
TPM1,Rs104894505,dilated cardiomyopathy.
TPM1,Rs104894505,dilated cardiomyopathy.
TPM1,Rs104894503,familial hypertrophic cardiomyopathy (HCM)
TPM1,Rs104894503,four most common
TPM1,Rs104894503,mutation
TPM1,Rs104894503,HCM
TPM1,Rs104894503,hypertrophic cardiomyopathy
TPM1,Rs104894503,pathogenic/likely pathogenic
TPM1,Rs104894503,variant
TPM1,Rs104894503,rare
TPP1,Rs56144125,CLN2 disease (neuronal ceroid lipofuscinosis)
TPP1,Rs28940573,neuronal ceroid lipofuscinosis
TPP1,Rs119455955,can greatly impact patient outcomes
TPP1,Rs119455955,Batten disease
TPP1,Rs119455955,CLN2 
TPP1,Rs119455955,neuronal ceroid lipofuscinosis
TPP1,Rs119455955,CLN2 disease
TPP1,Rs119455955,is one of two recessively inherited mutations in the TPP1 (aka CLN2) gene
TPP1,Rs119455955,Batten disease
TRAF1,Rs2416806,homozygotes (GG)
TRAF1,Rs2416806,heterozygotes (CG)
TRAF1,Rs2416806,Rheumatoid Arthritis
TRAF1,Rs2416806,increases susceptibility
TRAF1,Rs2416806,homozygotes
TRAF1,Rs2416806,heterozygotes 
TRAF1,Rs2416806,susceptibility to Rheumatoid Arthritis
TRAF1,Rs1930780,heterozygotes 
TRAF1,Rs2416804,increases susceptibility to Rheumatoid Arthritis
TRAF1,Rs1930780,susceptibility to Rheumatoid Arthritis
TRAF1,Rs1930780,Rheumatoid Arthritis
TRAF1,Rs1930780,polymorphism that increases susceptibility to Rheumatoid Arthritis
TRAF1,Rs10818488,juvenile idiopathic arthritis
TRAF1,Rs10818488,rheumatoid factor-negative polyarthritis
TRAF1,Rs10818488,rheumatoid arthritis
TRAF1,Rs10818488,rheumatoid arthritis
TRAF1,Rs1930780,homozygotes 
TRAF3IP2,Rs33980500,psoriatic arthritis
TRAF3IP2,Rs33980500,risk/non-risk alleles T/C
TRAF3IP2-AS1,Rs33980500,risk/non-risk alleles T/C
TRAF3IP2-AS1,Rs33980500,psoriatic arthritis
TREM2,Rs75932628,frontotemporal dementia–like syndrome
TREM2,Rs75932628,Alzheimer's disease
TREM2,Rs75932628,late-onset AD
TREM2,Rs75932628,Alzheimer's disease
TREM2,Rs75932628,poorer cognitive function
TREM2,Rs75932628,Alzheimer's disease
TREM2,Rs75932628,Alzheimer's 
TREM2,Rs75932628,AD 
TREM2,Rs75932628,AD 
TREM2,Rs75932628,Alzheimer 
TREM2,Rs75932628,Caucasian 
TREM2,Rs75932628,Alzheimer
TREM2,Rs75932628,AD 
TREM2,Rs75932628,Japanese 
TREM2,Rs75932628,European 
TREM2,Rs75932628,increased AD risk
TREM2,Rs75932628,Alzheimer's 
TREM2,Rs75932628,frontotemporal dementia–like syndrome
TREM2,Rs75932628,Alzheimer cases
TREM2,Rs143332484,Alzheimer's disease
TREM2,Rs143332484,immune system
TREM2,Rs143332484,disease 
TREM2,Rs143332484,gene 
TREM2,Rs143332484,gene 
TREM2,Rs143332484,expressed 
TREM2,Rs143332484,Alzheimer's 
TREM2,Rs143332484,immune 
TREM2,Rs143332484,system 
TREM2,Rs75932628,Alzheimer's disease
TREM2,Rs75932628,poorer cognitive function
TREM2,Rs75932628,Alzheimer's disease
TREM2,Rs143332484,microglia 
TREM2,Rs75932628,Alzheimer's disease 
TRPC6,Rs121434394,Focal segmental glomerulosclerosis
TRPC6,Rs121434391,Focal segmental glomerulosclerosis
TRPC6,Rs121434391,Focal segmental glomerulosclerosis
TRPC6,Rs121434391,segmental glomerulosclerosis
TRPC6,Rs121434391,Focal segmental glomerulosclerosis
TRPC6,Rs121434393,Focal segmental glomerulosclerosis
TRPC6,Rs121434393,Focal segmental glomerulosclerosis
TRPC6,Rs121434393,Called
TRPC6,Rs121434390,Focal segmental glomerulosclerosis
TRPC6,Rs121434392,Focal segmental glomerulosclerosis
TRPC6,Rs121434390,segmental glomerulosclerosis
TRPC6,Rs121434392,Focal segmental glomerulosclerosis
TRPC6,I6019083,glomerulosclerosis
TRPC6,I6019089,Focal segmental glomerulosclerosis
TRPC6,I5005218,Focal segmental glomerulosclerosis
TRPC6,I5005220,Focal segmental glomerulosclerosis
TRPC6,I5005221,Focal segmental
TRPC6,I5005221,glomerulosclerosis
TRPC6,I5005220,glomerulosclerosis
TRPC6,I6019080,Focal segmental glomerulosclerosis
TRPC6,I6019082,Focal segmental glomerulosclerosis
TRPC6,I6019082,Focal segmental glomerulosclerosis
TRPC6,I6019083,Focal segmental
TRPC6,I5005222,Focal segmental glomerulosclerosis
TRPM4,Rs200038418,progressive
TRPM4,Rs387907216,progressive familial heart block type 1B
TRPM4,Rs267607142,familial heart block type 1B
TRPM4,Rs200038418,type 1B
TRPM4,Rs200038418,familial 
TRPM4,Rs200038418,dominant 
TRPM4,Rs200038418,heart block
TRPM4,Rs200038418,rare
TRPM4,Rs200038418,progressive familial heart block type 1B
TRPM4,Rs200038418,progressive familial heart block
TRPM4,Rs172151858,progressive familial heart block type 1B
TRPM4,Rs172149856,progressive familial heart block type 1B
TRPM4,Rs200038418,mutation
TRPM8,Rs10166942,migraines
TRPV1,Rs222747,Meniere's disease
TRPV1,Rs222747,Meniere's disease
TSC1,Rs118203396,Missense mutations to the TSC1 gene cause tuberous sclerosis complex.
TSHR,Rs4704397,A separate study of 970 pregnant women at 28 weeks of gestation found that serum TSH was highest for rs4704397
TSHR,Rs12101255,Graves' disease
TSLP,Rs1837253,inflammation of cells in the trachea and alveoli
TSLP,Rs1837253,asthma
TSLP,Rs1837253,asthma
TSLP,Rs1837253,certain types of asthma
TSLP,Rs1837253,reduce the risk of developing late-onset (adult) asthma
TSNAX,Rs766288,X 
TSNAX,Rs766288,Japanese population
TSNAX,Rs766288,female major depressive disorder
TSNAX,Rs766288,depression
TSNAX,Rs766288,affective disorders
TSNAX,Rs766288,TSNAX
TSNAX,Rs766288,TSNAX
TSNAX,Rs766288,bipolar
TSNAX,Rs766288,associated 
TSNAX,Rs766288,Translin
TSNAX,Rs766288,BACCS
TSNAX,Rs766288,DeCC
TSNAX,Rs766288,TSNAX 
TSNAX,Rs766288,DISC1 
TSNAX,Rs766288,X 
TTC12,Rs10502172,associated with smoking during adolescence
TTC26,Rs13225917,"e gene prevented normal development of photoreceptor sensory and other cilia. The protein is necessary for assembly of full length cilia, although the effect (if any) of rs13225917 on its functioning has not been determined. One publication speculates that this protein may play a role in Inherited Retinal Degeneration and so screening for TTC26 mutations in human ciliopathy|ciliopathies could be warranted, but to date there is no evidence supporting rs13225917 as a mutation of any consequence. TTC26/DYF13 is an intraflagellar transport protein required for transport of motility-related proteins into flagella. Knockdown of ttc26 disrupts ciliogenesis of the photoreceptor cells and the pronephros in zebrafish. The tetratricopeptide repeat: a structural motif mediating protein-protein interactions."
TTC26,Rs13225917,"ozygous A-allele carriers exist in HapMap, OpenSNP or 1000 "
TTC29,Rs76715876,Asthenozoospermia and Male Infertility.
TTC29,Rs76715876,male infertility
TTC29,Rs763399136,Asthenozoospermia
TTC29,Rs766352190,"Axonemal Protein,"
TTC29,Rs766352190,Asthenozoospermia
TTC6,Rs1998359,Allergies
TTC6,Rs1998359,Allergies
TTC6,Rs1998359,Allergies
TTN,Rs1060500435,mutation 
TTN,Rs1060500435,fibrillation
TTN,Rs1060500435,inherited 
TTN,Rs1060500435,cardiomyopathy 
TTN,Rs1060500435,mutation 
TTN,Rs1060500435,very early-onset atrial fibrillation
TTN,Rs1060500435,dilated cardiomyopathy
TTN,Rs1060500435,dominantly 
TTR,Rs267607161,TTR gene mutation among ethnic
TTR,Rs267607161,ransthyretin familial amyloid polyneuropathy.
TTR,Rs28933979,"TTR-related familial amyloid polyneuropathy,"
TTR,Rs28933979,Portugal 
TTR,Rs28933979,Sweden 
TTR,Rs28933979,Japan
TTR,Rs28933979,"majority of carriers developing the condition by the time they are 80, although the age of onset varies."
TTR,Rs28933979,both retinal amyloid angiopathy (RAA) and choroidal amyloid angiopathy (CAA)
TTR,Rs76992529,risk of developing cardiac amyloidosis
TTR,Rs76992529,heart failure
TTR,Rs76992529,Cardiac amyloidosis
TTR,Rs76992529,cardiomyopathy
TTR,Rs76992529,amyloidosis
TTR,Rs76992529,hereditary amyloidoses
TTR,Rs76992529,African ancestry
TTR,Rs76992529,up to 4% of African-Americans
TTR,Rs76992529,"heart failure,"
TTR,Rs76992529,with increasing age.
TTR,Rs76992529,accelerated amyloidosis
TTR,Rs76992529,cardiomyopathy 
TTR,Rs267607161,Ala117Ser
TTR,Rs76992529,neuronal ceroid lipofuscinosis
TTR,Rs267607161,transthyretin familial amyloid polyneuropathy
TTR,Rs76992529,Cardiac amyloidosis:
TTR,Rs1800458,polymorphisms with hippocampal atrophy
TTR,Rs1800458,Alzheimer disease
TTR,I3002758,myloid PolyneuropathyFamilial
TTR,I3002758,amyloid polyneuropathies
TTR,I3002759,cardiac amyloidosis
TTR,I3002759,cardiac amyloidosisrs
TTR,I5004213,myloid PolyneuropathyFamilial
TTR,I6019130,cardiac amyloidosis
TTR,I6019130,cardiac amyloidosisrs
TTR,Rs121918070,TTR-related familial amyloid polyneuropathy
TTR,Rs121918070,heart-related symptoms
TTR,I5004213,amyloid polyneuropathies
TTR,Rs121918070,heart-related symptoms
TTR,Rs121918070,familial amyloid polyneuropathy
TTR,Rs1800458,Transthyretin:
TTR,Rs1800458,Alzheimer
TTR,Rs1800458,schizophrenia
TTR,Rs121918070,1% of Ireland's Donegal County may carry the T60A mutation
TTR,Rs1800458,gene variants and schizophrenia
TTR,Rs121918070,TTR-related
TTR,Rs121918070,familial amyloid polyneuropathy
TTR,Rs121918070,transthyretin TTR gene
TTR,Rs121918070,heart-related symptoms
TUB,Rs2272383,body mass index
TUB,Rs2272383,obesity
TUBB8,Rs869025610,TUBB8 and Human Oocyte Meiotic Arrest
TUBB8,Rs869025612,TUBB8 
TUBB8,Rs869025612,M300I 
TUBB8,Rs869025612,Met300Ile 
TUBB8,Rs869025612,900G
TUBB8,Rs869025612,Human Oocyte Meiotic Arrest
TUBB8,Rs869025612,Mutations in TUBB8
TUBB8,Rs869025611,Human Oocyte Meiotic Arrest
TUBB8,Rs869025610,Arg262Gln and R262Q Mutations
TUBB8,Rs869025271,Mutations
TUBB8,Rs869025610,Mutations in TUBB8
TUBB8,Rs869025609,Human Oocyte Meiotic Arrest
TUBB8,Rs869025609,Mutations in TUBB8
TUBB8,Rs869025273,R2K Mutations in TUBB8 
TUBB8,Rs869025273,Human Oocyte Meiotic Arrest
TUBB8,Rs869025272,Human Oocyte Meiotic Arrest
TUBB8,Rs869025272,Mutations in TUBB8
TUBB8,Rs869025271,Human Oocyte Meiotic Arrest
TUBB8,Rs869025610,Human Oocyte Meiotic Arrest
TXNRD1,Rs4630362,amyotrophic lateral sclerosis
TXNRD1,Rs4630362,sporadic amyotrophic lateral sclerosis
TXNRD1,Rs4630362,rs4630362 is one of several TXNRD1 SNPs significantly associated
TXNRD1,Rs4630362,familial amyotrophic lateral sclerosis
TXNRD1,Rs4630362,sporadic amyotrophic lateral sclerosis
TXNRD1,Rs4630362,familial
TXNRD1,Rs4630362,sporadic amyotrophic lateral sclerosis
TXNRD1,Rs10861192,sporadic amyotrophic lateral sclerosis (ALS).
TXNRD1,Rs4630362,amyotrophic lateral sclerosis (ALS)
TXNRD1,Rs4630362,amyotrophic lateral sclerosis (FALS)
TXNRD1,Rs10861192,sporadic amyotrophic lateral sclerosis
TXNRD1,Rs10861192,familial amyotrophic lateral sclerosis
TXNRD1,Rs10861192,familial amyotrophic lateral sclerosis (FALS)
TXNRD1,Rs4630362,familial amyotrophic lateral sclerosis
TXNRD2,Rs2097603,gray matter volume
TXNRD2,Rs2097603,related to extracellular dopamine
TXNRD2,Rs4485648,gastric cancer.
TXNRD2,Rs4485648,Polymorphisms
TXNRD2,Rs4485648,gastric cancer
TYK2,Rs2304256,systemic lupus erythematosus
TYK2,Rs2304256,myeloid leukemia
TYK2,Rs2304256,systemic lupus erythematosus
TYK2,Rs2304256,systemic lupus erythematosus
TYK2,Rs12720356,chronic hepatitis C
TYK2,Rs12720356,Japanese population
TYK2,Rs12720356, Crohn Disease
TYK2,Rs12720356,de novo acute myeloid leukemia
TYK2,Rs12720356,systemic lupus erythematosus
TYK2,Rs2304256,discoid and subacute cutaneous lupus erythematosus
TYK2,Rs2304256,associated with discoid and subacute cutaneous lupus erythematosus.
TYK2,Rs12720356,susceptibility to Crohn's disease
TYK2,Rs2304256,systemic lupus erythematosus
TYK2,Rs2304256,systemic lupus erythematosus
TYK2,Rs2304256,SLE
TYK2,Rs2304256,acute myeloid leukemia
TYK2,Rs2304256,systemic lupus erythematosus
TYK2,Rs2304256,sclerosis 
TYK2,Rs2304256,lupus erythematosus
TYK2,Rs2304256,"systemic lupus erythematosus (SLE),"
TYK2,Rs2304256,Japanese
TYK2,Rs2304256,de novo acute myeloid leukemia
TYK2,Rs2304256,systemic lupus erythematosus
TYK2,Rs2304256,systemic lupus erythematosus
TYK2,Rs2304256,Irish multiple sclerosis patients.
TYK2,Rs12720356,multiple sclerosis
TYK2,Rs2304256,SLE 
TYK2,Rs12720356,Irish
TYK2,Rs12720356,Crohn's disease
TYK2,Rs12720356,hepatitis C
TYK2,Rs12720270,systemic lupus erythematosus
TYK2,Rs12720270,SLE
TYK2,Rs12720270,Japanese
TYK2,Rs12720270,systemic lupus erythematosus
TYK2,Rs12720270,systemic lupus erythematosus
TYK2,Rs12720270,systemic lupus erythematosus
TYK2,Rs12720270, Replication of recently identified systemic lupus erythematosus genetic associations: a case-control study. Evidence for genetic association and interaction between the TYK2 and IRF5 genes in systemic lupus erythematosus.
TYK2,Rs12720270,No association was seen
TYK2,Rs12720270,SLE
TYK2,Rs12720270,systemic lupus erythematosus
TYK2,Rs12720270,systemic lupus erythematosus
TYK2,Rs12720270,Evidence for genetic association and interaction between the TYK2 and IRF5 genes
TYK2,Rs12720270,systemic lupus erythematosus
TYK2,Rs12720356,cirrhosis
TYK2,Rs12720270,Polymorphisms
TYK2,Rs12720270,study of 411 Japanese
TYK2,Rs12720356,chronic hepatitis C virus infection
TYK2,Rs12720356,Crohn Disease
TYK2,Rs12720356,de novo acute myeloid leukemia
TYK2,Rs12720356,systemic lupus erythematosus
TYK2,Rs12720270, genetic association and interaction
TYK2,Rs12720270,systemic lupus erythematosus.
TYK2,Rs12720270,systemic lupus erythematosus
TYK2,Rs12720270,Replication
TYK2,Rs12720270,systemic lupus erythematosus.
TYK2,Rs12720270,interferon
TYK2,Rs12720270,tyrosine kinase 2
TYK2,Rs12720270,case-control study
TYMS,Rs502396,prostate cancer
TYMS,Rs502396,endometrial cancer
TYMS,Rs502396,renal cancer
TYMS,Rs502396,Association of thymidylate synthase gene
TYMS,Rs502396,endometrial cancer
TYMS,Rs34743033,neutropenia and diarrhea 5-fluorouracil Neutropenia
TYMS,Rs34743033,colorectal cancer and toxicity 
TYMS,Rs502396,renal cancer
TYR,Rs1847134,eye color
TYR,Rs1393350,human eye color
TYR,Rs1393350,risk of skin cancer in Caucasians.
TYR,Rs1393350,hair color and skin pigmentation
TYR,Rs1393350,Skin sensitivity to sun
TYR,Rs1393350,Blond rather than brown
TYR,Rs1393350,Blue rather than green eyes
TYR,Rs1393350,skin cancer
TYR,Rs1393350,brown 
TYR,Rs1393350,Blond
TYR,Rs1042602,Influences appearanceThe
TYR,Rs1042602,absence of freckles
TYR,Rs1042602,absence of freckles
TYR,Rs1393350,Caucasians
TYRP1,Rs387907171,Melanesians
TYRP1,Rs2733832,skin pigmentation
TYRP1,Rs387907171,blond hair
TYRP1,Rs387907171,dark-skinned
TYRP1,Rs387907171,blond hair
TYRP1,Rs387907171,dark-skinned
UBA5,Rs540839115,recessive spinocerebellar
UBA5,Rs114925667,pathogenic
UBA5,Rs114925667,early infantile epileptic encephalopathy
UBA5,Rs114925667,early infantile epileptic encephalopathy-44
UGT1A1,Rs8175347,associated with ARDS development and mortality in sepsis.
UGT1A1,Rs8175347,are associated with ARDS development and mortality in sepsis
UGT1A1,Rs8175347,neonatal hyperbilirubinemia
UGT1A1,Rs8175347,"The rs8175347 SNP consists of variation of a short (TA)(n) repeat sequence covering the TATA box of the UGT1A1 UDP-glucuronosyltransferase1A1 gene. This SNP is associated with hyperbilirubinaemia (Gilbert's syndrome) and adverse drug reactions, and is used for dosage advice for irinotecan. The low-activity (risk) alleles are rs8175347(TA)7 and (TA)8. UGT1A1 genetic polymorphisms, endogenous estrogen exposure, soy food intake, and endometrial cancer risk. Genome-wide association meta-analysis for total serum bilirubin levels. Serum bilirubin levels on ICU admission are associated with ARDS development and mortality in sepsis. Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism. UGT1A1, SLCO1B1, and SLCO1B3 polymorphisms versus neonatal hyperbilirubinemia"
UGT1A1,Rs8175347,neonatal hyperbilirubinemia
UGT1A1,Rs8175347,endometrial cancer risk
UGT1A1,Rs8175347,Gilbert's syndrome
UGT1A1,Rs8175347,Gilbert's syndrome 
UGT1A1,Rs8175347,neonatal hyperbilirubinemia
UGT1A1,Rs887829,coronary artery disease..
UGT1A1,Rs887829,coronary artery disease
UGT1A1,Rs887829,higher levels of serum bilirubin
UGT1A1,Rs887829,coronary artery disease
UGT1A1,Rs887829,coronary artery disease
UGT1A1,Rs887829,minor allele
UGT1A1,Rs887829,serum bilirubin
UGT1A1,Rs887829,coronary artery disease
UGT1A1,Rs887829,recessive protective
UGT1A1,Rs8175347,endometrial cancer risk
UGT1A1,Rs8175347,associated with hyperbilirubinaemia (Gilbert's syndrome)
UGT1A1,Rs8175347,Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome
UGT1A1,Rs8175347,neonatal hyperbilirubinemia
UGT1A1,Rs3755319,hyperbilirubinemia
UGT1A1,Rs3755319,hyperbilirubinemia
UGT1A1,Rs4148325,Xenobiotic 
UGT1A1,Rs4148325,metabolizing 
UGT1A1,Rs4148325,cancer
UGT1A1,Rs4148325,prostate 
UGT1A1,Rs8175347,endogenous estrogen exposure
UGT1A1,Rs6742078,Serum bilirubin levels
UGT1A1,Rs6742078,ARDS
UGT1A1,Rs6742078,prostate cancer
UGT1A1,Rs6742078,sepsis
UGT1A1,Rs6742078,mortality
UGT1A1,Rs8175347,Pazopanib-induced hyperbilirubinemia
UGT1A1,Rs8175347,associated with ARDS development and mortality in sepsis
UGT1A1,Rs8175347,associated with Gilbert's syndrome 
UGT1A1,Rs8175347,associated with hyperbilirubinaemia (Gilbert's syndrome)
UGT1A1,Rs6742078,ARDS
UGT1A1,Rs6742078,prostate cancer
UGT1A1,Rs8175347,endometrial cancer risk
UGT1A10,Rs4124874,Chinese coke oven workers
UGT1A10,Rs4124874,Pazopanib-induced hyperbilirubinemia
UGT1A10,Rs4124874,Gilbert's syndrome
UGT1A10,Rs4124874,increased Bilirubin
UGT1A10,Rs4124874,people of African origin
UGT1A10,Rs4124874,risk factor for breast cancer
UGT1A10,Rs4124874,susceptibility of chronic benzene poisoning
UGT1A10,Rs4124874,predisposing to sporadic colorectal cancers
UGT1A10,Rs4124874,colorectal cancers
UGT1A10,Rs4124874,ARDS development
UGT1A10,Rs4124874,Pazopanib-induced hyperbilirubinemia
UGT1A10,Rs4124874,associated with Gilbert's syndrome
UGT1A10,Rs4148325,Xenobiotic 
UGT1A10,Rs4148325,metabolizing 
UGT1A10,Rs4148325,cancer
UGT1A10,Rs58597806,propofol
UGT1A10,Rs4124874,mortality in sepsis
UGT1A10,Rs4124874,benzene poisoning
UGT1A10,Rs4148325,prostate 
UGT1A10,Rs4124874,increased Bilirubin
UGT1A10,Rs10929302,Clinically relevant UGT1A10 variant
UGT1A10,Rs10929302,UGT1A10
UGT1A10,Rs10929302,variant.
UGT1A10,Rs11692021,Clinically relevant UGT1A10 variant
UGT1A10,Rs11692021,UGT1A10
UGT1A10,Rs11692021,variant.
UGT1A10,Rs11892031,urinary bladder cancer
UGT1A10,Rs3755319,hyperbilirubinemia
UGT1A10,Rs4124874,breast cancer
UGT1A10,Rs4124874,Bilirubin
UGT1A10,Rs4124874,breast cancer
UGT1A10,Rs4124874,chronic benzene poisoning
UGT1A10,Rs4124874,colorectal cancer
UGT1A10,Rs4124874,ARDS
UGT1A10,Rs4124874,sepsis
UGT1A10,Rs4124874,Gilbert's syndrome
UGT1A10,Rs3755319,hyperbilirubinemia
UGT1A3,Rs4124874,Chinese coke oven workers
UGT1A3,Rs4124874,predisposing to sporadic colorectal cancers
UGT1A3,Rs4124874,ARDS development
UGT1A3,Rs4124874,Pazopanib-induced hyperbilirubinemia
UGT1A3,Rs4124874,associated with Gilbert's syndrome
UGT1A3,Rs4148325,Xenobiotic 
UGT1A3,Rs4148325,metabolizing 
UGT1A3,Rs6742078,Serum bilirubin levels
UGT1A3,Rs4148325,prostate 
UGT1A3,Rs6742078,prostate cancer
UGT1A3,Rs4124874,susceptibility of chronic benzene poisoning
UGT1A3,Rs6742078,ARDS
UGT1A3,Rs6742078,mortality
UGT1A3,Rs6742078,sepsis
UGT1A3,Rs6742078,prostate cancer
UGT1A3,Rs6742078,ARDS
UGT1A3,Rs4148325,cancer
UGT1A3,Rs4124874,risk factor for breast cancer
UGT1A3,Rs4124874,mortality in sepsis
UGT1A3,Rs4124874,people of African origin
UGT1A3,Rs4124874,increased Bilirubin
UGT1A3,Rs10929302,Clinically relevant UGT1A10 variant
UGT1A3,Rs10929302,UGT1A10
UGT1A3,Rs10929302,variant.
UGT1A3,Rs3755319,hyperbilirubinemia
UGT1A3,Rs3755319,hyperbilirubinemia
UGT1A3,Rs4124874,breast cancer
UGT1A3,Rs4124874,chronic benzene poisoning
UGT1A3,Rs4124874,colorectal cancer
UGT1A3,Rs4124874,Bilirubin
UGT1A3,Rs4124874,sepsis
UGT1A3,Rs4124874,ARDS
UGT1A3,Rs4124874,Pazopanib-induced hyperbilirubinemia
UGT1A3,Rs4124874,colorectal cancers
UGT1A3,Rs4124874,benzene poisoning
UGT1A3,Rs4124874,Gilbert's syndrome
UGT1A3,Rs4124874,increased Bilirubin
UGT1A3,Rs4124874,Gilbert's syndrome
UGT1A3,Rs4124874,breast cancer
UGT1A4,Rs4124874,associated with Gilbert's syndrome
UGT1A4,Rs4124874,susceptibility of chronic benzene poisoning
UGT1A4,Rs4124874,Chinese coke oven workers
UGT1A4,Rs4124874,predisposing to sporadic colorectal cancers
UGT1A4,Rs4124874,mortality in sepsis
UGT1A4,Rs4124874,ARDS development
UGT1A4,Rs4124874,Pazopanib-induced hyperbilirubinemia
UGT1A4,Rs4148325,Xenobiotic 
UGT1A4,Rs4124874,risk factor for breast cancer
UGT1A4,Rs4148325,cancer
UGT1A4,Rs4148325,prostate 
UGT1A4,Rs6742078,prostate cancer
UGT1A4,Rs6742078,Serum bilirubin levels
UGT1A4,Rs6742078,ARDS
UGT1A4,Rs6742078,mortality
UGT1A4,Rs6742078,sepsis
UGT1A4,Rs6742078,prostate cancer
UGT1A4,Rs4148325,metabolizing 
UGT1A4,Rs6742078,ARDS
UGT1A4,Rs4124874,people of African origin
UGT1A4,Rs4124874,Gilbert's syndrome
UGT1A4,Rs10929302,Clinically relevant UGT1A10 variant
UGT1A4,Rs10929302,UGT1A10
UGT1A4,Rs10929302,variant.
UGT1A4,Rs3755319,hyperbilirubinemia
UGT1A4,Rs3755319,hyperbilirubinemia
UGT1A4,Rs4124874,Bilirubin
UGT1A4,Rs4124874,breast cancer
UGT1A4,Rs4124874,chronic benzene poisoning
UGT1A4,Rs4124874,increased Bilirubin
UGT1A4,Rs4124874,ARDS
UGT1A4,Rs4124874,sepsis
UGT1A4,Rs4124874,Gilbert's syndrome
UGT1A4,Rs4124874,increased Bilirubin
UGT1A4,Rs4124874,breast cancer
UGT1A4,Rs4124874,benzene poisoning
UGT1A4,Rs4124874,colorectal cancers
UGT1A4,Rs4124874,Pazopanib-induced hyperbilirubinemia
UGT1A4,Rs4124874,colorectal cancer
UGT1A5,Rs4124874,Pazopanib-induced hyperbilirubinemia
UGT1A5,Rs4124874,ARDS development
UGT1A5,Rs4124874,susceptibility of chronic benzene poisoning
UGT1A5,Rs4124874,predisposing to sporadic colorectal cancers
UGT1A5,Rs4124874,Chinese coke oven workers
UGT1A5,Rs4124874,associated with Gilbert's syndrome
UGT1A5,Rs4124874,mortality in sepsis
UGT1A5,Rs4148325,Xenobiotic 
UGT1A5,Rs6742078,Serum bilirubin levels
UGT1A5,Rs4148325,cancer
UGT1A5,Rs4148325,prostate 
UGT1A5,Rs6742078,prostate cancer
UGT1A5,Rs6742078,ARDS
UGT1A5,Rs6742078,mortality
UGT1A5,Rs6742078,sepsis
UGT1A5,Rs6742078,prostate cancer
UGT1A5,Rs4124874,risk factor for breast cancer
UGT1A5,Rs4148325,metabolizing 
UGT1A5,Rs6742078,ARDS
UGT1A5,Rs4124874,people of African origin
UGT1A5,Rs4124874,Gilbert's syndrome
UGT1A5,Rs4124874,increased Bilirubin
UGT1A5,Rs10929302,Clinically relevant UGT1A10 variant
UGT1A5,Rs10929302,UGT1A10
UGT1A5,Rs10929302,variant.
UGT1A5,Rs3755319,hyperbilirubinemia
UGT1A5,Rs4124874,Bilirubin
UGT1A5,Rs4124874,breast cancer
UGT1A5,Rs4124874,chronic benzene poisoning
UGT1A5,Rs3755319,hyperbilirubinemia
UGT1A5,Rs4124874,ARDS
UGT1A5,Rs4124874,colorectal cancer
UGT1A5,Rs4124874,colorectal cancers
UGT1A5,Rs4124874,benzene poisoning
UGT1A5,Rs4124874,breast cancer
UGT1A5,Rs4124874,Pazopanib-induced hyperbilirubinemia
UGT1A5,Rs4124874,Gilbert's syndrome
UGT1A5,Rs4124874,sepsis
UGT1A5,Rs4124874,increased Bilirubin
UGT1A6,Rs4124874,associated with Gilbert's syndrome
UGT1A6,Rs4124874,susceptibility of chronic benzene poisoning
UGT1A6,Rs4124874,Chinese coke oven workers
UGT1A6,Rs4124874,predisposing to sporadic colorectal cancers
UGT1A6,Rs4124874,mortality in sepsis
UGT1A6,Rs4124874,ARDS development
UGT1A6,Rs4124874,Pazopanib-induced hyperbilirubinemia
UGT1A6,Rs4148325,Xenobiotic 
UGT1A6,Rs4124874,risk factor for breast cancer
UGT1A6,Rs4148325,cancer
UGT1A6,Rs4148325,prostate 
UGT1A6,Rs6742078,prostate cancer
UGT1A6,Rs6742078,Serum bilirubin levels
UGT1A6,Rs6742078,ARDS
UGT1A6,Rs6742078,mortality
UGT1A6,Rs6742078,sepsis
UGT1A6,Rs6742078,ARDS
UGT1A6,Rs4148325,metabolizing 
UGT1A6,Rs4124874,people of African origin
UGT1A6,Rs6742078,prostate cancer
UGT1A6,Rs4124874,Gilbert's syndrome
UGT1A6,Rs10929302,Clinically relevant UGT1A10 variant
UGT1A6,Rs10929302,UGT1A10
UGT1A6,Rs10929302,variant.
UGT1A6,Rs3755319,hyperbilirubinemia
UGT1A6,Rs3755319,hyperbilirubinemia
UGT1A6,Rs4124874,Bilirubin
UGT1A6,Rs4124874,breast cancer
UGT1A6,Rs4124874,chronic benzene poisoning
UGT1A6,Rs4124874,increased Bilirubin
UGT1A6,Rs4124874,ARDS
UGT1A6,Rs4124874,Pazopanib-induced hyperbilirubinemia
UGT1A6,Rs4124874,colorectal cancers
UGT1A6,Rs4124874,benzene poisoning
UGT1A6,Rs4124874,colorectal cancer
UGT1A6,Rs4124874,increased Bilirubin
UGT1A6,Rs4124874,Gilbert's syndrome
UGT1A6,Rs4124874,sepsis
UGT1A6,Rs4124874,breast cancer
UGT1A7,Rs4148325,Xenobiotic 
UGT1A7,Rs4124874,risk factor for breast cancer
UGT1A7,Rs4124874,susceptibility of chronic benzene poisoning
UGT1A7,Rs4124874,predisposing to sporadic colorectal cancers
UGT1A7,Rs4124874,mortality in sepsis
UGT1A7,Rs4124874,ARDS development
UGT1A7,Rs4124874,Pazopanib-induced hyperbilirubinemia
UGT1A7,Rs4124874,associated with Gilbert's syndrome
UGT1A7,Rs4148325,metabolizing 
UGT1A7,Rs6742078,Serum bilirubin levels
UGT1A7,Rs4148325,prostate 
UGT1A7,Rs6742078,prostate cancer
UGT1A7,Rs4124874,people of African origin
UGT1A7,Rs6742078,ARDS
UGT1A7,Rs6742078,mortality
UGT1A7,Rs6742078,sepsis
UGT1A7,Rs6742078,prostate cancer
UGT1A7,Rs6742078,ARDS
UGT1A7,Rs4148325,cancer
UGT1A7,Rs4124874,increased Bilirubin
UGT1A7,Rs4124874,Chinese coke oven workers
UGT1A7,Rs4124874,Pazopanib-induced hyperbilirubinemia
UGT1A7,Rs10929302,Clinically relevant UGT1A10 variant
UGT1A7,Rs4124874,Gilbert's syndrome
UGT1A7,Rs10929302,variant.
UGT1A7,Rs11692021,Clinically relevant UGT1A10 variant
UGT1A7,Rs11692021,UGT1A10
UGT1A7,Rs11692021,variant.
UGT1A7,Rs3755319,hyperbilirubinemia
UGT1A7,Rs3755319,hyperbilirubinemia
UGT1A7,Rs4124874,Bilirubin
UGT1A7,Rs4124874,breast cancer
UGT1A7,Rs10929302,UGT1A10
UGT1A7,Rs4124874,colorectal cancer
UGT1A7,Rs4124874,chronic benzene poisoning
UGT1A7,Rs4124874,benzene poisoning
UGT1A7,Rs4124874,breast cancer
UGT1A7,Rs4124874,colorectal cancers
UGT1A7,Rs4124874,Gilbert's syndrome
UGT1A7,Rs4124874,sepsis
UGT1A7,Rs4124874,ARDS
UGT1A7,Rs4124874,increased Bilirubin
UGT1A8,Rs4124874,Pazopanib-induced hyperbilirubinemia
UGT1A8,Rs4124874,predisposing to sporadic colorectal cancers
UGT1A8,Rs4124874,Gilbert's syndrome
UGT1A8,Rs4124874,increased Bilirubin
UGT1A8,Rs4124874,people of African origin
UGT1A8,Rs4124874,susceptibility of chronic benzene poisoning
UGT1A8,Rs4124874,Chinese coke oven workers
UGT1A8,Rs4124874,mortality in sepsis
UGT1A8,Rs4148325,Xenobiotic 
UGT1A8,Rs4124874,Pazopanib-induced hyperbilirubinemia
UGT1A8,Rs4124874,associated with Gilbert's syndrome
UGT1A8,Rs4148325,metabolizing 
UGT1A8,Rs4148325,cancer
UGT1A8,Rs4148325,prostate 
UGT1A8,Rs58597806,propofol
UGT1A8,Rs4124874,colorectal cancers
UGT1A8,Rs4124874,ARDS development
UGT1A8,Rs4124874,benzene poisoning
UGT1A8,Rs4124874,risk factor for breast cancer
UGT1A8,Rs4124874,increased Bilirubin
UGT1A8,Rs4124874,breast cancer
UGT1A8,Rs10929302,UGT1A10
UGT1A8,Rs10929302,variant.
UGT1A8,Rs11692021,Clinically relevant UGT1A10 variant
UGT1A8,Rs11692021,UGT1A10
UGT1A8,Rs11692021,variant.
UGT1A8,Rs11892031,urinary bladder cancer
UGT1A8,Rs3755319,hyperbilirubinemia
UGT1A8,Rs10929302,Clinically relevant UGT1A10 variant
UGT1A8,Rs4124874,Bilirubin
UGT1A8,Rs4124874,breast cancer
UGT1A8,Rs4124874,chronic benzene poisoning
UGT1A8,Rs4124874,colorectal cancer
UGT1A8,Rs4124874,ARDS
UGT1A8,Rs4124874,sepsis
UGT1A8,Rs4124874,Gilbert's syndrome
UGT1A8,Rs3755319,hyperbilirubinemia
UGT1A9,Rs4124874,Gilbert's syndrome
UGT1A9,Rs4124874,increased Bilirubin
UGT1A9,Rs4124874,risk factor for breast cancer
UGT1A9,Rs4124874,susceptibility of chronic benzene poisoning
UGT1A9,Rs4124874,Chinese coke oven workers
UGT1A9,Rs4124874,predisposing to sporadic colorectal cancers
UGT1A9,Rs4124874,mortality in sepsis
UGT1A9,Rs4124874,associated with Gilbert's syndrome
UGT1A9,Rs4124874,Pazopanib-induced hyperbilirubinemia
UGT1A9,Rs4148325,Xenobiotic 
UGT1A9,Rs4148325,metabolizing 
UGT1A9,Rs4148325,cancer
UGT1A9,Rs4148325,prostate 
UGT1A9,Rs4124874,Pazopanib-induced hyperbilirubinemia
UGT1A9,Rs58597806,propofol
UGT1A9,Rs4124874,ARDS development
UGT1A9,Rs4124874,colorectal cancers
UGT1A9,Rs4124874,people of African origin
UGT1A9,Rs4124874,breast cancer
UGT1A9,Rs4124874,benzene poisoning
UGT1A9,Rs10929302,Clinically relevant UGT1A10 variant
UGT1A9,Rs10929302,UGT1A10
UGT1A9,Rs11692021,Clinically relevant UGT1A10 variant
UGT1A9,Rs11692021,UGT1A10
UGT1A9,Rs11692021,variant.
UGT1A9,Rs3755319,hyperbilirubinemia
UGT1A9,Rs3755319,hyperbilirubinemia
UGT1A9,Rs10929302,variant.
UGT1A9,Rs4124874,breast cancer
UGT1A9,Rs4124874,chronic benzene poisoning
UGT1A9,Rs4124874,colorectal cancer
UGT1A9,Rs4124874,ARDS
UGT1A9,Rs4124874,sepsis
UGT1A9,Rs4124874,Gilbert's syndrome
UGT1A9,Rs4124874,Bilirubin
UGT1A9,Rs4124874,increased Bilirubin
UGT2B17,Rs6857249,Koreans
UGT2B17,Rs6857249,Swedes
UGT2B17,Rs6857249,allele
UGT2B17,Rs6857249,steroid
UGT2B17,Rs6857249,metabolism
UGT2B17,Rs6552182, gene alters testosterone
UGT2B17,Rs6552182,steroid use undetectable
UGT2B17,Rs6552182,UGT2B17 
UGT2B17,Rs6552182,completely absent in Koreans
UGT2B17,Rs6857249,common polymorphism
UGT2B17,Rs6857249,testosterone
UGT2B17,Rs7435827,testosterone
UGT2B17,Rs7436338,steroid
UGT2B17,Rs7435827,steroid
UGT2B17,Rs7435827,allele
UGT2B17,Rs7435827,Swedes
UGT2B17,Rs7435827,Koreans
UGT2B17,Rs7435827,common polymorphism
UGT2B17,Rs7436338,testosterone
UGT2B17,Rs7436338,metabolism
UGT2B17,Rs7436338,allele
UGT2B17,Rs7436338,Swedes
UGT2B17,Rs7436338,Koreans
UGT2B17,Rs7436338,common polymorphism
UGT2B17,Rs6552182,4.8% in Swedes
UGT2B17,Rs7435827,metabolism
UGT2B17,Rs6552182,Deletion of both copies of this gene alters testosterone metabolism making steroid use undetectable.
UGT2B17,Rs11723091,steroid
UGT2B17,Rs13327941,Koreans
UGT2B17,Rs10025771,testosterone
UGT2B17,Rs10025771,metabolism
UGT2B17,Rs10025771,steroid
UGT2B17,Rs10025771,allele
UGT2B17,Rs10025771,Swedes
UGT2B17,Rs10025771,Koreans
UGT2B17,Rs10025771,common polymorphism
UGT2B17,Rs11723091,testosterone
UGT2B17,Rs11723091,metabolism
UGT2B17,Rs11723091,allele
UGT2B17,Rs11723091,Swedes
UGT2B17,Rs11723091,Koreans
UGT2B17,Rs13327941,common polymorphism
UGT2B17,Rs11938019,testosterone
UGT2B17,Rs11723091,common polymorphism
UGT2B17,Rs13327941,allele
UGT2B17,Rs13327941,steroid
UGT2B17,Rs13327941,metabolism
UGT2B17,Rs13327941,testosterone
UGT2B17,Rs11938019,common polymorphism
UGT2B17,Rs13327941,Swedes
UGT2B17,Rs11938019,Swedes
UGT2B17,Rs11938019,allele
UGT2B17,Rs11938019,steroid
UGT2B17,Rs11938019,metabolism
UGT2B17,Rs11938019,Koreans
UNC13D,Rs764196809,familial hemophagocytic lymphohistiocytosis
UNC13D,Rs764196809,familial hemophagocytic lymphohistiocytosis
UNC13D,Rs764196809,hemophagocytic lymphohistiocytosis
UNC13D,Rs764196809,pathogenic
UNC13D,Rs766657895,considered pathogenic
UNC13D,Rs777759523,familial hemophagocytic lymphohistiocytosis
UNC13D,Rs796065024,familial hemophagocytic lymphohistiocytosis
UNC13D,Rs796065024,familial hemophagocytic lymphohistiocytosis (HLH)
UNC13D,Rs796065026,amilial hemophagocytic lymphohistiocytosis
UNC13D,Rs747169857,familial hemophagocytic lymphohistiocytosis (HLH)
UNC13D,Rs796065026,familial hemophagocytic lymphohistiocytosis
UNC13D,Rs766657895,hemophagocytic lymphohistiocytosis (HLH)
UNC13D,Rs201908137,hagocytic lymphohistiocytosis (HLH) in ClinVar
UNC13D,Rs121434354,pathogenic for familial hemophagocytic lymphohistiocytosis (HLH)
UNC13D,Rs201908137,hemofagocytarnej 
UNC13D,Rs121434352,familial hemophagocytic lymphohistiocytosis
UNC13D,Rs201908137,pathogenic 
UNC13D,Rs121434352,considered pathogenic
UNC13D,Rs121434352,familial hemophagocytic lymphohistiocytosis (HLH)
UNC13D,Rs121434352,familial hemophagocytic lymphohistiocytosis
UNC13D,Rs121434354,familial hemophagocytic lymphohistiocytosis (HLH)
UNC13D,Rs121434354,cytosis
UNC13D,Rs201908137,chorobotwórczy 
UNC13D,Rs201908137,limfohistiocytozy 
UNC13D,Rs121434354,pathogenic
UNC13D,Rs121434352,c.766C>T (p.Arg256Ter)considered pathogenic for familial hemophagocytic lymphohistiocytosis (HLH)
UROS,Rs121908012,congenital erythropoietic porphyria
UROS,Rs121908012,congenital erythropoietic porphyria
UROS,Rs121908012,"mutation in the UROS gene,"
USH1C,Rs55843567,syndromic and non-syndromic deafness
USH1G,Rs397517925, Usher syndrome (type 1G)
USH1G,Rs397517925,pathogenic
USH1G,Rs397517925,Usher syndrome
USH2A,Rs111033367,Usher syndrome type 2a
USH2A,Rs111033367,Usher syndrome type 2 
USH2A,Rs111033367,mutations in usherin
USH2A,Rs111033367,Usher syndrome type IIa
USH2A,Rs111033367,Canadians of French origin
USH2A,Rs111033367,Quebecois and Acadians
USH2A,Rs111033367,Usher syndrome type 2
USH2A,Rs111033367,novel mutations in usherin
USH2A,Rs111033367,Usher syndrome type IIa
USH2A,Rs111033367,Canadians of French origin 
USH2A,Rs111033367,Usher syndrome type 2a 
USH2A,Rs111033367,Usher syndrome
USH2A,Rs111033367,Usher syndrome
USH2A,Rs111033367,Usher syndrome
USH2A,Rs111033273,Usher syndrome 2a
USH2A,Rs111033367,"on of novel mutations in usherin, the gene responsible for Usher syndro"
USH2A,Rs111033334,non-Ashkenazi Jews
USH2A,Rs111033334,Usher syndrome type 2
USH2A,Rs111033334,Usher syndrome type 2
USH2A,Rs111033334,retinitis pigmentosa
USH2A,Rs111033334,retinitis pigmentosa
USH2A,Rs111033273,USH2A mutations
USH2A,Rs111033367,syndrome type 2 in Canadians of French origin and confirms comm
USH2A,Rs111033273,Usher syndrome 1b
USH2A,Rs111033273,visual impairment
USH2A,Rs111033263,syndrome 
USH2A,Rs111033263,USH2A
USP9Y,Rs2032598,association with schizophrenia
USP9Y,Rs2032598,association with schizophrenia
USP9Y,Rs3212292,protective lipid
USP9Y,Rs2032598,Irish family
USP9Y,Rs2032597,HIV
USP9Y,Rs2032598,schizophrenia
USP9Y,Rs2032598,schizophrenia
USP9Y,Rs2032597,HIV
USP9Y,Rs2032598,association with schizophrenia
UTY,Rs2032658,HAART outcome
UTY,Rs2032658,HIV progression
UTY,Rs2032658,HAART outcome.
UTY,Rs2032658,Y chromosome
UTY,Rs2032658,Y chromosome haplogroup I
UTY,Rs2032658,"Association of Y chromosome haplogroup I with HIV progression, and HAART outcome."
UTY,Rs2032658,HIV progression
VARS,Rs150882285,Arg947His
VARS,Rs150882285,R947H
VCAN,Rs80356555,Erosive vitreoretinopathy
VCAN,Rs80356555,Erosive vitreoretinopathy
VCAN,Rs80356555,wagner disease
VCAN,Rs80356555,Wagner syndrome
VCAN,Rs80356555,Wagner syndrome
VCAN,Rs80356555,wagner disease
VCAN,Rs80356555,intronic mutations
VCAN,Rs80356555,Japanese
VCAN,Rs80356555,Wagner syndrome
VCAN,Rs80356555,Erosive vitreoretinopathy
VCAN,Rs80356554,wagner disease
VCAN,Rs80356555,imbalance of splice variants
VCAN,Rs80356553,Clinical characterisation and molecular analysis of Wagner syndrome
VCAN,Rs173686,Intracranial Aneurysm
VCAN,Rs173686,intracranial aneurysm
VCAN,Rs251124,disruption of the extracellular matrix (ECM) of the arterial wall
VCAN,Rs251124,intracranial aneurysms
VCAN,Rs251124,intracranial aneurysms
VCAN,Rs80356554,Erosive vitreoretinopathy
VCAN,Rs251124,intracranial aneurysms
VCAN,Rs80356553,genetic defect
VCAN,Rs80356553,Wagner syndrome
VCAN,Rs80356553,genetic defect in the original Wagner syndrome family
VCAN,Rs251124,disruption of the extracellular matrix (ECM) of the arterial wall
VDR,Rs2228570,Central and Eastern Europe
VDR,Rs2228570,osteonecrosis in children with acute lymphoblastic leukemia
VDR,Rs2228570,type 1 diabetes mellitus in the Portuguese population
VDR,Rs2228570,breast cancer risk in the Polish population
VDR,Rs2228570,Hispanic and African Americans.
VDR,Rs2228570,adiposity and colon cancer
VDR,Rs2228570,dietary vitamin D intake and colorectal cancer
VDR,Rs2228570,human height
VDR,Rs2228570,advanced non-small-cell lung cancer
VDR,Rs2228570,breast cancer
VDR,Rs2228570,renal cancer
VDR,Rs2228570,ischemic stroke
VDR,Rs2228570,multiple sclerosis
VDR,Rs2228570,ovarian cancer
VDR,Rs2228570,prostate cancer
VDR,Rs2228570,recurrent venous thromboembolism
VDR,Rs2228570,Brazilian individuals with type 1 diabetes
VDR,Rs2228570,blood pressure progression and incident hypertension
VDR,Rs2228570,sun exposure
VDR,Rs2228570,Colon tumor
VDR,Rs2228570,HIV-1 infection in injection drug users
VDR,Rs2228570,type 1 diabetes
VDR,Rs2228570,multiple sclerosis
VDR,Rs2228570,Chinese
VDR,Rs2228570,obesity and osteoporosis
VDR,Rs2228570,asthma
VDR,Rs2228570,Graves' disease in German and Polish but not in Serbian patients
VDR,Rs2228570,Asthma
VDR,Rs2228570,schizophrenia and selected anthropometric measures
VDR,Rs2228570,generalized aggressive periodontitis
VDR,Rs2228570,postmenopausal breast cancer
VDR,Rs2228570,fracture
VDR,Rs2228570,older women
VDR,Rs2228570,"acute lymphoblastic leukemia cases in Churchill County, Nevada"
VDR,Rs2228570,olon and rectal cancer
VDR,Rs2228570,respiratory syncytial virus bronchiolitis
VDR,Rs2228570,cancer
VDR,Rs2228570,bone mass and geometry
VDR,Rs2228570,hyroid autoimmune disorders
VDR,Rs2228570,colon cancer
VDR,Rs2228570,salmonellosis or campylobacteriosis and chronic illness
VDR,Rs2228570,ovarian cancer
VDR,Rs2228570,ovarian cancer
VDR,Rs2228570,colorectal cancer
VDR,Rs2228570,South Croatia.
VDR,Rs2228570,prostate cancer
VDR,Rs2228570,diabetic retinopathy
VDR,Rs2228570,periodontitis
VDR,Rs2228570,respiratory syncytial virus
VDR,Rs2228570,South African children
VDR,Rs2228570,tuberculosis
VDR,Rs2228570,East India.
VDR,Rs2228570,prostate cancer
VDR,Rs2228570,Parkinson's diseas
VDR,Rs2228570,HIV Patients
VDR,Rs2228570,Mycobacterium tuberculosis
VDR,Rs2228570,Turkish postmenopausal women.
VDR,Rs2228570,breast cancer risk among Chinese women
VDR,Rs2238135,prostate cancer
VDR,Rs2239186,vitamin D receptor
VDR,Rs2239186,asthma
VDR,Rs2239186,Asthma
VDR,Rs2239186,vitamin D metabolism
VDR,Rs2239186,type I diabetes
VDR,Rs3847987,COPD
VDR,Rs3847987,COPD
VDR,Rs3847987,men with two copies of the adenine variant
VDR,Rs3847987,more likely to develop COPD
VDR,Rs2238135,allele in the 630 Caucasian patients
VDR,Rs2228570,Irish
VDR,Rs2228570,inflammatory bowel
VDR,Rs2228570,active calcium stone disease.
VDR,Rs2228570,melanoma
VDR,Rs2228570,UK
VDR,Rs2228570,asthma
VDR,Rs2228570,Chinese Han
VDR,Rs2228570,malignant melanoma
VDR,Rs2228570,"type 1 diabetes in Crete, Greece"
VDR,Rs2228570,multiple sclerosis.
VDR,Rs2228570,diabetic nephropathy
VDR,Rs2228570,Asthma
VDR,Rs2228570,families with type I diabetes
VDR,Rs2228570,type I diabetes
VDR,Rs2228570,Type I Diabetes
VDR,Rs2228570,extrapulmonary tuberculosis
VDR,Rs2228570,rectal tumors
VDR,Rs2228570,colorectal cancer.
VDR,Rs2228570,hepatocellular carcinoma in alcoholic cirrhosis.
VDR,Rs2228570,periodontitis
VDR,Rs2228570,Prostate cancer
VDR,Rs2228570,African Americans
VDR,Rs2228570,multiple sclerosis in Canadians.
VDR,Rs2228570,breast cancer risk among Caucasian women in Ontario
VDR,Rs2228570,differentiated thyroid carcinoma
VDR,Rs2228570,race and ethnicity
VDR,Rs2228570,twins with multiple sclerosis.
VDR,Rs2228570,inflammatory bowel disease
VDR,Rs2107301,630 Caucasian patients
VDR,Rs2228570,FokI polymorphism
VDR,Rs2228570,Graves' disease
VDR,Rs2228570, FokI polymorphism
VDR,Rs2228570, breast cancer
VDR,Rs2228570,obesity
VDR,Rs2228570,osteoporosis
VDR,Rs2228570,Graves' disease
VDR,Rs2228570,schizophrenia
VDR,Rs2107301,homozygote carriers
VDR,Rs2228570,breast cancer
VDR,Rs2228570,colon and rectal cancer
VDR,Rs2228570,syncytial virus bronchiolitis
VDR,Rs2228570,thyroid autoimmune disorders
VDR,Rs2228570,colon cancer
VDR,Rs2228570,campylobacteriosis
VDR,Rs2228570,chronic illness
VDR,Rs2228570,ovarian cancer
VDR,Rs2228570,ovarian cancer
VDR,Rs2228570,colorectal cancer
VDR,Rs2228570,lymphoblastic leukemia
VDR,Rs2107301,~2.5x higher risk of prostate cancer
VDR,Rs2107301,homozygotes
VDR,Rs2107301,vitamin D
VDR,Rs10735810,Idiopathic short stature
VDR,Rs10735810,Osteonecrosis
VDR,Rs10735810,acute lymphoblastic leukemia
VDR,Rs10735810,breast cancer
VDR,Rs10735810,ymphoblastic leukemia
VDR,Rs10735810,breast cancer
VDR,Rs10735810,Idiopathic short stature
VDR,Rs10735810,Osteonecrosis in acute lymphoblastic leukemia
VDR,Rs10735810,breast cancer
VDR,Rs1544410,low BMD
VDR,Rs1544410,osteoporosis
VDR,Rs2228570,breast cancer
VDR,Rs2107301,prostate cancer
VDR,Rs2107301,~2.5x higher risk of prostate cancer
VDR,Rs2107301,prostate cancer
VDR,Rs2107301,Caucasian patients
VDR,Rs2107301,rs2107301
VDR,Rs2107301,SNP
VDR,Rs2107301,vitamin D
VDR,Rs2107301,VDR receptor gene.rs2107301(T;T)
VDR,Rs2107301,homozygotes
VDR,Rs2228570,polymorphism
VDR,Rs2228570,type 1 diabetes
VDR,Rs1544410,Shorter stature
VDR,Rs2228570,renal cancer
VDR,Rs2228570,multiple sclerosis
VDR,Rs2228570,prostate cancer
VDR,Rs2228570,thyroid carcinoma
VDR,Rs2228570,diabetic retinopathy
VDR,Rs2228570, polymorphisms
VDR,Rs2228570, asthma 
VDR,Rs2228570, type 1 diabetes
VDR,Rs2228570,sclerosis
VDR,Rs2228570,diabetic
VDR,Rs2228570,type I diabetes
VDR,Rs2228570, type I diabetes 
VDR,Rs2228570, Type I Diabetes
VDR,Rs2228570, Type I Diabetes
VDR,Rs2228570,rectal tumors
VDR,Rs2228570,colorectal cancer
VDR,Rs2228570,hepatocellular carcinoma
VDR,Rs2228570, cirrhosis
VDR,Rs2228570,polymorphisms
VDR,Rs2228570,Prostate cancer
VDR,Rs2228570,breast cancer 
VDR,Rs2228570,HIV-1 infection
VDR,Rs2228570, tuberculosis
VDR,Rs2228570,respiratory syncytial virus
VDR,Rs2228570,postmenopausal breast cancer
VDR,Rs2228570,Mycobacterium tuberculosis
VDR,Rs2228570,osteonecrosis
VDR,Rs2228570,prostate cancer
VDR,Rs2228570,type 1 diabetes
VDR,Rs2228570,postmenopausal breast cancer
VDR,Rs2228570,colon cancer
VDR,Rs2228570,adiposity
VDR,Rs2228570,colorectal cancer
VDR,Rs2228570,human height
VDR,Rs2228570,lung cancer
VDR,Rs2228570,Colon tumor 
VDR,Rs2228570,breast cancer
VDR,Rs2228570,breast cancer
VDR,Rs2228570,lymphotoxin-alpha
VDR,Rs2228570,ovarian cancer
VDR,Rs2228570,prostate cancer
VDR,Rs2228570,venous thromboembolism
VDR,Rs2228570,type 1 diabetes
VDR,Rs2228570,HIV
VDR,Rs2228570,blood pressure
VDR,Rs2228570,hypertension
VDR,Rs2228570,nonhypertensive
VDR,Rs2228570,postmenopausal women
VEGFA,Rs3025039,gastric cancer
VEGFA,Rs3025039,peptic ulcer diseases
VEGFA,Rs3025039,neovascular age-related macular degeneration
VEGFA,Rs3025039,multiple myeloma
VEGFA,Rs3025039,heumatoid arthritis
VEGFA,Rs699947,thyroid cancer
VEGFA,Rs833061,cancer risk
VEGFA,Rs833061,Polymorphisms in the vascular endothelial growth factor gene and breast cancer in the Cancer Prevention Study II cohort.
VEGFA,Rs833061,Large-scale evaluation of candidate genes
VEGFA,Rs833061,identifies
VEGFA,Rs833061,VEGF polymorphisms and survival in early-stage non-small-cell lung cancer.
VEGFA,Rs833061,"Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk."
VEGFA,Rs3025039,non-small-cell lung cancer
VEGFA,Rs833061,Genetic variation in VEGF does not contribute significantly to the risk of congenital cardiovascular malformation.
VEGFA,Rs699947,lymph node metastasis
VEGFA,Rs3025039,bladder cancer risk
VEGFA,Rs2010963,rheumatoid arthritis
VEGFA,Rs3025039,increased risk
VEGFA,Rs2010963,rheumatoid arthritis
VEGFA,Rs2010963,efficacy of thalidomide
VEGFA,Rs2010963,multiple myeloma
VEGFA,Rs2010963,age-related macular degeneration
VEGFA,Rs2010963,severe radiation pneumonitis
VEGFA,Rs2010963,non-small cell lung cancer
VEGFA,Rs2010963,highly myopic eyes
VEGFA,Rs833061,polymorphisms and esophageal cancer prognosis. The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors.
VEGFA,Rs25648,Kawasaki disease
VEGFA,Rs25648,bladder cancer
VEGFA,Rs25648,diabetic retinopathy
VEGFA,Rs25648,cardiovascular malformation
VEGFA,Rs25648,solid tumors
VEGFA,Rs25648,macular degeneration
VEGFA,Rs25648,diabetic retinopathy
VEGFA,Rs3025039,macular degeneration
VEGFA,Rs833061,Gene polymorphism of vascular endothelial growth factor -1154 G>A is associated with hypertensive nephropathy in a Hispanic population.
VEGFA,Rs833068,oxidative stress
VEGFA,Rs833061,breast cancer 
VEGFA,Rs833068,healthy population.
VEGFA,Rs833069,genes 
VEGFA,Rs833069,haplotypes 
VEGFA,Rs833069,arthritis 
VEGFA,Rs833069,rheumatoid 
VEGFA,Rs833069,Polymorphisms 
VEGFA,Rs833069,polypoidal 
VEGFA,Rs833069,choroidal 
VEGFA,Rs833069,vasculopathy 
VEGFA,Rs833069,polypoidal choroidal vasculopathy
VEGFA,Rs833069,Korean population
VEGFA,Rs833069,rheumatoid arthritis
VEGFA,Rs833070,smaller hippocampal volumes
VEGFA,Rs833070,T-allele and A-allele carriers
VEGFA,Rs2010963,cardiovascular disease
VEGFA,Rs833068,serum levels
VEGFA,Rs833061,Polymorphisms of the vascular endothelial growth factor gene and severe radiation pneumonitis in non-small cell lung cancer patients treated with definitive radiotherapy.
VEGFA,Rs833068,polymorphisms
VEGFA,Rs833068,ovarian cancer survival.
VEGFA,Rs833061,graft-versus-host disease
VEGFA,Rs833061,cardiovascular malformation
VEGFA,Rs833068,bladder cancer risk
VEGFA,Rs833068,neovascular age-related macular degeneration
VEGFA,Rs833068,ovarian cancer
VEGFA,Rs833068,brain mophology
VEGFA,Rs833068,bladder cancer risk
VEGFA,Rs833068,cognitive ability and cognitive ageing
VEGFA,Rs833068,325 markers
VEGFA,Rs833068,cognition
VEGFA,Rs833068,Polymorphisms
VEGFA,Rs833068,neovascular
VEGFA,Rs833068,degeneration
VEGFA,Rs833068,Vascular endothelial
VEGFA,Rs833068,polymorphisms
VEGFA,Rs833068,polymorphisms
VEGFA,Rs833069,rheumatoid arthritis
VEGFA,Rs2010963,heumatoid arthritis
VEGFA,Rs2010963,ischemic heart disease
VEGFA,Rs1570360,sporadic renal cell carcinoma
VEGFA,Rs1570360,diabetic retinopathy
VEGFA,Rs1570360,renal cancer
VEGFA,Rs1570360,Alzheimer's disease
VEGFA,Rs1570360,microdeletion syndrome
VEGFA,Rs1570360,Gilbert's syndrome
VEGFA,Rs1570360,Pazopanib-induced hyperbilirubinemia
VEGFA,Rs1570360,polymorphism
VEGFA,Rs1570360,nonproliferative and proliferative diabetic retinopathy
VEGFA,Rs1570360,diabetic retinopathy
VEGFA,Rs1570360,hypertensive nephropathy
VEGFA,Rs1570360,rheumatoid arthritis
VEGFA,Rs2010963,rheumatoid arthritis
VEGFA,Rs2010963,breast cancer
VEGFA,Rs2010963,Kawasaki disease
VEGFA,Rs1570360,diabetic retinopathy
VEGFA,Rs2010963,renal cancer
VEGFA,Rs1570360,polymorphisms
VEGFA,Rs1570360,polymorphism
VEGFA,Rs13207351,iabetic retinopathy
VEGFA,Rs13207351,polymorphisms
VEGFA,Rs1570360,Sudden Infant Death Syndrome
VEGFA,Rs2010963,myocardial infarction
VEGFA,Rs1570360,giant cell arteritis
VEGFA,Rs1570360,vascular endothelial growth factor (VEGF)
VEGFA,Rs1570360,rheumatoid arthritis
VEGFA,Rs1570360,Henoch-Schonlein purpura
VEGFA,Rs1570360,Polymorphisms
VEGFA,Rs1570360,breast cancer
VEGFA,Rs1570360,type 2 diabetes
VEGFA,Rs1570360,gene polymorphisms
VEGFA,Rs1570360, psoriatic arthritis
VEGFA,Rs1570360,polymorphisms 
VEGFA,Rs1570360,bladder cancer risk
VEGFA,Rs1570360,ventricular septal defect
VEGFA,Rs2010963,"growth, differentiation and apoptosis"
VEGFA,Rs1570360,ischemic complications
VEGFA,Rs2010963,coronary artery disease
VEGFA,Rs2010963,carotid intima-media thickness
VEGFA,Rs2010963,acute myocardial infarction
VEGFA,Rs2010963,esophageal cancer
VEGFA,Rs2010963,diabetic retinopathy.
VEGFA,Rs2010963,renal cancer
VEGFA,Rs2010963,diabetic retinopathy.
VEGFA,Rs2010963,major solid tumors.
VEGFA,Rs2010963,gastric cancer
VEGFA,Rs2010963,Pazopanib-induced hyperbilirubinemia
VEGFA,Rs2010963,Gilbert's syndrome
VEGFA,Rs2010963,nonproliferative and proliferative diabetic retinopathy
VEGFA,Rs2010963,coronary artery disease.
VEGFA,Rs2010963,ovarian cancer
VEGFA,Rs2010963,rheumatoid arthritis
VEGFA,Rs2010963,diabetes
VEGFA,Rs2010963,acute graft-versus-host disease
VEGFA,Rs2010963,acute graft-versus-host disease
VEGFA,Rs2010963,diabetes:
VEGFA,Rs2010963,endometriosis
VEGFA,Rs2010963,age-related macular degeneration
VEGFA,Rs2010963,giant cell arteritis
VEGFA,Rs2010963,severe ischemic complications
VEGFA,Rs2010963,Henoch-Schonlein purpura
VEGFA,Rs2010963,renal complications
VEGFA,Rs2010963,breast cancer
VEGFA,Rs2010963,Kawasaki disease
VEGFA,Rs2010963,rheumatoid arthritis
VEGFA,Rs2010963,bladder cancer
VEGFA,Rs2010963,cognitive ability
VEGFA,Rs2010963,cognitive ageing
VEGFA,Rs2010963,acute myeloid leukaemia
VEGFA,Rs2010963,non-small-cell lung cancer
VEGFA,Rs2010963,familial endometriosis
VEGFA,Rs2010963,psoriatic arthritis
VEGFA,Rs2010963,esophageal adenocarcinoma risk
VHL,Rs28940298,congenital Chuvash polycythemia
VHL,Rs28940298,Renal cell carcinomas
VHL,Rs28940298,von Hippel-Lindau disease
VHL,Rs28940298,acute mountain sickness
VHL,Rs28940298,polycythemia VHL mutation
VHL,Rs28940298,tumors
VHL,Rs28940298,thrombosis and vascular abnormalities
VHL,Rs28940298,Congenital disorder of oxygen sensing
VHL,Rs28940298,congenital Chuvash polycythemia
VHL,Rs28940298,von Hippel-Lindau disease
VHL,Rs28940298,human cancer
VHL,Rs28940298,thrombosis and vascular abnormalities
VHL,Rs28940298,von Hippel-Lindau
VHL,Rs28940298,acute mountain sickness
VHL,Rs28940298,Sherpas
VHL,Rs28940298,hypoxia
VHL,Rs28940298,fenestration of the vertebral artery
VHL,Rs28940298,on Hippel-Lindau disease
VHL,Rs28940298,Renal cell carcinomas
VHL,Rs28940298,Chuvash polycythemia
VHL,Rs28940298,Congenital disorder of oxygen sensing
VHL,Rs28940298,thrombosis
VHL,Rs28940298,vascular abnormalities
VHL,Rs28940298,tumors
VHL,Rs28940298,human cancer
VHL,Rs28940298,fenestration of the vertebral artery
VHL,Rs28940298,human cancer.
VHL,Rs28940298,human cancer
VHL,Rs28940298,thrombosis and vascular abnormalities
VHL,Rs28940298,vascular abnormalities
VHL,Rs193922608,Genetic mutation
VHL,Rs193922608,nonsyndromic pheochromocytoma
VHL,Rs193922608,paraganglioma
VHL,Rs193922613,Congenital polycythemia
VHL,Rs193922613,Von Hippel-Lindau-dependent polycythemia
VHL,Rs193922613,paraneoplastic polycythemia.
VHL,Rs28940298,acute mountain sickness
VHL,Rs28940298,tumors
VHL,Rs28940298,von Hippel-Lindau disease
VHL,Rs28940298,Renal cell carcinomas
VHL,Rs28940298,von Hippel-Lindau (VHL) tumour
VHL,Rs28940298,congenital Chuvash polycythemia
VHL,Rs28940298,fenestration of the vertebral artery
VHL,Rs28940298,Chuvash polycythemia
VHL,Rs28940298,Congenital disorder of oxygen sensing
VHL,Rs28940298,huvash polycythemia
VHL,Rs28940298,Congenital disorder of oxygen
VHL,Rs28940298,congenital Chuvash polycythemia
VHL,Rs28940298,von Hippel-Lindau (VHL) tumour
VHL,Rs28940298,thrombosis
VHL,Rs28940298,von Hippel-Lindau
VHL,Rs28940298,fenestration of the vertebral artery
VHL,Rs28940298,symptoms of acute mountain sickness
VHL,Rs28940298,human cancer
VHL,Rs28940298,tumors
VHL,Rs28940298,Renal cell carcinomas
VKORC1,Rs9934438,aortic calcification
VKORC1,Rs9934438,calcification of the aortic far wall 
VKORC1,Rs9934438,aortic calcification
VKORC1,Rs9934438,increase of calcification of the aortic
VKORC1,Rs9934438,aortic calcification
VKORC1,Rs9934438,calcification of the aortic far wall
VLDLR,Rs1454626,"BMI, and LDL-associated apolipoprotein B"
VLDLR,Rs1454626,associated with carotid artery disease
VLDLR,Rs1454626,LDL-associated apolipoprotein B
VLDLR,Rs1454626,BMI
VLDLR,Rs1454626,LDL-associated apolipoprotein B
VLDLR,Rs1454626,"BMI,"
VLDLR,Rs1454626,"carotid artery disease,"
VLDLR,Rs1454626,carotid artery disease
VPS35,Rs797044948,"inborn genetic disease"""
VPS35,Rs797044948,inborn genetic disease
VPS35,Rs146795505,pathogenic for Meier-Gorlin syndrome 3
VPS35,Rs146795505,ORC6 gene
VPS35,Rs797044948,autosomal dominant
VPS35,Rs146795505,recessively inherited
VPS35,Rs146795505,Meier-Gorlin syndrome 3
VPS35,Rs146795505,recessively inherited
VPS35,Rs146795505,Meier-Gorlin syndrome 3
VPS35,Rs146795505,Meier-Gorlin syndrome 3
VPS53,Rs587777466,leading to Pontocerebellar hypoplasia
VPS53,Rs587777465,type 2E
VPS53,Rs587777466,Pontocerebellar hypoplasia
VPS53,Rs587777465,VPS53 mutation
VPS53,Rs587777465,Pontocerebellar hypoplasia
VWF,Rs121964895,VWFdb
VWF,Rs1800386,Von Willebrand disease
VWF,Rs121964895,23andMe
VWF,Rs121964895,i5049161
VWF,Rs121964895,i3002797 
VWF,Rs121964895,SNP 
VWF,Rs1800386,Caucasians
VWF,Rs121964895,ClinVar 
VWF,I5049344,Von Willebrand disease
VWF,Rs121964895,R1205H
VWF,Rs121964895,Arg1205His
VWF,Rs121964895,Vicenza
VWF,Rs121964895,rs121964895
VWF,Rs121964895,Von Willebrand disease
VWF,Rs121964894,"Von Willebrand disease, type 2N"
VWF,Rs1800386,blood group type O
VWF,I5049344, Willebrand disease
VWF,Rs121964895,rs121964895
VWF,Rs1800386,"Von Willebrand disease, type 1"
VWF,Rs2363337,Von Willebrand
VWF,Rs1800386,not (fully) causative and has quite variable expressivity and penetrance
VWF,Rs33978901,Von Willebrand disease
VWF,Rs267607326,VWFdb
VWF,Rs267607326,ClinVar 
VWF,Rs267607326,rs267607326
VWF,Rs267607326,chromosome 
VWF,Rs267607326,VWF 
VWF,Rs267607326,SNP 
VWF,Rs267607326,Y1146C
VWF,Rs1800386,most common VWF mutations in Caucasians
VWF,Rs267607326,Tyr1146Cys 
VWF,Rs267607326,rs267607326
VWF,Rs267607326,"Von Willebrand disease, type 2A"
VWF,I5049338,Willebrand disease
VWF,Rs2363337,"Von Willebrand disease, type 1"
VWF,Rs2363337,rs2363337(T) allele
VWF,Rs2363337,chromosome 12
VWF,Rs2363337,VWF gene
VWF,Rs1800386,associations with blood group type O
VWF,Rs267607326,3437A
VWF,I5049327,Von Willebrand disease
VWF,Rs121964895,3614G
VWF,I5049289,Willebrand disease
VWF,I5049145,Willebrand disease
VWF,I5049144,rs41276738
VWF,I5049144,Von Willebrand disease
VWF,I5049144,Von Willebrand disease
VWF,I5049117,Willebrand disease
VWF,I5049115,disease
VWF,I5049104,Willebrand disease
VWF,I5049076,Willebrand disease
VWF,I5049076,Von Willebrand disease
VWF,I5049057,Willebrand disease
VWF,I5049057,Willebrand disease
VWF,I5049057,Willebrand
VWF,I5039483,Willebrand disease
VWF,I5039448,Von Willebrand disease
VWF,I5049314,Willebrand disease
VWF,I3002797,Willebrand disease
VWF,I3002797,Von Willebrand disease
VWF,I5049145,Von Willebrand disease
VWF,I5049157,Willebrand disease
VWF,I5004518,disease
VWF,I5049157,Von Willebrand disease
VWF,I5049282,Willebrand disease
VWF,I5049282,Von Willebrand disease
VWF,I5049282,Willebrand disease
VWF,I5049266,Von Willebrand disease
VWF,I5049157,Von Willebrand disease
VWF,I5049228,Von Willebrand disease
VWF,I5049208,Von Willebrand disease
VWF,I5049208,Von Willebrand disease
VWF,I5049192,Von Willebrand disease
VWF,I5049266,Von Willebrand disease
VWF,I5049192,Von Willebrand disease
VWF,I5049192,Willebrand disease
VWF,I5049192,Von Willebrand disease
VWF,I5049172,rs61750581Von 
VWF,I5049165,Willebrand
VWF,I5049165,Von Willebrand disease
VWF,I5049161,Willebrand disease
VWF,I5049161,Von Willebrand disease
VWF,I5049192,Von Willebrand disease
WDR66,Rs7961894,cerebral infarction
WDR66,Rs7961894,postevent morbidity
WFS1,Rs4458523,allele
WFS1,Rs4458523,II 
WFS1,Rs4458523,susceptibility 
WFS1,Rs4458523,disequilibrium 
WFS1,Rs4458523,polymorphism 
WFS1,Rs4458523,Type 
WFS1,Rs4458523,Diabetes 
WFS1,Rs28937895,deafness
WFS1,Rs28937895,deafness
WFS1,Rs28937894,deafness
WFS1,Rs28937894,deafness
WFS1,Rs28937893,deafness
WFS1,Rs28937893,deafness
WFS1,Rs4458523,polymorphism that increases susceptibility to Type II Diabetes
WISP3,Rs1230345,schizophrenia
WRN,Rs1801195,polymorphisms
WRN,Rs1801195,Colorectal cancer
WRN,Rs1801195,benzene hematotoxicity
WRN,Rs1801195,scan for cleft lip and cleft palate
WRN,Rs1801195,non-Hodgkin lymphoma
WRN,Rs17847577,Werner Syndrome
WRN,Rs17847577,Caucasians
WRN,Rs113993961,Werner Syndrome
WRN,Rs113993961,change in a splice donor sequence
WRN,Rs113993961,frameshift of codons
WRN,Rs17847577,non-Japanese populations
WT1,Rs28941779,Denys-Drash syndrome
WT1,Rs28941779,Frasier syndrome
WT1,Rs28941779,Denys-Drash syndrome
WT1,Rs28941779,Frasier syndrome
WT1,Rs28941778,enome sequencing
WT1,Rs28941778,"nephrotic syndrome, type IV"
WT1,Rs28941778,Asp396Asn
WT1,Rs28941778,enys-Drash syndrome
WT1,Rs28941778,"nephrotic syndrome, type IV"
WT1,Rs28941778,Denys-Drash syndrome
WT1,Rs28941778,"nephrotic syndrome, type IV"
WT1,Rs28941778,Denys-Drash syndrome
WT1,Rs16754,Wilms' tumor
WT1,Rs16754,acute myeloid leukemia
WT1,Rs16754,Wilms' tumor gene
WT1,Rs28941778,WT1 gene on chromosome 11.
WWC1,Rs749318706,Tourette syndrome
WWC1,Rs749318706,Tourette syndrome
WWC1,Rs17070145,Alzheimer's disease
WWC1,Rs17070145,mild cognitive impairment
WWC1,Rs17070145,Alzheimer's disease
WWC1,Rs17070145,Alzheimer's disease
WWC1,Rs17070145,Alzheimer's disease
WWC1,Rs17070145,Alzheimer's disease
WWC1,Rs17070145,hippocampal activations during memory retrieval
WWC1,Rs17070145,gene polymorphisms
WWC1,Rs17070145,Alzheimer's disease
WWOX,Rs2548861,Low serum HDL-cholesterol
WWOX,Rs2548861,coronary artery disease
XIAP,Rs387907301,lymphoproliferative syndrome
XIAP,Rs387907301,inflammatory bowel disease
XIAP,Rs1085307106,pathogenic
XIAP,Rs1085307106,pathogenic
XPC,Rs2228001,6797 cancer cases
XPC,Rs2470353,bladder cancer
XPC,Rs2470353,XPC gene
XPC,Rs2470353,vitro functional effects
XPC,Rs2228001,primarily a risk for lung cancer
XPC,Rs2228001,"increased overall cancer risk (odds ratio of 1.16, CI: 1.05-1.28)"
XPC,Rs2228001,9018 controls
XPC,Rs2228001,meta-analysis of 16 studies
XPC,Rs2228000,cancer 
XPC,Rs2228000,cancer.
XPC,Rs2228000,bladder cancer.
XPC,Rs2228000,cancer
XPC,Rs2228000,bladder cancer
XPC,Rs2228000,cancer
XPC,Rs2228000,cancer
XPC,Rs2228001,pigmentosum
XRCC1,Rs25487, squamous cell cancer
XRCC1,Rs25487,basal cell BCC
XRCC1,Rs25487, Koreans
XRCC1,Rs25487,basal cell cance
XRCC1,Rs25487,increased childhood risk of acute lymphoblastic leukemia among Asians 
XRCC1,Rs25487,No association was found in Caucasians
XRCC1,Rs25487,myeloid or lymphocytic leukemia
XRCC1,Rs25487,Hispanics with non-small cell lung cancer
XRCC1,Rs25487,Bladder cancer
XRCC1,Rs25487, early onset lung cancer
XRCC1,Rs25487,China
XRCC1,Rs25487,Turkish population
XRCC1,Rs25487, Central-South Italian population
XRCC1,Rs25487,melanoma
XRCC1,Rs25487,Lynch syndrome
XRCC1,Rs25487, Polish population
XRCC1,Rs25487,head and neck squamous cell cancer survival
XRCC1,Rs25487,"Caucasians,"
XRCC1,Rs25487,biliary tract cancer and biliary stones
XRCC1,Rs25487,melanoma risk
XRCC1,Rs25487,glioblastoma
XRCC1,Rs25487,carcinogen metabolism
XRCC1,Rs25487,carcinogen vinyl chloride
XRCC1,Rs25487,colorectal cancer risk
XRCC1,Rs25487,breast cancer
XRCC1,Rs25487,neutropenia
XRCC1,Rs25487,bladder cancer
XRCC1,Rs25487,lung adenocarcinoma
XRCC1,Rs25487,breast cancer
XRCC1,Rs25487,Breast Cancer
XRCC1,Rs25487,cell lung cancer
XRCC1,Rs25487,cancer
XRCC1,Rs25487,metastatic gastric cancer
XRCC1,Rs25487,radiation pneumonitis
XRCC1,Rs25487,non-small cell lung cancer
XRCC1,Rs25487,larynx cancer
XRCC1,Rs25487,colorectal cancer risk
XRCC1,Rs25487,systemic lupus erythematosus
XRCC1,Rs25487,ral precancer and cancer
XRCC1,Rs25487, cancer in Lynch syndrome
XRCC1,Rs25487,head and neck squamous cell cancer survival
XRCC1,Rs25487,lung cancer
XRCC1,Rs25487,non-small cell lung cancer
XRCC1,Rs25487,breast cancer
XRCC1,Rs25487,pneumonitis 
XRCC1,Rs25489,erectile dysfunction
XRCC1,Rs25489,gastric cancer
XRCC1,Rs25489,breast cancer risk
XRCC1,Rs25489,bladder cancer risk
XRCC1,Rs25489,biliary tract cancer and biliary stones
XRCC1,Rs25489,lung cancer
XRCC1,Rs25489,lung cancer
XRCC1,Rs25489,pancreatic adenocarcinoma risk
XRCC1,Rs25489,cancer
XRCC1,Rs25489,human breast cancer risk
XRCC1,Rs25489,Lung Cancer
XRCC1,Rs25489,lung cancer
XRCC1,Rs25489,HPV16-negative head and neck squamous cell carcinoma
XRCC1,Rs25489,breast cancer
XRCC1,Rs25489,breast cancer risk
XRCC1,Rs25489,risk of radiation pneumonitis
XRCC1,Rs25489,non-small cell lung cancer
XRCC1,Rs25489,melanoma risk
XRCC1,Rs761564262,pathogenic variant
XRCC1,Rs25489,prostate cancer
XRCC1,Rs25489,ncreased risk for breast cancer
XRCC1,Rs25489,lung cancer
XRCC1,Rs25489,prostate cancer
XRCC1,Rs25487,female
XRCC1,Rs25487,lung adenocarcinoma
XRCC1,Rs25487, Breast Cancer
XRCC1,Rs25487, Maharashtrian population of central India.
XRCC1,Rs25487,non-small cell lung cancer risk.
XRCC1,Rs25487,Gallbladder cancer predisposition
XRCC1,Rs25487,breast cancer risk
XRCC1,Rs25487,bladder cancer.
XRCC1,Rs25487,bladder cancer
XRCC1,Rs25487,metastatic gastric cancer 
XRCC1,Rs25487,neutropenia in cancer patients
XRCC1,Rs25487,breast cancer
XRCC1,Rs25487,non-small cell lung cancer in women
XRCC1,Rs25487,Lung Cancer
XRCC1,Rs25487,Japanese population
XRCC1,Rs25487,North Indian women
XRCC1,Rs25487, breast cancer risk.
XRCC1,Rs25487,head and neck squamous cell carcinoma
XRCC1,Rs25487,pancreatic adenocarcinoma
XRCC1,Rs25489,breast cancer
XRCC1,Rs25487,head and neck squamous cell carcinoma
XRCC1,Rs25487,cell lung cancer
XRCC1,Rs25487,Locally Advanced Head and Neck Cancer
XRCC1,Rs25487,Lung Cancer
XRCC1,Rs25487,basal cell cancer
XRCC1,Rs25487,increased childhood risk of acute lymphoblastic leukemia
XRCC1,Rs25487,risk of either myeloid or lymphocytic leukemia
XRCC1,Rs25487,non-small cell lung cancer
XRCC1,Rs25487,Hodgkin disease
XRCC1,Rs25487,risk of gastric cancer
XRCC1,Rs25487,Bladder cancer
XRCC1,Rs25487,Risk of non-Hodgkin lymphoma (NHL)
XRCC1,Rs25487,bladder cancer risk
XRCC1,Rs25487,lung cancer risk
XRCC1,Rs25487,biliary tract cancer and biliary stones
XRCC1,Rs25487,risk of breast cancer
XRCC1,Rs25487,lung cancer
XRCC1,Rs25487,lung cancer
XRCC1,Rs25487,pancreatic adenocarcinoma risk
XRCC1,Rs25487,cancer
XRCC1,Rs25487,risk of breast cancer
XRCC1,Rs25487,human breast cancer risk
XRCC1,Rs25487,colorectal cancer
XRCC1,Rs25487,squamous cell cancer (SCC
XRCC1,Rs25487,adult glioma
XRCC1,Rs25487,risk of both basal cell BCC
XRCC1,Rs25487,modulate oral precancer and cancer risk
XRCC1,Rs25486,lung cancer
XRCC1,Rs25487,both basal cell BCC
XRCC1,Rs25487,squamous cell cancer
XRCC1,Rs25487,acute lymphoblastic leukemia
XRCC1,Rs25487,myeloid or lymphocytic leukemia
XRCC1,Rs25487,lung cancer
XRCC1,Rs25487,Hodgkin disease
XRCC1,Rs25487,Bladder cancer 
XRCC1,Rs25487,gastric cancer
XRCC1,Rs25487,Hodgkin lymphoma (NHL)
XRCC1,Rs25487,biliary tract cancer and biliary stones
XRCC1,Rs25487,pancreatic adenocarcinoma risk
XRCC1,Rs25487,non-small cell lung cancer
XRCC1,Rs25487,neck squamous cell carcinoma
XRCC1,Rs25487,glioblastoma
XRCC1,Rs25487,adult glioma
XRCC1,Rs25487,Locally Advanced Head and Neck Cancer
XRCC1,Rs25487,breast cancer risk
XRCC1,Rs25487,Gallbladder cancer 
XRCC1,Rs25487,colorectal cancer in Lynch syndrome
XRCC1,Rs25487,risk of non-small cell lung cancer in women.
XRCC1,Rs25487,neutropenia
XRCC1,Rs25487,glioblastoma
XRCC1,Rs25487,lymphocytic leukemia
XRCC1,Rs25487,cell lung cancer
XRCC1,Rs25487,Hodgkin disease
XRCC1,Rs25487,Bladder cancer predisposition
XRCC1,Rs25487,non-Hodgkin lymphoma 
XRCC1,Rs25487,NHL)
XRCC1,Rs25487, cancer cells
XRCC1,Rs25487,bladder cancer risk
XRCC1,Rs25487,lung cancer
XRCC1,Rs25487,biliary tract cancer
XRCC1,Rs25487,biliary stones
XRCC1,Rs25487,breast cancer
XRCC1,Rs25487,lung cancer
XRCC1,Rs25487,lung cancer
XRCC1,Rs25487,pancreatic adenocarcinoma risk
XRCC1,Rs25487,breast cancer
XRCC1,Rs25487,breast cancer
XRCC1,Rs25487,colorectal cancer
XRCC1,Rs25487,HPV16-negative head and neck squamous cell carcinoma
XRCC1,Rs25487,acute lymphoblastic leukemia
XRCC1,Rs25487,basal cell BCC
XRCC1,Rs25487,SCC
XRCC1,Rs25487,squamous cell cancer
XRCC1,Rs25487,breast cancer
XRCC1,Rs25487,bladder cancer risk
XRCC1,Rs25487,bladder cancer
XRCC1,Rs25487,lung adenocarcinoma
XRCC1,Rs25487,Locally Advanced Head and Neck Cancer
XRCC1,Rs25487,Breast Cancer
XRCC1,Rs25487,risk factor for pterygium
XRCC1,Rs25487,non-small cell lung cancer risk
XRCC1,Rs25487,Gallbladder cancer
XRCC1,Rs25487,basal cell cancer
XRCC1,Rs25487,metastatic gastric cancer
XRCC1,Rs25487,non-small cell lung cancer
XRCC1,Rs25487,larynx cancer
XRCC1,Rs25487,colorectal cancer risk
XRCC1,Rs25487,risk of systemic lupus erythematosus
XRCC1,Rs25487,oral precancer and cancer risk
XRCC1,Rs25487,risk of early onset colorectal cancer in Lynch syndrome
XRCC1,Rs25487,early-stage head and neck squamous cell cancer survival
XRCC1,Rs25487,lung cancer risk
XRCC1,Rs25487,melanoma risk
XRCC1,Rs25487,radiation pneumonitis
XRCC2,Rs3218536,p=0.05.rs3218536(A)
XRCC2,Rs3218536,allele carriers is homozygote
XRCC2,Rs3218536,Cypriot women
XRCC2,Rs3218536,DNA-repair gene XRCC2
XRCC2,Rs3218536,His-encoding rs3218536(A)
XRCC2,Rs3218536,rare SNP
XRCC2,Rs3218536,rs3218536
XRCC2,Rs3218536,epithelial ovarian cancer
XRCC2,Rs3218536,Arg188His
ZBTB40,Rs7524102,Han Chinese women
ZBTB40,Rs7524102,osteoporosis
ZBTB40,Rs7524102,gothenburg osteoporosis
ZBTB40,Rs7524102,obesity
ZBTB40,Rs7524102,osteoporosis
ZBTB40,Rs7524102,Osteoporotic fractures
ZBTB40,Rs7524102,Bone mineral density variations
ZBTB40,Rs7524102,osteoporosis
ZBTB40,Rs7524102,osteoporosis
ZBTB40,Rs7524102,obesity
ZBTB40,Rs7524102,osteoporosis
ZBTB40,Rs7524102,Osteoporotic fractures
ZBTB40,Rs7524102,Bone mineral density variations
ZBTB40,Rs7524102,osteoporosis susceptibility
ZBTB40,Rs7524102,obesity determinants
ZBTB40,Rs7524102,gothenburg osteoporosis
ZBTB40,Rs7524102,cortical bone mineral density
ZBTB40,Rs7524102,osteoporosis
ZBTB40,Rs7524102,growth
ZBTB40,Rs7524102,bone mineral density
ZBTB40,Rs7524102,Osteoporotic fractures
ZBTB40,Rs7524102,Bone mineral density variations
ZFHX2,Rs1555344723,Marsili syndrome
ZFHX2,Rs1555344723,dominant
ZFHX2,Rs1555344723,autosomal
ZFHX2,Rs1555344723,inherited
ZFHX2,Rs1555344723,Italian family 
ZFHX2,Rs1555344723,pain
ZFHX2,Rs1555344723,inherited
ZFHX2,Rs1555344723,insensitivity
ZFPM1,Rs55637647,risk allele G
ZFPM1,Rs55637647,disease
ZFPM1,Rs55637647, testicular cancer
ZFPM1,Rs55637647,polygenic risk 
ZNF365,Rs7089814,breast size
ZNF365,Rs2944542,atopic dermatitis
ZNF365,Rs2944542,Multi-ancestry genome-wide
ZNF365,Rs10995190,associated with slightly lower odds
ZNF365,Rs10995190,2% decrease in mammographic density
ZNF365,Rs10995190,breast cancer
ZNF80,Rs3732782,Tardive dyskinesia
ZNF80,Rs7620754,Tardive dyskinesia
ZNF80,Rs905568,Tardive dyskinesia
ZNF804A,Rs7597593,schizophrenia.
ZNRF3,Rs2269577,Vitiligo
ZNRF3,Rs16986825,Pancreatic cancer
ZNRF3,Rs16986825,pancreatic cancer
ZNRF3,Rs16986825,Pancreatic cancer
ZSWIM6,Rs587777695,mutation in the ZSWIM6 gene on chromosome 5
